Citrus Sinensis ID: 029037

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200
Protein Sequence
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW
Secondary Structure (PSIPRED)
cccEEEEEEEccccEEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEcccccccccccccccccccccccccHHHcccccccccccHHHHHHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEEcccccHEEEEEEEcccccEEEEEEEccHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEEEcccccccccccccccccccccccccHHHHccccccccccHHHHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINhrslrhpniirfkevvltpTHLAIVMEYAAGGELFDRIcnagrfsedeGRYFFQQLISGvnychsmqICHRDLKLentlldgsaaprlkicdfgyskssvlhsrpkstvgtpayiapevlsrreyDGKVCILLLILFLWrnyrpnpfiw
Flexible Loop (DISEMBL)
mekyelvkdlgagnfgvarllrhketkelvavkyiergrkidenVAREIinhrslrhpniirFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSsvlhsrpkstvgtpayiapevlsrreydGKVCILLLILflwrnyrpnpfiw
Low Complexity Region (SEG)
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW
Disordered region (IsUnstruct)
*****LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH****STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF**
Disordered Region (DISOPRED)
*EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW
Disordered Region (DISEMBL)
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW
Disordered Region (DISPRO)
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	200	2.2.26 [Sep-21-2011]
Q9FFP9	360	Serine/threonine-protein	yes	no	0.895	0.497	0.921	7e-95
P43292	353	Serine/threonine-protein	no	no	0.895	0.507	0.905	2e-94
P43291	363	Serine/threonine-protein	no	no	0.905	0.498	0.895	3e-94
Q7XQP4	359	Serine/threonine-protein	yes	no	0.905	0.504	0.900	4e-94
Q6ZI44	365	Serine/threonine-protein	no	no	0.9	0.493	0.9	1e-93
Q9C958	361	Serine/threonine-protein	no	no	0.905	0.501	0.883	4e-92
Q940H6	362	Serine/threonine-protein	no	no	0.9	0.497	0.855	3e-91
A2YNT8	339	Serine/threonine-protein	N/A	no	0.905	0.533	0.856	5e-91
Q0D4J7	339	Serine/threonine-protein	no	no	0.905	0.533	0.850	1e-90
Q39193	361	Serine/threonine-protein	no	no	0.895	0.495	0.854	1e-90

>sp|Q9FFP9|SRK2H_ARATH Serine/threonine-protein kinase SRK2H OS=Arabidopsis thaliana GN=SRK2H PE=1 SV=1

 Score =  346 bits (887), Expect = 7e-95,   Method: Compositional matrix adjust.
 Identities = 165/179 (92%), Positives = 174/179 (97%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHKETKELVA+KYIERGRKIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSE E RYFFQQLI GV+YCHS+QIC
Sbjct: 61  IRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGS AP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct: 121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43292|SRK2G_ARATH Serine/threonine-protein kinase SRK2G OS=Arabidopsis thaliana GN=SRK2G PE=1 SV=2

 Score =  344 bits (883), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 162/179 (90%), Positives = 173/179 (96%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KY++VKDLGAGNFGVARLLRHK+TKELVA+KYIERGRKIDENVAREIINHRSL+HPNI
Sbjct: 1   MDKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEV+LTPTHLAIVMEYA+GGELFDRIC AGRFSE E RYFFQQLI GV+YCHS+QIC
Sbjct: 61  IRFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGS AP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct: 121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGK 179

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1

 Score =  344 bits (882), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 162/181 (89%), Positives = 174/181 (96%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYELVKD+GAGNFGVARL++ K +KELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAI MEYAAGGELF+RIC+AGRFSEDE RYFFQQLISGV+YCH+MQIC
Sbjct: 61  IRFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 C 181
            
Sbjct: 181 A 181

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2

 Score =  343 bits (881), Expect = 4e-94,   Method: Compositional matrix adjust.
 Identities = 163/181 (90%), Positives = 173/181 (95%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           ME+YEL+KD+GAGNFGVARL+R+KETKELVA+KYI RG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVV+TPTHLAIVMEYAAGGELFDRICNAGRFSEDE RYFFQQLI GV+YCH MQIC
Sbjct: 61  IRFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKT 180

Query: 181 C 181
            
Sbjct: 181 A 181

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6ZI44|SAPK6_ORYSJ Serine/threonine-protein kinase SAPK6 OS=Oryza sativa subsp. japonica GN=SAPK6 PE=2 SV=1

 Score =  342 bits (876), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 162/180 (90%), Positives = 174/180 (96%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYEL+KD+G+GNFGVARL+R++ETKELVA+KYI RG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MEKYELLKDIGSGNFGVARLMRNRETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELFDRIC+AGRFSEDE RYFFQQLI GV+YCH MQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICSAGRFSEDESRYFFQQLICGVSYCHFMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKM 180

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C958|SRK2B_ARATH Serine/threonine-protein kinase SRK2B OS=Arabidopsis thaliana GN=SRK2B PE=1 SV=1

 Score =  337 bits (864), Expect = 4e-92,   Method: Compositional matrix adjust.
 Identities = 160/181 (88%), Positives = 172/181 (95%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYELVKD+GAGNFGVARL+R K +KELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTH+AI MEYAAGGELF+RIC+AGRFSEDE RYFFQQLISGV+YCH+MQIC
Sbjct: 61  IRFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVLSR EYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKM 180

Query: 181 C 181
            
Sbjct: 181 A 181

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1

 Score =  334 bits (856), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 154/180 (85%), Positives = 172/180 (95%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL ++EYDGKV 
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198

Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2

 Score =  333 bits (854), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 155/181 (85%), Positives = 173/181 (95%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           ME+YE++KD+G+GNFGVA+L+R   TKEL AVK+IERG+KIDENV REI+NHRSLRHPNI
Sbjct: 1   MERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +RFKEVVLTPTHLAIVMEYAAGGELF+RIC+AGRFSEDE R+FFQQLISGV+YCHSMQIC
Sbjct: 61  VRFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL+R+EYDGKV
Sbjct: 121 HRDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKV 180

Query: 181 C 181
            
Sbjct: 181 A 181

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1

 Score =  332 bits (851), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 154/181 (85%), Positives = 173/181 (95%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           ME+YE++KD+G+GNFGVA+L+R   TKEL AVK+IERG+KIDENV REI+NHRSLRHPNI
Sbjct: 1   MERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +RFKEVVLTPTHLAIVMEYAAGGELF+RIC+AGRFSEDE R+FFQQLISGV+YCHSMQIC
Sbjct: 61  VRFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL+R+EYDGKV
Sbjct: 121 HRDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKV 180

Query: 181 C 181
            
Sbjct: 181 A 181

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1

 Score =  332 bits (851), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 153/179 (85%), Positives = 171/179 (95%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++Y+ VKD+G+GNFGVARL+R K TKELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAI+MEYA+GGEL++RICNAGRFSEDE R+FFQQL+SGV+YCHSMQICH
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL R+EYDGK+
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198

Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	200
449480851	355	PREDICTED: LOW QUALITY PROTEIN: serine/t	0.905	0.509	0.950	3e-97
449457283	355	PREDICTED: serine/threonine-protein kina	0.905	0.509	0.950	3e-97
449480931	337	PREDICTED: serine/threonine-protein kina	0.905	0.537	0.939	1e-96
224144496	204	predicted protein [Populus trichocarpa]	0.9	0.882	0.955	2e-96
449453216	355	PREDICTED: serine/threonine-protein kina	0.905	0.509	0.939	3e-96
225448215	356	PREDICTED: serine/threonine-protein kina	0.905	0.508	0.928	3e-95
147864363	357	hypothetical protein VITISV_028464 [Viti	0.905	0.507	0.928	3e-95
217071958	182	unknown [Medicago truncatula]	0.9	0.989	0.938	3e-95
38228677	359	serine/threonine-protein kinase [Fagus s	0.905	0.504	0.933	3e-95
404435149	360	sucrose non-fermenting 1-related protein	0.905	0.502	0.922	3e-95

>gi|449480851|ref|XP_004156012.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase SRK2H-like [Cucumis sativus]

 Score =  360 bits (923), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 172/181 (95%), Positives = 178/181 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHKETKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGVNYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVNYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGSAAPRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 C 181
            
Sbjct: 181 A 181

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449457283|ref|XP_004146378.1| PREDICTED: serine/threonine-protein kinase SRK2H-like [Cucumis sativus]

 Score =  359 bits (922), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 172/181 (95%), Positives = 178/181 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHKETKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGVNYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVNYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGSAAPRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 C 181
            
Sbjct: 181 A 181

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449480931|ref|XP_004156033.1| PREDICTED: serine/threonine-protein kinase SRK2H-like [Cucumis sativus]

 Score =  357 bits (916), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 170/181 (93%), Positives = 177/181 (97%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHK+TKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGVNYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVNYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSTAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 C 181
            
Sbjct: 181 A 181

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224144496|ref|XP_002325309.1| predicted protein [Populus trichocarpa] gi|222862184|gb|EEE99690.1| predicted protein [Populus trichocarpa]

 Score =  357 bits (915), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/180 (95%), Positives = 177/180 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYELVKDLGAGNFGVARLLRHKETKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGVNYCH+MQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVNYCHNMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449453216|ref|XP_004144354.1| PREDICTED: serine/threonine-protein kinase SRK2A-like [Cucumis sativus]

 Score =  356 bits (913), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 170/181 (93%), Positives = 177/181 (97%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHK+TKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGVNYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVNYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSTAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 C 181
            
Sbjct: 181 A 181

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225448215|ref|XP_002269221.1| PREDICTED: serine/threonine-protein kinase SRK2B isoform 1 [Vitis vinifera]

 Score =  353 bits (905), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 168/181 (92%), Positives = 178/181 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYELVKD+G+GNFGVARL+R+KETKELVA+KYIERG+KIDENVAREIINHRSLRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGV+YCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 C 181
            
Sbjct: 181 A 181

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147864363|emb|CAN78793.1| hypothetical protein VITISV_028464 [Vitis vinifera]

 Score =  353 bits (905), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 168/181 (92%), Positives = 178/181 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYELVKD+G+GNFGVARL+R+KETKELVA+KYIERG+KIDENVAREIINHRSLRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGV+YCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 C 181
            
Sbjct: 181 A 181

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|217071958|gb|ACJ84339.1| unknown [Medicago truncatula]

 Score =  353 bits (905), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 169/180 (93%), Positives = 178/180 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYELVKDLGAGNFGVARLLR+KETKELVA+KYIERG+KIDENVAREIINHRSLRHPNI
Sbjct: 2   MDKYELVKDLGAGNFGVARLLRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGV+YCH+MQIC
Sbjct: 62  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVHYCHAMQIC 121

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDG+V
Sbjct: 122 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGEV 181

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38228677|emb|CAE54075.1| serine/threonine-protein kinase [Fagus sylvatica]

 Score =  353 bits (905), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 169/181 (93%), Positives = 176/181 (97%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHKETKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RIC AG+FSEDE RYFFQQLISGVNYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICTAGKFSEDEARYFFQQLISGVNYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 C 181
            
Sbjct: 181 A 181

Source: Fagus sylvatica

Species: Fagus sylvatica

Genus: Fagus

Family: Fagaceae

Order: Fagales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|404435149|gb|AFR68941.1| sucrose non-fermenting 1-related protein kinase 2 family member [Solanum tuberosum]

 Score =  353 bits (905), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 167/181 (92%), Positives = 178/181 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYELVKD+G+GNFGVARL+R+KETKELVA+KYIERG KIDENVAREIINH+SLRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGHKIDENVAREIINHKSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGV+YCH+MQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVHYCHNMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLKLENTLLDGSAAPRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 C 181
            
Sbjct: 181 A 181

Source: Solanum tuberosum

Species: Solanum tuberosum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	200
TAIR|locus:2160559	360	SNRK2.5 "SNF1-related protein	0.895	0.497	0.921	2.9e-87
TAIR|locus:2159597	353	SNRK2.1 "SNF1-related protein	0.895	0.507	0.905	2.6e-86
TAIR|locus:2206046	361	SNRK2.10 "SNF1-related protein	0.9	0.498	0.888	2.1e-84
TAIR|locus:2118929	362	OST1 "OPEN STOMATA 1" [Arabido	0.895	0.494	0.860	1.5e-83
TAIR|locus:2174999	361	SNRK2.3 "sucrose nonfermenting	0.895	0.495	0.854	6.4e-83
TAIR|locus:2032075	343	SNRK2-8 "SNF1-RELATED PROTEIN	0.9	0.524	0.822	2.6e-79
TAIR|locus:2140104	350	SNRK2.7 "SNF1-related protein	0.9	0.514	0.805	1.1e-78
TAIR|locus:2045319	339	SNRK2.9 "SNF1-related protein	0.895	0.528	0.832	2.3e-78
ZFIN|ZDB-GENE-030325-1	573	prkaa1 "protein kinase, AMP-ac	0.865	0.301	0.469	3.7e-36
TAIR|locus:2059279	451	CIPK3 "CBL-interacting protein	0.85	0.376	0.449	5.7e-36

TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)]

 Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
 Identities = 165/179 (92%), Positives = 174/179 (97%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             M+KYE+VKDLGAGNFGVARLLRHKETKELVA+KYIERGRKIDENVAREIINHRSLRHPNI
Sbjct:     1 MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             IRFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSE E RYFFQQLI GV+YCHS+QIC
Sbjct:    61 IRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             HRDLKLENTLLDGS AP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct:   121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
 Identities = 162/179 (90%), Positives = 173/179 (96%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             M+KY++VKDLGAGNFGVARLLRHK+TKELVA+KYIERGRKIDENVAREIINHRSL+HPNI
Sbjct:     1 MDKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             IRFKEV+LTPTHLAIVMEYA+GGELFDRIC AGRFSE E RYFFQQLI GV+YCHS+QIC
Sbjct:    61 IRFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             HRDLKLENTLLDGS AP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct:   121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGK 179

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)]

 Score = 845 (302.5 bits), Expect = 2.1e-84, P = 2.1e-84
 Identities = 160/180 (88%), Positives = 172/180 (95%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             M+KYELVKD+GAGNFGVARL+R K +KELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct:     1 MDKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             IRFKEVVLTPTH+AI MEYAAGGELF+RIC+AGRFSEDE RYFFQQLISGV+YCH+MQIC
Sbjct:    61 IRFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
             HRDLKLENTLLDGS APRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVLSR EYDGK+
Sbjct:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKM 180

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA;RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0048527 "lateral root development" evidence=IMP

GO:0070300 "phosphatidic acid binding" evidence=IDA

TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
 Identities = 154/179 (86%), Positives = 172/179 (96%)

Query:     2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
             ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct:    19 DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78

Query:    62 RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct:    79 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138

Query:   122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
             RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL ++EYDGKV
Sbjct:   139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=IGI;IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IDA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0009931 "calcium-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:2000377 "regulation of reactive oxygen species metabolic process" evidence=IMP

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010118 "stomatal movement" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005985 "sucrose metabolic process" evidence=IMP

GO:0006636 "unsaturated fatty acid biosynthetic process" evidence=IMP

GO:0019432 "triglyceride biosynthetic process" evidence=IMP

GO:0040007 "growth" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0042744 "hydrogen peroxide catabolic process" evidence=RCA

TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
 Identities = 153/179 (85%), Positives = 171/179 (95%)

Query:     2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
             ++Y+ VKD+G+GNFGVARL+R K TKELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct:    20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79

Query:    62 RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             RFKEV+LTPTHLAI+MEYA+GGEL++RICNAGRFSEDE R+FFQQL+SGV+YCHSMQICH
Sbjct:    80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query:   122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
             RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL R+EYDGK+
Sbjct:   140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IGI

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0009739 "response to gibberellin stimulus" evidence=IGI

GO:0010029 "regulation of seed germination" evidence=IGI;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009414 "response to water deprivation" evidence=IGI

TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)]

 Score = 797 (285.6 bits), Expect = 2.6e-79, P = 2.6e-79
 Identities = 148/180 (82%), Positives = 169/180 (93%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             ME+YE+VKD+G+GNFGVA+L+R K +KEL AVK+IERG+KIDE+V REI+NHRSL HPNI
Sbjct:     1 MERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             IRFKEV+LT THLA+VMEYAAGGELF RIC+AGRFSEDE R+FFQQLISGVNYCHS+QIC
Sbjct:    61 IRFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
             HRDLKLENTLLDGS APR+KICDFGYSKS VLHS+PK+TVGTPAYIAPEVLS +EYDGK+
Sbjct:   121 HRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKI 180

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0080167 "response to karrikin" evidence=IEP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IGI

TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)]

 Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
 Identities = 145/180 (80%), Positives = 167/180 (92%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             ME+Y++++DLG+GNFGVA+L+R K   E  AVKYIERG KIDE+V REIINHR L+HPNI
Sbjct:     1 MERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             IRFKEV +TPTHLAIVMEYAAGGELF+RICNAGRFSEDEGRY+F+QLISGV+YCH+MQIC
Sbjct:    61 IRFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
             HRDLKLENTLLDGS +  LKICDFGYSKSSVLHS+PKSTVGTPAY+APEVLSR+EY+GK+
Sbjct:   121 HRDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKI 180

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)]

 Score = 788 (282.4 bits), Expect = 2.3e-78, P = 2.3e-78
 Identities = 149/179 (83%), Positives = 163/179 (91%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             MEKYE+VKDLG GNFG+ARL+R+K+T ELVAVK+I+RG KIDENVAREIINHR+L HPNI
Sbjct:     1 MEKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             +RFKEVVLTPTHL IVMEYAAGGELF+RI + GRFSE E RYFFQQLI GV+Y H++QIC
Sbjct:    61 VRFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             HRDLKLENTLLDGS APRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV  R EYDGK
Sbjct:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGK 179

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=IGI

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

ZFIN|ZDB-GENE-030325-1 prkaa1 "protein kinase, AMP-activated, alpha 1 catalytic subunit" [Danio rerio (taxid:7955)]

 Score = 376 (137.4 bits), Expect = 3.7e-36, Sum P(2) = 3.7e-36
 Identities = 84/179 (46%), Positives = 108/179 (60%)

Query:     4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDE--NVAREIINHRSLRHPN 59
             Y L   LG G FG  ++ +H+ TK  VAVK + R   R +D    + REI N +  RHP+
Sbjct:    17 YILGDTLGVGTFGKVKVGQHELTKHQVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 76

Query:    60 IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
             II+  +V+ TPT + +VMEY +GGELFD IC  G+  E E R  FQQ+ISGV+YCH   +
Sbjct:    77 IIKLYQVISTPTDIFMVMEYVSGGELFDYICKNGKLDEKESRRLFQQIISGVDYCHRHMV 136

Query:   120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
              HRDLK EN LLD  A    KI DFG S         +++ G+P Y APEV+S R Y G
Sbjct:   137 VHRDLKPENVLLD--AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 193

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 388 (141.6 bits), Expect = 5.7e-36, P = 5.7e-36
 Identities = 84/187 (44%), Positives = 116/187 (62%)

Query:     3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHP 58
             KYE+ + +G G F   +  R+ ET E VA+K +++ +    K+ E + REI   + ++HP
Sbjct:    23 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKLIKHP 82

Query:    59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
             N+++  EV+ + T + I++EY  GGELFD+I N GR  EDE R +FQQLI  V+YCHS  
Sbjct:    83 NVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRG 142

Query:   119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-------VLHSRPKSTVGTPAYIAPEVL 171
             + HRDLK EN LLD      LKI DFG S  S       +LH+    + GTP Y+APEVL
Sbjct:   143 VYHRDLKPENLLLDSYG--NLKISDFGLSALSQQVRDDGLLHT----SCGTPNYVAPEVL 196

Query:   172 SRREYDG 178
             + R YDG
Sbjct:   197 NDRGYDG 203

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=IEP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FFP9	SRK2H_ARATH	2, ., 7, ., 1, 1, ., 1	0.9217	0.895	0.4972	yes	no
Q7XQP4	SAPK7_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.9005	0.905	0.5041	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	grail3.0141004801	hypothetical protein (204 aa)
		(Populus trichocarpa)
Predicted Functional Partners:
	eugene3.00020801	hypothetical protein (277 aa)			•						0.432
	gw1.57.100.1	hypothetical protein (187 aa)			•						0.420
	gw1.X.6334.1	hypothetical protein (321 aa)			•						0.406

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	200
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-70
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-61
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-53
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-51
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-40
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-39
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-38
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-37
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-35
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-34
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-34
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-33
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-33
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-32
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-32
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-31
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-31
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-31
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-31
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-31
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-31
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-30
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-30
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-30
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-30
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-29
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-29
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-29
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-28
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-28
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-28
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-28
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-27
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-27
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-27
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-26
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-26
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-26
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-26
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-26
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-26
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-26
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-25
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-25
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-25
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-25
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-24
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-24
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-24
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-24
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-24
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-24
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-24
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-24
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-23
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-23
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-23
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-23
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-23
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-23
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-23
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-22
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-22
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-21
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-21
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-21
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-21
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-21
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-21
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-21
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-21
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-21
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-21
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-21
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-20
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-20
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-20
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-20
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-20
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-19
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-19
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-19
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-19
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-18
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-17
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-17
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-17
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-16
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-16
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-15
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-14
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-14
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-14
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-14
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-14
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-13
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-13
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-13
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-10
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	6e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-08
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-06
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-06
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-05
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-04
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.002
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.002
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	0.003
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.003
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.003
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  214 bits (547), Expect = 2e-70
 Identities = 79/188 (42%), Positives = 111/188 (59%), Gaps = 10/188 (5%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           YE+++ LG G+FG   L R K+T +LVA+K I  ++ +K  E + REI   + L+HPNI+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           R  +V      L +VMEY  GG+LFD +   GR SEDE R++ +Q++S + Y HS  I H
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV- 180
           RDLK EN LLD      +K+ DFG ++      +  + VGTP Y+APEVL  + Y   V 
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 181 -----CIL 183
                 IL
Sbjct: 179 IWSLGVIL 186

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  192 bits (489), Expect = 1e-61
 Identities = 78/180 (43%), Positives = 102/180 (56%), Gaps = 6/180 (3%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRHPNI 60
           YEL++ LG+G+FG     +HK T ++VAVK +       K D+   REI   R L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +R  +      HL +VMEY  GG+LFD +   G  SEDE +    Q++ G+ Y HS  I 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGK 179
           HRDLK EN LLD +    +KI DFG +K  +  S   +T VGTP Y+APEVL      G 
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  168 bits (428), Expect = 6e-53
 Identities = 77/174 (44%), Positives = 99/174 (56%), Gaps = 5/174 (2%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNIIRFKEVV 67
           LG G FG   L R K+T + VA+K I  E    + E + REI   + L HPNI++   V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 68  LTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKL 126
               HL +VMEY  GG L D +  N G+ SEDE      Q++ G+ Y HS  I HRDLK 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 127 ENTLLDGSAAPRLKICDFGYSK-SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           EN LLD S   ++K+ DFG SK  +   S  K+ VGTPAY+APEVL  + Y  +
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  164 bits (418), Expect = 6e-51
 Identities = 70/197 (35%), Positives = 104/197 (52%), Gaps = 20/197 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRHPN 59
           KYE++K +G G+FG   L+R K   +L  +K I       K  E+   E+   + L HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCH 115
           II++ E       L IVMEYA GG+L  +I    +    F E++   +F QL   + Y H
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLS 172
           S +I HRD+K +N  L   +   +K+ DFG SK   S+V  +  K+ VGTP Y++PE+  
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176

Query: 173 RREYDGKV------CIL 183
            + Y+ K       C+L
Sbjct: 177 NKPYNYKSDIWSLGCVL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (362), Expect = 1e-42
 Identities = 64/183 (34%), Positives = 93/183 (50%), Gaps = 10/183 (5%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPN 59
           ++   + LG G+FG   L   K+T EL+AVK +E     +E +    REI    SL+HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 60  IIRFK--EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           I+R+   E       L I +EY +GG L   +   G+  E   R + +Q++ G+ Y HS 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRD+K  N L+D      +K+ DFG +K            S  GTP ++APEV+   
Sbjct: 121 GIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 175 EYD 177
           EY 
Sbjct: 179 EYG 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  137 bits (348), Expect = 2e-40
 Identities = 64/184 (34%), Positives = 99/184 (53%), Gaps = 8/184 (4%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNII 61
            +E+++ +G G FG     RHK T + VA+K I    ++  E +  EI   +  +HPNI+
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++    L    L IVME+ +GG L D + +  +  +E +  Y  ++L+ G+ Y HS  I 
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120

Query: 121 HRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRD+K  N LL  DG     +K+ DFG S          + VGTP ++APEV++ + YD 
Sbjct: 121 HRDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176

Query: 179 KVCI 182
           K  I
Sbjct: 177 KADI 180

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  134 bits (341), Expect = 2e-39
 Identities = 64/173 (36%), Positives = 96/173 (55%), Gaps = 7/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS----LRHPNIIRFKE 65
           LG G+FG   L+R K+T +L A+K +++ + I        +  R+    + HP I++   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
              T   L +V+EYA GGELF  +   GRFSE+  R++  +++  + Y HS+ I +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 126 LENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRREYD 177
            EN LLD      +K+ DFG +K      SR  +  GTP Y+APEVL  + Y 
Sbjct: 121 PENILLDADG--HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  134 bits (339), Expect = 1e-38
 Identities = 66/184 (35%), Positives = 105/184 (57%), Gaps = 20/184 (10%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPN 59
           +E +K LG G+FG   L+RHK + +  A+K + + + +     E+V  E    +S+RHP 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 60  IIR----FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           ++     F++     ++L +VMEY  GGELF  +  +GRF E   R++  Q++  + Y H
Sbjct: 63  LVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 116 SMQICHRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           S+ I +RDLK EN LLD  G     +KI DFG++K   +  R  +  GTP Y+APE++  
Sbjct: 119 SLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEIILS 172

Query: 174 REYD 177
           + Y 
Sbjct: 173 KGYG 176

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  131 bits (331), Expect = 1e-37
 Identities = 64/185 (34%), Positives = 104/185 (56%), Gaps = 8/185 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E Y+ ++ +G G  G       + T + VA+K +   ++  E +  EI+  +  +HPNI+
Sbjct: 19  ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIV 78

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + +  L    L +VMEY  GG L D I  N  R +E +  Y  ++++ G+ Y HS  + 
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138

Query: 121 HRDLKLENTLL--DGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG++ + +   S+  S VGTP ++APEV+ R++Y 
Sbjct: 139 HRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 178 GKVCI 182
            KV I
Sbjct: 195 PKVDI 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  126 bits (318), Expect = 1e-35
 Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 10/185 (5%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPN 59
           +Y+++  +G G  G+    + +ET E VA+K +   R    I     REI   ++ +HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQ 118
           +++  +V    +   +VMEY     L + + +  R   E + + + + L+ GV Y H+  
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVL-SRRE 175
           I HRDLK  N L+  SA   LKI DFG ++  S          V T  Y APE+L   R+
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 176 YDGKV 180
           YD  V
Sbjct: 178 YDPGV 182

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 3e-34
 Identities = 62/183 (33%), Positives = 97/183 (53%), Gaps = 8/183 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRH 57
           +  E +K +G G FG   L+R + ++   A+K +     I     ++V  E    + + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P IIR          L ++MEY  GGELF  + N+GRFS   G ++  +++  + Y HS 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +I +RDLK EN LLD      +K+ DFG++K   L  R  +  GTP Y+APEV+  + ++
Sbjct: 121 EIVYRDLKPENILLDKEG--HIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGHN 176

Query: 178 GKV 180
             V
Sbjct: 177 KAV 179

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  121 bits (304), Expect = 5e-34
 Identities = 74/202 (36%), Positives = 105/202 (51%), Gaps = 12/202 (5%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIIN-HRSLRHPN 59
           KYE ++ +G G FG+  L R K  ++LV +K I  E+  K +   A+      + L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSM 117
           II + E  L    L IVMEYA GG L + I         ED   +FF Q++  +++ H+ 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I HRDLK +N LLD      +KI DFG SK     S+  + VGTP YI+PE+   + Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 178 GKV------CILLLILFLWRNY 193
            K       C+L  +  L R +
Sbjct: 180 QKSDIWALGCVLYELASLKRAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  120 bits (304), Expect = 1e-33
 Identities = 66/193 (34%), Positives = 99/193 (51%), Gaps = 17/193 (8%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHPN 59
           YE ++ LG G +GV    R K+T E+VA+K I R    +E +     REI   + L+HPN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I++  +V+ T   L +V EY    +L   +    G  S +  +    QL+ G+ YCHS +
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL-SRREY 176
           I HRDLK +N L++      LK+ DFG +++  +  R  +  V T  Y APE+L   + Y
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHY 176

Query: 177 DGKV------CIL 183
              V      CI 
Sbjct: 177 STAVDIWSVGCIF 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  119 bits (301), Expect = 2e-33
 Identities = 61/195 (31%), Positives = 97/195 (49%), Gaps = 23/195 (11%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHP 58
            YE+++ +G G+FG  R +R K   +++  K I+ G  + E   +++++     R L+HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHP 59

Query: 59  NIIRF--KEVVLTPTHLAIVMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVN 112
           NI+R+  + +  +   L IVMEY  GG+L   I           E+       QL+  + 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 113 YCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPA 164
            CH        + HRDLK  N  LD +    +K+ DFG +K  +L       K+ VGTP 
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDAN--NNVKLGDFGLAK--ILGHDSSFAKTYVGTPY 175

Query: 165 YIAPEVLSRREYDGK 179
           Y++PE L+   YD K
Sbjct: 176 YMSPEQLNHMSYDEK 190

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  120 bits (303), Expect = 3e-33
 Identities = 68/174 (39%), Positives = 91/174 (52%), Gaps = 7/174 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---RHPNIIRF 63
           K LG G FG   L+R K T +  A+K +++   I  + VA  +   R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           K    T   L  VMEYA GGELF  +     FSED  R++  +++S + Y HS  + +RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
           LKLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL   +Y
Sbjct: 121 LKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 3e-32
 Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 14/195 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPN 59
           ++++  +G G +G   L + K+T E+VA+K +++      N  R ++  R +    +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +++         +L + MEY  GG+    + N G  SED  R++  ++   V+  H +  
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN L+D S    +K+ DFG SK  V  +   S VG+P Y+APEVL  + YD  
Sbjct: 123 IHRDLKPENFLIDASG--HIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178

Query: 180 V------CILLLILF 188
           V      C+L   L 
Sbjct: 179 VDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 6e-32
 Identities = 63/193 (32%), Positives = 90/193 (46%), Gaps = 17/193 (8%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVA-REIINHRSLRHPNI 60
           Y+ +  +G G +GV    R K T E+VA+K I+     +     A REI   + L HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I+  +V      L +V E+      +L           E   + +  QL+ G+ +CHS  
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSR-REY 176
           I HRDLK EN L++      LK+ DFG ++S     RP +  V T  Y APE+L   + Y
Sbjct: 119 ILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 177 DGKV------CIL 183
              V      CI 
Sbjct: 177 STPVDIWSVGCIF 189

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  115 bits (290), Expect = 9e-32
 Identities = 60/181 (33%), Positives = 94/181 (51%), Gaps = 14/181 (7%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYI--ERGR-KIDENVAREIINHRSLRHPNIIRFKEV 66
           +G G FG      + +T EL+AVK I  +    K  + +A E+     L+HPN++++  V
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 67  VLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG--RYFFQQLISGVNYCHSMQICHRDL 124
            +    + I MEY +GG L + +   GR   DE   R +  QL+ G+ Y HS  I HRD+
Sbjct: 68  EVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125

Query: 125 KLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           K  N  LD +    +K+ DFG +      ++ +    +S  GTPAY+APEV++  +  G 
Sbjct: 126 KPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183

Query: 180 V 180
            
Sbjct: 184 G 184

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  116 bits (293), Expect = 1e-31
 Identities = 67/177 (37%), Positives = 93/177 (52%), Gaps = 8/177 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIRFK 64
           LG G+FG   L   K T EL AVK +++   + D++V   +   R L    +HP + +  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I  +GRF E   R++  +++ G+ + H   I +RDL
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKV 180
           KL+N LLD      +KI DFG  K  +L     ST  GTP YIAPE+LS + Y   V
Sbjct: 123 KLDNVLLDSEG--HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 1e-31
 Identities = 69/183 (37%), Positives = 95/183 (51%), Gaps = 18/183 (9%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG-RKIDENVA-REIINHRSLR----H 57
           Y+++K LG G FG   L R+KET ELVA+K +++     +E +  RE+   +SLR    H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++ KEV      L  V EY   G L+  +       FSE   R    Q++ G+ + H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVLSR 173
                HRDLK EN L+ G     +KI DFG ++   + SRP  T  V T  Y APE+L R
Sbjct: 117 KHGFFHRDLKPENLLVSGPE--VVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172

Query: 174 REY 176
              
Sbjct: 173 STS 175

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  115 bits (291), Expect = 1e-31
 Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 36/200 (18%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VARE-IINHRSLRHP 58
           ++  K +G G+F    L + KET +  A+K +++ + I E     V  E  +  R   HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 59  NIIR----FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
            II+    F++      +L  V+EYA  GEL   I   G   E   R++  +++  + Y 
Sbjct: 63  GIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---------------------SSVLH 153
           HS  I HRDLK EN LLD      +KI DFG +K                          
Sbjct: 119 HSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 154 SRPKSTVGTPAYIAPEVLSR 173
            R  S VGT  Y++PE+L+ 
Sbjct: 177 RRFASFVGTAEYVSPELLNE 196

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  116 bits (291), Expect = 2e-31
 Identities = 62/179 (34%), Positives = 93/179 (51%), Gaps = 8/179 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS-----LRHPNIIR 62
           K +G G+FG   L +HK   +  AVK +++   + +   + I+  R+     ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E   R++  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKV 180
           DLK EN LLD      L   DFG  K  + HS+  ST  GTP Y+APEVL ++ YD  V
Sbjct: 121 DLKPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  116 bits (291), Expect = 3e-31
 Identities = 67/185 (36%), Positives = 95/185 (51%), Gaps = 19/185 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHP 58
            Y +++ LG G+FG   L R ++    VA+K + +      K  E   REI    SL HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 59  -NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN---AGRFSEDEGRYFFQQLISGVNYC 114
            NI++  +       L +VMEY  GG L D +      G  SE E  +   Q++S + Y 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-------SSVLHSRPKSTVGTPAYIA 167
           HS  I HRD+K EN LLD      +K+ DFG +K       +S + + P ++VGTP Y+A
Sbjct: 118 HSKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 168 PEVLS 172
           PEVL 
Sbjct: 177 PEVLL 181

Length = 384

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 5e-31
 Identities = 68/180 (37%), Positives = 95/180 (52%), Gaps = 17/180 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
            KYE++  +G G +GV    R+K T E+VA+K   +  + DE+V     RE+   R LRH
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRH 59

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            NI+  KE       L +V EY      EL +   + G    D  R +  QL+  + YCH
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCH 117

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGTPAYIAPEVL 171
           S  I HRD+K EN L+  S    LK+CDFG++++  L +RP S     V T  Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSESGV--LKLCDFGFARA--LRARPASPLTDYVATRWYRAPELL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 5e-31
 Identities = 59/184 (32%), Positives = 93/184 (50%), Gaps = 6/184 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPN 59
           E + L++ +G G+FG       K T ++VA+K I+     D  E++ +EI      R P 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I ++    L  + L I+MEY  GG   D +   G+  E    +  ++++ G+ Y H    
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG S   +   S+  + VGTP ++APEV+ +  YD 
Sbjct: 120 IHRDIKAANILL--SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177

Query: 179 KVCI 182
           K  I
Sbjct: 178 KADI 181

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  113 bits (284), Expect = 6e-31
 Identities = 52/183 (28%), Positives = 100/183 (54%), Gaps = 10/183 (5%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLRHPN 59
           +EL++ +G G FG   +++ ++TK++ A+KY+ + + +++   R ++N R     L HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++          ++ +V++   GG+L   +    +FSE++ +++  +++  + Y HS  I
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVLSRREYD 177
            HRD+K +N LLD      + I DF    ++ +     +T   GTP Y+APEVL R+ Y 
Sbjct: 122 IHRDIKPDNILLDEQG--HVHITDFNI--ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177

Query: 178 GKV 180
             V
Sbjct: 178 VAV 180

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 7e-31
 Identities = 61/176 (34%), Positives = 90/176 (51%), Gaps = 12/176 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPN 59
            Y+L   +G G FGV     + ET + VA+K I   +  +E +    +EI   ++L+HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE-GRYFFQQLISGVNYCHSMQ 118
           I+++   + T   L I++EYA  G L   I   G F E     Y +Q L  G+ Y H   
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-QGLAYLHEQG 119

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL 171
           + HRD+K  N L   DG      K+ DFG + K + +     S VGTP ++APEV+
Sbjct: 120 VIHRDIKAANILTTKDGVV----KLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  111 bits (281), Expect = 1e-30
 Identities = 58/184 (31%), Positives = 93/184 (50%), Gaps = 7/184 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E +++++ LG G++G      HKET ++VA+K +     + + + +EI   +    P I+
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYIV 61

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++       T L IVMEY   G + D  +I N    +E+E      Q + G+ Y HS + 
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKK 120

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRREYDG 178
            HRD+K  N LL+       K+ DFG S         ++TV GTP ++APEV+    Y+ 
Sbjct: 121 IHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 179 KVCI 182
           K  I
Sbjct: 179 KADI 182

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 1e-30
 Identities = 69/195 (35%), Positives = 99/195 (50%), Gaps = 24/195 (12%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-----VAREIINHRSLR 56
           E YEL++ +G+G +G     R   T ELVA+K I    K++       + +EI   +  R
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI----KLEPGDDFEIIQQEISMLKECR 58

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCH 115
           HPNI+ +    L    L IVMEY  GG L D      G  SE +  Y  ++ + G+ Y H
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 116 SMQICHRDLKLENTLL--DGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEV 170
                HRD+K  N LL  DG     +K+ DFG S    +++  ++ KS +GTP ++APEV
Sbjct: 119 ETGKIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEV 172

Query: 171 L---SRREYDGKVCI 182
                +  YDGK  I
Sbjct: 173 AAVERKGGYDGKCDI 187

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  111 bits (279), Expect = 3e-30
 Identities = 70/205 (34%), Positives = 102/205 (49%), Gaps = 20/205 (9%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS----LRHPN 59
           Y  ++ LG G FG A L R  E   LV  K +   R + E   R+ +N       L+HPN
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCHSM 117
           II +    +    L I MEYA GG L+D+I       F E+   ++  Q++S V+Y H  
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRD+K  N  L  + A  +K+ DFG SK   S    +  ++ VGTP Y++PE+    
Sbjct: 121 GILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQGV 176

Query: 175 EYDGKV------CILLLILFLWRNY 193
           +Y+ K       C+L  +L L R +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  110 bits (277), Expect = 8e-30
 Identities = 56/180 (31%), Positives = 89/180 (49%), Gaps = 15/180 (8%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLRHPNIIRFKE 65
           +  G +G   L + K T ++ A+K I++   I +N   +++  R      + P +++   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                 +L +VMEY  GG+L   + N G   ED  R +  +++  + Y HS  I HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 126 LENTLLDGSAAPRLKICDFGYSK------SSVLHSRPKST---VGTPAYIAPEVLSRREY 176
            +N L+D +    LK+ DFG SK         L+   K     VGTP YIAPEV+  + +
Sbjct: 121 PDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  109 bits (274), Expect = 2e-29
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 6/172 (3%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS----LRHPNIIRFKE 65
           LG G FG   L++ K      A+K +++   ++      I + +       HP I++   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                 ++ ++MEY  GGEL+  + + G F E   R++   ++    Y H+  I +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 126 LENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            EN LLD +    +K+ DFG++K      +  +  GTP Y+APE++  + YD
Sbjct: 121 PENLLLDSNG--YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  108 bits (272), Expect = 3e-29
 Identities = 63/186 (33%), Positives = 104/186 (55%), Gaps = 14/186 (7%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPN 59
           KY  VK +G G+FG A L++ KE  +   +K I   +   K  E   +E+    +++HPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHS 116
           I++++E      +L IVM+Y  GG+L+ +I NA R   F ED+   +F Q+   + + H 
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSR 173
            +I HRD+K +N  L       +K+ DFG ++  VL+S     ++ +GTP Y++PE+   
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175

Query: 174 REYDGK 179
           R Y+ K
Sbjct: 176 RPYNNK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  110 bits (275), Expect = 3e-29
 Identities = 65/174 (37%), Positives = 91/174 (52%), Gaps = 7/174 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---RHPNIIRF 63
           K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS  + +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRREY 176
           +KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y
Sbjct: 121 IKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  109 bits (272), Expect = 9e-29
 Identities = 67/174 (38%), Positives = 94/174 (54%), Gaps = 7/174 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---RHPNIIRF 63
           K LG G FG   L+R K + +  A+K +++   I  + VA  +   R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           K    T   L  VMEY  GGELF  +     FSED  R++  +++S ++Y HS +I +RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVLSRREY 176
           LKLEN +LD      +KI DFG  K  +  +   K+  GTP Y+APEVL   +Y
Sbjct: 121 LKLENLMLDKDG--HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  107 bits (269), Expect = 1e-28
 Identities = 67/191 (35%), Positives = 99/191 (51%), Gaps = 21/191 (10%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE----------RGRKIDENVAREIINHRSLRHPN 59
           +G+G+FG   L  +  + EL+AVK +E          R R + + +AREI   + L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+++    L   HL I +EY  GG +   + N G F E   R F +Q++ G+NY H+  I
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--------RPKSTVGTPAYIAPEVL 171
            HRD+K  N L+D      +KI DFG SK    +S        RP S  G+  ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARP-SLQGSVFWMAPEVV 184

Query: 172 SRREYDGKVCI 182
            +  Y  K  I
Sbjct: 185 KQTSYTRKADI 195

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  107 bits (268), Expect = 1e-28
 Identities = 68/184 (36%), Positives = 93/184 (50%), Gaps = 12/184 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNI 60
           ++++K LG G++G    ++     +  A+K ++ G   +K  E+   EI    S+ HPNI
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCHS 116
           I +KE  L    L IVMEYA  G+L   I    +      E E    F QL+ G+   H 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKSTVGTPAYIAPEVLSRRE 175
            +I HRDLK  N LL   A   +KI D G SK  VL     K+ +GTP Y+APEV   R 
Sbjct: 122 QKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRP 177

Query: 176 YDGK 179
           Y  K
Sbjct: 178 YSYK 181

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  108 bits (271), Expect = 2e-28
 Identities = 61/181 (33%), Positives = 96/181 (53%), Gaps = 8/181 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPN 59
           +E+ + LG G+FG  R+ +HK T E  A+K +++      K  ++VA+E      L HP 
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+           +  ++E+  GGELF  +  AGRF  D  +++  +L+    Y HS  I
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            +RDLK EN LLD      +K+ DFG++K   +  R  +  GTP Y+APEV+  + +   
Sbjct: 140 IYRDLKPENLLLDNKG--HVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGHGKA 195

Query: 180 V 180
           V
Sbjct: 196 V 196

Length = 329

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (265), Expect = 4e-28
 Identities = 58/178 (32%), Positives = 87/178 (48%), Gaps = 10/178 (5%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPNIIR 62
           E VK LG G+ GV   +RHK T ++ A+K I      +  + + RE+   RS   P +++
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICH 121
                     ++IV+EY  GG L D +   G+  E    Y  +Q++ G++Y H+   I H
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123

Query: 122 RDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
           RD+K  N L+   G      KI DFG SK         +T VGT  Y++PE +    Y
Sbjct: 124 RDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  106 bits (267), Expect = 7e-28
 Identities = 67/181 (37%), Positives = 92/181 (50%), Gaps = 15/181 (8%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID---------ENVAREIINHRSLRHPNI 60
           LG G+FG   L  +K+T EL A+K +++G  I          E    E  N  S RHP +
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN--SERHPFL 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +       T  H+  VMEYAAGG+L   I +   FSE    ++   ++ G+ Y H  +I 
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIV 123

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGK 179
           +RDLKL+N LLD      +KI DFG  K  +      ST  GTP ++APEVL+   Y   
Sbjct: 124 YRDLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA 181

Query: 180 V 180
           V
Sbjct: 182 V 182

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  105 bits (264), Expect = 1e-27
 Identities = 66/179 (36%), Positives = 94/179 (52%), Gaps = 8/179 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSL----RHPNIIR 62
           K LG G+FG   L   K T E  A+K +++     D++V   ++  R L     HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T  HL  VMEY  GG+L   I ++GRF E   R++  ++I G+ + H   I +R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKV 180
           DLKL+N LLD      +KI DFG  K ++      ST  GTP YIAPE+L  ++Y+  V
Sbjct: 121 DLKLDNVLLDKDG--HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  105 bits (263), Expect = 2e-27
 Identities = 60/179 (33%), Positives = 87/179 (48%), Gaps = 8/179 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR-----SLRHPNIIR 62
           K +G G+FG   L + K      AVK +++   + +     I+  R     +L+HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E   R++  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKV 180
           DLK EN LLD      + + DFG  K  V      ST  GTP Y+APEVL +  YD  V
Sbjct: 121 DLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  103 bits (258), Expect = 5e-27
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 21/205 (10%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-----------VAREIINHRSLRHP 58
           +G G +G   L  +  T E++AVK +E    I              +  EI   + L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+++     T  +L+I +EY  GG +   +   GRF E   R+F +Q++ G+ Y HS  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSS---VLHSRPKSTVGTPAYIAPEV--LSR 173
           I HRDLK +N L+D       KI DFG SK S     + +  S  G+  ++APEV     
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 174 REYDGKVCILLL---ILFLWRNYRP 195
           + Y  KV I  L   +L ++   RP
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  102 bits (256), Expect = 5e-27
 Identities = 62/185 (33%), Positives = 100/185 (54%), Gaps = 13/185 (7%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPNI 60
           +Y +++ +G G+FG A L++H  + +  A+K I   +     E+  +E +    ++HPNI
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGR-FSEDEGRYFFQQLISGVNYCHSMQ 118
           + FKE      HL IVMEY  GG+L  +I    G+ F ED    +F Q+  GV + H  +
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS----TVGTPAYIAPEVLSRR 174
           + HRD+K +N  L  +   ++K+ DFG   S+ L + P +     VGTP Y+ PE+    
Sbjct: 121 VLHRDIKSKNIFLTQNG--KVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175

Query: 175 EYDGK 179
            Y+ K
Sbjct: 176 PYNNK 180

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 7e-27
 Identities = 68/202 (33%), Positives = 97/202 (48%), Gaps = 30/202 (14%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN------VAREIINHRSLRH 57
           YE +  +G G +G     R+K+T ELVA+K I   R  +E         REI   + LRH
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRH 57

Query: 58  PNIIRFKEVVLTPTHLAI--VMEYA----AGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           PNI+R KE+V +    +I  V EY      G  L D      +F+E + + + +QL+ G+
Sbjct: 58  PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGL 113

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPE 169
            Y HS  I HRD+K  N L++      LK+ DFG ++     +    T  V T  Y  PE
Sbjct: 114 QYLHSNGILHRDIKGSNILINNDG--VLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Query: 170 VL-SRREYDGKV------CILL 184
           +L     Y  +V      CIL 
Sbjct: 172 LLLGATRYGPEVDMWSVGCILA 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  103 bits (257), Expect = 1e-26
 Identities = 61/179 (34%), Positives = 91/179 (50%), Gaps = 8/179 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIR 62
           K LG G+FG   L   K T E+ A+K +++   + D++V   +   R L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T   L  VMEY  GG+L  +I  + +F E   R++  ++   + + H   + +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKV 180
           DLKL+N LLD  A    K+ DFG  K  +L+    +T  GTP YIAPE+L   EY   V
Sbjct: 121 DLKLDNILLD--AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  101 bits (254), Expect = 2e-26
 Identities = 55/184 (29%), Positives = 76/184 (41%), Gaps = 17/184 (9%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKE-TKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
            L K LG G FG     +L       K  VAVK +  +   +  E   RE    R L HP
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           N+++   V      L IVMEY  GG+L   +  N  + S  +   F  Q+  G+ Y  S 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG-----YSKSSVLHSRPKSTVGTPAYIAPEVLS 172
              HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L 
Sbjct: 122 NFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESLK 176

Query: 173 RREY 176
             ++
Sbjct: 177 EGKF 180

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  102 bits (256), Expect = 2e-26
 Identities = 66/175 (37%), Positives = 94/175 (53%), Gaps = 8/175 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---RHPNIIRF 63
           K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHR 122
           K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS   + +R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRREY 176
           DLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y
Sbjct: 121 DLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 173

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  102 bits (256), Expect = 2e-26
 Identities = 61/179 (34%), Positives = 96/179 (53%), Gaps = 8/179 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-----RHPNIIR 62
           K +G G+FG   L RHK  ++  AVK +++   + +   + I++ R++     +HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E   R++  ++ S + Y HS+ I +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKV 180
           DLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL ++ YD  V
Sbjct: 121 DLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  101 bits (253), Expect = 3e-26
 Identities = 55/185 (29%), Positives = 73/185 (39%), Gaps = 18/185 (9%)

Query: 5   ELVKDLGAGNFGV---ARLLRHK-ETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
            L K LG G FG      L       +  VAVK ++        E   RE    R L HP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI++   V      L IVMEY  GG+L  + R       S  +   F  Q+  G+ Y  S
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFG-----YSKSSVLHSRPKSTVGTPAYIAPEVL 171
               HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L
Sbjct: 122 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESL 176

Query: 172 SRREY 176
              ++
Sbjct: 177 KEGKF 181

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 3e-26
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 50/220 (22%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----- 56
           + +E++K +G G FG   L+R K+T ++ A+K +   RK D     +I + R+ R     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL---RKSDMIKRNQIAHVRAERDILAD 57

Query: 57  --HPNIIR----FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
              P I++    F++      HL +VMEY  GG+L + +     F E+  R++  +L+  
Sbjct: 58  ADSPWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--------------------- 149
           ++  H +   HRD+K +N L+D      +K+ DFG  K                      
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 150 ---------SVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
                         R  STVGTP YIAPEVL    Y  + 
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC 211

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 8e-26
 Identities = 59/187 (31%), Positives = 95/187 (50%), Gaps = 13/187 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRH--- 57
           + EL+   G G +G     +H  T  +VA+K I      D+  ++ RE+     LR    
Sbjct: 5   RLELI---GRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI ++    L    L I+MEYA GG +   +  AG  +E       ++++  + Y H +
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSR-RE 175
            + HRD+K  N L+  +    +K+CDFG +     +S  +ST VGTP ++APEV++  + 
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 176 YDGKVCI 182
           YD K  I
Sbjct: 179 YDTKADI 185

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  100 bits (251), Expect = 9e-26
 Identities = 62/173 (35%), Positives = 89/173 (51%), Gaps = 8/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIRFK 64
           LG G+FG   L R KE+  L AVK +++   + D++V   +   R L     HP + +  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               TP  L  VME+  GG+L   I  + RF E   R++  ++ S + + H   I +RDL
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
           KL+N LLD       K+ DFG  K  + + +  ST  GTP YIAPE+L    Y
Sbjct: 123 KLDNVLLDHEG--HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 1e-25
 Identities = 58/170 (34%), Positives = 93/170 (54%), Gaps = 10/170 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-----RGRKIDENVAREIINHRSLRH--PNIIR 62
           +G G FG    +R K+T+ + A+K +        +++   +    I  R+L    P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
            K    T + L +V +Y +GGELF  +   GRFSED  +++  +L+  + + H   I +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           DLK EN LLD  A   + +CDFG SK+++  ++  +T  GT  Y+APEVL
Sbjct: 121 DLKPENILLD--ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 99.8 bits (249), Expect = 1e-25
 Identities = 60/177 (33%), Positives = 97/177 (54%), Gaps = 9/177 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   K T   VAVK ++ R ++  E +  E++  R  +HPNI+      L
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  +++ H+  + HRD+K ++
Sbjct: 87  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145

Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL  DG    R+K+ DFG+ ++ S    R KS VGTP ++APEV+SR  Y  +V I
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 99.4 bits (248), Expect = 2e-25
 Identities = 62/191 (32%), Positives = 96/191 (50%), Gaps = 14/191 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           + +E++ +LG G FG     +HKET    A K I+   + + E+   EI      +HPNI
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           +   E       L I++E+  GG L   +    R  +E + RY  +Q++  +N+ HS ++
Sbjct: 65  VGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKV 124

Query: 120 CHRDLKLENTLL--DGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL----- 171
            HRDLK  N LL  DG     +K+ DFG S K+     +  + +GTP ++APEV+     
Sbjct: 125 IHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180

Query: 172 SRREYDGKVCI 182
               YD K  I
Sbjct: 181 KDNPYDYKADI 191

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 98.5 bits (245), Expect = 6e-25
 Identities = 61/175 (34%), Positives = 90/175 (51%), Gaps = 8/175 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSL----RHPNIIR 62
           K LG G+FG   L   K   E  AVK +++    ID++V   ++  R L     +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T  HL  VME+  GG+L   I + GRF      ++  +++ G+ + HS  I +R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVGTPAYIAPEVLSRREY 176
           DLKL+N +LD      +KI DFG  K +V   +R  +  GTP YIAPE+L   +Y
Sbjct: 121 DLKLDNVMLDRDG--HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 98.3 bits (245), Expect = 9e-25
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 8/183 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHP 58
           +  +  LG G+FG   L   K T EL A+K +++   I D++V   ++  R L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
            + +      T   L  VMEY  GG+L   I   G+F E    ++  ++  G+ + HS  
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           I +RDLKL+N +LD      +KI DFG  K ++   +   T  GTP YIAPE+++ + Y 
Sbjct: 122 IIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 178 GKV 180
             V
Sbjct: 180 KSV 182

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 96.6 bits (241), Expect = 1e-24
 Identities = 62/181 (34%), Positives = 93/181 (51%), Gaps = 11/181 (6%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREI-INHRSLRHPNII 61
           E + +LGAGN GV   + H+ T +++AVK I       I + + RE+ I H+    P I+
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIV 62

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHS-MQ 118
            F         ++I MEY  GG L D+I     GR  E         ++ G+ Y H   +
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           I HRD+K  N L++     ++K+CDFG S   V +S  K+ VGT +Y+APE +   +Y  
Sbjct: 122 IIHRDVKPSNILVNSRG--QIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 179 K 179
           K
Sbjct: 179 K 179

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.3 bits (240), Expect = 2e-24
 Identities = 52/170 (30%), Positives = 88/170 (51%), Gaps = 8/170 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYI------ERGRKIDENVAREIINHRSLRHPNIIRF 63
           LG+G+FG      + +  +  AVK +      + G++  + + +EI     L+HPNI+++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
                   +L I +E   GG L   +   G F E   R + +Q++ G+ Y H     HRD
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           +K  N L+D +    +K+ DFG +K  V  S  KS  G+P ++APEV+++
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 96.5 bits (241), Expect = 2e-24
 Identities = 67/200 (33%), Positives = 97/200 (48%), Gaps = 27/200 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA-------REIINHRS 54
           ++YE +  +  G +GV    R K+T E+VA+K +    K+++          REI     
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60

Query: 55  LRHPNIIRFKEVVL--TPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGV 111
           L+HPNI+  KEVV+      + +VMEY    +L   +      F + E +    QL+SGV
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGV 119

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPE 169
            + H   I HRDLK  N LL+      LKICDFG ++   S L    +  V T  Y APE
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRG--ILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176

Query: 170 VL-SRREYDGKV------CI 182
           +L   +EY   +      CI
Sbjct: 177 LLLGAKEYSTAIDMWSVGCI 196

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 96.8 bits (241), Expect = 2e-24
 Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 23/198 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E +E +K +  G +G   L+RHKET++  A+K I +   I  N  +++   R +     +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P ++       T  HL +VMEY  GG+    + N G    D  R +F + +  + Y H+ 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP----------------KSTVG 161
            I HRDLK +N L+  ++   +K+ DFG SK  ++                    K   G
Sbjct: 121 GIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178

Query: 162 TPAYIAPEVLSRREYDGK 179
           TP YIAPEV+ R+ Y GK
Sbjct: 179 TPEYIAPEVILRQGY-GK 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 96.2 bits (239), Expect = 3e-24
 Identities = 67/194 (34%), Positives = 98/194 (50%), Gaps = 17/194 (8%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRHPN 59
           K+E++  +G G +GV    RHKETKE+VA+K     E   ++ E   RE+   R+L+  N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           I+  KE       L +V EY      EL + + N      ++ R +  QLI  +++CH  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKN 119

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVLSRRE 175
            I HRD+K EN L+  S    LK+CDFG++++    S    T  V T  Y +PE+L    
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 176 YDGKV------CIL 183
           Y   V      CIL
Sbjct: 178 YGKAVDMWSVGCIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 97.0 bits (241), Expect = 3e-24
 Identities = 61/183 (33%), Positives = 94/183 (51%), Gaps = 8/183 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHP 58
           +  +  LG G+FG   L   K T EL A+K +++   I D++V   ++  R L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
            + +      T   L  VMEY  GG+L  +I   GRF E    ++  ++  G+ + HS  
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPAYIAPEVLSRREYD 177
           I +RDLKL+N +LD      +KI DFG  K ++      K+  GTP YIAPE+++ + Y 
Sbjct: 122 IIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179

Query: 178 GKV 180
             V
Sbjct: 180 KSV 182

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 95.7 bits (238), Expect = 3e-24
 Identities = 61/182 (33%), Positives = 90/182 (49%), Gaps = 8/182 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSLRHPNI 60
           +E++  +G G+FGV   +  K  K + A+K I+     R+  E    E      L    I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRI--CNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR+ E  L    L IVMEYA  G+L   +         ED+   FF Q++ G+ + HS +
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRD+K  N  LD  A   +KI D G +K  S   +   + VGTP Y++PE+   + Y+
Sbjct: 122 ILHRDIKSLNLFLD--AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179

Query: 178 GK 179
            K
Sbjct: 180 EK 181

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 3e-24
 Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 26/194 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----H 57
             +ELV+ +G G +G     RHK+T +LVA+K ++     +E +  E      LR    H
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSNH 62

Query: 58  PNIIRFKEVVLTPTH------LAIVMEYAAGGELFD-----RICNAGRFSEDEGRYFFQQ 106
           PNI  F    +          L +VME   GG + D     R     R  E+   Y  ++
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILRE 121

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTP 163
            + G+ Y H  ++ HRD+K +N LL  +A   +K+ DFG S    S++   R  + +GTP
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQLDSTL--GRRNTFIGTP 177

Query: 164 AYIAPEVLSRREYD 177
            ++APEV++  E  
Sbjct: 178 YWMAPEVIACDEQP 191

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 96.4 bits (241), Expect = 4e-24
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 38/208 (18%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN------VAREIINHRSLR 56
           +YEL+K +G+G +GV      K T   VA+K I     + ++      + REI   R LR
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHLR 57

Query: 57  HPNIIRFKEVVLTPT-----HLAIVMEYAAGGELFD----RICNAGRF-SEDEGRYFFQQ 106
           H NII   +++  P+      + IV E      L +    ++  + +  ++D  +YF  Q
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQYFLYQ 111

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGT 162
           ++ G+ Y HS  + HRDLK  N L++ +    LKICDFG ++        K      V T
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVT 169

Query: 163 PAYIAPEV-LSRREYDGKV------CIL 183
             Y APE+ LS   Y   +      CI 
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIF 197

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 94.7 bits (235), Expect = 7e-24
 Identities = 60/172 (34%), Positives = 89/172 (51%), Gaps = 6/172 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           E +EL++ +G+G +G     R+  T EL A+K I  E G      V +EII  +  +H N
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+ +    L    L I ME+  GG L D     G  SE +  Y  ++ + G+ Y HS   
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEV 170
            HRD+K  N LL  +    +K+ DFG S   +   ++ KS +GTP ++APEV
Sbjct: 128 MHRDIKGANILLTDNG--HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 95.8 bits (238), Expect = 7e-24
 Identities = 60/179 (33%), Positives = 94/179 (52%), Gaps = 8/179 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIR 62
           K LG G+FG   L   K T +  A+K +++   + D++V   ++  R L     HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T  +L  VMEY  GG+L   I +  +F      ++  ++I G+ + HS  I +R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           DLKL+N LLD      +KI DFG  K ++L  ++  +  GTP YIAPE+L  ++Y+  V
Sbjct: 121 DLKLDNILLDTDG--HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 94.6 bits (235), Expect = 8e-24
 Identities = 67/191 (35%), Positives = 100/191 (52%), Gaps = 17/191 (8%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPN 59
           +YE++K +G G+FG   L + K   E   +K I+  +   K  E   +E+I    ++HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHS 116
           I+ F         L IVMEY  GG+L  RI N  R   FSED+   +F Q+  G+ + H 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 117 MQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVL 171
            +I HRD+K +N  L  +G  A   K+ DFG ++   L+       + VGTP Y++PE+ 
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174

Query: 172 SRREYDGKVCI 182
             R Y+ K  I
Sbjct: 175 QNRPYNNKTDI 185

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 95.8 bits (238), Expect = 8e-24
 Identities = 59/177 (33%), Positives = 90/177 (50%), Gaps = 8/177 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIRFK 64
           LG G+FG   L   K T EL A+K +++   I D++V   ++  R L    + P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   G+F E +  ++  ++  G+ + H   I +RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKV 180
           KL+N +LD      +KI DFG  K  ++      T  GTP YIAPE+++ + Y   V
Sbjct: 128 KLDNVMLDSEG--HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 94.5 bits (235), Expect = 1e-23
 Identities = 60/178 (33%), Positives = 100/178 (56%), Gaps = 10/178 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           M++YE V+ +G G +GV    R + T E +A+K I R  + DE V     REI   + ++
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQ 59

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG--RYFFQQLISGVNYC 114
           H NI+R ++VV +   L +V EY    +L   + ++  F+++    + +  Q++ G+ YC
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           HS ++ HRDLK +N L+D      LK+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175

Length = 294

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 93.7 bits (234), Expect = 1e-23
 Identities = 54/184 (29%), Positives = 77/184 (41%), Gaps = 16/184 (8%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKE-TKELVAVKYIERGRKIDENVA--REIINHRSLRHP 58
           EL K LG G FG      L    E T+  VAVK ++ G   +E      E    + L HP
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           NI+R   V      L IV EY  GG+L D +  +  + +  +      Q+  G+ Y  S 
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI-----APEVLS 172
              HRDL   N L+  +    +KI DFG S+   ++            +     APE L 
Sbjct: 122 NFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 173 RREY 176
             ++
Sbjct: 178 DGKF 181

Length = 258

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 2e-23
 Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 38/205 (18%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRSLRH 57
           ++ +K LG G+ G   L+R K T +L A+K +++   I  N        +EI+   +L H
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATLDH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCH 115
           P +        T T+L +VM+Y  GGELF   +       SE+  R++  +++  + Y H
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 116 SMQICHRDLKLENTLLDGSA-----------------APRLKICDFGYSKSSVLHS---- 154
            + I +RDLK EN LL  S                   P  K    G  +SSV       
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 155 -------RPKSTVGTPAYIAPEVLS 172
                  R  S VGT  YIAPEV+S
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVIS 205

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 94.9 bits (236), Expect = 2e-23
 Identities = 58/180 (32%), Positives = 101/180 (56%), Gaps = 13/180 (7%)

Query: 7   VKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-KIDENV----AREIINHRSLRHP 58
           +K LG G+FG   L+R     +  +L A+K +++   K+ + V     R+I+    + HP
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHP 58

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
            I++      T   L +++++  GG+LF R+     F+E++ +++  +L   +++ HS+ 
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      +K+ DFG SK S+ H  +  S  GT  Y+APEV++RR + 
Sbjct: 119 IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 2e-23
 Identities = 61/182 (33%), Positives = 90/182 (49%), Gaps = 12/182 (6%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE------NVAREIINHRSLRHPNII 61
           K LG G FG   L    +T   +AVK +       E       +  EI   ++L+H  I+
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           ++   +     L+I MEY  GG + D++   G  +E   R + +Q++ GV Y HS  I H
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSR---PKSTVGTPAYIAPEVLSRREYD 177
           RD+K  N L D  +A  +K+ DFG SK    + S     KS  GTP +++PEV+S   Y 
Sbjct: 128 RDIKGANILRD--SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185

Query: 178 GK 179
            K
Sbjct: 186 RK 187

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 93.8 bits (234), Expect = 3e-23
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 13/178 (7%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLR 56
           +YE  K LG G + V    R KET  +VA+K I+ G +      I+    REI   + L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPNII   +V    +++ +V E+      ++      +   +  + + +    + G+ Y 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYL 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           HS  I HRDLK  N L+       LK+ DFG ++S    +R  +  V T  Y APE+L
Sbjct: 119 HSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 94.3 bits (234), Expect = 3e-23
 Identities = 56/179 (31%), Positives = 91/179 (50%), Gaps = 8/179 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-----RHPNIIR 62
           K +G G+FG   L + K   +  AVK +++   ++    + I+  R++     +HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T   L  V+++  GGELF  +     F E   R++  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKV 180
           DLK EN LLD      + + DFG  K  +  S   +T  GTP Y+APEV+ ++ YD  V
Sbjct: 121 DLKPENILLDSQG--HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 94.5 bits (235), Expect = 4e-23
 Identities = 59/187 (31%), Positives = 99/187 (52%), Gaps = 17/187 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE-NVA-----REIINHRSL 55
           E ++++K +G G FG  +L+RHK +K++ A+K + +   I   + A     R+I+ H + 
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN- 101

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
               I++         +L +VMEY  GG+L + + N     E   R++  +++  ++  H
Sbjct: 102 -SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH 159

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM   HRD+K +N LLD S    LK+ DFG       + ++     + VGTP YI+PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMDANGMVRC--DTAVGTPDYISPEVL 215

Query: 172 SRREYDG 178
             +  DG
Sbjct: 216 KSQGGDG 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 93.9 bits (233), Expect = 5e-23
 Identities = 57/175 (32%), Positives = 90/175 (51%), Gaps = 9/175 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHK-ETKELVAVKYIERGRKIDENVAREIINHRSL----R 56
           E +  ++ LG G+FG   L  +K E    VA+K  E+ + I +     + + R +     
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP  +         ++L +V+E+  GGE F  +    RF  D G ++  Q++    Y  S
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           + I +RDLK EN LLD      +K+ DFG++K  V+ +R  +  GTP YIAPE+L
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEIL 200

Length = 340

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 93.0 bits (231), Expect = 5e-23
 Identities = 62/185 (33%), Positives = 96/185 (51%), Gaps = 13/185 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA+K +  + +   E +  EI+  R  +HPNI
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ 
Sbjct: 136 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 176 YDGKV 180
           Y  KV
Sbjct: 192 YGPKV 196

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 93.2 bits (232), Expect = 5e-23
 Identities = 64/177 (36%), Positives = 91/177 (51%), Gaps = 14/177 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRK-IDENVAREIINHRSLRHPNI 60
           +E +  +G G +G+    R   + E+VA+K +  +  R  I  +  REI    +LRHPNI
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 61  IRFKEVVLTPTHLA---IVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +  KEVV    HL    +VMEY       L D +     FSE + +    QL+ G+ Y H
Sbjct: 69  VELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLH 125

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
              I HRDLK+ N LL       LKI DFG +++  L ++P +  V T  Y APE+L
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 91.6 bits (228), Expect = 9e-23
 Identities = 60/194 (30%), Positives = 89/194 (45%), Gaps = 17/194 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + YEL++ +G G   V          E VA+K I  E+ +   + + +E+       HPN
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFD---RICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           ++++    +    L +VM Y +GG L D        G   E       ++++ G+ Y HS
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 117 MQICHRDLKLENTLL--DGSAAPRLKICDFGYSKS-----SVLHSRPKSTVGTPAYIAPE 169
               HRD+K  N LL  DGS    +KI DFG S S            K+ VGTP ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 170 VLS-RREYDGKVCI 182
           V+     YD K  I
Sbjct: 177 VMEQVHGYDFKADI 190

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 91.0 bits (226), Expect = 5e-22
 Identities = 56/185 (30%), Positives = 99/185 (53%), Gaps = 13/185 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVA-----REIINHRSLRH 57
           +++   +G G+FG  +++R K T ++ A+K +++   +  E V+     R+I++  +   
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN--S 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHS 116
           P I + +       +L +VMEY  GG+L   +     +F ED  +++  +L+  ++  H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRR 174
           M   HRD+K EN L+D +    +K+ DFG +   ++      K  VGTP YIAPEVL+  
Sbjct: 121 MGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178

Query: 175 EYDGK 179
             DGK
Sbjct: 179 NGDGK 183

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 91.2 bits (226), Expect = 7e-22
 Identities = 61/185 (32%), Positives = 98/185 (52%), Gaps = 13/185 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E YE+VK +G G FG  +L+RHK T+++ A+K + +   I  + +      R +      
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   R++  +++  ++  HSM
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 161

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 162 GFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 217

Query: 174 REYDG 178
           +  DG
Sbjct: 218 QGGDG 222

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 90.0 bits (223), Expect = 8e-22
 Identities = 51/172 (29%), Positives = 85/172 (49%), Gaps = 7/172 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIRFKE 65
           +G G+FG    +R ++T+ + A+K I +   +  +     +  R++      P I+  K 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
              +P  L +V+ +  GGELF  +   GRF     R++  +L+  +   H   + +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 126 LENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
            EN LLD      + +CDFG  K ++      +T  GTP Y+APE+L    Y
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 90.8 bits (225), Expect = 1e-21
 Identities = 55/185 (29%), Positives = 97/185 (52%), Gaps = 13/185 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E Y++VK +G G FG  +L+RHK ++++ A+K + +   I  + +      R +      
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   +++  +++  ++  HSM
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            + HRD+K +N LLD      LK+ DFG      ++ ++     + VGTP YI+PEVL  
Sbjct: 162 GLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVRC--DTAVGTPDYISPEVLKS 217

Query: 174 REYDG 178
           +  DG
Sbjct: 218 QGGDG 222

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 89.0 bits (221), Expect = 1e-21
 Identities = 61/176 (34%), Positives = 95/176 (53%), Gaps = 12/176 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHP 58
           KYE ++ +G G +G     +++ET E+VA+K + R    DE V     REI   + L+H 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI+R  +V+ +   L +V EY      + FD  CN G    +  + F  QL+ G+ +CHS
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDS-CN-GDIDPEIVKSFMFQLLKGLAFCHS 117

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
             + HRDLK +N L++ +    LK+ DFG +++  +  R  S  V T  Y  P+VL
Sbjct: 118 HNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.0 bits (221), Expect = 1e-21
 Identities = 57/184 (30%), Positives = 85/184 (46%), Gaps = 13/184 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKIDENVAREIINHRSLRHPN 59
           EK   +  LG G  G     R K T  + A+K I       + + + RE+  ++S + P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRI-----CNAGRFSEDEGRYFFQQLISGVN 112
           I+++    L    + + I MEY  GG L D I        GR  E       + ++ G++
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           Y HS +I HRD+K  N LL       +K+CDFG S   V  S   +  GT  Y+APE + 
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQ 176

Query: 173 RREY 176
            + Y
Sbjct: 177 GKPY 180

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 1e-21
 Identities = 63/175 (36%), Positives = 91/175 (52%), Gaps = 11/175 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHPN 59
           Y+ V+ +G G +GV    R K T E+VA+K I R    DE V     REI   + L HPN
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           I+R  +VV +   L +V E+      +  D     G       + +  QL+ G+ YCHS 
Sbjct: 60  IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSH 118

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           ++ HRDLK +N L+D   A  LK+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 89.7 bits (223), Expect = 1e-21
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 27/216 (12%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR---EIINHRSLRHP 58
            +Y+ ++++G+G +GV        + + VA+K I     +     R   E+   R  +H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 59  NIIRFKEVVLTP----THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           NII  ++++  P      + +VM+     +L   I +    +E+  RYF  QL+ G+ Y 
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSR-PKSTVGTPAYIAPE 169
           HS  + HRDLK  N L++      L+I DFG     S S   H       V T  Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNEDC--ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 170 VL-SRREYDGKV------CIL--LLI---LFLWRNY 193
           +L S  EY   +      CI   +L    LF  +NY
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 88.4 bits (220), Expect = 2e-21
 Identities = 52/189 (27%), Positives = 75/189 (39%), Gaps = 19/189 (10%)

Query: 8   KDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPNIIR 62
           K LG G FG     +L         VAVK ++     +E     +E    + L HPN++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLIS-------GVNY 113
              V      L +V+EY  GG+L  + R       S ++     + L+S       G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI---APEV 170
             S +  HRDL   N L+       +KI DFG S+        +   G    I   APE 
Sbjct: 121 LASKKFVHRDLAARNCLVG--EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 171 LSRREYDGK 179
           L    +  K
Sbjct: 179 LKDGIFTSK 187

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 88.7 bits (220), Expect = 2e-21
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 13/183 (7%)

Query: 4   YELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-----KIDENVARE-IINHRS 54
           +EL++ LG G +G   L+R     +  +L A+K +++       K  E+   E  +    
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
            R P ++       T T L ++++Y  GGELF  +     F+E E R +  +++  +++ 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKSTVGTPAYIAPEVLS 172
           H + I +RD+KLEN LLD      + + DFG SK  +     R  S  GT  Y+APEV+ 
Sbjct: 122 HQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 173 RRE 175
              
Sbjct: 180 GGS 182

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 89.0 bits (220), Expect = 2e-21
 Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 13/187 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA+K +  + +   E +  EI+  R  ++PNI
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  +++ HS Q
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ 
Sbjct: 136 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 176 YDGKVCI 182
           Y  KV I
Sbjct: 192 YGPKVDI 198

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 3e-21
 Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 24/200 (12%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR-- 56
           YE + ++G G +G     R   T   VA+K +     E G  I  +  REI   + L   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58

Query: 57  -HPNIIRFKEVVLTP-----THLAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLIS 109
            HPNI+R  +V   P       L +V E+       +   C       +  +   +QL+ 
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           GV++ HS +I HRDLK +N L+  ++  ++KI DFG ++         S V T  Y APE
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILV--TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPE 176

Query: 170 VLSRREYDGKV------CIL 183
           VL +  Y   V      CI 
Sbjct: 177 VLLQSSYATPVDMWSVGCIF 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 87.9 bits (218), Expect = 3e-21
 Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 7/173 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSLRHPNI 60
           ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L HPNI
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++  +V+ T   L +V E+     + F              + +  QL+ G+ +CHS ++
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 122 LHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.8 bits (217), Expect = 5e-21
 Identities = 58/177 (32%), Positives = 99/177 (55%), Gaps = 9/177 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  + R K +   VAVK ++ R ++  E +  E++  R  +H N++   +  L
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L ++ME+  GG L D I +  R +E++     + ++  + Y HS  + HRD+K ++
Sbjct: 89  VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147

Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+SR  Y  +V I
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 87.4 bits (216), Expect = 5e-21
 Identities = 59/169 (34%), Positives = 90/169 (53%), Gaps = 4/169 (2%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-VAREIINHRSLRHPNIIR 62
           YEL++ +G+G +G     R+  T EL AVK I+     D + + +EI   +  +H NI+ 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           +    L+   L I MEY  GG L D     G  SE +  Y  ++ + G+ Y HS    HR
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130

Query: 123 DLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEV 170
           D+K  N LL  +    +K+ DFG  +K +   ++ KS +GTP ++APEV
Sbjct: 131 DIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 87.2 bits (217), Expect = 5e-21
 Identities = 60/180 (33%), Positives = 88/180 (48%), Gaps = 13/180 (7%)

Query: 2   EKYELVKDLGA--GNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HP 58
           +  E+VK L    G FG   +L+HK T++L   K I    K     A E + H+ ++ +P
Sbjct: 14  KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKII----KAKNFNAIEPMVHQLMKDNP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N I+    V T     ++M+Y   G+LFD +   G+ SE E +   +QL+  +N  H   
Sbjct: 70  NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN 129

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRREYD 177
           I H D+KLEN L D  A  R+ +CD+G  K         S   GT  Y +PE +    YD
Sbjct: 130 IIHNDIKLENVLYDR-AKDRIYLCDYGLCK----IIGTPSCYDGTLDYFSPEKIKGHNYD 184

Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 87.4 bits (217), Expect = 6e-21
 Identities = 58/180 (32%), Positives = 91/180 (50%), Gaps = 18/180 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK-YIERG-----RKIDENVAREIINHRSL 55
           EKYE +  +G G++GV    R++ET ++VA+K ++E       +KI     REI   + L
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI---ALREIRMLKQL 57

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +HPN++   EV      L +V EY     L +   N     E   +    Q +  VN+CH
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGTPAYIAPEVL 171
                HRD+K EN L+  +   ++K+CDFG+++   + + P       V T  Y APE+L
Sbjct: 118 KHNCIHRDVKPENILI--TKQGQIKLCDFGFAR---ILTGPGDDYTDYVATRWYRAPELL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 87.0 bits (215), Expect = 7e-21
 Identities = 65/188 (34%), Positives = 98/188 (52%), Gaps = 14/188 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E +E++ +LG G FG     ++KET  L A K I+   + + E+   EI    S  HPNI
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           ++  +      +L I++E+ AGG +   +    R  +E + R   +Q +  +NY H  +I
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124

Query: 120 CHRDLKLENTL--LDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL----- 171
            HRDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+     
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 172 SRREYDGK 179
             R YD K
Sbjct: 181 KDRPYDYK 188

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 87.1 bits (215), Expect = 8e-21
 Identities = 60/187 (32%), Positives = 100/187 (53%), Gaps = 13/187 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV++R+ 
Sbjct: 137 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 176 YDGKVCI 182
           Y  KV I
Sbjct: 193 YGPKVDI 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.8 bits (215), Expect = 8e-21
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 26/204 (12%)

Query: 4   YELVKDLGAGNFG-VARLLRHKETKELVAVKYI------------ERGRKIDENVAREII 50
           Y +++ LG+G FG V ++ +    + L+A+K I            ER + I + V+   I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 51  NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG---GELFDRICNAG-RFSEDEGRYFFQQ 106
               LRHPNI+R+ +  L    L IVM+   G   GE F+ +     RF+E+     F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 107 LISGVNYCH-SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY 165
           ++  + Y H   +I HRDL   N +L      ++ I DFG +K     S+  S VGT  Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 166 IAPEVLSRREYDGKV------CIL 183
             PE++    Y  K       CIL
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCIL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 86.8 bits (215), Expect = 9e-21
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 11/175 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLRHPN 59
           ++ ++ LG G +      R++ T E+VA+K I    E G        REI   + L+H N
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           I+R  +V+ T   L +V EY      +  D     G    +  + F  QL+ G+ +CH  
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVL 171
           ++ HRDLK +N L++      LK+ DFG +++  +  +   + V T  Y AP+VL
Sbjct: 120 RVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL 172

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.5 bits (214), Expect = 9e-21
 Identities = 61/186 (32%), Positives = 92/186 (49%), Gaps = 18/186 (9%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR-------KIDENVAREIINHRSLRHPNIIR 62
           LG G F      R  +T  L+AVK +   R       ++ E + +EI     L HP+IIR
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                   +H  + +E+ AGG +   +   G F E     + +QL+ G++Y H  QI HR
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-------VGTPAYIAPEVLSRRE 175
           D+K  N L+D S   RL+I DFG   ++ L ++           +GT A++APEVL   +
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 176 YDGKVC 181
           Y G+ C
Sbjct: 185 Y-GRSC 189

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 86.8 bits (215), Expect = 2e-20
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 8/177 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G++    L+  K+T+ + A+K I++        ID     + +   +  HP ++   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T + L  V+E+ +GG+L   +    +  E+  R++  ++   +N+ H   I +RDL
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKV 180
           KL+N LLD  A   +K+ D+G  K  +      ST  GTP YIAPE+L   +Y   V
Sbjct: 123 KLDNVLLD--AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 86.3 bits (214), Expect = 2e-20
 Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 25/194 (12%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLRH 57
           KYE +  +G G FG     RHK+TK++VA+K +     + G  I     REI   + L+H
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPI--TALREIKILQLLKH 70

Query: 58  PNIIRFKEVVLTPT--------HLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLI 108
            N++   E+  T             +V E+    +L   + N   +F+  E +   + L+
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-----VGTP 163
           +G+ Y H  +I HRD+K  N L+       LK+ DFG +++  L    K       V T 
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 164 AYIAPEV-LSRREY 176
            Y  PE+ L  R+Y
Sbjct: 188 WYRPPELLLGERDY 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 85.4 bits (211), Expect = 2e-20
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 24/200 (12%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETK---ELVAVKYIERG-----RKIDENVAREIINHRS 54
           +Y L + LG G+FG   L++ K+      L  +K I  G       +  N   ++++   
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS--K 58

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI----CNAGRFSEDEGRYFFQQLISG 110
           L HP I++F    L      I+ EY  G +L  ++          SE++   +F QL+ G
Sbjct: 59  LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPE 169
           V+Y H  +I HRDLK +N  L  +    LKI DFG S+  +      +T  GTP Y++PE
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL---LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175

Query: 170 VLSRREYDGKV------CIL 183
            L  + YD K       CIL
Sbjct: 176 ALKHQGYDSKSDIWSLGCIL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 2e-20
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 19/200 (9%)

Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-----PNII 61
           +K +  G FG   L + + T +  A+K +++   I +N    +   R++       P + 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           +      +  +L +VMEY  GG+    I   G   ED  + +  +++ GV   H   I H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV- 180
           RD+K EN L+D      LK+ DFG S++ +     K  VGTP Y+APE +     D    
Sbjct: 121 RDIKPENLLID--QTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSD 175

Query: 181 -----CILLLILFLWRNYRP 195
                C++   LF    Y P
Sbjct: 176 WWSLGCVIFEFLF---GYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 85.9 bits (212), Expect = 2e-20
 Identities = 61/185 (32%), Positives = 96/185 (51%), Gaps = 9/185 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA+K I   ++   E +  EI+  + L++PNI
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           + F +  L    L +VMEY AGG L D +       E +     ++ +  + + H+ Q+ 
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQVI 137

Query: 121 HRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ Y 
Sbjct: 138 HRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 178 GKVCI 182
            KV I
Sbjct: 194 PKVDI 198

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.9 bits (210), Expect = 4e-20
 Identities = 51/169 (30%), Positives = 88/169 (52%), Gaps = 6/169 (3%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           LG G +G+    R   T+  +A+K I ER  +  + +  EI  H  L+H NI+++     
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 69  TPTHLAIVMEYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                 I ME   GG L   + +     + +E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135

Query: 126 LENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSR 173
            +N L++ + +  +KI DFG SK  + ++   ++  GT  Y+APEV+ +
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 85.9 bits (213), Expect = 4e-20
 Identities = 64/178 (35%), Positives = 90/178 (50%), Gaps = 12/178 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKID-ENVAREIINHRSLRHPN 59
           KY  +K +G G +G+    ++ ET E VA+K I      +ID +   REI   R L H N
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDR-----ICNAGRFSEDEGRYFFQQLISGVNYC 114
           +I  K+++  P H     +     EL D      I ++   S+D  +YF  QL+ G+ Y 
Sbjct: 66  VIAIKDIM-PPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRPKSTVGTPAYIAPEVL 171
           HS  + HRDLK  N LL+  A   LKICDFG ++ +S         V T  Y APE+L
Sbjct: 125 HSANVLHRDLKPSNLLLN--ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.2 bits (211), Expect = 5e-20
 Identities = 60/188 (31%), Positives = 95/188 (50%), Gaps = 16/188 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRH 57
           + +  ++++G G+FG     R   T E+VA+K +   G++ +E   ++ +E+   + LRH
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PN I +K   L      +VMEY  G   ++ +   +     E E        + G+ Y H
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LS 172
           S +  HRD+K  N LL       +K+ DFG   S+ L S   S VGTP ++APEV   + 
Sbjct: 133 SHERIHRDIKAGNILLTEPGT--VKLADFG---SASLVSPANSFVGTPYWMAPEVILAMD 187

Query: 173 RREYDGKV 180
             +YDGKV
Sbjct: 188 EGQYDGKV 195

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 86.7 bits (214), Expect = 6e-20
 Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 33/212 (15%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE--NVAREIINHRSLRH 57
           + +YE++K +G G FG   L++HK T+E    K I  RG K  E   +  E+   R L+H
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71

Query: 58  PNIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGV 111
            NI+R+ +  L   +  L I+ME+   G+L   I       G+  E       +QL+  +
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 112 NYCHSMQ-------ICHRDLKLENTLLDG---------------SAAPRLKICDFGYSKS 149
            YCH+++       + HRDLK +N  L                 +  P  KI DFG SK+
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 150 SVLHSRPKSTVGTPAYIAPEVL--SRREYDGK 179
             + S   S VGTP Y +PE+L    + YD K
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDK 223

Length = 1021

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 84.7 bits (209), Expect = 1e-19
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 14/176 (7%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G++    L+R K+T+ + A+K +++        ID     + +  ++  HP ++   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T + L  V+EY  GG+L   +    +  E+  R++  ++   +NY H   I +RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV----GTPAYIAPEVLSRREY 176
           KL+N LLD      +K+ D+G  K  +   RP  T     GTP YIAPE+L   +Y
Sbjct: 123 KLDNVLLDSEG--HIKLTDYGMCKEGL---RPGDTTSTFCGTPNYIAPEILRGEDY 173

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.9 bits (210), Expect = 1e-19
 Identities = 57/181 (31%), Positives = 89/181 (49%), Gaps = 13/181 (7%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVK--YIERGRKIDENVAREIINHRSLRHPNIIR 62
           E V  +G+G  G    + H+ T  L A+K  Y      +   + REI   R + HPN+++
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
             ++      + +++E+  GG L        +F  D  R    Q++SG+ Y H   I HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEV----LSRREYD 177
           D+K  N L++  +A  +KI DFG S+       P  S+VGT AY++PE     L+   YD
Sbjct: 193 DIKPSNLLIN--SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250

Query: 178 G 178
           G
Sbjct: 251 G 251

Length = 353

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 83.7 bits (207), Expect = 1e-19
 Identities = 58/176 (32%), Positives = 82/176 (46%), Gaps = 12/176 (6%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVA---REIINHRSLRHPNIIRF 63
           LG G FG     + K T ++ A K +++ R   +  E +A   ++I+   S R   I+  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICH 121
                T   L +VM    GG+L   I N G   F E    ++  Q+I G+ + H  +I +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           RDLK EN LLD     R  I D G +       + K   GTP Y+APEVL    YD
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 83.9 bits (207), Expect = 1e-19
 Identities = 57/184 (30%), Positives = 95/184 (51%), Gaps = 6/184 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+     DE  ++ +EI        P 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +  AG F E +     ++++ G++Y HS + 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG + + +    +  + VGTP ++APEV+ +  YD 
Sbjct: 123 IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 179 KVCI 182
           K  I
Sbjct: 181 KADI 184

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 1e-19
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 54/227 (23%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-RSLR---- 56
           + +E +K +G G FG  RL++ K+T  + A+K +   RK  E + +E + H R+ R    
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL---RK-SEMLEKEQVAHVRAERDILA 56

Query: 57  ---HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
              +P +++         +L ++MEY  GG++   +     F+E+E R++  + I  ++ 
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---------------------SSVL 152
            H +   HRD+K +N LLD      +K+ DFG                            
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 153 HSRPK------------------STVGTPAYIAPEVLSRREYDGKVC 181
            S+P                   STVGTP YIAPEV  +  Y  K C
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKEC 220

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 83.6 bits (207), Expect = 1e-19
 Identities = 60/179 (33%), Positives = 93/179 (51%), Gaps = 16/179 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK-YIERG-----RKIDENVAREIINHRSL 55
           EKYE +  +G G++G+    +HKET ++VA+K ++E       +KI     REI   + L
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKI---AMREIRMLKQL 57

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           RH N++   EV      L +V E+     L D         E   R +  Q++ G+ +CH
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST---VGTPAYIAPEVL 171
           S  I HRD+K EN L+  S    +K+CDFG++++  L +  +     V T  Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSQSGV--VKLCDFGFART--LAAPGEVYTDYVATRWYRAPELL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 83.1 bits (206), Expect = 2e-19
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 14/176 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKY-IERGRKIDE-NVAREIINHRSLR-HPNI 60
           Y+++  +G G F      + ++T +  A+K   +  + +++ N  REI   R L  HPNI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 61  IRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSM 117
           +R  EV+       LA+V E      L++ I    R   E   + +  QL+  +++ H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            I HRD+K EN L+       LK+ DFG  +   ++S+P  T  + T  Y APE L
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECL 170

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.8 bits (204), Expect = 2e-19
 Identities = 63/191 (32%), Positives = 100/191 (52%), Gaps = 16/191 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-------ERGRKIDENVAREIINHRS 54
             + L K LG G FG   L    +T   +AVK +       E  ++++  +  EI   ++
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKN 60

Query: 55  LRHPNIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           LRH  I+++   +  P    L+I +EY  GG + D++   G  +E+  R + +Q++ GV+
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRP--KSTVGTPAYIAP 168
           Y HS  I HRD+K  N L D  +A  +K+ DFG SK   ++  S    KS  GTP +++P
Sbjct: 121 YLHSNMIVHRDIKGANILRD--SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 169 EVLSRREYDGK 179
           EV+S   Y  K
Sbjct: 179 EVISGEGYGRK 189

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.8 bits (204), Expect = 4e-19
 Identities = 59/175 (33%), Positives = 91/175 (52%), Gaps = 9/175 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E +E++ +LG G FG     ++KET  L A K IE   + + E+   EI    +  HP I
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           ++          L I++E+  GG +   +    R  +E + +   +Q++  + Y HSM+I
Sbjct: 72  VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131

Query: 120 CHRDLKLENTLL--DGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL 171
            HRDLK  N LL  DG     +K+ DFG S K+     R  S +GTP ++APEV+
Sbjct: 132 IHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 82.5 bits (204), Expect = 4e-19
 Identities = 53/176 (30%), Positives = 95/176 (53%), Gaps = 10/176 (5%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHP 58
            Y  ++ +G G +GV    R+K+T ++VA+K I R    +E V     REI   + L+HP
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHP 59

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI+  ++V++  + L ++ E+ +    +  D +        +  + +  Q++ G+ +CHS
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            ++ HRDLK +N L+D      +K+ DFG +++  +  R  +  V T  Y APEVL
Sbjct: 120 RRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 82.7 bits (204), Expect = 5e-19
 Identities = 57/189 (30%), Positives = 96/189 (50%), Gaps = 15/189 (7%)

Query: 4   YELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGRKIDE-------NVAREIINHR 53
           +EL+K LG G +G   L+R     +T +L A+K +++   + +          R ++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
             + P ++       T   L ++++Y +GGE+F  +     FSEDE R++  ++I  + +
Sbjct: 62  R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGTPAYIAPEVL 171
            H + I +RD+KLEN LLD      + + DFG SK   S    R  S  GT  Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 172 SRREYDGKV 180
             +   GK 
Sbjct: 179 RGKGGHGKA 187

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 82.0 bits (202), Expect = 6e-19
 Identities = 56/175 (32%), Positives = 96/175 (54%), Gaps = 5/175 (2%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   K T + VAVK ++ R ++  E +  E++  R   H N++      L
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++Y H+  + HRD+K ++
Sbjct: 90  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148

Query: 129 TLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL  ++  R+K+ DFG+ ++ S    + KS VGTP ++APEV+SR  Y  +V I
Sbjct: 149 ILL--TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 82.2 bits (203), Expect = 7e-19
 Identities = 56/186 (30%), Positives = 94/186 (50%), Gaps = 11/186 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHP 58
            +Y  ++ +G G FG+    R + T + VA+K I +      + +   RE+   + LRH 
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 59  NIIRFKEVVLTP-THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           NII   ++ ++P   +  V E    G    R+  +    +   +YF  Q++ G+ Y HS 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV-LSRREY 176
            + HRDLK  N L++ +    LKICDFG ++  +   +    V T  Y APE+ L+ ++Y
Sbjct: 128 GVVHRDLKPSNILINENC--DLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 177 DGKVCI 182
           D +V I
Sbjct: 184 DVEVDI 189

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 81.2 bits (200), Expect = 1e-18
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 15/180 (8%)

Query: 4   YELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGRKIDE-------NVAREIINHR 53
           +EL+K LG G +G   L+R     ++ +L A+K +++   + +          R+++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
             + P ++       T T L ++++Y  GGELF  +    RF E E + +  +++  + +
Sbjct: 62  R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKSTVGTPAYIAPEVL 171
            H + I +RD+KLEN LLD +    + + DFG SK        R  S  GT  Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 81.2 bits (200), Expect = 1e-18
 Identities = 59/176 (33%), Positives = 87/176 (49%), Gaps = 6/176 (3%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFKEVV 67
           +G G+FG         TKE+VA+K I+     DE  ++ +EI        P I R+    
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 68  LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
           L  T L I+MEY  GG   D +   G   E       ++++ G++Y HS +  HRD+K  
Sbjct: 72  LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130

Query: 128 NTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKVCI 182
           N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD K  I
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.8 bits (199), Expect = 1e-18
 Identities = 61/191 (31%), Positives = 96/191 (50%), Gaps = 14/191 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR------EIINHRSLRH 57
           + L K LG G FG   L    +T   +AVK ++   +  E          EI   ++L H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 58  PNIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
             I+++   +  P    L+I ME+  GG + D++ + G  +E+  R + +Q++ GV+Y H
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS----SVLHSRPKSTVGTPAYIAPEVL 171
           S  I HRD+K  N L D  +   +K+ DFG SK      +  +  KS  GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRD--SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 172 SRREYDGKVCI 182
           S   Y  K  I
Sbjct: 182 SGEGYGRKADI 192

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 81.2 bits (200), Expect = 2e-18
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 8/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G++    L+R K+  ++ A+K +++        ID     + +  ++  +P ++   
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T + L +V+EY  GG+L   +    +  E+  R++  ++   +N+ H   I +RDL
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
           KL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L   EY
Sbjct: 123 KLDNVLLDADG--HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.5 bits (198), Expect = 2e-18
 Identities = 57/177 (32%), Positives = 97/177 (54%), Gaps = 9/177 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   K + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146

Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL  DG    R+K+ DFG+ ++ S    R KS VGTP ++APE++SR  Y  +V I
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.1 bits (197), Expect = 2e-18
 Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 6/184 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+     DE  ++ +EI        P 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG + + +    +  + VGTP ++APEV+ +  YD 
Sbjct: 123 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 179 KVCI 182
           K  I
Sbjct: 181 KADI 184

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.5 bits (198), Expect = 3e-18
 Identities = 58/179 (32%), Positives = 89/179 (49%), Gaps = 12/179 (6%)

Query: 9   DLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRHPNIIRFK 64
           ++G G+FG      +  T E+VAVK +   G++ +E   ++ +E+   + L+HPN I +K
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
              L      +VMEY  G        +     E E        + G+ Y HS  + HRD+
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LSRREYDGKV 180
           K  N LL  +   ++K+ DFG   S+   S   S VGTP ++APEV   +   +YDGKV
Sbjct: 148 KAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKV 201

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.4 bits (196), Expect = 4e-18
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 19/192 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE----RGRKIDENVAREIINHRSLR 56
           +  +++ K +G G F V           +VA+K ++       K  ++  +EI   + L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIA 167
           + HS +I HRD+K  N  +  +    +K+ D G      SK++  HS     VGTP Y++
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMS 174

Query: 168 PEVLSRREYDGK 179
           PE +    Y+ K
Sbjct: 175 PERIHENGYNFK 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.6 bits (193), Expect = 1e-17
 Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 12/181 (6%)

Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRHPNIIR 62
           ++++G G+FG     R     E+VA+K +   G++ +E   ++ +E+   + LRHPN I+
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           ++   L      +VMEY  G        +     E E        + G+ Y HS  + HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LSRREYDGK 179
           D+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YDGK
Sbjct: 140 DVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 180 V 180
           V
Sbjct: 195 V 195

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.6 bits (193), Expect = 1e-17
 Identities = 57/181 (31%), Positives = 92/181 (50%), Gaps = 12/181 (6%)

Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRHPNIIR 62
           ++++G G+FG     R   T E+VA+K +   G++ +E   ++ +E+   + ++HPN I 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           +K   L      +VMEY  G        +     E E        + G+ Y HS  + HR
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LSRREYDGK 179
           D+K  N LL  +   ++K+ DFG   S+ + S   S VGTP ++APEV   +   +YDGK
Sbjct: 150 DIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYDGK 204

Query: 180 V 180
           V
Sbjct: 205 V 205

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 78.1 bits (192), Expect = 2e-17
 Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 14/186 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIR 62
           +E+++ +G G +G    + +K+   L AVK ++    +DE +  E    +SL  HPN+++
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83

Query: 63  F-----KEVVLTPTHLAIVMEYAAGG---ELFDRICNAG-RFSEDEGRYFFQQLISGVNY 113
           F     K   L    L +V+E   GG   EL   +   G R  E    Y     + G+ +
Sbjct: 84  FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLS 172
            H+ +I HRD+K  N LL  +    +K+ DFG S   +    R  ++VGTP ++APEV++
Sbjct: 144 LHNNRIIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201

Query: 173 -RREYD 177
             ++YD
Sbjct: 202 CEQQYD 207

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 78.7 bits (194), Expect = 2e-17
 Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 50/221 (22%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPN 59
           +  +K +G G FG   L+R  +T  L A+K + +   +  N A  +   R +     +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +++         +L  VM+Y  GG++   +   G F ED  R++  +L   +   H M  
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFG-------------YSK---------------SSV 151
            HRD+K +N L+D      +K+ DFG             Y K               S +
Sbjct: 123 IHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 152 LHSRPK----------------STVGTPAYIAPEVLSRREY 176
              R K                S VGTP YIAPEVL R  Y
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.8 bits (192), Expect = 2e-17
 Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 11/152 (7%)

Query: 6   LVKDLGAGNFGVARLLRHK----ETKELVAVKYIER--GRKIDENVAREIINHRSLRHPN 59
            +K LG G+FG   L R+      T E VAVK +      +   +  REI   R+L H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V   P    L ++MEY   G L D +  +  + +      F  Q+  G++Y  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N L++      +KI DFG +K
Sbjct: 128 QRYIHRDLAARNILVESED--LVKISDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 2e-17
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 28/203 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV-----AREIINHRSLR 56
            +Y+ +  +G G +G+     HK T   VA+K I      +         REI   R  +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS---PFEHQTFCQRTLREIKILRRFK 61

Query: 57  HPNIIRFKEVVLTPT-----HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           H NII   +++  P+      + IV E     +L+ ++      S D  +YF  Q++ G+
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGL 119

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGTPAYIA 167
            Y HS  + HRDLK  N LL+      LKICDFG ++ +             V T  Y A
Sbjct: 120 KYIHSANVLHRDLKPSNLLLN--TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 168 PEV-LSRREYDGKV------CIL 183
           PE+ L+ + Y   +      CIL
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCIL 200

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 77.1 bits (190), Expect = 5e-17
 Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 17/179 (9%)

Query: 7   VKDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDEN--------VAREIINHRSL 55
           +K LG G +G     R +   +T ++ A+K +++   I  N          R I+   ++
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA-TIVRNQKDTAHTKAERNIL--EAV 57

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +HP I+       T   L +++EY +GGELF  +   G F ED   ++  ++   + + H
Sbjct: 58  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSR 173
              I +RDLK EN LLD  A   +K+ DFG  K S+       T  GT  Y+APE+L R
Sbjct: 118 QQGIIYRDLKPENILLD--AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR 174

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 76.7 bits (189), Expect = 8e-17
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 21/183 (11%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRSLR 56
           +Y++ + +G G++GV        T E VA+K I     + E+V+      REI   R LR
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57

Query: 57  HPNIIRFKEVVLTPTH-----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           HP+I+  K ++L P+      + +V E     +L   I      + +  ++F  QL+  +
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK----STVGTPAYIA 167
            Y H+  + HRDLK +N L   +A  +LKICDFG ++ +   +         V T  Y A
Sbjct: 117 KYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 168 PEV 170
           PE+
Sbjct: 175 PEL 177

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 76.4 bits (188), Expect = 9e-17
 Identities = 63/194 (32%), Positives = 92/194 (47%), Gaps = 33/194 (17%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           ++K++++  +G G +G     R K+T ELVA+K +     + G  I     REI   R L
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPI--TAIREIKILRQL 63

Query: 56  RHPNIIRFKEVVLTPTH----------LAIVMEYAAG---GELFDRICNAGRFSEDEGRY 102
            H NI+  KE+V                 +V EY      G L   + +   FSED  + 
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKS 120

Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKS 158
           F +QL+ G+NYCH     HRD+K  N LL+     ++K+ DFG    Y+      SRP +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG--QIKLADFGLARLYNSEE---SRPYT 175

Query: 159 T-VGTPAYIAPEVL 171
             V T  Y  PE+L
Sbjct: 176 NKVITLWYRPPELL 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.4 bits (185), Expect = 1e-16
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 15/186 (8%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI------ERGRKIDENVAREIINHRSLRH 57
           Y  V+ +G G++G   L+RH+   +   +K +       R RK  E  A+ +     L+H
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLL---SQLKH 58

Query: 58  PNIIRFKEVVL-TPTHLAIVMEYAAGGELFDRIC-NAGRF-SEDEGRYFFQQLISGVNYC 114
           PNI+ ++E        L IVM +  GG+L+ ++    G+   E++   +F Q+   + Y 
Sbjct: 59  PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSR 173
           H   I HRDLK +N  L  +    +K+ D G ++         ST +GTP Y++PE+ S 
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 174 REYDGK 179
           + Y+ K
Sbjct: 177 KPYNYK 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.5 bits (185), Expect = 2e-16
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 6/178 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK--YIERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   ++HK +  ++A K  ++E    I   + RE+        P 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-Q 118
           I+ F     +   ++I ME+  GG L   +  A R  E+        ++ G+ Y     Q
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 125 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.8 bits (184), Expect = 2e-16
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 8/182 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK--YIERGRKIDENVAREIINHRSLRHPN 59
           E  E + DLGAGN G    ++H  T  ++A K  +I     + + + RE+      R P 
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSM- 117
           I+ F    L   ++ + ME+   G L DRI    G    +        ++ G+ Y +++ 
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +I HRD+K  N L++     ++K+CDFG S   +++S   + VGT  Y++PE +   +Y 
Sbjct: 124 RIMHRDIKPSNILVNSRG--QIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYT 180

Query: 178 GK 179
            K
Sbjct: 181 VK 182

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 75.1 bits (185), Expect = 2e-16
 Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 19/183 (10%)

Query: 5   ELVKDLGAGNFG--VARLLRHKETKELVAVKYIERGRKIDENVAR---EIINHRSLRHPN 59
           EL+  +G       +  L +HK T  LVAVK I       E++     EII  R L+HPN
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG---ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+ +    +  + L +V    A G   +L       G   E    +  + +++ ++Y HS
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYS--------KSSVLHSRPKSTVGTPAYIAP 168
               HR +K  + LL G    ++ +    YS        +  V+H  PKS+V    +++P
Sbjct: 120 KGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 169 EVL 171
           EVL
Sbjct: 178 EVL 180

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 76.1 bits (187), Expect = 2e-16
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 6/152 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----R 56
           +E++ +VK +  G FG   L R K   +L AVK +++   I++N+  ++   R      +
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P I+     + +  ++ +VMEY  GG++   +   G F E+    +  ++   ++Y H 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             I HRDLK +N L+  S    +K+ DFG SK
Sbjct: 123 HGIIHRDLKPDNMLI--SNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.3 bits (182), Expect = 3e-16
 Identities = 58/184 (31%), Positives = 91/184 (49%), Gaps = 14/184 (7%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR------EIINHRSLRHPNII 61
           K LG G FG   L    +T   +A K ++   +  E          EI   ++L+H  I+
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 62  RFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++   +       L I MEY  GG + D++   G  +E   R + +Q++ G++Y HS  I
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRP--KSTVGTPAYIAPEVLSRRE 175
            HRD+K  N L D  +A  +K+ DFG SK   ++  S    +S  GTP +++PEV+S   
Sbjct: 128 VHRDIKGANILRD--SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185

Query: 176 YDGK 179
           Y  K
Sbjct: 186 YGRK 189

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 74.3 bits (182), Expect = 3e-16
 Identities = 52/183 (28%), Positives = 90/183 (49%), Gaps = 15/183 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNI 60
           + +E+++ +G G +G    + +K+     AVK ++    IDE +  E    ++L  HPN+
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 61  IRF-----KEVVLTPTHLAIVMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGV 111
           ++F     K+ V     L +V+E   GG + D +        R  E    Y   + + G+
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPE 169
            + H  +  HRD+K  N LL       +K+ DFG S   +S    R  ++VGTP ++APE
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAPE 194

Query: 170 VLS 172
           V++
Sbjct: 195 VIA 197

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 74.3 bits (182), Expect = 4e-16
 Identities = 54/182 (29%), Positives = 93/182 (51%), Gaps = 12/182 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNIIR 62
           +ELV+ +G G +G     RH +T +L A+K ++     +E +  EI +  +   H NI  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 63  FKEVVLT---PTH---LAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYC 114
           +    +    P H   L +VME+   G + D + N       ED   Y  ++++ G+ + 
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSR 173
           H+ ++ HRD+K +N LL  +A   +K+ DFG S        R  + +GTP ++APEV++ 
Sbjct: 138 HAHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 174 RE 175
            E
Sbjct: 196 DE 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 74.3 bits (182), Expect = 4e-16
 Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 24/178 (13%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH-------PN 59
           +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +         P 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLSLVSTGDCPF 58

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+       TP  L  +++   GG+L   +   G FSE E R++  ++I G+ + H+  +
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV 118

Query: 120 CHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQK 169

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 73.4 bits (180), Expect = 6e-16
 Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 17/184 (9%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-------RGRKIDENVAREIINHRSLRHPNIIR 62
           LG G +G           +L+AVK +E          K  E +  E+   +SL+H NI++
Sbjct: 8   LGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           +    L    ++I ME+  GG +   +   G   E     + +Q++ GV Y H+  + HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRP-KSTVGTPAYIAPEVLSRRE 175
           D+K  N +L  +    +K+ DFG ++          HS   KS  GTP ++APEV++   
Sbjct: 127 DIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 176 YDGK 179
           Y  K
Sbjct: 185 YGRK 188

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.9 bits (181), Expect = 8e-16
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-Q 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 125 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 73.0 bits (179), Expect = 9e-16
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 24/178 (13%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH-------PN 59
           +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +         P 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLSLVSTGDCPF 58

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+       TP  L+ +++   GG+L   +   G FSE E R++  ++I G+ + H+  +
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118

Query: 120 CHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQK 169

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.1 bits (179), Expect = 9e-16
 Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 7/175 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           +E Y  +  LG G +      R K T+ LVA+K I  E          RE+   ++L+H 
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRF-SEDEGRYFFQQLISGVNYCHSM 117
           NI+   +++ T   L +V EY    +L   + N G   S    + F  QL+ G++YCH  
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           +I HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+VL
Sbjct: 123 KILHRDLKPQNLLINEKG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.4 bits (177), Expect = 2e-15
 Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 12/179 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNIIR 62
           +ELV+ +G G +G     RH +T +L A+K ++     +E + +EI +  +   H NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 63  FKEVVLTPT------HLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYC 114
           +    +          L +VME+   G + D I N       E+   Y  ++++ G+++ 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLS 172
           H  ++ HRD+K +N LL  +A   +K+ DFG S        R  + +GTP ++APEV++
Sbjct: 128 HQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 72.7 bits (178), Expect = 2e-15
 Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 12/175 (6%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVA---REIINHRSLRHPNIIRF 63
           LG G FG    ++ K T ++ A K +++ R   K  E +A   +EI+    +  P I+  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGR--YFFQQLISGVNYCHSMQICH 121
                + THL +VM    GG+L   I N G    +  R  ++  Q+  G+ + HSM I +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           RD+K EN LLD     RL   D G +             GT  Y+APE+L    Y
Sbjct: 119 RDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 72.6 bits (179), Expect = 2e-15
 Identities = 63/188 (33%), Positives = 89/188 (47%), Gaps = 18/188 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSLR- 56
           + KYE+++ LG G +G+      + TKE+VA+K I    R     +   REI+  + L  
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65

Query: 57  HPNIIRFKEVVLTPTHLAI--VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPNI++   V+       I  V EY    +L   I  A    +   RY   QL+  + Y 
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLKALKYI 123

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS----SVLHSRPKST--VGTPAYIAP 168
           HS  + HRDLK  N LL+     R+K+ DFG ++S          P  T  V T  Y AP
Sbjct: 124 HSGNVIHRDLKPSNILLNSDC--RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181

Query: 169 EVL--SRR 174
           E+L  S R
Sbjct: 182 EILLGSTR 189

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.8 bits (176), Expect = 3e-15
 Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 13/173 (7%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----PNI 60
           E++ +LG GN+G    + H+ T   +A+K I    ++DE+   +II    + H    P I
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG---ELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HS 116
           + F         + + MEY   G   +L+          ED  R     ++ G+ +    
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
             I HRD+K  N L++G+   ++K+CDFG S  +++ S  K+ +G  +Y+APE
Sbjct: 122 HNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPE 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 5e-15
 Identities = 59/178 (33%), Positives = 87/178 (48%), Gaps = 13/178 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLR 56
           +E Y+ +  LG G++      R K T +LVA+K I    E G        RE    + L+
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLK 61

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI+   +++ T   L +V EY      +  D  C  G  S    R F  QL+ G+ YC
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDD-CGGG-LSMHNVRLFLFQLLRGLAYC 119

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           H  ++ HRDLK +N L+  S    LK+ DFG +++  + S+  S  V T  Y  P+VL
Sbjct: 120 HQRRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVL 175

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 71.6 bits (175), Expect = 5e-15
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 44/201 (21%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVARE----IIN--- 51
           + +E++K +G G FG   +++ K T+ + A+K +   E  ++ +    RE    ++N   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 52  ------HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFF 104
                 H + +  N            +L +VM+Y  GG+L   +     R  ED  R++ 
Sbjct: 61  QWITTLHYAFQDEN------------YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI 108

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPR-------LKICDFGYSKSSVLHSRPK 157
            +++  ++  H +   HRD+K +N LLD +   R       LK+   G  +SSV      
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV------ 162

Query: 158 STVGTPAYIAPEVLSRREYDG 178
             VGTP YI+PE+L   E DG
Sbjct: 163 -AVGTPDYISPEILQAME-DG 181

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 71.2 bits (174), Expect = 6e-15
 Identities = 57/185 (30%), Positives = 91/185 (49%), Gaps = 8/185 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           ME Y  ++ LG G +      R K T+ LVA+K I  E          RE+   + L+H 
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSM 117
           NI+   ++V T   L +V EY    +L   + + G   S    + F  Q++ G+ YCH  
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEV-LSRRE 175
           ++ HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+V L   E
Sbjct: 124 KVLHRDLKPQNLLINERG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 176 YDGKV 180
           Y  ++
Sbjct: 182 YSTQI 186

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.9 bits (171), Expect = 1e-14
 Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 20/198 (10%)

Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E      L H  +++   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + IV EY + G L + +   G+      R+   QL+        G+ Y  S Q
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREHGK------RFQPSQLLEMCKDVCEGMAYLESKQ 120

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L+D      +K+ DFG S+  VL     S+VG+     +  PEVL   +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177

Query: 176 YDGKVCILLLILFLWRNY 193
           +  K  +    + +W  Y
Sbjct: 178 FSSKSDVWAFGVLMWEVY 195

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.2 bits (172), Expect = 1e-14
 Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 10/150 (6%)

Query: 7   VKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNII 61
           ++ LG GNFG   L R+      T E+VAVK ++        +  REI   +SL+H NI+
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDR-ICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           ++K V  +    +L +VMEY   G L D    +  R    +   +  Q+  G+ Y  S +
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL   N L++     R+KI DFG +K
Sbjct: 129 YVHRDLATRNILVESEN--RVKIGDFGLTK 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.5 bits (173), Expect = 1e-14
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 6/178 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + H+ +  ++A K I  E    I   + RE+        P 
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E+        ++ G+ Y     +
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK 120

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 121 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 175

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 70.3 bits (172), Expect = 1e-14
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 11/180 (6%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPN---IIRFKE 65
           LG G FG     + + T +L A K + + R K  +     ++  R L   +   I+    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCHSMQICH 121
              T T L +VM    GG+L   I N       F E    ++  Q+ISG+ + H  +I +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           RDLK EN LLD     R  I D G + +     S+ K   GTP ++APE+L   EYD  V
Sbjct: 121 RDLKPENVLLDNDGNVR--ISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 1e-14
 Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 22/189 (11%)

Query: 3   KYELVKDLGAGNFGVARLLRHKE--TKELVAVKYIE----RGRKIDENVAREIINHRSLR 56
           KYE+   +G G +G     + K     +  A+K  +    +   I ++  REI   R L+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 57  HPNIIRFKEVVLTPTHLAIVM--EYAAGGEL----FDRICNAGRFSEDEGRYFFQQLISG 110
           H N++   EV L     ++ +  +YA         F R            +    Q+++G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 111 VNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKS------TVGT 162
           V+Y HS  + HRDLK  N L+  +G     +KI D G ++  + ++  K        V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178

Query: 163 PAYIAPEVL 171
             Y APE+L
Sbjct: 179 IWYRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 70.8 bits (173), Expect = 1e-14
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 43/220 (19%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN-- 59
           E +E +K +G G FG  RL++ K+T  + A+K + +   +++     I   R +      
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 60  --IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             +++         +L ++ME+  GG++   +      +E+E +++  + +  ++  H +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS-----------SVLHSRPK--------- 157
              HRD+K +N LLD      +K+ DFG               ++ HS P          
Sbjct: 121 GFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 158 ----------------STVGTPAYIAPEVLSRREYDGKVC 181
                           STVGTP YIAPEV  +  Y+ K+C
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLC 217

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 70.4 bits (172), Expect = 1e-14
 Identities = 58/225 (25%), Positives = 86/225 (38%), Gaps = 54/225 (24%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPN 59
           +  +K LG G FG   L R  +TK L A+K + +   +  N    +   R +     +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++R         +L  VM+Y  GG++   +   G F ED  R++  +L   V   H M  
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-------------------------------- 147
            HRD+K +N L+D      +K+ DFG                                  
Sbjct: 123 IHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 148 --------------KSSVLHSR--PKSTVGTPAYIAPEVLSRREY 176
                         +++  H R    S VGTP YIAPEVL R  Y
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.0 bits (171), Expect = 2e-14
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 21/182 (11%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           +E Y  +  LG G +      R K T  LVA+K I  E          RE+   + L+H 
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG--------RYFFQQLISG 110
           NI+   +++ T   L +V EY       D+  +  ++ +D G        + F  QL+ G
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEY------LDK--DLKQYLDDCGNSINMHNVKLFLFQLLRG 116

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPE 169
           +NYCH  ++ HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPD 174

Query: 170 VL 171
           +L
Sbjct: 175 IL 176

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 70.1 bits (171), Expect = 2e-14
 Identities = 51/189 (26%), Positives = 89/189 (47%), Gaps = 18/189 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E +E++K +G G FG   +++ K   ++ A+K + +   +           R +    ++
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV----LV 56

Query: 62  RFKEVVLTPTHLA--------IVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVN 112
                 +T  H A        +VM+Y  GG+L   +     R  ED  R++  +++  ++
Sbjct: 57  NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
             H +   HRD+K +N L+D +   RL   DFG     +     +S+  VGTP YI+PE+
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 171 LSRREYDGK 179
           L   E DGK
Sbjct: 175 LQAME-DGK 182

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 70.4 bits (172), Expect = 2e-14
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 43/220 (19%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN-- 59
           + +E +K +G G FG  RL++ K+T  + A+K + +   +++     I   R +      
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 60  --IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             +++         +L ++ME+  GG++   +      SE+  +++  + +  ++  H +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS-----------SVLHSRPK--------- 157
              HRD+K +N LLD  A   +K+ DFG               ++ H+ P          
Sbjct: 121 GFIHRDIKPDNLLLD--AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 158 ----------------STVGTPAYIAPEVLSRREYDGKVC 181
                           STVGTP YIAPEV  +  Y+ K+C
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLC 217

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 70.7 bits (173), Expect = 2e-14
 Identities = 42/125 (33%), Positives = 68/125 (54%), Gaps = 9/125 (7%)

Query: 73  LAIVMEYAAGGELFDRICN---AGR-FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
           +A+V++YA  G+L   I +     R F E E    F Q++  V++ HS  + HRD+K  N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173

Query: 129 TLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLL 185
            LL  +    +K+ DFG+SK   ++V     ++  GTP Y+APE+  R+ Y  K  +  L
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231

Query: 186 ILFLW 190
            + L+
Sbjct: 232 GVLLY 236

Length = 496

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 2e-14
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 22/191 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK------YIERGRKIDENVAREIINHRSL 55
           + +E++K +G G FG   +++ K T ++ A+K       ++R         R+++ +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYC 114
           R   I           +L +VM+Y  GG+L   +     R  ED  R++  +++  ++  
Sbjct: 61  RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST------VGTPAYIAP 168
           H +   HRD+K +N LLD +   RL   DFG    S L      T      VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172

Query: 169 EVLSRREYDGK 179
           E+L   E DGK
Sbjct: 173 EILQAME-DGK 182

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.1 bits (169), Expect = 2e-14
 Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 21/175 (12%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----PNIIRFKE 65
           LG GN G      H  T+ ++AVK I     I   + ++I++   + +    P II F  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 66  VVLTPTHLAIVMEYAAGGEL--FDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICH 121
                  ++I  E+  GG L  + +I     GR +          ++ G+ Y  S++I H
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           RD+K  N L++     ++K+CDFG S   V +S  K+ VGT AY+APE +S  +Y
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY 170

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.9 bits (168), Expect = 3e-14
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 21/193 (10%)

Query: 1   MEKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSL 55
           +  +++ K +G G F  V R     + K  VA+K ++    +D    ++  +EI   + L
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKP-VALKKVQIFEMMDAKARQDCVKEIDLLKQL 59

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGV 111
            HPN+I++ +  +    L IV+E A  G+L   I    +      E     +F QL S V
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYI 166
            + HS ++ HRD+K  N  +  +A   +K+ D G      SK++  H    S VGTP Y+
Sbjct: 120 EHMHSRRVMHRDIKPANVFI--TATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYM 173

Query: 167 APEVLSRREYDGK 179
           +PE +    Y+ K
Sbjct: 174 SPERIHENGYNFK 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 69.3 bits (170), Expect = 3e-14
 Identities = 60/221 (27%), Positives = 90/221 (40%), Gaps = 43/221 (19%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI----ER-GRKIDENVAREIINHRSLRHP 58
           YE++  LG G FG     R  +T  +VA+K I    E+ G  I     REI   + L+HP
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPI--TALREIKILKKLKHP 67

Query: 59  NIIRFKEVVL--------TPTHLAIVMEYAA---GGELFD-RICNAGRFSEDEGRYFFQQ 106
           N++   ++ +            + +V  Y      G L +  +    + +E + + +  Q
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV----KLTESQIKCYMLQ 123

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
           L+ G+NY H   I HRD+K  N L+D      LKI DFG ++       P +  G     
Sbjct: 124 LLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGGG-- 177

Query: 167 APEVLSRREYDGKVCI-------LLLILFLWRNYRPNPFIW 200
                  R+Y   V         LLL     R Y     IW
Sbjct: 178 ----GGTRKYTNLVVTRWYRPPELLL---GERRYTTAVDIW 211

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 68.5 bits (168), Expect = 3e-14
 Identities = 47/153 (30%), Positives = 65/153 (42%), Gaps = 19/153 (12%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L + LGAG FG V     +  TK  VAVK ++ G    E   +E    + LRH  +
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF-FQQLI-------SGVN 112
           ++   V      + IV EY + G L D +         EG+     QL+        G+ 
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           Y  S    HRDL   N L+  +     KI DFG
Sbjct: 118 YLESRNYIHRDLAARNILVGENLV--CKIADFG 148

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 68.6 bits (168), Expect = 4e-14
 Identities = 53/152 (34%), Positives = 74/152 (48%), Gaps = 16/152 (10%)

Query: 8   KDLGAGNFGVARLLRHKETKEL-----VAVKYIERGR--KIDENVAREIINHRSLRHPNI 60
           K LG G+FGV R  R + +        VAVK ++  +   I ++  +E     SL H N+
Sbjct: 1   KKLGDGSFGVVR--RGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNA-GRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR   VVLT   L +V E A  G L DR+  +A G F       +  Q+ +G+ Y  S +
Sbjct: 59  IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 119 ICHRDLKLENTLLDGSAAPRL-KICDFGYSKS 149
             HRDL   N LL   A+    KI DFG  ++
Sbjct: 118 FIHRDLAARNILL---ASDDKVKIGDFGLMRA 146

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 68.4 bits (167), Expect = 5e-14
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 11/153 (7%)

Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIER--GRKIDENVAREIINHRSLRHP 58
           + ++ LG G+FG   L  +      T E+VAVK ++R  G++      +EI   ++L H 
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 59  NIIRFKEVVLTP--THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI+++K          L ++MEY   G L D +    + +  +   F QQ+  G+ Y HS
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
               HRDL   N LLD      +KI DFG +K+
Sbjct: 126 QHYIHRDLAARNVLLDNDRL--VKIGDFGLAKA 156

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.6 bits (167), Expect = 6e-14
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 13/177 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLRH 57
           + YE ++ LG G++      + K   +LVA+K I    E G        RE    + L+H
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLKH 62

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            NI+   +++ T   L +V EY      +  D+  + G    +  + F  QL+ G++Y H
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
              I HRDLK +N L+  +    LK+ DFG +++  + S   S  V T  Y  P+VL
Sbjct: 121 QRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 68.5 bits (167), Expect = 1e-13
 Identities = 56/188 (29%), Positives = 88/188 (46%), Gaps = 16/188 (8%)

Query: 21  LRHKETKELVAVKYIERGRKIDENVAR-EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY 79
            R  + KE V  K++    +     AR E+    +  H  I++  +   +   L ++MEY
Sbjct: 87  TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146

Query: 80  AAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA 135
            +GG+L  +I    +    F E E    F Q++  ++  HS ++ HRDLK  N  L  + 
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG 206

Query: 136 APRLKICDFGYSKS---SVLHSRPKSTVGTPAYIAPEVLSRREYDGKV------CILLLI 186
              +K+ DFG+SK    SV      S  GTP Y+APE+  R+ Y  K        IL  +
Sbjct: 207 I--IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264

Query: 187 LFLWRNYR 194
           L L R ++
Sbjct: 265 LTLHRPFK 272

Length = 478

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 1e-13
 Identities = 57/198 (28%), Positives = 86/198 (43%), Gaps = 14/198 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
            ++ +L   +G G FG   L  ++  K  VAVK ++      +    E     +LRHPN+
Sbjct: 5   SKELKLGATIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLAEASVMTTLRHPNL 62

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQ 118
           ++   VVL    L IV EY A G L D + + GR   +  +   F   +  G+ Y     
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVL-HSRPKSTVGTPAYIAPEVLSRRE 175
             HRDL   N L+  D  A    K+ DFG +K +       K  V    + APE L  ++
Sbjct: 123 FVHRDLAARNVLVSEDLVA----KVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKK 175

Query: 176 YDGKVCILLLILFLWRNY 193
           +  K  +    + LW  Y
Sbjct: 176 FSTKSDVWSFGILLWEIY 193

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 2e-13
 Identities = 44/180 (24%), Positives = 88/180 (48%), Gaps = 9/180 (5%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y ++K L  G+ G   +       + V +K  ++G  + E +  + +NH     P++IR 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           K+ +++     +V+ + +  +L+  +   +     D+     +Q++ G+ Y H+ +I HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           D+K EN  ++     ++ I D G ++  V+        GT    APEVL+R +Y+ K  I
Sbjct: 182 DVKTENIFIN--DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADI 239

Length = 357

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 67.2 bits (164), Expect = 2e-13
 Identities = 54/232 (23%), Positives = 95/232 (40%), Gaps = 55/232 (23%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E +  VK +G G FG  RL++ K+T ++ A+K + +     ++    +   R +      
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P ++          +L ++ME+  GG+L   +     FSED  R++  + +  +   H +
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK----------------------------- 148
              HRD+K +N L+D      +K+ DFG S                              
Sbjct: 121 GFIHRDIKPDNILID--RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 149 ------SSVLHSRPK-------------STVGTPAYIAPEVLSRREYDGKVC 181
                 +  + S+ +             STVGTP YIAPE+  ++ Y G+ C
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQEC 229

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.9 bits (164), Expect = 2e-13
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 26/200 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           ++Y+ +  +G+G +G        +T   VA+K + R     I  +   RE+   + + H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V    + L       +V     G +L + I    + S+D  ++   Q++ G+ 
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGLK 132

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 186

Query: 171 -LSRREYDGKV------CIL 183
            L+   Y+  V      CI+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIM 206

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 67.0 bits (164), Expect = 2e-13
 Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 55/217 (25%)

Query: 4   YELVKDLGAGNFGVARLLRHKETK--ELVAVKYIERGRKIDENVAREIINHRSLR----- 56
           YEL+K+LG G +G+    R+ ET   E VA+K      KI    +++I+  R+LR     
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKLL 55

Query: 57  -----HPNII-----------RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG 100
                H NI             F E+ L       +ME     +L   I +    ++   
Sbjct: 56  RHFRGHKNITCLYDMDIVFPGNFNELYLYEE----LMEA----DLHQIIRSGQPLTDAHF 107

Query: 101 RYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST- 159
           + F  Q++ G+ Y HS  + HRDLK  N L++  A   LKICDFG ++       P    
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLVN--ADCELKICDFGLARG--FSENPGENA 163

Query: 160 ------VGTPAYIAPEV-LSRREYDGKV------CIL 183
                 V T  Y APE+ LS + Y   +      CIL
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 3e-13
 Identities = 49/153 (32%), Positives = 65/153 (42%), Gaps = 20/153 (13%)

Query: 8   KDLGAGNFGVAR--LLRHKETKEL-VAVKYIERGRKIDENVA--REIINHRS----LRHP 58
           K+LG GNFG     +   K  KE+ VAVK +    K +   A  +E +   S    L HP
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTL----KQEHIAAGKKEFLREASVMAQLDHP 56

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
            I+R   V      L +VME A  G L   +         + +    Q+  G+ Y  S  
Sbjct: 57  CIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKS 149
             HRDL   N LL     A    KI DFG S++
Sbjct: 116 FVHRDLAARNVLLVNRHQA----KISDFGMSRA 144

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.7 bits (160), Expect = 4e-13
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 11/152 (7%)

Query: 7   VKDLGAGNFGVARLLRHK----ETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L R+      T E VAVK +  E G     ++ +EI   R+L H NI
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +++K +        + ++ME+   G L + +  N  + +  +   +  Q+  G++Y  S 
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
           Q  HRDL   N L++     ++KI DFG +K+
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKA 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 65.4 bits (159), Expect = 9e-13
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 54/222 (24%)

Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +K LG G FG   L    +T  L A+K + +   ++ N    +   R +     +  +++
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                    +L  VM+Y  GG++   +     F E   R++  +L   +   H M   HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 123 DLKLENTLLDGSAAPRLKICDFG-------------YSKSS------------------- 150
           D+K +N L+D      +K+ DFG             Y K S                   
Sbjct: 126 DIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183

Query: 151 -------VLHSRPK---------STVGTPAYIAPEVLSRREY 176
                   L  R           S VGTP YIAPEVL R+ Y
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 64.6 bits (157), Expect = 9e-13
 Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 8/192 (4%)

Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
           LV+++G+G FG+  L    E ++ VA+K I  G   +E+   E      L HP +++   
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V    + + +V E+   G L D +    G+FS++        +  G+ Y  S  + HRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGKVC 181
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S  +Y  K  
Sbjct: 127 AARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 182 ILLLILFLWRNY 193
           +    + +W  +
Sbjct: 184 VWSFGVLMWEVF 195

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 65.0 bits (158), Expect = 1e-12
 Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 20/189 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR- 56
           +YE V ++G G +G     R   +   VA+K +     E G  +  +  RE+   + L  
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL--STVREVALLKRLEA 58

Query: 57  --HPNIIRFKEVVLT-----PTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPNI+R  +V  T      T + +V E+         D++   G    +  +   +Q 
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ H+  I HRDLK EN L+  ++  ++K+ DFG ++           V T  Y A
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 168 PEVLSRREY 176
           PEVL +  Y
Sbjct: 176 PEVLLQSTY 184

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.8 bits (158), Expect = 1e-12
 Identities = 59/198 (29%), Positives = 83/198 (41%), Gaps = 31/198 (15%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNII 61
           +Y  ++ LG G+ G+       +  + VAVK I     +  ++  REI   R L H NI+
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 62  RFKEV-----------VLTPTHLA---IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           +  EV           V + T L    IV EY         +   G  SE+  R F  QL
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQL 123

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG--------YSKSSVLHSRPKST 159
           + G+ Y HS  + HRDLK  N  ++ +    LKI DFG        YS    L       
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYL----SEG 178

Query: 160 VGTPAYIAPE-VLSRREY 176
           + T  Y +P  +LS   Y
Sbjct: 179 LVTKWYRSPRLLLSPNNY 196

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.5 bits (154), Expect = 3e-12
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 19/203 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE----RGRKIDENVAREIINHRSLR 56
           +  + + K +G G F              VA+K ++       K   +  +EI   + L 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIA 167
           + HS ++ HRD+K  N  +  +A   +K+ D G      SK++  H    S VGTP Y++
Sbjct: 121 HMHSRRVMHRDIKPANVFI--TATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYMS 174

Query: 168 PEVLSRREYDGKVCILLLILFLW 190
           PE +    Y+ K  I  L   L+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLY 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 62.9 bits (153), Expect = 4e-12
 Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 8/178 (4%)

Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG+G FGV  L + +  K  VA+K I  G   +++   E      L HPN+++   
Sbjct: 8   FLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V      + IV EY A G L + +    G+   +        +   + Y  S    HRDL
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI---APEVLSRREYDGK 179
              N L+       +K+ DFG ++  VL  +  S+ GT   +    PEV     +  K
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.5 bits (154), Expect = 4e-12
 Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 25/184 (13%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y+L   +G G+FGV       +T E VA+K + +  +      RE++  ++L H NII  
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN---RELLIMKNLNHINIIFL 124

Query: 64  KEVVLTPT--------HLAIVMEYAAGG-----ELFDRICNAGRFSEDEGRYFFQQLISG 110
           K+   T           L +VME+         + + R  N         + +  QL   
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRA 182

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPR---LKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + Y HS  ICHRDLK +N L+D    P    LK+CDFG +K+ +   R  S + +  Y A
Sbjct: 183 LAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238

Query: 168 PEVL 171
           PE++
Sbjct: 239 PELM 242

Length = 440

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 61.2 bits (148), Expect = 1e-11
 Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 12/197 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M++ +L++ +G G FG   L  ++  K  VAVK I+        +A   +    LRH N+
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 61

Query: 61  IRFKEVVLTP-THLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSM 117
           ++   V++     L IV EY A G L D + + GR     D    F   +   + Y  + 
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-YIAPEVLSRREY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  +++
Sbjct: 122 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 176

Query: 177 DGKVCILLLILFLWRNY 193
             K  +    + LW  Y
Sbjct: 177 STKSDVWSFGILLWEIY 193

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 17/189 (8%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINH-RS 54
           ++YE V ++G G +G V +    K     VA+K +     E G  +       ++ H  +
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V         T L +V E+         D++   G  +E      FQ L
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 119

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y A
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRA 177

Query: 168 PEVLSRREY 176
           PEVL +  Y
Sbjct: 178 PEVLLQSSY 186

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.5 bits (149), Expect = 2e-11
 Identities = 56/178 (31%), Positives = 84/178 (47%), Gaps = 19/178 (10%)

Query: 4   YELVKDLGAGNF-----GVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRS 54
           Y  ++ LG G++     G++R+        LVA+K I    K +E V     RE    + 
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQ-----LVALKVISM--KTEEGVPFTAIREASLLKG 59

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           L+H NI+   +++ T   L  V EY         I + G       R F  QL+ G+ Y 
Sbjct: 60  LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           H   I HRDLK +N L+  S    LK+ DFG +++  + S+  S+ V T  Y  P+VL
Sbjct: 120 HGQHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.4 bits (149), Expect = 2e-11
 Identities = 56/186 (30%), Positives = 82/186 (44%), Gaps = 19/186 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRH 57
           + YE ++ +G G +G     R K T +LVA+K   R    +E +     REI   + L  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59

Query: 58  -PNIIRFKEVVLTPTH-----LAIVMEYAAGGELFDRICNAGR-----FSEDEGRYFFQQ 106
              I+R  +V           L +V EY    +L   + + GR           + F  Q
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAY 165
           L+ GV +CH   + HRDLK +N L+D      LKI D G  ++ S+        + T  Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177

Query: 166 IAPEVL 171
            APEVL
Sbjct: 178 RAPEVL 183

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 61.3 bits (149), Expect = 2e-11
 Identities = 46/146 (31%), Positives = 65/146 (44%), Gaps = 11/146 (7%)

Query: 45  VAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDR-----ICNAGRFSEDE 99
           V RE+      +H N++   ++ L P H+    E     EL        I +    S D 
Sbjct: 46  VFRELKMLCFFKHDNVLSALDI-LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDH 104

Query: 100 GRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST 159
            + F  Q++ G+ Y HS  I HRD+K  N L++ +    LKICDFG ++          T
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDESKHMT 162

Query: 160 --VGTPAYIAPEVL-SRREYDGKVCI 182
             V T  Y APE+L   R Y   V I
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDI 188

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.1 bits (148), Expect = 3e-11
 Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 16/179 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E+Y  +K +G+G +G       K T E VA+K + R  + +   +   RE+   + ++H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  +           +VM Y        +I      SED+ +Y   Q++ G+ 
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLK 131

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y HS  I HRDLK  N  ++      LKI DFG ++ +   +     V T  Y APEV+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHA--DAEMTGYVVTRWYRAPEVI 186

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 3e-11
 Identities = 43/161 (26%), Positives = 59/161 (36%), Gaps = 14/161 (8%)

Query: 25  ETKELVAVKYIE----RGRKIDENVAREIINHRSLRHPNIIRF-KEVVLTPTHLAIVMEY 79
            T   VA+K +               RE      L HPNI+         P  L  V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 80  AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APR 138
             G  L + +   G     E      Q++  +   H+  I HRDLK +N ++  +   P 
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 139 LKICDFGYS--------KSSVLHSRPKSTVGTPAYIAPEVL 171
            K+ DFG                +R    +GTP Y APE L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 59.9 bits (145), Expect = 4e-11
 Identities = 52/188 (27%), Positives = 84/188 (44%), Gaps = 8/188 (4%)

Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEV 66
           +K+LG+G FGV  L + +   + VA+K I  G   +E+   E      L HP +++   V
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 67  VLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                 L IV E+   G L + +    G+ S+D      Q +  G+ Y       HRDL 
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127

Query: 126 LENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGKVCI 182
             N L+  S+   +K+ DFG ++  VL     S+ G      +  PEV +  +Y  K  +
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 183 LLLILFLW 190
               + +W
Sbjct: 185 WSFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 59.6 bits (144), Expect = 6e-11
 Identities = 56/182 (30%), Positives = 85/182 (46%), Gaps = 18/182 (9%)

Query: 8   KDLGAGNFG-VAR-LLRHKETKEL-VAVKYIERG--RKIDENVAREIINHRSLRHPNIIR 62
           K +GAG FG V R +L+    KE+ VA+K ++ G   K  ++   E        H NIIR
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV       I+ EY   G L D+    + G FS  +     + + +G+ Y   M   
Sbjct: 71  LEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  VL   P+ T  T        + APE ++ R
Sbjct: 130 HRDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 175 EY 176
           ++
Sbjct: 186 KF 187

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.6 bits (144), Expect = 8e-11
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 17/180 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           ++Y  +K +G+G +G       + T   VA+K + R  + +   +   RE+   + ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 59  NIIRFKEVVLTP-------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           N+I   +V  TP           +VM +   G    ++    + SED  ++   Q++ G+
Sbjct: 75  NVIGLLDV-FTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            Y H+  I HRDLK  N  ++      LKI DFG ++ +   S     V T  Y APEV+
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQT--DSEMTGYVVTRWYRAPEVI 187

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 58.9 bits (142), Expect = 1e-10
 Identities = 50/156 (32%), Positives = 70/156 (44%), Gaps = 19/156 (12%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LVK LGAG FG V     +  TK  VAVK ++ G    +    E    ++L+H  +
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVN 112
           +R   VV     + I+ EY A G L D +        DEG          F  Q+  G+ 
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFL------KSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           Y       HRDL+  N L+  S +   KI DFG ++
Sbjct: 118 YIERKNYIHRDLRAANVLV--SESLMCKIADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 1e-10
 Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 33/191 (17%)

Query: 6   LVKDLGAGNFG---VARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNI 60
           + K +G G FG     RL    + +  VA+K ++ G   K   +   E        HPNI
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLI-------SGV 111
           IR + VV     + I+ EY   G L  F R        E++G++   QL+       SG+
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGM 119

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT-----PA-Y 165
            Y   M   HRDL   N L++ +     K+ DFG S+   L    ++T  T     P  +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSR--RLED-SEATYTTKGGKIPIRW 174

Query: 166 IAPEVLSRREY 176
            APE ++ R++
Sbjct: 175 TAPEAIAYRKF 185

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 58.4 bits (141), Expect = 2e-10
 Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 18/178 (10%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---------KIDENVAREIINHRSLRHPNI 60
           LG G FG     + + T ++ A K +E+ R          ++E    E +N +      +
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF-----V 62

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQ 118
           +       T   L +V+    GG+L   I N G   F E+   ++  +++ G+   H   
Sbjct: 63  VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
             +RDLK EN LLD      ++I D G +         +  VGT  Y+APEVL+ + Y
Sbjct: 123 TVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 42/166 (25%), Positives = 68/166 (40%), Gaps = 27/166 (16%)

Query: 1   MEKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS- 54
            EK  L+++LG G+FG     +A+ +   E +  VA+K +     + E    E +N  S 
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASV 62

Query: 55  ---LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ------ 105
                  +++R   VV T     +VME  A G+L   +    R  E E            
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQK 120

Query: 106 ------QLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
                 ++  G+ Y  + +  HRDL   N ++       +KI DFG
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFG 164

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 47/212 (22%), Positives = 80/212 (37%), Gaps = 36/212 (16%)

Query: 2   EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDE-----NV 45
           E+Y      LG G +G         T ++VA+K +          +  + +         
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67

Query: 46  AREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ 105
            RE+     ++H NI+   +V +    + +VM+  A  +L   +    R +E + +    
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILL 126

Query: 106 QLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV--LHSRPKSTVGTP 163
           Q+++G+N  H     HRDL   N  ++       KI DFG ++      +S   S   T 
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 164 AYIAPEVLSRREYDGKVCILLLILFLWRNYRP 195
                    R E   KV      + LW  YR 
Sbjct: 185 Q-------RREEMTSKV------VTLW--YRA 201

Length = 335

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.5 bits (141), Expect = 2e-10
 Identities = 52/173 (30%), Positives = 77/173 (44%), Gaps = 8/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPN---IIRFKE 65
           LG G FG     + + T ++ A K +E+ R K  +  A  +   R L   N   ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF--QQLISGVNYCHSMQICHRD 123
              T   L +V+    GG+L   I N G    DE R  F   +L  G+      +I +RD
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           LK EN LLD      ++I D G +         +  VGT  Y+APEV++  +Y
Sbjct: 128 LKPENILLDDRG--HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 57.7 bits (140), Expect = 3e-10
 Identities = 48/181 (26%), Positives = 67/181 (37%), Gaps = 39/181 (21%)

Query: 2   EKYELVKDLGAGNFGVARL-----------LRHKETKE-----LVAVKYIERGRKIDENV 45
           +    V+ LG G FG   L               E        LVAVK +    + D + 
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL----RPDASD 60

Query: 46  A------REIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FDR 88
                  +E+     L  PNI R   V      L ++MEY   G+L              
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 89  ICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            CN+   S     Y   Q+ SG+ Y  S+   HRDL   N L+  +    +KI DFG S+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY--TIKIADFGMSR 178

Query: 149 S 149
           +
Sbjct: 179 N 179

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.7 bits (139), Expect = 3e-10
 Identities = 51/178 (28%), Positives = 77/178 (43%), Gaps = 18/178 (10%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---------KIDENVAREIINHRSLRHPNI 60
           LG G FG     + + T ++ A K +E+ R          ++E    E +N R      +
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF-----V 62

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF--QQLISGVNYCHSMQ 118
           +       T   L +V+    GG+L   I + G    +EGR  F   ++  G+   H  +
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y
Sbjct: 123 IVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.7 bits (139), Expect = 4e-10
 Identities = 52/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VAVK + R    +   +   RE++  + + H
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C       D  R  Y   Q++ G+ + 
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 139

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+   
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM 197

Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 198 GYKENVDI 205

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.4 bits (138), Expect = 4e-10
 Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 20/187 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           +YE  K +G G +G     + K+ K+    A+K IE G  I  +  REI   R L+HPN+
Sbjct: 3   EYEGCK-VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNV 60

Query: 61  IRFKEVVLTPT--HLAIVMEYAAGGEL----FDRICNAGR----FSEDEGRYFFQQLISG 110
           I  ++V L+ +   + ++ +YA         F R   A +          +    Q++ G
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 111 VNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKS----TVGTPA 164
           ++Y H+  + HRDLK  N L+  +G    R+KI D G+++      +P +     V T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 165 YIAPEVL 171
           Y APE+L
Sbjct: 181 YRAPELL 187

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.4 bits (138), Expect = 5e-10
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 5e-10
 Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 8/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIRFKE 65
           LG G FG     + + T ++ A K +E+ R          +N + +        ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRD 123
              T   L +V+    GG+L   I N G   F E+   ++  ++  G+   H  +I +RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           LK EN LLD      ++I D G +         +  VGT  Y+APEV+    Y
Sbjct: 128 LKPENILLDDYG--HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.0 bits (138), Expect = 5e-10
 Identities = 48/188 (25%), Positives = 79/188 (42%), Gaps = 31/188 (16%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNIIRFKE 65
           +G G FG    + HK +  ++AVK I R    ++   R +++     RS   P I++F  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 66  VVLTPTHLAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVNYC---------H 115
            +       I ME      + F +        E       ++++  +             
Sbjct: 71  ALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEVL- 171
            ++I HRD+K  N LLD +    +K+CDFG S     S+  +R     G   Y+APE + 
Sbjct: 126 ELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVDSIAKTR---DAGCRPYMAPERID 180

Query: 172 -SRRE-YD 177
            S R+ YD
Sbjct: 181 PSARDGYD 188

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 56.8 bits (137), Expect = 6e-10
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 24/184 (13%)

Query: 10  LGAGNFG-VAR-LLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +GAG FG V R  L+    +E+ VA+K ++ G    E   R+ ++  S+     HPNII 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV     + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA--------YIAPEVLS 172
           HRDL   N L++ +     K+ DFG S+   L         T +        + APE ++
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 173 RREY 176
            R++
Sbjct: 185 YRKF 188

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.4 bits (138), Expect = 6e-10
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 56.9 bits (137), Expect = 6e-10
 Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 39/202 (19%)

Query: 5   ELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIIN------HRS- 54
           EL+  +G G  +     L R+K T E V V      R+I+ E    E++       H S 
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTV------RRINLEACTNEMVTFLQGELHVSK 54

Query: 55  -LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGV 111
              HPNI+ ++   +    L +V  + A G   D IC       SE    Y  Q ++  +
Sbjct: 55  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKAL 114

Query: 112 NYCHSMQICHRDLKLENTL--LDGSAAPRLKICDFGY----------SKSSVLHSRPKST 159
           +Y H M   HR +K  + L  +DG      K+   G            +  V+H  PK +
Sbjct: 115 DYIHHMGYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYS 168

Query: 160 VGTPAYIAPEVLSR--REYDGK 179
           V    +++PEVL +  + YD K
Sbjct: 169 VKVLPWLSPEVLQQNLQGYDAK 190

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.4 bits (138), Expect = 7e-10
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 33/204 (16%)

Query: 1   MEKYELVKDLGAGNFG---VARLLRHKE-----------------TKELVAVKYIERGRK 40
           +  + ++ DL AG FG   +  L    E                  + L+A K ++ G +
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIA-KRVKAGSR 205

Query: 41  IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM---EYAAGGELFDRICN-AGRFS 96
               +  EI+    L H NI++ +E++ +  +  ++    ++     ++D   +   R  
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPL 265

Query: 97  EDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVL 152
             + R   +QL+  V Y H  ++ HRD+KLEN  L+      L   DFG    + K    
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLG--DFGTAMPFEKERE- 322

Query: 153 HSRPKSTVGTPAYIAPEVLSRREY 176
            +     VGT A  +PE+L+   Y
Sbjct: 323 -AFDYGWVGTVATNSPEILAGDGY 345

Length = 501

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 56.1 bits (135), Expect = 1e-09
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 22/184 (11%)

Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG     RL    + +  VA+K ++ G    E   R+ ++  S+     HPNI
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNI 67

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I  + VV     + IV EY   G L  F R  + G+F+  +     + + SG+ Y   M 
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE ++
Sbjct: 127 YVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 173 RREY 176
            R++
Sbjct: 183 YRKF 186

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 11/177 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G          ++ VAVK + R  +         RE+   + ++H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           N+I   +V    T +     + +     G   + I    + S++  ++   QL+ G+ Y 
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQA--DDEMTGYVATRWYRAPEIM 187

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 12/178 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--VAREI-INHRSLRHP 58
              E + ++G+G  G    +R K+T  ++AVK + R    +EN  +  ++ +  +S   P
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC-H 115
            I++     +T + + I ME  +    +L  RI   G   ED        ++  ++Y   
Sbjct: 75  YIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE 132

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVLS 172
              + HRD+K  N LLD S    +K+CDFG S   V  S+ K+ + G  AY+APE + 
Sbjct: 133 KHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERID 187

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 55.2 bits (133), Expect = 2e-09
 Identities = 45/155 (29%), Positives = 67/155 (43%), Gaps = 18/155 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E  +LVK LGAG FG   +  +    + VA+K +++G    E    E    + L+HP ++
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLV 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           R   VV T   + I+ EY   G L D +         EG             Q+  G+ +
Sbjct: 65  RLYAVV-TQEPIYIITEYMENGSLVDFL------KTPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
                  HRDL+  N L+  S     KI DFG ++
Sbjct: 118 IERKNYIHRDLRAANILV--SETLCCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 2e-09
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 54/185 (29%), Positives = 83/185 (44%), Gaps = 28/185 (15%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRSLR 56
           +Y+ +K +G+G  G+        T + VA+K + R     +NV       RE++  + + 
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73

Query: 57  HPNIIRFKEVVLTP-------THLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQ 106
           H NII    V  TP         + +VME      L D  +C   +   D  R  Y   Q
Sbjct: 74  HKNIIGLLNV-FTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQ 126

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
           ++ G+ + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y 
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYR 184

Query: 167 APEVL 171
           APEV+
Sbjct: 185 APEVI 189

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 20/187 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           +YE  K +G G +G     + K+ K+    A+K IE G  I  +  REI   R L+HPN+
Sbjct: 3   EYEGCK-VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNV 60

Query: 61  IRFKEVVLTPT--HLAIVMEYAAGGEL----FDRICNAGR----FSEDEGRYFFQQLISG 110
           I  ++V L+     + ++ +YA         F R   A +          +    Q++ G
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 111 VNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKS----TVGTPA 164
           ++Y H+  + HRDLK  N L+  +G    R+KI D G+++      +P +     V T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 165 YIAPEVL 171
           Y APE+L
Sbjct: 181 YRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 53.8 bits (129), Expect = 6e-09
 Identities = 48/176 (27%), Positives = 71/176 (40%), Gaps = 30/176 (17%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKE--------------LVAVKYI--ERGRKIDENV 45
           ++  L + LG G FG   L   +   E              LVAVK +  +  +    + 
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 46  AREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL------------FDRICNAG 93
            +EI     L++PNIIR   V ++   L ++ EY   G+L            F    N  
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 94  RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             S     Y   Q+ SG+ Y  S+   HRDL   N L+       +KI DFG S++
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRN 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.1 bits (127), Expect = 1e-08
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 20/156 (12%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L K LGAG FG V     +K TK  VAVK ++ G    E    E    ++L+H  +
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVN 112
           ++   VV T   + I+ E+ A G L D +        DEG          F  Q+  G+ 
Sbjct: 64  VKLHAVV-TKEPIYIITEFMAKGSLLDFL------KSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +       HRDL+  N L+  SA+   KI DFG ++
Sbjct: 117 FIEQRNYIHRDLRAANILV--SASLVCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.1 bits (127), Expect = 1e-08
 Identities = 53/191 (27%), Positives = 76/191 (39%), Gaps = 10/191 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR---HPNIIRFKEV 66
           +G GNFG     R +     VAVK        D   A+ +   R L+   HPNI+R   V
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK-AKFLQEARILKQYSHPNIVRLIGV 61

Query: 67  VLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                 + IVME   GG+    +   G R    E     +   +G+ Y  S    HRDL 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 126 LENTLLDGSAAPRLKICDFGYSKSSV--LHSRPKSTVGTPA-YIAPEVLSRREYDGKVCI 182
             N L+       LKI DFG S+     +++        P  + APE L+   Y  +  +
Sbjct: 122 ARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179

Query: 183 LLLILFLWRNY 193
               + LW  +
Sbjct: 180 WSFGILLWEAF 190

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 52.8 bits (127), Expect = 1e-08
 Identities = 46/191 (24%), Positives = 73/191 (38%), Gaps = 25/191 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E++ L + LG+G FG       K     VA+K ++    +  ++  +E+   + LRH ++
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGR--------YFFQQLISGVN 112
           I    V      + I+ E    G L   + +       EG+            Q+  G+ 
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSP------EGQVLPVASLIDMACQVAEGMA 118

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS---KSSV-LHSRPKSTVGTPAYIAP 168
           Y       HRDL   N L+        K+ DFG +   K  V L S  K       + AP
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAP 173

Query: 169 EVLSRREYDGK 179
           E  S   +  K
Sbjct: 174 EAASHGTFSTK 184

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 52.4 bits (126), Expect = 2e-08
 Identities = 45/164 (27%), Positives = 67/164 (40%), Gaps = 23/164 (14%)

Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHP 58
           L ++LG G FG   L     L  +  KELVAVK ++        ++  RE     + +H 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGEL----------FDRICNA----GRFSEDEGRYFF 104
           NI++F  V        +V EY   G+L             + +     G  +  +     
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            Q+ SG+ Y  S    HRDL   N L+       +KI DFG S+
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.4 bits (126), Expect = 2e-08
 Identities = 48/179 (26%), Positives = 86/179 (48%), Gaps = 23/179 (12%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYI-------ERGRKI-DENVAREIINHRSLR 56
           E++++LG G +GV   +RH  T  ++AVK I       E+ R + D +++      RS+ 
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISM-----RSVD 58

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDE--GRYFFQQLISGVN 112
            P  + F   +     + I ME       + + ++ + G    ++  G+     ++  + 
Sbjct: 59  CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-IVKALE 117

Query: 113 YCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPE 169
           Y HS + + HRD+K  N L++     ++K+CDFG S   V  S  K+   G   Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPE 173

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 52.3 bits (125), Expect = 2e-08
 Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 22/198 (11%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
           ++K  L + +G G FG   +L+ + T + VAVK I    K D   +    E      L H
Sbjct: 5   LQKLTLGEIIGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHH 58

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCH 115
            N++R   V+L    L IVME  + G L + +   GR      +   F   +  G+ Y  
Sbjct: 59  KNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117

Query: 116 SMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-YIAPEVLS 172
           S ++ HRDL   N L+  DG A    K+ DFG ++   + S        P  + APE L 
Sbjct: 118 SKKLVHRDLAARNILVSEDGVA----KVSDFGLAR---VGSMGVDNSKLPVKWTAPEALK 170

Query: 173 RREYDGKVCILLLILFLW 190
            +++  K  +    + LW
Sbjct: 171 HKKFSSKSDVWSYGVLLW 188

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 3e-08
 Identities = 45/153 (29%), Positives = 66/153 (43%), Gaps = 19/153 (12%)

Query: 5   ELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           +L++ LGAG FG V   L +  T   VAVK ++ G    ++   E    + LRHP +I+ 
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL 66

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF-FQQLI-------SGVNYCH 115
             V      + IV E    G L + +          GR     QLI       SG+ Y  
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQG------GAGRALKLPQLIDMAAQVASGMAYLE 120

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +    HRDL   N L+  +     K+ DFG ++
Sbjct: 121 AQNYIHRDLAARNVLVGENNI--CKVADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 51.8 bits (124), Expect = 4e-08
 Identities = 38/134 (28%), Positives = 59/134 (44%), Gaps = 15/134 (11%)

Query: 29  LVAVKYI--ERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELF 86
           LVAVK +  +  +    +  +EI     L+ PNIIR   V +T   L ++ EY   G+L 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 87  DRIC-----------NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA 135
             +            +    S     +   Q+ SG+ Y  S+   HRDL   N L+  + 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167

Query: 136 APRLKICDFGYSKS 149
              +KI DFG S++
Sbjct: 168 T--IKIADFGMSRN 179

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 50.8 bits (121), Expect = 7e-08
 Identities = 50/157 (31%), Positives = 71/157 (45%), Gaps = 22/157 (14%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L+K LG G FG V     +  TK  VAVK ++ G    E+   E    + LRH  +
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED-EGRYF--------FQQLISGV 111
           ++   VV +   + IV EY + G L D       F +D EGR            Q+ +G+
Sbjct: 64  VQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            Y   M   HRDL+  N L+        KI DFG ++
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLV--CKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 50.9 bits (122), Expect = 7e-08
 Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 27/191 (14%)

Query: 2   EKYELVKDLGAGNFG---VARLLRHKETKELVAVKY--IERGRKIDENVAREIINHRSLR 56
           E   L + +G G FG       +  +  K  VAVK         + E   +E    R   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLI 108
           HP+I++   V+ T   + IVME A  GEL         + +             +  QL 
Sbjct: 66  HPHIVKLIGVI-TENPVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQLS 117

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGT-P-AY 165
           + + Y  S +  HRD+   N L+   ++P  +K+ DFG S+     S  K++ G  P  +
Sbjct: 118 TALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174

Query: 166 IAPEVLSRREY 176
           +APE ++ R +
Sbjct: 175 MAPESINFRRF 185

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 49.8 bits (119), Expect = 2e-07
 Identities = 41/143 (28%), Positives = 57/143 (39%), Gaps = 8/143 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL---RHPNIIRFKEV 66
           +G GNFG       K     VAVK   R     +   + +     L    HPNI++   V
Sbjct: 3   IGKGNFGDVYKGVLK-GNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 67  VLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
            +    + IVME   GG L   +     R +  +         +G+ Y  S    HRDL 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120

Query: 126 LENTLLDGSAAPRLKICDFGYSK 148
             N L+  +    LKI DFG S+
Sbjct: 121 ARNCLVGENNV--LKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 49.0 bits (117), Expect = 3e-07
 Identities = 45/163 (27%), Positives = 63/163 (38%), Gaps = 23/163 (14%)

Query: 5   ELVKDLGAGNFG-----VARLLRHKETKELVAVKYI-ERGRKIDE-NVAREIINHRSLRH 57
            L++ LG G FG     + R       +  VAVK + E   + DE +   E +      H
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL--FDRIC--NAGRFSEDEGRYFFQQLI----- 108
            NI+R   V        I++E  AGG+L  F R       R S        + L+     
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS----LTMKDLLFCARD 124

Query: 109 --SGVNYCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSK 148
              G  Y       HRD+   N LL      R+ KI DFG ++
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 48.4 bits (115), Expect = 4e-07
 Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 14/196 (7%)

Query: 8   KDLGAGNFGVAR--LLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNII 61
            +LG+GNFG  +  + + K++++ VAVK I +    D  +  E++      + L +P I+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           R   +        +VME A  G L   +      +E        Q+  G+ Y       H
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPA-YIAPEVLSRREYD 177
           RDL   N LL        KI DFG SK   +   + + K+    P  + APE ++  ++ 
Sbjct: 119 RDLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 178 GKVCILLLILFLWRNY 193
            K  +    + +W  +
Sbjct: 177 SKSDVWSFGVLMWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 48.6 bits (116), Expect = 4e-07
 Identities = 41/173 (23%), Positives = 68/173 (39%), Gaps = 29/173 (16%)

Query: 1   MEKYELVKDLGAGNFG-VAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHR 53
           +     +++LG G FG V +        + +   VA+K ++     K+ +   +E     
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSEDEGRY------- 102
            L+HPNI+    V        ++ EY A G+L +       ++   +E            
Sbjct: 64  DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123

Query: 103 --FFQ---QLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL--KICDFGYSK 148
             F     Q+ +G+ Y  S    HRDL   N L+       L  KI DFG S+
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV----GEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 48.3 bits (115), Expect = 5e-07
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 12/188 (6%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 74  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133

Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+       +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 134 NCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 188

Query: 183 LLLILFLW 190
               + LW
Sbjct: 189 WAFGVLLW 196

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 47.9 bits (114), Expect = 8e-07
 Identities = 47/175 (26%), Positives = 69/175 (39%), Gaps = 31/175 (17%)

Query: 3   KYELVKDLGAGNFGV---ARL--LRHKETKELVAVKYIERGRKID--ENVAREIINHRSL 55
             E V+D+G G FG    AR   L   E   +VAVK ++     D   +  RE       
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--------------------RICNAGR- 94
            HPNI++   V      + ++ EY A G+L +                    R C     
Sbjct: 66  DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 95  -FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             S  E     +Q+ +G+ Y    +  HRDL   N L+  +    +KI DFG S+
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 58/205 (28%), Positives = 84/205 (40%), Gaps = 40/205 (19%)

Query: 10  LGAGNFGVARLLRHKET---KELVAVKYIERGRKIDENVAREIINHRSLR---HPNIIRF 63
           LG GNFG       K T   K  VAVK  +     +  + + +   R L+   HPNI++ 
Sbjct: 3   LGKGNFGEV----FKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKL 57

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHS 116
             V      + IVME   GG+    +    R  +DE +   +QL+       +G+ Y  S
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLES 111

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK--------SSVLHSRPKSTVGTPAYIAP 168
               HRDL   N L+  +    LKI DFG S+        SS L   P        + AP
Sbjct: 112 KNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAP 163

Query: 169 EVLSRREYDGKVCILLLILFLWRNY 193
           E L+   Y  +  +    + LW  +
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETF 188

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 47.0 bits (111), Expect = 2e-06
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 24/207 (11%)

Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPN 59
           L ++LG G FG   L     L  ++ K LVAVK ++       ++  RE     +L+H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-------------RFSEDEGRYFFQQ 106
           I++F  V +    L +V EY   G+L   +   G               ++ +  +  QQ
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGTPA 164
           + +G+ Y  S    HRDL   N L+  +    +KI DFG S+   S  + R       P 
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 165 -YIAPEVLSRREYDGKVCILLLILFLW 190
            ++ PE +  R++  +  +  L + LW
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLW 213

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 46.6 bits (111), Expect = 2e-06
 Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 35/205 (17%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRS 54
           ++  L K LG G FG      A  L +      VAVK ++      +  ++  E+   + 
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI---------CNAGRFSEDEGRYFF 104
           + +H NII    V      L +V+EYAA G L D +          +       E     
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 105 QQLIS-------GVNYCHSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRP 156
           + L+S       G+ +  S +  HRDL   N L+ +      +KI DFG ++   +H   
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV---MKIADFGLARD--IHHID 186

Query: 157 ---KSTVG-TPA-YIAPEVLSRREY 176
              K+T G  P  ++APE L  R Y
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVY 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 28/85 (32%), Positives = 40/85 (47%), Gaps = 17/85 (20%)

Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLL---------DGSAAPRLK-----ICDFGYSKS 149
           F ++ + + Y HS  + HRDLK +N LL         D  AA   K     + D    + 
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 150 SVLHSR---PKSTVGTPAYIAPEVL 171
           ++ +S    P   VGTP Y+APE L
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERL 203

Length = 932

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.5 bits (110), Expect = 2e-06
 Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 15/181 (8%)

Query: 5   ELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKIDENV---AREIINHRSLRHPN 59
           EL  ++G G  N     L RH  T  LV V+  +     +E++     E++     RHPN
Sbjct: 1   ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60

Query: 60  IIRFKEVVLTPTHLAIV---MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+    V  T + L ++   M Y +   L       G  SE          + G+NY H 
Sbjct: 61  IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYS------KSSVLHSRPKSTVGTPAYIAPEV 170
               HR++K  + L+ G     L      YS      K+ V++  P+ +     +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179

Query: 171 L 171
           L
Sbjct: 180 L 180

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 46.1 bits (109), Expect = 3e-06
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 10/147 (6%)

Query: 9   DLGAGNFGVAR--LLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFK 64
           +LG+GNFG  +  + + ++ +  VA+K ++    + + + + RE      L +P I+R  
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHR 122
            V      L +VME A+GG L ++  +  +   +         Q+  G+ Y       HR
Sbjct: 62  GVC-EAEALMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS 149
           DL   N LL        KI DFG SK+
Sbjct: 120 DLAARNVLLVNQHYA--KISDFGLSKA 144

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 45.9 bits (109), Expect = 3e-06
 Identities = 46/192 (23%), Positives = 79/192 (41%), Gaps = 27/192 (14%)

Query: 5   ELVKDLGAGNFGVARLLRHK--------ETKELVAVKYI--ERGRKIDENVAREIINHRS 54
           E +K LG+G FG      +K        + K  VA+K +  E   K ++ +  E     S
Sbjct: 10  EKIKVLGSGAFGTV----YKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS 65

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNY 113
           + HP+++R   + L+     ++ +    G L D +  +           +  Q+  G++Y
Sbjct: 66  VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPA-----YIA 167
               ++ HRDL   N L+     P+  KI DFG +K  +L    K            ++A
Sbjct: 125 LEEKRLVHRDLAARNVLVK---TPQHVKITDFGLAK--LLDVDEKEYHAEGGKVPIKWMA 179

Query: 168 PEVLSRREYDGK 179
            E +  R Y  K
Sbjct: 180 LESILHRIYTHK 191

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.2 bits (107), Expect = 6e-06
 Identities = 43/159 (27%), Positives = 61/159 (38%), Gaps = 22/159 (13%)

Query: 10  LGAGNFG------VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPN 59
           LG+G FG         +L        VAVK + +G    E    E +    L     HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS-------GVN 112
           I++   V L      I+ME   GG+L   + +A            ++L+        G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 113 YCHSMQICHRDLKLENTLL---DGSAAPRLKICDFGYSK 148
           Y   M   HRDL   N L+      A   +KI DFG ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.4 bits (107), Expect = 6e-06
 Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 18/157 (11%)

Query: 3   KYELVKDLGAGNFG-VARLLRHKETKEL---VAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG V + L   E +++   VA+K +      K ++ +  E     S+ 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 68  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 122

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQ--HVKITDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 45.0 bits (106), Expect = 7e-06
 Identities = 54/206 (26%), Positives = 83/206 (40%), Gaps = 31/206 (15%)

Query: 10  LGAGNFG--VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-----RHPNIIR 62
           +G GNFG  +  +++    K   A+K ++      EN  R+      +      HPNII 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFD-----RIC-----------NAGRFSEDEGRYFFQQ 106
                    +L I +EYA  G L D     R+             A   +  +   F   
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT-PA- 164
           + +G+ Y    Q  HRDL   N L+  + A   KI DFG S+   ++   K T+G  P  
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183

Query: 165 YIAPEVLSRREYDGKVCILLLILFLW 190
           ++A E L+   Y  K  +    + LW
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLW 209

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 44.6 bits (105), Expect = 9e-06
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 33/213 (15%)

Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYIE----RGRKIDENVAREIINHRSLR 56
           L ++LG G FG   L     L   + K LVAVK ++      RK  +  A  + N   L+
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN---LQ 65

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FDR-------ICNAGRFSEDEGRYFFQQL 107
           H +I++F  V      L +V EY   G+L  F R       I   G+  + +G     Q+
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPK 157
           +       SG+ Y  S    HRDL   N L+   A   +KI DFG S+   S+  +    
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSRDVYSTDYYRVGG 183

Query: 158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLW 190
            T+    ++ PE +  R++  +  +    + LW
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 44.3 bits (104), Expect = 1e-05
 Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 31/206 (15%)

Query: 10  LGAGNFG--VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-----RHPNIIR 62
           +G GNFG  +   ++    +   A+K ++      ++  R+      +      HPNII 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFD-----RIC-----------NAGRFSEDEGRYFFQQ 106
                    +L + +EYA  G L D     R+             A   S  +  +F   
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT-PA- 164
           +  G++Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176

Query: 165 YIAPEVLSRREYDGKVCILLLILFLW 190
           ++A E L+   Y     +    + LW
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLW 202

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 2e-05
 Identities = 33/86 (38%), Positives = 42/86 (48%), Gaps = 15/86 (17%)

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC--DFGY------SKSSVLHSRP 156
           +QL+S ++Y H   I HRD+K EN L++G       IC  DFG       S S+  H   
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322

Query: 157 KSTVGTPAYIAPEVLSRREYDGKVCI 182
             TV T    APEVL+   Y   V I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSVDI 345

Length = 461

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 43.9 bits (103), Expect = 2e-05
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T + VA+K ++ G  + E   +E    + LRH  ++
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLV 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
               VV +   + IV E+   G L D +       E +G+Y           Q+  G+ Y
Sbjct: 65  PLYAVV-SEEPIYIVTEFMGKGSLLDFL------KEGDGKYLKLPQLVDMAAQIADGMAY 117

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     KI DFG ++
Sbjct: 118 IERMNYIHRDLRAANILVGDNLV--CKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 43.8 bits (103), Expect = 2e-05
 Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 45/180 (25%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKY---IERGRKIDENVAREII------NHRS------ 54
           LG G FG   L      ++L  +++   + +GR +   VA +I+      N R+      
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPL--LVAVKILRPDANKNARNDFLKEV 70

Query: 55  -----LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGR-------- 101
                L+ PNIIR   V +    L ++ EY   G+L ++  ++    + E          
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129

Query: 102 ------------YFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
                       +   Q+ SG+ Y  S+   HRDL   N L+  +    +KI DFG S++
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRN 187

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 43.8 bits (103), Expect = 2e-05
 Identities = 54/225 (24%), Positives = 84/225 (37%), Gaps = 42/225 (18%)

Query: 3   KYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSL 55
              L K LG G FG      A  L+ +     VAVK ++      E  ++  E    + +
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----FDRICNAGRFSEDEGRY-------- 102
            HP++I+          L +++EYA  G L       R         D  R         
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 103 -----------FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--- 148
                      F  Q+  G+ Y   M++ HRDL   N L+  +   ++KI DFG S+   
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVY 178

Query: 149 ---SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLW 190
              S V  S+ +  V    ++A E L    Y  +  +    + LW
Sbjct: 179 EEDSYVKRSKGRIPV---KWMAIESLFDHIYTTQSDVWSFGVLLW 220

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 43.5 bits (102), Expect = 2e-05
 Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 10/151 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSE----DEGRYFFQQLISGVNYCHSM 117
           +   VV +   + IV EY + G L D +   G   +     +      Q+ SG+ Y   M
Sbjct: 65  QLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM 121

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              HRDL+  N L+  +     K+ DFG ++
Sbjct: 122 NYVHRDLRAANILVGENLV--CKVADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.4 bits (102), Expect = 2e-05
 Identities = 47/162 (29%), Positives = 69/162 (42%), Gaps = 25/162 (15%)

Query: 9   DLGAGNFGVARL-----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIR 62
           +LG G FG   L     L  ++ K LVAVK + E      ++  RE      L+H +I+R
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQ 106
           F  V      L +V EY   G+L +R   +                G+ +  +      Q
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           + SG+ Y  S+   HRDL   N L+       +KI DFG S+
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.4 bits (102), Expect = 3e-05
 Identities = 57/196 (29%), Positives = 86/196 (43%), Gaps = 33/196 (16%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++++++  LG G FG       ++ KE  AVK +    K   +   EI     +R  +  
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188

Query: 62  -RFKEVVLT------PTHLAIVM-EYAAGGELFDRICNAGRFSEDEGRYFFQ---QLISG 110
            RF  + +         H+ IVM +Y  G  L D I   G FS    R+  Q   Q    
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSH---RHLAQIIFQTGVA 243

Query: 111 VNYCHS-MQICHRDLKLENTLLDGS----------AAP----RLKICDFGYSKSSVLHSR 155
           ++Y H+ + + H DLK EN L++ S          A P    R++ICD G       HSR
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR 302

Query: 156 PKSTVGTPAYIAPEVL 171
             + V T  Y +PEV+
Sbjct: 303 -TAIVSTRHYRSPEVV 317

Length = 467

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 42.6 bits (100), Expect = 4e-05
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 37/221 (16%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKE------LVAVKYIERGRKIDENVAREIINHRS 54
           ++  L K LG G FG V R   +   K        VAVK + +    D+++A ++I+   
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69

Query: 55  L-----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-----FSED-----E 99
           L     +H NII    V      L +++EYAA G L + +  A R     ++ D     E
Sbjct: 70  LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPE 128

Query: 100 GRYFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--S 150
            +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV--TEDNVMKIADFGLARGVHD 186

Query: 151 VLHSRPKSTVGTPA-YIAPEVLSRREYDGKVCILLLILFLW 190
           + + +  S    P  ++APE L  R Y  +  +    + +W
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 42.7 bits (100), Expect = 4e-05
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 26/216 (12%)

Query: 6   LVKDLGAGNFG--VARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNI 60
           L K LG G FG  +   L   ++   VAVK ++     R   E+   E +  +   HPN+
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 61  IRFKEVVLTPTHL------AIVMEYAAGGEL-----FDRICNAGRFSEDEGRY-FFQQLI 108
           +R   V L            +++ +   G+L     + R+ +  ++   +    F   + 
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGTPA-Y 165
           SG+ Y  S    HRDL   N +L+ +    + + DFG SK   +  + R       P  +
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 166 IAPEVLSRREYDGKVCILLLILFLW----RNYRPNP 197
           IA E L+ R Y  K  +    + +W    R   P P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP 216

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 1e-04
 Identities = 49/186 (26%), Positives = 80/186 (43%), Gaps = 14/186 (7%)

Query: 3   KYELVKDLGAGNFG-VARLLRH-KETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           +Y ++  L  G+ G V    +H  E ++ V VK +  G+       REI   +++ H  I
Sbjct: 93  QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAI 148

Query: 61  IRFKEVVLTPTHLAIVM-EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I         + + +VM +Y    +LF  +  +G    ++     ++L+  + Y H   I
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKC--DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGI 206

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST--VGTPAYIAPEVLSRREY 176
            HRD+K EN  LD      L   DFG +     H   P+     GT    +PE+L+   Y
Sbjct: 207 IHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264

Query: 177 DGKVCI 182
             K  I
Sbjct: 265 CAKTDI 270

Length = 392

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 41.2 bits (96), Expect = 1e-04
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 16/152 (10%)

Query: 7   VKDLGAGNFGVAR---LLRHKETKEL-VAVKYIER--GRKIDENVAREIINHRSLRHPNI 60
           VK LG+G FG       +   ET ++ VA+K +    G K +     E +   S+ HP++
Sbjct: 12  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ----QLISGVNYCHS 116
           +R   V L+PT + +V +    G L D +       ++ G         Q+  G+ Y   
Sbjct: 72  VRLLGVCLSPT-IQLVTQLMPHGCLLDYV---HEHKDNIGSQLLLNWCVQIAKGMMYLEE 127

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            ++ HRDL   N L+   +   +KI DFG ++
Sbjct: 128 RRLVHRDLAARNVLV--KSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 41.0 bits (96), Expect = 2e-04
 Identities = 40/168 (23%), Positives = 64/168 (38%), Gaps = 34/168 (20%)

Query: 6   LVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           L K LG G FG     +L +   ++  VAVK +    K+D       E    E    +  
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58

Query: 56  RHPNIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI- 108
            HPN+++   V    + L       +++ +   G+L   +    R      +   Q L+ 
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLK 117

Query: 109 ------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC--DFGYSK 148
                  G+ Y  +    HRDL   N +L       + +C  DFG SK
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 25/163 (15%)

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FDRICNAGRFSEDEGRYFF 104
           +H NII           L +++EYA+ G L            D   +  +  E++    F
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ--LTF 133

Query: 105 QQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRP 156
           + L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++    +    
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYK 191

Query: 157 KSTVGT-PA-YIAPEVLSRREYDGKVCILLLILFLWRNYRPNP 197
           K+T G  P  ++APE L  R Y  +  +    + LW  +    
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 40.6 bits (95), Expect = 2e-04
 Identities = 44/189 (23%), Positives = 78/189 (41%), Gaps = 22/189 (11%)

Query: 8   KDLGAGNFG------VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
            ++G G FG        R +     K  V VK +      DE +   +E+  +R L HPN
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMS----KARVVVKELRASATPDEQLLFLQEVQPYRELNHPN 56

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQL----ISGVNYC 114
           +++     +      +V+E+   G+L + +  N G  ++   +   Q++     SG+ + 
Sbjct: 57  VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFG--YSKSSVLHSRPKSTVGTP-AYIAPEVL 171
           H     H DL L N  L    +  +KI D+G    +    +   K     P  ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174

Query: 172 SRREYDGKV 180
             R  D   
Sbjct: 175 EIRGQDLLP 183

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 40.8 bits (95), Expect = 2e-04
 Identities = 52/219 (23%), Positives = 89/219 (40%), Gaps = 33/219 (15%)

Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------- 102
               +H NII           L +++EYA+ G L + +  A R    E  Y         
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQ 133

Query: 103 -FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVL 152
             F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  +++ 
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNID 191

Query: 153 HSRPKSTVGTPA-YIAPEVLSRREYDGKVCILLLILFLW 190
           + +  +    P  ++APE L  R Y  +  +    + +W
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 40.5 bits (95), Expect = 2e-04
 Identities = 42/158 (26%), Positives = 64/158 (40%), Gaps = 14/158 (8%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVAR----EIINH 52
                 K LGAG FG      A  L   +    VAVK ++      E  A     +I++H
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSE-DEGRYFFQQLISG 110
               H NI+           + ++ EY   G+L + +      F   ++   F  Q+  G
Sbjct: 95  LG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           + +  S    HRDL   N LL  +    +KICDFG ++
Sbjct: 154 MAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 39.8 bits (93), Expect = 4e-04
 Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 9/146 (6%)

Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      L+     K   AVK + R   ++E     +E I  +   HPN++   
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 65  EVVLTPTHLA-IVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L       +V+ Y   G+L + I +       +    F  Q+  G+ Y  S +  HR
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD S    +K+ DFG ++
Sbjct: 123 DLAARNCMLDESFT--VKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.2 bits (91), Expect = 7e-04
 Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 23/166 (13%)

Query: 2   EKYELVKDLGAGNF-----GVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+F     G AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63

Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELF--------DRICNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L         +   N GR      E   
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123

Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 38.1 bits (88), Expect = 0.002
 Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 12/102 (11%)

Query: 105 QQLISGVNYCHSMQICHRDLKLENTL--LDGSAAPRLKICDFGYS--KSSVLHSRPKSTV 160
           +Q+++G+   H + I HRD+K EN L  +DG    ++KI DFG +    + ++  P   +
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDG----QVKIIDFGAAVDMCTGINFNPLYGM 371

Query: 161 GTPAYIAPEVL----SRREYDGKVCILLLILFLWRNYRPNPF 198
             P Y  PE L    S           LL  F W   RP+ F
Sbjct: 372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF 413

Length = 507

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 37.6 bits (87), Expect = 0.002
 Identities = 39/143 (27%), Positives = 57/143 (39%), Gaps = 10/143 (6%)

Query: 10  LGAGNFG-VAR-LLRHKETKEL-VAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFK 64
           LG G FG + R  L+    +EL VA+  +  G   K       E +      H NI+R +
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 65  EVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
            V+     + IV EY + G L  F R  + G+    +       L SG+ Y   M   H+
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK 131

Query: 123 DLKLENTLLDGSAAPRLKICDFG 145
            L     L++       KI  F 
Sbjct: 132 GLAAHKVLVNSDLV--CKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 37.3 bits (86), Expect = 0.003
 Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 25/173 (14%)

Query: 10  LGAGNFG--VARLLRHKETKELVAVKYIERGRKIDE--NVAREI-INHRSLRHPNIIRFK 64
           +G GNFG  +   ++    +   A+K ++     D+  + A E+ +  +   HPNII   
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRFSEDEGRYFFQQLI 108
                  +L + +EYA  G L D +                  A   S  +  +F   + 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG 161
            G++Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMG 183

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 37.2 bits (86), Expect = 0.003
 Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 11/149 (7%)

Query: 8   KDLGAGNFGVARL--LRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPNIIRF 63
           K++G G FG   L  +    T   V VK +     + E +    E   +RSL+H N+++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 64  KEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQ---QLISGVNYCHSMQ 118
                  T   +VME+   G+L  + R C        +     +   ++  G+ + H   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYS 147
             H DL L N LL  +A   +KI D+G S
Sbjct: 121 FIHSDLALRNCLL--TADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 37.7 bits (87), Expect = 0.003
 Identities = 43/184 (23%), Positives = 77/184 (41%), Gaps = 16/184 (8%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           + +++    G  G A      +T E V +K  +RG       A E    R++ HP+II+ 
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG-----GTATEAHILRAINHPSIIQL 148

Query: 64  KEVVLTPTHLAIVM-EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           K          +++  Y    +L+  +      +  +     + ++  + Y H  +I HR
Sbjct: 149 KGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHR 206

Query: 123 DLKLENTLLDGSAAPRLKIC--DFGYS--KSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           D+K EN  ++        +C  DFG +     +  ++     GT A  APE+L+R  Y  
Sbjct: 207 DIKAENIFINHPG----DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGP 262

Query: 179 KVCI 182
            V I
Sbjct: 263 AVDI 266

Length = 391

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 36.9 bits (85), Expect = 0.004
 Identities = 38/150 (25%), Positives = 64/150 (42%), Gaps = 18/150 (12%)

Query: 7   VKDLGAGNFGVARLLRHK--------ETKELVAVKYIE--RGRKIDENVAREIINHRSLR 56
           +K LG+G FG      HK          K  VA+K I+   GR+  + +   ++   SL 
Sbjct: 12  LKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           H  I+R   +    + L +V + +  G L D +  +           +  Q+  G+ Y  
Sbjct: 68  HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFG 145
             ++ HR+L   N LL   +   ++I DFG
Sbjct: 127 EHRMVHRNLAARNILLKSDS--IVQIADFG 154

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	200
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PRK09188	365	serine/threonine protein kinase; Provisional	99.97
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.95
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PRK12274	218	serine/threonine protein kinase; Provisional	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PRK10345	210	hypothetical protein; Provisional	99.91
smart00090	237	RIO RIO-like kinase.	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
PRK14879	211	serine/threonine protein kinase; Provisional	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.87
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.87
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.86
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.82
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.82
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.7
KOG1243	690	consensus Protein kinase [General function predict	99.68
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.67
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.66
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.65
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.56
KOG3087	229	consensus Serine/threonine protein kinase [General	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.53
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.52
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.51
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.45
COG4248	637	Uncharacterized protein with protein kinase and he	99.41
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.38
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.37
PRK09902	216	hypothetical protein; Provisional	99.35
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.35
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.21
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.2
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	99.13
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.09
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	99.0
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.96
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.93
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.87
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.86
PLN02876	822	acyl-CoA dehydrogenase	98.81
PF01636	239	APH: Phosphotransferase enzyme family This family	98.79
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.79
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.76
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.67
KOG2270	520	consensus Serine/threonine protein kinase involved	98.64
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.63
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.61
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.53
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.43
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.39
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.32
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.28
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.27
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.25
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	98.23
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.11
PRK05231	319	homoserine kinase; Provisional	98.11
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	98.05
PRK10593	297	hypothetical protein; Provisional	98.03
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.99
PLN02236	344	choline kinase	97.91
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.9
PLN02756	418	S-methyl-5-thioribose kinase	97.77
PRK12396	409	5-methylribose kinase; Reviewed	97.74
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.69
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.63
PTZ00384	383	choline kinase; Provisional	97.56
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.43
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.33
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.14
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.05
PRK11768	325	serine/threonine protein kinase; Provisional	97.02
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.02
PTZ00296	442	choline kinase; Provisional	96.98
COG2334	331	Putative homoserine kinase type II (protein kinase	96.94
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.92
KOG2269	531	consensus Serine/threonine protein kinase [Signal	96.47
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.09

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-56  Score=322.72  Aligned_cols=199  Identities=36%  Similarity=0.598  Sum_probs=186.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +.+|.+.+.||+|+|++||+|+++.++..||+|.+.+..   +..+.+..|+.+|+.++||||+.+++++.+++++++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            468999999999999999999999999999999997653   34566889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC-CC---CCEEEeecCCCcccCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AA---PRLKICDFGYSKSSVLH  153 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~-~~---~~v~l~df~~~~~~~~~  153 (200)
                      |||+||+|.+++.+.+.+++.+++.++.|++.||++||+++|+||||||+||+++.. ..   ..+||+|||+|+....+
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999999999999999999999999999999999999999999999999999999754 22   56999999999988888


Q ss_pred             CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......+|++.|||||++..+.|+.++|+||+|+++|++++|.+||
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf  214 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPF  214 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCc
Confidence            8888889999999999999999999999999999999999999998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-56  Score=318.85  Aligned_cols=197  Identities=32%  Similarity=0.572  Sum_probs=183.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++++.||+|+||+||.++.+++++.+|+|++++..    +..+...+|..+|..++||+|+++...|++...+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            68999999999999999999999999999999998753    34567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~  156 (200)
                      ||+.||.|...+++.+.+++..+..++.+|+.||.|||+.||+||||||+||+++.++.  ++|+|||+|+..... ...
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~~~~t  182 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKDGDAT  182 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccCCCcc
Confidence            99999999999999999999999999999999999999999999999999999987775  999999999844444 445


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+||+.|+|||++.+..|+..+|+||||+++|+|++|.|||.
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~  226 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY  226 (357)
T ss_pred             ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence            55699999999999999999999999999999999999999994

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-54  Score=324.69  Aligned_cols=195  Identities=36%  Similarity=0.547  Sum_probs=184.6

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecc----cccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIER----GRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +|+..+.||+|||+.+|.+.+..+|+.||+|++.+    .....+.+.+|+++.++|+|||||+++++|++.+++|++.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            59999999999999999999999999999999987    45667889999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~  157 (200)
                      +|+.++|..++...+++++.+++.+++||+.||.|||+++|+|||||..|++++++.+  |||+|||+|...... ....
T Consensus        99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCcccccc
Confidence            9999999999998889999999999999999999999999999999999999987776  999999999766644 6667


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..+|||.|.|||++.+...++.+||||+||+||.||.|.|||
T Consensus       177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPF  218 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPF  218 (592)
T ss_pred             eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCc
Confidence            789999999999999999999999999999999999999999

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-53  Score=307.99  Aligned_cols=198  Identities=40%  Similarity=0.605  Sum_probs=179.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc--------hHHHHHHHHHHhhCCCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--------DENVAREIINHRSLRHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   73 (200)
                      +.|.+.+.||+|+||.|-+|.++.+++.||+|++.+....        .....+|+++|++++||+|+++.++|......
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            4688999999999999999999999999999999864211        12367999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC-CCCCEEEeecCCCcccCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~-~~~~v~l~df~~~~~~~~  152 (200)
                      |+||||++||.|.+++-.++.+.+...+.+++|++.|+.|||++||+||||||+||++..+ ....+||+|||+|+....
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~  331 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE  331 (475)
T ss_pred             EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence            9999999999999999999999999999999999999999999999999999999999765 334689999999998877


Q ss_pred             CCCCCcccCCCCccCCeeecCcc--cC-CeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRRE--YD-GKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~--~~-~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..-....+||+.|.|||++.+..  +. .++|+|||||++|-+|+|.|||
T Consensus       332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPF  381 (475)
T KOG0615|consen  332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPF  381 (475)
T ss_pred             ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCc
Confidence            77788899999999999998654  33 3679999999999999999999

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-53  Score=295.24  Aligned_cols=196  Identities=32%  Similarity=0.586  Sum_probs=182.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||.|+||.|.+++++.++..+|+|++.+..    +..+...+|..+|+.+.||+++++.+.+.+.+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            578999999999999999999999999999999998764    3346788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      |||++||.|.+++.+.+++++..++.++.|++.||+|||+++|++||+||+||++|.++.  +||+|||+|+.....  .
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc--E
Confidence            999999999999999999999999999999999999999999999999999999987765  999999999754433  5


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...||||.|+|||++....++.++|.||||+++|||+.|.|||+
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~  242 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY  242 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence            56789999999999999999999999999999999999999995

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-52  Score=299.12  Aligned_cols=195  Identities=32%  Similarity=0.424  Sum_probs=179.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecc--cccchHHHHHHHHHHhhCCCCCeeeEEEEEecCce-EEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTH-LAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e   78 (200)
                      ++.+..+.||+|..|+||++.|+.|++.+|+|.+..  ++...+++.+|+++++..+||||+.+++.|..+.. ..++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            356778899999999999999999999999999954  34556789999999999999999999999999995 999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ||++|||.+.+.+.+++++.....++.+++.||.|||+ ++|+||||||+|++++..++  |||||||.+...... .-.
T Consensus       159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~  235 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IAN  235 (364)
T ss_pred             hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hcc
Confidence            99999999999998999999999999999999999995 99999999999999987665  999999999755444 557


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +..||..|||||.+.+..|+.++||||||+.+.|+.+|+-||
T Consensus       236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~  277 (364)
T KOG0581|consen  236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPY  277 (364)
T ss_pred             cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCC
Confidence            788999999999999999999999999999999999999886

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-52  Score=307.99  Aligned_cols=196  Identities=32%  Similarity=0.474  Sum_probs=178.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|...+.||.|+|++|++|.++.+++.||+|++.+.-..    .+-...|-..|.+| .||.|++++..|+|+..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            6899999999999999999999999999999999875322    34577888888888 799999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      +||+++|.|.+++.+.+.+++..++.++.+|+.||+|||++||+||||||+|||++.++.  ++|+|||.|+........
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhcc
Confidence            999999999999999999999999999999999999999999999999999999987775  999999999754433222


Q ss_pred             --------------CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 --------------KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 --------------~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                                    .+++||..|++||.+.....++.+|+|+|||++|+|+.|.|||
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPF  287 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPF  287 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCC
Confidence                          3467999999999999999999999999999999999999999

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.5e-51  Score=302.04  Aligned_cols=198  Identities=29%  Similarity=0.461  Sum_probs=178.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++++.||+|+||.||+|+-+.||+.+|+|++++...    ..+.+..|-++|....+|.+|+++..|++..++|+|
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            4789999999999999999999999999999999998643    335688899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC----
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL----  152 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~----  152 (200)
                      |||++||++..++.+.+.+++..+..++.+++.|+..+|+.|++||||||+|++||..+.  +||+|||+|.....    
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhhh
Confidence            999999999999999999999999999999999999999999999999999999987775  99999999841110    


Q ss_pred             -------------------CCC-----C--------------------CcccCCCCccCCeeecCcccCCeeehhhhhhh
Q 029037          153 -------------------HSR-----P--------------------KSTVGTPAYIAPEVLSRREYDGKVCILLLILF  188 (200)
Q Consensus       153 -------------------~~~-----~--------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~  188 (200)
                                         ...     .                    .+.+|||.|+|||++.+..|+..+|+|||||+
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                               000     0                    12358999999999999999999999999999


Q ss_pred             hhhcCCCCCCCC
Q 029037          189 LWRNYRPNPFIW  200 (200)
Q Consensus       189 l~~~~~~~~pf~  200 (200)
                      |||||.|-|||.
T Consensus       378 myEmLvGyPPF~  389 (550)
T KOG0605|consen  378 MYEMLVGYPPFC  389 (550)
T ss_pred             HHHHHhCCCCCC
Confidence            999999999993

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-50  Score=303.39  Aligned_cols=197  Identities=36%  Similarity=0.603  Sum_probs=181.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      |++|.+.+.||+|+||.||+++.+.+.+.||+|.+.+..+..   +.+.+|+++++.++||||+.++++|+....+++|+
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            689999999999999999999999999999999998765444   56889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ||+.| +|..++...+.++++.+..++.++++||.|||+.+|.|||++|.||+++.++.  +|+||||+|+....+....
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceee
Confidence            99977 99999999999999999999999999999999999999999999999986664  9999999998655544333


Q ss_pred             -cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 -STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 -~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       ..-|||-|+|||...++.|+..+|+|||||++||+++|+|||+
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~  201 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY  201 (808)
T ss_pred             eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence             3359999999999999999999999999999999999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.7e-50  Score=281.01  Aligned_cols=196  Identities=28%  Similarity=0.468  Sum_probs=174.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      |++|+.+..+|+|++|+||+++++.||+.||+|.+..++.   ..+-..+|+++|++++|+|+|.++++|.....+++|+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            6899999999999999999999999999999999986543   2356889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC-CCCC
Q 029037           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~-~~~~  155 (200)
                      |||+. ++.+.+...+ .++.+.+..+++|++.|+.|+|+++++||||||+||++..++.  +||||||+|+... ++..
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcch
Confidence            99976 6666676665 4899999999999999999999999999999999999986664  9999999998766 3333


Q ss_pred             CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      -.....|..|.|||.+-+ .+|..++||||+||++.||++|+|.|
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~  202 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW  202 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC
Confidence            445678999999999988 58999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=292.32  Aligned_cols=197  Identities=50%  Similarity=0.746  Sum_probs=179.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----c--cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----R--KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|.+.+.||+|+||+|+.+.+..++..||+|++.+.    .  ...+.+.+|+.++++++ ||||+++++++.....++
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            5899999999999999999999999999999977653    1  23556778999999999 999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCccc-CCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLH  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~-~~~  153 (200)
                      +||||+.||+|.+++.+.+++.+..+..+++|+++|++|+|++||+||||||+|++++.+. ..+||+|||++... ...
T Consensus        97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~~~  175 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPGED  175 (370)
T ss_pred             EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCCCC
Confidence            9999999999999999988999999999999999999999999999999999999998773 35999999999866 455


Q ss_pred             CCCCcccCCCCccCCeeecCcc-cC-CeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSRRE-YD-GKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......+|++.|+|||++.+.. |+ .++|+||+|++||-|++|..||
T Consensus       176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF  223 (370)
T KOG0583|consen  176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPF  223 (370)
T ss_pred             CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence            6677789999999999999887 86 6679999999999999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-51  Score=285.28  Aligned_cols=197  Identities=29%  Similarity=0.456  Sum_probs=173.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEE-EEecCce-EEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKE-VVLTPTH-LAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~-~~~v   76 (200)
                      .+|++++.||+|+||.||++.+..+++.+|.|.++-+   .+..+....|+.+|++|+||||+++++ .|.+++. ++++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4699999999999999999999999999999999753   344578999999999999999999988 5555554 8999


Q ss_pred             EEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CC--cEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           77 MEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHS--MQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~--~~--i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      ||+|++|+|.+.++..    ..+++.+++.++.|++.||..+|.  ..  +.||||||.||+++.++.  +||+|||+++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r  176 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGR  176 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHh
Confidence            9999999999988532    349999999999999999999998  44  899999999999986665  9999999998


Q ss_pred             ccCCCCCC-CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          149 SSVLHSRP-KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       149 ~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ........ .+.+|||-|++||.+....|++++||||+||++|||..-.+||+
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~  229 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY  229 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence            65444332 34579999999999999999999999999999999999999995

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-48  Score=297.37  Aligned_cols=196  Identities=32%  Similarity=0.511  Sum_probs=177.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|+||+|+++..+.+++.+|+|+++++.    .+.+....|.+++...+ ||++++++..|+...++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            578999999999999999999999999999999999864    33456788888888775 9999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC-CCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~-~~~  154 (200)
                      ||||+.||++. .+.....+++..+..++..++.||.|||++||++||||.+||++|.++.  +||+|||+|+... .+.
T Consensus       447 vmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  447 VMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCCCC
Confidence            99999999943 3345567999999999999999999999999999999999999987775  9999999998666 455


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+||+.|+|||++....|+.++|+||||++||||+.|++||
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF  568 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPF  568 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCC
Confidence            556679999999999999999999999999999999999999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=285.01  Aligned_cols=195  Identities=32%  Similarity=0.448  Sum_probs=171.6

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCc-eEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPT-HLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e   78 (200)
                      +..+.+.+|+|+||+||++..+.+.. ||+|++......   .+.+.+|+.++.+++||||+++++.+.+.. .+++|||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            34567789999999999999985432 899999875433   458999999999999999999999999887 7999999


Q ss_pred             ecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-C
Q 029037           79 YAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-S  154 (200)
Q Consensus        79 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~  154 (200)
                      |+++|+|.+++.+  ...++...++.++.|++.||.|||+++ |+||||||+|++++.+. .++||+|||+++..... .
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~~  199 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISKT  199 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccccc
Confidence            9999999999988  567999999999999999999999999 99999999999998765 25999999999755443 3


Q ss_pred             CCCcccCCCCccCCeeec--CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLS--RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......||+.|+|||+++  ...++.++||||+|+++|||+||+.||
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf  246 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPF  246 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCC
Confidence            334467999999999999  668999999999999999999999997

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-47  Score=288.12  Aligned_cols=197  Identities=25%  Similarity=0.429  Sum_probs=175.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|+||++.+..+++.+|+|++.+..    .....+.+|..+++.++||+|+++++.+.+...+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999997642    22346788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      ||++|++|.+++.+.+.++...+..++.|++.||++||+.|++||||+|+||+++.++  .++|+|||+++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~--~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--CEEEeeccCccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999998665  499999999864321110  


Q ss_pred             ----------------------------------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 ----------------------------------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                                                        ....+|++.|+|||.+.+..++.++|+||||+++|||++|.+||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                              112468999999999999999999999999999999999999983

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-47  Score=286.48  Aligned_cols=196  Identities=28%  Similarity=0.440  Sum_probs=172.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.+..    ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            57999999999999999999999999999999987542    22356788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---  154 (200)
                      ||++|++|.+++.+...+++..+..++.|++.||+|||+.|++||||+|+||+++.++  .++|+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEEeecccccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999998665  49999999885211100   


Q ss_pred             ---------------------------------------------CCCcccCCCCccCCeeecCcccCCeeehhhhhhhh
Q 029037          155 ---------------------------------------------RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFL  189 (200)
Q Consensus       155 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l  189 (200)
                                                                   ......|++.|+|||.+.+..++.++|+||||+++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                                                         00123588999999999998999999999999999


Q ss_pred             hhcCCCCCCC
Q 029037          190 WRNYRPNPFI  199 (200)
Q Consensus       190 ~~~~~~~~pf  199 (200)
                      |||++|.+||
T Consensus       239 ~elltG~~Pf  248 (377)
T cd05629         239 FECLIGWPPF  248 (377)
T ss_pred             hhhhcCCCCC
Confidence            9999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-47  Score=281.59  Aligned_cols=195  Identities=30%  Similarity=0.486  Sum_probs=172.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v   76 (200)
                      +.|+.++.||+|.||.||++++..+++.||+|.+..+.   .......+|+.+|++|+||||+++.+...+.  ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            46889999999999999999999999999999998654   2345688999999999999999999998876  689999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-
Q 029037           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-  154 (200)
                      +|||+. +|.-++... -.|+..+++.++.|++.||.|+|.+|++|||||.+||++|+++.  +||+|||+|+...... 
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS  273 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCC
Confidence            999966 888888664 37999999999999999999999999999999999999987776  9999999998544444 


Q ss_pred             -CCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 -RPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 -~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                       .....+.|..|.|||.+.+. .|+.++|+||.||+|.||++|+|.|
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~  320 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL  320 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence             34455679999999999876 7999999999999999999999986

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.2e-47  Score=282.24  Aligned_cols=196  Identities=32%  Similarity=0.544  Sum_probs=176.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|.||++.+..+++.+|+|.+....    ...+.+.+|+.+++.++||||+++++++.+++..+++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999997642    2235688999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||++.+++|.+.+.+...++...+..++.|++.||++||++|++||||+|+||++++++.  ++|+|||++.....  ..
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--RT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--Cc
Confidence            999999999999988888999999999999999999999999999999999999987664  99999999864432  22


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  216 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF  216 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence            33568899999999999889999999999999999999999983

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.7e-47  Score=288.38  Aligned_cols=194  Identities=30%  Similarity=0.411  Sum_probs=177.2

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-C-----CCeeeEEEEEecCceEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-H-----PNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~~~~v   76 (200)
                      +|++.+.||+|.||.|.+|.+..|++.||+|++++....-.....|+.+|..++ |     -|+++++++|...+++|+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            689999999999999999999999999999999998887888889999999886 3     5899999999999999999


Q ss_pred             EEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           77 MEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +|.+ ..+|.+++..++  .++...++.++.||+.||..||+.||+|+||||+|||+.+.....|||+|||+|+......
T Consensus       267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v  345 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV  345 (586)
T ss_pred             ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence            9999 569999998776  4889999999999999999999999999999999999987777789999999998443332


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      -  ....+..|+|||++.+.+|+.+.|+|||||+++||++|.|+|
T Consensus       346 y--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  346 Y--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             e--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence            2  667888999999999999999999999999999999999887

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-46  Score=285.17  Aligned_cols=196  Identities=28%  Similarity=0.482  Sum_probs=174.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++.+.++..++++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            58999999999999999999999999999999997642    22345778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      |++++++|.+++.+.+.+++..+..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||++........  
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence            99999999999988888999999999999999999999999999999999999987664  99999998853321110  


Q ss_pred             -------------------------------------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          156 -------------------------------------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       156 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                                                           .....||+.|+|||.+.+..++.++|+|||||++|+|++|.+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                 0123588999999999998999999999999999999999999


Q ss_pred             C
Q 029037          199 I  199 (200)
Q Consensus       199 f  199 (200)
                      |
T Consensus       239 f  239 (364)
T cd05599         239 F  239 (364)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=271.35  Aligned_cols=197  Identities=35%  Similarity=0.443  Sum_probs=169.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeEEEEEecCc--eEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPT--HLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~   79 (200)
                      +|...+.||+|+||+||.+.+..++...|+|........ .+.+.+|+.+|.+++||+||++++......  .+++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            578889999999999999999999999999988765222 466899999999999999999999743333  69999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC----CC
Q 029037           80 AAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL----HS  154 (200)
Q Consensus        80 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~----~~  154 (200)
                      +++|+|.+++.+.+ .++++.+..+.+|++.||+|||++|++||||||+||++++. ++.+||+|||.++....    ..
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~-~~~~KlaDFG~a~~~~~~~~~~~  176 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS-NGDVKLADFGLAKKLESKGTKSD  176 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC-CCeEEeccCcccccccccccccc
Confidence            99999999999887 79999999999999999999999999999999999999873 22499999999875543    22


Q ss_pred             CCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ......||+.|+|||.+.++ ...+++|||||||++.||+||.+|++
T Consensus       177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~  223 (313)
T KOG0198|consen  177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS  223 (313)
T ss_pred             ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence            23456799999999999853 34468999999999999999988864

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-46  Score=284.30  Aligned_cols=197  Identities=27%  Similarity=0.441  Sum_probs=173.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+|+|.+.+..    ...+.+.+|+.+++.++||||+++++.+.+++.++++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987532    22356788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC----
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH----  153 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~----  153 (200)
                      ||+++++|.+++.+.+.++...+..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||+|......    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence            99999999999988888999999999999999999999999999999999999986664  999999987421100    


Q ss_pred             ----------------------------------------CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcC
Q 029037          154 ----------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNY  193 (200)
Q Consensus       154 ----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~  193 (200)
                                                              .......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                    0001235889999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 029037          194 RPNPFIW  200 (200)
Q Consensus       194 ~~~~pf~  200 (200)
                      +|.+||.
T Consensus       239 ~G~~Pf~  245 (376)
T cd05598         239 VGQPPFL  245 (376)
T ss_pred             hCCCCCC
Confidence            9999983

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-46  Score=279.75  Aligned_cols=194  Identities=30%  Similarity=0.479  Sum_probs=175.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+....+++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999997642    22356788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ||++|++|.+++.+...+++..+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++.....  ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence            99999999999988888999999999999999999999999999999999999986664  99999999864432  334


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...+++.|+|||.+.+..++.++|+||||+++|||++|.+||
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf  198 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF  198 (333)
T ss_pred             CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCC
Confidence            456899999999999989999999999999999999999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.6e-46  Score=284.30  Aligned_cols=197  Identities=26%  Similarity=0.392  Sum_probs=173.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ..|++.+.||+|+||+||++.+..+++.+|+|++.+..    ...+.+.+|+.+++.++||||+++++.+.+...++++|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            36899999999999999999999999999999997642    22356889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---  154 (200)
                      |+++|++|.+++.+...+++..+..++.|++.||.+||+.|++||||||+||+++.++  .++|+|||++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCcccccccccc
Confidence            9999999999998888899999999999999999999999999999999999998655  59999999874221000   


Q ss_pred             ---------------------------------------------CCCcccCCCCccCCeeecCcccCCeeehhhhhhhh
Q 029037          155 ---------------------------------------------RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFL  189 (200)
Q Consensus       155 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l  189 (200)
                                                                   ......|++.|+|||.+.+..++.++|+||||+++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                         00123588999999999988899999999999999


Q ss_pred             hhcCCCCCCCC
Q 029037          190 WRNYRPNPFIW  200 (200)
Q Consensus       190 ~~~~~~~~pf~  200 (200)
                      |||++|.+||.
T Consensus       239 ~elltG~~Pf~  249 (381)
T cd05626         239 FEMLVGQPPFL  249 (381)
T ss_pred             HHHHhCCCCCc
Confidence            99999999984

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-47  Score=277.72  Aligned_cols=195  Identities=32%  Similarity=0.541  Sum_probs=175.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+|+|.+....    ...+.+.+|+.+++.++||||+++++++.++...+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            57999999999999999999999999999999987532    23456888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      |++++++|.+++.+...++...+..++.|++.||++||++|++||||+|+||++++++  .++|+|||++.....  ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~--~~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRD--RTW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccC--Ccc
Confidence            9999999999998888899999999999999999999999999999999999998665  499999999864432  223


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~  199 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF  199 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            3468899999999998889999999999999999999999983

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-46  Score=280.84  Aligned_cols=196  Identities=30%  Similarity=0.471  Sum_probs=174.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCC-cEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETK-ELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~-~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|++|.||++.+..++ ..+|+|.+....    ...+.+.+|+.+++.++||||+++++++.+...+++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            368999999999999999999976654 679999987532    234567889999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      +|||+++++|.+++.+...++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++.....  .
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~--~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDT--R  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecCC--C
Confidence            9999999999999988888999999999999999999999999999999999999986654  99999999864322  2


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+++.|+|||.+.+..++.++|+||+|+++|+|++|.+||+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~  229 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY  229 (340)
T ss_pred             cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence            234568999999999998889999999999999999999999995

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.4e-46  Score=276.94  Aligned_cols=191  Identities=35%  Similarity=0.512  Sum_probs=169.9

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      +.||+|++|.||++.+..+++.+|+|++....    .....+.+|+.+++.++||||+++.+.+.+....+++||+++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997642    22346778999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccCC
Q 029037           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGT  162 (200)
Q Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~~  162 (200)
                      +|.+++.+...+++..+..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||++...... .......++
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence            99999988888999999999999999999999999999999999999986664  999999998643222 223345689


Q ss_pred             CCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          163 PAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       163 ~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +.|+|||.+.+..++.++|+||+|+++|||++|.+||+
T Consensus       159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  196 (323)
T cd05571         159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  196 (323)
T ss_pred             ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence            99999999999999999999999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.6e-46  Score=281.07  Aligned_cols=196  Identities=24%  Similarity=0.424  Sum_probs=173.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+|+|++....    ...+.+.+|..++..++||+++++++.+.+...+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999997532    22356788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---  154 (200)
                      |+++|++|.+++.+...++...+..++.|++.||.+||+.|++||||+|+||+++.++  .++|+|||++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCcccccccccc
Confidence            9999999999998888899999999999999999999999999999999999998665  49999999976332110   


Q ss_pred             ---------------------------------CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 ---------------------------------RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                                                       ......|++.|+|||++.+..++.++|+||||+++|||++|.+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                             011235889999999999999999999999999999999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.9e-46  Score=283.50  Aligned_cols=197  Identities=29%  Similarity=0.440  Sum_probs=173.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      .+|++.+.||+|++|+||++.+..+++.+|+|.+.+..    ...+.+.+|+.++++++||||+++++.+.++..+++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            46899999999999999999999999999999987642    22356888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---  154 (200)
                      |++++++|.+++.+...+++..+..++.|++.||++||+.|++||||||+||+++.++.  ++|+|||++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence            99999999999988888999999999999999999999999999999999999986664  9999999874211000   


Q ss_pred             ---------------------------------------------CCCcccCCCCccCCeeecCcccCCeeehhhhhhhh
Q 029037          155 ---------------------------------------------RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFL  189 (200)
Q Consensus       155 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l  189 (200)
                                                                   ......|++.|+|||.+.+..++.++|+|||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                         01123578999999999999999999999999999


Q ss_pred             hhcCCCCCCCC
Q 029037          190 WRNYRPNPFIW  200 (200)
Q Consensus       190 ~~~~~~~~pf~  200 (200)
                      |||++|.+||.
T Consensus       239 ~elltG~~Pf~  249 (382)
T cd05625         239 YEMLVGQPPFL  249 (382)
T ss_pred             HHHHhCCCCCC
Confidence            99999999983

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-46  Score=257.82  Aligned_cols=196  Identities=33%  Similarity=0.477  Sum_probs=175.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      .++|...+.+|+|.||.||+|++..+++.||+|.++..+..   .-...+|++.|+.++|+||+.+++.|...+.+.+|+
T Consensus         1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            46899999999999999999999999999999999876433   467899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||++. +|...+.... .+++..++.++.+++.|++|+|++.|+||||||.|+++++++.  +||+|||+|+........
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRI  157 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCcc
Confidence            99965 8988886554 5999999999999999999999999999999999999987765  999999999866554444


Q ss_pred             Cc-ccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KS-TVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~-~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .. ...|..|.|||.+.+ +.|+..+|+||.||++.||+-|.|.|
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f  202 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF  202 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence            33 367889999999875 57999999999999999999998876

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-47  Score=275.15  Aligned_cols=196  Identities=38%  Similarity=0.612  Sum_probs=182.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch----HHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      .+|++.+.||+|.+|+|-++.+...|+.||+|.+.++...+    -.+.+|++++..|+||||++++++|+......+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            47999999999999999999999999999999998864333    35789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ||..+|.|.+++.+.+.+++.++..+++||++|+.|+|+++++||||+.+||++|.+++  +||+|||++-......-..
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHH
Confidence            99999999999999999999999999999999999999999999999999999998777  9999999997666666677


Q ss_pred             cccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .++|++.|++||++.+..| .+.+|-||||+++|.++-|.+||
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF  253 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF  253 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc
Confidence            8899999999999999988 47789999999999999999998

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=276.34  Aligned_cols=198  Identities=40%  Similarity=0.648  Sum_probs=182.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +.|++.+.||.|.||.||.+.++.+|+.+|+|.+.+...    ..+.+.+|+.+++++. |||++.+.+.+++...+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            469999999999999999999999999999999987543    3368999999999998 99999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC--CCCEEEeecCCCcccCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~--~~~v~l~df~~~~~~~~~~  154 (200)
                      ||++.||.|.+.+.+. .+++..+..+++|++.++++||+.|++|||++|+|+++....  .+.++++|||++.......
T Consensus       115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~  193 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE  193 (382)
T ss_pred             EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence            9999999999999877 599999999999999999999999999999999999996543  2479999999998777655


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+|++.|+|||.+....|+..+|+||+|+++|.|++|.+|||
T Consensus       194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~  239 (382)
T KOG0032|consen  194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFW  239 (382)
T ss_pred             eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCc
Confidence            6677789999999999999999999999999999999999999998

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-47  Score=259.50  Aligned_cols=196  Identities=32%  Similarity=0.552  Sum_probs=181.4

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|.||.||.++.+.++..||+|++.+..    .....+.+|+++...|+||||++++++|.++...|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            578999999999999999999999999999999998753    3346788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           77 MEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        77 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +||.++|++...+.  ...++++.....+.+|++.|+.|+|..+++||||+|+|++++..+.  +|++|||.+.-.+ .+
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~  177 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SN  177 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CC
Confidence            99999999999998  5567999999999999999999999999999999999999986665  9999999987444 66


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+||..|.+||...+..++..+|+|++|++-||++.|.|||
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppF  222 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPF  222 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCch
Confidence            667779999999999999999999999999999999999999998

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=282.08  Aligned_cols=196  Identities=34%  Similarity=0.494  Sum_probs=176.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchH--HHHHHHHHHhhCC-CCCeeeEEEEEecCc-eEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLR-HPNIIRFKEVVLTPT-HLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~--~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~~~~v   76 (200)
                      +++|.+.+.||.|.||.||+|....+++.||+|.+++.-..-+  --++|+..|++++ ||||+++.+++.+.. .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            4799999999999999999999999999999999987543333  3568999999998 999999999999887 89999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||+| ..+|.+.+.... .++++.++.|++||+.||+++|++|+.|||+||+||++....  .|||+|||+|+......+
T Consensus        89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~--~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND--VIKIADFGLAREVRSKPP  165 (538)
T ss_pred             HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc--eeEecccccccccccCCC
Confidence            9999 569999997654 599999999999999999999999999999999999997544  499999999998777777


Q ss_pred             CCcccCCCCccCCeeec-CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLS-RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      -...+.|..|+|||++. ..-|+.+.|+|++||+++|+++-+|.|
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF  210 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF  210 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence            77888999999999986 557999999999999999999999887

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-46  Score=280.59  Aligned_cols=196  Identities=31%  Similarity=0.505  Sum_probs=176.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++....    .....+.+|..+++.++|||++++++.+.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            58999999999999999999999999999999997642    33456888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---  154 (200)
                      |++++++|.+++.+...++...+..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||++.......   
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence            99999999999988888999999999999999999999999999999999999987664  9999999986544332   


Q ss_pred             ---------------------------CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 ---------------------------RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                                                 ......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence                                       123345889999999999999999999999999999999999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-45  Score=269.59  Aligned_cols=196  Identities=24%  Similarity=0.318  Sum_probs=172.7

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      .|++.+.||+|+||.||++.+..+++.||+|.+....    .....+.+|+.+++.++|++++++.+.+.+++..+++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3788999999999999999999999999999987532    222457789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           79 YAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ++++++|.+.+...  ..+++..+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++.........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV  158 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence            99999998887543  35899999999999999999999999999999999999986654  999999998754433334


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|.+||.
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~  202 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR  202 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCC
Confidence            45578999999999999999999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-46  Score=283.25  Aligned_cols=197  Identities=38%  Similarity=0.645  Sum_probs=185.0

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++-|++.+.||.|+.|.|-.|.+..||+.+|+|++.+.    ......+++|+.+++.+.|||+++++++++++..+|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            35689999999999999999999999999999999875    23346799999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      .||++||-|.+++-..+++++.++..+++||+.|+.|+|..+|+|||+||+|++++...+  |||+|||.|.....+...
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccc
Confidence            999999999999999999999999999999999999999999999999999999987776  999999999988888888


Q ss_pred             CcccCCCCccCCeeecCcccC-CeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYD-GKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~-~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +..||++.|+|||++.+.+|+ .++||||.|++||.+|||..||
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF  212 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF  212 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC
Confidence            889999999999999999984 7789999999999999999998

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-46  Score=280.24  Aligned_cols=196  Identities=32%  Similarity=0.510  Sum_probs=178.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ..|...+.||+|+.|.||.+....+++.||+|.+...... .+-+.+|+.+++..+|+||+.+++.+...+.+++||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4688889999999999999999999999999999876544 355889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-Ccc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-~~~  159 (200)
                      +||+|.+.+.+. .+++.++..+.++++.||++||.+||+|||||.+||+++.++.  +||+|||+|......... ..-
T Consensus       353 ~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~Tm  429 (550)
T KOG0578|consen  353 EGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTM  429 (550)
T ss_pred             CCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccc
Confidence            999999988544 4899999999999999999999999999999999999987776  999999999766665544 445


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +||+-|+|||++....|+++.||||||+++.||+-|+|||.
T Consensus       430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl  470 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL  470 (550)
T ss_pred             cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence            79999999999999999999999999999999999999994

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-45  Score=278.98  Aligned_cols=196  Identities=28%  Similarity=0.438  Sum_probs=171.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+|+|++.+..    ...+.+.+|..+++.++||||+++++.+.++..+++||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999987532    22345778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      ||+++++|.+++.+. .++...+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++........  
T Consensus       123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCcee
Confidence            999999999988554 6899999999999999999999999999999999999986664  99999999875432222  


Q ss_pred             CCcccCCCCccCCeeecCcc----cCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRRE----YDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+++.|+|||.+.+..    ++.++|+||+|+++|+|++|.+||.
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~  248 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY  248 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence            23456899999999987543    7789999999999999999999984

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-45  Score=263.46  Aligned_cols=195  Identities=32%  Similarity=0.454  Sum_probs=172.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCC-eeeEEEEEecCc------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPN-IIRFKEVVLTPT------   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~------   71 (200)
                      ..|..++.||+|.+|+||+|+++.+++.||+|.+..+..   ......+|+.+++.++|+| |+.+.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            458889999999999999999999999999999986543   4567899999999999999 999999999877      


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037           72 HLAIVMEYAAGGELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                      .+++|+|+++ .+|..++...+    .++...++.+++|++.||++||+++|+||||||.|+++++++.  +||+|||+|
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlA  167 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLA  167 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchH
Confidence            7999999995 49999997655    4777899999999999999999999999999999999987664  999999999


Q ss_pred             cccCCCCC-CCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          148 KSSVLHSR-PKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       148 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +....... ...-..|..|+|||++.+. .|+...|+||+||+++||+++.+.|
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF  221 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF  221 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence            86553333 3444688899999999876 7999999999999999999999887

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.8e-45  Score=273.03  Aligned_cols=191  Identities=33%  Similarity=0.506  Sum_probs=169.1

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      +.||+|++|.||++.+..+++.||+|.+....    .....+.+|+.+++.++|||++++++.+......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997642    22345678999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccCC
Q 029037           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGT  162 (200)
Q Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~~  162 (200)
                      +|..++.+...+++..+..++.|++.||++||++|++||||+|+||++++++.  ++|+|||++...... .......++
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence            99999988888999999999999999999999999999999999999987664  999999988643222 222345689


Q ss_pred             CCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          163 PAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       163 ~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +.|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  196 (323)
T cd05595         159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  196 (323)
T ss_pred             cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCC
Confidence            99999999998899999999999999999999999983

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.2e-47  Score=262.45  Aligned_cols=197  Identities=35%  Similarity=0.506  Sum_probs=181.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---------KIDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      ++|...+.+|.|..++|-++.++.+++.+++|++....         ...+...+|+.+|+++ .||+|+++.++++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            57889999999999999999999999999999986421         1224567899999998 5999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      .+++|+|.++.|.|.+++.+.-.+++....++++|++.|+.|||.++|+||||||+||+++++.+  ++|+|||+++...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~  174 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence            99999999999999999998889999999999999999999999999999999999999987776  9999999999999


Q ss_pred             CCCCCCcccCCCCccCCeeecC------cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSR------REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+.+....+|||+|+|||.+..      ..|+..+|+|++|++||.++.|.||||
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence            9999999999999999999853      357888899999999999999999999

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-45  Score=271.27  Aligned_cols=189  Identities=29%  Similarity=0.510  Sum_probs=168.2

Q ss_pred             ccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037           10 LGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus        10 l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      ||+|++|.||++.+..+++.+|+|.+....    .....+.+|+.++++++||||+++++.+.+....+++||++++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999999999999999987532    2235678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcccCCCC
Q 029037           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPA  164 (200)
Q Consensus        86 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~~~~~~  164 (200)
                      .+++.+..+++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||++....... ......+++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence            999988888999999999999999999999999999999999999986664  9999999987432222 2233468999


Q ss_pred             ccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          165 YIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       165 ~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      |+|||.+.+..++.++|+||+|+++|+|++|.+||+
T Consensus       159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~  194 (312)
T cd05585         159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY  194 (312)
T ss_pred             cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence            999999999999999999999999999999999984

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4e-45  Score=272.67  Aligned_cols=191  Identities=34%  Similarity=0.509  Sum_probs=169.4

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      +.||+|++|.||++.+..+++.+|+|++.+..    .....+.+|+.+++.++||||+++.+.+.+....++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997642    22356788999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccCC
Q 029037           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGT  162 (200)
Q Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~~  162 (200)
                      +|..++.....+++.++..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++...... .......++
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence            99999988888999999999999999999999999999999999999986664  999999998643222 222334689


Q ss_pred             CCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          163 PAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       163 ~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~  196 (328)
T cd05593         159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  196 (328)
T ss_pred             cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCC
Confidence            99999999998899999999999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3e-45  Score=277.28  Aligned_cols=196  Identities=30%  Similarity=0.449  Sum_probs=171.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+|+|++.+..    ...+.+.+|..+++.++||||+++++.+.++...+++|
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999987532    22345778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      ||++|++|.+++.+ ..++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||++........  
T Consensus       123 Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         123 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCccc
Confidence            99999999998855 45889999999999999999999999999999999999986654  99999999875433222  


Q ss_pred             CCcccCCCCccCCeeecCcc----cCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRRE----YDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+++.|+|||.+.+..    ++.++|+||||+++|+|++|.+||+
T Consensus       200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  248 (371)
T cd05622         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY  248 (371)
T ss_pred             ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence            23456899999999987543    7889999999999999999999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.4e-45  Score=270.41  Aligned_cols=195  Identities=30%  Similarity=0.483  Sum_probs=171.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCC-CCeeeEEEEEecCceEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRH-PNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +|++.+.||+|++|.||++.+..+++.||+|++.+..    ...+.+..|..+++.+.| ++++++.+++.+.+.++++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5899999999999999999999999999999997642    233567788888888876 56888999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~~~  156 (200)
                      ||+++++|.+++.+...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.  ++|+|||++..... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence            99999999999988888999999999999999999999999999999999999987664  99999999864322 2222


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf  201 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF  201 (324)
T ss_pred             eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence            3446899999999999989999999999999999999999998

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.6e-45  Score=276.24  Aligned_cols=196  Identities=29%  Similarity=0.442  Sum_probs=170.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+|+|.+.+..    ...+.+.+|+.+++.++|||++++++++.++...++||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999997532    22345778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      ||++|++|.+++.+ ..++...+..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||++........  
T Consensus       123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCccc
Confidence            99999999998854 46889999999999999999999999999999999999987664  99999999865433222  


Q ss_pred             CCcccCCCCccCCeeecCc----ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRR----EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~----~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+++.|+|||.+.+.    .++.++|+||||+++|||++|.+||+
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  248 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY  248 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence            2345689999999998653    47889999999999999999999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.4e-45  Score=272.37  Aligned_cols=196  Identities=27%  Similarity=0.431  Sum_probs=172.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|+||++.+..+++.+|+|.+.....    ..+.+.+|+.+++.++||+++++++.+.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            579999999999999999999999999999999986432    3356788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           78 EYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||+++++|.+++.+. ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++.........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence            999999999999876 57999999999999999999999999999999999999986664  999999998654333222


Q ss_pred             --CcccCCCCccCCeeec------CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 --KSTVGTPAYIAPEVLS------RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 --~~~~~~~~~~aPE~~~------~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        ....+++.|+|||.+.      +..++.++|+||||+++|+|++|..||
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf  209 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF  209 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCC
Confidence              2235889999999986      456788999999999999999999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1e-44  Score=270.92  Aligned_cols=197  Identities=23%  Similarity=0.413  Sum_probs=171.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+|+|.+.+..    ...+.+.+|..++..++|++|+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999987532    22345778889999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||++|++|.+++.+ ...+++..+..++.|++.||++||++|++||||+|+||+++.++.  ++|+|||++.........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence            99999999999977 457899999999999999999999999999999999999986654  999999998644332221


Q ss_pred             --CcccCCCCccCCeeecC-----cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 --KSTVGTPAYIAPEVLSR-----REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 --~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                        ....+++.|+|||.+.+     ..++.++|+||+|+++|+|++|.+||.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  209 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence              23468999999999875     457889999999999999999999983

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-45  Score=263.66  Aligned_cols=197  Identities=27%  Similarity=0.409  Sum_probs=174.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++.|++++.||.|.-|+||++....++..+|+|++.+....    ..+...|-++|+.++||.++.++..|+.++..|++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            35789999999999999999999999999999999886433    34677899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC--
Q 029037           77 MEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--  152 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~--  152 (200)
                      ||||+||+|....++++  .++++.++.++.+++.||+|||-.|||+|||||+||+|.+++.  |.|+||.++.....  
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPVSP  233 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCCCC
Confidence            99999999999998875  5999999999999999999999999999999999999998876  99999988631100  


Q ss_pred             -------------------------------C------------------------CCCCcccCCCCccCCeeecCcccC
Q 029037          153 -------------------------------H------------------------SRPKSTVGTPAYIAPEVLSRREYD  177 (200)
Q Consensus       153 -------------------------------~------------------------~~~~~~~~~~~~~aPE~~~~~~~~  177 (200)
                                                     .                        ....+++||-.|+|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           0                        011233578899999999999999


Q ss_pred             CeeehhhhhhhhhhcCCCCCCC
Q 029037          178 GKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       178 ~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .++|+|+|||++|||+-|.-||
T Consensus       314 sAVDWWtfGIflYEmLyG~TPF  335 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPF  335 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCc
Confidence            9999999999999999999998

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.4e-44  Score=269.53  Aligned_cols=190  Identities=34%  Similarity=0.501  Sum_probs=168.0

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      +.||+|+||.||++.+..+++.+|+|++.+..    .....+.+|..+++.++||||+++.+.+.++...++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997642    22345678899999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccC
Q 029037           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVG  161 (200)
Q Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~  161 (200)
                      +|..++.+...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.  ++|+|||++...... .......+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence            999999888889999999999999999999997 89999999999999986664  999999998643222 22233468


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf  196 (325)
T cd05594         159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  196 (325)
T ss_pred             CcccCCHHHHccCCCCCccccccccceeeeeccCCCCC
Confidence            99999999999989999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-44  Score=269.35  Aligned_cols=196  Identities=30%  Similarity=0.457  Sum_probs=171.0

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +|++.+.||+|++|.||++.+..+++.+|+|++.+...    ..+....|..++..+ +|++++++.+++.+.+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58899999999999999999999999999999886422    223456677777766 5899999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~~~  156 (200)
                      |++++++|.+.+.....+++..+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++..... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence            99999999999988888999999999999999999999999999999999999987664  99999999864332 2223


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~  202 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE  202 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCC
Confidence            34568999999999999999999999999999999999999983

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-44  Score=265.92  Aligned_cols=196  Identities=31%  Similarity=0.468  Sum_probs=171.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|++....   ...+.+.+|+.+++.++||||+++++++.++...+++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            58999999999999999999999999999999987642   234568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--C
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--P  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--~  156 (200)
                      |++++.+.........++...++.++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++........  .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence            9988766655544456899999999999999999999999999999999999986664  99999999875433222  2


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf  201 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF  201 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCC
Confidence            2345788999999999888999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.5e-44  Score=265.27  Aligned_cols=196  Identities=30%  Similarity=0.472  Sum_probs=170.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++++.++...+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            578999999999999999999999999999999987542  234567899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-C
Q 029037           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~  156 (200)
                      ++++ +|.+++...+ .++...+..++.|++.||++||++|++||||+|+||++++++.  ++|+|||++........ .
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCccc
Confidence            9975 8988886654 4789999999999999999999999999999999999986664  99999999864332222 2


Q ss_pred             CcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf  204 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF  204 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence            33457889999999865 56889999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.3e-44  Score=270.08  Aligned_cols=190  Identities=26%  Similarity=0.448  Sum_probs=168.0

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..+++.||+|++++..    ...+.+.+|..+++.+ +||||+++++++.+.+.++++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999999999999998642    2234577888888888 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC-CCCCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~-~~~~~~~~~~  161 (200)
                      ++|.+++.+..+++...+..++.|++.||.+||++|++||||+|+||++++++.  ++|+|||++.... .........+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence            999999988888999999999999999999999999999999999999986654  9999999986422 2222334568


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++.|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf  196 (329)
T cd05588         159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF  196 (329)
T ss_pred             CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCc
Confidence            99999999999999999999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-45  Score=259.62  Aligned_cols=196  Identities=31%  Similarity=0.423  Sum_probs=172.0

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP--THLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~   75 (200)
                      +++|+.+..|++|.||.||++.|+.|++.||+|+++.+..   ..-.-.+|+.+|.+.+||||+.+-++..-.  +..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            4689999999999999999999999999999999986531   123578999999999999999998887654  56999


Q ss_pred             EEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      |||||+. +|.+.+.+-+ ++...+++.+..|++.|++|||...|+||||||+|+++.+.+.  +||+|||+|+......
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPL  231 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCc
Confidence            9999976 8989887766 7999999999999999999999999999999999999987765  9999999998655443


Q ss_pred             CC-CcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RP-KSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~-~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .. .....|..|.|||.+.+. .|+.+.|+||+||++.||+++.|.|
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf  278 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF  278 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence            33 344678999999999865 6999999999999999999999987

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-44  Score=269.51  Aligned_cols=197  Identities=23%  Similarity=0.427  Sum_probs=171.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.+..    ...+.+.+|..+++.++|++|+++++.+.++..+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999987532    22345788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||++|++|.+++.+ ...+++..+..++.|++.||++||++|++||||+|+||+++.++.  ++|+|||++.........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV  158 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence            99999999999976 446899999999999999999999999999999999999976664  999999998644333222


Q ss_pred             --CcccCCCCccCCeeecC-----cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 --KSTVGTPAYIAPEVLSR-----REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 --~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                        ....+++.|+|||.+..     ..++.++|+||+|+++|+|++|..||.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  209 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence              22458999999999863     356788999999999999999999983

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=270.62  Aligned_cols=195  Identities=25%  Similarity=0.332  Sum_probs=172.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeEEEEEecCc-eEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPT-HLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~   79 (200)
                      ++|.-...||+|+||.||++.-.++ ..||+|.+...... ..+|.+|+.++.+++|||+++++|+|.+.+ ..++|+||
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            4677778999999999999998765 77999988876554 567999999999999999999999999988 59999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-C
Q 029037           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQ---ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-H  153 (200)
Q Consensus        80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~  153 (200)
                      +++|+|.+.+....  +++|.+++.|+.+++.||+|||+..   |+||||||+||++|.+.+  .||+|||+|+..+. .
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGD  231 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccc
Confidence            99999999997665  7999999999999999999999743   999999999999997776  99999999975554 3


Q ss_pred             CCCCcc-cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SRPKST-VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~~~~~-~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...... .|+.+|++||....+..+.++||||+|+++.|++||+++.
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~  278 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAV  278 (361)
T ss_pred             cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCccc
Confidence            333333 7899999999999999999999999999999999999763

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.4e-44  Score=268.35  Aligned_cols=191  Identities=32%  Similarity=0.543  Sum_probs=164.9

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHH-HHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREI-INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..+++.+|+|++.+..    .....+..|. .+++.++||||+++++.+.+....+++||++++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999997542    1223344444 456788999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CCCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~~~~~~~~  161 (200)
                      ++|.+++.+...++...+..++.|++.||.+||+.|++||||+|+||++++++  .++|+|||++..... ........+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~--~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEEccCCCCcccccCCCCcccccC
Confidence            99999998888899999999999999999999999999999999999998665  499999999864322 222334568


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  197 (325)
T cd05602         159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY  197 (325)
T ss_pred             CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence            999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3e-44  Score=267.57  Aligned_cols=191  Identities=32%  Similarity=0.531  Sum_probs=165.1

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHH-HHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREII-NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|+||++.+..+++.||+|++....    .....+.+|.. +++.++||||+++++.+.+....+++||++++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999999999999999997542    12234444444 56788999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~  161 (200)
                      ++|.+++.+...+++..+..++.|++.||.+||++|++||||+|+||++++++.  ++|+|||++...... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence            999999988888999999999999999999999999999999999999987664  999999998643222 22233468


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  197 (323)
T cd05575         159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY  197 (323)
T ss_pred             ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence            999999999999899999999999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.6e-44  Score=268.42  Aligned_cols=190  Identities=27%  Similarity=0.454  Sum_probs=167.3

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..+++.+|+|++.+..    ...+.+.+|..++.++ +||||+++++++.+.+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998642    2234567788887766 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CCCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~~~~~~~~  161 (200)
                      ++|..++.+...++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||++..... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence            999999988888999999999999999999999999999999999999987664  99999999864322 222334568


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +..|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf  196 (329)
T cd05618         159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF  196 (329)
T ss_pred             CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCC
Confidence            99999999999999999999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=263.55  Aligned_cols=196  Identities=29%  Similarity=0.410  Sum_probs=174.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +.|++.+.||.|..++||+|+...++..||+|++..+...  .+.+.+|+..++.++||||++++..|..+..+|+||++
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            6799999999999999999999999999999999865433  46899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-
Q 029037           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-  156 (200)
Q Consensus        80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-  156 (200)
                      |.+||+.+.+...-  .+++..+..++++++.||.|||++|.+|||+|+.||++++++.  |+|+|||.+......+.. 
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccCcee
Confidence            99999999997643  3899999999999999999999999999999999999987776  999999987544333322 


Q ss_pred             ----CcccCCCCccCCeeec--CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 ----KSTVGTPAYIAPEVLS--RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ----~~~~~~~~~~aPE~~~--~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                          ....+++.|+|||.+.  ...|++++||||+||...|+.+|..||
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf  232 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF  232 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence                2346899999999954  357999999999999999999999998

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.7e-44  Score=266.96  Aligned_cols=191  Identities=32%  Similarity=0.516  Sum_probs=165.1

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHH-HHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREI-INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..+++.+|+|++.+..    .....+.+|. .+++.++||||+++++.+.+.+..+++||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987532    1223444554 457888999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CCCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~~~~~~~~  161 (200)
                      ++|...+.+...++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++..... ........+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence            999999988888999999999999999999999999999999999999987664  99999999864322 222333468


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  197 (321)
T cd05603         159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY  197 (321)
T ss_pred             CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCC
Confidence            899999999998889999999999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.9e-44  Score=267.86  Aligned_cols=197  Identities=23%  Similarity=0.429  Sum_probs=171.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|+||.||++.++.+++.+|+|++.+..    ...+.+.+|..++..++|++++++.+.+.+...+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999986532    22345778889999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           78 EYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      ||+++++|.+++.+. ..++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++........ 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence            999999999999774 56899999999999999999999999999999999999986654  99999999864332222 


Q ss_pred             -CCcccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       .....+++.|+|||.+.     ...++.++|+||||+++|||++|.+||+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~  209 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY  209 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence             12346899999999986     3457889999999999999999999984

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.5e-44  Score=266.14  Aligned_cols=191  Identities=29%  Similarity=0.437  Sum_probs=167.0

Q ss_pred             cccccCCcceEEEEEEEc---CCCcEEEEEEecccc-----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            7 VKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++.||+|+||.||++.+.   .+++.+|+|.+....     .....+.+|+.+++.++||||+++++.+.+++..+++||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999874   467889999987532     223457789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~  157 (200)
                      ++++++|.+++.+.+.++...+..++.|++.||.+||+.|++||||+|+||++++++.  ++|+|||++....... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence            9999999999988888999999999999999999999999999999999999986664  9999999986432222 223


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...+++.|+|||.+.+..++.++|+||||+++|||++|.+||
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf  200 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF  200 (323)
T ss_pred             ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCC
Confidence            346899999999999888999999999999999999999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.3e-44  Score=267.58  Aligned_cols=191  Identities=30%  Similarity=0.499  Sum_probs=165.6

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHH-HHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREII-NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|+||++.+..+++.+|+|++.+..    .....+..|.. +++.++||||+++++.+..+...+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999999999999999997542    22234455544 46778999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~  161 (200)
                      ++|...+.+..++++..+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++...... .......+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence            999999988888999999999999999999999999999999999999987664  999999998643222 22334468


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~  197 (325)
T cd05604         159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY  197 (325)
T ss_pred             ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCC
Confidence            999999999999999999999999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-45  Score=262.76  Aligned_cols=192  Identities=34%  Similarity=0.499  Sum_probs=170.0

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCc-----eEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT-----HLAIVM   77 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~   77 (200)
                      .|.-.+.+|+|+||.||++...++++.+|+|..-.+..   --.+|+.+++.++||||+++..+|....     +..+||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            46778999999999999999999999999998765443   2347899999999999999988886432     467999


Q ss_pred             EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           78 EYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        78 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ||++ .+|.+.+..    +.+++...++-+..|++.||+|||+.||+||||||.|+++|++.. .+||||||.|+....+
T Consensus       102 eymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  102 EYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVLVKG  179 (364)
T ss_pred             Hhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC-eEEeccCCcceeeccC
Confidence            9995 499888863    467999999999999999999999999999999999999997654 7999999999999888


Q ss_pred             CCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .+..+...+..|+|||.+.+. .|+.+.||||.||++.||+-|+|.|
T Consensus       180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF  226 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF  226 (364)
T ss_pred             CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence            888888899999999999875 7999999999999999999999987

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-44  Score=272.83  Aligned_cols=191  Identities=21%  Similarity=0.266  Sum_probs=169.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|...     .+.+.+|+.+++.++||||+++++++..+...++++|++.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            47999999999999999999999999999999643     3457889999999999999999999999999999999995


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC--CCCCcc
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--SRPKST  159 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~--~~~~~~  159 (200)
                       ++|.+++.....++...++.++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||++......  ......
T Consensus       167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccccc
Confidence             689888888778999999999999999999999999999999999999986654  999999998643221  222345


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+++.|+|||.+.+..+++++|+||||+++|+|++|.+||+
T Consensus       244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            68999999999998899999999999999999999998774

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.5e-44  Score=266.83  Aligned_cols=191  Identities=31%  Similarity=0.460  Sum_probs=167.3

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..+++.||+|++.+..    ...+.+..|..++..+ +|||++++++++.+...+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999987542    2234566788888766 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~  161 (200)
                      ++|.+++.+...++...+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++...... .......+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence            999999988888999999999999999999999999999999999999987664  999999998643222 22334468


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++|+||+|+++|+|++|.+||.
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  197 (320)
T cd05590         159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE  197 (320)
T ss_pred             CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence            999999999998889999999999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.9e-44  Score=266.24  Aligned_cols=190  Identities=31%  Similarity=0.470  Sum_probs=166.5

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..+++.+|+|++.+..    ...+.+..|..+++.+ +||+|+++++++.+....++|||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999997642    2234566788888765 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~~~  161 (200)
                      ++|...+.+...+++..+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++....... ......+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence            999999988888999999999999999999999999999999999999987664  9999999986432222 2233468


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf  196 (321)
T cd05591         159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF  196 (321)
T ss_pred             CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCC
Confidence            99999999999889999999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.6e-44  Score=265.78  Aligned_cols=191  Identities=33%  Similarity=0.495  Sum_probs=165.2

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhh-CCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRS-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..+++.||+|.+....    ...+....|...+.. .+||||+++++++..+..++++||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997642    222344556666654 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~  161 (200)
                      ++|.+++.....++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++...... .......+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence            999999988888999999999999999999999999999999999999986664  999999998643322 22334468


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~  197 (316)
T cd05592         159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH  197 (316)
T ss_pred             CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence            999999999998889999999999999999999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.3e-44  Score=266.32  Aligned_cols=195  Identities=30%  Similarity=0.398  Sum_probs=175.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..++..+++|.+....  ...+.+.+|+.+++.++|||++++++++.+++..+++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            68999999999999999999999999999999987642  2346789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      +++++|.+++.+...++...+..++.|++.||.+||+. +++||||+|+||++++++.  ++|+|||++..... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~  161 (331)
T cd06649          85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  161 (331)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-ccccc
Confidence            99999999998888899999999999999999999986 6999999999999986664  99999999864432 22334


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~  202 (331)
T cd06649         162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI  202 (331)
T ss_pred             CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            56889999999999888999999999999999999999997

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.7e-44  Score=266.70  Aligned_cols=195  Identities=29%  Similarity=0.477  Sum_probs=169.3

Q ss_pred             cccccccccCCcceEEEEEEEc---CCCcEEEEEEecccc-----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            3 KYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      +|++.+.||+|++|+||++.+.   .+++.+|+|++.+..     ...+.+.+|+.+++.+ +||+|+++++.+.++..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999998864   468899999987532     2234677899999999 599999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +++|||+++++|.+++.+...+++..+..++.|++.||++||++|++||||+|+||++++++.  ++|+|||++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence            999999999999999988888999999999999999999999999999999999999987664  999999998643322


Q ss_pred             CC--CCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SR--PKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..  .....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf  207 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF  207 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCC
Confidence            22  2234689999999999865 4788999999999999999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-45  Score=270.99  Aligned_cols=197  Identities=34%  Similarity=0.528  Sum_probs=180.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCce-EEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTH-LAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v   76 (200)
                      +++|..++.+|.|+||.++.+.++..++.+++|.+....   ...+...+|+.++++++||||+.+.+.|.+++. ++++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            579999999999999999999999999999999997643   334578999999999999999999999999988 9999


Q ss_pred             EEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           77 MEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      |+|++||++.+.+.+.+  .++++.+..|+.|++.|+.|||+..|+||||++.||++..+..  |+|.|||+|+......
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED  160 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence            99999999999997655  5999999999999999999999999999999999999987775  8999999998776665


Q ss_pred             -CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 -RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                       ......||+.|++||.+.+.+|+.++|+|||||++|||.+-+++|
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF  206 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAF  206 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhccccc
Confidence             455567999999999999999999999999999999999999987

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.6e-44  Score=266.23  Aligned_cols=194  Identities=34%  Similarity=0.495  Sum_probs=167.5

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHH---hhCCCCCeeeEEEEEecCceEEEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINH---RSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      |++.+.||+|++|.||++.+..+++.||+|++.+..    ...+.+.+|..++   +.++||||+++++++.+....++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            788999999999999999999999999999997542    2234566666554   466899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~  155 (200)
                      ||++++++|...+.+ +.+++..+..++.|++.||.+||+.|++||||+|+||++++++.  ++|+|||++...... ..
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence            999999999887744 56999999999999999999999999999999999999987664  999999988643222 22


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~  202 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP  202 (324)
T ss_pred             ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence            334568999999999999899999999999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.3e-44  Score=266.19  Aligned_cols=191  Identities=26%  Similarity=0.431  Sum_probs=168.3

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|+||++.+..+++.+|+|++.+..    ...+.+.+|..++.++ +||+++++++++.+.+.+++|||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998642    2234577888888887 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CCCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~~~~~~~~  161 (200)
                      ++|..++.+...++...+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++..... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence            999999988888999999999999999999999999999999999999987664  99999999864222 222334568


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~  197 (327)
T cd05617         159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD  197 (327)
T ss_pred             CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence            999999999999999999999999999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.9e-44  Score=264.83  Aligned_cols=191  Identities=31%  Similarity=0.448  Sum_probs=166.2

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhh-CCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRS-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..+++.||+|.+....    ...+....|..++.. .+||+++++++.+.+.+.+++|||++.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997642    223456667777765 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~  161 (200)
                      ++|.+++.+..+++..++..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||++...... .......+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence            999999988888999999999999999999999999999999999999986664  999999988643222 22233468


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++|+||+|+++|+|++|.+||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~  197 (316)
T cd05620         159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH  197 (316)
T ss_pred             CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence            999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.2e-44  Score=263.78  Aligned_cols=195  Identities=27%  Similarity=0.403  Sum_probs=168.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|+||++.+..+++.+|+|.+.....  ......+|+.+++.++|||++++++++.++...+++||+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            689999999999999999999999999999999875432  234678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCC
Q 029037           80 AAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (200)
Q Consensus        80 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~  157 (200)
                      ++ ++|.+++.+. ..++...+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++....... ...
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCccCC
Confidence            95 5787777654 46899999999999999999999999999999999999986654  9999999986432222 223


Q ss_pred             cccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  204 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF  204 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            3457889999999865 45788899999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.2e-44  Score=265.48  Aligned_cols=196  Identities=29%  Similarity=0.464  Sum_probs=170.6

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +|+..+.||+|++|.||++.+..+++.||+|++.+..    ...+.+..|..+++.+. |++++++.+++.+...+++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788999999999999999999999999999987642    22245677888888775 577888999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~  156 (200)
                      ||++|++|.+++.+...+++.++..++.|++.||++||++|++||||+|+||++++++.  ++|+|||++....... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence            99999999999988888999999999999999999999999999999999999987664  9999999986432222 23


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+++.|+|||.+.+..++.++|+||+|+++|+|++|.+||.
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~  202 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD  202 (323)
T ss_pred             cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCC
Confidence            34468999999999998889999999999999999999999983

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.6e-44  Score=266.97  Aligned_cols=194  Identities=28%  Similarity=0.469  Sum_probs=167.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC-----ceEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLA   74 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   74 (200)
                      +|++.+.||+|++|.||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++...     ..++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            6999999999999999999999999999999987532   2234688999999999999999999987543     3489


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      ++||+++ ++|.+++.....+++..+..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||+++......
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence            9999995 689999988888999999999999999999999999999999999999986664  9999999986432222


Q ss_pred             C----CCcccCCCCccCCeeecC--cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 R----PKSTVGTPAYIAPEVLSR--REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .    .....+++.|+|||.+.+  ..++.++|+||||+++|+|++|.+||
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf  208 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF  208 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC
Confidence            1    123468899999999865  57889999999999999999999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.5e-44  Score=264.42  Aligned_cols=191  Identities=29%  Similarity=0.467  Sum_probs=167.6

Q ss_pred             cccccCCcceEEEEEEE---cCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            7 VKDLGAGNFGVARLLRH---KETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~---~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++.||+|++|.||++.+   ..+++.+|+|++....   .....+.+|+.++++++||||+++++.+.++...++|||++
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999886   3578899999997643   22345778999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~  159 (200)
                      ++++|.+++.+...+++..+..++.|++.||+|||+.|++||||+|+||++++++.  ++|+|||++...... ......
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence            99999999988888999999999999999999999999999999999999986664  999999998644333 222344


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~  198 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF  198 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCC
Confidence            6889999999999888899999999999999999999998

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.5e-43  Score=262.96  Aligned_cols=191  Identities=31%  Similarity=0.454  Sum_probs=165.9

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhh-CCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRS-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..+++.||+|.+....    ...+....|...+.. ++||||+++++++.+...++++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999999999999999997642    223455667777765 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~  161 (200)
                      ++|.+++.+...++..++..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++...... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence            999999988778999999999999999999999999999999999999987664  999999998643222 22234468


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++|+||+|+++|+|++|.+||.
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~  197 (316)
T cd05619         159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH  197 (316)
T ss_pred             CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence            899999999998899999999999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=265.00  Aligned_cols=198  Identities=33%  Similarity=0.506  Sum_probs=167.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---------------cchHHHHHHHHHHhhCCCCCeeeEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---------------KIDENVAREIINHRSLRHPNIIRFKE   65 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---------------~~~~~~~~e~~~l~~l~~~~i~~~~~   65 (200)
                      |++|++.+.||+|.+|.|-+|++..+++.||+|++.+.+               ...+...+|+.+++++.|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            689999999999999999999999999999999997532               11257899999999999999999999


Q ss_pred             EEecC--ceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEee
Q 029037           66 VVLTP--THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (200)
Q Consensus        66 ~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~d  143 (200)
                      +..+.  ..+|+|+|||..|.+..--.....++..+++.++++++.||+|||.+||+||||||+|+++++++  +|||.|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g--~VKIsD  253 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG--TVKISD  253 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC--cEEeec
Confidence            98764  56999999999887754332233389999999999999999999999999999999999998775  599999


Q ss_pred             cCCCcccCCCCCC------CcccCCCCccCCeeecCc---cc-CCeeehhhhhhhhhhcCCCCCCCC
Q 029037          144 FGYSKSSVLHSRP------KSTVGTPAYIAPEVLSRR---EY-DGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       144 f~~~~~~~~~~~~------~~~~~~~~~~aPE~~~~~---~~-~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ||.+...+.+...      ..+.|||.|+|||.....   .+ +.+.||||+|+.||-|+-|+-||.
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            9998755333221      235799999999998763   22 455699999999999999999994

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=258.44  Aligned_cols=195  Identities=24%  Similarity=0.327  Sum_probs=171.7

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      .|++.+.||+|++|+||++.+..+++.||+|.+....    .....+.+|+.+++.++||+++++++.+.++...+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4889999999999999999999999999999987532    122456789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           79 YAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ++++++|.+.+...  ..++...+..++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC--CEEEeeCCCceecCCCCcc
Confidence            99999999888654  3589999999999999999999999999999999999998665  4999999998754433333


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|+|||.+.+..++.++|+||+|+++|++++|.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf  201 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF  201 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCC
Confidence            4456889999999999888999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=257.86  Aligned_cols=194  Identities=32%  Similarity=0.477  Sum_probs=169.8

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecC-----ceEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLA   74 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   74 (200)
                      +|...+.||.|++|.|..+.+..+++.||+|.+.+.   ....++..+|+++++.++|+||+.+.+.+...     +.+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            456679999999999999999999999999999853   33357899999999999999999999998762     4589


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-  153 (200)
                      +|+|++ +.+|.+.+..++.++...+..+++|++.||+|+|+.+++|||+||+|++++.+..  +||+|||+|+..... 
T Consensus       103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKFF  179 (359)
T ss_pred             EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeeccccC
Confidence            999999 5699999988878999999999999999999999999999999999999976654  999999999865432 


Q ss_pred             --CCCCcccCCCCccCCeeec-CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 --SRPKSTVGTPAYIAPEVLS-RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 --~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        ........|..|.|||.+. ...|+.+.||||+||++.||++|+|.|
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF  228 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF  228 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence              2223456789999999986 568999999999999999999999988

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-46  Score=254.53  Aligned_cols=199  Identities=33%  Similarity=0.521  Sum_probs=178.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|.+.+.||+|.|+.|+++.+..+|+.+++|++...   ...-+++.+|+++-+.|+||||+++.+...+....++|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            5799999999999999999999999999999988653   2345789999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC-CCCCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~-~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      +++|+.|-.-+-..--+++..+...++||+.+|.|+|.+||+|||++|.|+++.+ +....+||+|||+|.....+..-.
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~  170 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWH  170 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccc
Confidence            9999999766655445778888899999999999999999999999999999943 223369999999998777666677


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...|+|.|+|||++++.+|+.++|||+.|+++|-++.|.+|||
T Consensus       171 G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~  213 (355)
T KOG0033|consen  171 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  213 (355)
T ss_pred             cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence            7889999999999999999999999999999999999999999

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-44  Score=265.54  Aligned_cols=191  Identities=27%  Similarity=0.418  Sum_probs=167.9

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      .+++.+.||+|.||.|+.+..+.+. .||+|.++......+.+.+|+.++++|+|++|+++++++..+..++|||||++.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            3567899999999999999998654 489999998777788999999999999999999999999998999999999999


Q ss_pred             CchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc--
Q 029037           83 GELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS--  158 (200)
Q Consensus        83 ~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~--  158 (200)
                      |+|.+++.+  ...+...+.+.++.||++||+||+++++|||||...||||+++..  +||+|||+|+. .....-..  
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~-~~d~~Y~~~~  362 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARL-IGDDEYTASE  362 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccc-cCCCceeecC
Confidence            999999987  446999999999999999999999999999999999999987664  99999999983 22222111  


Q ss_pred             -ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCC
Q 029037          159 -TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNP  197 (200)
Q Consensus       159 -~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~  197 (200)
                       .--...|.|||.+....++.++||||+|++|+|++|-..
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~  402 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGR  402 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCC
Confidence             223567999999999999999999999999999998543

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.4e-43  Score=262.21  Aligned_cols=190  Identities=35%  Similarity=0.518  Sum_probs=166.9

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|+||++.+..+++.+|+|++.+..    ...+.+.+|..+++.+ +|||++++++++.+...++++||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998642    2234567788888777 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~  161 (200)
                      ++|...+.+...+++..+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++...... .......+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence            999999988888999999999999999999999999999999999999987664  999999988642222 22233468


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++.|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus       159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf  196 (318)
T cd05570         159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF  196 (318)
T ss_pred             CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCC
Confidence            89999999999999999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4e-43  Score=265.04  Aligned_cols=194  Identities=26%  Similarity=0.350  Sum_probs=167.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc------
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT------   71 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   71 (200)
                      +++|++.+.||+|++|.||++.+..+++.+|+|.+....   .....+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999999999999999987542   22456788999999999999999999986543      


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      .++++||++++ +|.+.+..  .++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++....
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~  174 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAC  174 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccc
Confidence            47999999965 66665533  4788999999999999999999999999999999999987664  9999999987544


Q ss_pred             CCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .........++..|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf  222 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF  222 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence            444444557889999999999999999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=268.28  Aligned_cols=195  Identities=31%  Similarity=0.443  Sum_probs=177.8

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      .|+..+.||+|.||.||+|.+..+++.||+|++..+...  .+++.+|+.++.+++++||.++++.+..+..++++|||+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            578889999999999999999999999999999876443  468999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~  159 (200)
                      .||++.+.+.....+.+..+..++++++.|+.|||.++.+||||++.||++..++  .++|+|||.+........ ...+
T Consensus        94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g--~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG--DVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC--cEEEEecceeeeeechhhccccc
Confidence            9999999997777779999999999999999999999999999999999998775  499999999864443333 3667


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .||+.|||||++....|+.++||||||++.+||.+|.||+
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~  211 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPH  211 (467)
T ss_pred             cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCC
Confidence            8999999999999889999999999999999999999996

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.5e-43  Score=283.32  Aligned_cols=198  Identities=25%  Similarity=0.321  Sum_probs=171.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      |++|++.+.||+|++|.||++.+..+++.||+|.+....    ...+++.+|+.+++.++|||++++++++.+++..+++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            689999999999999999999999999999999987532    2245788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecC
Q 029037           77 MEYAAGGELFDRICNA-----------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~  145 (200)
                      ||+++|++|.+++...           ...+...++.++.|++.||++||+.|++||||||+||+++.++.  ++|+|||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFG  158 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWG  158 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecC
Confidence            9999999999988542           23456678899999999999999999999999999999987665  9999999


Q ss_pred             CCcccCCCC-------------------CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          146 YSKSSVLHS-------------------RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       146 ~~~~~~~~~-------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.......                   ......|++.|+|||.+.+..++.++|+||+|+++|||++|.+||.
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            986441110                   0112358999999999999999999999999999999999999983

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.2e-43  Score=261.83  Aligned_cols=195  Identities=30%  Similarity=0.403  Sum_probs=173.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||.|++|.||++.+..++..+++|.+....  ...+.+.+|+++++.++||||+++++++.+++..+++|||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            68999999999999999999999999999999887542  2235788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      +++++|.+++.+.+.++...+..++.|++.||.|||+. +++|+||+|+||++++++.  ++|+|||++..... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~~~  161 (333)
T cd06650          85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  161 (333)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hcccc
Confidence            99999999998888899999999999999999999975 7999999999999986654  99999999864322 22234


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~  202 (333)
T cd06650         162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI  202 (333)
T ss_pred             CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            46888999999999888999999999999999999999887

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-43  Score=264.14  Aligned_cols=196  Identities=22%  Similarity=0.339  Sum_probs=162.6

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecC-ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTP-TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~   72 (200)
                      ++|++.+.||+|+||.||++.+.     .+++.||+|.+.....  ..+.+.+|+.+++.+ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            58999999999999999999752     3456799999875432  235688999999999 899999999988764 45


Q ss_pred             EEEEEEecCCCchHHHHHhc------------------------------------------------------------
Q 029037           73 LAIVMEYAAGGELFDRICNA------------------------------------------------------------   92 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~------------------------------------------------------------   92 (200)
                      ++++|||+++++|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            89999999999999998653                                                            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC---CCcccCCCCccC
Q 029037           93 --GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIA  167 (200)
Q Consensus        93 --~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~a  167 (200)
                        .+++..++..++.|++.||+|||+.|++||||||+||+++.++  .++|+|||+++.......   .....++..|+|
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCccccC
Confidence              2367788899999999999999999999999999999998665  499999999864322211   112234578999


Q ss_pred             CeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          168 PEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       168 PE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ||.+.+..++.++|+||+|+++|||++ |.+||
T Consensus       245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf  277 (338)
T cd05102         245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY  277 (338)
T ss_pred             cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCC
Confidence            999998899999999999999999997 88886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-43  Score=261.67  Aligned_cols=189  Identities=30%  Similarity=0.487  Sum_probs=161.4

Q ss_pred             ccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhC---CCCCeeeEEEEEecCceEEEEEEecCC
Q 029037           10 LGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSL---RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus        10 l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      ||+|+||+||++.+..+++.||+|++.+...    .......|..++...   +||+|+++++.+.+...++++|||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999999999999999875321    122344555565544   699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~~~  161 (200)
                      ++|.+++.+...++...+..++.|++.||+|||++|++||||+|+||+++.++.  ++|+|||++...... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence            999999988888999999999999999999999999999999999999987664  999999998643322 22334568


Q ss_pred             CCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +..|+|||.+.+. .++.++|+||||+++|+|++|..||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~  198 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY  198 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence            9999999998754 47899999999999999999999984

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.5e-43  Score=254.81  Aligned_cols=188  Identities=30%  Similarity=0.391  Sum_probs=163.7

Q ss_pred             ccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037           10 LGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus        10 l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      ||+|+||+||++.+..+++.+|+|.+.....    ..+.+..|+.+++.++|++++++.+.+..+...+++||++++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999999999999999999875422    124567899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCccc
Q 029037           86 FDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKSTV  160 (200)
Q Consensus        86 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~~  160 (200)
                      .+.+..    ...+++..+..++.|++.||++||+.|++||||+|+||++++++  .++|+|||.+........ .....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG--NVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCccceecCCCCccccccC
Confidence            887743    34589999999999999999999999999999999999998655  499999999864433222 23346


Q ss_pred             CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          161 GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +++.|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf  197 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF  197 (280)
T ss_pred             CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            889999999999999999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.6e-43  Score=255.93  Aligned_cols=196  Identities=28%  Similarity=0.425  Sum_probs=164.2

Q ss_pred             ccccccccccCCcceEEEEEEEcC-CCcEEEEEEeccccc---chHHHHHHHHHHhhC---CCCCeeeEEEEEec-----
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-TKELVAVKYIERGRK---IDENVAREIINHRSL---RHPNIIRFKEVVLT-----   69 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----   69 (200)
                      ++|++.+.||+|++|.||++.+.. +++.+|+|.+.....   ......+|+..++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            589999999999999999999854 467899998875322   234566677776655   69999999998852     


Q ss_pred             CceEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037           70 PTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus        70 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                      ...++++||+++ ++|.+++....  .++...+..++.|++.||.+||+.|++||||+|+||++++++.  ++|+|||.+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence            356899999996 58988886543  4889999999999999999999999999999999999987664  999999998


Q ss_pred             cccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          148 KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .............+++.|+|||.+.+..++.++|+||+|+++|||++|.+||.
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~  210 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  210 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence            75544434445568899999999988889999999999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-42  Score=252.89  Aligned_cols=188  Identities=26%  Similarity=0.346  Sum_probs=164.3

Q ss_pred             ccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037           10 LGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus        10 l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      ||+|+||.||++.+..+++.+++|.+.....    .......|+.+++.++|||++++.+.+.++...+++||+++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6999999999999999999999999865321    223456799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCC
Q 029037           86 FDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP  163 (200)
Q Consensus        86 ~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~  163 (200)
                      .+.+....  .++...+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++.............++.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence            88886543  4888899999999999999999999999999999999987664  9999999987554433334456889


Q ss_pred             CccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          164 AYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       164 ~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus       159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~  194 (277)
T cd05607         159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF  194 (277)
T ss_pred             CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCC
Confidence            999999999888999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-42  Score=270.85  Aligned_cols=195  Identities=27%  Similarity=0.365  Sum_probs=169.4

Q ss_pred             cccccccccCCcceEEEEEEEcCC-CcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            3 KYELVKDLGAGNFGVARLLRHKET-KELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~-~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      .|.+.+.||+|++|.||.+.+..+ +..+++|.+..... ....+.+|+.+++.++||||+++++++.+++.+++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            489999999999999999998877 67788887754432 2346778999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           81 AGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        81 ~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      +|++|.+.+..    ..+++..++..++.|++.||.+||+.|++||||+|+||++++++.  ++|+|||+++....... 
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCcccc
Confidence            99999887753    345889999999999999999999999999999999999986654  99999999875433222 


Q ss_pred             --CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 --PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        .....|++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf  271 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF  271 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence              23346899999999999989999999999999999999999997

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.1e-42  Score=253.55  Aligned_cols=196  Identities=24%  Similarity=0.329  Sum_probs=171.9

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      .|++.+.||+|++|.||++.+..+++.+++|.+......    .+.+.+|+.+++.++|++++++.+.+.+....+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            378889999999999999999999999999988754221    2456789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           79 YAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      +++|++|.+++....  .++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||++.........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence            999999998885443  5899999999999999999999999999999999999986654  999999998654433333


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|.+||.
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~  202 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ  202 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            44568899999999998899999999999999999999999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=249.83  Aligned_cols=196  Identities=30%  Similarity=0.411  Sum_probs=173.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|++|.||.+.+..+++.+++|.+.....      ..+.+.+|+.++++++|||++++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999999999999998875321      12467889999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ++|++++++|.+.+.+.+.++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence            9999999999999988888999999999999999999999999999999999999986654  99999999864332221


Q ss_pred             C----CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 P----KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .    ....++..|+|||.+.+..++.++|+||+|+++|++++|.+||
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~  207 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW  207 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence            1    2234678899999999888999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.2e-43  Score=269.58  Aligned_cols=193  Identities=30%  Similarity=0.413  Sum_probs=163.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecC--------ceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTP--------THL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~   73 (200)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+....   ....+|+.+++.++|||++++.+++...        ..+
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            47999999999999999999999999999999886532   3345799999999999999998876432        247


Q ss_pred             EEEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           74 AIVMEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      +++|||+++ +|.+++.    ....++...+..++.|++.||+|||+.|++||||+|+||+++.++. .++|+|||+|+.
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~~  220 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKN  220 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccchh
Confidence            799999965 7766664    3456899999999999999999999999999999999999975542 599999999976


Q ss_pred             cCCCCCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          150 SVLHSRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...........+++.|+|||.+.+. .++.++|+||||+++|||++|.+||
T Consensus       221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf  271 (440)
T PTZ00036        221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF  271 (440)
T ss_pred             ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            5554444556789999999998654 6899999999999999999999998

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-43  Score=255.35  Aligned_cols=195  Identities=38%  Similarity=0.522  Sum_probs=173.5

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchH---HHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE---NVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      |++.+.||+|++|+||++.+..+++.+|+|.+........   ...+|+..+++++||||+++.+++.++...+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            7899999999999999999999999999999987654433   2345999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCccc-CCCCCCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHSRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~-~~~~~~~~~  159 (200)
                      ++++|.+++.+...++...+..++.|++.||++||+.|++|+||+|+||+++.++.  ++|+|||.+... .........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence            99999999988888999999999999999999999999999999999999986654  999999998642 223333445


Q ss_pred             cCCCCccCCeeec-CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLS-RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~-~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .++..|.|||.+. +..++.++|+||||+++++|++|..||+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~  200 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE  200 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc
Confidence            6788999999998 7889999999999999999999999884

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.5e-42  Score=253.82  Aligned_cols=194  Identities=35%  Similarity=0.599  Sum_probs=174.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....    ...+.+.+|+.++++++||||+++++++.+....+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            57999999999999999999999999999999987542    23456889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      |++++++|.+++.+...++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||++......  ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence            99999999999988888999999999999999999999999999999999999986654  999999998754333  33


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  198 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF  198 (290)
T ss_pred             CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            346788999999998888899999999999999999999997

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.2e-42  Score=252.63  Aligned_cols=195  Identities=24%  Similarity=0.326  Sum_probs=171.5

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      .|+..+.||+|+||+||++.+..+++.+|+|.+.....    ....+.+|+.+++.++|++++++.+.+.+++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999875422    22457789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           79 YAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ++++++|.+.+...  .+++...+..++.|++.||.+||+.|++||||+|+||++++++  .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCCCcc
Confidence            99999998888653  3599999999999999999999999999999999999998665  4999999998654433333


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|+|||.+.+..++.++|+||+|+++|++++|.+||
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~  201 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF  201 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence            4456889999999999889999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=271.69  Aligned_cols=196  Identities=31%  Similarity=0.397  Sum_probs=174.2

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCc------eEEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLTPT------HLAI   75 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~~   75 (200)
                      +...+.||+|+||.||+++++.+|+.||+|.+.+.  .+..+..-+|++++++++|||||+.+++=++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            45678999999999999999999999999999863  344577889999999999999999998765543      3589


Q ss_pred             EEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC--CCCCEEEeecCCCccc
Q 029037           76 VMEYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS--AAPRLKICDFGYSKSS  150 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~--~~~~v~l~df~~~~~~  150 (200)
                      +||||.||+|...+.+..   .+++.+.+.++.++..||.+||++||+||||||.||++..+  +....||+|||.|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999999999999996543   49999999999999999999999999999999999998533  4445799999999988


Q ss_pred             CCCCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          151 VLHSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..+....+..||..|++||...+ +.|+..+|.||+|+++|+..||.-||
T Consensus       175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF  224 (732)
T KOG4250|consen  175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPF  224 (732)
T ss_pred             CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCC
Confidence            88888888899999999999985 78888899999999999999999998

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=286.47  Aligned_cols=197  Identities=29%  Similarity=0.461  Sum_probs=177.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++++.||+|+||.|..++++++++.||+|++.+-    .....-|.+|-.++.--+++=|+++...|+++.++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            5799999999999999999999999999999999873    233455778888888888999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      ||++||+|...+.+..++++..++.++..|+.||..+|+.|+|||||||+||++|..+.  |+|+|||.|-.....+.  
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCcEE
Confidence            99999999999999999999999999999999999999999999999999999987765  99999999865543333  


Q ss_pred             CCcccCCCCccCCeeecC-----cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSR-----REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+|||.|.|||++..     +.|++.+|+||+|+++|||+-|.-||+
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            345689999999999852     468999999999999999999999996

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.8e-42  Score=253.18  Aligned_cols=194  Identities=27%  Similarity=0.428  Sum_probs=164.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhC---CCCCeeeEEEEEecC-----c
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSL---RHPNIIRFKEVVLTP-----T   71 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~-----~   71 (200)
                      +|++.+.||+|++|+||++.+..+++.+|+|.+....   .......+|+..++.+   +||||+++++++.+.     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            6899999999999999999999999999999887532   2234556677666655   799999999988642     4


Q ss_pred             eEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           72 HLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      ..+++||++++ +|.+++....  .++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||++..
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI  157 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence            58999999975 8888886643  4899999999999999999999999999999999999986664  99999999875


Q ss_pred             cCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          150 SVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...........++..|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f  207 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF  207 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc
Confidence            54433334456788999999998888999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.5e-42  Score=249.96  Aligned_cols=192  Identities=27%  Similarity=0.336  Sum_probs=169.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....  ...+.+.+|+.++++++|||++++++.+...+..+++||+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            57899999999999999999999999999999987542  2235688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      +++++|..+    ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||++..... ......
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~-~~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVN-SIAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceeccc-ccccCC
Confidence            999988654    35788899999999999999999999999999999999987664  99999999864332 223345


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|.+||+
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~  194 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP  194 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCch
Confidence            68889999999998899999999999999999999999984

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-42  Score=261.58  Aligned_cols=194  Identities=26%  Similarity=0.351  Sum_probs=168.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC------c
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------T   71 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   71 (200)
                      +++|++.+.||+|++|.||++.+..+++.+|+|.+....   ...+.+.+|+.+++.++|||++++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            478999999999999999999999999999999987542   2235678899999999999999999887643      3


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      ..++|||++++ +|.+.+..  .++...+..++.|++.||++||++|++||||+|+||++++++.  ++|+|||++....
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~  177 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  177 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccC
Confidence            57999999965 77776643  4788999999999999999999999999999999999987664  9999999997554


Q ss_pred             CCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .........++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf  225 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF  225 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence            444444557889999999999999999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.8e-42  Score=254.93  Aligned_cols=196  Identities=29%  Similarity=0.466  Sum_probs=168.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +++|++.+.||+|++|.||++.+..+++.+|+|.+....  .....+.+|+.+++.++|||++++++++..++..+++||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            478999999999999999999999999999999987542  223467889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-C
Q 029037           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~  156 (200)
                      ++++ +|.+++...+ .++...+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++........ .
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCcccc
Confidence            9975 8888876654 4889999999999999999999999999999999999986654  99999999864332222 2


Q ss_pred             CcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf  205 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF  205 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            23457889999999865 46788999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.7e-42  Score=268.38  Aligned_cols=195  Identities=25%  Similarity=0.356  Sum_probs=164.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC------CCCeeeEEEEEecC-ceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR------HPNIIRFKEVVLTP-THLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~-~~~~   74 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|++............|+.+++.++      |++++++++++..+ ..++
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            5799999999999999999999999999999999764444455566777666654      45688899888765 4689


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCC--------------CCE
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAA--------------PRL  139 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~--------------~~v  139 (200)
                      ++|+++ |++|.+++.+...++...+..++.|++.||.|||+ .||+||||||+||+++.++.              ..+
T Consensus       209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v  287 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV  287 (467)
T ss_pred             EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence            999988 77899999888889999999999999999999997 69999999999999975442              249


Q ss_pred             EEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       140 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ||+|||.+....  .......+++.|+|||.+.+..++.++|||||||++|||++|.+||
T Consensus       288 kl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        288 RICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             EECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999875322  2233457899999999999999999999999999999999999998

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-42  Score=261.42  Aligned_cols=194  Identities=26%  Similarity=0.356  Sum_probs=168.0

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecC------c
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP------T   71 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   71 (200)
                      +++|++.+.||+|++|.||++.+..+++.+|+|.+.....   ..+.+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            4789999999999999999999999999999999875422   235677899999999999999999988654      3


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      ..+++||++++ ++.+.+..  .++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++....
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~  170 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  170 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCC
Confidence            47999999965 67666643  4788999999999999999999999999999999999987664  9999999997554


Q ss_pred             CCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .........++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  218 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF  218 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            444445567899999999999989999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.6e-42  Score=250.03  Aligned_cols=197  Identities=20%  Similarity=0.304  Sum_probs=167.1

Q ss_pred             ccccccccccCCcceEEEEEEEc---CCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|+||.||++.+.   ..+..+++|.++...  .....+.+|+..+++++|||++++++++..+...+++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            47899999999999999999865   345689999988653  2235688999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.+. ..+++..++.++.|++.||++||++|++||||+|+||+++++.  .++++|||.+........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCcccccccccch
Confidence            9999999999998764 4689999999999999999999999999999999999998665  499999998654322211


Q ss_pred             CC--cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          156 PK--STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       156 ~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      ..  ...++..|+|||.+.+..++.++|+||+|+++||+++ |.+|||
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~  210 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence            11  1234567999999998899999999999999999764 999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.3e-42  Score=259.51  Aligned_cols=193  Identities=27%  Similarity=0.361  Sum_probs=163.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|+..+.||+|++|.||++.+..+++.|++|++....  ...+.+.+|+.+++.++|+||+++++++.+++.++++|||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            56889999999999999999999999999999986542  2246788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~  158 (200)
                      +++++|.+.    ...+...+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++........ ...
T Consensus       154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccccccc
Confidence            999988543    23567788899999999999999999999999999999987664  99999999865432222 234


Q ss_pred             ccCCCCccCCeeecC-----cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSR-----REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..++..|+|||.+..     ...+.++||||||+++|||++|..||.
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~  274 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG  274 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            468899999999743     233568999999999999999999983

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=251.48  Aligned_cols=198  Identities=36%  Similarity=0.539  Sum_probs=180.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      |++|..++.||+|.||+|.+++.+.+++.+|+|++++.-..    ......|-+.|+..+||.+..+-..|+.+.++|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            57899999999999999999999999999999999886322    34567788999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC-CCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~-~~~~  155 (200)
                      |||..||.|.-.+....-+++.....+-..|++||.|||+++|+.||+|.+|.++|.++.  |||+|||+|+... .+..
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence            999999999988888778999999999999999999999999999999999999998886  9999999997544 3444


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+|||.|+|||++....|..++|.|.+|++||||+.|..||+
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy  369 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY  369 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence            567799999999999999999999999999999999999999996

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.8e-42  Score=252.58  Aligned_cols=195  Identities=30%  Similarity=0.408  Sum_probs=173.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..++..+++|.+.....  ....+.+|++++++++||||+++++.+.++..++++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            579999999999999999999999999999998875422  235688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      +++++|.+++.+..+++...+..++.|++.||.|||+ .+++|+||+|+||++++++.  ++|+|||.+..... .....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~  157 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  157 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-ccccc
Confidence            9999999999888889999999999999999999997 69999999999999987654  99999998864322 22334


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~  198 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI  198 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            56788999999998888999999999999999999999997

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.3e-42  Score=248.18  Aligned_cols=197  Identities=31%  Similarity=0.446  Sum_probs=172.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.++..... ...+.+|+.+++.++|||++++++.+.+....+++||++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            5799999999999999999999999999999998764322 345788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~  159 (200)
                      ++++|.+++...+.++..+++.++.|++.|+.+||+.|++|+||+|+||+++.++.  ++|+|||.+....... .....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccccccc
Confidence            99999999988888999999999999999999999999999999999999986654  9999999986433221 22344


Q ss_pred             cCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .++..|+|||.+.   ...++.++|+||+|+++|+|++|.+||+
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~  210 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence            6888999999974   4457889999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.2e-42  Score=278.32  Aligned_cols=200  Identities=33%  Similarity=0.537  Sum_probs=171.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEec--CceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~   75 (200)
                      +++|++.+.||+|+||+||++.+..+++.+++|.+....   .....+..|+.+++.++||||++++++|.+  ...+++
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            478999999999999999999999999999999987532   234568899999999999999999998864  356899


Q ss_pred             EEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-------CcEeecCCCCCeeecCC----------
Q 029037           76 VMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSM-------QICHRDLKLENTLLDGS----------  134 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~-------~i~h~dl~~~ni~i~~~----------  134 (200)
                      ||||+++++|.+++...    ..+++..++.++.||+.||.|||+.       +|+|+||+|+||+++.+          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            99999999999988653    4699999999999999999999985       49999999999999642          


Q ss_pred             -----CCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecC--cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          135 -----AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR--REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       135 -----~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                           ....++|+|||++.............+++.|+|||++.+  ..++.++|||||||++|+|++|.+||.
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                 233589999999875544444445578999999999864  457889999999999999999999983

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=246.41  Aligned_cols=195  Identities=36%  Similarity=0.499  Sum_probs=172.4

Q ss_pred             cccccc-ccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecC----ceEEE
Q 029037            2 EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTP----THLAI   75 (200)
Q Consensus         2 ~~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----~~~~~   75 (200)
                      ++|.+. +.||-|-.|+|..+.++.|++.+|+|++...    ++..+|+++.-.. .||||+.++++++..    .++.+
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            456665 7899999999999999999999999988764    4455777776555 699999999998753    56899


Q ss_pred             EEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC-CCCCCEEEeecCCCcccCC
Q 029037           76 VMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~-~~~~~v~l~df~~~~~~~~  152 (200)
                      |||.++||.|.+.++..+.  +++.++..|++||..|+.|||+.+|.||||||+|+++.. ..+..+||+|||+|+....
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            9999999999999988765  999999999999999999999999999999999999953 3345699999999987766


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .......+.|+.|+|||++...+|+..+|+||+|++||-|+.|.|||+
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY  264 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence            677778889999999999999999999999999999999999999996

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=247.89  Aligned_cols=192  Identities=28%  Similarity=0.419  Sum_probs=169.1

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      +.||+|+++.|-.+.+..+++.+|+|++.+.+ ....+..+|++++.+.+ |+||++++++|+++..+|+|||-+.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            78999999999999999999999999998864 44678999999999996 99999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec-CCCCCCEEEeecCCCcccCCC--------CCC
Q 029037           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-GSAAPRLKICDFGYSKSSVLH--------SRP  156 (200)
Q Consensus        86 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~-~~~~~~v~l~df~~~~~~~~~--------~~~  156 (200)
                      .+.+++...+++.++.+++.+|++||.+||.+||.|||+||+||+.. ++....||||||.+.......        +..
T Consensus       164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L  243 (463)
T KOG0607|consen  164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL  243 (463)
T ss_pred             HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence            99999999999999999999999999999999999999999999984 344456999999886422111        112


Q ss_pred             CcccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...+|+..|||||+..     ...|+.++|.||||+++|-|++|.|||
T Consensus       244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF  291 (463)
T KOG0607|consen  244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF  291 (463)
T ss_pred             cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence            2346888999999974     235899999999999999999999999

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.6e-42  Score=267.30  Aligned_cols=197  Identities=27%  Similarity=0.388  Sum_probs=168.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCc-------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT-------   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------   71 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|.+.....   ....+.+|+..+..++|++++++.+.+....       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            589999999999999999999999999999999876432   2346788999999999999999987765322       


Q ss_pred             -eEEEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           72 -HLAIVMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        72 -~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                       .++++|||+++++|.+++...    ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.  ++|+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEeccc
Confidence             368999999999999988643    35899999999999999999999999999999999999986654  99999999


Q ss_pred             CcccCCC---CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          147 SKSSVLH---SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       147 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.....   .......+++.|+|||.+.+..++.++|+||||+++|||++|.+||.
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~  246 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD  246 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            8643322   11233468999999999999899999999999999999999999983

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.9e-42  Score=260.72  Aligned_cols=194  Identities=26%  Similarity=0.369  Sum_probs=167.5

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc-----eEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT-----HLA   74 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   74 (200)
                      +|++.+.||+|++|.||++.+..+++.||+|.+....   ...+.+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5889999999999999999999999999999886532   22356889999999999999999999998776     789


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      ++||++. ++|.+.+.....++...+..++.|++.||.+||+.|++||||+|+||++++++.  ++|+|||++.......
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence            9999996 588888877778999999999999999999999999999999999999987664  9999999986433222


Q ss_pred             C--CCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 R--PKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~--~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .  .....++..|+|||.+.+. .++.++|+||+|+++|||++|.+||
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  205 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF  205 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC
Confidence            1  2233568889999998764 4788999999999999999999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=245.22  Aligned_cols=197  Identities=35%  Similarity=0.485  Sum_probs=174.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+.+++.++|||++++++++.+...++++||++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            689999999999999999999998899999999986533 3467899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCc
Q 029037           81 AGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKS  158 (200)
Q Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~  158 (200)
                      ++++|.+++... .+++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+....... ....
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhcccc
Confidence            999999998776 67999999999999999999999999999999999999987664  9999999986543322 2233


Q ss_pred             ccCCCCccCCeeecCc---ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRR---EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~---~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..++..|+|||.+.+.   .++.++|+||+|+++|+|++|.+||+
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~  205 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF  205 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence            4577889999999776   78889999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.7e-42  Score=252.20  Aligned_cols=196  Identities=24%  Similarity=0.325  Sum_probs=162.8

Q ss_pred             ccccccccccCCcceEEEEEEEcC----------------CCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE----------------TKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRF   63 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~----------------~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~   63 (200)
                      ++|++.+.||+|+||.||++.+..                ++..||+|.+....  .....+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            479999999999999999998643                34469999887642  223568899999999999999999


Q ss_pred             EEEEecCceEEEEEEecCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecC
Q 029037           64 KEVVLTPTHLAIVMEYAAGGELFDRICNAG-------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDL  124 (200)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl  124 (200)
                      ++++.+.+..+++||++++++|.+++....                   .++......++.|++.||.+||+.|++||||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence            999999999999999999999999885432                   3567788999999999999999999999999


Q ss_pred             CCCCeeecCCCCCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC--CCCCC
Q 029037          125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR--PNPFI  199 (200)
Q Consensus       125 ~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~--~~~pf  199 (200)
                      +|+||++++++  .++|+|||++........   .....++..|+|||.+.+..++.++|+||||+++|+|++  +..||
T Consensus       165 kp~Nill~~~~--~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         165 ATRNCLVGENL--TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             chhheEEcCCc--cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            99999998665  499999999864322211   112234678999999988889999999999999999976  44554

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.9e-42  Score=260.01  Aligned_cols=196  Identities=23%  Similarity=0.325  Sum_probs=164.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-----CcEEEEEEecccccc--hHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|+||.||++.+..+     .+.||+|.+......  .+.+.+|+.+++.+ +|+||+++++.+.+....
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            4699999999999999999986443     357999999764322  35688999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC------------------------------------------------------------
Q 029037           74 AIVMEYAAGGELFDRICNAG------------------------------------------------------------   93 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~------------------------------------------------------------   93 (200)
                      +++|||+++++|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885421                                                            


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC---Cccc
Q 029037           94 ----------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTV  160 (200)
Q Consensus        94 ----------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~---~~~~  160 (200)
                                +++..++..++.|++.||+|||++|++||||+|+||+++++.  .++|+|||++.........   ....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeeccCCC
Confidence                      367788999999999999999999999999999999998655  4999999998644322211   1122


Q ss_pred             CCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          161 GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++..|+|||.+.+..++.++|+||+|+++|+|++ |.+||
T Consensus       276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf  315 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY  315 (374)
T ss_pred             CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            4567999999988899999999999999999997 88887

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-41  Score=246.27  Aligned_cols=196  Identities=31%  Similarity=0.423  Sum_probs=171.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|++..... ....+.+|+..++.++|||++++++++..+...+++||++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            579999999999999999999999999999999875432 3356788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~  159 (200)
                      ++++|.+++....+++...+..++.|++.||.+||+.|++|+|++|+||++++++.  ++|+|||.+....... .....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06646          89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCcc
Confidence            99999999988788999999999999999999999999999999999999986654  9999999986443222 12334


Q ss_pred             cCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .++..|+|||.+.   ...++.++|+||+|+++|+|++|.+||
T Consensus       167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~  209 (267)
T cd06646         167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM  209 (267)
T ss_pred             ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCc
Confidence            5788999999985   344778899999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.5e-41  Score=245.47  Aligned_cols=196  Identities=32%  Similarity=0.425  Sum_probs=169.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR------KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   73 (200)
                      ++|++.+.||+|++|.||.+.+..+++.|++|.+....      ...+.+.+|+.+++.++|||++++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            58999999999999999999999999999999875322      1234678899999999999999999988764  468


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +++||++++++|.+++.+...++...+..++.|++.+|++||++|++|+||+|+||++++++.  ++|+|||.+......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~  159 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence            899999999999999988778899999999999999999999999999999999999986664  999999988643221


Q ss_pred             ----CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 ----SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                          .......++..|+|||.+.+..++.++|+||||+++|++++|.+||
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~  209 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW  209 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCC
Confidence                1122235778899999998888999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=257.95  Aligned_cols=196  Identities=28%  Similarity=0.395  Sum_probs=180.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +.|+.-+.||+||||.|+-++-..||+.+|+|.+.+..    ....-.++|-.+|.+++.++||.+-..|++...+|+|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45778899999999999999999999999999887532    22345778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ..|.||+|.-.+.+.+  .+++..+..++.+|+.||.+||+.+||.||+||+||++|+.++  +.|+|+|+|+..+.+..
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCc
Confidence            9999999988887766  5999999999999999999999999999999999999987776  99999999998888888


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....||.+|||||++.+..|+.+.|.|||||++|||+.|+.||
T Consensus       343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPF  386 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPF  386 (591)
T ss_pred             cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCch
Confidence            88889999999999999999999999999999999999999998

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.6e-42  Score=258.85  Aligned_cols=196  Identities=23%  Similarity=0.308  Sum_probs=164.4

Q ss_pred             ccccccccccCCcceEEEEEEE-----cCCCcEEEEEEecccc--cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRH-----KETKELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|+||.||++.+     ..++..||+|++....  ...+.+.+|+.+++.+ +||||+++++++.+....
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4799999999999999999974     3456789999987543  2345688999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC------------------------------------------------------------
Q 029037           74 AIVMEYAAGGELFDRICNAG------------------------------------------------------------   93 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~------------------------------------------------------------   93 (200)
                      +++|||+++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999886421                                                            


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--
Q 029037           94 ---------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--  156 (200)
Q Consensus        94 ---------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--  156 (200)
                                     .++...+..++.|++.||.+||+.|++||||+|+||+++++.  .++|+|||++.........  
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCccceeccCcccccc
Confidence                           367788999999999999999999999999999999998655  4999999998644332211  


Q ss_pred             -CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          157 -KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       157 -~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                       ....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~  317 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY  317 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence             11234567999999999899999999999999999997 77776

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1e-41  Score=251.97  Aligned_cols=197  Identities=24%  Similarity=0.301  Sum_probs=164.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcE--EEEEEecccc--cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~--~~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|++|.||++.+..++..  +++|......  .....+.+|+..+.++ +|||++++++++.++..+++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            46899999999999999999998776654  5777665422  2235688899999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCE
Q 029037           76 VMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v  139 (200)
                      +||++++++|.+++.+..                .++..+++.++.|++.|+++||+.|++||||+|+||++++++.  +
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--A  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--E
Confidence            999999999999996542                4788899999999999999999999999999999999986654  9


Q ss_pred             EEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       140 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +|+|||++..............+..|+|||.+.+..++.++|+||||+++|+|+| |.+||
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  224 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY  224 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCc
Confidence            9999998853222212222234567999999988888999999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-43  Score=263.62  Aligned_cols=192  Identities=24%  Similarity=0.376  Sum_probs=166.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++..+.+.||+|+||+||+|.+...   ||+|++.....   ..+.|++|+..+++-+|.||+-+.|++..... .+|+.
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             HHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            4567889999999999999999854   99999986533   34679999999999999999999999988766 99999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCccc---CCCC
Q 029037           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS---VLHS  154 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~---~~~~  154 (200)
                      +|+|.+|..+++-.. .+...+.+.|++|++.|+.|||.++|+|+|||..||++.++.  +|+|+|||++...   ....
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~--kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL--KVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC--cEEEecccceeeeeeecccc
Confidence            999999999997554 589999999999999999999999999999999999998775  4999999998532   2223


Q ss_pred             CCCcccCCCCccCCeeecCc---ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRR---EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......+...|+|||+++.+   +|++.+||||+|+++|||++|.-||
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy  593 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY  593 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence            33445678899999999754   6889999999999999999999997

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.3e-42  Score=248.07  Aligned_cols=195  Identities=28%  Similarity=0.477  Sum_probs=176.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +|++.+.||.|++|.||++.+..+++.+++|.+.+..    ...+.+.+|+..+++++|||++++++.+.+....++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999999999999999997643    234678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      ++.|++|.+++.+..+++...+..++.|++.+|.+||+.|++|+||+|+||++++++.  ++|+|||.+...........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence            9999999999987778999999999999999999999999999999999999987665  99999999876554444445


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||+|+++|++++|..||
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  199 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY  199 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCC
Confidence            56788999999998888999999999999999999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-41  Score=245.95  Aligned_cols=196  Identities=21%  Similarity=0.294  Sum_probs=170.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .+|.+.+.||+|++|.||++.+..+++.+++|.+..+....+.+.+|+..++.++||+++++++++..+..++++||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            46889999999999999999999999999999988765556778999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC--
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK--  157 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~--  157 (200)
                      +++|.+++....  .++...++.++.|++.+|++||+.|++|+||+|+||++++++  .++|+|||.+..........  
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC--cEEeCCCccccccccceeeccC
Confidence            999999986543  588999999999999999999999999999999999998665  49999999986443222111  


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ....+..|+|||.+.+..++.++|+||||+++|||++ |.+||
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~  206 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY  206 (263)
T ss_pred             CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence            1223567999999988899999999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-41  Score=246.30  Aligned_cols=196  Identities=30%  Similarity=0.455  Sum_probs=174.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+....  .....+.+|+.+++.++|+|++++.+++.++...++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            58999999999999999999999999999999987643  2235688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~  158 (200)
                      +++++|.+++... +++...+..++.|++.++.+||+.+++|+||+|+||++++++.  ++|+|||.+...... .....
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence            9999999998665 7899999999999999999999999999999999999987665  999999998655433 22334


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..+++.|+|||.+.+..++.++|+||+|+++|+|++|.+||.
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~  199 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS  199 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            467788999999998889999999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-43  Score=263.49  Aligned_cols=185  Identities=34%  Similarity=0.437  Sum_probs=169.5

Q ss_pred             cccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCc
Q 029037            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (200)
Q Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   84 (200)
                      .-++=||+|+.|.||+++.+  ++.||+|.+.      +..+.+++-|++|+||||+.+.++|....++|+|||||..|.
T Consensus       127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            34677999999999999987  4669999544      344567999999999999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCC
Q 029037           85 LFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA  164 (200)
Q Consensus        85 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~  164 (200)
                      |...+.....+.+.....|..+|+.|+.|||.+.|+|||||.-||+|..+..  |||+|||.++........-+++||..
T Consensus       199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVa  276 (904)
T KOG4721|consen  199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVA  276 (904)
T ss_pred             HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHh
Confidence            9999998889999999999999999999999999999999999999976654  99999999987777777778899999


Q ss_pred             ccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          165 YIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       165 ~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      |||||++++...+.++||||+|++||||+||..||
T Consensus       277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPY  311 (904)
T KOG4721|consen  277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPY  311 (904)
T ss_pred             hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCc
Confidence            99999999999999999999999999999999997

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-42  Score=260.07  Aligned_cols=191  Identities=25%  Similarity=0.318  Sum_probs=166.8

Q ss_pred             cccccccccCCcceEEEEEEEc--CCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            3 KYELVKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +|++.+.||+|++|.||++...  .+++.+++|.+...    ....+|+.+++.++||||+++++.+......+++||++
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~  168 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY  168 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence            6999999999999999999764  35677899987653    34568999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC---CC
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PK  157 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~---~~  157 (200)
                      . ++|.+++.....++...++.++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||+++.......   ..
T Consensus       169 ~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~~~  245 (392)
T PHA03207        169 K-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQCY  245 (392)
T ss_pred             C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccccc
Confidence            5 688888877778999999999999999999999999999999999999986664  99999999864433222   22


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...++..|+|||.+.+..++.++|+||||+++|||++|..||+
T Consensus       246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~  288 (392)
T PHA03207        246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF  288 (392)
T ss_pred             ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            3468999999999998899999999999999999999999985

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.4e-41  Score=248.43  Aligned_cols=196  Identities=29%  Similarity=0.446  Sum_probs=172.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+.+++.+.|+|++++++.+..+...++|||++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            589999999999999999999999999999998876433 3467889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~  159 (200)
                      ++++|.+++.+ ..++..++..++.|++.||++||+.|++|+||+|+||+++.++  .++|+|||.+........ ....
T Consensus       100 ~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654         100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEECccccchhccccccccCcc
Confidence            99999998854 4688999999999999999999999999999999999998666  499999998864433222 2234


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+++.|+|||.+.+..++.++|+||+|+++|+|++|.+||+
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~  217 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL  217 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            67889999999988888999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-42  Score=257.82  Aligned_cols=196  Identities=28%  Similarity=0.367  Sum_probs=168.8

Q ss_pred             cccccccccCCcceEEEEEEEcCCCc---E-EEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKE---L-VAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~---~-~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      +-.+.+.||+|.||.||+|.....+.   . ||+|.....    .....++.+|.+++++++||||++++|+...+..++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            34566899999999999999876422   3 899988742    233467999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           75 IVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +|||+|+||+|.+++.+++. ++..+...++.+.+.||+|||+++++||||-.+|+++..+..  +||+|||+++....-
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQY  315 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcce
Confidence            99999999999999999884 999999999999999999999999999999999999986554  899999998755422


Q ss_pred             CCCC-cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          154 SRPK-STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       154 ~~~~-~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      .... ..--..+|+|||.+....+++++||||+|+++||+++ |..||+
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~  364 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP  364 (474)
T ss_pred             eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC
Confidence            2222 2235678999999999999999999999999999998 677774

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.8e-41  Score=243.19  Aligned_cols=195  Identities=31%  Similarity=0.458  Sum_probs=172.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|.+.+.||+|++|.||++.+..+++.+++|.+...   ....+.+.+|+..++.++|||++++++++.+.+..+++||+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            588999999999999999999999999999998753   23456788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-C
Q 029037           80 AAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (200)
Q Consensus        80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~  156 (200)
                      +++++|.+++.+.  ..++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+........ .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence            9999999999775  46899999999999999999999999999999999999987654  99999998864433322 2


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||...+..++.++|+||||+++++|++|..||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  201 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF  201 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence            2335788899999999888999999999999999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-41  Score=256.90  Aligned_cols=196  Identities=39%  Similarity=0.617  Sum_probs=183.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ..|.+.+.||+|.|++|..+.+..++..||+|.+.+....   .+.+.+|+.+++.++||||++++.+.+.+..+++|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            5689999999999999999999999999999999875332   3568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      |+.++.+.+++.+.+++.+.++..++.|+++|++|+|+++++||||+++|++++.+.+  +||+|||++.....+.....
T Consensus       136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccccc
Confidence            9999999999999999999999999999999999999999999999999999988777  99999999988888888999


Q ss_pred             ccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++|++.|+|||.+.+.+| .+.+|+||+|+++|.++.|.-||
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF  255 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF  255 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence            999999999999998876 57789999999999999999998

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.8e-41  Score=245.79  Aligned_cols=197  Identities=32%  Similarity=0.439  Sum_probs=169.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +.|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++|||++++++.+..+...+++||++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            46999999999999999999999999999999987643 23467888999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCc
Q 029037           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKS  158 (200)
Q Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~  158 (200)
                      ++++|...+.+ ...++...+..++.|++.++.+||+.|++|+||+|+||+++.++  .++|+|||.+...... .....
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~  169 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRDS  169 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceeccccccccce
Confidence            99999887754 34689999999999999999999999999999999999997655  4999999987643222 12233


Q ss_pred             ccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..++..|+|||.+.     ...++.++|+||||+++|+|++|.+||+
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  216 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH  216 (292)
T ss_pred             ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence            45788999999985     3346778999999999999999999984

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.5e-41  Score=249.64  Aligned_cols=196  Identities=27%  Similarity=0.463  Sum_probs=168.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +++|++.+.||+|++|.||++.+..+++.|++|.+....  .....+.+|+..++.++||||+++++++.++...+++||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            578999999999999999999999999999999987532  234567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-C
Q 029037           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~  156 (200)
                      +++ ++|.+++.+. ..++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||++........ .
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCcc
Confidence            996 5888888664 45889999999999999999999999999999999999987664  99999999864332222 2


Q ss_pred             CcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f  205 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF  205 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCC
Confidence            233567889999998654 5788899999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.8e-41  Score=247.32  Aligned_cols=198  Identities=21%  Similarity=0.346  Sum_probs=168.5

Q ss_pred             CccccccccccCCcceEEEEEEEcCCC-----cEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETK-----ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~-----~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   73 (200)
                      +++|++.+.||+|++|.||++.+...+     +.+++|.+....  ...+.+.+|+..++.++|||++++++++.+....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            367999999999999999999986654     679999886543  2235688999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC
Q 029037           74 AIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~  137 (200)
                      +++||++++++|.+++...                ..++..+++.++.|++.||.+||+.|++|+||+|+||++++++. 
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~-  162 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT-  162 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc-
Confidence            9999999999999999764                34778899999999999999999999999999999999987654 


Q ss_pred             CEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          138 RLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       138 ~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                       ++|+|||++........   .....++..|+|||.+.+..++.++|+||||+++|||++ |..||+
T Consensus       163 -~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~  228 (283)
T cd05048         163 -VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY  228 (283)
T ss_pred             -EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence             99999999864322211   222345678999999988889999999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.6e-41  Score=242.30  Aligned_cols=196  Identities=31%  Similarity=0.475  Sum_probs=171.8

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +|++.+.||.|++|.||++.+..+++.+++|.+...  ....+.+.+|..+++.++|+|++++.+.+.++..++++||++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            589999999999999999999999999999988643  233467888999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CC
Q 029037           81 AGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PK  157 (200)
Q Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~  157 (200)
                      ++++|.+++...  ..++...++.++.|++.||.+||+.|++|+||+|+||++++++.  ++++|||.+........ ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence            999999988653  34889999999999999999999999999999999999986654  99999999864433222 22


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+.+..++.++|+||+|+++|+|++|.+||.
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~  201 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ  201 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC
Confidence            3457888999999988889999999999999999999999983

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.1e-41  Score=245.80  Aligned_cols=196  Identities=30%  Similarity=0.444  Sum_probs=170.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....   ...+.+.+|+.++++++|||++++++++......+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            58999999999999999999999999999999887542   223567899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~  157 (200)
                      ++++++|.........+++..+..++.|++.+|.+||+.|++|+||+|+||++++++  .++|+|||.+....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCCCccccc
Confidence            999988888776666799999999999999999999999999999999999998665  49999999987544333 222


Q ss_pred             cccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~  201 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW  201 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence            3456788999999876 45788999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-41  Score=254.76  Aligned_cols=190  Identities=24%  Similarity=0.364  Sum_probs=164.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .+|++.+.||+|++|.||++.+..+++.|++|.....     ....|..+++.++||||+++++++.+....++++|++.
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            3699999999999999999999999999999975432     23568999999999999999999999999999999995


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCccc
Q 029037           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV  160 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~  160 (200)
                       ++|.+++.+. ..++...+..++.|++.||.+||++|++||||+|+||++++++.  ++|+|||.+.............
T Consensus       141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~  217 (357)
T PHA03209        141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLA  217 (357)
T ss_pred             -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCccccccc
Confidence             5888888654 46899999999999999999999999999999999999986664  9999999987544333344456


Q ss_pred             CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          161 GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++..|+|||.+.+..++.++|+||||+++|||+++..|+
T Consensus       218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            889999999999989999999999999999999865544

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.4e-41  Score=242.99  Aligned_cols=195  Identities=24%  Similarity=0.406  Sum_probs=168.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.... +..+++|.+.......+.+.+|+..++.++|||++++++++.+....+++||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            578999999999999999998765 4568999887665556788999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--Cc
Q 029037           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--KS  158 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~~  158 (200)
                      +++|.+++... ..++...+..++.|++.||++||+.|++|+||+|+||+++++.  .++|+|||.+.........  ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG--VVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC--eEEECCCCCccccCCCceeccCC
Confidence            99999998654 4589999999999999999999999999999999999998665  4999999988643222211  12


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||+|+++|++++ |.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~  202 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF  202 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCC
Confidence            234567999999988889999999999999999999 88887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.2e-41  Score=247.10  Aligned_cols=197  Identities=31%  Similarity=0.464  Sum_probs=171.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+.....    ..+.+.+|+.+++.++|||++++++.+..+...+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            579999999999999999999999999999998876432    2346778999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---  154 (200)
                      |+++|++|.+++.+...+++..+..++.|++.||++||+.|++|+||+|+||++++++  .++|+|||.+.......   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~--~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC--CEEEeeCCCccccCcCcccc
Confidence            9999999999998888899999999999999999999999999999999999998665  49999999875311100   


Q ss_pred             -------------CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 -------------RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                                   ......++..|+|||.+.+..++.++|+||||+++|++++|..||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~  217 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  217 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                         0011245778999999988889999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.2e-41  Score=242.07  Aligned_cols=195  Identities=29%  Similarity=0.437  Sum_probs=174.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+..... .+.+.+|+..++.++|||++++++.+.+....++++|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            689999999999999999999998889999999876533 6789999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcc
Q 029037           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~  159 (200)
                      +++|.+++... ..+++..+..++.|++.|+.+||+.|++|+||+|+||++++++.  ++|+|||.+....... .....
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCccccccc
Confidence            99999998764 46899999999999999999999999999999999999987664  9999999987544333 22334


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .++..|+|||.+.+..++.++|+||+|+++++|++|.+||
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~  199 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPY  199 (256)
T ss_pred             cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            5788999999998888999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.9e-41  Score=247.23  Aligned_cols=196  Identities=29%  Similarity=0.445  Sum_probs=172.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+.+++.++|||++++++++..+...+++||++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            57999999999999999999999899999999987643 23456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-Ccc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-~~~  159 (200)
                      ++++|.+++.+ ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.  ++|+|||.+......... ...
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~  175 (297)
T cd06656          99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM  175 (297)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCcCcc
Confidence            99999998854 45889999999999999999999999999999999999986654  999999988644333222 233


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+++.|+|||.+.+..++.++|+||+|+++|++++|.+||+
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~  216 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL  216 (297)
T ss_pred             cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            57888999999998888999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.8e-41  Score=246.23  Aligned_cols=197  Identities=25%  Similarity=0.349  Sum_probs=169.0

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|.+.+.||.|++|.||++.+..     +++.+++|.+......  .+.+.+|+++++.++|+|++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            579999999999999999998753     3578999998765333  467899999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEE
Q 029037           75 IVMEYAAGGELFDRICNAG--------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLK  140 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~  140 (200)
                      ++||++++++|.+++...+              .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++  .++
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~k  162 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL--VVK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC--eEE
Confidence            9999999999999997542              378888999999999999999999999999999999998765  499


Q ss_pred             EeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          141 ICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       141 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      |+|||.+........   ......+..|+|||.+.+..+++++|+||||+++|+|++ |..||+
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~  226 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence            999998864322211   122335678999999999999999999999999999998 999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.9e-41  Score=243.68  Aligned_cols=198  Identities=26%  Similarity=0.395  Sum_probs=170.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|.||++.+..+++.+++|.+....    .....+.+|+.+++.++|||++++++++.+.+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            578999999999999999999999999999999876422    2234678899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      +|++++++|.+++..    ...++...+..++.|++.||++||++|++|+||+|+||+++.++.  ++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~  158 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccc
Confidence            999999999888753    234788999999999999999999999999999999999987654  99999998764432


Q ss_pred             CCC-CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 HSR-PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||+
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~  207 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            222 122357788999999988888999999999999999999999973

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.6e-41  Score=242.57  Aligned_cols=196  Identities=33%  Similarity=0.448  Sum_probs=171.3

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc----------hHHHHHHHHHHhhCCCCCeeeEEEEEecCce
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----------DENVAREIINHRSLRHPNIIRFKEVVLTPTH   72 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   72 (200)
                      +|.+...||+|++|.||++.+..+++.+++|.+......          .+.+.+|+.+++.++|||++++++++.++..
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            588899999999999999999988999999988653221          1457889999999999999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .+++||++++++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence            9999999999999999988888999999999999999999999999999999999999986654  99999999864432


Q ss_pred             CCC-------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 HSR-------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...       .....++..|+|||.+.+..++.++|+||+|+++|++++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  213 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP  213 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence            111       112346788999999988888999999999999999999999983

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=254.14  Aligned_cols=195  Identities=35%  Similarity=0.572  Sum_probs=179.8

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      |.+.+.||+|.|..|-++++.-||..||+|++.+.+..   ...+.+|++.++.++||||++++++...+..+|+|.|+=
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            78899999999999999999999999999999876433   357899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      ++|+|.+++.+.. .+.++.+..+++||+.|+.|+|+..+|||||||+||++-... +-|||+|||++-...++.+....
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl-GlVKLTDFGFSNkf~PG~kL~Ts  178 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL-GLVKLTDFGFSNKFQPGKKLTTS  178 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec-CceEeeeccccccCCCcchhhcc
Confidence            9999999998876 499999999999999999999999999999999998876433 35999999999888888888999


Q ss_pred             cCCCCccCCeeecCcccC-CeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYD-GKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~-~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +|+..|.|||++.+..|+ +++||||||+++|.++.|++||
T Consensus       179 CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF  219 (864)
T KOG4717|consen  179 CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF  219 (864)
T ss_pred             cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc
Confidence            999999999999999986 5569999999999999999999

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-41  Score=254.21  Aligned_cols=192  Identities=24%  Similarity=0.405  Sum_probs=164.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecC------ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   72 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|.+.....   ..+.+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            589999999999999999999999999999999875422   234577899999999999999999887643      34


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .+++++++ +++|.+.+ +...++...+..++.|++.||.|||+.|++||||+|+||++++++.  ++|+|||++.....
T Consensus        95 ~~~~~~~~-~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~  170 (343)
T cd07878          95 VYLVTNLM-GADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADD  170 (343)
T ss_pred             EEEEeecC-CCCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCC
Confidence            78999988 77888776 4456999999999999999999999999999999999999987664  99999999874332


Q ss_pred             CCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       171 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  216 (343)
T cd07878         171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF  216 (343)
T ss_pred             --CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence              2334568899999999876 46889999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.3e-41  Score=242.48  Aligned_cols=195  Identities=26%  Similarity=0.322  Sum_probs=168.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+.. +..+++|.+.......+.+.+|+.+++.++|+|++++++.+.+....+++||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            679999999999999999999754 5568999887655556789999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--C
Q 029037           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--K  157 (200)
Q Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~  157 (200)
                      +++|.+++.+.  ..++..+++.++.|++.||++||+.+++|+||+|+||++++++  .++|+|||.+.........  .
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL--MCKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC--cEEECCCccceecCCCceeccC
Confidence            99999998653  4588899999999999999999999999999999999998665  4999999998654322211  1


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||.+.+..+++++|+||||+++|+|++ |.+||
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~  205 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY  205 (261)
T ss_pred             CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCC
Confidence            2234567999999988889999999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.7e-41  Score=244.73  Aligned_cols=198  Identities=26%  Similarity=0.368  Sum_probs=172.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|.||++.+..+++.+++|.+....    ...+++.+|+.+++.++|||++++++++.+++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            578999999999999999999999899999999876532    2335788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ||++++++|.+++..    ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~  158 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEECcchhhhcccc
Confidence            999999999998863    23589999999999999999999999999999999999998665  499999998764433


Q ss_pred             CCC-CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 HSR-PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||+
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  207 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence            222 223457888999999988889999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.3e-41  Score=247.51  Aligned_cols=197  Identities=24%  Similarity=0.303  Sum_probs=164.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCc--EEEEEEeccc--ccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKE--LVAVKYIERG--RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~--~~~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      .++|++.+.||+|++|.||++.+..++.  .+++|.++..  ....+.+.+|+..++++ +|||++++++++.+....++
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            3789999999999999999999876654  3678877642  22335788999999999 79999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCE
Q 029037           76 VMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v  139 (200)
                      ++|++++++|.+++.+..                .++...+..++.|++.||++||+.|++||||+|+||+++++.  .+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~  158 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL--AS  158 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC--eE
Confidence            999999999999997542                378889999999999999999999999999999999998665  49


Q ss_pred             EEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       140 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +|+|||++..............+..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf  219 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY  219 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            9999998863322222222233457999999988889999999999999999997 88887

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.2e-40  Score=241.95  Aligned_cols=196  Identities=30%  Similarity=0.402  Sum_probs=169.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR------KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   73 (200)
                      .+|++.+.||+|++|.||++.+..+++.+++|.+....      ...+.+.+|+.+++.++|||++++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999999999999999886432      1224678899999999999999999988763  568


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++++|++++++|.+++.+...++....+.++.|++.||++||+.+++|+||+|+||++++++.  ++|+|||++......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~  159 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence            899999999999999988888999999999999999999999999999999999999986654  999999998643221


Q ss_pred             C----CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 S----RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .    ......++..|+|||.+.+..++.++|+||+|+++|++++|.+||
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf  209 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW  209 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCc
Confidence            1    112234778899999999888999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=241.31  Aligned_cols=197  Identities=31%  Similarity=0.440  Sum_probs=170.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR------KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   73 (200)
                      .+|++.+.||+|++|.||++.+..+++.+++|.+....      .....+.+|+..+++++|+|++++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999875321      2234688899999999999999999998764  468


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++++|++++++|.+++.+...++......++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||.+......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECccccccccccc
Confidence            89999999999999998877899999999999999999999999999999999999998655  4999999998644321


Q ss_pred             C----CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 S----RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .    ......++..|+|||.+.+..++.++|+||||+++|++++|.+||.
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  210 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA  210 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            1    1122357888999999998889999999999999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2e-40  Score=242.74  Aligned_cols=195  Identities=32%  Similarity=0.436  Sum_probs=168.5

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+.+++.++|||++++++.+..+...++++|+++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            4788999999999999999999999999999887543 334678889999999999999999999999999999999999


Q ss_pred             CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcc
Q 029037           82 GGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (200)
Q Consensus        82 ~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~  159 (200)
                      +++|...+.+ ..++++..+..++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||++....... .....
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC--CEEEccccccccccccccccccc
Confidence            9999888765 45689999999999999999999999999999999999998665  49999999986433221 22334


Q ss_pred             cCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .++..|+|||.+.     +..++.++|+||+|+++|+|++|.+||
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~  208 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH  208 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCc
Confidence            5788999999984     345778999999999999999999997

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=241.18  Aligned_cols=195  Identities=24%  Similarity=0.389  Sum_probs=167.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .+|++.+.||+|++|.||++.++. +..+++|.+.......+.+.+|+.+++.++|||++++++++.+....+++||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            478999999999999999998864 5568999987665566788899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--Cc
Q 029037           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--KS  158 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~~  158 (200)
                      +++|.+++... ..++...+..++.|++.|+++||+.|++|+||+|+||++++++.  ++|+|||.+.........  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCC
Confidence            99999999764 36899999999999999999999999999999999999986664  999999988643322111  11


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...+..|+|||.+.+..++.++|+||+|+++|++++ |.+||
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  202 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY  202 (256)
T ss_pred             CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCC
Confidence            123457999999998889999999999999999998 67776

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.1e-41  Score=244.96  Aligned_cols=198  Identities=20%  Similarity=0.292  Sum_probs=166.2

Q ss_pred             CccccccccccCCcceEEEEEEEc----CCCcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~----~~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      +++|++.+.||+|++|+||++.+.    .+++.+++|.+......  ...+.+|+.+++.++|||++++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            467899999999999999999853    35578999988753322  256888999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC
Q 029037           75 IVMEYAAGGELFDRICNA-----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~  137 (200)
                      ++||++++++|.+++...                 ..++......++.|++.||++||++|++|+||+|+||+++++.. 
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~-  162 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc-
Confidence            999999999999998532                 23678889999999999999999999999999999999987654 


Q ss_pred             CEEEeecCCCcccCCCC---CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          138 RLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       138 ~v~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                       ++|+|||++.......   ......++..|+|||.+.+..++.++|+||||+++|||++ |.+||+
T Consensus       163 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~  228 (283)
T cd05090         163 -VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY  228 (283)
T ss_pred             -EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence             9999999986433221   1222334567999999988889999999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8e-41  Score=243.29  Aligned_cols=197  Identities=23%  Similarity=0.370  Sum_probs=167.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc---EEEEEEeccc--ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|++|.||++.+..+++   .|++|.+...  ......+..|+..++.++|||++++.+++.++...+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            578999999999999999999887654   5999988753  22346789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++... +.++..+++.++.|++.|+++||++|++|+||+|+||+++++.  .++|+|||++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCcc
Confidence            9999999999998754 4589999999999999999999999999999999999997655  499999998864332222


Q ss_pred             CCc---cc---CCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          156 PKS---TV---GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       156 ~~~---~~---~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      ...   ..   .+..|+|||.+.+..++.++|+||+|+++||+++ |.+|||
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~  213 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  213 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence            111   11   1346999999998899999999999999999886 999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-41  Score=244.39  Aligned_cols=197  Identities=31%  Similarity=0.443  Sum_probs=170.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+.+++.++|||++++++.+.++...+++||++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            57999999999999999999999889999999987543 23457889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCc
Q 029037           81 AGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKS  158 (200)
Q Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~  158 (200)
                      ++++|.+++.+. ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.  ++|+|||.+........ ...
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccce
Confidence            999999998764 46899999999999999999999999999999999999986654  99999998764332222 223


Q ss_pred             ccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..+++.|+|||.+.     ...++.++|+||+|+++|+|++|.+||+
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~  209 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH  209 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc
Confidence            45788899999975     3346778999999999999999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.1e-41  Score=241.67  Aligned_cols=195  Identities=28%  Similarity=0.410  Sum_probs=173.3

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR------KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +|+..+.||+|++|.||++.+..+++.+++|.+....      ...+.+.+|+.+++.++|++++++++++.+...++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5888999999999999999999889999999887543      1235688999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      +|++++++|.+++.+..+++...+..++.|++.|+++||+.|++|+||+|+||++++++.  ++|+|||.+.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence            999999999999988878999999999999999999999999999999999999987664  999999998654444333


Q ss_pred             CcccCCCCccCCeeecCcc-cCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRRE-YDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|++||.+.... ++.++|+||+|+++|++++|.+||
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf  202 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW  202 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence            4456788899999987766 889999999999999999999998

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1e-40  Score=243.01  Aligned_cols=197  Identities=28%  Similarity=0.432  Sum_probs=169.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecC------ceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTP------THLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.........+.+|+.+++.+ +|+|++++.+++...      ...+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            468999999999999999999999999999999987666667888999999988 699999999998753      4689


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           75 IVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ++||++++++|.+++...  ..+++..+..++.|++.|+++||+++++|+||+|+||++++++.  ++|+|||++.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~  163 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceeccc
Confidence            999999999999998764  35899999999999999999999999999999999999987664  99999999864332


Q ss_pred             C-CCCCcccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 H-SRPKSTVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      . .......++..|+|||.+.     +..++.++|+||+|+++|+|++|.+||+
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~  217 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC  217 (272)
T ss_pred             ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            2 2223345788999999986     3357888999999999999999999984

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=247.77  Aligned_cols=196  Identities=32%  Similarity=0.436  Sum_probs=171.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.....    ..+.+.+|+..++.++|++++++++.+.+....+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            579999999999999999999999999999999986532    2346888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      |++.+++|.+++.+.  ..+++..+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||++........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence            999999999998754  46899999999999999999999999999999999999987654  99999998753322111


Q ss_pred             ------------------------------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 ------------------------------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                                                    .....++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence                                          11224677899999999888999999999999999999999997

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-40  Score=244.62  Aligned_cols=196  Identities=30%  Similarity=0.461  Sum_probs=172.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++|||++++++.+.+....++++|++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            469999999999999999999999999999998875432 3467889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~  159 (200)
                      ++++|.+++.+ ..+++.++..++.|++.++++||+.|++|+||+|+||++++++.  ++|+|||++........ ....
T Consensus        99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655          99 AGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             CCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCCc
Confidence            99999998854 46899999999999999999999999999999999999986654  99999998864433322 2233


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .++..|+|||.+.+..++.++|+||+|+++|++++|.+||.
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~  216 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL  216 (296)
T ss_pred             CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            57889999999998889999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.3e-41  Score=241.35  Aligned_cols=195  Identities=25%  Similarity=0.402  Sum_probs=167.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|+||.+.... +..+++|.+.......+.+.+|+..+++++|||++++++++.+....+++||++.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            578999999999999999998764 3459999888765556789999999999999999999999998888999999999


Q ss_pred             CCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--Cc
Q 029037           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--KS  158 (200)
Q Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~~  158 (200)
                      +++|.+++.... .+++..++.++.|++.||++||+.|++|+||+|+||++++++  .++|+|||.+.........  ..
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCceeecCC
Confidence            999999997643 689999999999999999999999999999999999998655  4999999987643322211  12


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~  202 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY  202 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCc
Confidence            234567999999988889999999999999999998 88876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=241.37  Aligned_cols=195  Identities=22%  Similarity=0.250  Sum_probs=168.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+.. ++.+++|.+.......+.+.+|+..+++++|||++++++++...+..+++||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            578999999999999999999764 4679999988765556778999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--C
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--K  157 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~  157 (200)
                      +++|.+++....  .++...+..++.|++.|+.+||+.|++|+||+|+||++++++.  ++|+|||++.........  .
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEARE  162 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccccC
Confidence            999999997654  6899999999999999999999999999999999999987664  999999998654322111  1


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ....+..|+|||.+.+..++.++|+||||+++|++++ |.+||
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  205 (261)
T cd05068         163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY  205 (261)
T ss_pred             CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            1123457999999998899999999999999999999 88876

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-40  Score=244.36  Aligned_cols=197  Identities=26%  Similarity=0.384  Sum_probs=167.1

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|.+.+.||.|++|+||++.+.     .++..+++|.+.... ...+.+.+|+..++.++||+++++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46899999999999999999863     345668999887543 334578899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEe
Q 029037           76 VMEYAAGGELFDRICNAG-------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC  142 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~  142 (200)
                      +||++++++|.+++....             .+++.+++.++.|++.||++||++|++||||+|+||++++++.  ++|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~kl~  162 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIG  162 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEec
Confidence            999999999999997543             3899999999999999999999999999999999999986664  9999


Q ss_pred             ecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          143 DFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       143 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      |||.+........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~  224 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY  224 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999864432221   112234678999999998889999999999999999998 888873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.1e-40  Score=239.43  Aligned_cols=195  Identities=34%  Similarity=0.496  Sum_probs=172.6

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||.|++|.||.+.+..+++.+++|.+....   ...+.+.+|+.++++++|+|++++++++.+....+++||+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            6899999999999999999999999999999887532   3345688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CC
Q 029037           80 AAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RP  156 (200)
Q Consensus        80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~  156 (200)
                      +++++|.+++.+.  ..++...+..++.|++.++.+||+.|++|+||+|+||++++++.  ++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence            9999999999765  45899999999999999999999999999999999999987664  9999999986443333 22


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||...+..++.++|+||+|+++++|++|..||
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~  201 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF  201 (256)
T ss_pred             cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCC
Confidence            3345788999999998888899999999999999999999887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.2e-41  Score=242.73  Aligned_cols=196  Identities=30%  Similarity=0.440  Sum_probs=172.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-------KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +|+..+.||+|++|.||++.+..+++.+++|.+....       ...+.+.+|+..++.++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5889999999999999999999999999999987532       123578899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ++|++++++|.+++.+..++++..+..++.|++.||.+||++|++|+||+|+||+++.++. .++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence            9999999999999988888999999999999999999999999999999999999975543 589999999864433211


Q ss_pred             -----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 -----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 -----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                           .....++..|+|||.+.+..++.++|+||+|++++++++|.+||
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  208 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW  208 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence                 12235678899999998888999999999999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-40  Score=241.84  Aligned_cols=194  Identities=24%  Similarity=0.279  Sum_probs=165.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+..+. .+++|.+.......+.+.+|+.+++.++|||++++++.+.+ ...+++||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            57999999999999999999987664 59999998755556788999999999999999999988754 55799999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--C
Q 029037           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--K  157 (200)
Q Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~  157 (200)
                      +++|.+++.+.  ..++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+.........  .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccccc
Confidence            99999999763  34788999999999999999999999999999999999987654  999999998644322221  1


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||...+..++.++|+||||+++|++++ |.+||
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~  204 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY  204 (262)
T ss_pred             CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            2335567999999988889999999999999999999 77776

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.3e-41  Score=244.79  Aligned_cols=187  Identities=18%  Similarity=0.159  Sum_probs=162.1

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccccch----HHHHHHHHHHhhCCCCCeeeEEEEEec----CceEEEEEEe
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLT----PTHLAIVMEY   79 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v~e~   79 (200)
                      ..|++|+++.||++..  +++.||+|.+.......    +.+.+|+.++++++||||+++++++.+    ...++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5789999999999998  47789999998654333    567799999999999999999999877    3468999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      +++++|.+++.+...++......++.+++.||.+||+ .+++||||+|+||++++++  .++|+|||++.....  ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~--~~kl~dfg~~~~~~~--~~~~  179 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY--KLKIICHGLEKILSS--PPFK  179 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC--cEEEcccchHhhhcc--cccc
Confidence            9999999999888889999999999999999999998 4999999999999998765  499999999864322  2223


Q ss_pred             ccCCCCccCCeeecC--cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSR--REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~--~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..++..|+|||.+.+  ..++.++|+||||+++|||++|..||.
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~  223 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE  223 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence            457889999999976  678999999999999999999999983

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.7e-40  Score=240.64  Aligned_cols=189  Identities=29%  Similarity=0.481  Sum_probs=169.2

Q ss_pred             ccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037           10 LGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus        10 l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      ||.|++|.||++.+..+++.+++|.+.+..    ...+.+.+|+.+++.++|||++++++.+.++...++++|++++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999999989999999987643    2345788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCCc
Q 029037           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY  165 (200)
Q Consensus        86 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~  165 (200)
                      .+++.+...++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+.............++..|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence            999988878999999999999999999999999999999999999987664  999999998755444333445678899


Q ss_pred             cCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          166 IAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       166 ~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++||.+.+..++.++|+||+|+++|++++|.+||.
T Consensus       159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  193 (262)
T cd05572         159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG  193 (262)
T ss_pred             cChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcC
Confidence            99999988889999999999999999999999984

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=252.57  Aligned_cols=193  Identities=31%  Similarity=0.520  Sum_probs=173.2

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      .+.||+|-||+||-+.++.+|+.||+|++.+.   .+..+.+.+|+.+|+.+.||.|+.+.-.|+.....++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            47899999999999999999999999999863   45567899999999999999999999999999999999999966 


Q ss_pred             chHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC-CCCCEEEeecCCCcccCCCCCCCccc
Q 029037           84 ELFDRI-C-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHSRPKSTV  160 (200)
Q Consensus        84 ~L~~~l-~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~-~~~~v~l~df~~~~~~~~~~~~~~~~  160 (200)
                      ++.+.+ . +.+++++.....++.||+.||.|||-++|+|+||||+||++.+. .-+++||||||+|+......-..+-.
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV  727 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV  727 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence            555544 3 34579999999999999999999999999999999999999643 33679999999999877777777778


Q ss_pred             CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          161 GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ||+.|+|||+++++.|+.+-|+||+|+++|--++|..||.
T Consensus       728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             CCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence            9999999999999999999999999999999999999984

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=241.00  Aligned_cols=197  Identities=25%  Similarity=0.364  Sum_probs=168.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCC---CcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|++|.||++.+..+   ...+++|.+....  .....+.+|+..++.++|||++++++.+.+....+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5799999999999999999998654   4579999887543  2245688899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.... .++...+..++.|++.|+.+||+.+++|+||+|+||++++++.  ++|+|||.+........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccccc
Confidence            99999999999987643 6899999999999999999999999999999999999986654  99999999875431111


Q ss_pred             ---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          156 ---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       156 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                         ......+..|+|||.+.+..++.++|+||||+++|++++ |..|||
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~  210 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence               111234567999999998899999999999999999988 888875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-40  Score=253.17  Aligned_cols=196  Identities=23%  Similarity=0.304  Sum_probs=163.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-----CcEEEEEEeccccc--chHHHHHHHHHHhhCC-CCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRK--IDENVAREIINHRSLR-HPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|+||.||++.+...     ...||+|.+.....  ..+.+.+|+.+++.+. ||||+++++++.+....
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            4788999999999999999987532     34699999875432  2457889999999996 99999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc-------------------------------------------------------------
Q 029037           74 AIVMEYAAGGELFDRICNA-------------------------------------------------------------   92 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~-------------------------------------------------------------   92 (200)
                      +++|||+++++|.+++.++                                                             
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            9999999999999888642                                                             


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC
Q 029037           93 -----------------------------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (200)
Q Consensus        93 -----------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~  137 (200)
                                                         ..++...+..++.|++.||++||+.+++|+||+|+||+++++.  
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~--  274 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK--  274 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC--
Confidence                                               1366777889999999999999999999999999999998665  


Q ss_pred             CEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          138 RLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       138 ~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .++|+|||++........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~  340 (400)
T cd05105         275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY  340 (400)
T ss_pred             EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            499999999864332221   122345678999999988889999999999999999986 77776

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-40  Score=242.26  Aligned_cols=188  Identities=30%  Similarity=0.402  Sum_probs=165.8

Q ss_pred             ccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037           10 LGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus        10 l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      ||+|++|+||++.+..+++.+++|.+....    .....+.+|+.++++++||+++++++++...+..+++||++++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999999999999999987532    2234567899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCC
Q 029037           86 FDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP  163 (200)
Q Consensus        86 ~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~  163 (200)
                      .+++.+..  .++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+.............++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence            99997766  6899999999999999999999999999999999999987664  9999999886544333334456778


Q ss_pred             CccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          164 AYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       164 ~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  194 (277)
T cd05577         159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF  194 (277)
T ss_pred             CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCC
Confidence            899999998888999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.3e-41  Score=244.12  Aligned_cols=196  Identities=31%  Similarity=0.426  Sum_probs=173.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....  ...+.+.+|++.++.++|||++++++.+..++.+++++|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            57899999999999999999999999999999987653  2345688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           80 AAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        80 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      +++++|.+++... ..++...+..++.|++.++++||+ .|++|+||+|+||++++++  .++|+|||.+........ .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~-~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNSLA-K  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHHHh-h
Confidence            9999999999776 678999999999999999999999 9999999999999998755  499999998764322222 2


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...++..|+|||.+.+..++.++|+||+|++++++++|..||+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  200 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP  200 (265)
T ss_pred             cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            2567888999999988899999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=243.69  Aligned_cols=197  Identities=29%  Similarity=0.457  Sum_probs=168.4

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +++|++.+.||+|++|.||++.++.+++.|++|.+.....  ....+.+|+.+++.++|+||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            5789999999999999999999998999999999875432  23457789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-C
Q 029037           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~  156 (200)
                      ++.+ +|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+........ .
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccc
Confidence            9975 8998887654 5899999999999999999999999999999999999987664  99999998864322211 1


Q ss_pred             CcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||.
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~  205 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP  205 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            22245778999999865 457889999999999999999999983

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.8e-40  Score=239.28  Aligned_cols=190  Identities=26%  Similarity=0.369  Sum_probs=161.8

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      +.||+|++|.||++.+..+++.+++|.+....  .....+.+|+++++.++|||++++++++......+++||++++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999999899999999876532  2245788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC---cccC
Q 029037           86 FDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVG  161 (200)
Q Consensus        86 ~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~---~~~~  161 (200)
                      .+++.+.. .+++.+++.++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+..........   ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence            99987644 5899999999999999999999999999999999999986654  9999999986432211110   1122


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +..|+|||.+.+..++.++|+||||+++|++++ |.+||
T Consensus       159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~  197 (252)
T cd05084         159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPY  197 (252)
T ss_pred             ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence            456999999988889999999999999999997 77776

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.2e-40  Score=239.32  Aligned_cols=195  Identities=29%  Similarity=0.412  Sum_probs=173.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|.+.+.||+|++|.||++.+..+++.+++|.+.....   ..+.+.+|+..++.++|+|++++++.+.+.+.+++++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            68999999999999999999998899999999886544   346789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC--
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK--  157 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~--  157 (200)
                      +++++|.+++.+...++...+..++.+++.|+.+||+.|++|+||+|+||++++++  .++|+|||.+..........  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG--VIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEcccccccccCCCCCcccc
Confidence            99999999998877789999999999999999999999999999999999998755  49999999986543332221  


Q ss_pred             ---cccCCCCccCCeeecCcc---cCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 ---STVGTPAYIAPEVLSRRE---YDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ---~~~~~~~~~aPE~~~~~~---~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                         ...++..|+|||.+.+..   ++.++|+||+|++++++++|.+||
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf  206 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW  206 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence               235678999999998765   889999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-40  Score=243.76  Aligned_cols=195  Identities=26%  Similarity=0.389  Sum_probs=173.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|+||++.+..+++.+++|++....  ...+.+.+|+.+++.++|||++++++.+.....++++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57999999999999999999999999999999887542  2346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      +++++|.+++.+.++++...+..++.+++.+|.+||+ .+++|+||+|+||++++++  .++|+|||++..... .....
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~-~~~~~  161 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELIN-SIADT  161 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhh-hccCc
Confidence            9999999999888889999999999999999999996 6999999999999998665  499999998754322 22233


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||+|+++|++++|.+||
T Consensus       162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~  202 (284)
T cd06620         162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF  202 (284)
T ss_pred             cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            46788999999998888999999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-40  Score=239.59  Aligned_cols=196  Identities=31%  Similarity=0.429  Sum_probs=176.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.....  ..+.+.+|+..+..++|+|++++++++......++++|+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            579999999999999999999999999999999876543  356789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC-
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-  157 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~-  157 (200)
                      +++++|.+++.....++...+..++.|++.++.+||+ .|++|+||+|+||++++++.  ++|+|||.+.......... 
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence            9999999999887889999999999999999999999 99999999999999987654  9999999987544333332 


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++..|.|||.+.+..++.++|+||||+++|++++|.+||
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~  200 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF  200 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            345778899999999888899999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.6e-40  Score=238.28  Aligned_cols=195  Identities=25%  Similarity=0.441  Sum_probs=168.6

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEec-CceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   78 (200)
                      .|++.+.||+|++|.||.+.+..+++.+++|.+....   ...+.+.+|+..+++++|+|++++.+.+.. +..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5899999999999999999999999999999987543   233568889999999999999999988764 446899999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-C
Q 029037           79 YAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-R  155 (200)
Q Consensus        79 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~  155 (200)
                      ++++++|.+++.+.  ..+++.++..++.+++.++++||+.|++|+||+|+||++++++  .++|+|||.+....... .
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN--IIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC--cEEEecccceEEecccCCc
Confidence            99999999998763  3589999999999999999999999999999999999998665  49999999986443222 2


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+++.|+|||...+..++.++|+||+|++++++++|.+||
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~  202 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF  202 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence            22345788999999999989999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5e-41  Score=246.13  Aligned_cols=195  Identities=28%  Similarity=0.455  Sum_probs=167.0

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....   .....+.+|+..++.++|||++++++++.+....++++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            6899999999999999999999999999999987532   2235678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CC
Q 029037           80 AAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PK  157 (200)
Q Consensus        80 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~  157 (200)
                      +++ +|.+++.+ ...++...++.++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+........ ..
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence            965 78777755 456899999999999999999999999999999999999987654  99999999864432222 22


Q ss_pred             cccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||+
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            33567889999998764 46889999999999999999988864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.8e-41  Score=257.18  Aligned_cols=189  Identities=23%  Similarity=0.261  Sum_probs=164.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      .|.+.+.||+|++|.||++.+..+++.|++|...     .....+|+.++++++|+||+++++++..+...+++|+++. 
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            6999999999999999999999999999999532     2346789999999999999999999999999999999995 


Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC---CCc
Q 029037           83 GELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKS  158 (200)
Q Consensus        83 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~---~~~  158 (200)
                      ++|.+++... ..++..+++.++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||+++.......   ...
T Consensus       244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~  321 (461)
T PHA03211        244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPFHYG  321 (461)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceecccccccccccc
Confidence            6888888654 46999999999999999999999999999999999999986654  99999999864432221   123


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||||+++|||+++..|+
T Consensus       322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            45899999999999999999999999999999998877654

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.9e-40  Score=243.14  Aligned_cols=194  Identities=28%  Similarity=0.464  Sum_probs=166.2

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||+|++|.||++.+..+++.|++|.+....   ...+.+.+|+.++++++|||++++++++.++...+++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5899999999999999999999999999999986532   2235688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           80 AAGGELFDRICNA---GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      ++ ++|.+++...   ..++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence            97 5888887543   45899999999999999999999999999999999999987665  99999999864332221 


Q ss_pred             CCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~  202 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF  202 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCC
Confidence            1223467889999988654 5688899999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.3e-40  Score=238.26  Aligned_cols=196  Identities=36%  Similarity=0.498  Sum_probs=173.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||.|++|.||++.+..+++.+++|.+....   ...+.+.+|+..++.++|||++++++.+...+..+++||+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            6899999999999999999999999999999987542   2345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           80 AAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      +++++|.+++.+.  ..++...++.++.+++.++++||++|++|+||+|+||+++++.. .++|+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence            9999999999764  34899999999999999999999999999999999999975543 58999999987655444444


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++..|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~  201 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF  201 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence            456788999999999888899999999999999999999887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.3e-40  Score=241.97  Aligned_cols=197  Identities=27%  Similarity=0.442  Sum_probs=167.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEe-----cCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVL-----TPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~~~~   75 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.........+.+|+.+++.+ +|||++++++++.     .+..+++
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            689999999999999999999999999999998876544556788899999998 6999999999874     3457899


Q ss_pred             EEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           76 VMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      +||++++++|.+++..    ...++...+..++.|++.||.+||+.+++||||+|+||++++++.  ++|+|||.+....
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~  175 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLT  175 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeecc
Confidence            9999999999988753    245888999999999999999999999999999999999987664  9999999986443


Q ss_pred             CCC-CCCcccCCCCccCCeeecC-----cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          152 LHS-RPKSTVGTPAYIAPEVLSR-----REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       152 ~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ... ......++..|+|||.+..     ..++.++|+||+|+++|+|++|.+||+
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~  230 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA  230 (286)
T ss_pred             cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence            322 2233457889999999853     347889999999999999999999974

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.9e-40  Score=241.27  Aligned_cols=197  Identities=27%  Similarity=0.460  Sum_probs=168.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecC-----ceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTP-----THLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----~~~~~   75 (200)
                      ++|.+.+.||+|++|.||++.+..+++.+++|.+.......+.+.+|+.+++.+ +|||++++++++...     ...++
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l  101 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL  101 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence            579999999999999999999999999999999876555567788899999988 799999999998753     35899


Q ss_pred             EEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           76 VMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      +|||+++++|.+++..    ...+++..++.++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+....
T Consensus       102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~  179 (291)
T cd06639         102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLT  179 (291)
T ss_pred             EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcc
Confidence            9999999999988753    346899999999999999999999999999999999999987664  9999999986543


Q ss_pred             CCCC-CCcccCCCCccCCeeecCc-----ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          152 LHSR-PKSTVGTPAYIAPEVLSRR-----EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       152 ~~~~-~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .... .....++..|+|||.+...     .++.++|+||+|+++|+|++|.+||.
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~  234 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF  234 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence            3222 2234578889999998643     36789999999999999999999983

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-40  Score=247.60  Aligned_cols=195  Identities=21%  Similarity=0.293  Sum_probs=164.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcE----EEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKEL----VAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~----~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|++|.||++.+..+++.    |++|.+....  ...+.+.+|+..++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            5799999999999999999997665553    8999886532  3346788999999999999999999998765 5679


Q ss_pred             EEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +++++++++|.+++.+.. .++......++.|++.||+|||+.|++||||+|+||+++++..  ++|+|||+++......
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~  163 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADE  163 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCCC
Confidence            999999999999997654 5889999999999999999999999999999999999986664  9999999987544322


Q ss_pred             CCC---cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          155 RPK---STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       155 ~~~---~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...   ....+..|+|||.+.+..++.++|+||||+++||+++ |.+||
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~  212 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY  212 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            221   1223567999999999899999999999999999987 88876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.9e-40  Score=239.26  Aligned_cols=197  Identities=27%  Similarity=0.381  Sum_probs=171.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||.|++|.||++.+..+++.+++|.++...    ...+.+.+|+..+++++|++++++++.+.+++..+++
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            478999999999999999999999899999999886422    2245788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           77 MEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ||++++++|.+++.+.    ..++..++..++.+++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~  158 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccC
Confidence            9999999999988642    34889999999999999999999999999999999999986664  99999998764332


Q ss_pred             CCC-CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSR-PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ... .....++..|+|||.+.+..++.++|+||+|+++|++++|..||
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  206 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF  206 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCc
Confidence            222 22345788899999998888999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.5e-40  Score=242.50  Aligned_cols=195  Identities=27%  Similarity=0.391  Sum_probs=165.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.....  ....+.+|+..++.++|+|++++.+++.++...++++|+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            579999999999999999999999999999999875432  234678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CC
Q 029037           80 AAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PK  157 (200)
Q Consensus        80 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~  157 (200)
                      +. +++.+++... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.  ++|+|||.+........ ..
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCCC
Confidence            95 5777666543 45788899999999999999999999999999999999986664  99999998864332221 22


Q ss_pred             cccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++..|+|||.+.+. .++.++|+||||+++|++++|.+||
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f  204 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF  204 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            33468889999998754 5788899999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-40  Score=243.35  Aligned_cols=195  Identities=25%  Similarity=0.362  Sum_probs=168.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....  ...+.+.+|+..+++++|||++++++.+..++..+++||+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            57999999999999999999999999999999887532  2235788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           80 AAGGELFDRICNA---GRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      +++++|.+++...   ..++...+..++.|++.||.+||+ .|++|+||+|+||++++++  .++|+|||.+..... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA-SL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC-Cc
Confidence            9999999888663   368999999999999999999996 6999999999999998755  599999998864322 22


Q ss_pred             CCcccCCCCccCCeeecCc------ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRR------EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....++..|+|||.+.+.      .++.++|+||+|+++|++++|..||
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  207 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY  207 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCC
Confidence            2334577889999998554      3478899999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=242.83  Aligned_cols=196  Identities=32%  Similarity=0.502  Sum_probs=171.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+....   ...+.+.+|+..++.++|+|++++++++.+++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            57999999999999999999999999999999887532   234678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--C
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--P  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--~  156 (200)
                      +++++.+.....+...++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+........  .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL  158 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence            9988777666656667999999999999999999999999999999999999987554  99999999875444332  2


Q ss_pred             CcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~  202 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF  202 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            234567889999999887 7889999999999999999999887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=239.80  Aligned_cols=195  Identities=24%  Similarity=0.279  Sum_probs=169.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+.. ++.+++|.+.......+++.+|+..++.++|+|++++++++.+....+++||+++
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            689999999999999999999764 4679999998766667789999999999999999999999999889999999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--CC
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--~~  157 (200)
                      +++|.+++.+..  .++...+..++.|++.|+.+||+.|++|+||+|+||++++++.  ++|+|||.+........  ..
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~  162 (261)
T cd05034          85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTARE  162 (261)
T ss_pred             CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhhhh
Confidence            999999997653  5899999999999999999999999999999999999987654  99999998864432111  11


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ....+..|+|||.+.+..++.++|+||+|+++|++++ |.+||
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  205 (261)
T cd05034         163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY  205 (261)
T ss_pred             ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence            2224567999999998889999999999999999998 88886

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.8e-40  Score=239.23  Aligned_cols=195  Identities=27%  Similarity=0.395  Sum_probs=169.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +|++.+.||+|++|.||++.+. +++.+++|.+.....       ..+.+.+|+..++.++|+|++++.+++.+....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5889999999999999999874 677899998864321       12457889999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC--
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--  153 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~--  153 (200)
                      ++|++++++|.+++.+..+++...+..++.|++.+|++||+.|++|+||+|+||++++++.  ++|+|||.+......  
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence            9999999999999988788999999999999999999999999999999999999986664  999999988643211  


Q ss_pred             -----CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 -----SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                           .......++..|+|||.+.+..++.++|+||||+++|++++|.+||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~  209 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA  209 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence                 11123457888999999998889999999999999999999999983

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.6e-40  Score=240.83  Aligned_cols=195  Identities=28%  Similarity=0.424  Sum_probs=170.8

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      .|+..+.||+|++|.||.+.+..++..+++|.+....  ...+.+.+|+..++.+.||+++++++.+.++...+++||++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            5888999999999999999999989999999987543  23457889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~  159 (200)
                      ++++|.+++.+ .+++...+..++.|++.|+++||+.+++|+||+|+||++++++.  ++|+|||.+........ ....
T Consensus        85 ~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06640          85 GGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCccccccc
Confidence            99999998854 56899999999999999999999999999999999999986654  99999999864433221 2233


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06640         162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence            56788999999988889999999999999999999999973

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.6e-40  Score=240.93  Aligned_cols=195  Identities=27%  Similarity=0.366  Sum_probs=163.4

Q ss_pred             ccc-cccccccCCcceEEEEEE----EcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecC--ce
Q 029037            2 EKY-ELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTP--TH   72 (200)
Q Consensus         2 ~~y-~~~~~l~~g~~g~v~~~~----~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~   72 (200)
                      ++| ++.+.||+|++|+||.+.    ...++..+++|.+.....  ....+.+|+..++.++|||++++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            466 899999999999998765    345677899999876432  346788999999999999999999987653  46


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .+++||++++++|.+++.+. .++...+..++.|++.||.+||+.|++|+||+|+||+++++.  .++|+|||++.....
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~  159 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC--cEEEeecccccccCC
Confidence            89999999999999998654 589999999999999999999999999999999999998665  499999999864433


Q ss_pred             CCC----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSR----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...    .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~  210 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK  210 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCC
Confidence            222    11123455699999998888999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.6e-40  Score=239.70  Aligned_cols=197  Identities=24%  Similarity=0.336  Sum_probs=167.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc---EEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|+..+.||+|++|.||++.+..+++   .+++|.+....  ...+.+.+|+..++.++|||++++.+++.+....+++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            578899999999999999999876554   68999887542  2345788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.+. ..++..++..++.|++.|+.+||+.|++|+||+|+||+++++.  .++|+|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceecccccc
Confidence            9999999999999764 4689999999999999999999999999999999999998655  499999999864432222


Q ss_pred             CCc----ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          156 PKS----TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       156 ~~~----~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      ...    ...+..|+|||.+.+..++.++|+||+|+++|++++ |..|||
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~  212 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW  212 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            111    112357999999988889999999999999999987 999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-40  Score=237.37  Aligned_cols=192  Identities=27%  Similarity=0.399  Sum_probs=169.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++...  ++.+++|.+.......+++.+|+.+++.++|+|++++++++.+....+++||+++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            57899999999999999999876  6779999998765556789999999999999999999999999889999999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      +++|.+++.+..  .+++..+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~--~~  159 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQD--SG  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccccc--cC
Confidence            999999997765  6899999999999999999999999999999999999986654  99999999875432222  23


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..+..|+|||.+....++.++|+||+|++++++++ |..||
T Consensus       160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  200 (256)
T cd05039         160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY  200 (256)
T ss_pred             CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCC
Confidence            34567999999988888999999999999999997 88776

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.2e-40  Score=244.78  Aligned_cols=191  Identities=27%  Similarity=0.400  Sum_probs=157.2

Q ss_pred             cccccCCcceEEEEEEEc--CCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEec--CceEEEEEEecCC
Q 029037            7 VKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAIVMEYAAG   82 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~   82 (200)
                      .+.||+|+||.||++.+.  .+++.+|+|.+... .......+|+.+++.++||||+++++.+..  +...+++||+++ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            468999999999999975  36688999988764 334567899999999999999999998854  456899999985 


Q ss_pred             CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC--CCCCCEEEeecCCCcccC
Q 029037           83 GELFDRICNA---------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG--SAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        83 ~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~--~~~~~v~l~df~~~~~~~  151 (200)
                      ++|.+++...         ..++...+..++.|++.||.+||+.|++||||+|+||++..  +..+.++|+|||++....
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence            5887777532         24888999999999999999999999999999999999943  223469999999987543


Q ss_pred             CCCC----CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSR----PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....    .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f  216 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  216 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence            3221    223467889999999876 45889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-40  Score=248.03  Aligned_cols=197  Identities=22%  Similarity=0.327  Sum_probs=163.3

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecC-ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTP-TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~   72 (200)
                      ++|++.+.||.|+||.||++.+..     +++.|++|.+.....  ..+.+.+|+..++++ +|+||+++++.+... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            489999999999999999997543     457899998875422  234677899999999 799999999988654 56


Q ss_pred             EEEEEEecCCCchHHHHHhc------------------------------------------------------------
Q 029037           73 LAIVMEYAAGGELFDRICNA------------------------------------------------------------   92 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~------------------------------------------------------------   92 (200)
                      +++++||+++++|.+++...                                                            
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            88999999999999888542                                                            


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC---CCcccCCCCccCC
Q 029037           93 -GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAP  168 (200)
Q Consensus        93 -~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aP  168 (200)
                       .+++...+..++.|++.||++||+.|++||||+|+||+++.++  .++|+|||++........   .....++..|+||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence             2578889999999999999999999999999999999998655  499999999865432221   1122345679999


Q ss_pred             eeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          169 EVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       169 E~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      |.+.+..++.++|+||||+++|+|++ |.+||+
T Consensus       245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~  277 (337)
T cd05054         245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP  277 (337)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999999999997 888873

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4e-40  Score=240.57  Aligned_cols=196  Identities=19%  Similarity=0.254  Sum_probs=163.3

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..     ++..+++|.+.....  ...++.+|+..++.++|||++++++++.+....+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            579999999999999999998753     356799998865322  2356889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           75 IVMEYAAGGELFDRICNAG----------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                      ++||++++++|.+++.+..          .++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+||
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~df  163 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDF  163 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEECCC
Confidence            9999999999999986532          2466788999999999999999999999999999999986654  999999


Q ss_pred             CCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          145 GYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       145 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      |++........   .....++..|+|||.+.+..++.++|+||||+++|||++ |.+||
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~  222 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY  222 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence            98864322111   112234678999999998889999999999999999999 56765

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=240.21  Aligned_cols=197  Identities=30%  Similarity=0.474  Sum_probs=169.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCc------eEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPT------HLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~------~~~   74 (200)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+.......+.+.+|+.+++.+ +|+|++++++++.+..      .++
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            689999999999999999999998899999999987666667899999999998 6999999999997644      489


Q ss_pred             EEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCccc
Q 029037           75 IVMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~  150 (200)
                      ++||++++++|.+++..    ...++...+..++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||.+...
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~  163 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC--eEEECCCccceec
Confidence            99999999999988865    34689999999999999999999999999999999999998665  4999999988643


Q ss_pred             CCCC-CCCcccCCCCccCCeeecC-----cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          151 VLHS-RPKSTVGTPAYIAPEVLSR-----REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       151 ~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .... ......++..|+|||.+..     ..++.++|+||||+++|++++|.+||+
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  219 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC  219 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence            3222 2233457888999998753     346788999999999999999999984

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.9e-40  Score=245.92  Aligned_cols=193  Identities=25%  Similarity=0.376  Sum_probs=162.6

Q ss_pred             cccccccCC--cceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            5 ELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         5 ~~~~~l~~g--~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++.+.||+|  ++++||++.+..+++.||+|.+....   ...+.+.+|+.+++.++||||+++++++.+++..++|||+
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            357889999  67899999999999999999987642   2234677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           80 AAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      +++++|.+++...  ..+++..++.++.|++.||++||+.|++||||+|+||+++.++.  +++.||+.+........  
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccc
Confidence            9999999999653  35899999999999999999999999999999999999986664  99999976432211111  


Q ss_pred             ------CCcccCCCCccCCeeecC--cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 ------PKSTVGTPAYIAPEVLSR--REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ------~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                            .....++..|+|||.+.+  ..++.++|+||+|+++|+|++|.+||
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  210 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  210 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence                  112235667999999975  45889999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-43  Score=260.38  Aligned_cols=197  Identities=27%  Similarity=0.439  Sum_probs=182.5

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      |.+++++..||-||||.|=++..++....+|+|++++.    .+..+....|-.++....+|+|++++..|.++..+|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            35677888999999999999988766656889988764    34556788899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||.|-||.|+..+.+.+.+...++..++..+++|++|||++||++|||||+|.+++.++-  +||.|||+|+....+.+.
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCce
Confidence            999999999999999999999999999999999999999999999999999999987665  999999999999999999


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++||+.|.|||++.++..+.++|.||||+++||+++|.|||
T Consensus       577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPF  619 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPF  619 (732)
T ss_pred             eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999999999999999999999999

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.2e-40  Score=237.90  Aligned_cols=194  Identities=24%  Similarity=0.295  Sum_probs=165.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+.. +..+++|.+.......+.+.+|+.+++.++|++++++++++.+ ...+++||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            689999999999999999998764 4558999988765566789999999999999999999998754 56789999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--C
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--K  157 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~  157 (200)
                      +++|.+++.+..  .++..+++.++.|++.||++||+.|++|+||+|+||++++++  .++|+|||.+.........  .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCccccccc
Confidence            999999987643  489999999999999999999999999999999999998665  4999999998644332211  1


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||.+.+..++.++|+||||+++|++++ |.+||
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~  204 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY  204 (260)
T ss_pred             CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCC
Confidence            2234567999999988889999999999999999999 78887

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.7e-40  Score=239.97  Aligned_cols=194  Identities=28%  Similarity=0.441  Sum_probs=169.3

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||.|++|.||++.+..+++.+++|.+....   ...+.+.+|+.++++++|||++++++++.+....++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            6899999999999999999999899999999987643   2346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--C
Q 029037           80 AAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--P  156 (200)
Q Consensus        80 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--~  156 (200)
                      + +++|.+++... ..++..++..++.|++.+|++||+.|++|+||+|+||++++++  .++|+|||.+........  .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC--cEEEeeeeecccccCCCCCcc
Confidence            9 99999988654 4689999999999999999999999999999999999998755  499999999875443332  2


Q ss_pred             CcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|+|||.+.+. .++.++|+||+|+++++|++|.+||
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~  201 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF  201 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence            334578899999998654 4688999999999999999998776

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.6e-40  Score=239.09  Aligned_cols=197  Identities=25%  Similarity=0.352  Sum_probs=166.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCC---cEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETK---ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~---~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|++|.||++.+..++   ..+++|.+....  ...+.+.+|+..++.++|||++++++++.++...+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57999999999999999999986544   368999886542  2245788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.+. ..++..++..++.|++.|+++||+.|++|+||+|+||++++++  .++|+|||.+........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCcccccccccc
Confidence            9999999999999765 4589999999999999999999999999999999999997655  499999999865433221


Q ss_pred             CC----cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          156 PK----STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       156 ~~----~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      ..    ....+..|+|||.+.+..++.++|+||+|+++|++++ |..||+
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~  211 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  211 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence            11    1112457999999998889999999999999999886 998885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.9e-40  Score=237.08  Aligned_cols=196  Identities=29%  Similarity=0.421  Sum_probs=172.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||.|++|+||++.+..++..+++|++....  ...+.+.+|+..++.++|+|++++++.+.+....++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            58999999999999999999998889999999987543  2346789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           80 AAGGELFDRICNA---GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      +++++|.+++.+.   ..+++..+..++.|++.|+++||+.|++|+||+|+||++++++.  ++|+|||.+.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence            9999999999764   34899999999999999999999999999999999999987654  999999998644433222


Q ss_pred             -----CcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 -----KSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 -----~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                           ....++..|+|||.+... .++.++|+||+|+++++|++|..||
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~  207 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY  207 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCc
Confidence                 223578889999998776 7889999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-40  Score=239.92  Aligned_cols=195  Identities=21%  Similarity=0.267  Sum_probs=169.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+.. ++.+++|.+..... ..+.+.+|+..++.++|||++++++++.+....+++||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            479999999999999999999988 77899999887654 4567889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-C
Q 029037           81 AGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-K  157 (200)
Q Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-~  157 (200)
                      ++++|.+++.+.  ..++...+..++.|++.|+.+||+.|++|+||+|+||+++++..  ++|+|||.+......... .
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence            999999999764  35899999999999999999999999999999999999987664  999999998644322211 1


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~  205 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY  205 (261)
T ss_pred             CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            2234567999999988889999999999999999998 77776

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=230.94  Aligned_cols=196  Identities=26%  Similarity=0.339  Sum_probs=168.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecC-----ceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   75 (200)
                      +||++.+.+|.|||+-||.+.+..+++.+|+|.+.-.. ...+...+|++..++++|||+++++++...+     ...|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            58999999999999999999999999999999987655 4467899999999999999999998877544     34899


Q ss_pred             EEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           76 VMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      +++|...|||.+.+...    ..+++.+++.++.+++.||++||+..  +.||||||.||++.+++.  ++|.|||.++.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEeccCccc
Confidence            99999999999998643    35999999999999999999999998  999999999999987554  99999999874


Q ss_pred             cCCCCCCCc----------ccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          150 SVLHSRPKS----------TVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       150 ~~~~~~~~~----------~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .+.......          ...|..|.|||.+.   +...+.++|||||||++|+|+-|..||
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPf  241 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPF  241 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcc
Confidence            443333221          12578899999986   446789999999999999999999998

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-40  Score=239.49  Aligned_cols=196  Identities=21%  Similarity=0.289  Sum_probs=166.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-----CcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+...     ++.+++|.+.....  ....+.+|+.+++.++|||++++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            6899999999999999999998654     37899999875432  2346788999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           75 IVMEYAAGGELFDRICNAG----------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                      ++||++++++|.+++....          .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+||
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~df  163 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDF  163 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECCc
Confidence            9999999999999986432          3677889999999999999999999999999999999987664  999999


Q ss_pred             CCCcccCCCC---CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          145 GYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       145 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      |+++......   ......++..|+|||.+.+..++.++|+||||+++||+++ |.+||
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  222 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY  222 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCC
Confidence            9986433221   1122345678999999988889999999999999999998 88886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.5e-40  Score=240.32  Aligned_cols=198  Identities=21%  Similarity=0.289  Sum_probs=167.1

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|.+.+.||+|++|.||++.+..     ++..+++|.+.....  ....+.+|+..++.++|+|++++++++.+....+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            578999999999999999999987     678899998875432  2356888999999999999999999999988999


Q ss_pred             EEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCC
Q 029037           75 IVMEYAAGGELFDRICNAG-------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGY  146 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~  146 (200)
                      ++||+++|++|.+++....       .++...++.++.|++.||++||+.+++|+||+|+||++++++ ...++|+|||.
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999999997653       478899999999999999999999999999999999997544 23589999999


Q ss_pred             CcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          147 SKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       147 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +........   ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf  222 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY  222 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence            875422111   112223467999999988889999999999999999997 88876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-40  Score=243.57  Aligned_cols=196  Identities=31%  Similarity=0.486  Sum_probs=169.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.....   ..+.+.+|++.++.++|||++++++++.++...++++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            579999999999999999999998999999998875432   23567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-C
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-K  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-~  157 (200)
                      |+++++|.++......++..+++.++.|++.+|++||+.|++|+||+|+||++++++.  ++|+|||++......... .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence            9999888887766667999999999999999999999999999999999999987664  999999998644332221 2


Q ss_pred             cccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~  201 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF  201 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC
Confidence            2346788999999875 34678899999999999999999887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.2e-40  Score=243.43  Aligned_cols=194  Identities=31%  Similarity=0.428  Sum_probs=167.9

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc------hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI------DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +|++.+.||+|++|.||++.+..+++.+++|.+......      ...+.+|+..++.++|+|++++++++.++...++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588999999999999999999999999999999764322      34577899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++ +++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||.+........
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC--CEEEccceeeeeccCCCc
Confidence            9999 889999997766 799999999999999999999999999999999999998665  499999999865443322


Q ss_pred             -CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                       .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~  203 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL  203 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc
Confidence             222345778999998854 45788999999999999999997765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.7e-40  Score=243.50  Aligned_cols=196  Identities=24%  Similarity=0.310  Sum_probs=164.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-------CcEEEEEEecccc--cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-------KELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-------~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      ++|.+.+.||+|++|.||++.+...       ...+++|.+....  ...+.+.+|+.+++.+ +|||++++++++.++.
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            5799999999999999999987532       3469999887542  2235688899999999 7999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           72 HLAIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      ..+++||++++++|.+++....                .++..+++.++.|++.||++||+.|++|+||+|+||++++++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            9999999999999999997642                378889999999999999999999999999999999998665


Q ss_pred             CCCEEEeecCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                        .++|+|||.+.........   .....+..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       178 --~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~  243 (307)
T cd05098         178 --VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  243 (307)
T ss_pred             --cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence              4999999998644322111   11223467999999988889999999999999999998 77776

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.2e-40  Score=239.83  Aligned_cols=195  Identities=21%  Similarity=0.306  Sum_probs=163.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc----EEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|++|+||++.+..+++    .||+|.+....  .....+.+|...++.++|||++++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            578999999999999999999876665    47899886532  2345688899999999999999999998754 4678


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +++++++++|.+++... ..++...++.++.|++.||++||+.|++||||+|+||++++++.  ++|+|||+++......
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~  163 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeeccccc
Confidence            99999999999999764 46899999999999999999999999999999999999976654  9999999987543322


Q ss_pred             CC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          155 RP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..   ....++..|+|||...+..++.++|+||||+++||+++ |.+||
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  212 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY  212 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence            21   11234567999999988889999999999999999998 77775

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.7e-40  Score=240.99  Aligned_cols=196  Identities=26%  Similarity=0.347  Sum_probs=166.7

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      .+|.+.+.||+|++|.||++.+..     ++..+++|.+...... .+.+.+|+..++.++|||++++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            478899999999999999998643     4556888888764433 3578899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCE
Q 029037           76 VMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v  139 (200)
                      +||++++++|.+++....                .++...++.++.|++.|+++||++|++|+||+|+||++++++  .+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--LV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cE
Confidence            999999999999996542                378899999999999999999999999999999999998666  49


Q ss_pred             EEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          140 KICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       140 ~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  226 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW  226 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999864433221   122345678999999998889999999999999999999 88886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.3e-40  Score=240.99  Aligned_cols=196  Identities=32%  Similarity=0.437  Sum_probs=167.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTP--THLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~   75 (200)
                      +++|++.+.||.|++|.||++.+..+++.+++|.++.....   ...+.+|+..+++++|||++++.+++...  ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            46899999999999999999999999999999999754322   23567899999999999999999998877  78999


Q ss_pred             EEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +||++++ +|.+.+.... .++...++.++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+.......
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~  160 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL  160 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc
Confidence            9999975 8988886654 4899999999999999999999999999999999999987654  9999999887544332


Q ss_pred             -CCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 -RPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 -~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                       ......++..|+|||.+.+. .++.++|+||+|+++++|++|.+||
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f  207 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF  207 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCC
Confidence             22234567889999998754 4688899999999999999999987

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.2e-40  Score=238.30  Aligned_cols=195  Identities=32%  Similarity=0.432  Sum_probs=168.7

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-----------chHHHHHHHHHHhhCCCCCeeeEEEEEecCc
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-----------IDENVAREIINHRSLRHPNIIRFKEVVLTPT   71 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (200)
                      +|.+.+.||.|++|.||++.+..+++.+++|.+.....           ..+.+.+|+..++.++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68899999999999999999998899999998864211           1235778999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      ..+++||++++++|.+++.+...++...+..++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||.+....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG--ICKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC--eEEEeecccccccc
Confidence            9999999999999999998888899999999999999999999999999999999999998665  49999999986432


Q ss_pred             CCCC---CCcccCCCCccCCeeecCcc--cCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSR---PKSTVGTPAYIAPEVLSRRE--YDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~---~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....   .....++..|+|||.+....  ++.++|+||+|++++++++|.+||
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  212 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW  212 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCC
Confidence            2111   12234678899999987654  788999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5e-40  Score=247.69  Aligned_cols=193  Identities=26%  Similarity=0.352  Sum_probs=167.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC------ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   72 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.+..   ...+.+.+|+.+++.++|||++++++++...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            67999999999999999999999999999999987532   2234677899999999999999999988654      34


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .+++||++.+ +|.+.+...  ++...+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||.+.....
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~  170 (353)
T cd07850          96 VYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  170 (353)
T ss_pred             EEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCC
Confidence            7999999954 888877554  889999999999999999999999999999999999987664  99999999875544


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf  217 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF  217 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCC
Confidence            43334446788999999999999999999999999999999999887

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-39  Score=238.34  Aligned_cols=195  Identities=25%  Similarity=0.342  Sum_probs=164.8

Q ss_pred             cccccccccCCcceEEEEEEE----cCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEE
Q 029037            3 KYELVKDLGAGNFGVARLLRH----KETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLA   74 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~----~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   74 (200)
                      -|++.+.||+|++|.||.+..    ..+++.+++|.+....  ...+.+.+|+.+++.++|||++++.+++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            368899999999999999974    4567889999987542  2235788999999999999999999998875  5689


Q ss_pred             EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           75 IVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++||+++|++|.+++.+.. .++...+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||.+......
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~  162 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccccC
Confidence            9999999999999997654 5899999999999999999999999999999999999986654  999999998754432


Q ss_pred             CCC----CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SRP----KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...    ....++..|+|||.+.+..++.++|+||||+++|+++++..|+
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            221    1234566799999998888999999999999999999977654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.3e-40  Score=239.57  Aligned_cols=196  Identities=27%  Similarity=0.360  Sum_probs=165.3

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|.+.+.||+|++|.||++...     .++..+++|.+.... ...+.+.+|+..++.++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46888999999999999999753     346678889877543 334678999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEE
Q 029037           76 VMEYAAGGELFDRICNAG---------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLK  140 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~  140 (200)
                      +||++++++|.+++....               .++...++.++.|++.|+++||+.|++|+||+|+||++++++  .++
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~~k  162 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--VVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--CEE
Confidence            999999999999987643               378899999999999999999999999999999999998655  499


Q ss_pred             EeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          141 ICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       141 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      |+|||++........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  225 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW  225 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence            999998864322211   112234678999999998889999999999999999998 78876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1e-39  Score=236.37  Aligned_cols=194  Identities=24%  Similarity=0.314  Sum_probs=166.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++..+. ++.+++|.+.......+.+.+|+.+++.++|+|++++++++. ....+++||++.
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            578999999999999999998764 567999999876666778999999999999999999999874 456899999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--CC
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--~~  157 (200)
                      +++|.+++....  .++..++..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTARE  161 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCccccc
Confidence            999999886543  5889999999999999999999999999999999999987664  99999999864432221  11


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||.+....++.++|+||||+++|++++ |.+||
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  204 (260)
T cd05067         162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY  204 (260)
T ss_pred             CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCC
Confidence            2335678999999988889999999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2e-40  Score=242.12  Aligned_cols=195  Identities=30%  Similarity=0.427  Sum_probs=170.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +.|+..+.||+|++|.||++.+..+++.+++|.+....  ...+.+.+|+..++.++|||++++++.+..++..+++||+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            35888999999999999999999999999999887542  2345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~  158 (200)
                      +++++|.+++.. ..++...+..++.|++.|+.+||+.|++|+||+|+||++++++.  ++|+|||++........ ...
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence            999999988854 56899999999999999999999999999999999999986654  99999999864433222 122


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~  201 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN  201 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCC
Confidence            35778899999999888999999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=258.55  Aligned_cols=191  Identities=29%  Similarity=0.427  Sum_probs=170.5

Q ss_pred             cccCCcceEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCchHH
Q 029037            9 DLGAGNFGVARLLRHKETKELVAVKYIERG-RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD   87 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   87 (200)
                      .||+|.+|+||-++|..|+...|+|-++.. ....+.+.+|+.+.++++|.||++++|.+.+++++-+.||-++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            689999999999999999999999998764 4446789999999999999999999999999999999999999999999


Q ss_pred             HHH-hcCCC--CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCccc-CCCCCCCcccCCC
Q 029037           88 RIC-NAGRF--SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHSRPKSTVGTP  163 (200)
Q Consensus        88 ~l~-~~~~~--~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~-~~~~~~~~~~~~~  163 (200)
                      .+. +.+++  ++.++-.+..||++||.|||+..|||||||-+||+|+. ..+.+||.|||.+++. ...+....+.||.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCccccccccch
Confidence            985 45676  88899999999999999999999999999999999973 3346999999998644 4445566778999


Q ss_pred             CccCCeeecCc--ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          164 AYIAPEVLSRR--EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       164 ~~~aPE~~~~~--~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .|+|||++..+  .|..++|||||||.+.||.||+|||.
T Consensus       741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~  779 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV  779 (1226)
T ss_pred             hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence            99999999854  68899999999999999999999993

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-39  Score=235.65  Aligned_cols=188  Identities=24%  Similarity=0.358  Sum_probs=159.2

Q ss_pred             cccCCcceEEEEEEE--cCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            9 DLGAGNFGVARLLRH--KETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~--~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      .||+|++|.||++..  ..+++.+++|++.....   ..+.+.+|+.+++.++|||++++++++.. ...+++||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999965  45678899998875432   24578899999999999999999998754 4678999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC----Ccc
Q 029037           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP----KST  159 (200)
Q Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~----~~~  159 (200)
                      +|.+++.+...++...+..++.|++.||++||++|++|+||+|+||+++++.  .++|+|||.+.........    ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCCC
Confidence            9999998877899999999999999999999999999999999999998665  4999999998654333221    112


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .++..|+|||.+....++.++|+||||+++|||++ |.+||
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  199 (257)
T cd05116         159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY  199 (257)
T ss_pred             CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence            23578999999988888999999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.9e-39  Score=233.44  Aligned_cols=195  Identities=33%  Similarity=0.506  Sum_probs=175.2

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .|++.+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++|++++++.+.+..+...++++|+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            48899999999999999999998899999999987544 45788999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCccc
Q 029037           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV  160 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~  160 (200)
                      +++|.+++... ..++...+..++.|++.++++||+.|++|+||+|+||++++++.  ++|+|||.+.............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence            99999999776 57899999999999999999999999999999999999987654  9999999987554443334456


Q ss_pred             CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          161 GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++..|+|||.+.+..++.++|+||+|+++|++++|.+||
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  197 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY  197 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            788999999998888899999999999999999999987

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=234.86  Aligned_cols=189  Identities=26%  Similarity=0.304  Sum_probs=161.4

Q ss_pred             ccccCCcceEEEEEEEcCCC---cEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETK---ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~---~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++....+.   ..+++|.+.....  ..+.+.+|+..++.+.|||++++++++.. ...+++||++++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            47999999999999876554   7899999886544  45678899999999999999999998764 468999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc----
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS----  158 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~----  158 (200)
                      ++|.+++.+...+++..+..++.|++.+|++||+.|++|+||+|+||++++++.  ++|+|||.+...........    
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence            999999988888999999999999999999999999999999999999987664  99999999875433322111    


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||||+++|++++ |.+||
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~  199 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY  199 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCc
Confidence            112457999999988889999999999999999998 88886

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=236.07  Aligned_cols=190  Identities=27%  Similarity=0.397  Sum_probs=167.1

Q ss_pred             ccccCCcceEEEEEEEcCC---CcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKET---KELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+...   +..+++|.+......  .+.+.+|+..++.++|++++++++++.+...++++||++++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999865   888999999875443  46788999999999999999999999999999999999999


Q ss_pred             CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           83 GELFDRICNA---------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        83 ~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++|.+++...         ..+++..+..++.|++.||++||+.|++|+||+|+||++++++  .++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC--cEEEcccccccccccc
Confidence            9999999875         6799999999999999999999999999999999999998765  4999999998755443


Q ss_pred             C---CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          154 S---RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       154 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .   ......++..|+|||.+....++.++|+||+|+++|+|++ |.+||
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  208 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY  208 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence            2   2233456788999999988889999999999999999998 47776

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-39  Score=239.84  Aligned_cols=197  Identities=30%  Similarity=0.472  Sum_probs=166.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +++|++.+.||.|++|+||++.+..+++.+++|.+.....   ..+.+.+|++.+++++|||++++++++.++...++||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            6899999999999999999999999999999998865432   2356888999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++ ++|.+.+.....  ++...+..++.|++.||++||++|++|+||+|+||+++.++. .++|+|||.+........
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVR  158 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCcc
Confidence            9996 478887765443  577888899999999999999999999999999999975443 589999999864433222


Q ss_pred             -CCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                       .....+++.|+|||.+.+. .++.++|+||+|+++|+|+||.+||
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf  204 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF  204 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence             1223467889999988664 5788999999999999999999987

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-39  Score=238.44  Aligned_cols=196  Identities=29%  Similarity=0.437  Sum_probs=167.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEec------CceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLT------PTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~~~~   74 (200)
                      +.|++.+.||.|++|.||++.+..+++.+++|.+.........+..|+.+++.+ +|+|++++++++..      ....+
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            478999999999999999999999999999999877655566788899999888 69999999999853      45789


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           75 IVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ++||++++++|.+++...  ..++...+..++.|++.|+.+||+.|++|+||+|+||++++++.  ++|+|||.+.....
T Consensus        96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~  173 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhc
Confidence            999999999999988654  34788889999999999999999999999999999999986664  99999998764332


Q ss_pred             C-CCCCcccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 H-SRPKSTVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      . .......++..|+|||.+.     ...++.++|+||||+++|+|++|.+||
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~  226 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL  226 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCc
Confidence            2 2233446788999999986     345788899999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.6e-40  Score=236.56  Aligned_cols=194  Identities=23%  Similarity=0.276  Sum_probs=165.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|.+.+.||+|++|.||++.+..+. .+++|.+.......+.+.+|+.+++.++||+++++++++.. ...+++||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            57899999999999999999987654 48999887665556788999999999999999999988754 56789999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--C
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--K  157 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~  157 (200)
                      +++|.+++.+..  .++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+.........  .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccccC
Confidence            999999997643  4788999999999999999999999999999999999987664  999999998644322211  1


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||...+..++.++|+||||+++|++++ |.+||
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  204 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY  204 (260)
T ss_pred             CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCC
Confidence            2234567999999988889999999999999999999 88886

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-39  Score=240.13  Aligned_cols=196  Identities=26%  Similarity=0.350  Sum_probs=166.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCC----------------cEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETK----------------ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRF   63 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~----------------~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~   63 (200)
                      ++|++.+.||+|++|.||++.+..++                ..+++|.+....  ...+.+.+|+.++++++|||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            58999999999999999999886543                457999887643  234678899999999999999999


Q ss_pred             EEEEecCceEEEEEEecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec
Q 029037           64 KEVVLTPTHLAIVMEYAAGGELFDRICNAG-----------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD  132 (200)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~  132 (200)
                      ++++..+...+++||++++++|.+++.+..           .++...++.++.|++.||++||+.|++|+||+|+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~  164 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence            999999999999999999999999997765           689999999999999999999999999999999999998


Q ss_pred             CCCCCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC--CCCCC
Q 029037          133 GSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR--PNPFI  199 (200)
Q Consensus       133 ~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~--~~~pf  199 (200)
                      +++  .++|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++|++++  +.+||
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         165 KNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             CCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            765  499999999864332221   122335678999999988889999999999999999987  55554

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.7e-39  Score=234.53  Aligned_cols=195  Identities=34%  Similarity=0.450  Sum_probs=175.6

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLAIVM   77 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   77 (200)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....   ...+.+.+|+..+++++||+++++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5889999999999999999999899999999987654   3456789999999999999999999999988  8899999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      |++++++|.+++.+...++...+..++.|++.+|++||+.|++|+||+|+||++++++  .++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEecccccccc
Confidence            9999999999998887899999999999999999999999999999999999998755  499999999875554443  


Q ss_pred             -CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                       .....++..|+|||.+....++.++|+||||++++++++|..||
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  203 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW  203 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence             34456788999999998888999999999999999999999887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.8e-40  Score=240.41  Aligned_cols=196  Identities=19%  Similarity=0.292  Sum_probs=164.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-----CcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      .+|++.+.||+|++|.||++.+..+     ++.+++|.+......  .+.+.+|..++..++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            5789999999999999999987543     577999998754322  356888999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCC
Q 029037           75 IVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPR  138 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~  138 (200)
                      +++|++.+++|.+++...                ..++...+..++.|++.||.+||+.|++||||+|+||+++++..  
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--
Confidence            999999999999998532                24788889999999999999999999999999999999986654  


Q ss_pred             EEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          139 LKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       139 v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++|+|||+++.......   .....+++.|+|||.+.+..++.++|+||||+++|||++ |.+||
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~  227 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY  227 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence            99999998864332221   122234678999999988889999999999999999998 66665

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-39  Score=237.93  Aligned_cols=197  Identities=31%  Similarity=0.504  Sum_probs=174.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      +.|++.+.||+|++|.||++.+..+++.+++|.+.......+.+.+|+..++.++|+|++++++.+......++++|+++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   98 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD   98 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence            46888999999999999999999888999999998755556678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-Ccc
Q 029037           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KST  159 (200)
Q Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-~~~  159 (200)
                      +++|.+++.... .++...+..++.|++.+|++||+.|++|+||+|+||++++++.  ++|+|||.+......... ...
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhccc
Confidence            999999998876 7999999999999999999999999999999999999986654  999999987543322221 223


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .++..|+|||.+.+..++.++|+||+|+++|++++|.+||.
T Consensus       177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~  217 (286)
T cd06614         177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL  217 (286)
T ss_pred             cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            46788999999988889999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=236.98  Aligned_cols=190  Identities=25%  Similarity=0.309  Sum_probs=159.0

Q ss_pred             ccccCCcceEEEEEEEcCCCc--EEEEEEeccc--ccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKE--LVAVKYIERG--RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~--~~~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..++.  .+++|.+...  ....+.+.+|+..++.+ +|||++++++++......+++||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999987765  4688877643  23345788999999999 799999999999999999999999999


Q ss_pred             CchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           83 GELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        83 ~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                      ++|.+++.+..                .++..++..++.|++.|+++||+.|++|+||+|+||++++++  .++|+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC--eEEECCCCC
Confidence            99999987543                378889999999999999999999999999999999998665  499999998


Q ss_pred             CcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          147 SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +..............+..|+|||.+....++.++|+||||+++|+|++ |.+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf  212 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY  212 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence            753222212222233567999999988889999999999999999997 88887

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-39  Score=237.62  Aligned_cols=196  Identities=29%  Similarity=0.401  Sum_probs=168.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTP--THLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   77 (200)
                      ++|+..+.||.|++|.||++.+..+++.+++|.+.....  ....+.+|++.++.++||||+++++++.+.  ..++++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            578999999999999999999999999999999875433  346788999999999999999999988654  4689999


Q ss_pred             EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           78 EYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        78 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      |++++++|.+++..    ...++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence            99999999887643    335889999999999999999999999999999999999986654  999999997643322


Q ss_pred             CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       159 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  204 (287)
T cd06621         159 L-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP  204 (287)
T ss_pred             c-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            2 223456788999999998899999999999999999999999973

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-39  Score=237.00  Aligned_cols=189  Identities=29%  Similarity=0.445  Sum_probs=158.8

Q ss_pred             cccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHHHHHh---hCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            9 DLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHR---SLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~---~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .||+|++|.||++.+..+++.+|+|.+.+....    .....++..+++   ..+||+++.+.+.+..++..+++|||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999988754211    222344443333   3479999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccC
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~  161 (200)
                      +++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||++...... ......+
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~--~~~l~dfg~~~~~~~~-~~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKK-KPHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC--CEEEccCCcceecccc-CccCcCC
Confidence            999999998888899999999999999999999999999999999999998665  4999999998643322 2233468


Q ss_pred             CCCccCCeeec-CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLS-RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~-~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +..|+|||.+. +..++.++|+||+|+++|+|++|..||+
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  197 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR  197 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence            89999999986 4567899999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2e-39  Score=234.91  Aligned_cols=195  Identities=24%  Similarity=0.289  Sum_probs=166.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+.. +..+++|.+.......+.+.+|+.+++.++|+|++++.+.+.+ ...+++||+++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            689999999999999999998654 4558999887765556788999999999999999999999887 77899999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--C
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--K  157 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~  157 (200)
                      +++|.+++.+..  .++..+++.++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||.+.........  .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~  161 (260)
T cd05073          84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTARE  161 (260)
T ss_pred             CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCCccccc
Confidence            999999997643  478889999999999999999999999999999999998665  4999999988644322211  1


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      ...++..|+|||.+....++.++|+||||+++|++++ |.+||.
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~  205 (260)
T cd05073         162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP  205 (260)
T ss_pred             CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCC
Confidence            2234567999999988889999999999999999998 888873

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-39  Score=235.59  Aligned_cols=192  Identities=26%  Similarity=0.392  Sum_probs=163.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEe-cCceEEEEEEe
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVL-TPTHLAIVMEY   79 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~   79 (200)
                      +++|++.+.||+|++|.||++...  +..+++|..... ...+.+.+|+..+++++|++++++++++. ++...+++||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            367999999999999999999875  567899988654 33567889999999999999999998764 45678999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      +++++|.+++.+..  .++...++.++.|++.||++||++|++|+||+|+||++++++.  ++|+|||++.......  .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~--~  157 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQ--D  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccccC--C
Confidence            99999999997654  3788999999999999999999999999999999999986664  9999999886433222  2


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ....+..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~  200 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY  200 (256)
T ss_pred             CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence            2334567999999988889999999999999999997 88887

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.5e-39  Score=234.90  Aligned_cols=195  Identities=31%  Similarity=0.513  Sum_probs=170.6

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||+|++|.+|.+.+..+++.+++|.+...   ....+++.+|+..++.++|||++++.+.+.+.+..++++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            689999999999999999999999999999998753   23345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-C
Q 029037           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (200)
Q Consensus        80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~  156 (200)
                      +.+++|.+.+....  .++..++..++.|++.|+.+||++|++|+||+|+||++++++.  ++|+|||.+........ .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence            99999999887643  4789999999999999999999999999999999999986654  99999998864332221 1


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||...+..++.++|+||+|++++++++|..||
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~  201 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF  201 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCc
Confidence            2234778899999998888999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-40  Score=241.09  Aligned_cols=193  Identities=31%  Similarity=0.452  Sum_probs=161.6

Q ss_pred             cccccccCCcceEEEEEEEc----CCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            5 ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         5 ~~~~~l~~g~~g~v~~~~~~----~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++.+.||.|.||.||+|...    ..+..|++|.++....  ..+.+.+|++.+++++||||+++++++......++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46789999999999999988    4567799999965322  35789999999999999999999999998888999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           79 YAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        79 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      ++++++|.+++...  ..++..++..++.|++.||.|||+.+++|++|+++||+++.++  .+||+|||++........ 
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG--QVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT--EEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccc
Confidence            99999999999886  5799999999999999999999999999999999999998766  499999999865421111 


Q ss_pred             --CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 --PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                        .........|+|||.+....++.++||||||+++||+++ +..||
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~  206 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPF  206 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence              222345678999999998889999999999999999999 56775

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.3e-39  Score=240.67  Aligned_cols=196  Identities=23%  Similarity=0.313  Sum_probs=166.0

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEecccc--cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|.+.+.||+|++|.||++.+.     .++..+++|.+....  ...+.+.+|+.+++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            47889999999999999999852     345579999887543  2235688999999999 799999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           74 AIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      +++||++.+++|.+++....  .++..+...++.|++.||.+||+.+++|+||+|+||+++++.  .++|+|||.+....
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~  192 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIM  192 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCccccccc
Confidence            99999999999999997543  289999999999999999999999999999999999997655  49999999987443


Q ss_pred             CCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          152 LHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       152 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ....   .....++..|+|||.+.+..++.++|+||+|+++|++++ |.+||
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~  244 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY  244 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCc
Confidence            3221   112235678999999988889999999999999999998 88886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.6e-39  Score=239.23  Aligned_cols=196  Identities=25%  Similarity=0.338  Sum_probs=165.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-----CcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|++|.||++.....     ...+++|.+.....  ....+.+|+..++.+ +|+|++++++++..+..+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            5789999999999999999998643     36799998875422  234688899999999 799999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC
Q 029037           74 AIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~  137 (200)
                      +++||++++++|.+++...                ..++...++.++.|++.||.+||+.|++|+||+|+||++++++  
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~--  169 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH--  169 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC--
Confidence            9999999999999998642                3588899999999999999999999999999999999998665  


Q ss_pred             CEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          138 RLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       138 ~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .++|+|||.+........   .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  235 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  235 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCC
Confidence            499999999864432221   111224567999999988889999999999999999997 87776

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.2e-39  Score=237.23  Aligned_cols=196  Identities=24%  Similarity=0.325  Sum_probs=163.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHH-HhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIIN-HRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....  ....+..|+.. ++.++|||++++++++..+...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            579999999999999999999999999999999876432  23345556554 566789999999999999999999999


Q ss_pred             ecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           79 YAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        79 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +++ ++|.+++..    ...+++..+..++.|++.||++||++ +++||||+|+||++++++.  ++|+|||.+......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence            996 578777654    23589999999999999999999997 9999999999999987664  999999998754333


Q ss_pred             CCCCcccCCCCccCCeeecC----cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSR----REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .......++..|+|||.+.+    ..++.++|+||+|+++|+|++|..||.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  208 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD  208 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence            22333457888999999865    346888999999999999999999983

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=232.92  Aligned_cols=196  Identities=31%  Similarity=0.425  Sum_probs=175.0

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||+|++|.||++.+..+++.+++|.+.....   ..+.+.+|++.+++++||+++++.+++.+++..+++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            58999999999999999999998999999999987643   346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-Cc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-~~  158 (200)
                      +++++|.+++....++++..+..++.|++.++.+||+.|++|+||+|+||++++++  .++|+|||.+......... ..
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCcccccc
Confidence            99999999998888899999999999999999999999999999999999998755  5999999998754433331 23


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..++..|+|||...+..++.++|+||+|++++++++|.+||+
T Consensus       159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~  200 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY  200 (254)
T ss_pred             cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            457888999999988778899999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.1e-39  Score=234.21  Aligned_cols=195  Identities=25%  Similarity=0.406  Sum_probs=168.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .+|++.+.||.|++|.||++.+.. +..+++|.+.......+.+.+|++++++++||+++++++++......+++||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            578999999999999999998864 5679999988766666789999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--CCc
Q 029037           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PKS  158 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--~~~  158 (200)
                      +++|.+++... ..++...+..++.|++.++++||+.+++|+||+|+||+++.++  .++|+|||.+........  ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCcccccCC
Confidence            99999998764 4588999999999999999999999999999999999998655  499999998864322211  112


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...+..|+|||.+.+..++.++|+||+|+++|++++ |.+||
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~  202 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY  202 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence            234568999999988889999999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=237.49  Aligned_cols=197  Identities=26%  Similarity=0.460  Sum_probs=176.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|.+++.||.|++.+|..++.+.|.+.+|+|++++.    ....+....|-....+- +||+++-+...|+.+.++++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            57899999999999999999999999999999999864    23335566676666555 79999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~  154 (200)
                      |.||++||+|.-.++.+..++++.+..+...|..||.+||++||+.||+|.+|++++..+.  +||+|+|.++.... +.
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhcCCCCCc
Confidence            9999999999888888889999999999999999999999999999999999999986665  99999999975443 34


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+|||.|.|||++++.+|.+++|.|+||++|+||+.|..||
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspf  451 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF  451 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence            455678999999999999999999999999999999999999998

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-41  Score=254.20  Aligned_cols=192  Identities=24%  Similarity=0.349  Sum_probs=169.4

Q ss_pred             cccccccCCcceEEEEEEEcCCCcEEEEEEecc-----cccchHHHHHHHHHHhhCCCCCeeeEEEEEecCce--EEEEE
Q 029037            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTH--LAIVM   77 (200)
Q Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~v~   77 (200)
                      +..+.||+|+|-+||+|.|..+|..||.--++.     .+...+++..|+.+|+.|+||||+++++++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            456789999999999999999998888765543     23445789999999999999999999999988655  89999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM--QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      |.+.+|+|..|+.+.+.++...++.|++||+.||.|||++  .|+|||||-+||||+. ..+.|||+|+|+|........
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG-~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG-NLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-CcCceeecchhHHHHhhcccc
Confidence            9999999999999999999999999999999999999987  5999999999999974 345799999999975544444


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .. -.|||.|||||.+. ..|+..+||||||++|.||.|+.-||
T Consensus       202 ks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPY  243 (632)
T KOG0584|consen  202 KS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPY  243 (632)
T ss_pred             ce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCCh
Confidence            33 67999999999997 78999999999999999999999887

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-39  Score=238.97  Aligned_cols=195  Identities=30%  Similarity=0.453  Sum_probs=170.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG-RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+.+|+.+++.++|||++++++++......++++|++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5799999999999999999999888999999998643 233467889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-Ccc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-~~~  159 (200)
                      ++++|.+++.+ ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++  .++|+|||++......... ...
T Consensus        99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~--~~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647          99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             CCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC--CEEEccCcceecccccccccccc
Confidence            99999998855 3578899999999999999999999999999999999998665  4999999987644333222 223


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .+++.|++||.+.+..++.++|+||+|+++|++++|.+||
T Consensus       176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf  215 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY  215 (293)
T ss_pred             cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            5778899999998888899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.7e-39  Score=235.09  Aligned_cols=190  Identities=30%  Similarity=0.458  Sum_probs=162.0

Q ss_pred             ccccccccc--cCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhh-CCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDL--GAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS-LRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l--~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.+  |+|++|.||++.++.++..+++|.+........    |...... .+|||++++++.+...+.++++||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            467777777  999999999999999999999999876432211    2222221 279999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      ++++++|.+++.+...+++.++..++.|++.||.+||+.|++|+||+|+||++++++. .++|+|||.+....   ....
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~---~~~~  165 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIG---TPSC  165 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecC---CCcc
Confidence            9999999999988778999999999999999999999999999999999999986662 59999999886432   2223


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~  206 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF  206 (267)
T ss_pred             CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            45788999999999888999999999999999999999997

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=257.96  Aligned_cols=195  Identities=28%  Similarity=0.393  Sum_probs=164.3

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHHHHhhCC-CCCeeeEEEEEec----C---ceE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG-RKIDENVAREIINHRSLR-HPNIIRFKEVVLT----P---THL   73 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~---~~~   73 (200)
                      ++++.+.|.+|||+.||.|.+...++.+|+|++-.. +...+.+.+|+.++++|+ |+|||.+++....    +   -.+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            578899999999999999999998788999987654 344578999999999997 9999999994321    1   247


Q ss_pred             EEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           74 AIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      .++||||.|++|.+++.+  +..+++.+++.|+++++.|++.||.++  ++|||||-+|||+..+++  .||||||.++-
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt  195 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATT  195 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccccccc
Confidence            899999999999999974  345999999999999999999999887  999999999999987775  99999999874


Q ss_pred             cCCCCCCC----------cccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          150 SVLHSRPK----------STVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       150 ~~~~~~~~----------~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........          ....|+.|+|||++.   +...+.++|||+|||+||.+.-...||
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PF  258 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPF  258 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCc
Confidence            43333221          123689999999985   567899999999999999998887777

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5e-39  Score=234.93  Aligned_cols=189  Identities=28%  Similarity=0.438  Sum_probs=159.1

Q ss_pred             cccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHH---HHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            9 DLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREI---INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~---~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .||+|++|.||++.+..+++.||+|.+.+....    ......|.   ..++...||+++++.+.+.+....+++|||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999988754211    11233333   33444579999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccC
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~  161 (200)
                      |++|.+++.+.+.+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++  .++|+|||.+...... ......+
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~--~~kl~dfg~~~~~~~~-~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKK-KPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC--CEEEccCcCccccCcc-CCcCcCC
Confidence            999999998888899999999999999999999999999999999999998665  4999999998644322 2234468


Q ss_pred             CCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +..|+|||.+.++ .++.++|+||+|+++|+|++|.+||.
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~  197 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR  197 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence            8999999998754 68899999999999999999999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-40  Score=258.73  Aligned_cols=196  Identities=23%  Similarity=0.336  Sum_probs=156.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc-EE------------------EEEEecccccchHHHHHHHHHHhhCCCCCeee
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE-LV------------------AVKYIERGRKIDENVAREIINHRSLRHPNIIR   62 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~-~~------------------~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   62 (200)
                      ++|++.+.||+|+||+||++..+.... ..                  +.|...........+.+|+.++++++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            579999999999999999987643221 11                  11222222233456789999999999999999


Q ss_pred             EEEEEecCceEEEEEEecCCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC
Q 029037           63 FKEVVLTPTHLAIVMEYAAGGELFDRICNAG-----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (200)
Q Consensus        63 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~  137 (200)
                      +++++.+....+++++++. ++|.+++....     ......+..++.|++.||.|||++|++||||||+||+++.++. 
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~-  305 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK-  305 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence            9999999999999999984 57777764432     2345678889999999999999999999999999999986664 


Q ss_pred             CEEEeecCCCcccCCCCC--CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          138 RLKICDFGYSKSSVLHSR--PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       138 ~v~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       ++|+|||++........  .....++..|+|||.+.+..++.++||||||+++|||+++..++|
T Consensus       306 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        306 -IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             -EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence             99999999875433222  223568999999999999999999999999999999999886554

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.8e-39  Score=236.42  Aligned_cols=195  Identities=19%  Similarity=0.270  Sum_probs=161.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc----EEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||.|++|+||++.+..++.    .+++|.+.....  ...++..|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            578999999999999999999876665    467777654321  23467778888899999999999998754 45788


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      ++|++++++|.+++... ..+++..+..++.|++.||++||+.|++|+||+|+||+++++.  .++|+|||.++......
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCccceeccCCC
Confidence            99999999999999764 4689999999999999999999999999999999999998665  49999999986543322


Q ss_pred             CC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          155 RP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..   ....++..|+|||.+.+..++.++|+||||+++||+++ |.+||
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~  212 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY  212 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence            21   12235668999999988889999999999999999998 88876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=240.08  Aligned_cols=196  Identities=26%  Similarity=0.369  Sum_probs=163.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCC--------------CcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET--------------KELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKE   65 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~--------------~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~   65 (200)
                      ++|++.+.||+|++|.||++.+..+              ...|++|.+....  ...+.+.+|++.++.++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4899999999999999999987643              2358999887542  22456889999999999999999999


Q ss_pred             EEecCceEEEEEEecCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC
Q 029037           66 VVLTPTHLAIVMEYAAGGELFDRICNAG------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG  133 (200)
Q Consensus        66 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~  133 (200)
                      ++......+++||++++++|.+++....            .++...++.++.|++.||++||+.|++|+||+|+||++++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            9999999999999999999999986432            3678889999999999999999999999999999999986


Q ss_pred             CCCCCEEEeecCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC--CCCCC
Q 029037          134 SAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR--PNPFI  199 (200)
Q Consensus       134 ~~~~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~--~~~pf  199 (200)
                      +..  ++|+|||++.........   ....++..|+|||...+..++.++|+||||+++|+|++  +..||
T Consensus       165 ~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~  233 (295)
T cd05097         165 HYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY  233 (295)
T ss_pred             CCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence            654  999999998643322211   11234568999999988889999999999999999987  55565

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-39  Score=235.84  Aligned_cols=195  Identities=22%  Similarity=0.312  Sum_probs=165.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc----EEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|++|.||++.++.+++    .+++|.......  ....+.+|+..++.++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            578999999999999999999876554    588898776532  23578899999999999999999999887 77899


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +||++++++|.+++.+. ..+++..+..++.|++.||++||++|++|+||+|+||++++++.  ++|+|||.++......
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~~  163 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccCcc
Confidence            99999999999999764 36899999999999999999999999999999999999986654  9999999987544322


Q ss_pred             CCCc---ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          155 RPKS---TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       155 ~~~~---~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ....   ...+..|+|||.+....++.++|+||+|+++||+++ |.+||
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  212 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY  212 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCC
Confidence            2111   123467999999988889999999999999999998 88876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=236.21  Aligned_cols=195  Identities=29%  Similarity=0.470  Sum_probs=169.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHHHhhCC---CCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLR---HPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +.|++.+.||+|++|.||++.+..+++.+++|.+...  ....+.+.+|+.+++.++   ||+++++++++.++...+++
T Consensus         1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            3688999999999999999999999999999998754  233456888999998886   99999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      ||++++++|.+++.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||++++++  .++|+|||.+........ 
T Consensus        81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCccc
Confidence            999999999998855 4789999999999999999999999999999999999998755  499999999865443332 


Q ss_pred             CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~  202 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY  202 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCC
Confidence            223457888999999865 45788999999999999999999997

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.4e-39  Score=240.71  Aligned_cols=190  Identities=27%  Similarity=0.414  Sum_probs=155.4

Q ss_pred             ccccCCcceEEEEEEEcC--CCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEec--CceEEEEEEecCCC
Q 029037            8 KDLGAGNFGVARLLRHKE--TKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAIVMEYAAGG   83 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~   83 (200)
                      ..||+|+||.||++.+..  +++.+++|.+.... ....+.+|+.+++.++|||++++++++..  +...++++|++++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            579999999999999754  56789999887542 34567899999999999999999998854  5678999999864 


Q ss_pred             chHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC--CCCCEEEeecCCCcccCC
Q 029037           84 ELFDRICNA---------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS--AAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        84 ~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~--~~~~v~l~df~~~~~~~~  152 (200)
                      +|.+++...         ..++...+..++.|++.||.+||+.|++||||+|+||++..+  ..+.++|+|||+++....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            777776421         247888999999999999999999999999999999999422  234699999999875433


Q ss_pred             CCC----CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSR----PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...    .....+++.|+|||.+.+ ..++.++|+||+|+++|||+||.+||
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f  216 (317)
T cd07867         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  216 (317)
T ss_pred             CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence            222    223457889999999876 45788999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.7e-40  Score=241.45  Aligned_cols=195  Identities=28%  Similarity=0.441  Sum_probs=169.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .|.....||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++|+|++++++.+...+..+++||+++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            4566788999999999999999899999999887543 234568899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCccc
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKSTV  160 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~~  160 (200)
                      +++|.+++. ...++..++..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++........ .....
T Consensus       103 ~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~  179 (292)
T cd06658         103 GGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSLV  179 (292)
T ss_pred             CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCceee
Confidence            999998874 456899999999999999999999999999999999999987654  99999998864322222 22345


Q ss_pred             CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          161 GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++..|+|||.+.+..++.++|+||+|+++||+++|..||+
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  219 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF  219 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            7889999999988889999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=233.15  Aligned_cols=187  Identities=29%  Similarity=0.401  Sum_probs=160.6

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHHH-HHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREII-NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+..+++.+++|.+.+....    ...+..|.. .....+|+|++++++.+.+....++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            6799999999999999999999999998764321    122334443 34455899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT  162 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~  162 (200)
                      ++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||++.....   .....++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~---~~~~~~~  156 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG--HLKLTDFGLSRNGLE---NKKFVGT  156 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEeecccceeccc---cccCCCC
Confidence            99999998888899999999999999999999999999999999999998665  499999998764322   2334577


Q ss_pred             CCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          163 PAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       163 ~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..|+|||.+.+..++.++|+||+|+++|++++|.+||
T Consensus       157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  193 (260)
T cd05611         157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF  193 (260)
T ss_pred             cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCC
Confidence            8899999998888899999999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.5e-39  Score=236.36  Aligned_cols=195  Identities=28%  Similarity=0.416  Sum_probs=162.8

Q ss_pred             ccccccccccCCcceEEEEEE----EcCCCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeEEEEEec--CceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLT--PTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~----~~~~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~   74 (200)
                      ++|++.+.||+|++|.||.+.    +..+++.+++|.+...... .+.+.+|+..++.++|||++++.+++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            468999999999999999997    4456888999998764332 4578899999999999999999998754  34689


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           75 IVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +++|++++++|.+++.+. ..++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||++......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~  161 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccCC
Confidence            999999999999999764 35899999999999999999999999999999999999986664  999999998754332


Q ss_pred             CCC----CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          154 SRP----KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       154 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      ...    .....+..|+|||.+.+..++.++|+||||++++||+++..|
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~  210 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK  210 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence            221    111233459999999888899999999999999999997654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.3e-39  Score=233.20  Aligned_cols=194  Identities=30%  Similarity=0.388  Sum_probs=168.3

Q ss_pred             ccccccccCCcceEEEEEEEcCCC----cEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETK----ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~----~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +++.+.||.|++|.||++.+...+    ..+++|.+.....  ..+.+.+|+..++.++|+|++++++.+.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467899999999999999998766    8899999976543  3567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      |++++++|.+++.....  +++..+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence            99999999999976554  899999999999999999999999999999999999987664  99999999864443312


Q ss_pred             CC--cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 PK--STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 ~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..  ...++..|+|||.+.+..++.++|+||+|+++++|++ |.+||
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~  205 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPY  205 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            11  1235678999999988889999999999999999998 67776

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.4e-39  Score=239.62  Aligned_cols=196  Identities=24%  Similarity=0.309  Sum_probs=163.2

Q ss_pred             ccccccccccCCcceEEEEEEEcC-------CCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-------TKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      ++|.+.+.||+|++|.||++.+..       ....+++|.+.....  ....+.+|+.+++.+ +||||+++++++.+..
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            478999999999999999998632       345689998875422  235678899999999 6999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           72 HLAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      .++++||++++++|.+++...                ..++..++..++.|++.||.+||++|++|+||+|+||++++++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            999999999999999999653                2378888999999999999999999999999999999998665


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                        .++|+|||.++.......   .....++..|+|||.+.+..++.++|+||||+++|++++ |.+||
T Consensus       172 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         172 --VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             --cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence              499999999864432211   111223457999999988889999999999999999998 77776

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.4e-39  Score=234.64  Aligned_cols=194  Identities=28%  Similarity=0.430  Sum_probs=168.7

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      -|++.+.||+|++|.||++.+..+++.+++|.+....  ...+.+.+|+..++.++|||++++++.+.++...+++||++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4778899999999999999999889999999876533  22356888999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~  159 (200)
                      ++++|.+++.+ ..++...+..++.|++.++.+||+.|++|+||+|+||++++++.  ++|+|||.+........ ....
T Consensus        85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhccc
Confidence            99999988854 46899999999999999999999999999999999999986654  99999998764332221 1223


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .++..|+|||.+.+..++.++|+||+|+++|++++|.+||
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  201 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH  201 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            5678899999998888889999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.7e-39  Score=236.76  Aligned_cols=193  Identities=31%  Similarity=0.453  Sum_probs=165.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|.+.+.||+|++|.||++.+..+++.|++|.+.....    ..+.+.+|+.+++.++|||++++.+++.++...++++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            468899999999999999999998899999998864322    2246889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      |++.| ++.+.+.. ...++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||++.....   .
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~---~  168 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP---A  168 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC---C
Confidence            99965 67666643 456899999999999999999999999999999999999987664  99999998864322   2


Q ss_pred             CcccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....++..|+|||.+.   ...++.++|+||+|+++|+|++|.+||+
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~  215 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence            2345778899999974   3567889999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.3e-39  Score=237.22  Aligned_cols=195  Identities=23%  Similarity=0.296  Sum_probs=163.2

Q ss_pred             cccccccccCCcceEEEEEEEcC-----CCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +|++.+.||+|++|.||++.+..     ....+++|.+.....  ..+.+.+|+..++.++||||+++++.+..+...++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58899999999999999998753     235688888875432  23568899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeee
Q 029037           76 VMEYAAGGELFDRICNA------------------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL  131 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i  131 (200)
                      ++|++.+++|.+++...                        ..++..++..++.|++.||.+||+.|++||||+|+||++
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999999988642                        236788899999999999999999999999999999999


Q ss_pred             cCCCCCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          132 DGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       132 ~~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++++  .++|+|||++........   .....++..|+|||.+.+..++.++|+||||+++++|++ |.+||
T Consensus       161 ~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  230 (290)
T cd05045         161 AEGR--KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  230 (290)
T ss_pred             cCCC--cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence            8665  499999999864322221   122234568999999988889999999999999999998 77776

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.5e-39  Score=239.34  Aligned_cols=196  Identities=23%  Similarity=0.320  Sum_probs=163.7

Q ss_pred             ccccccccccCCcceEEEEEEEc-------CCCcEEEEEEecccc--cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-------ETKELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      ++|++.+.||+|++|.||.+.+.       ..+..+++|......  ...+.+.+|+..++.+ +|||++++++.+....
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            57899999999999999999753       234568999887532  2345788999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           72 HLAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      ..+++||++++++|.+++.+.                ..++..++..++.|++.||.+||+.|++|+||+|+||++++++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence            999999999999999999763                2367788999999999999999999999999999999998655


Q ss_pred             CCCEEEeecCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                        .++|+|||.+.........   ....++..|+|||.+.+..++.++|+||||+++|++++ |.+||
T Consensus       175 --~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  240 (304)
T cd05101         175 --VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  240 (304)
T ss_pred             --cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence              4999999998644322221   12234567999999988889999999999999999998 67776

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-39  Score=233.94  Aligned_cols=188  Identities=16%  Similarity=0.121  Sum_probs=159.9

Q ss_pred             ccccCCcceEEEEEEEcCCC----------cEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            8 KDLGAGNFGVARLLRHKETK----------ELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~----------~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +.||+|++|.||++.+..++          ..+++|.+.........+.+|+.+++.++|||++++++++.. ...+++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46899999999999998776          347788776554446788899999999999999999999988 7789999


Q ss_pred             EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC-----CEEEeecCCCcccC
Q 029037           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP-----RLKICDFGYSKSSV  151 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~-----~v~l~df~~~~~~~  151 (200)
                      |++++++|.+++.... .++...+..++.|++.||++||++|++|+||+|+||+++.++..     .++|+|||.+....
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            9999999999998766 68999999999999999999999999999999999999765521     59999999986433


Q ss_pred             CCCCCCcccCCCCccCCeeecCc--ccCCeeehhhhhhhhhhcCCC-CCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSRR--EYDGKVCILLLILFLWRNYRP-NPFI  199 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~~l~~~~~~-~~pf  199 (200)
                      .   .....++..|+|||.+.+.  .++.++|+||+|+++++++++ .+||
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~  207 (259)
T cd05037         160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL  207 (259)
T ss_pred             c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCc
Confidence            2   2234456789999999876  788999999999999999985 5554

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.4e-39  Score=231.57  Aligned_cols=188  Identities=25%  Similarity=0.368  Sum_probs=156.4

Q ss_pred             cccCCcceEEEEEEEc--CCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCc
Q 029037            9 DLGAGNFGVARLLRHK--ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~~--~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   84 (200)
                      .||+|++|.||++.+.  .++..+++|.+.....  ..+.+.+|+.++++++|||++++++.+.. ...+++||++++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999765  4455699998876432  23568899999999999999999998754 57899999999999


Q ss_pred             hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC----Ccc
Q 029037           85 LFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP----KST  159 (200)
Q Consensus        85 L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~----~~~  159 (200)
                      |.+++.. ...++...++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||.+.........    ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH--YAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC--cEEeccCCccccccCCccceeccCCC
Confidence            9999875 34689999999999999999999999999999999999998665  4999999998643322211    111


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .++..|+|||.+....++.++|+||||+++|++++ |.+||
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  199 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY  199 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            23468999999988889999999999999999996 88887

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-39  Score=233.79  Aligned_cols=194  Identities=21%  Similarity=0.292  Sum_probs=161.0

Q ss_pred             ccccccccCCcceEEEEEEEcCC---CcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCce-----
Q 029037            4 YELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTH-----   72 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   72 (200)
                      |++.+.||+|++|.||++....+   +..+|+|.++.....   .+.+.+|+..++.++|||++++++.+.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67899999999999999987653   477999998764322   3568899999999999999999998866543     


Q ss_pred             -EEEEEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecC
Q 029037           73 -LAIVMEYAAGGELFDRICNA------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (200)
Q Consensus        73 -~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~  145 (200)
                       .++++||+++++|..++...      ..++...+..++.|++.||.+||+.+++|+||+|+||+++++.  .++|+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCcc
Confidence             79999999999999888542      2588999999999999999999999999999999999998665  49999999


Q ss_pred             CCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          146 YSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       146 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .++........   .....+..|+|||.+.+..++.++|+||+|+++|||++ |.+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~  216 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY  216 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            98644322211   11234567999999988889999999999999999999 77775

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.6e-39  Score=233.78  Aligned_cols=195  Identities=33%  Similarity=0.534  Sum_probs=169.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEec--CceEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAIVM   77 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~   77 (200)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....   ...+.+.+|+..++.++|||++++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5899999999999999999999999999999887532   234568889999999999999999998764  45689999


Q ss_pred             EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           78 EYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        78 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh-----~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      |++++++|.+++..    ..+++...++.++.|++.||++||     +.+++|+||+|+||++++++  .++|+|||.+.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEecccccc
Confidence            99999999999865    356899999999999999999999     89999999999999998665  49999999987


Q ss_pred             ccCCCCC-CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          149 SSVLHSR-PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       149 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....... .....+++.|+|||.+.+..++.++|+||||+++++|++|..||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  210 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF  210 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcc
Confidence            5544332 23346788999999999888999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=240.68  Aligned_cols=193  Identities=25%  Similarity=0.411  Sum_probs=173.8

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      |.+++.||+|++|.||++.++.+|+.+|+|..+.+ ...+++..|+.+++++++|+++++++.+.....+++|||||..|
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            67899999999999999999999999999998874 45788999999999999999999999999999999999999999


Q ss_pred             chHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCcccC
Q 029037           84 ELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKSTVG  161 (200)
Q Consensus        84 ~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~~~  161 (200)
                      +..+.+. .++++++.++..+++..+.||.|||...-+||||+..||+++.++  ..||+|||.+......-. ...-.|
T Consensus       114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G--~AKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T KOG0574|consen  114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG--IAKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T ss_pred             cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc--hhhhhhccccchhhhhHHhhCcccc
Confidence            9999885 456799999999999999999999999999999999999997655  499999999854433222 334469


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      |+.|+|||++..-.|+..+||||||+...||..|+|||
T Consensus       192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPY  229 (502)
T KOG0574|consen  192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPY  229 (502)
T ss_pred             CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCc
Confidence            99999999999888999999999999999999999997

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.2e-39  Score=239.25  Aligned_cols=196  Identities=32%  Similarity=0.476  Sum_probs=165.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTP--THLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~   75 (200)
                      +++|++.+.||.|++|.||++.+..+++.||+|.+......   .....+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            47899999999999999999999999999999998753221   23567899999999999999999998765  46899


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +||++++ +|.+++... ..++..++..++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||.+.......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--CLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccceeeecCCcc
Confidence            9999965 888887653 5689999999999999999999999999999999999998666  49999999986544332


Q ss_pred             C-CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 R-PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~-~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      . ......+..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f  209 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL  209 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC
Confidence            2 222345778999999865 45788999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.4e-39  Score=234.33  Aligned_cols=192  Identities=28%  Similarity=0.408  Sum_probs=163.4

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHhhCC-CCCeeeEEEEEecC--ceEEEEEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLR-HPNIIRFKEVVLTP--THLAIVME   78 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~v~e   78 (200)
                      |++.+.||+|++|.||++.+..+++.+++|.+.+....  .....+|+..++++. |+|++++++++.++  +..+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            78899999999999999999999999999998764222  234457888888885 99999999999987  88999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ++++ +|.+.+.+. ..+++.++..++.|++.||++||+.|++|+||+|+||++++   +.++|+|||.+..........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEecccccccccCCCcC
Confidence            9965 888877654 46899999999999999999999999999999999999987   359999999987654444444


Q ss_pred             cccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++..|+|||.+.. ..++.++|+||+|+++|+|++|.+||
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~  199 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF  199 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC
Confidence            4557889999997654 45788999999999999999999887

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.2e-39  Score=230.96  Aligned_cols=195  Identities=35%  Similarity=0.529  Sum_probs=172.8

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....   ...+.+.+|++.++.++|||++++.+.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            6899999999999999999999899999999997643   3346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-
Q 029037           80 AAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (200)
Q Consensus        80 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-  154 (200)
                      +++++|.+.+.+.    ..++...+..++.+++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence            9999999999764    56999999999999999999999999999999999999986654  9999999886443332 


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......+++.|+|||...+..++.++|+||+|+++++|++|.+||
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~  203 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF  203 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCC
Confidence            223345788899999998888999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.8e-39  Score=239.29  Aligned_cols=194  Identities=28%  Similarity=0.443  Sum_probs=168.3

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .|.....||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.+.|||++++++.+..+...++++|+++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            4556678999999999999999889999999986533 334568899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCccc
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKSTV  160 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~~  160 (200)
                      +++|.+.+.. ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.  ++|+|||++........ .....
T Consensus       102 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         102 GGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhccccccccccee
Confidence            9999887744 56899999999999999999999999999999999999986664  99999998864332222 23345


Q ss_pred             CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          161 GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++..|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~  217 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY  217 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            788999999998888999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.1e-39  Score=245.22  Aligned_cols=196  Identities=24%  Similarity=0.334  Sum_probs=163.6

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEecccccc--hHHHHHHHHHHhhCC-CCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKI--DENVAREIINHRSLR-HPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   73 (200)
                      ++|.+.+.||+|+||.||++.+.     .+++.||+|++......  .+.+.+|+.++.++. ||||+++++.+......
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46788899999999999999964     34567999999864322  346889999999997 99999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC------------------------------------------------------------
Q 029037           74 AIVMEYAAGGELFDRICNAG------------------------------------------------------------   93 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~------------------------------------------------------------   93 (200)
                      +++|||+++++|.+++..+.                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999986532                                                            


Q ss_pred             --------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           94 --------------------------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        94 --------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                                                            .++...+..++.|++.||+|||+.+++||||+|+||+++++.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence                                                  245667788999999999999999999999999999998655


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                        .++|+|||++........   .....++..|+|||.+.+..++.++|+||+|+++|||++ |.+||
T Consensus       277 --~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         277 --LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             --EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence              499999999864332211   122346778999999988889999999999999999998 77775

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.9e-39  Score=235.30  Aligned_cols=196  Identities=21%  Similarity=0.284  Sum_probs=162.2

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.++.     .+..+++|.+.....  ....+.+|+..++.++|||++++++++.+....+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            589999999999999999997652     345799998765432  2345778999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           75 IVMEYAAGGELFDRICNAG----------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                      ++|||+++++|.+++.+..          .++...+..++.|++.||.+||++|++||||+|+||++++++  .++|+||
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--~~~L~Df  163 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--TVKIGDF  163 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--cEEECcC
Confidence            9999999999999996532          245677889999999999999999999999999999998655  4999999


Q ss_pred             CCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          145 GYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       145 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      |++........   .....++..|+|||.+.+..++.++|+||+|+++|||++ +.+||
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~  222 (288)
T cd05061         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY  222 (288)
T ss_pred             CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCC
Confidence            98864322211   111234567999999988889999999999999999998 67776

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.2e-39  Score=235.96  Aligned_cols=194  Identities=29%  Similarity=0.444  Sum_probs=165.9

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||.|++|.||++.+..+++.+++|.+.....   ..+.+.+|++.+++++|||++++++++.++...+++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            58899999999999999999999999999998875422   235788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-C
Q 029037           80 AAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (200)
Q Consensus        80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~  156 (200)
                      +. ++|.+++...  ..++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+........ .
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence            95 5888888653  45899999999999999999999999999999999999987664  99999998864432222 1


Q ss_pred             CcccCCCCccCCeeecCcc-cCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRRE-YDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|+|||.+.+.. ++.++|+||||+++|+|+||.+||
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~  201 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF  201 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            2234578899999987644 588899999999999999999887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-41  Score=243.26  Aligned_cols=196  Identities=31%  Similarity=0.504  Sum_probs=173.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch----HHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      .+|..+..||+|+||+|.++..+.+.+.+|+|+++++-..+    +-...|-++|... +-|.++++...|+.-.++|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            36778899999999999999999999999999998864322    2234566666655 467888999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-C
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-R  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~  155 (200)
                      |||+.||+|...++..+++.+..+..++.+|+.||-+||++||+.|||+.+||+++.++.  |||+|||.++...... .
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeecccccccccCCcc
Confidence            999999999999999999999999999999999999999999999999999999987765  9999999997544443 3


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+||+.|.|||++..++|+.++|.||+|++||||+.|+|||
T Consensus       507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPF  550 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF  550 (683)
T ss_pred             eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCC
Confidence            45678999999999999999999999999999999999999998

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-38  Score=234.38  Aligned_cols=195  Identities=27%  Similarity=0.445  Sum_probs=167.8

Q ss_pred             cccccccccCCcceEEEEEEEc---CCCcEEEEEEecccc-----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            3 KYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      +|++.+.||.|++|.||.+.+.   .+++.+++|.+....     ...+.+.+|+.+++++ +|++|+++.+.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5889999999999999999975   468889999987532     2345678899999999 589999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +++||++++++|.+++....+++...+..++.|++.||.+||+.|++||||+|+||+++.++  .++|+|||.+......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceecccc
Confidence            99999999999999998888899999999999999999999999999999999999998765  4999999988654332


Q ss_pred             CCC--CcccCCCCccCCeeecCc--ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SRP--KSTVGTPAYIAPEVLSRR--EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~~--~~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...  ....++..|+|||.+.+.  .++.++|+||+|+++|++++|.+||
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~  208 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF  208 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCC
Confidence            211  234578889999998753  4678899999999999999999987

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9.9e-39  Score=234.15  Aligned_cols=195  Identities=29%  Similarity=0.461  Sum_probs=169.3

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      +|.-.+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+.+++.++|||++++++++......++++|+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            45556799999999999999998899999998865432 24568899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCccc
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKSTV  160 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~~  160 (200)
                      +++|.+++.. .+++...+..++.|++.||++||+.|++||||+|+||++++++  .++|+|||.+........ .....
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648         100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG--RVKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC--cEEEcccccchhhccCCccccccc
Confidence            9999999876 6789999999999999999999999999999999999998665  499999998764332222 22345


Q ss_pred             CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          161 GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++..|+|||.+.+..++.++|+||+|+++|+|++|.+||+
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~  216 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF  216 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence            7889999999988889999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.1e-39  Score=233.35  Aligned_cols=194  Identities=23%  Similarity=0.319  Sum_probs=159.7

Q ss_pred             ccccccccCCcceEEEEEEEcCCCc--EEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC------ce
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKE--LVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~--~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   72 (200)
                      +.+.+.||+|++|.||++.+..++.  .+++|.++...   ...+.+.+|...++.++|||++++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678999999999999999877765  58999887542   2245688899999999999999999987432      24


Q ss_pred             EEEEEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           73 LAIVMEYAAGGELFDRICNA------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                      .+++|||+++++|.+++...      ..++...+..++.|++.||++||++|++||||+|+||++++++.  ++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence            68999999999998887421      23789999999999999999999999999999999999986654  99999999


Q ss_pred             CcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          147 SKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       147 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +........   ......++.|++||...+..++.++|+||||+++|++++ |.+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~  215 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY  215 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence            875432221   122235678999999999899999999999999999999 77776

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.1e-39  Score=234.48  Aligned_cols=196  Identities=20%  Similarity=0.347  Sum_probs=166.7

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++..+.     ..+.+++|.+.....  ..+.+.+|+.++++++|+|++++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            578999999999999999999754     346789998876433  2467899999999999999999999999989999


Q ss_pred             EEEEecCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecC
Q 029037           75 IVMEYAAGGELFDRICNAG---------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~  145 (200)
                      ++||++++++|.+++....         .++...+..++.|++.+|++||+.|++|+||+|+||+++.++.  ++++||+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccc
Confidence            9999999999999997665         6899999999999999999999999999999999999987664  9999999


Q ss_pred             CCcccCCCC--CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          146 YSKSSVLHS--RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       146 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++.......  ......++..|+|||.+.+..+++++|+||||+++|++++ |.+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~  219 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF  219 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            875332111  1222345667999999988888999999999999999998 66666

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-38  Score=231.01  Aligned_cols=196  Identities=28%  Similarity=0.378  Sum_probs=165.8

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      +......||+|++|.||++.+..++..+++|.+..... ..+.+.+|+.+++.++|+|++++++++..++..++++|+++
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   88 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP   88 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence            34445689999999999999999999999998876433 34578899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CC
Q 029037           82 GGELFDRICNA-GRF--SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PK  157 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~  157 (200)
                      +++|.+++... ..+  +...+..++.|++.||++||+.|++|+||+|+||+++.+. ..++|+|||.+........ ..
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCccc
Confidence            99999999764 445  7888999999999999999999999999999999997533 2599999998864332222 22


Q ss_pred             cccCCCCccCCeeecCc--ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRR--EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++..|+|||.+.+.  .++.++|+||+|+++|++++|.+||
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~  211 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF  211 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCC
Confidence            33578899999998654  3788999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.6e-39  Score=237.64  Aligned_cols=196  Identities=24%  Similarity=0.364  Sum_probs=162.9

Q ss_pred             ccccccccccCCcceEEEEEEEcC----------------CCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE----------------TKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRF   63 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~----------------~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~   63 (200)
                      ++|++.+.||+|++|.||++.+..                +...+++|.+....  ...+.+.+|+..++.++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            479999999999999999986543                34468999887542  234678899999999999999999


Q ss_pred             EEEEecCceEEEEEEecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec
Q 029037           64 KEVVLTPTHLAIVMEYAAGGELFDRICNAG-----------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD  132 (200)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~  132 (200)
                      ++++.++...+++||++++++|.+++.+..           .++..++..++.|++.||++||+.|++|+||+|+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~  164 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence            999999999999999999999999987643           256678999999999999999999999999999999998


Q ss_pred             CCCCCCEEEeecCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC--CCCCC
Q 029037          133 GSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR--PNPFI  199 (200)
Q Consensus       133 ~~~~~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~--~~~pf  199 (200)
                      +++  .++|+|||++.........   .....+..|++||...+..++.++|+||||+++|||++  +..||
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~  234 (296)
T cd05095         165 KNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY  234 (296)
T ss_pred             CCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence            655  4999999998644322211   11233567999999888889999999999999999997  66665

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.8e-39  Score=231.64  Aligned_cols=189  Identities=30%  Similarity=0.407  Sum_probs=162.3

Q ss_pred             ccccCCcceEEEEEEEcC-CC--cEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKE-TK--ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~-~~--~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|++|.||++.+.. ++  ..+++|.+.....  ..+.+.+|+..+++++|||++++++.+.+ ...+++||++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 33  3589999887544  35678899999999999999999999988 889999999999


Q ss_pred             CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC----C
Q 029037           83 GELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR----P  156 (200)
Q Consensus        83 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~----~  156 (200)
                      ++|.+++.+..  .++...+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||.+........    .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccccceecc
Confidence            99999997764  589999999999999999999999999999999999998775  499999999875433221    1


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  201 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW  201 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence            12345678999999988889999999999999999998 88886

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.9e-39  Score=237.42  Aligned_cols=196  Identities=28%  Similarity=0.436  Sum_probs=163.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc------
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT------   71 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   71 (200)
                      +++|++.+.||+|++|.||++.+..+++.|++|.+....   .......+|+.++++++||+++++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            478999999999999999999999999999999886532   22345678999999999999999999886543      


Q ss_pred             --eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           72 --HLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        72 --~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                        ..+++||++.+ +|.+.+.+.. .++..+++.++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||.+.
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~  167 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG--ILKLADFGLAR  167 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--cEEECcCCCcc
Confidence              45999999964 8887776543 689999999999999999999999999999999999998665  49999999986


Q ss_pred             ccCCCCCC-----CcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          149 SSVLHSRP-----KSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       149 ~~~~~~~~-----~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........     ....++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~  224 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM  224 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence            44332221     223467789999988654 4688899999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.2e-39  Score=240.09  Aligned_cols=196  Identities=23%  Similarity=0.309  Sum_probs=162.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-------CcEEEEEEecccc--cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-------KELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-------~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      .+|++.+.||+|++|.||.+.+...       ...+++|.+....  ...+.+.+|+.+++++ +||||+++++.+.++.
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            3689999999999999999986432       2368999887532  2245788999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           72 HLAIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      ..++++|++++++|.+++.+..                .++..++..++.|++.||.+||+.|++||||+|+||++++++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            9999999999999999997532                367788899999999999999999999999999999998665


Q ss_pred             CCCEEEeecCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                        .++|+|||+++........   ....++..|+|||.+.+..++.++|+||||+++|||++ |.+||
T Consensus       172 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  237 (334)
T cd05100         172 --VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  237 (334)
T ss_pred             --cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence              4999999998643322211   11223457999999999899999999999999999998 77776

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-39  Score=237.09  Aligned_cols=196  Identities=31%  Similarity=0.458  Sum_probs=172.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|.+.+.||+|++|.||++.+..+++.+++|++....    ...+.+.+|..++++++ |||++++++.+.++...+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            58999999999999999999999999999999987632    22356788999999998 99999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      ||++++++|.+++.+...++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+........ 
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence            999999999999988888999999999999999999999999999999999999986664  99999999864332221 


Q ss_pred             --------------------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 --------------------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 --------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                                          .....++..|+|||......++.++|+||||++++++++|.+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  222 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF  222 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence                                11234678899999998888899999999999999999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.6e-39  Score=233.74  Aligned_cols=188  Identities=31%  Similarity=0.466  Sum_probs=166.0

Q ss_pred             ccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037           10 LGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus        10 l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      ||+|++|.||++.+..+++.+++|.+.....    ..+.+.+|+..++.++|||++++++.+......++++|++++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999876432    345788899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC---------C
Q 029037           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---------P  156 (200)
Q Consensus        86 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~---------~  156 (200)
                      .+++.+...+++..+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||++........         .
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence            999988778999999999999999999999999999999999999987664  99999998864433321         1


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|++||...+..++.++|+||||+++|++++|.+||
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~  201 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF  201 (265)
T ss_pred             cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence            2234678899999998888899999999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-40  Score=244.59  Aligned_cols=193  Identities=24%  Similarity=0.301  Sum_probs=161.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ..|++++.||+||.+.||++.....+. +|+|.+...   ....+.+.+|+.+|.+|+ |.+|+++++|-..++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            369999999999999999999876544 666655543   344567999999999996 899999999999999999999


Q ss_pred             EecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           78 EYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      |+ ...+|...+.+... ++...++.+..|++.++.++|+.||||.||||.|+++-.   +.+||+|||+|........ 
T Consensus       440 E~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk---G~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  440 EC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK---GRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             ec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe---eeEEeeeechhcccCccccc
Confidence            96 35699999977664 444689999999999999999999999999999998843   3599999999975554443 


Q ss_pred             --CCcccCCCCccCCeeecCc-----------ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 --PKSTVGTPAYIAPEVLSRR-----------EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~~-----------~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        ....+||+.|++||.+...           +.++++|||||||+||+|+-|++||
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf  572 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF  572 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch
Confidence              3556899999999998432           2567889999999999999999998

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-39  Score=248.02  Aligned_cols=194  Identities=28%  Similarity=0.465  Sum_probs=172.0

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      |..++.||-|+||.|.++....|...+|+|.+.+.+    ......+.|-++|..-.++-||+++..|+++.++|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            566789999999999999999999999999998753    2234678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC------
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH------  153 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~------  153 (200)
                      ++||++.+++-+-+-|+++.++.++.++..|++..|+.|++||||||+||+||.++.  |||+|||+|.....-      
T Consensus       711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccccc
Confidence            999999999999889999999999999999999999999999999999999998886  999999998511100      


Q ss_pred             --CC-----------------------------------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCC
Q 029037          154 --SR-----------------------------------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPN  196 (200)
Q Consensus       154 --~~-----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~  196 (200)
                        +.                                   .-...||+.|+|||++.+..|+..+|+||.|++||||+.|+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence              00                                   00124889999999999999999999999999999999999


Q ss_pred             CCC
Q 029037          197 PFI  199 (200)
Q Consensus       197 ~pf  199 (200)
                      +||
T Consensus       869 ~pf  871 (1034)
T KOG0608|consen  869 PPF  871 (1034)
T ss_pred             CCc
Confidence            999

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-38  Score=233.91  Aligned_cols=194  Identities=28%  Similarity=0.461  Sum_probs=166.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +|++.+.||.|++|.||++.+..+++.+++|.+.....  ..+.+.+|+.++++++|||++++++++.+.+..+++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            58999999999999999999999999999999876432  2456778999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-C
Q 029037           81 AGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (200)
Q Consensus        81 ~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~  156 (200)
                      ++ +|.+++....   .+++..+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+........ .
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence            75 8888876543   5899999999999999999999999999999999999986664  99999998864332222 1


Q ss_pred             CcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|++||.+.+ ..++.++|+||+|+++|++++|.+||
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~  201 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF  201 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            22346788999998765 45688999999999999999999886

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-38  Score=232.44  Aligned_cols=196  Identities=27%  Similarity=0.386  Sum_probs=167.7

Q ss_pred             ccccccccccCCcceEEEEEEEc----CCCcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEec--CceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLT--PTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~----~~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   73 (200)
                      +.|++.+.||+|++|.||++...    .+++.+++|.+......  .+.+.+|++.++.++|||++++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46888999999999999999864    34788999999876543  5689999999999999999999999887  5578


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           74 AIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      +++||++++++|.+++.+.. .++...+..++.|++.||++||+.|++|+||+|+||+++.++  .++|+|||.+.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEccccccccccc
Confidence            99999999999999997765 589999999999999999999999999999999999998765  499999999875442


Q ss_pred             CCCC----CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRP----KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....    .....+..|++||.+....++.++|+||||+++++|++|..||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~  212 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS  212 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCc
Confidence            2221    1123445699999998888999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.9e-39  Score=232.09  Aligned_cols=194  Identities=36%  Similarity=0.496  Sum_probs=171.5

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||.|++|.||++.+..+++.+++|.+....   ....++.+|+..++.++|+|++++.+++.+....++++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5899999999999999999999999999999987642   2345677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           80 AAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        80 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      +++++|.+++.+    ...++...+..++.|++.||++||+.|++|+||+|+||++++++  .++|+|||.+...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhccC-C
Confidence            999999998866    34589999999999999999999999999999999999998755  4999999998755443 3


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....++..|+|||.+.+..+++++|+||+|++++++++|.+||
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~  201 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF  201 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            33345788999999999888999999999999999999999987

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-38  Score=234.53  Aligned_cols=196  Identities=29%  Similarity=0.383  Sum_probs=163.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCC-CCCeeeEEEEEecCce-----
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLR-HPNIIRFKEVVLTPTH-----   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~-----   72 (200)
                      ++|++.+.||.|++|.||++.+..+++.|++|.+.....   ....+.+|+.+++.+. |||++++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            589999999999999999999999999999998875422   2357888999999995 6999999999887655     


Q ss_pred             EEEEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037           73 LAIVMEYAAGGELFDRICNA-----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                      .+++||++++ +|.+++...     ..++...++.++.|++.||.+||+.|++|+||+|+||+++++. +.++|+|||.+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~-~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQK-GLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCC-CeEEEeecccc
Confidence            8999999976 788887543     3479999999999999999999999999999999999998622 35999999988


Q ss_pred             cccCCCC-CCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          148 KSSVLHS-RPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       148 ~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~  212 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF  212 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC
Confidence            6433221 1222346788999998865 45788999999999999999999987

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.2e-39  Score=235.26  Aligned_cols=195  Identities=15%  Similarity=0.142  Sum_probs=153.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCC---CcEEEEEEecccccch------------HHHHHHHHHHhhCCCCCeeeEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRKID------------ENVAREIINHRSLRHPNIIRFKEV   66 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~~~~------------~~~~~e~~~l~~l~~~~i~~~~~~   66 (200)
                      ++|++.+.||+|+||+||++.+..+   +..+++|.........            .....+...+..+.|++++++++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4799999999999999999998877   6667777643322110            112233345566789999999987


Q ss_pred             EecCc----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEe
Q 029037           67 VLTPT----HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC  142 (200)
Q Consensus        67 ~~~~~----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~  142 (200)
                      +....    ..+++++.+ ..++.+.+......+...+..++.|++.||.+||+.+++||||||+||++++++  .++|+
T Consensus        92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l~  168 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYII  168 (294)
T ss_pred             eeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEEE
Confidence            65543    346778877 347777776655578888999999999999999999999999999999998655  49999


Q ss_pred             ecCCCcccCCCC--------CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          143 DFGYSKSSVLHS--------RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       143 df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      |||+|+......        ......+++.|+|||...+..++.++|+||||+++|||++|.+||
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~  233 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW  233 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999986443221        112235889999999999999999999999999999999999998

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.6e-39  Score=240.60  Aligned_cols=195  Identities=33%  Similarity=0.502  Sum_probs=167.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecC-----ceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   73 (200)
                      ++|.+.+.||+|++|+||++.+..+++.|++|.+...   ......+.+|+..++.++|+|++++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            5899999999999999999999999999999988753   22345677899999999999999999987654     347


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++++|++. ++|.+++.+..+++...+..++.|++.||.+||+.+++|+||+|+||+++.++.  ++|+|||++......
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~  161 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEK  161 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCC
Confidence            99999995 689999988888999999999999999999999999999999999999986654  999999998754333


Q ss_pred             C-CCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 S-RPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      . ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  209 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF  209 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC
Confidence            2 1223356788999998865 46889999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=233.68  Aligned_cols=193  Identities=32%  Similarity=0.473  Sum_probs=166.6

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      |++.+.||.|++|.||++.+..+++.+++|.+....   .....+.+|+..++.++||+++++++++.+....+++||++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            678999999999999999999999999999987543   22356888999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CC
Q 029037           81 AGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PK  157 (200)
Q Consensus        81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~  157 (200)
                      + ++|.+++....  .+++..++.++.|++.||++||+.+++|+||+|+||++++++  .++|+|||.+........ ..
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCccccC
Confidence            5 58999987766  689999999999999999999999999999999999998755  499999999864432221 12


Q ss_pred             cccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  200 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF  200 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence            23457889999988654 5688999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.1e-39  Score=235.21  Aligned_cols=196  Identities=23%  Similarity=0.372  Sum_probs=164.7

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||.|++|.||++.+..     ++..+++|.+.....  ....+.+|+..++.+.|||++++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            579999999999999999998753     567899998875432  2356888999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec
Q 029037           75 IVMEYAAGGELFDRICNAG----------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD  132 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~  132 (200)
                      +++|++++++|.+++.+..                      .++...++.++.|++.||.+||+.|++||||+|+||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            9999999999999997532                      367788899999999999999999999999999999997


Q ss_pred             CCCCCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          133 GSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       133 ~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +++.  ++|+|||.+........   ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       165 ~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~  233 (288)
T cd05050         165 ENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY  233 (288)
T ss_pred             CCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            6654  99999998764322211   112234567999999988889999999999999999997 66666

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.3e-39  Score=240.41  Aligned_cols=196  Identities=22%  Similarity=0.343  Sum_probs=160.7

Q ss_pred             ccccccccccCCcceEEEEEEE-----cCCCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecC-ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRH-----KETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTP-TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~   72 (200)
                      ++|++.+.||+|+||.||++.+     ..+++.||+|.+.....  ..+.+.+|+..+..+ +|||++++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5899999999999999999985     34577899999875432  235688899999999 689999999987654 56


Q ss_pred             EEEEEEecCCCchHHHHHhcC-----------------------------------------------------------
Q 029037           73 LAIVMEYAAGGELFDRICNAG-----------------------------------------------------------   93 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~-----------------------------------------------------------   93 (200)
                      .+++|||+++++|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            899999999999999886421                                                           


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC---CCcccCC
Q 029037           94 --------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGT  162 (200)
Q Consensus        94 --------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~  162 (200)
                              .++......++.|++.||++||+.|++||||+|+||+++.+.  .++|+|||++........   .....++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEecccccccccCcchhhcCCCCCC
Confidence                    256777888999999999999999999999999999998665  499999999864322211   1112345


Q ss_pred             CCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          163 PAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       163 ~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..|+|||.+.+..++.++|+||||+++|++++ |.+||
T Consensus       245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  282 (343)
T cd05103         245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  282 (343)
T ss_pred             cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            67999999988889999999999999999996 77776

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.3e-39  Score=231.40  Aligned_cols=196  Identities=33%  Similarity=0.499  Sum_probs=171.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +|++.+.||+|++|.||++.+..++..+++|.+....   ...+.+.+|+..++.++|+|++++++.+.+....++++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5889999999999999999999999999999987542   3345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-
Q 029037           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-  156 (200)
Q Consensus        80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-  156 (200)
                      +++++|.+++.+..  .+++..+..++.|++.||.+||+.+++|+||+|+||++++++. .++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence            99999999987654  4789999999999999999999999999999999999986643 4799999988654332221 


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|+|||...+..++.++|+||+|++++++++|..||
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  202 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF  202 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            2235788899999998888999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=227.93  Aligned_cols=189  Identities=25%  Similarity=0.331  Sum_probs=161.3

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      +.||.|++|.||++.+.. ++.+++|.+.....  ....+.+|++++++++|++++++++++.+....+++||++++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999987 88899998876433  345788999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC---CcccC
Q 029037           86 FDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVG  161 (200)
Q Consensus        86 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~---~~~~~  161 (200)
                      .+++.+. ..++...+..++.+++.++++||+++++|+||+|+||++++++  .++|+|||.+.........   .....
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC--cEEEeeccccccccCCcceeccccCcc
Confidence            9998654 4588999999999999999999999999999999999998665  4999999998643321111   11223


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~  196 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY  196 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCC
Confidence            456999999988889999999999999999998 67776

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=238.52  Aligned_cols=195  Identities=24%  Similarity=0.327  Sum_probs=165.1

Q ss_pred             ccccc-cccccCCcceEEEEEEEcCCCcEEEEEEecccccch---------------HHHHHHHHHHhhCCCCCeeeEEE
Q 029037            2 EKYEL-VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---------------ENVAREIINHRSLRHPNIIRFKE   65 (200)
Q Consensus         2 ~~y~~-~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~---------------~~~~~e~~~l~~l~~~~i~~~~~   65 (200)
                      ++|.. .+.||+|++|+||++.+..+++.|++|.+.......               ..+.+|+..++.++|+|++++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            46764 577999999999999999999999999987543221               24778999999999999999999


Q ss_pred             EEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecC
Q 029037           66 VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (200)
Q Consensus        66 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~  145 (200)
                      ++..+...+++||+++ ++|.+++.....++......++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg  164 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFG  164 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCcc
Confidence            9999999999999996 589999987778999999999999999999999999999999999999986664  9999999


Q ss_pred             CCcccCCC---------------CCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          146 YSKSSVLH---------------SRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       146 ~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .+......               .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            88643311               111122357789999998764 4688899999999999999999887

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.6e-38  Score=230.14  Aligned_cols=190  Identities=23%  Similarity=0.275  Sum_probs=155.2

Q ss_pred             ccccCCcceEEEEEEEc--CCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            8 KDLGAGNFGVARLLRHK--ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~--~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      +.||+|++|.||++...  .++..+++|.+.....  ....+.+|+.+++.++|||++++++.+.+....+++|||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46899999999999864  3456789998875432  2346888999999999999999999999988999999999999


Q ss_pred             chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC---
Q 029037           84 ELFDRICNAG-----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---  155 (200)
Q Consensus        84 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~---  155 (200)
                      +|.+++....     ..+...+..++.|++.|+++||+.|++|+||+|+||+++++.  .++|+|||.+........   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCccccccccCcceeec
Confidence            9999986532     356677889999999999999999999999999999998655  499999998864322211   


Q ss_pred             CCcccCCCCccCCeeecCc-------ccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRR-------EYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~-------~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .....++..|+|||.+.+.       .++.++|+||+|+++|||++ |.+||
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  210 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY  210 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCC
Confidence            1223456789999998642       35788999999999999996 88887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-38  Score=227.54  Aligned_cols=189  Identities=25%  Similarity=0.320  Sum_probs=159.6

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      +.||+|++|.||++... .+..+++|.+.....  ....+.+|+..++.++|||++++++++......+++||++++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            47899999999999865 567899998875432  234688999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC--cccCC
Q 029037           86 FDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK--STVGT  162 (200)
Q Consensus        86 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~--~~~~~  162 (200)
                      .+++... ..++...+..++.|++.+|.++|+.|++|+||+|+||++++++.  ++|+|||++..........  ....+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence            9988654 35789999999999999999999999999999999999986664  9999999885332221111  12335


Q ss_pred             CCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          163 PAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       163 ~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..|+|||.+.+..++.++|+||+|+++|++++ |.+||
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~  195 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY  195 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCC
Confidence            67999999988889999999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.5e-39  Score=240.83  Aligned_cols=195  Identities=26%  Similarity=0.434  Sum_probs=166.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEec----CceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT----PTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~   74 (200)
                      ++|++.+.||.|++|.||++.+..+++.|++|.+....   ...+.+.+|+.+++.++||||+++.+++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            47999999999999999999999999999999987642   234567889999999999999999888763    34689


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      ++||++. ++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+.......
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~  161 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccC
Confidence            9999995 589999877778999999999999999999999999999999999999987664  9999999986433222


Q ss_pred             CC-----CcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RP-----KSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~-----~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..     ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf  212 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF  212 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc
Confidence            11     22357888999999865 46889999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-38  Score=230.27  Aligned_cols=191  Identities=26%  Similarity=0.366  Sum_probs=162.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +++|++.+.||+|++|.||++..  +++.+++|.+... ...+.+.+|+..++.++|||++++++++..+ ..+++||++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            36799999999999999999864  5677999988654 3456788999999999999999999998765 478999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           81 AGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      ++++|.+++....  .++...+..++.|++.|+.+||+.|++||||+|+||+++.++  .++|+|||.+......  ...
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~--~~kl~Dfg~~~~~~~~--~~~  156 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSMG--VDN  156 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--cEEECCCccceecccc--CCC
Confidence            9999999997654  478999999999999999999999999999999999998665  4999999988643221  122


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...+..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~  198 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY  198 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            234567999999988889999999999999999997 88876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.6e-38  Score=232.43  Aligned_cols=196  Identities=19%  Similarity=0.208  Sum_probs=164.7

Q ss_pred             ccccccccccCCcceEEEEEEEcC----CCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEec-CceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE----TKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~----~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..    ++..+++|.+....  ...+.+.+|...++.++|||++++++++.+ +...+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            579999999999999999999876    35778999887542  224568899999999999999999998766 46789


Q ss_pred             EEEEecCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           75 IVMEYAAGGELFDRICNA--------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                      ++++++++++|.+++...        ..++..++..++.|++.||++||+.+++|+||+|+||+++++.  .++|+|||+
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d~g~  163 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNAL  163 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECCCCC
Confidence            999999999999998653        3488999999999999999999999999999999999998665  499999999


Q ss_pred             CcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          147 SKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       147 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++.......   .....++..|+|||.+.+..++.++|+||||+++|++++ |.+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  220 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY  220 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCc
Confidence            864322211   112234567999999988889999999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=236.48  Aligned_cols=196  Identities=27%  Similarity=0.370  Sum_probs=164.4

Q ss_pred             cccccccccCCcceEEEEEEEcC--CCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKE--TKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLA   74 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~--~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   74 (200)
                      +|++.+.||+|++|.||++.+..  +++.+|+|.+....    ...+...+|+.+++.++|||++++++++.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58899999999999999999988  78999999998632    3346778899999999999999999999988  7899


Q ss_pred             EEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC--CCCEEEeecCCC
Q 029037           75 IVMEYAAGGELFDRICNA-----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYS  147 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~--~~~v~l~df~~~  147 (200)
                      +|||++++ ++.+.+...     ..++...+..++.|++.||.+||+.+++|+||+|+||+++.++  .+.++|+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999965 676666432     2588999999999999999999999999999999999997611  345999999998


Q ss_pred             cccCCCCC----CCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          148 KSSVLHSR----PKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       148 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........    .....++..|+|||.+.+. .++.++|+||||+++++|++|.+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~  216 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF  216 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCC
Confidence            75433222    1233567889999988664 5788999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-38  Score=233.91  Aligned_cols=195  Identities=24%  Similarity=0.308  Sum_probs=164.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|+..+.||+|++|.||++.+..+++.+++|.+....  .....+.+|+..+.++. |+|++++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            46788899999999999999999999999999987543  23456788999998886 9999999999999889999999


Q ss_pred             ecCCCchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           79 YAAGGELFDRI---C--NAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        79 ~~~~~~L~~~l---~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ++.. ++.++.   .  ....++...+..++.|++.||++||+ .+++||||+|+||++++++  .++|+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG--NIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC--cEEEeecchhHHhcc
Confidence            9854 554433   2  23568999999999999999999997 5999999999999998665  499999999864443


Q ss_pred             CCCCCcccCCCCccCCeeecCc---ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRR---EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........++..|+|||.+.+.   .++.++|+||+|+++|++++|.+||
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  210 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY  210 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCc
Confidence            3333344678889999998765   6889999999999999999999997

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=232.31  Aligned_cols=193  Identities=32%  Similarity=0.484  Sum_probs=166.7

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEEEEEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLAIVME   78 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e   78 (200)
                      |++.+.||+|++|.||++.+..+++.+++|.+....   ...+.+.+|+.+++.++|+|++++++++.+.  ...++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            778999999999999999999999999999998752   2345688999999999999999999999988  78999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        79 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      ++++ +|.+++... ..++...++.++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+........  
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence            9975 888888665 47999999999999999999999999999999999999987664  99999999865443331  


Q ss_pred             CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....++..|+|||.+.+ ..+++++|+||||+++++|++|.+||
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~  202 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF  202 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCC
Confidence            222345778999998765 45788999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-39  Score=240.11  Aligned_cols=194  Identities=30%  Similarity=0.480  Sum_probs=163.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHHHhhCCCCCeeeEEEEEecC-----ceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+...  ......+.+|+.+++.++|||++++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            5899999999999999999999999999999998642  23345688899999999999999999887654     3479


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +++|++++ +|.+.+ ...+++...+..++.|++.||.+||+.|++||||+|+||++++++.  ++|+|||++.......
T Consensus        85 lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~  160 (336)
T cd07849          85 IVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEH  160 (336)
T ss_pred             EEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccc
Confidence            99999964 787776 4457899999999999999999999999999999999999986664  9999999986433222


Q ss_pred             CC----CcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RP----KSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~----~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..    ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f  210 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF  210 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            21    22357888999998754 46888999999999999999999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-38  Score=235.17  Aligned_cols=195  Identities=21%  Similarity=0.308  Sum_probs=162.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc----EEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|+..+.||+|++|.||++.+..++.    .+++|.+.....  ....+.+|..+++.++|||++++++.+... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            578899999999999999999877665    468887765422  234678899999999999999999998754 4678


Q ss_pred             EEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +++++++++|.+++.... .++...+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||.+.......
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDE  163 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccCcc
Confidence            999999999999987654 5889999999999999999999999999999999999976654  9999999987543322


Q ss_pred             CC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          155 RP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..   ....++..|+|||.+.+..++.++|+||||+++||+++ |..||
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~  212 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY  212 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence            21   12234568999999988889999999999999999997 77776

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2e-38  Score=230.85  Aligned_cols=195  Identities=24%  Similarity=0.284  Sum_probs=163.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCC---CcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|.+.+.||.|++|.||++.+..+   ...+++|......  ...+.+.+|+..++.++|||++++++++.++ ..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEE
Confidence            4688999999999999999987654   4468999887643  2345788999999999999999999998764 56799


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.+.. .++...+..++.|++.||++||+.|++|+||+|+||+++.++  .++|+|||++........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC--CeEEccCceeeecccccc
Confidence            99999999999997654 589999999999999999999999999999999999998655  499999998864433221


Q ss_pred             CC--cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 PK--STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 ~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..  ....+..|+|||.+....++.++|+||||+++|++++ |.+||
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf  209 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF  209 (270)
T ss_pred             eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCC
Confidence            11  1223467999999988889999999999999999985 88886

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.4e-38  Score=230.28  Aligned_cols=190  Identities=21%  Similarity=0.313  Sum_probs=152.9

Q ss_pred             ccccCCcceEEEEEEEcC--CCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            8 KDLGAGNFGVARLLRHKE--TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~--~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      +.||+|+||.||++....  ....+++|.+.....  ....+.+|+..++.++||||+++++.+.+...++++||+++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            468999999999997543  344688887764322  2346788999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC---
Q 029037           84 ELFDRICNAGR-----FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---  155 (200)
Q Consensus        84 ~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~---  155 (200)
                      +|.+++.+...     .+......++.|++.|+++||++|++||||+|+||++++++.  ++|+|||.+........   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence            99999976432     457788999999999999999999999999999999987664  99999998854322211   


Q ss_pred             CCcccCCCCccCCeeecC-------cccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSR-------REYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .....++..|+|||.+..       ..++.++|+||+|+++|||++ |.+||
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  210 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY  210 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC
Confidence            122345677999998743       356788999999999999998 56665

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.9e-38  Score=229.81  Aligned_cols=195  Identities=30%  Similarity=0.496  Sum_probs=166.0

Q ss_pred             cccccccccCCcceEEEEEEEcC-CCcEEEEEEecccc-----------cchHHHHHHHHHHhh-CCCCCeeeEEEEEec
Q 029037            3 KYELVKDLGAGNFGVARLLRHKE-TKELVAVKYIERGR-----------KIDENVAREIINHRS-LRHPNIIRFKEVVLT   69 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~~K~~~~~~-----------~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~   69 (200)
                      .|++.+.||+|++|.||++.+.. +++.+++|.+....           ....++.+|+.++.. ++|||++++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 67889999875321           112346677777764 799999999999999


Q ss_pred             CceEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           70 PTHLAIVMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        70 ~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                      +...+++||++++++|.+.+..    ...++...++.++.|++.+|.+||+ .|++|+||+|+||++++++.  ++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence            9999999999999999888743    3458999999999999999999995 78999999999999986664  999999


Q ss_pred             CCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          145 GYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      |.+.............++..|++||.+.+..++.++|+||||+++|++++|.+||
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~  213 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF  213 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcc
Confidence            9987544443334456788999999999888999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=230.77  Aligned_cols=193  Identities=30%  Similarity=0.445  Sum_probs=164.4

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhC---CCCCeeeEEEEEecCce-----
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSL---RHPNIIRFKEVVLTPTH-----   72 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~-----   72 (200)
                      |++.+.||.|++|.||++.++.+++.+++|.+......   ...+.+|+.+++++   +|||++++++.+.+...     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            67899999999999999999988999999999753222   23566777776655   69999999999988766     


Q ss_pred             EEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCccc
Q 029037           73 LAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~  150 (200)
                      .+++||++.+ +|.+++....  .+++..+..++.|++.||.+||+.+++|+||+|+||++++++  .++|+|||.+...
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceec
Confidence            9999999965 8988887643  489999999999999999999999999999999999998775  5999999998755


Q ss_pred             CCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          151 VLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..........++..|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~  206 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF  206 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcc
Confidence            4443334445788899999999888999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=231.94  Aligned_cols=193  Identities=35%  Similarity=0.510  Sum_probs=167.0

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEec
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      |++.+.||+|++|+||++.+..+++.+++|.+.....  ......+|+..++.++ |+|++++++++.++...+++||++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7889999999999999999998899999999876432  2234567889999998 999999999999999999999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           81 AGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                       +++|.+.+....  .++...+..++.|++.+|.+||++|++|+||+|+||++++++.  ++|+|||.+...........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence             779988887765  6899999999999999999999999999999999999987654  99999999875544333344


Q ss_pred             ccCCCCccCCeeec-CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLS-RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~-~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++..|+|||.+. ...++.++|+||+|++++++++|.+||
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~  199 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF  199 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc
Confidence            55788899999885 456789999999999999999999887

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=225.44  Aligned_cols=196  Identities=24%  Similarity=0.311  Sum_probs=167.4

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +++.+.+..||+|..|+|+++..++++..+|+|.+....  .+.++++..+.+....+ +|+|++++++|..+..+++.|
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            356778899999999999999999999999999998643  23456777777776665 999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      |.+.. .+..++.. .+++++..+-.+...++.||.||- ++|++|||+||+||++|..++  |||||||++-.......
T Consensus       171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecccc
Confidence            99843 33333332 346888888899999999999997 679999999999999998776  99999999987777777


Q ss_pred             CCcccCCCCccCCeeecCc---ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRR---EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....|.+.|+|||.+...   +|+.++||||||+.++|+.||+-||
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy  294 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPY  294 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCC
Confidence            7777899999999999743   6889999999999999999999997

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.8e-39  Score=238.90  Aligned_cols=194  Identities=32%  Similarity=0.475  Sum_probs=170.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc-----eEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT-----HLA   74 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   74 (200)
                      +|++.+.||.|++|.||++.+..+++.+++|.+....   ...+.+.+|+..++.++|+|++++.+++.+..     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6899999999999999999999889999999987643   23467889999999999999999999988775     789


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      ++|++++ ++|.+.+.+..+++...++.++.|++.||++||+.|++|+||+|+||++++++  .++|+|||.+.......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccc
Confidence            9999996 48989887777899999999999999999999999999999999999998765  59999999987544433


Q ss_pred             C----CCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 R----PKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .    .....++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf  207 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF  207 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc
Confidence            1    2233567889999999887 7899999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.8e-39  Score=231.88  Aligned_cols=188  Identities=16%  Similarity=0.164  Sum_probs=157.1

Q ss_pred             ccccCCcceEEEEEEEcCCCc-------EEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            8 KDLGAGNFGVARLLRHKETKE-------LVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~-------~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +.||+|+||.||++.+...+.       .+++|...... ...+.+.+|..+++.+.|||++++++.+..+...+++||+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            579999999999999865433       37888776543 2346788899999999999999999999998899999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC------CEEEeecCCCcccCC
Q 029037           80 AAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP------RLKICDFGYSKSSVL  152 (200)
Q Consensus        80 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~------~v~l~df~~~~~~~~  152 (200)
                      +++++|.+++...+ .++...++.++.|++.||++||+.|++||||+|+||++++++..      .++++|||.+.....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~  160 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP  160 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence            99999999997654 48999999999999999999999999999999999999765531      379999998754322


Q ss_pred             CCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                         .....++..|+|||.+.+ ..++.++|+||+|+++|++++|..+
T Consensus       161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~  204 (258)
T cd05078         161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK  204 (258)
T ss_pred             ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCC
Confidence               223456788999999976 4578899999999999999999533

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=243.23  Aligned_cols=196  Identities=29%  Similarity=0.400  Sum_probs=173.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchH---------HHHHHHHHHhhCC---CCCeeeEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE---------NVAREIINHRSLR---HPNIIRFKEVVLT   69 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~---------~~~~e~~~l~~l~---~~~i~~~~~~~~~   69 (200)
                      ..|...+.+|.|+||.|+.+.++.+...|++|.+.+..-..+         ..-.|+.++..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            468999999999999999999999999999999987643322         2456999999997   9999999999999


Q ss_pred             CceEEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           70 PTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        70 ~~~~~~v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      +.+++++||.-.- -+|.+++.-.+++++.++..|++|++.|+++||+.||+|||||-+|+.++.++  -+||+|||.+.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g--~~klidfgsaa  718 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG--FVKLIDFGSAA  718 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC--eEEEeeccchh
Confidence            9999999997643 38999998888999999999999999999999999999999999999997555  59999999886


Q ss_pred             ccCCCCCCCcccCCCCccCCeeecCcccC-CeeehhhhhhhhhhcCCCCCCCC
Q 029037          149 SSVLHSRPKSTVGTPAYIAPEVLSRREYD-GKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       ....++...+.||..|+|||.+.+.+|- ...|||+||+++|.++-..-||+
T Consensus       719 -~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  719 -YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             -hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence             5566777888999999999999998874 55699999999999988877775

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.9e-38  Score=232.19  Aligned_cols=197  Identities=24%  Similarity=0.325  Sum_probs=164.4

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +++|++.+.||+|++|.||++.+..+++.+++|.+.....  ....+.+|+..+... .|||++++++++.+....+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4689999999999999999999999899999999976432  234566677666666 4999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      |+++ +++.+.... ...++...+..++.|++.|+++||+ .|++|+||+|+||++++++  .++|+|||.+........
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhccCCCc
Confidence            9985 477766654 3468999999999999999999997 6999999999999998665  499999999865443333


Q ss_pred             CCcccCCCCccCCeeecCcc----cCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRRE----YDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....++..|+|||.+.+..    ++.++|+||+|+++|+|++|.+||+
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  219 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK  219 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence            33445778899999987553    7889999999999999999999984

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-37  Score=231.40  Aligned_cols=192  Identities=30%  Similarity=0.456  Sum_probs=164.2

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      .|...+.||+|++|.||++.+..++..+++|.+.....    ..+.+.+|+..++.++|||++++++++.++...+++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            47888999999999999999999999999999875322    22467889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ++.| ++.+.+.. ..+++..++..++.|++.|+.+||+.|++|+||+|+||++++++.  ++|+|||.+....   ...
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~~  179 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PAN  179 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---Ccc
Confidence            9975 77776644 456899999999999999999999999999999999999986654  9999999875432   223


Q ss_pred             cccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...++..|+|||.+.   .+.++.++|+||+|+++|+|++|.+||+
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  225 (317)
T cd06635         180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  225 (317)
T ss_pred             cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            345778899999974   4568889999999999999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=246.85  Aligned_cols=192  Identities=31%  Similarity=0.464  Sum_probs=168.9

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch----HHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      .|.-++.||+|+||.||.+++..+.+.||+|.+.-+.+..    +++..|+..|++++|||++.+-+++..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3666789999999999999999999999999997543332    468899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ||-| |..+.+.-. +++.+.++..|..+.+.||+|||+.+.+|||||..||++.+.+.  |||+|||.|..   ..+..
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi---~~PAn  180 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASI---MAPAN  180 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhh---cCchh
Confidence            9965 777777543 36899999999999999999999999999999999999986664  99999998753   34556


Q ss_pred             cccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +++|||.|+|||++.   .+.|+-++|||||||.-.|+.-++||.|
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF  226 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  226 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence            789999999999985   4579999999999999999999999975

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.9e-38  Score=233.78  Aligned_cols=192  Identities=29%  Similarity=0.458  Sum_probs=163.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEec-CceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~   77 (200)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+.+..   ...+.+.+|+.+++.++|||++++.+++.. ....++++
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            58999999999999999999999999999999886432   234678899999999999999999999876 45789999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      |++ +++|.+.+. ..+++...+..++.|++.||++||+.|++|+||+|+||++++++  .++|+|||.+.....  ...
T Consensus        90 e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~~~~--~~~  163 (328)
T cd07856          90 ELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLARIQDP--QMT  163 (328)
T ss_pred             ehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC--CEEeCccccccccCC--CcC
Confidence            998 568887774 44688889999999999999999999999999999999998655  499999998864322  223


Q ss_pred             cccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++..|+|||.+.+ ..++.++|+||+|+++|++++|.+||
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f  206 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF  206 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC
Confidence            3456788999999865 56889999999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.1e-38  Score=235.92  Aligned_cols=194  Identities=30%  Similarity=0.456  Sum_probs=164.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhC-CCCCeeeEEEEEecC--ceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSL-RHPNIIRFKEVVLTP--THLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~   75 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+...   ......+.+|+.+++++ +||||+++++++...  ...++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            6899999999999999999999988999999988643   22235677899999999 999999999998654  36899


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      +||+++ ++|.+++.+. .+++.....++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+........
T Consensus        87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEE  162 (337)
T ss_pred             Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccc
Confidence            999996 4998888665 7889999999999999999999999999999999999987665  99999999864433221


Q ss_pred             ------CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 ------PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                            .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf  213 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF  213 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC
Confidence                  112346788999998765 45788999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.3e-38  Score=233.10  Aligned_cols=196  Identities=30%  Similarity=0.495  Sum_probs=164.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc------
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT------   71 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   71 (200)
                      +++|++.+.||+|++|.||++.+..+++.+++|.+....   .....+.+|+.+++.++|||++++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            368999999999999999999999999999999987542   22356788999999999999999999887654      


Q ss_pred             ----eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           72 ----HLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        72 ----~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                          .+++++|++++ ++...+.+. ..++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~  162 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGL  162 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccc
Confidence                78999999976 777777554 36899999999999999999999999999999999999986664  99999999


Q ss_pred             CcccCCCCCC--CcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          147 SKSSVLHSRP--KSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       147 ~~~~~~~~~~--~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +.........  .....+..|+|||.+.+. .++.++|+||+|+++++|++|.+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~  218 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF  218 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            8654333221  122456789999988653 5688999999999999999999887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.2e-38  Score=230.43  Aligned_cols=192  Identities=23%  Similarity=0.321  Sum_probs=160.3

Q ss_pred             ccccCCcceEEEEEEEcCCC------cEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            8 KDLGAGNFGVARLLRHKETK------ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~------~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +.||+|++|.||++.+....      +.+++|.+....  .....+.+|+..++.++||||+++++++.+....+++||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            46899999999999986543      678999886543  3346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC---CCCEEEeecCCCcc
Q 029037           80 AAGGELFDRICNA-------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA---APRLKICDFGYSKS  149 (200)
Q Consensus        80 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~---~~~v~l~df~~~~~  149 (200)
                      +++++|.+++.+.       ..++..+++.++.|++.||.+||+.+++|+||+|+||+++++.   ...++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999998642       2377889999999999999999999999999999999997655   12599999999864


Q ss_pred             cCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          150 SVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       150 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ......   ......+..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~  214 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY  214 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCC
Confidence            322211   112234678999999998889999999999999999998 88887

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-38  Score=236.06  Aligned_cols=192  Identities=25%  Similarity=0.392  Sum_probs=162.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecC------ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   72 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....   ..+.+.+|+.++++++||||+++.+++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            689999999999999999999999999999999875422   235677899999999999999999988643      34


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .+++++++ +++|.+.+.. ..++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||++.... 
T Consensus        97 ~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~-  171 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD-  171 (345)
T ss_pred             EEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccc-
Confidence            67888877 7789887744 46899999999999999999999999999999999999987664  9999999986432 


Q ss_pred             CCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                       .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  218 (345)
T cd07877         172 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  218 (345)
T ss_pred             -ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence             22233457888999999866 46788999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.7e-39  Score=251.66  Aligned_cols=194  Identities=25%  Similarity=0.368  Sum_probs=166.5

Q ss_pred             cccccccccCCcceEEEEEEEcCC-----CcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +-+..+.||+|.||+||+++..+.     ...||+|.+++...  ..++|.+|+.++..++|||||+++|+|.+++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            446778999999999999997543     45699999987543  45789999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc----------C----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEE
Q 029037           76 VMEYAAGGELFDRICNA----------G----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKI  141 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~----------~----~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l  141 (200)
                      |+||+..|+|.+++...          .    +++..+.+.++.||+.||.||-++.+|||||..+|++|.++..  |||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKI  644 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKI  644 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EEe
Confidence            99999999999999542          1    2788899999999999999999999999999999999986665  999


Q ss_pred             eecCCCcccCCCCCCC---cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          142 CDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       142 ~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      +|||+++..-...--.   ...-..+|||||.+..+++|.++||||+|++|||+|+-..-
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~Q  704 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQ  704 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccC
Confidence            9999997443332222   23346799999999999999999999999999999986543

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.3e-38  Score=230.99  Aligned_cols=191  Identities=28%  Similarity=0.441  Sum_probs=165.4

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCc
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   84 (200)
                      ....||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++|+|++++++.+......+++||++++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            3467999999999999999999999999886533 234568899999999999999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcccCCC
Q 029037           85 LFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTP  163 (200)
Q Consensus        85 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~~~~~  163 (200)
                      |.+++. ...++...+..++.|++.++++||+.|++|+||+|+||+++.++  .++|+|||.+....... ......++.
T Consensus       104 L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~  180 (292)
T cd06657         104 LTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSLVGTP  180 (292)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEcccccceecccccccccccccCc
Confidence            988764 45689999999999999999999999999999999999998665  49999999876443222 122345788


Q ss_pred             CccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          164 AYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       164 ~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .|+|||.+.+..+++++|+||+|+++|++++|.+||
T Consensus       181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~  216 (292)
T cd06657         181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY  216 (292)
T ss_pred             cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            899999998888899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.8e-38  Score=228.88  Aligned_cols=189  Identities=18%  Similarity=0.150  Sum_probs=155.4

Q ss_pred             cccCCcceEEEEEEEcC------------------------CCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeE
Q 029037            9 DLGAGNFGVARLLRHKE------------------------TKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRF   63 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~~~------------------------~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~   63 (200)
                      .||+|+||.||++....                        ....+++|.+...... ...+.+|..+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997532                        1245888888654322 3568888999999999999999


Q ss_pred             EEEEecCceEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-----CC
Q 029037           64 KEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-----AP  137 (200)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-----~~  137 (200)
                      ++++.++...++||||+++++|..++.+ .+.++...+..++.|++.||+|||++|++||||+|+||+++..+     ..
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            9999999999999999999999998865 45689999999999999999999999999999999999997432     23


Q ss_pred             CEEEeecCCCcccCCCCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhc-CCCCCCCC
Q 029037          138 RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRN-YRPNPFIW  200 (200)
Q Consensus       138 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~-~~~~~pf~  200 (200)
                      .++++|||.+.....   .....++..|+|||.+.+ ..+++++|+||||+++||+ ++|.+||.
T Consensus       162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  223 (274)
T cd05076         162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK  223 (274)
T ss_pred             eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence            489999998753221   122346778999998865 5688999999999999998 67888873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.6e-38  Score=226.34  Aligned_cols=189  Identities=17%  Similarity=0.170  Sum_probs=155.4

Q ss_pred             ccccCCcceEEEEEEEcC------------CCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            8 KDLGAGNFGVARLLRHKE------------TKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~------------~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      +.||+|++|.||++....            ....+++|.+..... ....+.+|..+++.++||||+++++++.++...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532            233588888765432 2356788899999999999999999999988999


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC-----CCEEEeecCCCc
Q 029037           75 IVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-----PRLKICDFGYSK  148 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~-----~~v~l~df~~~~  148 (200)
                      ++||++++++|..++... ..++...+..++.|++.||+|||+.|++||||+|+||+++.++.     ..++++|||.+.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            999999999998888654 46899999999999999999999999999999999999975442     138999999875


Q ss_pred             ccCCCCCCCcccCCCCccCCeeec-CcccCCeeehhhhhhhhhhcC-CCCCCC
Q 029037          149 SSVLHSRPKSTVGTPAYIAPEVLS-RREYDGKVCILLLILFLWRNY-RPNPFI  199 (200)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slg~~l~~~~-~~~~pf  199 (200)
                      ...   ......++..|+|||.+. +..++.++|+||||+++|+|+ +|.+||
T Consensus       161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  210 (262)
T cd05077         161 TVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL  210 (262)
T ss_pred             ccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            432   122345678899999986 467888999999999999996 677775

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2e-38  Score=235.09  Aligned_cols=196  Identities=28%  Similarity=0.431  Sum_probs=162.0

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecC-------
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP-------   70 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------   70 (200)
                      +++|++.+.||+|++|.||++.+..+++.+++|.+.....   ......+|+.+++.++|||++++++.+.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999999999999998865322   234678899999999999999999887543       


Q ss_pred             -ceEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           71 -THLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        71 -~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                       ..++++++++.+ ++.+.+... ..++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccch
Confidence             347999999865 677766543 46999999999999999999999999999999999999987664  9999999886


Q ss_pred             ccCCCCCCC------------cccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          149 SSVLHSRPK------------STVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       149 ~~~~~~~~~------------~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .........            ...+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~  227 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL  227 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence            433222111            11356779999987654 5788999999999999999999886

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.3e-38  Score=226.57  Aligned_cols=190  Identities=24%  Similarity=0.322  Sum_probs=154.3

Q ss_pred             ccccCCcceEEEEEEEcC---CCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEe-cCceEEEEEEecC
Q 029037            8 KDLGAGNFGVARLLRHKE---TKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVL-TPTHLAIVMEYAA   81 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~---~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~~~   81 (200)
                      +.||+|++|.||++.+..   ....+++|.+....  ...+.+.+|...++.++|||++++++.+. .+...+++||++.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998653   34579999885432  23457888999999999999999999765 4556899999999


Q ss_pred             CCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-----
Q 029037           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-----  155 (200)
Q Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-----  155 (200)
                      +++|.+++.+.. ..+......++.|++.||++||+.+++|+||+|+||++++++.  ++|+|||++........     
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence            999999997643 4677788999999999999999999999999999999986654  99999999864322111     


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCC-CCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPN-PFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~-~pf  199 (200)
                      .....++..|+|||.+.+..++.++|+||||+++|||++|. +||
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  203 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY  203 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence            11223456899999998888999999999999999999964 444

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-38  Score=235.58  Aligned_cols=192  Identities=27%  Similarity=0.396  Sum_probs=164.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc------e
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT------H   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~   72 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+....   ...+.+.+|+.+++.++||||+++.+++..+.      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            57999999999999999999999999999999986532   22356789999999999999999999987653      3


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ++++|+++ +++|.+++. ..+++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+.....
T Consensus        95 ~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~  170 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQTDS  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccccccccc
Confidence            68999998 678887774 457899999999999999999999999999999999999986654  99999999864332


Q ss_pred             CCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        ......+++.|+|||.+.+ ..++.++|+||||+++|++++|.+||
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  216 (343)
T cd07880         171 --EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF  216 (343)
T ss_pred             --CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence              2233456788999999875 35788899999999999999999997

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-38  Score=230.42  Aligned_cols=193  Identities=32%  Similarity=0.452  Sum_probs=167.2

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      |++.+.||.|++|.||++.+..+++.+++|.+.....   ....+.+|+..++.++|++++++++.+.++...++++|++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            6788999999999999999998999999998876432   2467888999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCc
Q 029037           81 AGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKS  158 (200)
Q Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~  158 (200)
                      ++ ++.+.+... ..++...+..++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||.+....... ....
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG--VLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC--cEEEeeeeeeEecCCCcccccC
Confidence            75 888877664 5789999999999999999999999999999999999998665  49999999886544333 2223


Q ss_pred             ccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++..|+|||.+.+. .++.++|+||+|+++|++++|.+||
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~  199 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF  199 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            4567789999998876 7889999999999999999999886

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.5e-38  Score=229.79  Aligned_cols=195  Identities=29%  Similarity=0.469  Sum_probs=167.0

Q ss_pred             cccccccccCCcceEEEEEEEc---CCCcEEEEEEecccc-----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            3 KYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      +|++.+.||+|++|.||++.+.   .+++.+++|.+.+..     ...+.+.+|+.++.++ +||+++++.+.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5889999999999999999864   456789999887532     2235678899999999 599999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +++||++++++|.+++.+...++...+..++.|++.+|.+||+.|++|+||+|+||+++.++  .++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECccccccccc
Confidence            99999999999999998877899999999999999999999999999999999999998665  4999999988654333


Q ss_pred             CC--CCcccCCCCccCCeeecCcc--cCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SR--PKSTVGTPAYIAPEVLSRRE--YDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~--~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..  .....++..|++||.+.+..  ++.++|+||+|+++|+|++|.+||
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~  208 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF  208 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCc
Confidence            22  12235788999999987654  778899999999999999999987

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=212.79  Aligned_cols=193  Identities=23%  Similarity=0.303  Sum_probs=165.1

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEec
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ..-.+.||+|++|.|-+.++..+|...|+|.+...  ....+++.+|+++..+. .+|+++.+++...++...++.||.+
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            34567899999999999999999999999999753  44556788888887665 6999999999999999999999999


Q ss_pred             CCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           81 AGGELFDRI----CNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        81 ~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      + .||..+-    .+.+.+++..+-.++..+..||.+||+ ..++|||+||+||+++.++.  ||+||||.+-....+..
T Consensus       128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDSIA  204 (282)
T ss_pred             h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhhhH
Confidence            5 4775444    345679999999999999999999995 58999999999999987664  99999999876655555


Q ss_pred             CCcccCCCCccCCeeecC----cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSR----REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....|...|+|||.+..    ..|+.++||||||+.+.||.++..||
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY  252 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY  252 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence            555678899999999863    36899999999999999999999987

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.6e-37  Score=228.67  Aligned_cols=191  Identities=31%  Similarity=0.461  Sum_probs=162.8

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      |...+.||+|++|.||++.+..+++.+++|.+.....    ..+.+.+|+..++.++|||++++.+++.+....+++||+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            5566789999999999999999999999999875322    224678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      +.+ ++.+.+.. ..+++..++..++.|++.++.+||+.|++|+||+|+||++++++.  ++|+|||.+....   ....
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---~~~~  176 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---PANS  176 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---CCCC
Confidence            964 77777754 346899999999999999999999999999999999999986654  9999999875322   2234


Q ss_pred             ccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..++..|+|||.+.   ...++.++|+||+|+++|+|++|.+||+
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~  221 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  221 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            46788899999984   3567888999999999999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=229.23  Aligned_cols=193  Identities=34%  Similarity=0.497  Sum_probs=168.1

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      |+..+.||+|++|.||++.+..+++.+++|.+...   ....+.+.+|+..++.++|++++++.+++.+....++++|++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            67889999999999999999999999999999864   233467788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCc
Q 029037           81 AGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKS  158 (200)
Q Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~  158 (200)
                      + ++|.+++.+. ..++...+..++.|++.+|++||+.|++|+||+|+||++++++  .++|+|||.+........ ...
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC--CEEEecCCcccccCCCccccCc
Confidence            7 5899999776 5799999999999999999999999999999999999998755  499999998865433322 222


Q ss_pred             ccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...+..|+|||.+.+. .++.++|+||||++++++++|.+||
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~  199 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF  199 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC
Confidence            3456789999998766 7889999999999999999999887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.3e-38  Score=223.56  Aligned_cols=180  Identities=18%  Similarity=0.228  Sum_probs=154.6

Q ss_pred             CcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCchHHHHHhc
Q 029037           13 GNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA   92 (200)
Q Consensus        13 g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~   92 (200)
                      |.+|.||++.+..+++.+++|.+....    ...+|...+....|||++++++++.+....+++||+++|++|.+++.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            889999999999999999999987643    2233445555567999999999999999999999999999999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeec
Q 029037           93 GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS  172 (200)
Q Consensus        93 ~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~  172 (200)
                      .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++++|||.+.....  .......+..|+|||...
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~--~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVED--SCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhcccc--ccccCCcCccccCCcccC
Confidence            78999999999999999999999999999999999999986664  99999997653322  222334567799999998


Q ss_pred             CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          173 RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       173 ~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +..+++++|+||+|+++|+|++|.+||+
T Consensus       156 ~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         156 ISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence            8888999999999999999999998763

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=224.06  Aligned_cols=188  Identities=36%  Similarity=0.585  Sum_probs=166.6

Q ss_pred             ccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037           10 LGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus        10 l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      ||.|++|.||++.+..+++.+++|.+.....    ..+.+.+|+.+++.++||+++++++.+.++...+++||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999998899999999876432    235788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcccCCCC
Q 029037           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPA  164 (200)
Q Consensus        86 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~~~~~~  164 (200)
                      .+++.....+++.....++.|++.++.+||+.+++|+||+|+||++++++.  ++|+|||.+....... ......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence            999988878999999999999999999999999999999999999987664  9999999886543332 2333457888


Q ss_pred             ccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          165 YIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       165 ~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      |+|||...+..++.++|+||||+++|++++|..||
T Consensus       159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~  193 (250)
T cd05123         159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF  193 (250)
T ss_pred             ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            99999998888899999999999999999999987

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.6e-37  Score=226.37  Aligned_cols=194  Identities=23%  Similarity=0.309  Sum_probs=158.7

Q ss_pred             ccccccccCCcceEEEEEEEc---CCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc------
Q 029037            4 YELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT------   71 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   71 (200)
                      |++.+.||+|++|.||++...   .+++.+++|.+....   ...+.+.+|+..++.++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999864   357889999887542   23456888999999999999999999886532      


Q ss_pred             eEEEEEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecC
Q 029037           72 HLAIVMEYAAGGELFDRICNA------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~  145 (200)
                      ..+++++++.+++|.+++...      ..++......++.|++.||++||+.|++|+||+|+||+++++.  .++|+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~--~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM--TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC--CEEECccc
Confidence            247889999999998877432      1478889999999999999999999999999999999997655  49999999


Q ss_pred             CCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          146 YSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       146 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++........   .....++..|++||.+.+..++.++|+||||+++|++++ |.+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~  216 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY  216 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCC
Confidence            9875432221   112234567999999988889999999999999999999 77776

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.3e-37  Score=232.87  Aligned_cols=194  Identities=28%  Similarity=0.434  Sum_probs=162.7

Q ss_pred             cccccccccCCcceEEEEEEEcCC--CcEEEEEEecccc---cchHHHHHHHHHHhhC-CCCCeeeEEEEEecC----ce
Q 029037            3 KYELVKDLGAGNFGVARLLRHKET--KELVAVKYIERGR---KIDENVAREIINHRSL-RHPNIIRFKEVVLTP----TH   72 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~--~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----~~   72 (200)
                      +|++.+.||+|++|.||++.+..+  ++.+|+|.+....   ...+.+.+|+.+++.+ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999888  8899999887532   2245678899999988 599999999875432    45


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .++++++++ ++|.+.+.....++...++.++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+.....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence            788889885 689999988788999999999999999999999999999999999999987664  99999999864432


Q ss_pred             CCC-----CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSR-----PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...     .....++..|+|||.+.+ ..++.++|+||+|+++|++++|.+||
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf  210 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF  210 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC
Confidence            221     122357888999998765 46889999999999999999999887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.5e-38  Score=234.89  Aligned_cols=195  Identities=28%  Similarity=0.385  Sum_probs=162.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecC----------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTP----------   70 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----------   70 (200)
                      ++|.+.+.||.|++|.||++.+..+++.|++|.+..... ..+.+.+|+.+++.++|||++++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            589999999999999999999999999999998876443 346688999999999999999998776543          


Q ss_pred             ----ceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           71 ----THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        71 ----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                          ...+++||+++ ++|.+++. ..+++...++.++.|++.||.+||+.|++||||+|+||+++.++. .++|+|||.
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg~  161 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGL  161 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCccc
Confidence                35789999996 58888774 446899999999999999999999999999999999999975443 589999999


Q ss_pred             CcccCCCCCC----CcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          147 SKSSVLHSRP----KSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       147 ~~~~~~~~~~----~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +.........    ....++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf  219 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF  219 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence            8643222111    12246778999998654 56788999999999999999999998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2e-37  Score=229.56  Aligned_cols=192  Identities=29%  Similarity=0.439  Sum_probs=163.6

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      .|...+.||+|++|.||++.+..+++.+++|.+....    ...+++.+|+.+++.++|+|++++.+++......+++||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            5778899999999999999999999999999886431    123467789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ++. +++.+.+.. ..+++..++..++.|++.|+.+||+.+++|+||+|+||++++++  .++|+|||.+.....   ..
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~---~~  169 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---AN  169 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeecC---cc
Confidence            996 577776644 44689999999999999999999999999999999999998655  499999998764322   22


Q ss_pred             cccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...++..|+|||.+.   ...++.++|+||||+++|++++|.+||+
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  215 (308)
T cd06634         170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (308)
T ss_pred             cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence            345778899999974   3467889999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-37  Score=231.40  Aligned_cols=192  Identities=21%  Similarity=0.255  Sum_probs=158.8

Q ss_pred             ccccccCC--cceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            6 LVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         6 ~~~~l~~g--~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +.+.||.|  ++|+||.+.+..+++.||+|+.......   .+.+.+|+.+++.++||||+++++++..+...++++|++
T Consensus         2 ~~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             hHHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            34567777  8899999999999999999998754322   356788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--
Q 029037           81 AGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--  156 (200)
Q Consensus        81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--  156 (200)
                      .+++|.+++.+..  .++...+..++.|++.||++||+.|++||||+|+||++++++  .++++||+.+.........  
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~--~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC--cEEEechHHHhhhhccCcccc
Confidence            9999999887643  488999999999999999999999999999999999998665  4999999754321111111  


Q ss_pred             ------CcccCCCCccCCeeecCc--ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 ------KSTVGTPAYIAPEVLSRR--EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ------~~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                            ....++..|+|||.+.+.  .++.++|+||+|+++|+|++|.+||
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  210 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF  210 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                  111245669999999764  4788999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=241.89  Aligned_cols=190  Identities=31%  Similarity=0.459  Sum_probs=164.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHh-hCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR-SLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +.|++...+|.|+++.|-.+.+..+++..++|++.+..   ....+|...+. .-+|||+++..+.+.++...++|||.+
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            57889999999999999999999999999999998762   22334554444 447999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec-CCCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-GSAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~-~~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      .|+-+.+.+.....+. .++..|+++|+.|+.+||++|++||||+|+||+++ +.+  .++|+|||.++..+..  ....
T Consensus       399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g--~lrltyFG~a~~~~~~--~~tp  473 (612)
T KOG0603|consen  399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG--HLRLTYFGFWSELERS--CDTP  473 (612)
T ss_pred             cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC--cEEEEEechhhhCchh--hccc
Confidence            9998888887776666 88888999999999999999999999999999995 333  5999999998755444  3344


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +-|..|+|||.....+|++++|+||||++||+|++|..||
T Consensus       474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~  513 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLF  513 (612)
T ss_pred             chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcc
Confidence            6788999999999999999999999999999999999997

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.2e-37  Score=223.18  Aligned_cols=190  Identities=21%  Similarity=0.276  Sum_probs=151.8

Q ss_pred             ccccCCcceEEEEEEEcCC--CcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            8 KDLGAGNFGVARLLRHKET--KELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~--~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      +.||+|++|.||++.....  ...+++|.+....  ...+.+.+|...++.++|||++++++.+.+....+++||+++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            4699999999999975433  3346677665432  23467889999999999999999999999999999999999999


Q ss_pred             chHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC---CCC
Q 029037           84 ELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SRP  156 (200)
Q Consensus        84 ~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~---~~~  156 (200)
                      +|.+++.+..    ..+...+..++.|++.||++||+.+++|+||+|+||+++.++  .++|+|||++......   ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL--TVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc--cEEecccccccccCcchhhhcc
Confidence            9999997542    356677889999999999999999999999999999997665  4999999987532211   112


Q ss_pred             CcccCCCCccCCeeecC-------cccCCeeehhhhhhhhhhcCCC-CCCC
Q 029037          157 KSTVGTPAYIAPEVLSR-------REYDGKVCILLLILFLWRNYRP-NPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slg~~l~~~~~~-~~pf  199 (200)
                      ....++..|+|||.+..       ..++.++|+||+|+++|||+++ .+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  209 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY  209 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence            23456788999999753       2457789999999999999864 5555

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=227.24  Aligned_cols=195  Identities=29%  Similarity=0.392  Sum_probs=170.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCC--C----CeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH--P----NIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~--~----~i~~~~~~~~~~~~~~~   75 (200)
                      ++|.++..+|+|.||.|-.+.+..++..||+|+++.-.+..+...-|++.+.++++  |    -++++.++|...++.|+
T Consensus        89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi  168 (415)
T KOG0671|consen   89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI  168 (415)
T ss_pred             cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence            68999999999999999999999999999999999888888889999999999842  2    36677888988999999


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC------------------
Q 029037           76 VMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA------------------  135 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~------------------  135 (200)
                      |+|.+ |.|+.+++.+++  +++...+..+++|++.++++||+.+++|.||||+||++-++.                  
T Consensus       169 vfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k  247 (415)
T KOG0671|consen  169 VFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK  247 (415)
T ss_pred             EEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence            99998 779999998765  699999999999999999999999999999999999983211                  


Q ss_pred             CCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +..|+|+|||.|.......  ...+.|..|.|||++.+-.++.++||||+||+|+|+++|...|
T Consensus       248 s~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  248 STAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             CcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence            2358999999986433222  4446788999999999999999999999999999999999877

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-40  Score=225.24  Aligned_cols=193  Identities=25%  Similarity=0.333  Sum_probs=163.0

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEec
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      .+-+..||.|+||+|++..++.+++.+|+|.+...  +++.+++..|.+...+- ++|||+++++.+..++..|+.||++
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            44567899999999999999999999999999864  34566788888766554 7999999999999999999999999


Q ss_pred             CCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           81 AGGELFDRIC-----NAGRFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      + .||..+..     +...++++-.-.+.-..+.||.||- +..|+|||+||+||+++..+.  |||||||++.....+.
T Consensus       146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLVDSI  222 (361)
T ss_pred             h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHHHHH
Confidence            4 46644332     2346888888889999999999997 569999999999999986665  9999999987666556


Q ss_pred             CCCcccCCCCccCCeeecCc--ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRR--EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......|...|+|||.+...  .|+.++|+||||+.|||+.||+.|+
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPy  269 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPY  269 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCc
Confidence            66666788999999999743  4899999999999999999999998

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.5e-37  Score=225.09  Aligned_cols=194  Identities=30%  Similarity=0.453  Sum_probs=163.6

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG------RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +|.+.+.||+|++|.||++.+..++..+++|..+..      ......+.+|..+++.++|||++++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            689999999999999999999877766666666532      12233566788999999999999999999998999999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      +|++++++|.+.+.+    ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++++   .++|+|||.+.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence            999999999888754    3458999999999999999999999999999999999999642   499999998864433


Q ss_pred             CCC-CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSR-PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ... .....++..|+|||...+..++.++|+||+|++++++++|..||
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~  205 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF  205 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            222 22345778899999998888889999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-37  Score=231.37  Aligned_cols=191  Identities=29%  Similarity=0.418  Sum_probs=161.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC------ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   72 (200)
                      ++|.+.+.||+|++|.||++.+..+++.+++|.+....   .....+.+|+.+++.++|||++++.+++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            58999999999999999999999999999999987532   2235678999999999999999999988754      34


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      +++++|++.. +|.+..  ...++...+..++.|++.||++||+.|++||||+|+||+++.++  .++|+|||++.....
T Consensus        95 ~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~dfg~~~~~~~  169 (342)
T cd07879          95 FYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHADA  169 (342)
T ss_pred             EEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCCCCcCCCC
Confidence            6999999854 676654  34689999999999999999999999999999999999998765  499999999864322


Q ss_pred             CCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf  215 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF  215 (342)
T ss_pred             --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCC
Confidence              2233456788999999876 46888999999999999999999998

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=230.55  Aligned_cols=198  Identities=26%  Similarity=0.362  Sum_probs=169.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchH--------HHHHHHHHHhhCCCCCeeeEEEEEe-cCce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--------NVAREIINHRSLRHPNIIRFKEVVL-TPTH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~--------~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~   72 (200)
                      ++|.++..||+|||+.||++.|....+.||+|+...+..+.+        ..-+|.++.+.|.||.|++++++|. +...
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            579999999999999999999999899999999876654442        3567899999999999999999997 4567


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CcEeecCCCCCeeecCC-CCCCEEEeecCCCcc
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM--QICHRDLKLENTLLDGS-AAPRLKICDFGYSKS  149 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--~i~h~dl~~~ni~i~~~-~~~~v~l~df~~~~~  149 (200)
                      +|-|.|||+|.+|.-++..+.-+++.++..|+.||+.||.||.+.  .|+|-||+|.||++-++ ..+.|||+|||+++.
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            899999999999999998888899999999999999999999965  69999999999998533 345799999999975


Q ss_pred             cCCCCCC--------CcccCCCCccCCeeecC----cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          150 SVLHSRP--------KSTVGTPAYIAPEVLSR----REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       150 ~~~~~~~--------~~~~~~~~~~aPE~~~~----~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .......        ....||..|++||.+--    .+.+.++||||+|+++|+.+-|..||
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF  684 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF  684 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence            4433322        23468999999999853    35688899999999999999999998

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=245.40  Aligned_cols=195  Identities=31%  Similarity=0.431  Sum_probs=173.0

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG-RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      -|.|+..||.|+||+||++.++.++-..|.|++... ....+++.-|+.+|..++||+|+++++.|..++.++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            367888999999999999999999988889988754 3445789999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc-ccCCCCCCCcc
Q 029037           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRPKST  159 (200)
Q Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~-~~~~~~~~~~~  159 (200)
                      ||.....+-.-+ .+.+.++..+.+|++.||.|||+.+|+||||+..||++.-++.  |+|+|||.+. .........++
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDsF  190 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDSF  190 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhccc
Confidence            998888776665 5999999999999999999999999999999999999987765  9999999974 33444556678


Q ss_pred             cCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .|||-|+|||+..     .++|+.++||||||+.|.||..+.||.
T Consensus       191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH  235 (1187)
T KOG0579|consen  191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH  235 (1187)
T ss_pred             cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc
Confidence            8999999999973     557999999999999999999999984

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.1e-37  Score=227.94  Aligned_cols=184  Identities=27%  Similarity=0.399  Sum_probs=154.0

Q ss_pred             cceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCchHHHHH
Q 029037           14 NFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC   90 (200)
Q Consensus        14 ~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~   90 (200)
                      +.+.||.+.+..+++.+|+|.+...   ....+.+.+|+..++.++|+||+++++++.++...+++||++++++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4456677777778999999998764   2334578999999999999999999999999999999999999999999997


Q ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--------CCccc
Q 029037           91 NA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--------PKSTV  160 (200)
Q Consensus        91 ~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--------~~~~~  160 (200)
                      +.  ..+++..+..++.|++.||++||+.+++|+||+|+||++++++.  ++|+||+.+........        .....
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~  169 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV  169 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence            64  35889999999999999999999999999999999999986654  99999998754332211        11223


Q ss_pred             CCCCccCCeeecC--cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          161 GTPAYIAPEVLSR--REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       161 ~~~~~~aPE~~~~--~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++..|+|||.+.+  ..++.++|+||+|+++++|++|.+||
T Consensus       170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf  210 (314)
T cd08216         170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF  210 (314)
T ss_pred             ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence            5668999999876  35788999999999999999999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.2e-38  Score=252.85  Aligned_cols=193  Identities=32%  Similarity=0.471  Sum_probs=159.5

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEe----------
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVL----------   68 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----------   68 (200)
                      +++|+.++.||+||||.||+++++-.|..||+|++....  .....+.+|+..+++++|||+++++..+.          
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            357899999999999999999999999999999998763  33467899999999999999999865220          


Q ss_pred             --------------------------------------------------------------------c-----------
Q 029037           69 --------------------------------------------------------------------T-----------   69 (200)
Q Consensus        69 --------------------------------------------------------------------~-----------   69 (200)
                                                                                          +           
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                0           


Q ss_pred             ----------------------C--------ceEEEEEEecCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 029037           70 ----------------------P--------THLAIVMEYAAGGELFDRICNAGRF-SEDEGRYFFQQLISGVNYCHSMQ  118 (200)
Q Consensus        70 ----------------------~--------~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~l~~lh~~~  118 (200)
                                            +        ..+|+-||||+..++.+.+..+... .....++++++|+.||+|+|+.|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                  0        1268999999988888877666544 58889999999999999999999


Q ss_pred             cEeecCCCCCeeecCCCCCCEEEeecCCCcccC-------------------CCCCCCcccCCCCccCCeeecCcc---c
Q 029037          119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-------------------LHSRPKSTVGTPAYIAPEVLSRRE---Y  176 (200)
Q Consensus       119 i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~---~  176 (200)
                      ++||||||.||+++++.+  |||+|||+|+...                   ..+...+..||..|+|||.+.+..   |
T Consensus       718 iIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             eeeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999996665  9999999987411                   001122346899999999998654   9


Q ss_pred             CCeeehhhhhhhhhhcCCC
Q 029037          177 DGKVCILLLILFLWRNYRP  195 (200)
Q Consensus       177 ~~~~Di~slg~~l~~~~~~  195 (200)
                      +.++|+||||++++||+..
T Consensus       796 n~KiDmYSLGIVlFEM~yP  814 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLYP  814 (1351)
T ss_pred             cchhhhHHHHHHHHHHhcc
Confidence            9999999999999999754

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-37  Score=233.07  Aligned_cols=192  Identities=24%  Similarity=0.371  Sum_probs=164.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCce------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTH------   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------   72 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....   ...+.+.+|+.+++.++|||++++.+++.....      
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            57999999999999999999999999999999886532   223567789999999999999999887766544      


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .++++|++ +++|.+++.. .+++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+.....
T Consensus        95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~~  170 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTDD  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEccccccccccc
Confidence            89999998 6699888854 57999999999999999999999999999999999999987664  99999999864432


Q ss_pred             CCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .  .....++..|+|||.+.+ ..++.++|+||||+++|++++|.+||
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf  216 (343)
T cd07851         171 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF  216 (343)
T ss_pred             c--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            2  233456788999999865 36788999999999999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=243.74  Aligned_cols=196  Identities=26%  Similarity=0.384  Sum_probs=171.2

Q ss_pred             cccccccccCCcceEEEEEEEcCCC---cEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETK---ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~---~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ..+|.+.||.|.||.|+++..+..+   ..||+|.++...  +...+|+.|..++-++.||||+++.++....+..++++
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3468899999999999999987765   459999998753  44567999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      |||++|+|..++.++. .+...+..-+++.|+.||+||-+.++|||||..+||+++.+-  ..|+.|||+++........
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL--vCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce--EEEeccccceeecccCCCc
Confidence            9999999999997664 699999999999999999999999999999999999997555  4899999999855444422


Q ss_pred             -CcccC---CCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          157 -KSTVG---TPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       157 -~~~~~---~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                       ..+.|   ..+|.|||.+..++++.++||||+|++|||.++ |.-|||
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW  836 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  836 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence             12222   468999999999999999999999999999865 778998

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=203.87  Aligned_cols=195  Identities=28%  Similarity=0.471  Sum_probs=168.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +.+|.-.+.||+|.+|+||++++.++.+.||+|....++   .......+|+-+++.++|.||++++++...++.+-+|+
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            467888999999999999999999999999999987643   33478999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      |+| ..+|..+... ++.+..+.+..++.|++.||.++|++++.|||++|.|.+|+.+++  +|+.|||+++....... 
T Consensus        81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrc  157 (292)
T KOG0662|consen   81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEe
Confidence            999 4577776654 456999999999999999999999999999999999999987765  99999999976554432 


Q ss_pred             CCcccCCCCccCCeeecCcc-cCCeeehhhhhhhhhhcCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRRE-YDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      ......|..|.+|.++.+.+ |+.+.|+||.||++.|+..-.-|
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            23345788999999998764 78888999999999999654433

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=248.35  Aligned_cols=193  Identities=25%  Similarity=0.374  Sum_probs=164.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCc-----EEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKE-----LVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~-----~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +-+..+.||+|.||.||.|.......     .||+|.+.+..  ....+|.+|..+++.++||||+++++++.+....++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            34677899999999999999765332     38999888753  345679999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc------C-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           76 VMEYAAGGELFDRICNA------G-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~------~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      ++|||+||+|.+++.+.      . .++....+.++.+++.|+.||+++++|||||..+|+|++..  ..|||+|||+|+
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~--r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER--RVVKIADFGLAR  850 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc--CcEEEcccchhH
Confidence            99999999999999876      3 48999999999999999999999999999999999999866  469999999998


Q ss_pred             ccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCC
Q 029037          149 SSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNP  197 (200)
Q Consensus       149 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~  197 (200)
                      ......-.   ....-..+|+|||.+..+.++.++||||+|+++||+||...
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~  902 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGA  902 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCC
Confidence            33222111   11234568999999999999999999999999999998663

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=255.20  Aligned_cols=195  Identities=30%  Similarity=0.395  Sum_probs=167.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++.-...||.|.||.||.+.+.++|...|+|-+...+   +..+...+|++++..++|||+++++++-.+....++.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            4556678999999999999999999999999776543   3345688999999999999999999998888889999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-----
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-----  154 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-----  154 (200)
                      |++|+|.+.+.-....++.....+..|++.|++|||++|||||||||.||+++.++  .+|++|||.|.......     
T Consensus      1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g--~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG--LIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC--cEEeecccceeEecCchhcCCH
Confidence            99999999997766667777778889999999999999999999999999998766  49999999996443332     


Q ss_pred             CCCcccCCCCccCCeeecCc---ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRR---EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..+...||+-|||||.+.+.   ....+.|||||||++.||.||+-|.
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPW 1441 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCch
Confidence            12345699999999999764   3456789999999999999999884

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5e-38  Score=221.26  Aligned_cols=198  Identities=28%  Similarity=0.408  Sum_probs=166.0

Q ss_pred             CccccccccccCCcceEEEEEEEcCCC----cEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEec-Cce
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETK----ELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLT-PTH   72 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~----~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   72 (200)
                      +..|++...||+|.+|.||++...++.    +.+|+|.++.+   .......-+|+.+++.++|||++.+..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            357999999999999999999665442    36899988754   2445788999999999999999999998877 788


Q ss_pred             EEEEEEecCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC--CCCCEEEeecC
Q 029037           73 LAIVMEYAAGGELFDRIC-----NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS--AAPRLKICDFG  145 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~--~~~~v~l~df~  145 (200)
                      +++++||.+. +|.+.+.     +...++...++.++.||+.|+.|||++=++||||||.||++..+  ..++|||+|+|
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999999976 8888774     23458999999999999999999999999999999999999644  23679999999


Q ss_pred             CCcccCCCCCCC----cccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          146 YSKSSVLHSRPK----STVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       146 ~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +++.....-.+-    .-..|..|.|||.+.+. .|+++.|+|++||++.||+|-+|.|
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF  240 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF  240 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence            998554433332    22467899999999875 6899999999999999999999987

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-35  Score=208.98  Aligned_cols=194  Identities=40%  Similarity=0.622  Sum_probs=171.5

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      |++.+.||+|++|.||++.+..+++.+++|.+.....  ..+.+.+|+..++.++|++++++++.+......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6788999999999999999998889999999987543  35688899999999999999999999999899999999999


Q ss_pred             CCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC--CCCc
Q 029037           82 GGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKS  158 (200)
Q Consensus        82 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~--~~~~  158 (200)
                      +++|.+++..... ++......++.+++.++.+||+.+++|+|++|.||+++++.  .++|+|||.+.......  ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~--~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG--LVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeCceeeEecCcccccccc
Confidence            9999999987766 89999999999999999999999999999999999998764  59999999987554432  2234


Q ss_pred             ccCCCCccCCeee-cCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVL-SRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~-~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..+...|++||.. ....++.++|+|++|++++++++|.+||
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf  200 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF  200 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence            4577889999998 6667788999999999999999999998

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.8e-36  Score=249.52  Aligned_cols=185  Identities=19%  Similarity=0.227  Sum_probs=156.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      .+...+.||+|++|.||++.+..+++.||+|.+......   ..+|+..+++++||||+++++++.+....++||||+++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            455667899999999999999888999999988754322   23458889999999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCH---SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      ++|.+++..   +++.++..++.|++.||+|||   +.+++|||++|+||+++.+..  .++. ++.+....   .....
T Consensus       768 g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~  838 (968)
T PLN00113        768 KNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKC  838 (968)
T ss_pred             CcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCc
Confidence            999999954   789999999999999999999   679999999999999987665  4443 44332111   11223


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .+++.|+|||.+.+..++.++||||+|+++|||+||++||
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~  878 (968)
T PLN00113        839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA  878 (968)
T ss_pred             cccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence            5788999999999999999999999999999999999997

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=229.36  Aligned_cols=189  Identities=25%  Similarity=0.390  Sum_probs=163.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ...+++.||+|-||.|-.++-.. +..||+|.++....  ...+|.+|+++|.+++||||+.++++|..++.+++++||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            45788999999999999998765 57799999986533  3468999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC-
Q 029037           81 AGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-  157 (200)
Q Consensus        81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~-  157 (200)
                      +.|+|.+++.++.  ........+++.||++||+||.+.++|||||.+.|++++.+.  ++||+|||.++..-.+.-.. 
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~--~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF--TIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc--cEEecCcccccccccCCceee
Confidence            9999999998874  346677888999999999999999999999999999997665  49999999987444333221 


Q ss_pred             --cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC
Q 029037          158 --STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR  194 (200)
Q Consensus       158 --~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~  194 (200)
                        ...-..+|+|||.+..++++.++|+|++|+.+||+++
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~  734 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFM  734 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHH
Confidence              2245689999999999999999999999999999854

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=6.4e-37  Score=228.32  Aligned_cols=195  Identities=23%  Similarity=0.297  Sum_probs=172.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCC------CCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH------PNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|.+....|+|-|++|.+|.+...+..||+|++.+++..-+.-+.|+.+|++|+.      .|.++++..|...+++|+
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            47999999999999999999999999999999999987777888999999999953      488899999999999999


Q ss_pred             EEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           76 VMEYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      |+|-+ ..+|.+.+.+.+.   +....+..++.|++.||..|-++|++|.||+|+||+++.+.+ .+||||||.|... .
T Consensus       512 VFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~-~  588 (752)
T KOG0670|consen  512 VFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFA-S  588 (752)
T ss_pred             Eehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCcccccc-c
Confidence            99988 5599999988763   788899999999999999999999999999999999987665 7999999988633 2


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .........+-.|.|||++.+-.|+...|+||+||+|||++||+.+|
T Consensus       589 eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF  635 (752)
T KOG0670|consen  589 ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF  635 (752)
T ss_pred             cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence            23333445677899999999999999999999999999999999877

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-35  Score=227.34  Aligned_cols=196  Identities=28%  Similarity=0.472  Sum_probs=173.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEec-----CceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLT-----PTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-----~~~~~~   75 (200)
                      +-|++.+.||.|-+|.||++.+..+++..|+|+.......+++.+.|.++++.. .|||++.+++++.-     ++.+|+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            357899999999999999999999999999999998888889999999999988 59999999999864     346999


Q ss_pred             EEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc-cCC
Q 029037           76 VMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVL  152 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~-~~~  152 (200)
                      |||+|.|||..+++.+.  .++.++.+..|.+.++.|+.+||+..++|||++=.||+++.++.  |||+|||.+.. ...
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST  176 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc
Confidence            99999999999998654  46899999999999999999999999999999999999987665  99999999853 344


Q ss_pred             CCCCCcccCCCCccCCeeecCc-----ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRR-----EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........||+.|+|||++...     .|+.++|+||||++..||-.|.||+
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl  228 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPL  228 (953)
T ss_pred             cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCc
Confidence            4555667899999999999633     4678889999999999999999997

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-36  Score=219.70  Aligned_cols=189  Identities=26%  Similarity=0.360  Sum_probs=154.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHh--hCCCCCeeeEEEEEecCc----eEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR--SLRHPNIIRFKEVVLTPT----HLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~~----~~~~   75 (200)
                      ....+.+.+|+|+||.||+|...  ++.||+|+++...  .+.+.+|-++.+  .++|+||+++++.-+...    .+++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            45677899999999999999987  4789999998743  455666665555  558999999998876655    7999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS---------MQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~---------~~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                      |++|.+.|+|.+++ +...+++....+++..++.||+|||+         ..|+|||||.+||++.+|.+  ..|+|||+
T Consensus       286 Vt~fh~kGsL~dyL-~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGL  362 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYL-KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGL  362 (534)
T ss_pred             EeeeccCCcHHHHH-HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccce
Confidence            99999999999999 44568999999999999999999995         35999999999999988775  89999999


Q ss_pred             CcccCCCCCC---CcccCCCCccCCeeecCcc-cC-----CeeehhhhhhhhhhcCCCCC
Q 029037          147 SKSSVLHSRP---KSTVGTPAYIAPEVLSRRE-YD-----GKVCILLLILFLWRNYRPNP  197 (200)
Q Consensus       147 ~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~-~~-----~~~Di~slg~~l~~~~~~~~  197 (200)
                      |-........   -...||.+|||||++.+.- ..     .+.||||+|.++||++++-.
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~  422 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT  422 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            9655433332   2346999999999997652 22     34599999999999987653

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=227.94  Aligned_cols=196  Identities=28%  Similarity=0.403  Sum_probs=169.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-C--cEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-K--ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-~--~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++.++.+.||+|+||.|+++.+... |  ..||+|.+..+..  ..++|.+|...+.+|+|+|+++++++..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            3456789999999999999998653 2  3599999987543  45789999999999999999999999988 778999


Q ss_pred             EEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           77 MEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +|+++.|+|.+.+.+..  .+-......++.||+.||.||..++.|||||...|+++....  .|||+|||+.+....+.
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--tVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--TVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc--eeeeecccceeccCCCC
Confidence            99999999999998733  488899999999999999999999999999999999997543  59999999998776665


Q ss_pred             CCCccc----CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTV----GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~----~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ......    -...|+|||.++.+.++.++|+|++|+.+|||||+.--.|
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW  316 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW  316 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence            554322    3457999999999999999999999999999999887766

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.5e-34  Score=205.54  Aligned_cols=184  Identities=40%  Similarity=0.634  Sum_probs=164.4

Q ss_pred             cceEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCchHHHHHh
Q 029037           14 NFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN   91 (200)
Q Consensus        14 ~~g~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~   91 (200)
                      ++|.||++.+..+++.+++|++......  .+.+.+|+..+++++|++++++.+.+......++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            5799999999988999999999865433  47899999999999999999999999998999999999999999999987


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeee
Q 029037           92 AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL  171 (200)
Q Consensus        92 ~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~  171 (200)
                      ...++...+..++.+++.++.+||+.+++|+||+|+||++++++  .++|+|||.+.............++..|++||..
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            76689999999999999999999999999999999999998765  5999999998765544444555678899999999


Q ss_pred             cCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          172 SRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       172 ~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .+..++.++|+||+|++++++++|.+||
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~  186 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPF  186 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            8888899999999999999999999887

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=212.22  Aligned_cols=129  Identities=26%  Similarity=0.418  Sum_probs=117.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC--------CCCeeeEEEEEecC---
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR--------HPNIIRFKEVVLTP---   70 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~~~---   70 (200)
                      .+|.+.++||.|.|++||++.|.++.+.||+|+.+......+....|+++|++++        ..+|+++++.|...   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            4899999999999999999999999999999999988788889999999999883        24799999999754   


Q ss_pred             -ceEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCCeee
Q 029037           71 -THLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLENTLL  131 (200)
Q Consensus        71 -~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~ni~i  131 (200)
                       .++|+|+|++ |.+|..++....  .++...++.|++|++.||.||| ++||+|.||||+||++
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence             5799999999 889999997654  5999999999999999999999 6799999999999998

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=213.15  Aligned_cols=193  Identities=27%  Similarity=0.397  Sum_probs=160.4

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc-----eEEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT-----HLAI   75 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~   75 (200)
                      .+..+.||.|+||.||.+.|+..++.|++|.+.+-.   ...+.+.+|++++...+|.|++..++..+..+     ..|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            355689999999999999999999999999887632   33478999999999999999999888877653     2577


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ++|.+. .+|...+-....++...++-+++||+.||+|||+.+|.||||||.|.+++++.  .+||||||+++.......
T Consensus       135 ~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC--vLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC--ILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc--eEEecccccccccchhhh
Confidence            888874 37777776667799999999999999999999999999999999999997554  599999999974433333


Q ss_pred             CCc--ccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKS--TVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~--~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...  ...|.-|.|||++.+. .|+.+.||||+||++.|++.++..|
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF  258 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF  258 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh
Confidence            222  2357789999999864 6999999999999999999887665

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-35  Score=201.89  Aligned_cols=195  Identities=27%  Similarity=0.378  Sum_probs=160.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEE-EEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKE-VVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~-~~~~~~~~~~v~e~   79 (200)
                      +.|.|.+.+|.|.||.+-++.++.+...+++|.++.+-....+|.+|...--.| .|.||+.-++ .|+..+.+++++|+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            579999999999999999999999999999999999877888999998766555 5899988665 46677889999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      ++.|+|.+-+.. ..+.+.....++.|+++|+.+||+.++||||||.+||+|-+..-.+|||||||.+.....  .-.-.
T Consensus       104 aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--tV~~~  180 (378)
T KOG1345|consen  104 APRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--TVKYL  180 (378)
T ss_pred             CccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--eehhh
Confidence            999999887744 347888999999999999999999999999999999999544445899999998753211  11111


Q ss_pred             cCCCCccCCeeecC-----cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSR-----REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~-----~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      -....|.+||...-     -...+.+|+|.+|+++|.++||++|.
T Consensus       181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW  225 (378)
T KOG1345|consen  181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW  225 (378)
T ss_pred             hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence            23456888988642     24577889999999999999999884

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-36  Score=209.14  Aligned_cols=195  Identities=28%  Similarity=0.403  Sum_probs=164.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecC--------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTP--------   70 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------   70 (200)
                      +.|+-...||+|.||.||+++..++++.|++|+.--+   ........+|+++|..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4677888999999999999999999999998866432   23346788999999999999999998887542        


Q ss_pred             ceEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           71 THLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        71 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      ..+++|+++|+. +|...+.+. .+++..++..++.++++||.|+|+..|+|||+||.|++|+.++.  ++|+|||+++.
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~  173 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARA  173 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccc
Confidence            348999999976 888888765 47999999999999999999999999999999999999986664  99999999965


Q ss_pred             cCCCCCCC-----cccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          150 SVLHSRPK-----STVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       150 ~~~~~~~~-----~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........     ....|..|.+||.+.+ ++|+++.|+|..||++.||.|+.|.|
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim  229 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM  229 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence            44333321     2235788999999986 47999999999999999999999865

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9.2e-34  Score=223.40  Aligned_cols=194  Identities=21%  Similarity=0.202  Sum_probs=137.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCC----CcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEE------EecC
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKET----KELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEV------VLTP   70 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~----~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~~~~   70 (200)
                      .++|.+.+.||+|+||.||++.+..+    +..+|+|.+...... +....+  .++...+.++..+...      ....
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence            36899999999999999999999988    889999987653221 111111  1111111222111111      2345


Q ss_pred             ceEEEEEEecCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCee
Q 029037           71 THLAIVMEYAAGGELFDRICNAGR--------------------FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (200)
Q Consensus        71 ~~~~~v~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~  130 (200)
                      ...++++||+++++|.+++.....                    .....+..++.|++.||.|||+.||+||||||+||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            678999999999999998865421                    112345679999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCC--CCCCcccCCCCccCCeeecCcc----------------------cCCeeehhhhh
Q 029037          131 LDGSAAPRLKICDFGYSKSSVLH--SRPKSTVGTPAYIAPEVLSRRE----------------------YDGKVCILLLI  186 (200)
Q Consensus       131 i~~~~~~~v~l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~----------------------~~~~~Di~slg  186 (200)
                      ++++. ..+||+|||+++.....  .......+++.|+|||.+....                      ++.++||||+|
T Consensus       288 l~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        288 FSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            97533 25999999999744322  2233456889999999764221                      23456999999


Q ss_pred             hhhhhcCCCCCC
Q 029037          187 LFLWRNYRPNPF  198 (200)
Q Consensus       187 ~~l~~~~~~~~p  198 (200)
                      |++|||+++..+
T Consensus       367 viL~el~~~~~~  378 (566)
T PLN03225        367 LIFLQMAFPNLR  378 (566)
T ss_pred             HHHHHHHhCcCC
Confidence            999999986544

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=7.3e-35  Score=197.58  Aligned_cols=194  Identities=24%  Similarity=0.409  Sum_probs=167.0

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEecC--ceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTP--THLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~v~   77 (200)
                      .++|++.+.+|.|.++.||.+.+..+.+.+++|+++.  -..+.+.+|+.+|+.+. +|||+++++...+.  ....+++
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            3689999999999999999999998888999999875  23567899999999997 99999999999875  4578999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      |++.+.+.....   +.++...+...+.+++.||.|+|+.||.|||++|.|++|+.... .++|+|+|+|....++..-.
T Consensus       115 E~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eYn  190 (338)
T KOG0668|consen  115 EYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYN  190 (338)
T ss_pred             hhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCceee
Confidence            999886555444   34788899999999999999999999999999999999986655 69999999998776666666


Q ss_pred             cccCCCCccCCeeec-CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLS-RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~-~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+.-|--||.+- -+.|+.+-|+|||||++..|+-.+-||+
T Consensus       191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF  234 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  234 (338)
T ss_pred             eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence            666677778899986 4568888999999999999988888875

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=216.92  Aligned_cols=192  Identities=23%  Similarity=0.305  Sum_probs=161.7

Q ss_pred             cccccccCCcceEEEEEEEcCC----CcEEEEEEeccc--ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            5 ELVKDLGAGNFGVARLLRHKET----KELVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~----~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++.+.||.|-||.||++.....    .--||+|..+.+  ....+.|..|..+++.++||||++++|++.+ ...++|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            4568899999999999996543    234899999874  2335789999999999999999999999976 56899999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      .++-|.|..+++.++ .++.....-+++|++.||+|||+...|||||..+||++.+..  -|||+|||+++......--.
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~--CVKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ--CVKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc--eeeecccchhhhccccchhh
Confidence            999999999998776 588899999999999999999999999999999999997544  49999999998655444333


Q ss_pred             ccc--CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCC-CCCC
Q 029037          158 STV--GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRP-NPFI  199 (200)
Q Consensus       158 ~~~--~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~-~~pf  199 (200)
                      ...  -...|+|||.+.-++++.++|||.+|++|||+++- -.||
T Consensus       549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPf  593 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPF  593 (974)
T ss_pred             ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcc
Confidence            332  24679999999999999999999999999999653 3444

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=209.07  Aligned_cols=184  Identities=29%  Similarity=0.379  Sum_probs=150.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHh--hCCCCCeeeEEEEEecC----ceEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR--SLRHPNIIRFKEVVLTP----THLAIV   76 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~----~~~~~v   76 (200)
                      +..+.+.||+|.||.||++..+  |+.||+|++...  +.+...+|.++.+  .++|+||+.++..-..+    ..+++|
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            4578899999999999999998  677999999864  3455666666665  56999999998876543    248999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS--------MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~--------~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      ++|.+.|||.+++.. ..++.+..++++..+++||++||-        -.|.|||||.+||+|..++.  ..|+|+|+|.
T Consensus       288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv  364 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV  364 (513)
T ss_pred             eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeE
Confidence            999999999999966 679999999999999999999994        24999999999999987765  8999999996


Q ss_pred             ccCCC-----CCCCcccCCCCccCCeeecCcc----c-C-CeeehhhhhhhhhhcC
Q 029037          149 SSVLH-----SRPKSTVGTPAYIAPEVLSRRE----Y-D-GKVCILLLILFLWRNY  193 (200)
Q Consensus       149 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~~----~-~-~~~Di~slg~~l~~~~  193 (200)
                      .....     ......+||.+|+|||++...-    + + ..+||||+|.++||+.
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia  420 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA  420 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence            44433     3345668999999999986431    1 1 2359999999999984

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.3e-33  Score=214.80  Aligned_cols=194  Identities=21%  Similarity=0.258  Sum_probs=143.6

Q ss_pred             ccccccccccCCcceEEEEEEEc----------------CCCcEEEEEEecccccc-h--------------HHHHHHHH
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK----------------ETKELVAVKYIERGRKI-D--------------ENVAREII   50 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~----------------~~~~~~~~K~~~~~~~~-~--------------~~~~~e~~   50 (200)
                      ++|++.+.||+|+||+||++...                ..++.||+|.+...... .              +....|+.
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            68999999999999999999752                23457999998653211 1              22334666


Q ss_pred             HHhhCCCCCe-----eeEEEEEec--------CceEEEEEEecCCCchHHHHHhcC------------------------
Q 029037           51 NHRSLRHPNI-----IRFKEVVLT--------PTHLAIVMEYAAGGELFDRICNAG------------------------   93 (200)
Q Consensus        51 ~l~~l~~~~i-----~~~~~~~~~--------~~~~~~v~e~~~~~~L~~~l~~~~------------------------   93 (200)
                      ++.+++|.++     +++++++..        +...++|+||+++++|.+++....                        
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            6666665544     556666643        345899999999999998885321                        


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc--ccCCCCccCCeee
Q 029037           94 RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS--TVGTPAYIAPEVL  171 (200)
Q Consensus        94 ~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~--~~~~~~~~aPE~~  171 (200)
                      ..+...+..++.|++.+|.+||+.+++||||+|+||+++.+..  ++|+|||++...........  ...++.|+|||.+
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            1345678889999999999999999999999999999987654  99999999864433222222  2347899999998


Q ss_pred             cCcc--------------------c--CCeeehhhhhhhhhhcCCCCC
Q 029037          172 SRRE--------------------Y--DGKVCILLLILFLWRNYRPNP  197 (200)
Q Consensus       172 ~~~~--------------------~--~~~~Di~slg~~l~~~~~~~~  197 (200)
                      ....                    +  ..+.|+||+|+++|+|+++..
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l  430 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPEL  430 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCC
Confidence            5432                    1  124699999999999999874

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-34  Score=217.75  Aligned_cols=191  Identities=22%  Similarity=0.306  Sum_probs=167.4

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      ..+...||.|-+|.||.+.++.-.-.||+|.++.+....++|+.|..+++.++|||+++++++|..+..+|+|+|||..|
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG  348 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG  348 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence            35668999999999999999988888999999998888899999999999999999999999999999999999999999


Q ss_pred             chHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--Ccc
Q 029037           84 ELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--KST  159 (200)
Q Consensus        84 ~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~~~  159 (200)
                      +|.+++.+..  .++....+.++.||.+|+.||..++++||||...|+++..+.  .||++|||+++......-.  -..
T Consensus       349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh--iVKvADFGLsRlMtgDTYTAHAGA  426 (1157)
T KOG4278|consen  349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--IVKVADFGLSRLMTGDTYTAHAGA  426 (1157)
T ss_pred             cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc--eEEeeccchhhhhcCCceecccCc
Confidence            9999997655  378888999999999999999999999999999999997544  5999999999743322111  111


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPN  196 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~  196 (200)
                      --...|.|||-+....++.++|||++|++|||+.|-.
T Consensus       427 KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYG  463 (1157)
T KOG4278|consen  427 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYG  463 (1157)
T ss_pred             cCcccccCcccccccccccchhhHHHHHHHHHHHhcC
Confidence            2356799999999999999999999999999997754

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.3e-32  Score=219.06  Aligned_cols=187  Identities=26%  Similarity=0.367  Sum_probs=159.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||+|+++++.+......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            5789999999999999999999999999999999976432    235688899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-C
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-R  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~  155 (200)
                      |||+.|++|.+++...+.++...++.++.|++.||.|||++||+||||+|+||+++.++  .++|+|||+++...... .
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g--~vkL~DFGls~~~~~~~~~  160 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLSKVTLNRELN  160 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC--CEEEEeCCCCccccCCccc
Confidence            99999999999998878899999999999999999999999999999999999998665  49999999987443222 2


Q ss_pred             CCcccCCCCccCCeeecCcc-cCCeeehhhhhhhh
Q 029037          156 PKSTVGTPAYIAPEVLSRRE-YDGKVCILLLILFL  189 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~~l  189 (200)
                      .....+++.|.+||....+. ....+++|++|.--
T Consensus       161 ~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~  195 (669)
T cd05610         161 MMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFNT  195 (669)
T ss_pred             ccccccCccccCccccccCCCCceeeeeeecCcCC
Confidence            23456888999999865443 34456888888543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=219.07  Aligned_cols=190  Identities=29%  Similarity=0.281  Sum_probs=157.3

Q ss_pred             cccccccCCcce-EEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            5 ELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         5 ~~~~~l~~g~~g-~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      .-.+.+|.|+.| .||++...  ++.||+|++-.+  ..+-..+|+.+|+.. +||||+++++.-.+..+.|++.|.| .
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~  586 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A  586 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence            345778899887 68999887  568999977653  234577999999988 5999999999999999999999999 5


Q ss_pred             CchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC---CCCCCEEEeecCCCcccCCCCC
Q 029037           83 GELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG---SAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        83 ~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~---~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      .+|.+++....    .........+..|+++||++||+.+|+||||+|.||+|..   ++..+++|.|||+|+....+..
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            69999997631    1222566888999999999999999999999999999965   4556799999999986655544


Q ss_pred             CC----cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCC-CCCC
Q 029037          156 PK----STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRP-NPFI  199 (200)
Q Consensus       156 ~~----~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~-~~pf  199 (200)
                      .-    ...|+.+|.|||++.....+.++|||||||++|+.++| ..||
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpF  715 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPF  715 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCC
Confidence            32    34689999999999988888899999999999999998 5776

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=197.13  Aligned_cols=192  Identities=25%  Similarity=0.312  Sum_probs=164.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCc------e
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT------H   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~   72 (200)
                      .+|.-++.++.|.. .|..+.|.-.+++|++|....+..   ..++..+|...+..++|+|++.++..|....      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            47888899999998 777888888899999998876532   2357889999999999999999999987553      4


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .++|||++. .+|.+.+.  -.++=+++..++.|++.|+++||+.||+||||||+||++..+.  .+||.|||+|.....
T Consensus        96 ~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~--~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC--TLKILDFGLARTEDT  170 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh--heeeccchhhcccCc
Confidence            799999994 58887776  3467789999999999999999999999999999999997665  499999999975555


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .-.......+.-|.|||++.+..+...+||||+||++.||++|...|
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf  217 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF  217 (369)
T ss_pred             ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence            54555667788899999999988999999999999999999998766

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=5.7e-31  Score=184.25  Aligned_cols=181  Identities=43%  Similarity=0.614  Sum_probs=158.1

Q ss_pred             ccCCcceEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCchHH
Q 029037           10 LGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD   87 (200)
Q Consensus        10 l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   87 (200)
                      ||+|++|.||++.+..+++.+++|.+......  .+.+.+|+..++.++|++++++++++......++++|+++|++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999988999999999876442  5789999999999999999999999999999999999999899999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC-CCCCCEEEeecCCCcccCCCC-CCCcccCCCC
Q 029037           88 RICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHS-RPKSTVGTPA  164 (200)
Q Consensus        88 ~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~-~~~~~v~l~df~~~~~~~~~~-~~~~~~~~~~  164 (200)
                      ++... ..++...+..++.+++.++.+||+.|++|+||+|.||++++ +.  .++|+||+.+....... ......+...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG--KVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC--cEEEecCCceEEccCCcchhhcccCCCC
Confidence            99766 46899999999999999999999999999999999999986 44  59999999886443332 1233457788


Q ss_pred             ccCCeeecCc-ccCCeeehhhhhhhhhhc
Q 029037          165 YIAPEVLSRR-EYDGKVCILLLILFLWRN  192 (200)
Q Consensus       165 ~~aPE~~~~~-~~~~~~Di~slg~~l~~~  192 (200)
                      |++||..... .++.+.|+|++|++++++
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            9999999877 788899999999999886

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.7e-33  Score=217.63  Aligned_cols=189  Identities=24%  Similarity=0.313  Sum_probs=164.0

Q ss_pred             cccccccCCcceEEEEEEEcCCC----cEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            5 ELVKDLGAGNFGVARLLRHKETK----ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~----~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +-.+.||+|+||+||++...-.+    .+||+|++....  +..+++.+|.-.+.++.|||++++++++..+. +.+|++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            45678999999999999985443    468888887654  33678999999999999999999999998765 889999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ++++|+|.++.+... ++.....+.|..||++||.|||+++++||||-.+||++..-..  +|++|||+++.........
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcccccc
Confidence            999999999997654 6999999999999999999999999999999999999986554  9999999998776666655


Q ss_pred             ccc---CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCC
Q 029037          158 STV---GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPN  196 (200)
Q Consensus       158 ~~~---~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~  196 (200)
                      ...   ..+.|+|-|.+..+.++.++||||+|+.+||++|..
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFG  897 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFG  897 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcC
Confidence            443   356799999999999999999999999999998744

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=8.5e-32  Score=214.07  Aligned_cols=193  Identities=24%  Similarity=0.373  Sum_probs=162.1

Q ss_pred             ccccccccCCcceEEEEEEEcC-------CCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            4 YELVKDLGAGNFGVARLLRHKE-------TKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~-------~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      .++.+.+|+|.||.|+++.-..       ....||+|..+....  ..+.+..|++.++.+ +|+|++.+++.+...+.+
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~  377 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL  377 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence            4566799999999999998542       145699998886543  356799999999988 599999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC
Q 029037           74 AIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~  137 (200)
                      ++++||+..|+|.+++.+..                .++....+.++.||+.|++||++...+||||..+||++..+.  
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~--  455 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK--  455 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC--
Confidence            99999999999999997665                378889999999999999999999999999999999998665  


Q ss_pred             CEEEeecCCCcccCCCCCCCc--cc--CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          138 RLKICDFGYSKSSVLHSRPKS--TV--GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       138 ~v~l~df~~~~~~~~~~~~~~--~~--~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      .+||+|||+|+..........  ..  -...|+|||.+....++.++||||+|+++||++|...+
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~  520 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT  520 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence            499999999985443333221  11  24569999999999999999999999999999886643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-33  Score=212.33  Aligned_cols=196  Identities=33%  Similarity=0.479  Sum_probs=175.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++++.+|+|.+|.||+++++.+++..|+|+++.....+ +-..+|+-+++..+||||+.+++.+.....++++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            57999999999999999999999999999999999865544 56788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc-cCCCCCCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~-~~~~~~~~~~  159 (200)
                      .||+|++.-+-.+++++.++....+..+.+++|||+.|-+|||||=.||++.+.+.  +++.|||.+.. ...-.+..++
T Consensus        95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krksf  172 (829)
T KOG0576|consen   95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKSF  172 (829)
T ss_pred             CCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhcc
Confidence            99999998888889999999999999999999999999999999999999987665  99999999743 3344556778


Q ss_pred             cCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .|++-|+|||+-.   ...|...+|+|++|+...|+---+||-
T Consensus       173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence            8999999999964   457889999999999999987777664

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-30  Score=192.72  Aligned_cols=195  Identities=25%  Similarity=0.223  Sum_probs=161.7

Q ss_pred             cccccccccCCcceEEEEEEEcCCC-cEEEEEEecccccc-hHHHHHHHHHHhhCC----CCCeeeEEEEE-ecCceEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETK-ELVAVKYIERGRKI-DENVAREIINHRSLR----HPNIIRFKEVV-LTPTHLAI   75 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~-~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~~   75 (200)
                      +|++.+.||+|+||.||.+.+..++ +.+|+|........ ...+..|..++..+.    .++++.+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999998774 56888877664322 226778888888776    36999999999 47778899


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-C--CCEEEeecCCCc--
Q 029037           76 VMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-A--PRLKICDFGYSK--  148 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~--~~v~l~df~~~~--  148 (200)
                      ||+.+ |.+|.+......  .++..++..++.|++.+|.+||+.|++||||||.|+++.... .  ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99988 889999885554  699999999999999999999999999999999999997543 1  369999999997  


Q ss_pred             ccCCCC--------C-CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          149 SSVLHS--------R-PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       149 ~~~~~~--------~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      ......        . .....||.+|++++...+.+.+++.|+||++.++.+++.|..|
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LP  236 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLP  236 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCC
Confidence            311111        1 2234599999999999999999999999999999999999844

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=3.4e-31  Score=192.86  Aligned_cols=194  Identities=26%  Similarity=0.344  Sum_probs=165.2

Q ss_pred             ccccccccccCCcceEEEEEEEcC---CCcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE---TKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +.|+++++||.|.|++||++.+..   .++.||+|.+... ....++.+|+++|..+. +.||+++.+.+..++...+|+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            568999999999999999999987   7888999988763 33567999999999984 899999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc--------
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--------  149 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~--------  149 (200)
                      ||++..+..++...   ++...+..+++.++.||+++|..||+||||||+|++++.... +-.|+|||+|..        
T Consensus       115 p~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~~  190 (418)
T KOG1167|consen  115 PYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQTE  190 (418)
T ss_pred             cccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhhhh
Confidence            99999888887765   678999999999999999999999999999999999987665 689999999740        


Q ss_pred             ---c------CC-C---------------------------CCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhh
Q 029037          150 ---S------VL-H---------------------------SRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWR  191 (200)
Q Consensus       150 ---~------~~-~---------------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~  191 (200)
                         .      .. .                           ...-...||++|.|||++.+ ...++++|+||.|+++..
T Consensus       191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence               0      00 0                           00011248999999999875 467889999999999999


Q ss_pred             cCCCCCCCC
Q 029037          192 NYRPNPFIW  200 (200)
Q Consensus       192 ~~~~~~pf~  200 (200)
                      ++++..||+
T Consensus       271 lls~~~PFf  279 (418)
T KOG1167|consen  271 LLSRRYPFF  279 (418)
T ss_pred             hhccccccc
Confidence            999999985

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.1e-29  Score=189.17  Aligned_cols=161  Identities=17%  Similarity=0.129  Sum_probs=124.4

Q ss_pred             ccccccccccCCcceEEEEEEEcC-CCcEEEEEEeccc------ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-TKELVAVKYIERG------RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|.+.+.||+|+||+||++.+.. ++..+|+|.....      ....+.+.+|+.++++++|+++++.+..   ....+
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~   94 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG   94 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence            679999999999999999999876 6777899986532      1124568999999999999999853322   24579


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecC-CCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL-KLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl-~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++|||++|++|.. ...   ..   ...++.+++.+|.+||+.|++|||| ||+||+++.++  .++|+|||+|+.....
T Consensus        95 LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikLiDFGlA~~~~~~  165 (365)
T PRK09188         95 LVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAVIDFQLASVFRRR  165 (365)
T ss_pred             EEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEEEECccceecccC
Confidence            9999999999963 211   11   2467899999999999999999999 89999997555  4999999999754433


Q ss_pred             CCCC---------cccCCCCccCCeeecCc
Q 029037          154 SRPK---------STVGTPAYIAPEVLSRR  174 (200)
Q Consensus       154 ~~~~---------~~~~~~~~~aPE~~~~~  174 (200)
                      ....         ...++..|.+||.+...
T Consensus       166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        166 GALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            3221         22467789999998654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=171.97  Aligned_cols=195  Identities=23%  Similarity=0.229  Sum_probs=162.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++++.||+|+||.+|.+.....|..||+|+-.+. ..-..+..|.++.+.++ ...|+.+..+..+...-.+||+.+
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            6899999999999999999999999999999976553 33456778888888886 467777777778888889999998


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccCCCC----
Q 029037           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHS----  154 (200)
Q Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~~~~----  154 (200)
                       |.||.+...- ..+++..+++-++-|++.-++|+|.++++||||||+|++..-+. ...+.|+|||+|+......    
T Consensus        94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H  172 (341)
T KOG1163|consen   94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH  172 (341)
T ss_pred             -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence             8899888753 34699999999999999999999999999999999999985322 1368999999997433222    


Q ss_pred             ----CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          155 ----RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       155 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                          ......||.+|++-....+-+.+.+.|+-|+|.++..+.-|..|
T Consensus       173 Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LP  220 (341)
T KOG1163|consen  173 IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLP  220 (341)
T ss_pred             CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCc
Confidence                23345689999999998888999999999999999887777655

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-28  Score=173.01  Aligned_cols=194  Identities=24%  Similarity=0.255  Sum_probs=166.1

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .|++.+.||.|+||.++.+.+.-+++.||+|.-+. ......+..|.+..+.|. .+.|++++.+.++..+-.+|+|++ 
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            58999999999999999999999999999996554 334456788888888885 799999998888888889999998 


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC---CCEEEeecCCCcccCCCCC--
Q 029037           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA---PRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~---~~v~l~df~~~~~~~~~~~--  155 (200)
                      |.||.++..=. .+++..++.-++.|++.-++++|++.++.|||||+|++|...++   ..|.++|||+|+.......  
T Consensus       107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq  186 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ  186 (449)
T ss_pred             CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence            88999888544 36999999999999999999999999999999999999963322   3589999999974443332  


Q ss_pred             ------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          156 ------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       156 ------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                            ..+..||.+||+-....+++.+.+.|+-|||-++++++-|..|
T Consensus       187 HIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLP  235 (449)
T KOG1165|consen  187 HIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP  235 (449)
T ss_pred             cCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCc
Confidence                  3455799999999999999999999999999999999998877

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.95  E-value=1.5e-27  Score=166.33  Aligned_cols=166  Identities=17%  Similarity=0.167  Sum_probs=126.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHH----------HHHHHHHHhhCCCCCeeeEEEEEecC-
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----------VAREIINHRSLRHPNIIRFKEVVLTP-   70 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~----------~~~e~~~l~~l~~~~i~~~~~~~~~~-   70 (200)
                      ++|++.+.+|.|++|.||.+.+ . +..+++|.+.......+.          +.+|+..+.++.||++..+.+++... 
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~-~-~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT-D-YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec-C-CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            5899999999999999999766 3 556999999754333322          57888999999999999998886643 


Q ss_pred             -------ceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEee
Q 029037           71 -------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (200)
Q Consensus        71 -------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~d  143 (200)
                             +..+++|||++|.+|.+..    .++.    ....+++.++..+|+.|++|||++|+|+++++++   ++|+|
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liD  177 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIID  177 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEE
Confidence                   3579999999999997763    1222    2456899999999999999999999999997654   99999


Q ss_pred             cCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhh
Q 029037          144 FGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWR  191 (200)
Q Consensus       144 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~  191 (200)
                      ||.+.........           ......+.+..++|+||||+.+..
T Consensus       178 fg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~  214 (232)
T PRK10359        178 LSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLI  214 (232)
T ss_pred             CCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehH
Confidence            9976532111110           113345567778999999998764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.95  E-value=5.7e-27  Score=161.40  Aligned_cols=138  Identities=20%  Similarity=0.199  Sum_probs=108.4

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEEEecccccc--h-------------------------HHHHHHHHHHhhCCCC
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--D-------------------------ENVAREIINHRSLRHP   58 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~--~-------------------------~~~~~e~~~l~~l~~~   58 (200)
                      +.+.||+|++|.||++.+. +|+.||+|++......  .                         .....|...+..+.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            3578999999999999997 7899999999754211  0                         1223588999999777


Q ss_pred             CeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCCeeecCCCCC
Q 029037           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQICHRDLKLENTLLDGSAAP  137 (200)
Q Consensus        59 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~h~dl~~~ni~i~~~~~~  137 (200)
                      ++.....+...  ..++|||+++|+++.....+..+++...+..++.|++.+|.++ |+.|++||||||+||++++   +
T Consensus        80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---~  154 (190)
T cd05147          80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---G  154 (190)
T ss_pred             CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC---C
Confidence            66433322222  2389999999887766544556789999999999999999999 7999999999999999973   3


Q ss_pred             CEEEeecCCCcc
Q 029037          138 RLKICDFGYSKS  149 (200)
Q Consensus       138 ~v~l~df~~~~~  149 (200)
                      .++|+|||+|..
T Consensus       155 ~v~LiDFG~a~~  166 (190)
T cd05147         155 KLYIIDVSQSVE  166 (190)
T ss_pred             cEEEEEcccccc
Confidence            599999999863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.9e-28  Score=201.35  Aligned_cols=141  Identities=16%  Similarity=0.131  Sum_probs=108.6

Q ss_pred             CCeeeEEEEE-------ecCceEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCe
Q 029037           58 PNIIRFKEVV-------LTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT  129 (200)
Q Consensus        58 ~~i~~~~~~~-------~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni  129 (200)
                      +||..++++|       .+...++.++|++ +++|.+++.+. ..++..+++.+++||+.||+|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4666666665       2234577788877 56999999653 3589999999999999999999999999999999999


Q ss_pred             eecCC-----------------CCCCEEEeecCCCcccCCCC-----------------CCCcccCCCCccCCeeecCcc
Q 029037          130 LLDGS-----------------AAPRLKICDFGYSKSSVLHS-----------------RPKSTVGTPAYIAPEVLSRRE  175 (200)
Q Consensus       130 ~i~~~-----------------~~~~v~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~~~  175 (200)
                      +++..                 ....+|++|||+++......                 ......+++.|+|||.+.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            99542                 22346777777765321100                 000124678899999999999


Q ss_pred             cCCeeehhhhhhhhhhcCCCCCCC
Q 029037          176 YDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       176 ~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++.++||||+||++|||+++.+|+
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~  215 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSR  215 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCch
Confidence            999999999999999999998886

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.94  E-value=5.7e-26  Score=156.94  Aligned_cols=139  Identities=17%  Similarity=0.143  Sum_probs=109.8

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---------------------------hHHHHHHHHHHhhCCCC
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---------------------------DENVAREIINHRSLRHP   58 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---------------------------~~~~~~e~~~l~~l~~~   58 (200)
                      +.+.||+|++|.||++.+. +|+.||+|++......                           .....+|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4578999999999999987 8899999998764211                           12245788999999888


Q ss_pred             CeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCC
Q 029037           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAP  137 (200)
Q Consensus        59 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~  137 (200)
                      ++.....+....  .+++||+++|+++........+++......++.|++.++.++|+ .|++||||+|+||+++ ++  
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--
Confidence            875443333332  48999999887654443345568889999999999999999999 9999999999999997 33  


Q ss_pred             CEEEeecCCCccc
Q 029037          138 RLKICDFGYSKSS  150 (200)
Q Consensus       138 ~v~l~df~~~~~~  150 (200)
                      .++|+|||++...
T Consensus       155 ~~~liDFG~a~~~  167 (190)
T cd05145         155 KPYIIDVSQAVEL  167 (190)
T ss_pred             CEEEEEcccceec
Confidence            5999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=1.6e-25  Score=166.68  Aligned_cols=192  Identities=36%  Similarity=0.540  Sum_probs=164.8

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCC-CeeeEEEEEecCceEEEEEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHP-NIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~e   78 (200)
                      |++.+.||.|+++.||.+.+.   +.+++|.+.....    ....+.+|...++.+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            678899999999999999998   6689998876533    356788999999999988 79999999987777899999


Q ss_pred             ecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-
Q 029037           79 YAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-  154 (200)
                      ++.++++.+.+....   .++......++.|++.++.++|+.+++|||++|+||+++.... .++++|||.+....... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence            999999997776664   6999999999999999999999999999999999999986552 48999999986333332 


Q ss_pred             ------CCCcccCCCCccCCeeecC---cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 ------RPKSTVGTPAYIAPEVLSR---REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ------~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                            ......++..|.+||.+.+   ..++...|+||+|+++++++++..||
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~  211 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF  211 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence                  2345578999999999987   57788899999999999999999884

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.5e-26  Score=157.24  Aligned_cols=182  Identities=17%  Similarity=0.158  Sum_probs=137.0

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchH-----HHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE-----NVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-----~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ..+...|++|+||+|+.+..  .+..++.+.+...+....     .+.+|+++++++. ++++++++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            45678999999999997776  456677777776555433     5789999999995 5889999886    3469999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecC-CCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL-KLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl-~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      +|+.|.+|.+....       ....++.|++.+|.++|++|++|||| +|+||+++.++  .++|+|||++.........
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCCcchH
Confidence            99999888654321       12457789999999999999999999 79999998655  4999999999744433321


Q ss_pred             ----C----------cccCCCCccCCeeecCc-ccC-CeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 ----K----------STVGTPAYIAPEVLSRR-EYD-GKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ----~----------~~~~~~~~~aPE~~~~~-~~~-~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                          .          ....++.+++|+.-.-- ..+ .+.+.++.|..+|.++|+..|+|
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence                0          01146667777664322 223 44599999999999999999998

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-26  Score=165.73  Aligned_cols=194  Identities=16%  Similarity=0.164  Sum_probs=151.5

Q ss_pred             cccccccccCCcceEEEEEEEcCC-----CcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecC-ceEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTP-THLA   74 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~   74 (200)
                      |++....+.+|.||.||.++.+..     .+.|.+|.++.....  ...+..|--.+.-+.|||+.++.++..++ ...+
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~  364 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF  364 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence            566777889999999999976532     334556655543222  24577788888888999999999988654 4678


Q ss_pred             EEEEecCCCchHHHHH-----hc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           75 IVMEYAAGGELFDRIC-----NA---GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~-----~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                      +++++..-++|..++.     +.   ..++..+...++.|++.|+++||++|++|.||..+|.+|++.-  ++||+|=.+
T Consensus       365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDsaL  442 (563)
T KOG1024|consen  365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDSAL  442 (563)
T ss_pred             EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccchh
Confidence            8999998899999997     21   2377888999999999999999999999999999999998664  599999888


Q ss_pred             CcccCCCCCCCc---ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCC-CCC
Q 029037          147 SKSSVLHSRPKS---TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRP-NPF  198 (200)
Q Consensus       147 ~~~~~~~~~~~~---~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~-~~p  198 (200)
                      ++..-+..-...   --....|++||.+.+..|+.++|+||||+++|||.|- +.|
T Consensus       443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~P  498 (563)
T KOG1024|consen  443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLP  498 (563)
T ss_pred             ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCC
Confidence            874433322211   1134579999999999999999999999999999663 344

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=9.7e-26  Score=182.30  Aligned_cols=192  Identities=23%  Similarity=0.262  Sum_probs=153.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC---CCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR---HPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +.|.|.+.||.|++|+||.|.+.+ ++.||+|+-+.+..+.  +.--..++.+|+   -+.|..+.....-.+...++++
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e  774 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE  774 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence            468899999999999999999988 9999999877655443  111122222222   2445555555555667799999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec-----CCCCCCEEEeecCCCcc---c
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-----GSAAPRLKICDFGYSKS---S  150 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~-----~~~~~~v~l~df~~~~~---~  150 (200)
                      |.+-|||.+++...+.+++..++.++.|++..++.||..+||||||||+|+++.     +.....++|+|||.+-.   .
T Consensus       775 y~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf  854 (974)
T KOG1166|consen  775 YSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF  854 (974)
T ss_pred             ccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence            999999999998778899999999999999999999999999999999999983     22234599999999853   3


Q ss_pred             CCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCC
Q 029037          151 VLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPN  196 (200)
Q Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~  196 (200)
                      +.+......+++..+-.+|+..++.++...|.|.|+.+++-|+-|+
T Consensus       855 p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  855 PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            3333444557889999999999999999999999999999988764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=8.8e-25  Score=149.45  Aligned_cols=104  Identities=22%  Similarity=0.165  Sum_probs=89.9

Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccC
Q 029037           83 GELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~  161 (200)
                      |+|.+++.+. .++++.++..++.|++.||.|||+.+      ||+||+++.++.  +++  ||.+......    ...+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence            5889999764 45999999999999999999999999      999999986664  777  9987643321    2257


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++||||+|+++|||++|.+||+
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~  105 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN  105 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence            899999999999999999999999999999999999984

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK10345 hypothetical protein; Provisional

Probab=99.91  E-value=5e-23  Score=143.14  Aligned_cols=139  Identities=22%  Similarity=0.274  Sum_probs=108.2

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHHHHhhC-----CCCCeeeEEEEEecCc---e-E
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG-RKIDENVAREIINHRSL-----RHPNIIRFKEVVLTPT---H-L   73 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~-~   73 (200)
                      +.-.+.||+|++|.||.  ++.+... ++|++... ....+.+.+|+..++.+     .||||++++++++++.   . +
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34467899999999995  7666655 68887654 23356789999999999     5799999999999874   3 3


Q ss_pred             EEEEEe--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCcEeecCCCCCeeecCC--CCCCEEEee-cCCC
Q 029037           74 AIVMEY--AAGGELFDRICNAGRFSEDEGRYFFQQLISGV-NYCHSMQICHRDLKLENTLLDGS--AAPRLKICD-FGYS  147 (200)
Q Consensus        74 ~~v~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l-~~lh~~~i~h~dl~~~ni~i~~~--~~~~v~l~d-f~~~  147 (200)
                      .+|+|+  +.+++|.+++.+. .+++.  ..++.+++.++ +|||+++|+||||+|+||+++..  +...++|+| ||..
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            378999  4478999999653 45555  45678888777 89999999999999999999743  334699999 5543


Q ss_pred             c
Q 029037          148 K  148 (200)
Q Consensus       148 ~  148 (200)
                      .
T Consensus       158 ~  158 (210)
T PRK10345        158 T  158 (210)
T ss_pred             c
Confidence            3

>smart00090 RIO RIO-like kinase

Probab=99.91  E-value=1.5e-23  Score=149.07  Aligned_cols=139  Identities=17%  Similarity=0.115  Sum_probs=110.5

Q ss_pred             ccccccccCCcceEEEEEE-EcCCCcEEEEEEecccccc-------------------------hHHHHHHHHHHhhCCC
Q 029037            4 YELVKDLGAGNFGVARLLR-HKETKELVAVKYIERGRKI-------------------------DENVAREIINHRSLRH   57 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~-~~~~~~~~~~K~~~~~~~~-------------------------~~~~~~e~~~l~~l~~   57 (200)
                      |++.+.||+|++|.||+|. +..+++.||+|++......                         ...+.+|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            7889999999999999999 6678999999998753210                         1235689999998865


Q ss_pred             --CCeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeecCCCCCeeecCC
Q 029037           58 --PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ-ICHRDLKLENTLLDGS  134 (200)
Q Consensus        58 --~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~h~dl~~~ni~i~~~  134 (200)
                        ..++++++.    ...++|||+++|.+|.............+...++.|++.++.+||+.| ++|+||+|+||+++ +
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~  184 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D  184 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence              334455443    234899999999888665544455667778899999999999999999 99999999999997 3


Q ss_pred             CCCCEEEeecCCCcc
Q 029037          135 AAPRLKICDFGYSKS  149 (200)
Q Consensus       135 ~~~~v~l~df~~~~~  149 (200)
                      +  .++|+|||.+..
T Consensus       185 ~--~i~LiDFg~a~~  197 (237)
T smart00090      185 G--KVVIIDVSQSVE  197 (237)
T ss_pred             C--CEEEEEChhhhc
Confidence            3  599999998763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.2e-24  Score=171.80  Aligned_cols=191  Identities=31%  Similarity=0.450  Sum_probs=151.5

Q ss_pred             cccccccCCcceEEEEEEEcCCCcEEEEEEec----ccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIE----RGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~----~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      .....+|.|.+|.|+.+......+....|.+.    .....   ...+..|+-+-..+.||+++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35678899999988888776655545555433    11111   112455666677889999988877777666555559


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      |||++ +|..++.....+....+..++.|++.|++|+|+.|+.|||++++|+++..++.  +||+|||.+........  
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchh
Confidence            99999 99999988878999999999999999999999999999999999999987664  99999999854333322  


Q ss_pred             ---CCcccCCCCccCCeeecCcccCCee-ehhhhhhhhhhcCCCCCC
Q 029037          156 ---PKSTVGTPAYIAPEVLSRREYDGKV-CILLLILFLWRNYRPNPF  198 (200)
Q Consensus       156 ---~~~~~~~~~~~aPE~~~~~~~~~~~-Di~slg~~l~~~~~~~~p  198 (200)
                         .....|+..|+|||.+.+.+|+++. ||||.|+++..|.+|+-|
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~  524 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFP  524 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCc
Confidence               3445789999999999999998775 999999999999999655

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=3.4e-25  Score=178.07  Aligned_cols=192  Identities=22%  Similarity=0.333  Sum_probs=149.7

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHH--HhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIIN--HRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++...+.||++.|=+|.++.++++-  |++|++.+..  .....+.+++..  ....++||.+++......+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~--vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL--VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce--EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5778899999999999999998643  8899987653  223444444433  455689999999888778888899999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      |+. .+|.+.+...+-+...+.++++.|++.|+..+|+.||.|||||.+||+|.+-..  +.|+||..-+..-.......
T Consensus       102 yvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  102 YVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcc
Confidence            984 499999988877899999999999999999999999999999999999986665  99999986542222222111


Q ss_pred             ----cc----CCCCccCCeeecCc----------c-cCCeeehhhhhhhhhhcCCC-CCCC
Q 029037          159 ----TV----GTPAYIAPEVLSRR----------E-YDGKVCILLLILFLWRNYRP-NPFI  199 (200)
Q Consensus       159 ----~~----~~~~~~aPE~~~~~----------~-~~~~~Di~slg~~l~~~~~~-~~pf  199 (200)
                          +.    ....|.|||.+-..          . .+++.||||+||+++|+++. .|||
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF  239 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF  239 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence                11    23459999998542          1 56788999999999999776 6766

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-24  Score=166.41  Aligned_cols=184  Identities=24%  Similarity=0.383  Sum_probs=155.8

Q ss_pred             cccCCcceEEEEEEE---cCCCcEEEEEEecccc---cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEecC
Q 029037            9 DLGAGNFGVARLLRH---KETKELVAVKYIERGR---KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~---~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .+|.|.+|.|+.+.-   ...++.+++|+..+..   ........|..++...+ ||+++++...++.+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            368899999887764   3346778999887642   22235666778888886 9999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccC
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~  161 (200)
                      |+.|...+.+...+...........++.+++.+|+.|++++|+|++||+++.++.  +++.|||.++........   +|
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---cc
Confidence            9999998888888888999999999999999999999999999999999987765  999999998754433333   89


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +..|+|||++.  ....+.|.||+|++++||+||..||
T Consensus       156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf  191 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPF  191 (612)
T ss_pred             chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCC
Confidence            99999999998  4457789999999999999999998

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1e-21  Score=138.11  Aligned_cols=134  Identities=25%  Similarity=0.241  Sum_probs=109.7

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEeccccc---------chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++.||+|++|.||++..  .+..+++|.......         ....+.+|...+..+.++++.....++.+....+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  455688887653211         1235778999999999988877766776777889999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      |+++|++|.+.+.....    ....++.+++.+|.++|+.|++|+|++|.||+++ ++  .++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~--~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG--KIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC--CEEEEECCcccC
Confidence            99999999998865332    8889999999999999999999999999999997 33  599999998864

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=5.3e-23  Score=147.71  Aligned_cols=191  Identities=20%  Similarity=0.153  Sum_probs=123.7

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCC----------CCeeeEEEEEe-
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRH----------PNIIRFKEVVL-   68 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~----------~~i~~~~~~~~-   68 (200)
                      +...+.||.|+++.||.+.+..|++.+++|+......    .-+++++|.-....+.+          -.++-.++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4567899999999999999999999999998865431    22455666544444322          12222222221 


Q ss_pred             -----------cCc-----eEEEEEEecCCCchHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 029037           69 -----------TPT-----HLAIVMEYAAGGELFDRIC---NAGR----FSEDEGRYFFQQLISGVNYCHSMQICHRDLK  125 (200)
Q Consensus        69 -----------~~~-----~~~~v~e~~~~~~L~~~l~---~~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~  125 (200)
                                 +.+     +.+++|+.+. ++|.+.+.   ....    ......+.+..|++..+++||..|++|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                       111     2478888884 47766653   2222    2333456667899999999999999999999


Q ss_pred             CCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCc--------ccCCeeehhhhhhhhhhcCCCCC
Q 029037          126 LENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR--------EYDGKVCILLLILFLWRNYRPNP  197 (200)
Q Consensus       126 ~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~Di~slg~~l~~~~~~~~  197 (200)
                      |+|++++.++.  +.|+||+...........  ...+..|.+||.....        .++.+.|.|+||+++|.+..+..
T Consensus       173 ~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999987765  999999876533222211  3345678899876432        46777899999999999999998


Q ss_pred             CC
Q 029037          198 FI  199 (200)
Q Consensus       198 pf  199 (200)
                      ||
T Consensus       249 Pf  250 (288)
T PF14531_consen  249 PF  250 (288)
T ss_dssp             ST
T ss_pred             CC
Confidence            87

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-23  Score=146.61  Aligned_cols=189  Identities=20%  Similarity=0.351  Sum_probs=155.5

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +..+..+|.....|..|+++...+.  ++.|++...   .....+|.+|.-.++.+.||||+++++.|....++.++..|
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            4456677889999999999998554  677877653   33456799999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           80 AAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ++.+||.+.+.++..  .+..++.+++.+++.|+++||+..  +.---++...+++|++...++...|--++.      .
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------q  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------Q  342 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------e
Confidence            999999999988765  678899999999999999999764  444578999999998887777777744332      2


Q ss_pred             CCcccCCCCccCCeeecCcccC---CeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYD---GKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~---~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .......+.|++||.+.+.+-+   .++|+||++++++|+-|+..||
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf  389 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF  389 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence            3345568899999999866432   3469999999999999999998

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.7e-22  Score=145.94  Aligned_cols=143  Identities=26%  Similarity=0.376  Sum_probs=111.8

Q ss_pred             CCCCeeeEEEEEec---------------------------CceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHH
Q 029037           56 RHPNIIRFKEVVLT---------------------------PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI  108 (200)
Q Consensus        56 ~~~~i~~~~~~~~~---------------------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~  108 (200)
                      +||||+++.+.|.+                           ...+|+||..+ ..+|.+++..+. .+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHH
Confidence            69999999877642                           24589999988 459999996654 57778888899999


Q ss_pred             HHHHHHHhCCcEeecCCCCCeee--cCCCCCCEEEeecCCCcccCC-------CCCCCcccCCCCccCCeeecCccc---
Q 029037          109 SGVNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVL-------HSRPKSTVGTPAYIAPEVLSRREY---  176 (200)
Q Consensus       109 ~~l~~lh~~~i~h~dl~~~ni~i--~~~~~~~v~l~df~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~---  176 (200)
                      +|+.+||++|+.|||+|.+||++  ++|.-+.+.+.|||.|-....       .+.....-|+..-+|||+....+-   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999998  566667789999998732221       122222346778999999864321   


Q ss_pred             --C-CeeehhhhhhhhhhcCCCCCCCC
Q 029037          177 --D-GKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       177 --~-~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                        + .++|.|+.|.+.||+|+..-||+
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY  458 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFY  458 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCccc
Confidence              1 34699999999999999999986

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.87  E-value=3e-21  Score=134.37  Aligned_cols=133  Identities=22%  Similarity=0.261  Sum_probs=104.0

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-----------------------chHHHHHHHHHHhhCCCC--
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-----------------------IDENVAREIINHRSLRHP--   58 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~--   58 (200)
                      |.+.+.||+|++|.||++... +++.+++|++..+..                       ......+|...+..+.++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999885 688899998764320                       012356788888888766  


Q ss_pred             CeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCC
Q 029037           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPR  138 (200)
Q Consensus        59 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~  138 (200)
                      .+++.++.    ...+++||+++|++|.....      ......++.+++.++.++|+.|++|+||+|+||++++++  .
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--~  163 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--K  163 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--c
Confidence            44444432    34589999999988866432      145667889999999999999999999999999998655  5


Q ss_pred             EEEeecCCCcc
Q 029037          139 LKICDFGYSKS  149 (200)
Q Consensus       139 v~l~df~~~~~  149 (200)
                      ++|+|||.+..
T Consensus       164 ~~liDfg~~~~  174 (198)
T cd05144         164 IYIIDWPQMVS  174 (198)
T ss_pred             EEEEECCcccc
Confidence            99999998853

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.87  E-value=5.3e-21  Score=133.30  Aligned_cols=129  Identities=22%  Similarity=0.205  Sum_probs=101.6

Q ss_pred             cccCCcceEEEEEEEcCCCcEEEEEEecccc-c--------chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            9 DLGAGNFGVARLLRHKETKELVAVKYIERGR-K--------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      .||+|++|.||++...  +..+++|...... .        ...++.+|..+++.+.++++.....++......+++||+
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            4899999999999853  5668888765321 1        124567899999999887655444444556667899999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      ++|++|.+.+.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++  .++++|||.+..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~--~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD--KLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC--cEEEEECCCCcC
Confidence            999999888754321       8899999999999999999999999999997 33  599999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.86  E-value=6.6e-21  Score=150.63  Aligned_cols=134  Identities=22%  Similarity=0.189  Sum_probs=107.7

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEe-cccc--------cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYI-ERGR--------KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~-~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      |...+.||+|++|+||++......  +++|.. .+..        ...+++.+|.++++.++|++++....+..+....+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            456789999999999999876544  333322 2211        11246889999999999999988777777777789


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCccc
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~  150 (200)
                      ++|||++|++|.+++.        ....++.+++.+|.+||+.|++|||++|+||+++ ++  .++|+|||+++..
T Consensus       413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCcccccC
Confidence            9999999999998874        4577899999999999999999999999999993 33  4999999998743

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=6.8e-22  Score=158.81  Aligned_cols=161  Identities=30%  Similarity=0.487  Sum_probs=120.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      +.|..++.|..|++|.||.++|+.+.+++|+|+ .+++.    +.+.  ++....+|.++                    
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn--ilt~a~npfvv--------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN--ILTFAGNPFVV--------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc--cccccCCccee--------------------
Confidence            468889999999999999999999999999953 33221    1111  22322344433                    


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC--------
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--------  153 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~--------  153 (200)
                       |+-...+.+-++++...        +.+++|+|+.||+|||++|+|.+|..-+.  +|++|||+++...-.        
T Consensus       136 -gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  136 -GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             -chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhhc
Confidence             34444454444444443        78899999999999999999999986664  999999997622111        


Q ss_pred             --------CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 --------SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 --------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                              -..+.-++++.|.|||++..+.|...+|+|++|+++||++-|..||+
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff  259 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  259 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence                    11123368999999999999999999999999999999999999985

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.82  E-value=6.9e-19  Score=125.42  Aligned_cols=134  Identities=19%  Similarity=0.219  Sum_probs=101.3

Q ss_pred             cccc-CCcceEEEEEEEcCCCcEEEEEEecccc--------------cchHHHHHHHHHHhhCCCCCe--eeEEEEEecC
Q 029037            8 KDLG-AGNFGVARLLRHKETKELVAVKYIERGR--------------KIDENVAREIINHRSLRHPNI--IRFKEVVLTP   70 (200)
Q Consensus         8 ~~l~-~g~~g~v~~~~~~~~~~~~~~K~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~   70 (200)
                      ..|| .||.|+||.+...  +..+++|.+....              .....+.+|+.++..++++++  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 8899999999875  5568888885321              123467889999999988774  5666654332


Q ss_pred             c----eEEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecC
Q 029037           71 T----HLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (200)
Q Consensus        71 ~----~~~~v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~  145 (200)
                      .    ..++|||+++| .+|.+.+.+ .+++..    .+.+++.++.+||+.|++|+||+|.||++++++  .++|+|||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg  187 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFD  187 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECC
Confidence            2    23599999997 688888754 344443    357899999999999999999999999998655  49999999


Q ss_pred             CCccc
Q 029037          146 YSKSS  150 (200)
Q Consensus       146 ~~~~~  150 (200)
                      .+...
T Consensus       188 ~~~~~  192 (239)
T PRK01723        188 RGELR  192 (239)
T ss_pred             CcccC
Confidence            88643

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.82  E-value=1.1e-19  Score=125.37  Aligned_cols=133  Identities=21%  Similarity=0.279  Sum_probs=94.6

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEEEecccccchH---H----------------------HHHHHHHHhhCCCC--
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE---N----------------------VAREIINHRSLRHP--   58 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~---~----------------------~~~e~~~l~~l~~~--   58 (200)
                      +.+.||+|++|+||++.+. +++.|++|++........   .                      ...|...+..+.+.  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999987 788899999875422111   1                      13455555555433  


Q ss_pred             CeeeEEEEEecCceEEEEEEecCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCC
Q 029037           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAA  136 (200)
Q Consensus        59 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~  136 (200)
                      .+++.++.    ...+++||+++++++.. .+... .. ...+..++.+++.++..+|+ .|++|+||+|+||+++ ++ 
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-  151 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-  151 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-
Confidence            24444433    23589999999854321 11111 11 16788899999999999999 9999999999999998 33 


Q ss_pred             CCEEEeecCCCc
Q 029037          137 PRLKICDFGYSK  148 (200)
Q Consensus       137 ~~v~l~df~~~~  148 (200)
                       .++++|||.+.
T Consensus       152 -~~~liDfg~a~  162 (187)
T cd05119         152 -KVYIIDVPQAV  162 (187)
T ss_pred             -cEEEEECcccc
Confidence             59999999885

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.81  E-value=9e-19  Score=116.63  Aligned_cols=131  Identities=25%  Similarity=0.274  Sum_probs=110.2

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCC--CCeeeEEEEEecCceEEEEEEecCCC
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH--PNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      +.+.|++|.++.||++....  +.+++|....... ...+.+|...++.+++  .++++++.+....+..+++||+++|.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            56789999999999999865  5689998876544 5678899999999976  58889988888778899999999887


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM---QICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      ++...       +......++.+++.+++.+|+.   +++|+|++|+||++++.+  .++++||+.+.
T Consensus        79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~  137 (155)
T cd05120          79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAG  137 (155)
T ss_pred             ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEeccccc
Confidence            77543       5567778899999999999985   799999999999998644  59999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=3.6e-18  Score=130.39  Aligned_cols=146  Identities=23%  Similarity=0.289  Sum_probs=120.1

Q ss_pred             HhhCCCCCeeeEEEEEecCceEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc-EeecCCCCCe
Q 029037           52 HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQI-CHRDLKLENT  129 (200)
Q Consensus        52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i-~h~dl~~~ni  129 (200)
                      ++.+.|.|+.++++.+.++...+.|.++|+.|+|.+.+.+. ..++......++++++.||+|+|...+ .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45788999999999999999999999999999999999874 368899999999999999999998766 9999999999


Q ss_pred             eecCCCCCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcc-------cCCeeehhhhhhhhhhcCCCCCCC
Q 029037          130 LLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRRE-------YDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       130 ~i~~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~-------~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +++..-  .+||+|||+.........   ........-|.|||.++...       .+.+.|+||+|++++|+++...||
T Consensus        81 lvd~~w--~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   81 LVDSRW--VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             eeeeeE--EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            997544  599999998764432111   11112345699999997642       355679999999999999999887

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=2.1e-19  Score=135.43  Aligned_cols=118  Identities=31%  Similarity=0.348  Sum_probs=101.0

Q ss_pred             eEEEEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           72 HLAIVMEYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      .+++.|++|.-.+|.+++....   ..+....+.++.|++.++.|   +|.+|+|++|.||+...+.  .++|.|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhhhhhhee
Confidence            5789999999999999996433   36788899999999999999   9999999999999997666  49999999976


Q ss_pred             ccCCCC-------CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC
Q 029037          149 SSVLHS-------RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR  194 (200)
Q Consensus       149 ~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~  194 (200)
                      ......       ......++..|++||.+.++.|+.++||||||++++|++.
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            444433       2334568999999999999999999999999999999975

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=1e-18  Score=138.50  Aligned_cols=196  Identities=29%  Similarity=0.421  Sum_probs=158.8

Q ss_pred             ccccccccccCCcceEEEEEEEcC-CCcEEEEEEecccccc---hHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-TKELVAVKYIERGRKI---DENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ..|.+.+.||+|+++.|-...... +...++.|.+......   .+....|..+...+. |+|++.+++...+....++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            368889999999999998888744 3444666766554322   344555788888776 99999999999999999999


Q ss_pred             EEecCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-
Q 029037           77 MEYAAGGELFDRI-CNAG-RFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-  152 (200)
Q Consensus        77 ~e~~~~~~L~~~l-~~~~-~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-  152 (200)
                      +++..|+++.+.+ .... ..+...+-..+.|+..++.++| ..++.|+|++|+|.+++..+. .+++.||++|..... 
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNK  178 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccccc
Confidence            9999999998888 5554 5788889999999999999999 999999999999999986663 489999999975554 


Q ss_pred             CCC---CCcccC-CCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCC
Q 029037          153 HSR---PKSTVG-TPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       153 ~~~---~~~~~~-~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      .+.   ....++ ++.|.|||...+. -..+..|+||.|+++..+++|..|
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p  229 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP  229 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence            222   233467 8999999999885 346778999999999999999876

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.70  E-value=1.1e-15  Score=104.77  Aligned_cols=136  Identities=13%  Similarity=0.146  Sum_probs=99.2

Q ss_pred             cccccCCcceEEEEEEEcC------CCcEEEEEEeccc--------------cc--------c-hH----HHHHHHHHHh
Q 029037            7 VKDLGAGNFGVARLLRHKE------TKELVAVKYIERG--------------RK--------I-DE----NVAREIINHR   53 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~------~~~~~~~K~~~~~--------------~~--------~-~~----~~~~e~~~l~   53 (200)
                      ...||.|.-+.||.+....      .+..+|+|++...              ..        . .+    ..++|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998754      2467999988521              00        0 11    2348999998


Q ss_pred             hCCC--CCeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCCee
Q 029037           54 SLRH--PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQICHRDLKLENTL  130 (200)
Q Consensus        54 ~l~~--~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~h~dl~~~ni~  130 (200)
                      ++..  -++++++++    ...+++||++.+..+....-+...++..+...+..+++.+|..| |+.|++||||++.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8853  466666654    45599999997654422222333455667778889999999988 8999999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcc
Q 029037          131 LDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus       131 i~~~~~~~v~l~df~~~~~  149 (200)
                      +++ +  .+.++||+.+..
T Consensus       158 ~~~-~--~v~iIDF~qav~  173 (197)
T cd05146         158 WHD-G--KVWFIDVSQSVE  173 (197)
T ss_pred             EEC-C--cEEEEECCCcee
Confidence            963 2  499999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.68  E-value=5.7e-16  Score=120.28  Aligned_cols=167  Identities=16%  Similarity=0.170  Sum_probs=131.6

Q ss_pred             EEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHH
Q 029037           20 LLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED   98 (200)
Q Consensus        20 ~~~~~~~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~   98 (200)
                      .+..+..+.++.+..++..+.. .+...+-++.++.++||+|+++++.++.++..|+|+|.+.  .|..++.+   ++..
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l~~~  104 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---LGKE  104 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---hHHH
Confidence            3556667888888888875542 3557888899999999999999999999999999999984  66777765   3477


Q ss_pred             HHHHHHHHHHHHHHHHH-hCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCcccCCCCccCCeeecCccc
Q 029037           99 EGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKSTVGTPAYIAPEVLSRREY  176 (200)
Q Consensus        99 ~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  176 (200)
                      ....-+.||+.||.+|| +++++|+++..+.|+++.++.  -+|++|.+++....... .........|..|+.+...+ 
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence            88888999999999997 789999999999999987776  89999998754333332 22223334567777665443 


Q ss_pred             CCeeehhhhhhhhhhcCCC
Q 029037          177 DGKVCILLLILFLWRNYRP  195 (200)
Q Consensus       177 ~~~~Di~slg~~l~~~~~~  195 (200)
                       -..|.|.||+++++++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             345999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.67  E-value=6.1e-16  Score=105.07  Aligned_cols=128  Identities=20%  Similarity=0.242  Sum_probs=95.0

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCe-eeEEEEEecCceEEEEEEecCCCch
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      .+.++.|..+.||++...  ++.+++|..............|...++.+.+..+ ++++....  ...+++||+++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            467899999999999875  6679999887654333456788888888765443 44554432  334799999999877


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI-----CHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        86 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i-----~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      .+.     .   ......+.+++.+|+.||+.++     +|+|++|.||+++ ++  .++++||+.+..
T Consensus        79 ~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~~  136 (170)
T cd05151          79 LTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAGM  136 (170)
T ss_pred             ccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEecccccC
Confidence            542     0   1123456789999999999885     9999999999997 33  499999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.66  E-value=2e-15  Score=116.32  Aligned_cols=138  Identities=21%  Similarity=0.205  Sum_probs=92.5

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccch-----------------------------------H------HH
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-----------------------------------E------NV   45 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-----------------------------------~------~~   45 (200)
                      .+.||+|+.|.||+|..+ +|+.||+|+....-...                                   .      ++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            368999999999999976 57889999885421000                                   0      13


Q ss_pred             HHHHHHHhhC----CCCCeeeEEEEE-ecCceEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHH-HHHHHHhCC
Q 029037           46 AREIINHRSL----RHPNIIRFKEVV-LTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLIS-GVNYCHSMQ  118 (200)
Q Consensus        46 ~~e~~~l~~l----~~~~i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~-~l~~lh~~~  118 (200)
                      .+|...+.++    ++.+-+.+-.++ ...+..+++|||++|.+|.+...... ..   ....++.+++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence            3344444443    222222222222 22345699999999999987764321 22   23445666655 477899999


Q ss_pred             cEeecCCCCCeeecCCCCCCEEEeecCCCccc
Q 029037          119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (200)
Q Consensus       119 i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~  150 (200)
                      ++|+|++|.||++++++  +++++|||.+...
T Consensus       278 ~~H~D~hPgNilv~~~g--~i~liDfG~~~~l  307 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDG--KIIALDFGIVGRL  307 (437)
T ss_pred             ceeCCCCcccEEECCCC--cEEEEeCCCeeEC
Confidence            99999999999997665  4999999998644

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.65  E-value=2e-16  Score=123.45  Aligned_cols=141  Identities=22%  Similarity=0.303  Sum_probs=91.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-----------------------------------chH---
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-----------------------------------IDE---   43 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-----------------------------------~~~---   43 (200)
                      ..|+. +.||+|+.|.|++|..+.+|+.||+|+....-.                                   ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 899999999999999998899999999964310                                   011   


Q ss_pred             ---HHHHHHHHHhhC----CCCCeeeEEEEEec-CceEEEEEEecCCCchHHHH--HhcCC----CCHHHHHHHHHHHHH
Q 029037           44 ---NVAREIINHRSL----RHPNIIRFKEVVLT-PTHLAIVMEYAAGGELFDRI--CNAGR----FSEDEGRYFFQQLIS  109 (200)
Q Consensus        44 ---~~~~e~~~l~~l----~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~l--~~~~~----~~~~~~~~~~~~i~~  109 (200)
                         ++.+|...+.++    .+...+.+-.++.+ .+..+++|||++|+++.+..  ...+.    +....+..+      
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~------  272 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF------  272 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH------
Confidence               133344444444    23333333333322 45568999999999997642  22221    222223333      


Q ss_pred             HHHHHHhCCcEeecCCCCCeeecCCC--CCCEEEeecCCCccc
Q 029037          110 GVNYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKSS  150 (200)
Q Consensus       110 ~l~~lh~~~i~h~dl~~~ni~i~~~~--~~~v~l~df~~~~~~  150 (200)
                       +..+...|++|+|++|.||+++.++  .++++++|||.+...
T Consensus       273 -~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        273 -FTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             -HHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence             3345579999999999999997655  236999999997643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=1.6e-13  Score=91.67  Aligned_cols=129  Identities=24%  Similarity=0.234  Sum_probs=93.9

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEE-Eeccc---cc-----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVK-YIERG---RK-----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K-~~~~~---~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ..+.+|+-+.++.+...  +..+++| .+++.   +.     ...+..+|..++..++...+.-..-+..+.....++||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            45788999999999664  2234444 33332   11     12457789999988866555555545567777799999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      +++|..|.+.+...       ...+++.+=.-+.-||+.||+||||+++|+++.++.   +.++|||++.
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~  139 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE  139 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence            99998888888665       244555565667789999999999999999996433   9999999986

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.54  E-value=2.2e-13  Score=90.77  Aligned_cols=142  Identities=17%  Similarity=0.131  Sum_probs=104.3

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEE-Eecc----c----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVK-YIER----G----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K-~~~~----~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ....+.+|+-+.|+++...  |+..++| ++.+    +    .....+.++|.+.+.++.--.|.-..-++.+...-.+.
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            4567788999999999886  4444555 2322    1    12235788899999888655555555566677778999


Q ss_pred             EEecCC-CchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC-CEEEeecCCCcc
Q 029037           77 MEYAAG-GELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP-RLKICDFGYSKS  149 (200)
Q Consensus        77 ~e~~~~-~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~-~v~l~df~~~~~  149 (200)
                      |||++| .++.+++.+...  ........+++++=..+.-||..+++||||+.+||++.++++. .+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999987 477787765432  3333346888888889999999999999999999999766652 358999999753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=6.3e-15  Score=113.10  Aligned_cols=193  Identities=20%  Similarity=0.169  Sum_probs=153.8

Q ss_pred             cccccccccC--CcceEEEEEEE--cCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEE
Q 029037            3 KYELVKDLGA--GNFGVARLLRH--KETKELVAVKYIERG---RKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         3 ~y~~~~~l~~--g~~g~v~~~~~--~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   74 (200)
                      .+-+.+.+|+  |.+|.+|.+..  ...+..+++|.-+..   ......-.+|+...+.++ |++.++....+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3556788999  99999999998  788888999875443   233455667777777775 899999888888999999


Q ss_pred             EEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           75 IVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLIS----GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~----~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      +-+|.+ +.+|.++-..... ++.......+.+...    |+.++|..+++|-|++|.||+...+.. ..+++||++...
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~-s~~~~df~~v~~  272 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT-SCKLTDFGLVSK  272 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc-eeecCCcceeEE
Confidence            999998 5788888776655 888889999999999    999999999999999999999986632 489999999865


Q ss_pred             cCCCCCCCc------ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          150 SVLHSRPKS------TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       150 ~~~~~~~~~------~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      ...+.....      ..+...|++||... ..++...|+|++|.++.+...+..+
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~  326 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHL  326 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccc
Confidence            554443222      24677899999974 4667889999999999987666543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.52  E-value=2.9e-13  Score=95.77  Aligned_cols=140  Identities=23%  Similarity=0.283  Sum_probs=101.1

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCC--CCeeeEEEEEecCc---eEEEEEEe
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRH--PNIIRFKEVVLTPT---HLAIVMEY   79 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~---~~~~v~e~   79 (200)
                      .+.++.|..+.+|++...+ ++.+++|.......  ....+.+|...++.+++  ..+++++.+.....   ..+++||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            3678999999999998754 56799998776433  35678899999999865  34566777766542   56899999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-------------------------------------------  116 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-------------------------------------------  116 (200)
                      ++|.++.+.+.. ..++......++.+++.+|..||+                                           
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999877654421 235555566666666666666653                                           


Q ss_pred             -------------CCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          117 -------------MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       117 -------------~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                                   ..++|+|+.|.||+++++....+.++||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                         34689999999999986422347899999775

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.51  E-value=2.8e-12  Score=92.66  Aligned_cols=131  Identities=15%  Similarity=0.047  Sum_probs=93.6

Q ss_pred             eEEEEEEEcCCCcEEEEEEecccccc------------hHHHHHHHHHHhhCCC--CCeeeEEEEEec-----CceEEEE
Q 029037           16 GVARLLRHKETKELVAVKYIERGRKI------------DENVAREIINHRSLRH--PNIIRFKEVVLT-----PTHLAIV   76 (200)
Q Consensus        16 g~v~~~~~~~~~~~~~~K~~~~~~~~------------~~~~~~e~~~l~~l~~--~~i~~~~~~~~~-----~~~~~~v   76 (200)
                      ..|.+...  .|+.+.+|........            ...+.+|...+..+..  -..++.+.+.+.     ....++|
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            34556544  3567899977432210            1147788888887743  233344444433     2347899


Q ss_pred             EEecCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC-----CCCCCEEEeecCCCc
Q 029037           77 MEYAAGG-ELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-----SAAPRLKICDFGYSK  148 (200)
Q Consensus        77 ~e~~~~~-~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~-----~~~~~v~l~df~~~~  148 (200)
                      ||++++. +|.+++..  ..+.+......++.+++..+..||+.|++|+|+++.||+++.     ++...+.++||+.+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999886 78888754  234567778899999999999999999999999999999975     234579999999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.45  E-value=2.5e-12  Score=87.99  Aligned_cols=123  Identities=26%  Similarity=0.307  Sum_probs=80.0

Q ss_pred             EEEEEEEcCCCcEEEEEEeccc--------------c-------------cchHHHHHHHHHHhhCCCC--CeeeEEEEE
Q 029037           17 VARLLRHKETKELVAVKYIERG--------------R-------------KIDENVAREIINHRSLRHP--NIIRFKEVV   67 (200)
Q Consensus        17 ~v~~~~~~~~~~~~~~K~~~~~--------------~-------------~~~~~~~~e~~~l~~l~~~--~i~~~~~~~   67 (200)
                      .||.|...+ +..+|+|++...              .             .......+|.+.|.++...  ++++++++-
T Consensus         1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            488888854 557999988421              0             0113578899999999765  566666542


Q ss_pred             ecCceEEEEEEecC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           68 LTPTHLAIVMEYAA--GGELFDRICNAGRFSEDEGRYFFQQLISGVNY-CHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        68 ~~~~~~~~v~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~-lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                          ...+||||++  |..+.. +... .++.+....++.+++..+.. +|+.|++|||+++.||+++++   .+.++||
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf  150 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDF  150 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--G
T ss_pred             ----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEec
Confidence                2389999998  555543 3222 12255667777888885554 689999999999999999865   4999999


Q ss_pred             CCCcc
Q 029037          145 GYSKS  149 (200)
Q Consensus       145 ~~~~~  149 (200)
                      +.+..
T Consensus       151 ~qav~  155 (188)
T PF01163_consen  151 GQAVD  155 (188)
T ss_dssp             TTEEE
T ss_pred             Cccee
Confidence            98753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.41  E-value=2.6e-12  Score=95.92  Aligned_cols=187  Identities=12%  Similarity=0.012  Sum_probs=127.1

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHhhCCCCCeeeEEEE------Ee-cCceEEEEE
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIRFKEV------VL-TPTHLAIVM   77 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~------~~-~~~~~~~v~   77 (200)
                      ..+.||+|+.+.+|....-..   -+.|++..+.... .+...|+.  +.-.||-+-.-+.+      .- ......++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk~a~la--~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQKVAELA--ATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchhhc---hhheeecCCCchHHHHHHHHhc--cCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            457899999999998765433   2568888764332 22222221  12234433220100      11 122367888


Q ss_pred             EecCCC-chHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCccc
Q 029037           78 EYAAGG-ELFDRI------CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (200)
Q Consensus        78 e~~~~~-~L~~~l------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~  150 (200)
                      +.++|. ....+.      +..+...+...++.++.++.+.+.||+.|.+-||++++|+++++++.  |.|.|=..-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeec
Confidence            888775 222222      12334889999999999999999999999999999999999987776  888875443323


Q ss_pred             CCCCCCCcccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCC-CCCC
Q 029037          151 VLHSRPKSTVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRP-NPFI  199 (200)
Q Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~-~~pf  199 (200)
                      ..+.......+.+.|.+||...     +.+.+...|.|.||+++++++.| ..||
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPy  222 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY  222 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCC
Confidence            3334445567899999999975     34556778999999999999766 7776

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.40  E-value=5.5e-12  Score=89.20  Aligned_cols=132  Identities=20%  Similarity=0.238  Sum_probs=101.1

Q ss_pred             cccccccCCcceEEEEEEEcCCCcEEEEEEecccc-----------------------cchHHHHHHHHHHhhCCCC--C
Q 029037            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----------------------KIDENVAREIINHRSLRHP--N   59 (200)
Q Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-----------------------~~~~~~~~e~~~l~~l~~~--~   59 (200)
                      .+...||-|.-+.||.+.++. +..+++|......                       ......++|...|..|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            466889999999999999984 6678999764210                       1123567899999988644  6


Q ss_pred             eeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCE
Q 029037           60 IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (200)
Q Consensus        60 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v  139 (200)
                      +++.++.    +..+++||+++|-.|...-     +..+....++..|+..+..+-..|++|||+++-||++++++.  +
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~  241 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--I  241 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--E
Confidence            7777654    6779999999986554321     245666677777888888777999999999999999987765  9


Q ss_pred             EEeecCCCc
Q 029037          140 KICDFGYSK  148 (200)
Q Consensus       140 ~l~df~~~~  148 (200)
                      .++||-.+.
T Consensus       242 ~vIDwPQ~v  250 (304)
T COG0478         242 VVIDWPQAV  250 (304)
T ss_pred             EEEeCcccc
Confidence            999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=3.7e-13  Score=103.50  Aligned_cols=195  Identities=22%  Similarity=0.182  Sum_probs=145.4

Q ss_pred             ccccccccccCCcceEEEEEEEc-CCCcEEEEEEecccccc---hHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-ETKELVAVKYIERGRKI---DENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      .+|..+..||.+.++.++...-+ .++..+++|-..+.-..   +..-..|+-+...+ .|.+.+.....+......++-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            46778899999999999887755 56777888877664222   22234555555555 488888887788777777899


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      -|+++++++.........+.+...+++..|++.++.++|+..++|+|++|+||++.+++ .--++.||+....  .....
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~--~~~~~  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTR--LAFSS  421 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccc--cceec
Confidence            99999988766664445688889999999999999999999999999999999998653 2468899987653  11122


Q ss_pred             CcccCCCCcc--CCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYI--APEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~--aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .......++.  +|.......+..+.|++|||.-+.+..++.+.-
T Consensus       422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             ccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence            2223344444  455555667888899999999999998887654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=4.8e-13  Score=96.48  Aligned_cols=149  Identities=17%  Similarity=0.230  Sum_probs=109.2

Q ss_pred             HHHHHHHHhhCCCCCeeeEEEEEecC-----ceEEEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH
Q 029037           45 VAREIINHRSLRHPNIIRFKEVVLTP-----THLAIVMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCH  115 (200)
Q Consensus        45 ~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh  115 (200)
                      ...-+..+.++-|.|++++..|+.+.     ....+++||++.+++.+++.+.    ..+....-.+|..||++||.|||
T Consensus       114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh  193 (458)
T KOG1266|consen  114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH  193 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence            33445666777899999998888654     3578999999999999999653    34788888999999999999999


Q ss_pred             hC--CcEeecCCCCCeeecCCCCCCEEEeecCCCcccC-----CCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhh
Q 029037          116 SM--QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-----LHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILF  188 (200)
Q Consensus       116 ~~--~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~-----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~  188 (200)
                      +.  -++|++++.+.|++..++.  ||+.--.-....+     .........+.++|.+||.=....-+.++|||++|++
T Consensus       194 s~~PpiihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  194 SCDPPIIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC  271 (458)
T ss_pred             ccCCccccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence            87  5999999999999986664  6654211110000     0011112235678999998655566778899999999


Q ss_pred             hhhcCCC
Q 029037          189 LWRNYRP  195 (200)
Q Consensus       189 l~~~~~~  195 (200)
                      ..+|.-+
T Consensus       272 Alemail  278 (458)
T KOG1266|consen  272 ALEMAIL  278 (458)
T ss_pred             HHHHHHh
Confidence            9888543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.37  E-value=1.1e-13  Score=112.37  Aligned_cols=196  Identities=23%  Similarity=0.267  Sum_probs=147.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch----HHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +.+.+.+.+.++.++.++.+.-..++.....|+....+...    +....+-..+-...+|.++.....+.-....++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            45677888999999999998888777666666655433221    22233333333345566666554444456789999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-----
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-----  152 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-----  152 (200)
                      +++.+++|...+++.+..+.+-+......+..++++||...+.|+|++|.|.++..++.  .++.||+.......     
T Consensus       884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccCcC
Confidence            99999999999988887888888888888999999999999999999999999976654  78888863210000     


Q ss_pred             ----------------C-----------CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 ----------------H-----------SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ----------------~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                                      .           .......+++.|.+||...+......+|+|+.|+++++.++|.+||
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence                            0           0011224788999999999999999999999999999999999998

>PRK09902 hypothetical protein; Provisional

Probab=99.35  E-value=1e-10  Score=80.68  Aligned_cols=135  Identities=12%  Similarity=0.100  Sum_probs=100.3

Q ss_pred             cCCcceEEEEEEEcCCCcEEEEEEeccc-------ccchHHHHHHHHHHhhCCC--CCeeeEEEEEe-c----CceEEEE
Q 029037           11 GAGNFGVARLLRHKETKELVAVKYIERG-------RKIDENVAREIINHRSLRH--PNIIRFKEVVL-T----PTHLAIV   76 (200)
Q Consensus        11 ~~g~~g~v~~~~~~~~~~~~~~K~~~~~-------~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~-~----~~~~~~v   76 (200)
                      +.||-+.|++.....  +.+-+|...+-       +.-...+.+|+..++.+..  ..++++. ++. .    .-..++|
T Consensus        27 ~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            348888888877653  35777876521       2245689999999998843  2344544 222 1    1236899


Q ss_pred             EEecCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           77 MEYAAG-GELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        77 ~e~~~~-~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      +|.++| .+|.+++.+.  .+.+......+..+++.+++-||+.|+.|+|+.+.||+++.++...+.++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            998865 4888888653  34678888999999999999999999999999999999985555569999998765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.35  E-value=6.1e-11  Score=82.96  Aligned_cols=108  Identities=19%  Similarity=0.173  Sum_probs=85.2

Q ss_pred             hHHHHHHHHHHhhCCC--CCeeeEEEEEecC----ceEEEEEEecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 029037           42 DENVAREIINHRSLRH--PNIIRFKEVVLTP----THLAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVNYC  114 (200)
Q Consensus        42 ~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~----~~~~~v~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l  114 (200)
                      .....+|...+..+..  -.+++.+.+.+..    ...++++|.+++. +|.+++......+......++.+++..++-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            3567888888877743  3344455555442    2468999999885 8999987765678888999999999999999


Q ss_pred             HhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcc
Q 029037          115 HSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKS  149 (200)
Q Consensus       115 h~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~  149 (200)
                      |+.|++|+|+++.||+++.+. ...+.++||+.+..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999998664 44699999997763

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.21  E-value=3.1e-10  Score=86.84  Aligned_cols=164  Identities=20%  Similarity=0.212  Sum_probs=120.2

Q ss_pred             cceEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeEEEEEec----CceEEEEEEecCCC-chHH
Q 029037           14 NFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLT----PTHLAIVMEYAAGG-ELFD   87 (200)
Q Consensus        14 ~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v~e~~~~~-~L~~   87 (200)
                      -..+.|++....+|..|++|+++..... ....-.-++.++++.|+|++++.++|..    +..+++|++|.++. +|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4468899999999999999999433211 2234456788999999999999998873    45689999998874 7766


Q ss_pred             HHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           88 RICNA---------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        88 ~l~~~---------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      +-..+               ...++...+.++.|+..||.++|+.|+..+-|.|.+|++..+.  +++|...|.......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecC
Confidence            65332               2366788999999999999999999999999999999997443  588876665432111


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRP  195 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~  195 (200)
                      ..           .  |-+..+   .+.|.=.||.++..+.+|
T Consensus       446 d~-----------~--~~le~~---Qq~D~~~lG~ll~aLAt~  472 (655)
T KOG3741|consen  446 DP-----------T--EPLESQ---QQNDLRDLGLLLLALATG  472 (655)
T ss_pred             CC-----------C--cchhHH---hhhhHHHHHHHHHHHhhc
Confidence            11           0  122222   235777888888888777

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.20  E-value=7.1e-10  Score=76.93  Aligned_cols=134  Identities=19%  Similarity=0.251  Sum_probs=84.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHH----------HHHHHHHHhhCCC---CC-----eeeE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----------VAREIINHRSLRH---PN-----IIRF   63 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~----------~~~e~~~l~~l~~---~~-----i~~~   63 (200)
                      ++|.+.+.+-......|.+..-.  ++.+++|.........++          ..+.+.....++.   ..     ++.-
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            35677777777777677666554  466888877654322222          1223333333321   22     2222


Q ss_pred             EEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEee
Q 029037           64 KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (200)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~d  143 (200)
                      --.+......+++|||++|..|.+...    +++    .+...+..++..+|+.|++|||.+|.|+++.+++   ++++|
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID  177 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIID  177 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEE
Confidence            222223345679999999988865431    222    2445677789999999999999999999997544   89999


Q ss_pred             cCCCc
Q 029037          144 FGYSK  148 (200)
Q Consensus       144 f~~~~  148 (200)
                      ++..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            97543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=99.13  E-value=1.5e-09  Score=76.30  Aligned_cols=134  Identities=16%  Similarity=0.126  Sum_probs=92.2

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccc--------------------cc-----hHHHHHHHHHHhhCC--CCCe
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR--------------------KI-----DENVAREIINHRSLR--HPNI   60 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--------------------~~-----~~~~~~e~~~l~~l~--~~~i   60 (200)
                      ..|++|.-+.||+|... .+..+|+|++....                    ..     ......|+..|+++.  +-.+
T Consensus        54 g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            46667888899999873 46779999985321                    00     123567888888884  4455


Q ss_pred             eeEEEEEecCceEEEEEEecCCCch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCC
Q 029037           61 IRFKEVVLTPTHLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPR  138 (200)
Q Consensus        61 ~~~~~~~~~~~~~~~v~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~  138 (200)
                      ++.+...    ...++||++..... .-.| +..++.......+..+++..+.-|-. .++||+||+.-||++. ++  .
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~--~  204 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG--E  204 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC--e
Confidence            5555443    34899999965311 1111 12224444678888889998888876 9999999999999998 33  3


Q ss_pred             EEEeecCCCccc
Q 029037          139 LKICDFGYSKSS  150 (200)
Q Consensus       139 v~l~df~~~~~~  150 (200)
                      +.++|++.|...
T Consensus       205 p~iID~~QaV~~  216 (268)
T COG1718         205 PYIIDVSQAVTI  216 (268)
T ss_pred             EEEEECcccccc
Confidence            899999988643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.09  E-value=3.4e-11  Score=98.07  Aligned_cols=79  Identities=19%  Similarity=0.115  Sum_probs=59.0

Q ss_pred             EeecCCCC-CeeecCCCCCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCC
Q 029037          120 CHRDLKLE-NTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRP  195 (200)
Q Consensus       120 ~h~dl~~~-ni~i~~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~  195 (200)
                      .+++..|. |+++.++.  .+++.||+.++....+..   .....||+.|+|||.+.+..++.++||||+||++|||++|
T Consensus       499 ~~~~~~p~~~~~~~p~~--~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG  576 (669)
T cd05610         499 PTQKPRPHGNLYQTPKQ--VKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTG  576 (669)
T ss_pred             CCCCCCCCCceeECCcc--ccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            34555665 45555444  367888998764333222   2334689999999999998899999999999999999999


Q ss_pred             CCCCC
Q 029037          196 NPFIW  200 (200)
Q Consensus       196 ~~pf~  200 (200)
                      .+||.
T Consensus       577 ~~pf~  581 (669)
T cd05610         577 IPPFN  581 (669)
T ss_pred             CCCCC
Confidence            99983

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=99.00  E-value=2e-08  Score=71.20  Aligned_cols=72  Identities=18%  Similarity=0.169  Sum_probs=54.6

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCC--CeeeEEEEEecCceEEEEEEecCCCc
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--NIIRFKEVVLTPTHLAIVMEYAAGGE   84 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~~v~e~~~~~~   84 (200)
                      ..|++|..+.||+..    +..+++|..... .......+|.+.++.+...  .+++++++..+.+...++|++++|.+
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            678999999999842    334778887653 3456688999999888643  35677888877788899999999963

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=3.6e-10  Score=88.91  Aligned_cols=90  Identities=14%  Similarity=0.274  Sum_probs=70.1

Q ss_pred             HHHHHHHHHH-hCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC----------CcccCCCCccCCeeecCc
Q 029037          106 QLISGVNYCH-SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP----------KSTVGTPAYIAPEVLSRR  174 (200)
Q Consensus       106 ~i~~~l~~lh-~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~  174 (200)
                      +++.|+.++| +.++||++|.|++|.++..+.  .||++|+++........-          ........|.|||.+.+.
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4458999999 569999999999999986664  899999987644332211          111245679999999988


Q ss_pred             ccCCeeehhhhhhhhhhcCCCCC
Q 029037          175 EYDGKVCILLLILFLWRNYRPNP  197 (200)
Q Consensus       175 ~~~~~~Di~slg~~l~~~~~~~~  197 (200)
                      .-++++|+||+|+++|.++.++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk  207 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGK  207 (700)
T ss_pred             cccccccceeeeeEEEEEecCCc
Confidence            88899999999999999995543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.93  E-value=1.2e-07  Score=65.55  Aligned_cols=134  Identities=22%  Similarity=0.227  Sum_probs=94.7

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccc-----------------cchHHHHHHHHHHhhCC------CCCeeeE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----------------KIDENVAREIINHRSLR------HPNIIRF   63 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-----------------~~~~~~~~e~~~l~~l~------~~~i~~~   63 (200)
                      ...||+|+.-.||.-=+..   ...+|+.....                 .......+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~dp---~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPDDP---NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCCCC---CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4678999999888543332   25788887644                 22355667776666665      7899999


Q ss_pred             EEEEecCceEEEEEEecCC------CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC
Q 029037           64 KEVVLTPTHLAIVMEYAAG------GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (200)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~  137 (200)
                      +|..+++.-..+|+|.+.+      .||.+++.+ +.++. .....+.   .-..+|-+..|+.+|++|.||++.....+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999989999988654      267888843 34555 4444333   34567889999999999999999644432


Q ss_pred             --CEEEee-cCCCc
Q 029037          138 --RLKICD-FGYSK  148 (200)
Q Consensus       138 --~v~l~d-f~~~~  148 (200)
                        .+.|+| ||...
T Consensus       158 ~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  158 EFRLVLIDGLGEKE  171 (199)
T ss_pred             ceEEEEEeCCCCcc
Confidence              478888 66543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.87  E-value=8.1e-08  Score=69.07  Aligned_cols=76  Identities=13%  Similarity=0.038  Sum_probs=53.5

Q ss_pred             ccccCCcc-eEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037            8 KDLGAGNF-GVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus         8 ~~l~~g~~-g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      +.|..|.+ ..||++....  ..+.+|+.....  .....+|...++.+. +-.++++++....++..+++|++++|.++
T Consensus         4 ~~~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           4 ERVTEGQSGATVYRLDGKN--PGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             eecCCCCCcCeEEEEcCCC--CcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            34555555 6889997653  467888776543  345677888887774 34566778777766678999999999776


Q ss_pred             HH
Q 029037           86 FD   87 (200)
Q Consensus        86 ~~   87 (200)
                      ..
T Consensus        80 ~~   81 (244)
T cd05150          80 AA   81 (244)
T ss_pred             hH
Confidence            53

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.86  E-value=2.3e-08  Score=78.45  Aligned_cols=137  Identities=19%  Similarity=0.202  Sum_probs=86.2

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEeccc-----------------------cc------------chHH------HH
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERG-----------------------RK------------IDEN------VA   46 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~-----------------------~~------------~~~~------~~   46 (200)
                      +.|++++-|.||+|.-++ |+.||+|+...+                       +.            ..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            678899999999999986 888999988421                       00            0011      23


Q ss_pred             HHHHHHhhC----C-CCCeeeEEEEEecCceEEEEEEecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcE
Q 029037           47 REIINHRSL----R-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQIC  120 (200)
Q Consensus        47 ~e~~~l~~l----~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~  120 (200)
                      +|...+.++    + .+.+.=.--+.+-.+.-.++|||++|-.+.+... +....+...+.....++  .+..+=..|++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCcc
Confidence            333333333    2 2332211113333456699999999988877642 22334433333222222  23445569999


Q ss_pred             eecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037          121 HRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus       121 h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      |+|..|.||+++.++  ++.+.|||....
T Consensus       288 HaDpHpGNi~v~~~g--~i~~lDfGi~g~  314 (517)
T COG0661         288 HADPHPGNILVRSDG--RIVLLDFGIVGR  314 (517)
T ss_pred             ccCCCccceEEecCC--cEEEEcCcceec
Confidence            999999999998775  499999998753

>PLN02876 acyl-CoA dehydrogenase

Probab=98.81  E-value=1.8e-07  Score=78.28  Aligned_cols=78  Identities=21%  Similarity=0.251  Sum_probs=55.9

Q ss_pred             cccccCCcceEEEEEEEcCCC--cEEEEEEecccc--cchHHHHHHHHHHhhCC-CCCe--eeEEEEEecC---ceEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETK--ELVAVKYIERGR--KIDENVAREIINHRSLR-HPNI--IRFKEVVLTP---THLAIV   76 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~--~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~~v   76 (200)
                      .+.++.|.+..+|+......+  ..+++|+.+...  .....+.+|..+++.+. |+++  ++++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            466788888899998765432  357778765432  22356889999999885 5554  7777777664   457899


Q ss_pred             EEecCCCc
Q 029037           77 MEYAAGGE   84 (200)
Q Consensus        77 ~e~~~~~~   84 (200)
                      ||+++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998864

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.79  E-value=1.8e-07  Score=66.56  Aligned_cols=78  Identities=19%  Similarity=0.198  Sum_probs=55.3

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCC--CeeeEEEEEe---cCceEEEEEEecC
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--NIIRFKEVVL---TPTHLAIVMEYAA   81 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~---~~~~~~~v~e~~~   81 (200)
                      ++.++.|..+.+|++...+ + .+++|..... .....+.+|...++.+...  .+++++....   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-S-EEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678889999999999876 3 6899987765 4456777888888777432  3455665432   2345799999999


Q ss_pred             CCchHH
Q 029037           82 GGELFD   87 (200)
Q Consensus        82 ~~~L~~   87 (200)
                      |.++..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.79  E-value=8.4e-08  Score=75.21  Aligned_cols=136  Identities=20%  Similarity=0.223  Sum_probs=86.4

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccc--------------------------------cchH------HHHHH
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGR--------------------------------KIDE------NVARE   48 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--------------------------------~~~~------~~~~e   48 (200)
                      .+.|+..+.|.|++++-++ |+.||+|+.+..-                                ...+      ++.+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3789999999999999987 8889999875320                                0001      12233


Q ss_pred             HHHHh----hCCCCC------eeeEEEEEecCceEEEEEEecCCCchHH--HHHhcCCCCHHHHHHHHHHHHHH-HHHHH
Q 029037           49 IINHR----SLRHPN------IIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISG-VNYCH  115 (200)
Q Consensus        49 ~~~l~----~l~~~~------i~~~~~~~~~~~~~~~v~e~~~~~~L~~--~l~~~~~~~~~~~~~~~~~i~~~-l~~lh  115 (200)
                      .+...    .++|-+      |++++-.  -...-.++|||++|..+.+  .+.+. .++...+..   .+..+ +..+=
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~---~l~~~~~~qIf  318 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILN---KLVEAYLEQIF  318 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHH---HHHHHHHHHHH
Confidence            32222    223333      4444322  2345699999999986644  44343 355554333   33333 23344


Q ss_pred             hCCcEeecCCCCCeeecCC--CCCCEEEeecCCCcc
Q 029037          116 SMQICHRDLKLENTLLDGS--AAPRLKICDFGYSKS  149 (200)
Q Consensus       116 ~~~i~h~dl~~~ni~i~~~--~~~~v~l~df~~~~~  149 (200)
                      ..|.+|+|-.|.||++.++  +...+.+.|+|+...
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            6899999999999999853  356799999999763

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.76  E-value=2.5e-09  Score=83.96  Aligned_cols=180  Identities=20%  Similarity=0.193  Sum_probs=128.9

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCC-eeeEEEEEecCceEEEEEEecCCC-c
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVMEYAAGG-E   84 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~v~e~~~~~-~   84 (200)
                      ..-.++++.+++++.+...+...+ .+.+...    ....-++++|.+++||| .+..++-+..+...++.++++.++ +
T Consensus       247 fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            344567888888888776554433 4443332    44556788999999999 556666666677789999999877 2


Q ss_pred             hHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCC
Q 029037           85 LFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP  163 (200)
Q Consensus        85 L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~  163 (200)
                      ....+ .....+..-+...+.+.-+.+++++|+..-+|+|    ||+..++   ..+..||+...............+++
T Consensus       322 ~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~---~~~~~~~~v~~~L~~~~~~~t~~~~~  394 (829)
T KOG0576|consen  322 SALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE---EVKLLDFAVPPQLTRTMKPRTAIGTP  394 (829)
T ss_pred             ccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc---ccccccccCCcccCcccccccCCCCC
Confidence            21111 1112345556666777778899999988778888    7776543   37999999887666555667778999


Q ss_pred             CccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          164 AYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       164 ~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      .++|||......+....|.|+++.-..++--|.+|
T Consensus       395 ~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  395 EPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             CCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            99999999988898899999999866666666655

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.67  E-value=5.9e-07  Score=60.17  Aligned_cols=127  Identities=20%  Similarity=0.164  Sum_probs=90.4

Q ss_pred             cccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeee-EEEEEecCceEEEEEEecCCC
Q 029037            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR-FKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      ...+.|++|.+|.||++...  +..+++|+-.. +.....++.|.+++..++-.++.+ ++.+..+    ++.|||+.|.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence            45678999999999999987  44688886554 345678999999999998766654 5554333    5569999998


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC--CCeeecCCCCCCEEEeecCCCc
Q 029037           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKL--ENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~--~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      +|.+.....   ...+...    ++..-.-|-..||-|+.|+-  .||++.+ .  ++.|+||..|+
T Consensus        98 ~L~~~~~~~---~rk~l~~----vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~--~~~iIDFd~At  154 (201)
T COG2112          98 PLGKLEIGG---DRKHLLR----VLEKAYKLDRLGIEHGELSRPWKNVLVND-R--DVYIIDFDSAT  154 (201)
T ss_pred             chhhhhhcc---cHHHHHH----HHHHHHHHHHhccchhhhcCCceeEEecC-C--cEEEEEccchh
Confidence            887655321   3344333    44444457788999999975  4566643 2  49999999886

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.64  E-value=3.4e-07  Score=68.27  Aligned_cols=137  Identities=19%  Similarity=0.228  Sum_probs=98.5

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEEEeccc--------------------------cc-chHHHHHHHHHHhhCCCC
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERG--------------------------RK-IDENVAREIINHRSLRHP   58 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~--------------------------~~-~~~~~~~e~~~l~~l~~~   58 (200)
                      +..+|..|.-+.||.+.... |..+|+|+++.+                          .+ ..-..+.|++.|.+++..
T Consensus       148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            45678888899999998765 556999988531                          01 112456789999999776


Q ss_pred             CeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCCeeecCCCCC
Q 029037           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQICHRDLKLENTLLDGSAAP  137 (200)
Q Consensus        59 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~h~dl~~~ni~i~~~~~~  137 (200)
                      .|+-.--....  ...+||+++.+.....-.-+..+++...+..+-.+++.-+.-| +.+++||.||+--|+++.++   
T Consensus       227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG---  301 (520)
T KOG2270|consen  227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG---  301 (520)
T ss_pred             CCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC---
Confidence            65443323332  3489999997544433333555688888888888888888877 57899999999999999643   


Q ss_pred             CEEEeecCCCc
Q 029037          138 RLKICDFGYSK  148 (200)
Q Consensus       138 ~v~l~df~~~~  148 (200)
                      .+.++|.+.+.
T Consensus       302 ~lyiIDVSQSV  312 (520)
T KOG2270|consen  302 KLYIIDVSQSV  312 (520)
T ss_pred             EEEEEEccccc
Confidence            38999998775

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.63  E-value=5.5e-07  Score=64.40  Aligned_cols=73  Identities=11%  Similarity=-0.009  Sum_probs=47.0

Q ss_pred             cccccCCcce-EEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCC---CeeeEEEEEecC---ceEEEEEEe
Q 029037            7 VKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP---NIIRFKEVVLTP---THLAIVMEY   79 (200)
Q Consensus         7 ~~~l~~g~~g-~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~~v~e~   79 (200)
                      ++.++.|+.. .||+..     ..+++|.... ......+.+|.+.++.+...   .++++++.....   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            4677877776 588763     2367786554 33355788999999877532   344455443332   234789999


Q ss_pred             cCCCch
Q 029037           80 AAGGEL   85 (200)
Q Consensus        80 ~~~~~L   85 (200)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            999665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.61  E-value=2.4e-06  Score=58.92  Aligned_cols=124  Identities=19%  Similarity=0.262  Sum_probs=87.2

Q ss_pred             ccccccccccCCcc-eEEEEEEEcCCCcEEEEEEecc-----c----------c-------cchHHHHHHHHHHhhCC--
Q 029037            2 EKYELVKDLGAGNF-GVARLLRHKETKELVAVKYIER-----G----------R-------KIDENVAREIINHRSLR--   56 (200)
Q Consensus         2 ~~y~~~~~l~~g~~-g~v~~~~~~~~~~~~~~K~~~~-----~----------~-------~~~~~~~~e~~~l~~l~--   56 (200)
                      ++++.++.||+|.. |.||++...  |+.+|+|++..     +          .       ...+.|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            35778899999999 999999986  56899999321     0          0       11235777877777664  


Q ss_pred             -CCCe--eeEEEEEecC------------------ceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 029037           57 -HPNI--IRFKEVVLTP------------------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH  115 (200)
Q Consensus        57 -~~~i--~~~~~~~~~~------------------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh  115 (200)
                       +..+  ++++++..=.                  ....+|-|+.+...         .+..    +-+.++++-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence             3444  8898887311                  12467778776543         1223    33556677788899


Q ss_pred             hCCcEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037          116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus       116 ~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                      +.||+-+|+++.|..    +   -+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~----~---G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR----G---GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc----C---CEEEecccC
Confidence            999999999999986    2   389999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.53  E-value=2.4e-06  Score=61.07  Aligned_cols=75  Identities=17%  Similarity=0.238  Sum_probs=48.4

Q ss_pred             cccccCCcceEEEEEEEcC-CCcEEEEEEecccccchHHHHHHHHHHhhCCCCC-eeeEEEEEecCceEEEEEEecCCCc
Q 029037            7 VKDLGAGNFGVARLLRHKE-TKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVMEYAAGGE   84 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~v~e~~~~~~   84 (200)
                      .+.|..|-...+|++.... .++.+++|+........-...+|..+++.+.... .++++..+.  +  .++|||++|.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            4567778888999997653 3456889977654332234457888888775333 344444332  2  47999999866


Q ss_pred             h
Q 029037           85 L   85 (200)
Q Consensus        85 L   85 (200)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.43  E-value=2.7e-06  Score=61.63  Aligned_cols=132  Identities=15%  Similarity=0.102  Sum_probs=75.8

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHhhCCCCCe-eeEEEEEecCceEEEEEEecCCCch
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      ..+..|-...+|+...  +++.+++|......... -...+|..+++.+....+ ++++...  .  -++|+++++|.++
T Consensus         2 ~~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~   75 (256)
T TIGR02721         2 QTLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI   75 (256)
T ss_pred             CcCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence            3456677789998873  35568888766543221 245778888888854333 3444333  2  2689999998654


Q ss_pred             HH--------------HHHh---cC----CCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcEeecCCC
Q 029037           86 FD--------------RICN---AG----RFSED-EGRYFFQQL---------ISGVNYCHS--------MQICHRDLKL  126 (200)
Q Consensus        86 ~~--------------~l~~---~~----~~~~~-~~~~~~~~i---------~~~l~~lh~--------~~i~h~dl~~  126 (200)
                      ..              .+.+   ..    +++.. .......++         ...+..+-+        ..++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            21              1111   11    11111 111111111         111222211        2589999999


Q ss_pred             CCeeecCCCCCCEEEeecCCCc
Q 029037          127 ENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       127 ~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      .||++++++   +.++||..+.
T Consensus       156 ~Nil~~~~~---~~lIDwE~a~  174 (256)
T TIGR02721       156 YNLVVTPQG---LKLIDWEYAS  174 (256)
T ss_pred             CcEEEeCCC---CEEEeccccC
Confidence            999997544   7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.39  E-value=2.9e-06  Score=58.45  Aligned_cols=97  Identities=14%  Similarity=0.093  Sum_probs=75.4

Q ss_pred             HHHHHHHhhCCC-CCeeeEEEEEecCceEEEEEEecCCCchHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 029037           46 AREIINHRSLRH-PNIIRFKEVVLTPTHLAIVMEYAAGGELFD---RICNAGRFSEDEGRYFFQQLISGVNYCHS---MQ  118 (200)
Q Consensus        46 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~---~l~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~  118 (200)
                      ..|.-+++.+++ +++++++|+|-+    ++++|+...+++..   .+...-..++..+..++.+++..+..++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357778888865 699999999844    77889987665532   11122246899999999999999999986   45


Q ss_pred             cEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       119 i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      +.-.|++|+|+-+++++.  ++++|...+.
T Consensus        83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~  110 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF  110 (188)
T ss_pred             EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence            788899999999986654  9999998764

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.32  E-value=7.1e-05  Score=57.43  Aligned_cols=75  Identities=15%  Similarity=0.061  Sum_probs=52.4

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEeccc--------ccchHHHHHHHHHHhhCC---CCCeeeEEEEEecCceEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERG--------RKIDENVAREIINHRSLR---HPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~--------~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~   75 (200)
                      .+.||.|....||++.+..+++.+++|.-...        +...++...|.+.|+.+.   -.++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36789899999999999765457899974311        123456677777777663   2456777666  4455789


Q ss_pred             EEEecCCC
Q 029037           76 VMEYAAGG   83 (200)
Q Consensus        76 v~e~~~~~   83 (200)
                      |||++++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.28  E-value=6.7e-06  Score=69.30  Aligned_cols=153  Identities=20%  Similarity=0.205  Sum_probs=112.1

Q ss_pred             HHHHHHHHHHhhCCCCCeeeEEEEEecCceEE----EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 029037           43 ENVAREIINHRSLRHPNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ  118 (200)
Q Consensus        43 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~----~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~  118 (200)
                      +..+-|...+....|+|++.++.+........    +..+++...++.+.++.....+..+.+.+..+...|++++|+..
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            44566777788889999999988876654332    44577777888898988889999999999999999999999997


Q ss_pred             cEeecCCCCC---eeecCCCCCCEEEe--ecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCe--eehhhhhhhhhh
Q 029037          119 ICHRDLKLEN---TLLDGSAAPRLKIC--DFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK--VCILLLILFLWR  191 (200)
Q Consensus       119 i~h~dl~~~n---i~i~~~~~~~v~l~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~--~Di~slg~~l~~  191 (200)
                      ..|.-+..+.   --.+.+.  .+...  ||+.+.................+.+||.......+++  .|+|.+|.+...
T Consensus       307 l~~v~L~~s~~~~~~~~~e~--~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEG--VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             cceeEEecccccccccCccc--eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence            6666665552   2223222  34444  8887765555555555556667888888876655444  699999999988


Q ss_pred             cCCCCC
Q 029037          192 NYRPNP  197 (200)
Q Consensus       192 ~~~~~~  197 (200)
                      +..+..
T Consensus       385 ~~~~~~  390 (1351)
T KOG1035|consen  385 LSQGED  390 (1351)
T ss_pred             hhhcCc
Confidence            877654

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.27  E-value=5.8e-07  Score=66.02  Aligned_cols=132  Identities=14%  Similarity=0.163  Sum_probs=89.8

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-------------------cc----hHHHHHHHHHHhhCCC--C
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-------------------KI----DENVAREIINHRSLRH--P   58 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-------------------~~----~~~~~~e~~~l~~l~~--~   58 (200)
                      +.+.+.||-|.-+.||.+.+.. |.+.++|......                   .+    .-...+|...++.+..  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            3567889999999999999875 5667888653211                   11    1134567777776642  2


Q ss_pred             CeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCC
Q 029037           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPR  138 (200)
Q Consensus        59 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~  138 (200)
                      .+++.+++    ++.++|||++.|..|.+.-.-      .....+...+..-+.-|-.+|++|||++--||+++++..  
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~--  240 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK--  240 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC--
Confidence            34444443    567999999999877553311      122233444555567788999999999999999986654  


Q ss_pred             EEEeecCCCc
Q 029037          139 LKICDFGYSK  148 (200)
Q Consensus       139 v~l~df~~~~  148 (200)
                      ++++||-.+.
T Consensus       241 i~vIDFPQmv  250 (465)
T KOG2268|consen  241 IVVIDFPQMV  250 (465)
T ss_pred             EEEeechHhh
Confidence            9999997654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.25  E-value=3.9e-05  Score=56.84  Aligned_cols=136  Identities=18%  Similarity=0.127  Sum_probs=78.5

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCC--CeeeEEEE------EecCceEEEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--NIIRFKEV------VLTPTHLAIVME   78 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~------~~~~~~~~~v~e   78 (200)
                      .+.+..|....+|+....+  ..+++|+...  ...+.+..|..++..+...  .+++++..      ...++..+.+++
T Consensus        19 i~~i~~G~~n~~y~v~~~~--~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS--GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC--CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4566677778899887543  3588898765  3345667777777776432  24444332      123455789999


Q ss_pred             ecCCCchHH-----------HH---Hhc-CCCCH--------HHHH------------HHHHHHHHHHHHHHh-------
Q 029037           79 YAAGGELFD-----------RI---CNA-GRFSE--------DEGR------------YFFQQLISGVNYCHS-------  116 (200)
Q Consensus        79 ~~~~~~L~~-----------~l---~~~-~~~~~--------~~~~------------~~~~~i~~~l~~lh~-------  116 (200)
                      +++|.++..           .+   ++. ..+..        ....            .....+..++..+.+       
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999865421           11   100 00000        0000            011112223334432       


Q ss_pred             CCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       117 ~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      .+++|+|+.|.|++++++.  .+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDE--LSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCc--eEEEeehhhhc
Confidence            4799999999999998643  25799999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=98.23  E-value=2.1e-05  Score=58.44  Aligned_cols=74  Identities=11%  Similarity=0.130  Sum_probs=48.4

Q ss_pred             ccccCCcceEEEEEEEcC------CCcEEEEEEecccccchHHHHHHHHHHhhCCCCC-eeeEEEEEecCceEEEEEEec
Q 029037            8 KDLGAGNFGVARLLRHKE------TKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +.+..|-.-.+|++....      .++.+++|+............+|..+++.+.... .++++..+..    ..|++++
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            455556667899987653      2567899997765444456678888887775333 3445555432    3588998


Q ss_pred             CCCch
Q 029037           81 AGGEL   85 (200)
Q Consensus        81 ~~~~L   85 (200)
                      +|.++
T Consensus        80 ~G~~l   84 (302)
T cd05156          80 PSRTL   84 (302)
T ss_pred             CCCcC
Confidence            88665

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.11  E-value=7.9e-05  Score=55.53  Aligned_cols=137  Identities=17%  Similarity=0.168  Sum_probs=76.5

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCC--CeeeEEEEE------ecCceEEEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--NIIRFKEVV------LTPTHLAIVME   78 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~------~~~~~~~~v~e   78 (200)
                      .+.++.|....+|++... ++ .+++|+.... ...+....|..++..+...  .+++++...      ..++..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeC-CC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            456666766789988754 33 4778877552 2234555666666666322  234443321      12356789999


Q ss_pred             ecCCCchH-----------HHH---Hhc-CCCC--------HH---H--HH----------HHHHHHHHHHHHHH-----
Q 029037           79 YAAGGELF-----------DRI---CNA-GRFS--------ED---E--GR----------YFFQQLISGVNYCH-----  115 (200)
Q Consensus        79 ~~~~~~L~-----------~~l---~~~-~~~~--------~~---~--~~----------~~~~~i~~~l~~lh-----  115 (200)
                      +++|.++.           ..+   +.. ..++        ..   .  ..          .....+...++++.     
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99885321           111   110 0010        00   0  00          00111223344443     


Q ss_pred             --hCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       116 --~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                        ..+++|+|+.+.|++++++.  ...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDS--VKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence              36899999999999997654  25899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=98.11  E-value=0.00027  Score=52.99  Aligned_cols=73  Identities=12%  Similarity=0.033  Sum_probs=42.3

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCC--CCeeeEEE------EEecCceEEEEEEe
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH--PNIIRFKE------VVLTPTHLAIVMEY   79 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~------~~~~~~~~~~v~e~   79 (200)
                      +.++.|....+|.+.... + .+++|++..  ...+.+..+...++.+..  -.+++++.      +....+..++++++
T Consensus        28 ~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQ-G-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCC-C-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            456667767899987653 3 478898762  223444445555554421  12333332      12234567899999


Q ss_pred             cCCCc
Q 029037           80 AAGGE   84 (200)
Q Consensus        80 ~~~~~   84 (200)
                      ++|..
T Consensus       104 l~G~~  108 (319)
T PRK05231        104 LEGKW  108 (319)
T ss_pred             cCCCC
Confidence            99864

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=98.05  E-value=8.7e-05  Score=55.09  Aligned_cols=138  Identities=12%  Similarity=0.081  Sum_probs=78.7

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecc---cccchHHHHHHHHHHhhCCC--CCeeeEEEEEecCc--eEEEEEEe
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH--PNIIRFKEVVLTPT--HLAIVMEY   79 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~~~v~e~   79 (200)
                      ++.+..|-.-.+|...+.  ++.++++ .+.   ......+..+|+..++.+..  ..+...++++.++.  ..+.+|++
T Consensus        30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             eeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            344433444455565554  6668888 331   22334567788888887753  33444566666655  67999999


Q ss_pred             cCCCchH----------HHHH--------hc--------CC------CCHHHHHHHHHHH--------------HHHHHH
Q 029037           80 AAGGELF----------DRIC--------NA--------GR------FSEDEGRYFFQQL--------------ISGVNY  113 (200)
Q Consensus        80 ~~~~~L~----------~~l~--------~~--------~~------~~~~~~~~~~~~i--------------~~~l~~  113 (200)
                      ++|..+.          ++..        .-        ..      ....+...+..+.              .....+
T Consensus       107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W  186 (321)
T COG3173         107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW  186 (321)
T ss_pred             ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence            9983221          1111        00        00      0111122222222              112334


Q ss_pred             HHh--------CCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037          114 CHS--------MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus       114 lh~--------~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      +++        ..++|||+.+.|++++++..  +-+.||+.+..
T Consensus       187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~l  228 (321)
T COG3173         187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATL  228 (321)
T ss_pred             HHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEecccccc
Confidence            432        24899999999999987665  88999998763

>PRK10593 hypothetical protein; Provisional

Probab=98.03  E-value=0.0001  Score=54.62  Aligned_cols=102  Identities=10%  Similarity=0.019  Sum_probs=69.6

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCC---CCeeeEEEEEecC---ceEEEEEEec
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH---PNIIRFKEVVLTP---THLAIVMEYA   80 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~---~~~~~v~e~~   80 (200)
                      .+.|+.|..+.||.......  .+++|..+. ......+..|...++.+..   ..++++++.+.++   +..++|||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~--~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG--NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCC--CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            46899999999999976433  366676433 2234678899999988853   4678888877543   5689999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS  116 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~  116 (200)
                      +|.++.+.     ..+......+..+++.+|+.||+
T Consensus        96 ~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~  126 (297)
T PRK10593         96 RGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHR  126 (297)
T ss_pred             CCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhC
Confidence            99776541     12233344555566666666665

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.99  E-value=0.00034  Score=52.84  Aligned_cols=72  Identities=17%  Similarity=0.093  Sum_probs=46.9

Q ss_pred             cccCCcceEEEEEEEcCCCcEEEEEEecc-------c-ccchHHHHHHHHHHhhCC--CC-CeeeEEEEEecCceEEEEE
Q 029037            9 DLGAGNFGVARLLRHKETKELVAVKYIER-------G-RKIDENVAREIINHRSLR--HP-NIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~~~~~~~~~~K~~~~-------~-~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~~v~   77 (200)
                      .||.|-..-||++.+..+++.+++|.-..       + +...++..-|...|+...  .| .+++++.+  +.....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57888888999999865446788885431       1 233455666777776653  34 45555433  555567999


Q ss_pred             EecCC
Q 029037           78 EYAAG   82 (200)
Q Consensus        78 e~~~~   82 (200)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99865

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.91  E-value=0.00022  Score=54.02  Aligned_cols=136  Identities=17%  Similarity=0.196  Sum_probs=77.7

Q ss_pred             ccccCCcceEEEEEEEcC----CCcEEEEEEecccccchHHHHHHHHHHhhCCCCCee-eEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKE----TKELVAVKYIERGRKIDENVAREIINHRSLRHPNII-RFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~----~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.+..|-.-.+|++....    +++.+++|+........-...+|..+++.+...++. ++++.+.. .   .+++|+++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g  117 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA  117 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence            445457777899987432    246789998876533322347788888888544443 45555533 2   57888887


Q ss_pred             CchHHH----------H----H---hcC-C----C-CHHHHHHHHHHH-----------------HHHHHHH--------
Q 029037           83 GELFDR----------I----C---NAG-R----F-SEDEGRYFFQQL-----------------ISGVNYC--------  114 (200)
Q Consensus        83 ~~L~~~----------l----~---~~~-~----~-~~~~~~~~~~~i-----------------~~~l~~l--------  114 (200)
                      .++...          +    .   +.. +    . ...++..+..++                 ...+..|        
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            665311          1    1   111 0    1 112222222111                 1111122        


Q ss_pred             HhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       115 h~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      +...+.|+|+.+.||+++++. ..+.++||..+.
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~  230 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS  230 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence            123579999999999997543 259999999875

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.90  E-value=0.00016  Score=54.43  Aligned_cols=74  Identities=14%  Similarity=0.150  Sum_probs=45.3

Q ss_pred             ccccCCcceEEEEEEEcCC---CcEEEEEEecccccchHHHHHHHHHHhhCCCCCe-eeEEEEEecCceEEEEEEecCCC
Q 029037            8 KDLGAGNFGVARLLRHKET---KELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      +.+..|-.-.+|++.....   +..+++|+........-...+|..+++.+...++ +++++++. +.   ++.+|++|.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            4444466678898875432   2368899887643333334678888887765444 34555542 22   488888776


Q ss_pred             ch
Q 029037           84 EL   85 (200)
Q Consensus        84 ~L   85 (200)
                      ++
T Consensus        96 ~l   97 (330)
T PLN02421         96 TL   97 (330)
T ss_pred             CC
Confidence            54

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.77  E-value=0.0014  Score=50.48  Aligned_cols=72  Identities=18%  Similarity=0.170  Sum_probs=48.2

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecc-----cc---cchHHHHHHHHHHhhCC---CCCeeeEEEEEecCceEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIER-----GR---KIDENVAREIINHRSLR---HPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~-----~~---~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~   75 (200)
                      .+.||.|..-.||++.+.  ++.+++|.-..     +.   ...++...|...|+.+.   -..+++++.++.+.  .++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEE
Confidence            467788888899999874  34588887652     11   13344455566666553   24777888777644  478


Q ss_pred             EEEecCC
Q 029037           76 VMEYAAG   82 (200)
Q Consensus        76 v~e~~~~   82 (200)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999977

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.74  E-value=0.00067  Score=51.93  Aligned_cols=74  Identities=16%  Similarity=0.112  Sum_probs=48.6

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecc----c---ccchHHHHHHHHHHhhCC--CC-CeeeEEEEEecCceEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIER----G---RKIDENVAREIINHRSLR--HP-NIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~----~---~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~~v   76 (200)
                      .+.||.|--.-||++.+...++.+++|.-..    .   +...++..-|...|+...  .| ++++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4678888889999999854455688885431    1   233466677777777653  34 45556443  55556788


Q ss_pred             EEecCC
Q 029037           77 MEYAAG   82 (200)
Q Consensus        77 ~e~~~~   82 (200)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888865

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.69  E-value=0.00046  Score=50.67  Aligned_cols=31  Identities=26%  Similarity=0.337  Sum_probs=24.2

Q ss_pred             CcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037          118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus       118 ~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      .++|+|++|.||++++++. -.-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCC-EEEEECcHhccc
Confidence            4799999999999985432 245999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.63  E-value=0.0033  Score=47.01  Aligned_cols=31  Identities=19%  Similarity=0.245  Sum_probs=26.3

Q ss_pred             CcEeecCCCCCeeecCCCCCCEEEeecCCCccc
Q 029037          118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (200)
Q Consensus       118 ~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~  150 (200)
                      +++|+|+.+.|+++++++.  +.++||..++..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~~d  227 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG--GYFINFEKASFA  227 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC--EEEEEhhhcccC
Confidence            7999999999999976654  899999987643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=97.56  E-value=0.0017  Score=49.91  Aligned_cols=75  Identities=11%  Similarity=0.046  Sum_probs=45.3

Q ss_pred             cccccCCcceEEEEEEEcCCC------cEEEEEEecccccchHHHHHHHHHHhhCCCCCee-eEEEEEecCceEEEEEEe
Q 029037            7 VKDLGAGNFGVARLLRHKETK------ELVAVKYIERGRKIDENVAREIINHRSLRHPNII-RFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~------~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~v~e~   79 (200)
                      .+.+..|-...+|++......      +.|.++.........-+-.+|..+++.+...++. ++++.+..    +++.||
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            345555778899998754321      2255555433322222346688888888655444 45555532    689999


Q ss_pred             cCCCch
Q 029037           80 AAGGEL   85 (200)
Q Consensus        80 ~~~~~L   85 (200)
                      ++|.+|
T Consensus       131 IeGr~l  136 (383)
T PTZ00384        131 VEGNTM  136 (383)
T ss_pred             eccccC
Confidence            998765

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.43  E-value=0.00064  Score=47.81  Aligned_cols=55  Identities=16%  Similarity=0.090  Sum_probs=33.3

Q ss_pred             CcEEEEEEecccccchHHHHHHHHHHhhCCCCCe-eeEEEEEecCceEEEEEEecCCCch
Q 029037           27 KELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus        27 ~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      .+.|++|+........-...+|..+++.+....+ +++++.+..    ..+.+|++|.+|
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE-
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEeccccc
Confidence            3568899888775555677788888887764444 445555433    256688877553

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.33  E-value=0.026  Score=42.15  Aligned_cols=29  Identities=31%  Similarity=0.637  Sum_probs=24.7

Q ss_pred             CCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       117 ~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      .+++|||+.+.|+++++ +  .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C--cEEEEECcccc
Confidence            57899999999999975 3  48999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.14  E-value=0.012  Score=43.45  Aligned_cols=73  Identities=12%  Similarity=0.073  Sum_probs=45.7

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC---CCCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL---RHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      .+.++.|.-..+|+..  .+++.+.+|.-..  .....+..|..-|+.+   ..-.+++++.+...++..+++||+++.+
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4677778888999887  4567789997763  3345677777777766   3456778888887777779999998876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.05  E-value=2.3e-05  Score=68.25  Aligned_cols=153  Identities=16%  Similarity=0.096  Sum_probs=104.5

Q ss_pred             HHHHHHHHhhCCCCCeeeEEEEEec--CceEEEEEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC-
Q 029037           45 VAREIINHRSLRHPNIIRFKEVVLT--PTHLAIVMEYAAGGELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSM-  117 (200)
Q Consensus        45 ~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~-  117 (200)
                      ...|.+.++...|+++.....-..+  +...+..++++.+|.+.+.+.++.    .....-+...-.+.+....-+|+. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3445455566688888766544433  234688899999999999886653    233333333333335555565532 


Q ss_pred             ----CcEeecCCCCCeeecCCCCCCEEEeecCCCcccC-CCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhc
Q 029037          118 ----QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRN  192 (200)
Q Consensus       118 ----~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~  192 (200)
                          --+|+++++.|.+|..+.  .+++.++|+.+..+ .........+++-|+.|++...-+++.++|+|..|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny--~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY--NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC--cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence                257899999999997444  49999999987222 22222334567778888888777888889999999999998


Q ss_pred             CCCCCCC
Q 029037          193 YRPNPFI  199 (200)
Q Consensus       193 ~~~~~pf  199 (200)
                      -.++++|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8887765

>PRK11768 serine/threonine protein kinase; Provisional

Probab=97.02  E-value=0.044  Score=41.34  Aligned_cols=69  Identities=10%  Similarity=0.030  Sum_probs=40.8

Q ss_pred             ceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCC--eeeEE---E--EEecCceEEEEEEecCCCc
Q 029037           15 FGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN--IIRFK---E--VVLTPTHLAIVMEYAAGGE   84 (200)
Q Consensus        15 ~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~---~--~~~~~~~~~~v~e~~~~~~   84 (200)
                      --.||++.... +..+++|+..........+..|...+..+....  ++...   +  ....++..+.++++++|..
T Consensus        38 eN~vy~v~~~~-~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         38 ENRVYQFGDED-GRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cceEEEEecCC-CCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            34688887643 455899988654445566777777776663211  11111   1  1222456788999998753

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.02  E-value=0.008  Score=45.60  Aligned_cols=105  Identities=22%  Similarity=0.251  Sum_probs=68.7

Q ss_pred             ceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           71 THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        71 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      ...|++|++- |+++.. +   +....+++..++.+.+..++-+.. ...-||++...||+|+ .++  |.|+||-+++.
T Consensus       299 ~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn--vtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN--VTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc--eEEEEeeeeec
Confidence            4567888865 545421 2   224678888898888887777764 4678999999999998 454  99999999873


Q ss_pred             cCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhh
Q 029037          150 SVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILF  188 (200)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~  188 (200)
                      ......    ....++-.|-.+.+.+ +...|||-+.-.
T Consensus       371 ~~~q~~----isy~rldhp~lF~G~d-d~QFeIYrlMr~  404 (488)
T COG5072         371 SYSQGI----ISYNRLDHPDLFNGVD-DYQFEIYRLMRR  404 (488)
T ss_pred             ccCCce----eeccccCchhhhcCcc-ceeeeHHHHHHH
Confidence            322221    1222334455555444 566678775433

>PTZ00296 choline kinase; Provisional

Probab=96.98  E-value=0.019  Score=45.13  Aligned_cols=75  Identities=15%  Similarity=0.072  Sum_probs=45.5

Q ss_pred             cccccCCcceEEEEEEEcCC--------CcEEEEEEecccccchHHHHHHHHHHhhCCCCCee-eEEEEEecCceEEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKET--------KELVAVKYIERGRKIDENVAREIINHRSLRHPNII-RFKEVVLTPTHLAIVM   77 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~--------~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~v~   77 (200)
                      .+.|..|-.-.+|++.....        ++.|++|+........-...+|..+++.+....+. ++++.+.    -..+.
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~  185 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIE  185 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEE
Confidence            34555566668888875421        46789998876543333456677777777544444 3444442    25678


Q ss_pred             EecCCCch
Q 029037           78 EYAAGGEL   85 (200)
Q Consensus        78 e~~~~~~L   85 (200)
                      +|++|.+|
T Consensus       186 efi~g~~l  193 (442)
T PTZ00296        186 EWLYGDPL  193 (442)
T ss_pred             EeeCCccC
Confidence            99987643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.94  E-value=0.0088  Score=45.02  Aligned_cols=135  Identities=18%  Similarity=0.191  Sum_probs=77.6

Q ss_pred             cccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCC---CCeee---E----EEEEecCceEEEEEE
Q 029037            9 DLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH---PNIIR---F----KEVVLTPTHLAIVME   78 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~---~----~~~~~~~~~~~~v~e   78 (200)
                      .|.+ .--.+|+....+.+  +++|++... ....++..|+..+..+..   +-.++   .    +.......+.+-+.+
T Consensus        33 ~l~s-~eN~~f~~~~~~g~--~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGR--YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCC--eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 44577888876544  499998887 667778888888877731   21122   1    111111237788899


Q ss_pred             ecCCCchHH------------HHH---h----cC--------CCCHH----H---------HHHHHHHHHHHHHHHH---
Q 029037           79 YAAGGELFD------------RIC---N----AG--------RFSED----E---------GRYFFQQLISGVNYCH---  115 (200)
Q Consensus        79 ~~~~~~L~~------------~l~---~----~~--------~~~~~----~---------~~~~~~~i~~~l~~lh---  115 (200)
                      +++|..+..            .+.   .    .+        ...+.    .         ......++...+..+.   
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            998876551            110   0    00        01111    0         0012223333333333   


Q ss_pred             -----hCC--cEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          116 -----SMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       116 -----~~~--i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                           ..+  ++|+|+.|.||+++.+.. -+-++||+-|+
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence                 234  999999999999986653 36899999875

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.92  E-value=0.011  Score=41.83  Aligned_cols=98  Identities=17%  Similarity=0.126  Sum_probs=63.0

Q ss_pred             EEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHH
Q 029037           30 VAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL  107 (200)
Q Consensus        30 ~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i  107 (200)
                      ..+|.+...+.  ...-+..+.++++++.  .|+++..=  +...+.++.|.|.....             ....++..=
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~N~i~ag  150 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NFSNFITAG  150 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------chhHHHHHh
Confidence            45555554433  3455678888888765  66666521  33457899998854221             112222223


Q ss_pred             HHHHHHHH--hCCcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037          108 ISGVNYCH--SMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus       108 ~~~l~~lh--~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                      +.+|...|  +.+.+|||-.|+||+.|..+.  +||.|=+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhh
Confidence            46677788  347999999999999987775  89988543

The function of this family is unknown.

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=96.47  E-value=0.027  Score=42.31  Aligned_cols=92  Identities=20%  Similarity=0.304  Sum_probs=67.0

Q ss_pred             HHHHHHHhhC-----CCCCeeeEEEEEecCceEEEEEEecCCCch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCC
Q 029037           46 AREIINHRSL-----RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ  118 (200)
Q Consensus        46 ~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~  118 (200)
                      ++|+-.|.++     .+|-++.+       ....+||-++...-+ .-.+ +...++..+....-.|+...+.-| |++-
T Consensus       333 EkEmhNL~RMq~~GlpcP~vV~l-------kkhvLVMsFiGd~~~aAPkL-K~v~l~d~E~~~aY~q~~~~M~~lY~Ec~  404 (531)
T KOG2269|consen  333 EKEMHNLSRMQKHGLPCPQVVKL-------KKHVLVMSFIGDQGLAAPKL-KNVELTDDERRNAYDQVQSIMCRLYKECL  404 (531)
T ss_pred             HHHHHHHHHHHhcCCCCCceeee-------ecceEEEEeecCCCCCCccc-cccccChHHHHHHHHHHHHHHHHHHHhhh
Confidence            3455555554     45666655       345889999855333 2222 444588889999899999988877 6889


Q ss_pred             cEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       119 i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      +||.|++--|+++.++   .+.++|...+.
T Consensus       405 LVHADlSEyN~Lw~~g---Kvw~IDVsQsv  431 (531)
T KOG2269|consen  405 LVHADLSEYNLLWTPG---KVWVIDVSQSV  431 (531)
T ss_pred             eeecchhhhhheecCC---ceEEEechhcc
Confidence            9999999999999754   48999988765

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.09  E-value=0.076  Score=41.20  Aligned_cols=59  Identities=17%  Similarity=0.112  Sum_probs=40.9

Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCcEeecCCCCCeeec
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY-CHSMQICHRDLKLENTLLD  132 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~-lh~~~i~h~dl~~~ni~i~  132 (200)
                      ..++-++..|-++..++.. ...++.....++.-.+.|+.. +--.+.+|.|+.|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            4566677778788887743 334445566666555666544 3467899999999999984

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	200
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-92
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-91
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-91
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-91
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-91
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-89
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-35
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-35
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-35
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-35
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-34
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-34
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-34
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-34
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-34
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-34
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-34
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-34
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-34
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-33
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-32
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-32
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-32
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-32
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-28
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-28
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-28
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-28
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-28
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-28
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-28
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-28
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-28
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-28
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-28
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-28
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-28
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-27
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-27
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-27
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-27
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-27
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-27
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-27
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-27
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-27
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-27
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-27
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-27
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-27
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-27
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-27
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-27
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-27
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-27
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-27
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-27
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-26
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-26
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-26
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-26
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-26
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-25
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-25
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-25
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-25
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-25
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-25
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-25
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-25
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-25
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-25
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-25
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-25
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-25
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-25
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-25
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-25
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-25
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-25
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-24
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-24
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-24
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-24
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-24
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-24
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-24
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-24
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-24
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-24
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-24
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-24
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-24
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-24
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-24
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-24
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-24
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-24
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-24
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-24
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-24
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-24
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-24
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-24
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-24
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-24
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-24
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-24
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-24
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-24
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-24
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-24
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-24
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-24
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-24
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-24
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-24
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-24
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-24
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-24
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-24
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-24
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-24
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-24
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-24
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-24
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-24
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-24
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-24
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-24
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-24
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-24
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-24
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-24
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-24
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-24
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-24
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-24
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-24
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-24
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-24
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-24
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-24
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-24
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-24
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-23
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-23
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-23
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-23
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-23
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-23
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-23
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-23
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-23
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-23
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-23
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-23
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-23
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-23
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-23
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-23
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-23
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-23
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-23
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-23
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-23
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-23
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-23
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-22
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-22
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-22
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-22
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-22
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-22
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-22
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-22
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-22
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-22
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-22
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-22
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-21
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-21
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-21
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-21
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-21
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-21
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-21
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-21
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-21
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-21
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-21
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-20
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-20
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-20
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-20
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-20
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-20
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-20
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-20
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-19
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-19
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-19
3soa_A	444	Full-Length Human Camkii Length = 444		3e-19
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-19
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-19
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-18
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-18
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-18
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-18
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-18
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-18
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-18
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-18
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-18
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-18
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-18
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-18
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-18
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-17
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-17
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-17
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-17
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-17
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-17
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-17
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-17
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-17
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-17
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-16
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-16
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-15
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-15
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-15
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-14
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-13
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-12
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-12
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-12
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		5e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		4e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-07
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-07
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-06
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-06
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		8e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-06
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		9e-06
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		9e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-06
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-05
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		4e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-05
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-05
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-05
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-04
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		6e-04
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		8e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-04

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  334 bits (856), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 154/180 (85%), Positives = 172/180 (95%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 77
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct: 78  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 137
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL ++EYDGKV 
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 197

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  331 bits (848), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 153/180 (85%), Positives = 171/180 (95%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           RDLKLENTLLDGS APRLKIC FGYSKSSVLHS+PKSTVGTPAYIAPEVL ++EYDGKV 
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  330 bits (845), Expect = 4e-91,   Method: Compositional matrix adjust.
 Identities = 152/179 (84%), Positives = 170/179 (94%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++Y+ VKD+G+GNFGVARL+R K TKELVAVKYIERG  IDENV REIINHRSLRHPNI+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAI+MEYA+GGEL++RICNAGRFSEDE R+FFQQL+SGV+YCHSMQICH
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL R+EYDGK+
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  329 bits (844), Expect = 6e-91,   Method: Compositional matrix adjust.
 Identities = 152/180 (84%), Positives = 170/180 (94%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           RDLKLENTLLDGS APRLKIC FGYSKSSVLHS+PK TVGTPAYIAPEVL ++EYDGKV 
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVA 198

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  328 bits (842), Expect = 8e-91,   Method: Compositional matrix adjust.
 Identities = 152/180 (84%), Positives = 170/180 (94%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KI  NV REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL ++EYDGKV 
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  323 bits (827), Expect = 6e-89,   Method: Compositional matrix adjust.
 Identities = 150/180 (83%), Positives = 167/180 (92%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+GAGNFGVARL+R K+  ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+Y H+MQ+ H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAH 138
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           RDLKLENTLLDGS APRLKI DFGYSK+SVLHS+PKS VGTPAYIAPEVL ++EYDGKV 
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVA 198

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/179 (45%), Positives = 106/179 (59%), Gaps = 6/179 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKID--ENVAREIINHRSLRHPN 59
           Y L   LG G FG  ++ +H+ T   VAVK + R   R +D    + REI N +  RHP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ TP+ + +VMEY +GGELFD IC  GR  E E R  FQQ++SGV+YCH   +
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN LLD  A    KI DFG S         + + G+P Y APEV+S R Y G
Sbjct: 138 VHRDLKPENVLLD--AHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAG 194

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  144 bits (364), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/179 (45%), Positives = 114/179 (63%), Gaps = 7/179 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDEN--VAREIINHRSLRHPN 59
           Y + + LG G+FG  +L  H +T++ VA+K+I R   +K D +  V REI   + LRHP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ TPT + +V+EYA GGELFD I    R +EDEGR FFQQ+I  + YCH  +I
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV++ + Y G
Sbjct: 130 VHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 82/179 (45%), Positives = 104/179 (58%), Gaps = 6/179 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKID--ENVAREIINHRSLRHPN 59
           Y L   LG G FG  ++  H+ T   VAVK + R   R +D    + REI N +  RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ TPT   +VMEY +GGELFD IC  GR  E E R  FQQ++S V+YCH   +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN LLD  A    KI DFG S         +++ G+P Y APEV+S R Y G
Sbjct: 133 VHRDLKPENVLLD--AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  144 bits (362), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 82/179 (45%), Positives = 103/179 (57%), Gaps = 6/179 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKID--ENVAREIINHRSLRHPN 59
           Y L   LG G FG  ++  H+ T   VAVK + R   R +D    + REI N +  RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ TPT   +VMEY +GGELFD IC  GR  E E R  FQQ++S V+YCH   +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN LLD  A    KI DFG S         + + G+P Y APEV+S R Y G
Sbjct: 133 VHRDLKPENVLLD--AHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAG 189

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  142 bits (358), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 76/178 (42%), Positives = 105/178 (58%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNI 60
           Y L K +G GNF   +L RH  T   VAVK I++ +      + + RE+   + L HPNI
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIV 136
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LLDG     +KI DFG+S    + ++  +  G+P Y APE+   ++YDG
Sbjct: 137 HRDLKAENLLLDGDM--NIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 192

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  142 bits (357), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 76/178 (42%), Positives = 106/178 (59%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAVK I++ +    ++    RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G+P Y APE+   ++YDG
Sbjct: 136 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  142 bits (357), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 76/178 (42%), Positives = 106/178 (59%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAVK I++ +    ++    RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G+P Y APE+   ++YDG
Sbjct: 136 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  141 bits (355), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 76/178 (42%), Positives = 105/178 (58%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAVK I++ +    ++    RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G P Y APE+   ++YDG
Sbjct: 136 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  141 bits (355), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 74/178 (41%), Positives = 106/178 (59%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T   VA+K I++ +      + + RE+   + L HPNI
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L ++MEYA+GGE+FD +   GR  E E R  F+Q++S V YCH  +I 
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LLD  A   +KI DFG+S    +  +  +  G+P Y APE+   ++YDG
Sbjct: 134 HRDLKAENLLLD--ADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDG 189

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 75/178 (42%), Positives = 106/178 (59%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAV+ I++ +    ++    RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G+P Y APE+   ++YDG
Sbjct: 136 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  140 bits (353), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 74/178 (41%), Positives = 105/178 (58%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T   VA+K I++ +      + + RE+   + L HPNI
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L ++MEYA+GGE+FD +   GR  E E R  F+Q++S V YCH  +I 
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LLD  A   +KI DFG+S    +  +  +  G P Y APE+   ++YDG
Sbjct: 137 HRDLKAENLLLD--ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  140 bits (352), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 75/178 (42%), Positives = 105/178 (58%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAV+ I++ +    ++    RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LLD  A   +KI DFG+S      ++     G+P Y APE+   ++YDG
Sbjct: 136 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  139 bits (351), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 75/178 (42%), Positives = 105/178 (58%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAVK I++ +    ++    RE+   + L HPNI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   G   E E R  F+Q++S V YCH   I 
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G+P Y APE+   ++YDG
Sbjct: 129 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 75/178 (42%), Positives = 104/178 (58%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAVK I++ +    ++    RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +V EYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G P Y APE+   ++YDG
Sbjct: 136 HRDLKAENLLLD--ADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  134 bits (338), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/179 (43%), Positives = 105/179 (58%), Gaps = 7/179 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPN 59
           Y++VK LG G+FG  +L  H  T + VA+K I +       +   + REI   R LRHP+
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELFD I    + SE E R FFQQ+IS V YCH  +I
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G
Sbjct: 135 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/179 (43%), Positives = 105/179 (58%), Gaps = 7/179 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPN 59
           Y++VK LG G+FG  +L  H  T + VA+K I +       +   + REI   R LRHP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELFD I    + SE E R FFQQ+IS V YCH  +I
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G
Sbjct: 125 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/179 (43%), Positives = 105/179 (58%), Gaps = 7/179 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPN 59
           Y++VK LG G+FG  +L  H  T + VA+K I +       +   + REI   R LRHP+
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELFD I    + SE E R FFQQ+IS V YCH  +I
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G
Sbjct: 129 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/179 (43%), Positives = 105/179 (58%), Gaps = 7/179 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPN 59
           Y++VK LG G+FG  +L  H  T + VA+K I +       +   + REI   R LRHP+
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELFD I    + SE E R FFQQ+IS V YCH  +I
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G
Sbjct: 134 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  121 bits (304), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 66/178 (37%), Positives = 103/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTPA++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVN 190

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  121 bits (303), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 65/180 (36%), Positives = 103/180 (57%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRS 54
           + YE+ ++LG+G F + R  R K T +  A K+I++ R          E + RE+   R 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           +RHPNII   ++    T + +++E  +GGELFD +      +EDE   F +Q++ GV+Y 
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 145
Query: 115 HSMQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           HS +I H DLK EN  LLD +   PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 146 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 205

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  120 bits (302), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           YE+ ++LG+G F + R  R K T +  A K+I++ R          E + RE+   R +R
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNII   ++    T + +++E  +GGELFD +      +EDE   F +Q++ GV+Y HS
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 191

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  120 bits (302), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           YE+ ++LG+G F + R  R K T +  A K+I++ R          E + RE+   R +R
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNII   ++    T + +++E  +GGELFD +      +EDE   F +Q++ GV+Y HS
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  119 bits (299), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  119 bits (299), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  119 bits (299), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  119 bits (299), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  119 bits (299), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  119 bits (299), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  119 bits (299), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  119 bits (299), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  119 bits (299), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  118 bits (295), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  118 bits (295), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  118 bits (295), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  118 bits (295), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  118 bits (295), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  118 bits (295), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  118 bits (295), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  118 bits (295), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  118 bits (295), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 124 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 176 Y 176
           +
Sbjct: 182 F 182

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  117 bits (294), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 101/178 (56%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + ++ E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  117 bits (294), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  117 bits (293), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  117 bits (292), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 65/180 (36%), Positives = 96/180 (53%), Gaps = 3/180 (1%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNII 61
           +E  + LG G F    L   K T +L AVK I +   +  + ++  EI   R ++H NI+
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             +++  +P HL +VM+  +GGELFDRI   G ++E +     +Q++  V Y H M I H
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 122 RDLKLENTL-LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           RDLK EN L        ++ I DFG SK         +  GTP Y+APEVL+++ Y   V
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAV 203

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  116 bits (291), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 104/181 (57%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  +  L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  115 bits (289), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 104/181 (57%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G  G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  114 bits (286), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/180 (39%), Positives = 100/180 (55%), Gaps = 6/180 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR-EIINHRSLRHPNIIR 62
           +E+  +LG G   +    + K T++  A+K +++   +D+ + R EI     L HPNII+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
            KE+  TPT +++V+E   GGELFDRI   G +SE +     +Q++  V Y H   I HR
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 123 DLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           DLK EN LL  + AP   LKI DFG SK        K+  GTP Y APE+L    Y  +V
Sbjct: 173 DLKPEN-LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEV 231

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  114 bits (286), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 76/203 (37%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHP 58
           E+Y +V  LG G+FG     + + T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  E++   +   IV E   GGELFD I    RFSE +     +Q+ SG+ Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GKVCILL--LILFLWRNYRPNPF 198
            K  +    +IL++  +  P PF
Sbjct: 201 EKCDVWSAGVILYILLSGTP-PF 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  114 bits (285), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/182 (39%), Positives = 97/182 (53%), Gaps = 5/182 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHP 58
           E+Y +V  LG G+FG     + + T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  E++   +   IV E   GGELFD I    RFSE +     +Q+ SG+ Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GK 179
            K
Sbjct: 201 EK 202

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  114 bits (284), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/182 (39%), Positives = 97/182 (53%), Gaps = 5/182 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHP 58
           E+Y +V  LG G+FG     + + T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  E++   +   IV E   GGELFD I    RFSE +     +Q+ SG+ Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GK 179
            K
Sbjct: 201 EK 202

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 97/173 (56%), Gaps = 3/173 (1%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVL 68
           LG+G F    L++ + T +L A+K I++     D ++  EI   + ++H NI+  +++  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
           + TH  +VM+  +GGELFDRI   G ++E +     QQ++S V Y H   I HRDLK EN
Sbjct: 77  STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPEN 136
Query: 129 TL-LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
            L L      ++ I DFG SK    +    +  GTP Y+APEVL+++ Y   V
Sbjct: 137 LLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPYSKAV 188

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 97/182 (53%), Gaps = 7/182 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           Y+    LG G F    L   K T++LVA+K I  E     + ++  EI     ++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
              ++  +  HL ++M+  +GGELFDRI   G ++E +      Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 179 KV 180
            V
Sbjct: 198 AV 199

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 97/182 (53%), Gaps = 7/182 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           Y+    LG G F    L   K T++LVA+K I  E     + ++  EI     ++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
              ++  +  HL ++M+  +GGELFDRI   G ++E +      Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 179 KV 180
            V
Sbjct: 198 AV 199

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH--- 57
           ++++E ++ LG G+FG   L++HKET    A+K +++ + +        +N + ++    
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 58  -PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +V+EYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 97/182 (53%), Gaps = 7/182 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           Y+    LG G F    L   K T++LVA+K I  E     + ++  EI     ++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
              ++  +  HL ++M+  +GGELFDRI   G ++E +      Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 179 KV 180
            V
Sbjct: 198 AV 199

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 97/182 (53%), Gaps = 7/182 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNII 61
           Y+    LG G F    L   K T++LVA+K I +      + ++  EI     ++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
              ++  +  HL ++M+  +GGELFDRI   G ++E +      Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 179 KV 180
            V
Sbjct: 198 AV 199

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  110 bits (274), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 65/173 (37%), Positives = 98/173 (56%), Gaps = 5/173 (2%)
Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEV 66
           K LG G+F + R   HK++ +  AVK I   ++++ N  +EI   +    HPNI++  EV
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 67  VLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKL 126
                H  +VME   GGELF+RI     FSE E  Y  ++L+S V++ H + + HRDLK 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 127 ENTLL-DGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVLSRREYD 177
           EN L  D +    +KI DFG+++     ++P K+   T  Y APE+L++  YD
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD 187

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  110 bits (274), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 153 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 177 DGKV 180
           +  V
Sbjct: 209 NKAV 212

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  109 bits (273), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLAGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  109 bits (273), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  109 bits (273), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 177 DGKV---CILLLILFLWRNYRP 195
           +  V    + +LI  +   Y P
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPP 258

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  109 bits (273), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 106/189 (56%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  GE++  +    +F E     +  +L + ++YCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 189 DEKVDLWSL 197

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLXGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/175 (38%), Positives = 97/175 (55%), Gaps = 5/175 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKID-ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 118 QICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 200

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/175 (38%), Positives = 97/175 (55%), Gaps = 5/175 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKID-ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 151
Query: 118 QICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 206

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 109/195 (55%), Gaps = 8/195 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKVCILLLILFLWR 191
           +  V    L + +++
Sbjct: 216 NKAVDWWALGVLIYQ 230

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 86
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 147 LDLIYRDLKPENLLIDEQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 202
Query: 177 DGKV 180
           +  V
Sbjct: 203 NKAV 206

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 98/178 (55%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNII   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 105/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  GE++  +    +F E     +  +L + ++YCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRXXLXGTLDYLPPEMIEGRMH 188
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 189 DEKVDLWSL 197

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/175 (38%), Positives = 97/175 (55%), Gaps = 5/175 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKID-ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 168
Query: 118 QICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 105/197 (53%), Gaps = 10/197 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRH 57
           ++Y+ VK LG+G +G   L + K T    A+K I++      + +  +++     + L H
Sbjct: 21  DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +VME   GGELFD I    +FSE +     +Q++SG  Y H  
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 118 QICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HRDLK EN LL+  +   L KI DFG S    +  + K  +GT  YIAPEVL R++Y
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKY 199
Query: 177 DGKV----CILLLILFL 189
           D K     C ++L + L
Sbjct: 200 DEKCDVWSCGVILYILL 216

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/175 (38%), Positives = 97/175 (55%), Gaps = 5/175 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKID-ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 169
Query: 118 QICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 224

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R  +  GTP Y+APE++  + Y
Sbjct: 146 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 177 DGKV 180
           +  V
Sbjct: 202 NKAV 205

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 105/197 (53%), Gaps = 10/197 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRH 57
           ++Y+ VK LG+G +G   L + K T    A+K I++      + +  +++     + L H
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +VME   GGELFD I    +FSE +     +Q++SG  Y H  
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 118 QICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HRDLK EN LL+  +   L KI DFG S    +  + K  +GT  YIAPEVL R++Y
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKY 182
Query: 177 DGKV----CILLLILFL 189
           D K     C ++L + L
Sbjct: 183 DEKCDVWSCGVILYILL 199

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 74/201 (36%), Positives = 103/201 (51%), Gaps = 8/201 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRHP 58
           E Y+ VK LG+G +G   L R K T    A+K I +       +  +  E+   + L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  +      +  +VME   GGELFD I +  +F+E +     +Q++SGV Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 119 ICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+      L KI DFG S       + K  +GT  YIAPEVL R++YD
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYD 215
Query: 178 GKV---CILLLILFLWRNYRP 195
            K     I +++  L   Y P
Sbjct: 216 EKCDVWSIGVILFILLAGYPP 236

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 95/181 (52%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 176 Y 176
           Y
Sbjct: 182 Y 182

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 95/181 (52%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 176 Y 176
           Y
Sbjct: 182 Y 182

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R  +  GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 153 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 177 DGKV 180
           +  V
Sbjct: 209 NKAV 212

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 95/181 (52%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 7   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 127 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 176 Y 176
           Y
Sbjct: 185 Y 185

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLIIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIIISKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 104/184 (56%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF+E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K +G G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/182 (37%), Positives = 100/182 (54%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M ++E +K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   R
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 117 MQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRR 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   
Sbjct: 267 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 175 EY 176
           +Y
Sbjct: 325 DY 326

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG +K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQG--YIKVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  107 bits (268), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 68/182 (37%), Positives = 100/182 (54%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M ++E +K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   R
Sbjct: 150 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 209
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS
Sbjct: 210 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 269
Query: 117 MQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRR 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   
Sbjct: 270 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 175 EY 176
           +Y
Sbjct: 328 DY 329

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  107 bits (268), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 68/175 (38%), Positives = 96/175 (54%), Gaps = 5/175 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKID-ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI +  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 86  PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN 145
Query: 118 QICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL 200

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 94/181 (51%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 9   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 128
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 129 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 176 Y 176
           Y
Sbjct: 187 Y 187

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 111/202 (54%), Gaps = 11/202 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +     +  GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGATWTLCGTPEYLAPEIILSKGY 236
Query: 177 DGKV---CILLLILFLWRNYRP 195
           +  V    + +LI  +   Y P
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPP 258

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 94/181 (51%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 176 Y 176
           Y
Sbjct: 182 Y 182

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 94/181 (51%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 176 Y 176
           Y
Sbjct: 182 Y 182

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 177 DGKV---CILLLILFLWRNYRP 195
           +  V    + +LI  +   Y P
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPP 258

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  107 bits (267), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 94/181 (51%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 176 Y 176
           Y
Sbjct: 182 Y 182

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  107 bits (267), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 68/182 (37%), Positives = 99/182 (54%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M ++E +K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   R
Sbjct: 7   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 126
Query: 117 MQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRR 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   
Sbjct: 127 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 175 EY 176
           +Y
Sbjct: 185 DY 186

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  107 bits (267), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 154
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 155 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 210
Query: 177 DGKV 180
           +  V
Sbjct: 211 NKAV 214

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 68/182 (37%), Positives = 99/182 (54%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M ++E +K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   R
Sbjct: 8   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 127
Query: 117 MQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRR 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   
Sbjct: 128 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 175 EY 176
           +Y
Sbjct: 186 DY 187

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  107 bits (266), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 68/182 (37%), Positives = 99/182 (54%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M ++E +K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   R
Sbjct: 9   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 128
Query: 117 MQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRR 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   
Sbjct: 129 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 175 EY 176
           +Y
Sbjct: 187 DY 188

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  107 bits (266), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 103/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKV 180
           D KV
Sbjct: 187 DEKV 190

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+AP ++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPAIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  106 bits (265), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 103/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 6   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 65
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 66  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 125
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 126 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 182
Query: 177 DGKV 180
           D KV
Sbjct: 183 DEKV 186

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  106 bits (265), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 103/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 11  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGKV 180
           D KV
Sbjct: 188 DEKV 191

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 105/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRDTLCGTLDYLPPEMIEGRMH 184
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 185 DEKVDLWSL 193

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  106 bits (265), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 101/184 (54%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  106 bits (265), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 103/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKV 180
           D KV
Sbjct: 184 DEKV 187

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  106 bits (265), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 103/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMH 183
Query: 177 DGKV 180
           D KV
Sbjct: 184 DEKV 187

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +++ DFG +K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQG--YIQVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 103/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKV 180
           D KV
Sbjct: 187 DEKV 190

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K +G G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GG++F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K +G G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GG++F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 103/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 177 DGKV 180
           D KV
Sbjct: 189 DEKV 192

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 103/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMH 186
Query: 177 DGKV 180
           D KV
Sbjct: 187 DEKV 190

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 105/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 24  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 83
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 84  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 143
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 144 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 200
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 201 DEKVDLWSL 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S      SR  +  GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GSAG-ELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMH 184
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 185 DEKVDLWSL 193

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE +  R +
Sbjct: 132 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEXIEGRXH 188
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 189 DEKVDLWSL 197

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 187 DEKVDLWSL 195

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 105/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 153 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 209
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 210 DEKVDLWSL 218

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 102/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKV 180
           D KV
Sbjct: 184 DEKV 187

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 102/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKV 180
           D KV
Sbjct: 184 DEKV 187

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 102/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTXLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKV 180
           D KV
Sbjct: 184 DEKV 187

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 185 DEKVDLWSL 193

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 102/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKV 180
           D KV
Sbjct: 184 DEKV 187

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 102/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKV 180
           D KV
Sbjct: 187 DEKV 190

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 102/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K +K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KKVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMH 183
Query: 177 DGKV 180
           D KV
Sbjct: 184 DEKV 187

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTELCGTLDYLPPEMIEGRMH 183
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 184 DEKVDLWSL 192

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 188
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 189 DEKVDLWSL 197

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 103/184 (55%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP  +APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEALAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 102/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K+ K ++A+K + + +     ++  + RE+     LR
Sbjct: 4   LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 64  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 124 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 177 DGKV 180
           D KV
Sbjct: 181 DEKV 184

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 101/184 (54%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 101/184 (54%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKV 180
           +  V
Sbjct: 217 NKAV 220

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 129 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMH 185
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 186 DEKVDLWSL 194

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 101/184 (54%), Gaps = 8/184 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 7/189 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 153 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMH 209
Query: 177 DGKVCILLL 185
           D KV +  L
Sbjct: 210 DEKVDLWSL 218

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 99/188 (52%), Gaps = 15/188 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDEN---------VAR 47
           E Y  V+ LG+G +G   L + K      A+K I     ++GR  D+N         +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 48  EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           EI   +SL HPNII+  +V     +  +V E+  GGELF++I N  +F E +     +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
           +SG+ Y H   I HRD+K EN LL+  ++   +KI DFG S       + +  +GT  YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 167 APEVLSRR 174
           APEVL ++
Sbjct: 216 APEVLKKK 223

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 103/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI +FG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIANFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKV 180
           D KV
Sbjct: 187 DEKV 190

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 61/183 (33%), Positives = 97/183 (53%), Gaps = 8/183 (4%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-----RHP 58
           +  +K +G G+FG   L RHK  +   AVK +++   + +   + I++ R++     +HP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
            ++       T   L  V++Y  GGELF  +     F E   R++  ++ S + Y HS+ 
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL ++ YD
Sbjct: 160 IVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 178 GKV 180
             V
Sbjct: 218 RTV 220

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 99/184 (53%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           ++ +++V+ LG G FG   L R K+ K ++A+K + + +     ++  + REI     LR
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R          + +++E+A  GEL+  +   GRF E     F ++L   ++YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN L+       LKI DFG+S  +    R +   GT  Y+ PE++  + +
Sbjct: 133 RKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPSLRR-RXMCGTLDYLPPEMIEGKTH 189
Query: 177 DGKV 180
           D KV
Sbjct: 190 DEKV 193

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 103/184 (55%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI +FG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 129 KRVIHRDIKPENLLL-GSAG-ELKIANFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 185
Query: 177 DGKV 180
           D KV
Sbjct: 186 DEKV 189

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 101/184 (54%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +++ + LG G FG   L R +++K ++A+K + + +     ++  + RE+     LR
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    RF E     +  +L + ++YCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL  +    LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLLGSNG--ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGKV 180
           D KV
Sbjct: 188 DEKV 191

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 101/184 (54%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +++ + LG G FG   L R +++K ++A+K + + +     ++  + RE+     LR
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    RF E     +  +L + ++YCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL  +    LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLLGSNG--ELKIADFGWSVHAP-SSRRDTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGKV 180
           D KV
Sbjct: 188 DEKV 191

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  103 bits (257), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 65/186 (34%), Positives = 97/186 (52%), Gaps = 8/186 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---- 55
           ++ +E ++ LG G+FG   L R KET +L AVK +++   + D++V   +   R L    
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP + +      TP  L  VME+  GG+L   I  + RF E   R++  ++IS + + H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRR 174
              I +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+L   
Sbjct: 142 DKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 175 EYDGKV 180
            Y   V
Sbjct: 200 LYGPAV 205

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/170 (36%), Positives = 90/170 (52%), Gaps = 2/170 (1%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           Y L   +G G++G  ++   K T+   A K I +    D +   +EI   +SL HPNIIR
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
             E     T + +VME   GGELF+R+ +   F E +     + ++S V YCH + + HR
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 147
Query: 123 DLKLENTL-LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           DLK EN L L  S    LK+ DFG +         ++ VGTP Y++P+VL
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 197

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/170 (36%), Positives = 90/170 (52%), Gaps = 2/170 (1%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           Y L   +G G++G  ++   K T+   A K I +    D +   +EI   +SL HPNIIR
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
             E     T + +VME   GGELF+R+ +   F E +     + ++S V YCH + + HR
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 123 DLKLENTL-LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           DLK EN L L  S    LK+ DFG +         ++ VGTP Y++P+VL
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 98/184 (53%), Gaps = 7/184 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           ++ +++ + LG G FG   L R K+ K ++A+K + + +     ++  + REI     LR
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R          + +++E+A  GEL+  +   GRF E     F ++L   ++YCH 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 133
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN L+       LKI DFG+S  +    R +   GT  Y+ PE++  + +
Sbjct: 134 RKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPSLRR-RXMCGTLDYLPPEMIEGKTH 190
Query: 177 DGKV 180
           D KV
Sbjct: 191 DEKV 194

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/196 (35%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
            + YE+ +D+G G++ V +   HK T    AVK I++ ++ D     EI+  R  +HPNI
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKR-DPTEEIEIL-LRYGQHPNI 78
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           I  K+V     ++ +V E   GGEL D+I     FSE E       +   V Y H+  + 
Sbjct: 79  ITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 121 HRDLKLENTL-LDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAY----IAPEVLSRR 174
           HRDLK  N L +D S  P  ++ICDFG++K   L +     + TP Y    +APEVL R+
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAE-NGLLXTPCYTANFVAPEVLERQ 195
Query: 175 EYDGKVCILLLILFLW 190
            YD    I  L + L+
Sbjct: 196 GYDAACDIWSLGVLLY 211

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  100 bits (250), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           + YE+ +D+G G++ V +   HK T    AVK I++ ++ D     EI+  R  +HPNII
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEIL-LRYGQHPNII 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             K+V     ++ +V E   GGEL D+I     FSE E       +   V Y H+  + H
Sbjct: 80  TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 122 RDLKLENTL-LDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAY----IAPEVLSRRE 175
           RDLK  N L +D S  P  ++ICDFG++K   L +     + TP Y    +APEVL R+ 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLERQG 196
Query: 176 YDGKVCILLLILFLW 190
           YD    I  L + L+
Sbjct: 197 YDAACDIWSLGVLLY 211

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  100 bits (248), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           + Y++ ++LG G F V R   HK T    A K I   +   +  + + RE    R L+HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HR+LK EN LL   A    +K+ DFG +             GTP Y++PEVL +  Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 178 GKV----CILLLILFL 189
             V    C ++L + L
Sbjct: 186 KPVDIWACGVILYILL 201

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  100 bits (248), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 63/186 (33%), Positives = 99/186 (53%), Gaps = 8/186 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---- 55
           +E +EL K LG G+FG   L   K+T +  A+K +++   + D++V   ++  R L    
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP +        T  +L  VMEY  GG+L   I +  +F      ++  ++I G+ + H
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVGTPAYIAPEVLSRR 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+L  +
Sbjct: 137 SKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 175 EYDGKV 180
           +Y+  V
Sbjct: 195 KYNHSV 200

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           + Y++ ++LG G F V R   HK T    A K I   +   +  + + RE    R L+HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HR+LK EN LL   A    +K+ DFG +             GTP Y++PEVL +  Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 178 GKV----CILLLILFL 189
             V    C ++L + L
Sbjct: 186 KPVDIWACGVILYILL 201

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  100 bits (248), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           + Y++ ++LG G F V R   HK T    A K I   +   +  + + RE    R L+HP
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS  
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 124
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HR+LK EN LL   A    +K+ DFG +             GTP Y++PEVL +  Y 
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 184
Query: 178 GKV----CILLLILFL 189
             V    C ++L + L
Sbjct: 185 KPVDIWACGVILYILL 200

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 99.8 bits (247), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           + Y++ ++LG G F V R   HK T    A K I   +   +  + + RE    R L+HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS  
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HR+LK EN LL   A    +K+ DFG +             GTP Y++PEVL +  Y 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 208
Query: 178 GKV----CILLLILFL 189
             V    C ++L + L
Sbjct: 209 KPVDIWACGVILYILL 224

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 99.8 bits (247), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +        R+ D   NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +        R+ D   NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +        R+ D   NV  EI   
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +        R+ D   NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +        R+ D   NV  EI   
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 60/165 (36%), Positives = 84/165 (50%), Gaps = 2/165 (1%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           LG G FG         T   +A K I+ RG K  E V  EI     L H N+I+  +   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 69  TPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
           +   + +VMEY  GGELFDRI +     +E +   F +Q+  G+ + H M I H DLK E
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216
Query: 128 NTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           N L     A ++KI DFG ++      + K   GTP ++APEV++
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 18/201 (8%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH 57
           MEKY  ++ +G G+FG A L++  E      +K I   R   K  E   RE+    +++H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYC 114
           PNI++++E       L IVM+Y  GG+LF RI NA +   F ED+   +F Q+   + + 
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 115 HSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPE 169
           H  +I HRD+K +N  L  DG+    +++ DFG ++  VL+S     ++ +GTP Y++PE
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT----VQLGDFGIAR--VLNSTVELARACIGTPYYLSPE 195
Query: 170 VLSRREYDGKVCILLLILFLW 190
           +   + Y+ K  I  L   L+
Sbjct: 196 ICENKPYNNKSDIWALGCVLY 216

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA++ I +        R+ D   NV  EI   
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 209 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA++ I +        R+ D   NV  EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 104/181 (57%), Gaps = 13/181 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-----KIDENVAREIINHRS 54
           ++EL+K LG G+FG   L++     + ++L A+K +++       ++   + R+I+    
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 83
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   +++ 
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSR 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 144 HSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 174 R 174
           R
Sbjct: 202 R 202

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 104/181 (57%), Gaps = 13/181 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-----KIDENVAREIINHRS 54
           ++EL+K LG G+FG   L++     + ++L A+K +++       ++   + R+I+    
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   +++ 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSR 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 143 HSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 174 R 174
           R
Sbjct: 201 R 201

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 97.8 bits (242), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 104/181 (57%), Gaps = 13/181 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-----KIDENVAREIINHRS 54
           ++EL+K LG G+FG   L++     + ++L A+K +++       ++   + R+I+    
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   +++ 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSR 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 143 HSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 174 R 174
           R
Sbjct: 201 R 201

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 97.4 bits (241), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/195 (35%), Positives = 100/195 (51%), Gaps = 11/195 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           + Y + + +G G++   +   HK T    AVK I++ ++ D +   EI+  R  +HPNII
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKR-DPSEEIEIL-LRYGQHPNII 84
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             K+V     H+ +V E   GGEL D+I     FSE E  +    +   V Y HS  + H
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVH 144
Query: 122 RDLKLENTL-LDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAY----IAPEVLSRRE 175
           RDLK  N L +D S  P  L+ICDFG++K     +     + TP Y    +APEVL R+ 
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN---GLLMTPCYTANFVAPEVLKRQG 201
Query: 176 YDGKVCILLLILFLW 190
           YD    I  L + L+
Sbjct: 202 YDEGCDIWSLGILLY 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 97.4 bits (241), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           + Y + + +G G++   +   HK T    AVK I++ ++ D +   EI+  R  +HPNII
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKR-DPSEEIEIL-LRYGQHPNII 84
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             K+V     H+ +V E   GGEL D+I     FSE E  +    +   V Y HS  + H
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVH 144
Query: 122 RDLKLENTL-LDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAY----IAPEVLSRRE 175
           RDLK  N L +D S  P  L+ICDFG++K   L +     + TP Y    +APEVL R+ 
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQG 201
Query: 176 YDGKVCILLLILFLW 190
           YD    I  L + L+
Sbjct: 202 YDEGCDIWSLGILLY 216

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 98/186 (52%), Gaps = 8/186 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---- 55
           +E + L K LG G+FG   L   K+T +  A+K +++   + D++V   ++  R L    
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP +        T  +L  VMEY  GG+L   I +  +F      ++  ++I G+ + H
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVGTPAYIAPEVLSRR 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+L  +
Sbjct: 136 SKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 175 EYDGKV 180
           +Y+  V
Sbjct: 194 KYNHSV 199

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 103/180 (57%), Gaps = 13/180 (7%)
Query: 4   YELVKDLGAGNFGVARLLR---HKETKELVAVKYIERGR-----KIDENVAREIINHRSL 55
           +EL+K LG G+FG   L+R     ++  L A+K +++       ++   + R+I+    +
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILA--DV 87
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP +++      T   L +++++  GG+LF R+     F+E++ +++  +L  G+++ H
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRR 174
           S+ I +RDLK EN LLD      +K+ DFG SK ++ H +   S  GT  Y+APEV++R+
Sbjct: 148 SLGIIYRDLKPENILLDEEG--HIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQ 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           ++Y+L ++LG G F V R      T +  A K I   +   +  + + RE    R L+HP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +       +V +   GGELF+ I     +SE +  +  QQ++  VN+CH   
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 119 ICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRREY 176
           I HRDLK EN LL   S    +K+ DFG +       +      GTP Y++PEVL +  Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 177 ----DGKVCILLLILFL 189
               D   C ++L + L
Sbjct: 184 GKPVDMWACGVILYILL 200

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/185 (32%), Positives = 98/185 (52%), Gaps = 13/185 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E YE+VK +G G FG  +L+RHK T+++ A+K + +   I  + +      R +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   R++  +++  ++  HSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 192
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 193 GFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 248
Query: 174 REYDG 178
           +  DG
Sbjct: 249 QGGDG 253

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           ++Y+L ++LG G F V R      T +  A K I   +   +  + + RE    R L+HP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +       +V +   GGELF+ I     +SE +  +  QQ++  VN+CH   
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 119 ICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRREY 176
           I HRDLK EN LL   S    +K+ DFG +       +      GTP Y++PEVL +  Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 177 ----DGKVCILLLILFL 189
               D   C ++L + L
Sbjct: 184 GKPVDMWACGVILYILL 200

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/185 (32%), Positives = 98/185 (52%), Gaps = 13/185 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E YE+VK +G G FG  +L+RHK T+++ A+K + +   I  + +      R +      
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   R++  +++  ++  HSM
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 187
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 188 GFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 243
Query: 174 REYDG 178
           +  DG
Sbjct: 244 QGGDG 248

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 94.4 bits (233), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/185 (32%), Positives = 98/185 (52%), Gaps = 13/185 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E YE+VK +G G FG  +L+RHK T+++ A+K + +   I  + +      R +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   R++  +++  ++  HSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 192
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 193 GFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 248
Query: 174 REYDG 178
           +  DG
Sbjct: 249 QGGDG 253

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 94.0 bits (232), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 61/177 (34%), Positives = 89/177 (50%), Gaps = 8/177 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIRFK 64
           LG G+FG   L   K T EL AVK +++   I D++V   ++  R L    + P + +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   GRF E    ++  ++  G+ +  S  I +RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPAYIAPEVLSRREYDGKV 180
           KL+N +LD      +KI DFG  K ++      K   GTP YIAPE+++ + Y   V
Sbjct: 148 KLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSV 202

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 96/187 (51%), Gaps = 14/187 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLR 56
           ++ +++++ LG G+FG   L+R +      A+K +++      K  E+   E +    + 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP IIR          + ++M+Y  GGELF  +  + RF     +++  ++   + Y HS
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV---GTPAYIAPEVLSR 173
             I +RDLK EN LLD +    +KI DFG++K       P  T    GTP YIAPEV+S 
Sbjct: 125 KDIIYRDLKPENILLDKNG--HIKITDFGFAKYV-----PDVTYXLCGTPDYIAPEVVST 177
Query: 174 REYDGKV 180
           + Y+  +
Sbjct: 178 KPYNKSI 184

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 45/216 (20%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------------------ 42
           + +Y L  ++G G++GV +L  ++      A+K + + + I                   
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 43  ---------ENVAREIINHRSLRHPNIIRFKEVVLTPT--HLAIVMEYAAGGELFDRICN 91
                    E V +EI   + L HPN+++  EV+  P   HL +V E    G + + +  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130
Query: 92  AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSK- 148
               SED+ R++FQ LI G+ Y H  +I HRD+K  N L+  DG     +KI DFG S  
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNE 186
Query: 149 ---SSVLHSRPKSTVGTPAYIAPEVLS--RREYDGK 179
              S  L S   +TVGTPA++APE LS  R+ + GK
Sbjct: 187 FKGSDALLS---NTVGTPAFMAPESLSETRKIFSGK 219

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 93.2 bits (230), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 8/177 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIRFK 64
           LG G+FG   L   K T+EL A+K +++   I D++V   ++  R L    + P + +  
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   G+F E +  ++  ++  G+ + H   I +RDL
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDL 146
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPAYIAPEVLSRREYDGKV 180
           KL+N +LD      +KI DFG  K  ++     +   GTP YIAPE+++ + Y   V
Sbjct: 147 KLDNVMLDSEG--HIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSV 201

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/177 (34%), Positives = 89/177 (50%), Gaps = 8/177 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIRFK 64
           LG G+FG   L   K T EL AVK +++   I D++V   ++  R L    + P + +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   GRF E    ++  ++  G+ +  S  I +RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPAYIAPEVLSRREYDGKV 180
           KL+N +LD      +KI DFG  K ++      K   GTP YIAPE+++ + Y   V
Sbjct: 469 KLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSV 523

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 2/172 (1%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           ++ Y++ ++LG G FGV   +  + T    A K++    + D E V +EI     LRHP 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQ 118
           ++   +       + ++ E+ +GGELF+++ +   + SEDE   + +Q+  G+ + H   
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 221

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 2/172 (1%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           ++ Y++ ++LG G FGV   +  + T    A K++    + D E V +EI     LRHP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQ 118
           ++   +       + ++ E+ +GGELF+++ +   + SEDE   + +Q+  G+ + H   
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNI 60
           Y+L ++LG G F V R        +  A K I   +   +  + + RE    R L+HPNI
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +R  + +    H  ++ +   GGELF+ I     +SE +  +  QQ++  V +CH M + 
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 143
Query: 121 HRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRREYDG 178
           HRDLK EN LL        +K+ DFG +       +      GTP Y++PEVL +  Y  
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 203
Query: 179 KV----CILLLILFL 189
            V    C ++L + L
Sbjct: 204 PVDLWACGVILYILL 218

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 2   EKYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH 57
           E+Y+L ++LG G F V R    +L  +E   ++ +   +   +  + + RE    R L+H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMI-INTKKLSARDHQKLEREARICRLLKH 69
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI+R  + +    H  ++ +   GGELF+ I     +SE +  +  QQ++  V +CH M
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 118 QICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRRE 175
            + HR+LK EN LL        +K+ DFG +       +      GTP Y++PEVL +  
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 176 YDGKV----CILLLILFL 189
           Y   V    C ++L + L
Sbjct: 190 YGKPVDLWACGVILYILL 207

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/181 (34%), Positives = 89/181 (49%), Gaps = 13/181 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDENVAREIIN 51
           E YE  + LG G   V R   HK T +  AVK I          E  +++ E   +E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 52  HRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
            R +  HPNII+ K+   T T   +V +    GELFD +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +S  GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 171 L 171
           +
Sbjct: 195 I 195

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 2/172 (1%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE-NVAREIINHRSLRHPNIIR 62
           Y+++++LG+G FGV      K T  +   K+I     +D+  V  EI     L HP +I 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICH 121
             +       + +++E+ +GGELFDRI     + SE E   + +Q   G+ + H   I H
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            D+K EN + +   A  +KI DFG +         K T  T  + APE++ R
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 224

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 98/185 (52%), Gaps = 13/185 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E Y++VK +G G FG  +L+RHK ++++ A+K + +   I  + +      R +      
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   +++  +++  ++  HSM
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM 193
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            + HRD+K +N LLD      LK+ DFG      ++ ++H    + VGTP YI+PEVL  
Sbjct: 194 GLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVHC--DTAVGTPDYISPEVLKS 249
Query: 174 REYDG 178
           +  DG
Sbjct: 250 QGGDG 254

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/181 (34%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDENVAREIIN 51
           E YE  + LG G   V R   HK T +  AVK I          E  +++ E   +E+  
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 52  HRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
            R +  HPNII+ K+   T T   +V +    GELFD +      SE E R   + L+  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 171 L 171
           +
Sbjct: 182 I 182

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/173 (35%), Positives = 88/173 (50%), Gaps = 7/173 (4%)
Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKE 65
           + LG+G FG   L+  + +     +K I + R     E +  EI   +SL HPNII+  E
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNA---GR-FSEDEGRYFFQQLISGVNYCHSMQICH 121
           V     ++ IVME   GGEL +RI +A   G+  SE       +Q+++ + Y HS  + H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 122 RDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           +DLK EN L  D S    +KI DFG ++         +  GT  Y+APEV  R
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR 200

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/187 (32%), Positives = 97/187 (51%), Gaps = 13/187 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ 
Sbjct: 137 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 176 YDGKVCI 182
           Y  KV I
Sbjct: 193 YGPKVDI 199

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           + Y+L ++LG G F V R    K   +  A K I   +   +  + + RE    R L+HP
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +       +V +   GGELF+ I     +SE +  +   Q++  VN+ H   
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD 150
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRREY 176
           I HRDLK EN LL        +K+ DFG +       +      GTP Y++PEVL +  Y
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPY 210
Query: 177 DGKV----CILLLILFL 189
              V    C ++L + L
Sbjct: 211 GKPVDIWACGVILYILL 227

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           M++Y   + LG G F     +   +TKE+ A K + +   +     E ++ EI  H+SL 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +P+++ F         + +V+E      L +        +E E RYF +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG  +K      R K+  GTP YIAPEVL ++ 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 176 YDGKV------CILLLIL 187
           +  +V      CIL  +L
Sbjct: 219 HSFEVDIWSLGCILYTLL 236

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/181 (34%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDENVAREIIN 51
           E YE  + LG G   V R   HK T +  AVK I          E  +++ E   +E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 52  HRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
            R +  HPNII+ K+   T T   +V +    GELFD +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 171 L 171
           +
Sbjct: 195 I 195

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           ++Y+L +D+G G F V R      T    A K I   +   +  + + RE    R L+H 
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +       +V +   GGELF+ I     +SE +  +  QQ++  V +CH M 
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRREY 176
           + HRDLK EN LL        +K+ DFG +       +      GTP Y++PEVL +  Y
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 177 DGKV----CILLLILFL 189
              V    C ++L + L
Sbjct: 184 GKPVDIWACGVILYILL 200

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           M++Y   + LG G F     +   +TKE+ A K + +   +     E ++ EI  H+SL 
Sbjct: 25  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +P+++ F         + +V+E      L +        +E E RYF +Q I GV Y H+
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++ 
Sbjct: 145 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 176 YDGKV------CILLLIL 187
           +  +V      CIL  +L
Sbjct: 203 HSFEVDIWSLGCILYTLL 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           M++Y   + LG G F     +   +TKE+ A K + +   +     E ++ EI  H+SL 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +P+++ F         + +V+E      L +        +E E RYF +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++ 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 176 YDGKV------CILLLIL 187
           +  +V      CIL  +L
Sbjct: 219 HSFEVDIWSLGCILYTLL 236

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 99/187 (52%), Gaps = 13/187 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ 
Sbjct: 137 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA 192
Query: 176 YDGKVCI 182
           Y  KV I
Sbjct: 193 YGPKVDI 199

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 99/187 (52%), Gaps = 13/187 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ 
Sbjct: 138 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA 193
Query: 176 YDGKVCI 182
           Y  KV I
Sbjct: 194 YGPKVDI 200

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSL 55
           ++ ++L++ +G G++    L+R K+T  + A+K +++        ID     + +  ++ 
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +NY H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV----GTPAYIAPEVL 171
              I +RDLKL+N LLD      +K+ D+G  K  +   RP  T     GTP YIAPE+L
Sbjct: 128 ERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 182
Query: 172 SRREY 176
              +Y
Sbjct: 183 RGEDY 187

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSL 55
           ++ ++L++ +G G++    L+R K+T  + A+K +++        ID     + +  ++ 
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +NY H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV----GTPAYIAPEVL 171
              I +RDLKL+N LLD      +K+ D+G  K  +   RP  T     GTP YIAPE+L
Sbjct: 124 ERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 178
Query: 172 SRREY 176
              +Y
Sbjct: 179 RGEDY 183

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 99/187 (52%), Gaps = 13/187 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ 
Sbjct: 137 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA 192
Query: 176 YDGKVCI 182
           Y  KV I
Sbjct: 193 YGPKVDI 199

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           M++Y   + LG G F     +   +TKE+ A K + +   +     E ++ EI  H+SL 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +P+++ F         + +V+E      L +        +E E RYF +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++ 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 176 YDGKV------CILLLIL 187
           +  +V      CIL  +L
Sbjct: 219 HSFEVDIWSLGCILYTLL 236

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 87.8 bits (216), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSL 55
           ++ ++L++ +G G++    L+R K+T  + A+K +++        ID     + +  ++ 
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +NY H
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV----GTPAYIAPEVL 171
              I +RDLKL+N LLD      +K+ D+G  K  +   RP  T     GTP YIAPE+L
Sbjct: 139 ERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 193
Query: 172 SRREY 176
              +Y
Sbjct: 194 RGEDY 198

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 16/195 (8%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           ++ +E+ + LG G FG   L R K++  +VA+K + + +     ++  + REI     L 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R          + +++EYA  GEL+  +  +  F E       ++L   + YCH 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSR 173
            ++ HRD+K EN LL       LKI DFG+S    +H+   R K+  GT  Y+ PE++  
Sbjct: 142 KKVIHRDIKPENLLLGLKGE--LKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 174 REYDGKV---CILLL 185
           R ++ KV   CI +L
Sbjct: 196 RMHNEKVDLWCIGVL 210

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 149 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           +E++ +LG G FG     ++KET  L A K I+   + + E+   EI    S  HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  +NY H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL-----SR 173
           RDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 174 REYDGKVCILLLILFL 189
           R YD K  +  L + L
Sbjct: 215 RPYDYKADVWSLGITL 230

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 97/187 (51%), Gaps = 13/187 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
           + HR++K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ 
Sbjct: 138 VIHRNIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 193
Query: 176 YDGKVCI 182
           Y  KV I
Sbjct: 194 YGPKVDI 200

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 98/193 (50%), Gaps = 19/193 (9%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIER----GRKIDENVAREIINHRSLRHPNIIRFKE 65
           +GAG+FG     R +     VAVK +        +++E   RE+   + LRHPNI+ F  
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNIVLFMG 101
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQ--QLISGVNYCHSMQ--IC 120
            V  P +L+IV EY + G L+  +  +G R   DE R       +  G+NY H+    I 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HR+LK  N L+D      +K+CDFG S+   S+ L S  KS  GTP ++APEVL     +
Sbjct: 162 HRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSN 217
Query: 178 GKVCILLLILFLW 190
            K  +    + LW
Sbjct: 218 EKSDVYSFGVILW 230

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 87
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 88  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 147
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K C
Sbjct: 148 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 205

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           +E++ +LG G FG     ++KET  L A K I+   + + E+   EI    S  HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  +NY H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL-----SR 173
           RDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 174 REYDGKVCILLLILFL 189
           R YD K  +  L + L
Sbjct: 215 RPYDYKADVWSLGITL 230

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 93/182 (51%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSL 55
           ++ ++L++ +G G++    L+R K+T  + A++ +++        ID     + +  ++ 
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +NY H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRR 174
              I +RDLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L   
Sbjct: 171 ERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 175 EY 176
           +Y
Sbjct: 229 DY 230

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 86
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 87  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 146
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K C
Sbjct: 147 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 204

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K C
Sbjct: 143 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 200

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 88
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 89  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 148
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K C
Sbjct: 149 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 206

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 95/181 (52%), Gaps = 15/181 (8%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-RSLRHPNIIR----FK 64
           LG G  G    + +K T+E  A+K ++   K      RE+  H R+ + P+I+R    ++
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 125
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 123 DLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           D+K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K 
Sbjct: 186 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 243
Query: 181 C 181
           C
Sbjct: 244 C 244

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 81
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 82  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 141
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K C
Sbjct: 142 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 199

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 80
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 81  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 140
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K C
Sbjct: 141 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 198

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 153 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 95/181 (52%), Gaps = 15/181 (8%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-RSLRHPNIIR----FK 64
           LG G  G    + +K T+E  A+K ++   K      RE+  H R+ + P+I+R    ++
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 131
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HR
Sbjct: 132 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 191
Query: 123 DLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           D+K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K 
Sbjct: 192 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 249
Query: 181 C 181
           C
Sbjct: 250 C 250

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 96
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 97  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 156
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K C
Sbjct: 157 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 214

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K C
Sbjct: 143 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 200

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 96/193 (49%), Gaps = 19/193 (9%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIER----GRKIDENVAREIINHRSLRHPNIIRFKE 65
           +GAG+FG     R +     VAVK +        +++E   RE+   + LRHPNI+ F  
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNIVLFMG 101
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQ--QLISGVNYCHSMQ--IC 120
            V  P +L+IV EY + G L+  +  +G R   DE R       +  G+NY H+    I 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRDLK  N L+D      +K+CDFG S+   S  L S  K   GTP ++APEVL     +
Sbjct: 162 HRDLKSPNLLVDKKYT--VKVCDFGLSRLKASXFLXS--KXAAGTPEWMAPEVLRDEPSN 217
Query: 178 GKVCILLLILFLW 190
            K  +    + LW
Sbjct: 218 EKSDVYSFGVILW 230

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 93/180 (51%), Gaps = 13/180 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 80
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 81  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 140
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVC 181
           +K EN LL  S  P   LK+ DFG++K +  H+       TP Y+APEVL   +YD K C
Sbjct: 141 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYD-KSC 198

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E YE++  +G G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SRPKSTVGTPA 164
            CH        + HRDLK  N  LDG     +K+ DFG ++  +L+   S  K+ VGTP 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR--ILNHDTSFAKTFVGTPY 181
Query: 165 YIAPEVLSRREYDGKVCILLLILFLW 190
           Y++PE ++R  Y+ K  I  L   L+
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLY 207

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  + VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E YE++  +G G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SRPKSTVGTPA 164
            CH        + HRDLK  N  LDG     +K+ DFG ++  +L+   S  K+ VGTP 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR--ILNHDTSFAKAFVGTPY 181
Query: 165 YIAPEVLSRREYDGKVCILLLILFLW 190
           Y++PE ++R  Y+ K  I  L   L+
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLY 207

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 149 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 134 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 92/182 (50%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIIN----HRSLR 56
           +E +++   LG G+F          T   VA+K I++       + + + N    H  L+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCH 115
           HP+I+          ++ +V+E    GE+   + N  + FSE+E R+F  Q+I+G+ Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRR 174
           S  I HRDL L N LL  +    +KI DFG +    + H +  +  GTP YI+PE+ +R 
Sbjct: 130 SHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 175 EY 176
            +
Sbjct: 188 AH 189

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 127 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 128 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------ENVAREIINHRSLRH 57
           YEL + +G G F V R   ++ET +  AVK ++  +         E++ RE      L+H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI---CNAG-RFSEDEGRYFFQQLISGVNY 113
           P+I+   E   +   L +V E+  G +L   I    +AG  +SE    ++ +Q++  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 114 CHSMQICHRDLKLENTLLDG--SAAPRLKICDFGYS----KSSVLHSRPKSTVGTPAYIA 167
           CH   I HRD+K EN LL    ++AP +K+ DFG +    +S ++       VGTP ++A
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAP-VKLGDFGVAIQLGESGLVAG---GRVGTPHFMA 201
Query: 168 PEVLSRREYDGKV----CILLLILFL 189
           PEV+ R  Y   V    C ++L + L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILL 227

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 130 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 129 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           +E++ +LG G FG     ++KET  L A K I+   + + E+   EI    S  HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  +NY H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL-----SR 173
           RDLK  N L  LDG     +K+ DFG S K++    R    +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 174 REYDGKVCILLLILFL 189
           R YD K  +  L + L
Sbjct: 215 RPYDYKADVWSLGITL 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 97/178 (54%), Gaps = 12/178 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           M+KYE ++ +G G +G     +++ET E+VA+K + R    DE V     REI   + L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI+R  +V+ +   L +V E+      + FD  CN G    +  + F  QL+ G+ +C
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CN-GDLDPEIVKSFLFQLLKGLGFC 117
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           HS  + HRDLK +N L++ +    LK+ DFG +++  +  R  S  V T  Y  P+VL
Sbjct: 118 HSRNVLHRDLKPQNLLINRNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 153 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 155 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 93/175 (53%), Gaps = 13/175 (7%)
Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-----PNIIR 62
           K+LG G F V R    K T +  A K++++ R+  ++   EI++  ++       P +I 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRIC---NAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
             EV    + + +++EYAAGGE+F  +C    A   SE++     +Q++ GV Y H   I
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFS-LCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 120 CHRDLKLENTLLDGSAAP--RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            H DLK +N LL  S  P   +KI DFG S+        +  +GTP Y+APE+L+
Sbjct: 153 VHLDLKPQNILL-SSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 157 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 5/178 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E +++++ LG G++G      HKET ++VA+K +     + E + +EI   +    P+++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHVV 87
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++       T L IVMEY   G + D I       +EDE     Q  + G+ Y H M+  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K  N LL+       K+ DFG + + +   ++    +GTP ++APEV+    Y+
Sbjct: 148 HRDIKAGNILLNTEG--HAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYN 203

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 98/177 (55%), Gaps = 9/177 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  L R K +   VAVK ++ R ++  E +  E++  R  +H N++   +  L
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L ++ME+  GG L D I +  R +E++     + ++  + Y H+  + HRD+K ++
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APEV+SR  Y  +V I
Sbjct: 172 ILLTLDG----RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDI 224

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E YE++  +G G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPA 164
            CH        + HRDLK  N  LDG     +K+ DFG ++  +L+      K  VGTP 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR--ILNHDEDFAKEFVGTPY 181
Query: 165 YIAPEVLSRREYDGKVCILLLILFLW 190
           Y++PE ++R  Y+ K  I  L   L+
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLY 207

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  G L   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 89/186 (47%), Gaps = 14/186 (7%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           +E+ + LG G FG      H++T E VA+K    E   K  E    EI   + L HPN++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 62  RFKEVV-----LTPTHLAIV-MEYAAGGEL---FDRICNAGRFSEDEGRYFFQQLISGVN 112
             +EV      L P  L ++ MEY  GG+L    ++  N     E   R     + S + 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL--KICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           Y H  +I HRDLK EN +L      RL  KI D GY+K           VGT  Y+APE+
Sbjct: 137 YLHENRIIHRDLKPENIVLQ-PGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 195
Query: 171 LSRREY 176
           L +++Y
Sbjct: 196 LEQKKY 201

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 93/175 (53%), Gaps = 5/175 (2%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   K T + VAVK ++ R ++  E +  E++  R   H N++      L
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++Y H+  + HRD+K ++
Sbjct: 113 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 171
Query: 129 TLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL      R+K+ DFG+ ++ S    + K  VGTP ++APEV+SR  Y  +V I
Sbjct: 172 ILLTSDG--RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDI 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 89/186 (47%), Gaps = 14/186 (7%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           +E+ + LG G FG      H++T E VA+K    E   K  E    EI   + L HPN++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 62  RFKEVV-----LTPTHLAIV-MEYAAGGEL---FDRICNAGRFSEDEGRYFFQQLISGVN 112
             +EV      L P  L ++ MEY  GG+L    ++  N     E   R     + S + 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL--KICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           Y H  +I HRDLK EN +L      RL  KI D GY+K           VGT  Y+APE+
Sbjct: 136 YLHENRIIHRDLKPENIVLQ-PGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194
Query: 171 LSRREY 176
           L +++Y
Sbjct: 195 LEQKKY 200

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/181 (35%), Positives = 94/181 (51%), Gaps = 15/181 (8%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-RSLRHPNIIR----FK 64
           LG G  G    + +K T+E  A+K ++   K      RE+  H R+ + P+I+R    ++
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 125
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHR 122
            +      L IV E   GGELF RI + G   F+E E     + +   + Y HS+ I HR
Sbjct: 126 NLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHR 185
Query: 123 DLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           D+K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K 
Sbjct: 186 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 243
Query: 181 C 181
           C
Sbjct: 244 C 244

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/178 (33%), Positives = 97/178 (54%), Gaps = 12/178 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           M+KYE ++ +G G +G     +++ET E+VA+K + R    DE V     REI   + L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI+R  +V+ +   L +V E+      + FD  CN G    +  + F  QL+ G+ +C
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CN-GDLDPEIVKSFLFQLLKGLGFC 117
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           HS  + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL
Sbjct: 118 HSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 13/189 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV---- 180
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++ +  +V    
Sbjct: 149 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWS 206
Query: 181 --CILLLIL 187
             CI+  +L
Sbjct: 207 IGCIMYTLL 215

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 13/189 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV---- 180
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++ +  +V    
Sbjct: 145 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWS 202
Query: 181 --CILLLIL 187
             CI+  +L
Sbjct: 203 IGCIMYTLL 211

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 13/189 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV---- 180
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++ +  +V    
Sbjct: 145 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWS 202
Query: 181 --CILLLIL 187
             CI+  +L
Sbjct: 203 IGCIMYTLL 211

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+ +    +  D     G        Y FQ L+ G+ +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 122 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+ +    +  D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+++CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLSFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVLSRR 174
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 178
Query: 175 EY 176
           +Y
Sbjct: 179 KY 180

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 51/222 (22%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKID----ENVAREIINHRSL 55
           +KY L   +G G++GV R+    +T+ + A+K + +   R+I+    E +  E+   + L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDR--------------------ICNAGRF 95
            HPNI R  EV     ++ +VME   GG L D+                    IC     
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 96  SED----------EGRYFFQ----------QLISGVNYCHSMQICHRDLKLENTLLDGSA 135
           +E+          E   F Q          Q+ S ++Y H+  ICHRD+K EN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 136 APRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLS 172
           +  +K+ DFG SK     ++  +    +  GTP ++APEVL+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+ +    +  D     G        Y FQ L+ G+ +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+ +    +  D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 127
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVLSRR 174
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L   
Sbjct: 128 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 185
Query: 175 EY 176
           +Y
Sbjct: 186 KY 187

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 13/189 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV---- 180
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++ +  +V    
Sbjct: 143 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 200
Query: 181 --CILLLIL 187
             CI+  +L
Sbjct: 201 IGCIMYTLL 209

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 123 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 122 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 13/189 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV---- 180
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++ +  +V    
Sbjct: 169 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 226
Query: 181 --CILLLIL 187
             CI+  +L
Sbjct: 227 IGCIMYTLL 235

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 13/189 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV---- 180
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++ +  +V    
Sbjct: 167 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 224
Query: 181 --CILLLIL 187
             CI+  +L
Sbjct: 225 IGCIMYTLL 233

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 95/183 (51%), Gaps = 15/183 (8%)
Query: 1   MEKYELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGRKIDE-------NVAREII 50
           +E +EL+K LG G +G   L+R     +T +L A+K +++   + +          R+++
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 51  NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
            H   + P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++  
Sbjct: 113 EHIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--SRPKSTVGTPAYIAP 168
           + + H + I +RD+KLEN LLD +    + + DFG SK  V     R     GT  Y+AP
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 169 EVL 171
           +++
Sbjct: 230 DIV 232

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 127
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 128 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 122 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 176

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 91/176 (51%), Gaps = 8/176 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           MEKYE +  +G G++G+    R+K+T  +VA+K     +  + + +   REI   + LRH
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N++   EV        +V E+     L D  +   G   +   +Y FQ +I+G+ +CHS
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ-IINGIGFCHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
             I HRD+K EN L+  S    +K+CDFG++++           V T  Y APE+L
Sbjct: 143 HNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 88/180 (48%), Gaps = 12/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE---------RGRKIDENVAREI-IN 51
           +KY+    +G G   V R   H+ T    AVK +E         +  ++ E   RE  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 52  HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            +   HP+II   +   + + + +V +    GELFD +      SE E R   + L+  V
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           ++ H+  I HRDLK EN LLD +   ++++ DFG+S       + +   GTP Y+APE+L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 124
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 125 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 179

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 174

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 122 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 174

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 122 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 124
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 125 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 179

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+         D     G        Y FQ L+ G+ +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 94/194 (48%), Gaps = 25/194 (12%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR----EIINHRSLRHPNIIRFKE 65
           LG G FG A  + H+ET E++ +K + R    DE   R    E+   R L HPN+++F  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V+     L  + EY  GG L   I +   ++   +   F + + SG+ Y HSM I HRDL
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSV--------LHSRPK-------STVGTPAYIAPE 169
              N L+  +    + + DFG ++  V        L S  K       + VG P ++APE
Sbjct: 135 NSHNCLVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 170 VLSRREYDGKVCIL 183
           +++ R YD KV + 
Sbjct: 193 MINGRSYDEKVDVF 206

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 92/181 (50%), Gaps = 6/181 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRH 57
           + +E+++ +G G+FG   +++  +TK++ A+KY+ + + ++ N  R +       + L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P ++           + +V++   GG+L   +     F E+  + F  +L+  ++Y  + 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +I HRD+K +N LLD      + I DF  +      ++  +  GT  Y+APE+ S R+  
Sbjct: 135 RIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192
Query: 178 G 178
           G
Sbjct: 193 G 193

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 89/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+         D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 96/177 (54%), Gaps = 9/177 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 146
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y  +V I
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 199

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 96/177 (54%), Gaps = 9/177 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 92  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 150
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y  +V I
Sbjct: 151 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 203

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+  I        +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+  I        +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 96/177 (54%), Gaps = 9/177 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 99  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 157
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y  +V I
Sbjct: 158 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 210

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 96/177 (54%), Gaps = 9/177 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 97  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 155
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y  +V I
Sbjct: 156 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 208

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRHP 58
           E ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CHS
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHS 120
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 121 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 83/175 (47%), Gaps = 10/175 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR 56
           E+Y++V  LG G      L         VA+K I     E+   + +   RE+ N   L 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL-KRFEREVHNSSQLS 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H NI+   +V        +VMEY  G  L + I + G  S D    F  Q++ G+ + H 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPE 169
           M+I HRD+K +N L+D +    LKI DFG +K  S    ++    +GT  Y +PE
Sbjct: 130 MRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 96/177 (54%), Gaps = 9/177 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 142 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 200
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y  +V I
Sbjct: 201 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 253

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 87/191 (45%), Gaps = 24/191 (12%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKEL-VAVKYIERGRKIDENVAREIIN---------- 51
           +Y L   LG G FG      H+ T  L VA+K I R R +  +   + +           
Sbjct: 32  EYRLGPLLGKGGFGTV-FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 52  -HRSLRHPNIIRFKEVVLTPTHLAIVMEYA-AGGELFDRICNAGRFSEDEGRYFFQQLIS 109
                 HP +IR  +   T     +V+E      +LFD I   G   E   R FF Q+++
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 110 GVNYCHSMQICHRDLKLENTLLD---GSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAY 165
            + +CHS  + HRD+K EN L+D   G A    K+ DFG    ++LH  P +   GT  Y
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCA----KLIDFG--SGALLHDEPYTDFDGTRVY 204
Query: 166 IAPEVLSRREY 176
             PE +SR +Y
Sbjct: 205 SPPEWISRHQY 215

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHP 58
           MEKY  ++ +G G +GV    ++   ET  L  ++  +    I     REI   + L+H 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI++  +V+ T   L +V E+      +L D +C  G       + F  QL++G+ YCH 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            ++ HRDLK +N L++      LKI DFG +++  +  R  +  V T  Y AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHP 58
           MEKY  ++ +G G +GV    ++   ET  L  ++  +    I     REI   + L+H 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI++  +V+ T   L +V E+      +L D +C  G       + F  QL++G+ YCH 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            ++ HRDLK +N L++      LKI DFG +++  +  R  +  V T  Y AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 219 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 277
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLL 185
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y  +V I  L
Sbjct: 278 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSL 333

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 6/187 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+        E++ +EI        P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 126 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 183
Query: 179 KVCILLL 185
           K  I  L
Sbjct: 184 KADIWSL 190

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 87/178 (48%), Gaps = 12/178 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           MEKYE +  +G G++GV    R+++T ++VA+K     E    I +   REI   + L+H
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PN++   EV      L +V EY     L +         E   +    Q +  VN+CH  
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK----STVGTPAYIAPEVL 171
              HRD+K EN L+   +   +K+CDFG+++   L + P       V T  Y +PE+L
Sbjct: 122 NCIHRDVKPENILITKHSV--IKLCDFGFAR---LLTGPSDYYDDEVATRWYRSPELL 174

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHP 58
           MEKY  ++ +G G +GV    ++   ET  L  ++  +    I     REI   + L+H 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI++  +V+ T   L +V E+      +L D +C  G       + F  QL++G+ YCH 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            ++ HRDLK +N L++      LKI DFG +++  +  R  +  + T  Y AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 6/184 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+        E++ +EI        P 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 146 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 203
Query: 179 KVCI 182
           K  I
Sbjct: 204 KADI 207

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 91/193 (47%), Gaps = 14/193 (7%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           E+ + +G G FGV  + + K   + VA+K IE   +    +  E+     + HPNI++  
Sbjct: 12  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIV-ELRQLSRVNHPNIVKLY 68
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNA---GRFSEDEGRYFFQQLISGVNYCHSMQ--- 118
              L P  + +VMEYA GG L++ +  A     ++      +  Q   GV Y HSMQ   
Sbjct: 69  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           + HRDLK  N LL       LKICDFG +     H    +  G+ A++APEV     Y  
Sbjct: 127 LIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSE 183
Query: 179 KVCILLLILFLWR 191
           K  +    + LW 
Sbjct: 184 KCDVFSWGIILWE 196

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 91/193 (47%), Gaps = 14/193 (7%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           E+ + +G G FGV  + + K   + VA+K IE   +    +  E+     + HPNI++  
Sbjct: 11  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIV-ELRQLSRVNHPNIVKLY 67
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNA---GRFSEDEGRYFFQQLISGVNYCHSMQ--- 118
              L P  + +VMEYA GG L++ +  A     ++      +  Q   GV Y HSMQ   
Sbjct: 68  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           + HRDLK  N LL       LKICDFG +     H    +  G+ A++APEV     Y  
Sbjct: 126 LIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSE 182
Query: 179 KVCILLLILFLWR 191
           K  +    + LW 
Sbjct: 183 KCDVFSWGIILWE 195

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G+FG    ++ K+T    AVK +    +++     E++    L  P I+     V  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 135
Query: 70  PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT 129
              + I ME   GG L   I   G   ED   Y+  Q + G+ Y H+ +I H D+K +N 
Sbjct: 136 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 195
Query: 130 LLDGSAAPRLKICDFGYSKSSVLHSRPKSTV------GTPAYIAPEVLSRREYDGKV--- 180
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  +  D KV   
Sbjct: 196 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 254
Query: 181 ---CILLLIL---FLWRNYRPNPF 198
              C++L +L     W  Y   P 
Sbjct: 255 SSCCMMLHMLNGCHPWTQYFRGPL 278

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/179 (32%), Positives = 87/179 (48%), Gaps = 6/179 (3%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNIIRFKEVV 67
           +G G+FG         TKE+VA+K I+        E++ +EI        P I R+    
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 68  LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
           L  T L I+MEY  GG   D +   G   E       ++++ G++Y HS +  HRD+K  
Sbjct: 87  LKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 145
Query: 128 NTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLL 185
           N LL  S    +K+ DFG + + +    +    VGTP ++APEV+ +  YD K  I  L
Sbjct: 146 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSL 202

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           +++Y  +  LG G +G         T E VA+K I     E G  +     RE+   + L
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG--VPGTAIREVSLLKEL 90
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +H NII  K V+     L ++ EYA   +L   +      S    + F  QLI+GVN+CH
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 116 SMQICHRDLKLENTLL---DGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEV- 170
           S +  HRDLK +N LL   D S  P LKI DFG +++  +  R     + T  Y  PE+ 
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 171 LSRREYDGKVCI 182
           L  R Y   V I
Sbjct: 210 LGSRHYSTSVDI 221

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 93/187 (49%), Gaps = 6/187 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+        E++ +EI          
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  + L I+MEY  GG   D +  AG F E +     ++++ G++Y HS + 
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 142 IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 199
Query: 179 KVCILLL 185
           K  I  L
Sbjct: 200 KADIWSL 206

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------ENVAREIINHRSLRH 57
           YEL + +G G F V R   ++ET +  AVK ++  +         E++ RE      L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI---CNAG-RFSEDEGRYFFQQLISGVNY 113
           P+I+   E   +   L +V E+  G +L   I    +AG  +SE    ++ +Q++  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 114 CHSMQICHRDLKLENTLLDG--SAAPRLKICDFGYS----KSSVLHSRPKSTVGTPAYIA 167
           CH   I HRD+K    LL    ++AP +K+  FG +    +S ++       VGTP ++A
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHFMA 201
Query: 168 PEVLSRREYDGKV----CILLLILFL 189
           PEV+ R  Y   V    C ++L + L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILL 227

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRHPNIIR 62
           ++++G G+FG     R     E+VA+K +   G++ +E   ++ +E+   + LRHPN I+
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           ++   L      +VMEY  G        +     E E        + G+ Y HS  + HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LSRREYDGK 179
           D+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YDGK
Sbjct: 140 DVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 180 VCILLL 185
           V +  L
Sbjct: 195 VDVWSL 200

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRHPNIIR 62
           ++++G G+FG     R     E+VA+K +   G++ +E   ++ +E+   + LRHPN I+
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           ++   L      +VMEY  G        +     E E        + G+ Y HS  + HR
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LSRREYDGK 179
           D+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YDGK
Sbjct: 179 DVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 180 VCILLL 185
           V +  L
Sbjct: 234 VDVWSL 239

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------ENVAREIINHRSLRH 57
           YEL + +G G F V R   ++ET +  AVK ++  +         E++ RE      L+H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI---CNAG-RFSEDEGRYFFQQLISGVNY 113
           P+I+   E   +   L +V E+  G +L   I    +AG  +SE    ++ +Q++  + Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 114 CHSMQICHRDLKLENTLLDG--SAAPRLKICDFGYS----KSSVLHSRPKSTVGTPAYIA 167
           CH   I HRD+K    LL    ++AP +K+  FG +    +S ++       VGTP ++A
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHFMA 203
Query: 168 PEVLSRREYDGKV----CILLLILFL 189
           PEV+ R  Y   V    C ++L + L
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILL 229

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 92/187 (49%), Gaps = 6/187 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+        E++ +EI        P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG + + +    +    VGTP ++APEV+ +  YD 
Sbjct: 126 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 183
Query: 179 KVCILLL 185
           K  I  L
Sbjct: 184 KADIWSL 190

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 89/192 (46%), Gaps = 21/192 (10%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G+FG    +  K+T    AVK +    +++   A E++    L  P I+     V  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 156
Query: 70  PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT 129
              + I ME   GG L   +   G   ED   Y+  Q + G+ Y HS +I H D+K +N 
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 216
Query: 130 LL--DGSAAPRLKICDFGYSKSSVLHSRPKSTV------GTPAYIAPEVLSRREYDGKV- 180
           LL  DGS A    +CDFG++         KS +      GT  ++APEV+  R  D KV 
Sbjct: 217 LLSSDGSHA---ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVD 273
Query: 181 -----CILLLIL 187
                C++L +L
Sbjct: 274 VWSSCCMMLHML 285

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 89/169 (52%), Gaps = 6/169 (3%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           LG G +G+    R    +  +A+K I ER  +  + +  EI  H+ L+H NI+++     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 69  TPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGR--YFFQQLISGVNYCHSMQICHRDLK 125
               + I ME   GG L   +    G   ++E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 126 LENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSR 173
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +
Sbjct: 136 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 183

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 92/187 (49%), Gaps = 6/187 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+        E++ +EI        P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG + + +    +    VGTP ++APEV+ +  YD 
Sbjct: 141 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 198
Query: 179 KVCILLL 185
           K  I  L
Sbjct: 199 KADIWSL 205

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 8/196 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E+  L+K+LG+G FGV +L + K   + VAVK I+ G   ++   +E      L HP ++
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSE-DEGRYFFQQLISGVNYCHSMQIC 120
           +F  V      + IV EY + G L + + + G+  E  +       +  G+ +  S Q  
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYD 177
           HRDL   N L+D      +K+ DFG ++  VL  +  S+VGT     + APEV    +Y 
Sbjct: 127 HRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 178 GKVCILLLILFLWRNY 193
            K  +    + +W  +
Sbjct: 184 SKSDVWAFGILMWEVF 199

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           +G G+FG    ++ K+T    AVK +    +++     E++    L  P I+     V  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 70  PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT 129
              + I ME   GG L   I   G   ED   Y+  Q + G+ Y H+ +I H D+K +N 
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 130 LLDGSAAPRLKICDFGYSKSSVLHSRPKSTV------GTPAYIAPEVLSRREYDGKV--- 180
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  +  D KV   
Sbjct: 182 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240
Query: 181 ---CILLLIL---FLWRNYRPNPF 198
              C++L +L     W  Y   P 
Sbjct: 241 SSCCMMLHMLNGCHPWTQYFRGPL 264

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 89/169 (52%), Gaps = 6/169 (3%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           LG G +G+    R    +  +A+K I ER  +  + +  EI  H+ L+H NI+++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 69  TPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGR--YFFQQLISGVNYCHSMQICHRDLK 125
               + I ME   GG L   +    G   ++E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 126 LENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSR 173
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           +G G+FG    ++ K+T    AVK +    +++     E++    L  P I+     V  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 137
Query: 70  PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT 129
              + I ME   GG L   I   G   ED   Y+  Q + G+ Y H+ +I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 197
Query: 130 LLDGSAAPRLKICDFGYSKSSVLHSRPKSTV------GTPAYIAPEVLSRREYDGKV--- 180
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  +  D KV   
Sbjct: 198 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 256
Query: 181 ---CILLLIL---FLWRNYRPNPF 198
              C++L +L     W  Y   P 
Sbjct: 257 SSCCMMLHMLNGCHPWTQYFRGPL 280

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 96/189 (50%), Gaps = 12/189 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSLRH 57
           MEKY+ ++ +G G +GV    +  + + +VA+K I        I     REI   + L H
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI+   +V+ +   L +V E+      ++ D   N     + + + +  QL+ GV +CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL-SR 173
             +I HRDLK +N L++   A  LK+ DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 174 REYDGKVCI 182
           ++Y   V I
Sbjct: 195 KKYSTSVDI 203

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 94/190 (49%), Gaps = 17/190 (8%)
Query: 2   EKYELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH--RSLRHP 58
           + Y+L K  LG G  G      H+ T +  A+K +      D   AR+ ++H  ++   P
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGP 82
Query: 59  NIIRFKEVVLTPTH----LAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVN 112
           +I+   +V     H    L I+ME   GGELF RI   G   F+E E     + + + + 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           + HS  I HRD+K EN L         LK+ DFG++K +  ++  ++   TP Y+APEVL
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVL 201
Query: 172 SRREYDGKVC 181
              +YD K C
Sbjct: 202 GPEKYD-KSC 210

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 94/190 (49%), Gaps = 17/190 (8%)
Query: 2   EKYELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH--RSLRHP 58
           + Y+L K  LG G  G      H+ T +  A+K +      D   AR+ ++H  ++   P
Sbjct: 9   DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGP 63
Query: 59  NIIRFKEVVLTPTH----LAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVN 112
           +I+   +V     H    L I+ME   GGELF RI   G   F+E E     + + + + 
Sbjct: 64  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 123
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           + HS  I HRD+K EN L         LK+ DFG++K +  ++  ++   TP Y+APEVL
Sbjct: 124 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVL 182
Query: 172 SRREYDGKVC 181
              +YD K C
Sbjct: 183 GPEKYD-KSC 191

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 96/189 (50%), Gaps = 12/189 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSLRH 57
           MEKY+ ++ +G G +GV    +  + + +VA+K I        I     REI   + L H
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI+   +V+ +   L +V E+      ++ D   N     + + + +  QL+ GV +CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL-SR 173
             +I HRDLK +N L++   A  LK+ DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 174 REYDGKVCI 182
           ++Y   V I
Sbjct: 195 KKYSTSVDI 203

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE---------NVAREIINH 52
           +KY  +  LG+G FG       KE  + V VK+I++ + +++          V  EI   
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVME-YAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
             + H NII+  ++        +VME + +G +LF  I    R  E    Y F+QL+S V
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAP 168
            Y     I HRD+K EN ++  +    +K+ DFG   S+    R K   +  GT  Y AP
Sbjct: 144 GYLRLKDIIHRDIKDENIVI--AEDFTIKLIDFG---SAAYLERGKLFYTFCGTIEYCAP 198
Query: 169 EVLSRREYDG 178
           EVL    Y G
Sbjct: 199 EVLMGNPYRG 208

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 91/174 (52%), Gaps = 7/174 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E +E+V +LG G FG     ++KET  L A K IE   + + E+   EI    +  HP I
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           ++          L I++E+  GG +   +    R  +E + +   +Q++  +N+ HS +I
Sbjct: 71  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 130
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSV--LHSRPKSTVGTPAYIAPEVL 171
            HRDLK  N L+  +    +++ DFG S  ++  L  R  S +GTP ++APEV+
Sbjct: 131 IHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVV 181

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 23/194 (11%)
Query: 2   EKYELVKDLGAGNFG---VARLLRHKETKELVAVKYIERG-----------RKIDENVAR 47
           E +EL++ LG G +G     R +    T ++ A+K +++             K + N+  
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 48  EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           E+      +HP I+       T   L +++EY +GGELF ++   G F ED   ++  ++
Sbjct: 77  EV------KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYI 166
              + + H   I +RDLK EN +L+      +K+ DFG  K S+       T  GT  Y+
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 167 APEVLSRREYDGKV 180
           APE+L R  ++  V
Sbjct: 189 APEILMRSGHNRAV 202

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 91/174 (52%), Gaps = 7/174 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E +E+V +LG G FG     ++KET  L A K IE   + + E+   EI    +  HP I
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           ++          L I++E+  GG +   +    R  +E + +   +Q++  +N+ HS +I
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSV--LHSRPKSTVGTPAYIAPEVL 171
            HRDLK  N L+  +    +++ DFG S  ++  L  R  S +GTP ++APEV+
Sbjct: 139 IHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVV 189

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 88/192 (45%), Gaps = 21/192 (10%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G+FG    +  K+T    AVK +    +++   A E++    L  P I+     V  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 137
Query: 70  PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT 129
              + I ME   GG L   +   G   ED   Y+  Q + G+ Y HS +I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 197
Query: 130 LL--DGSAAPRLKICDFGYSKSSVLHSRPKSTV------GTPAYIAPEVLSRREYDGKV- 180
           LL  DGS A    +CDFG++         K  +      GT  ++APEV+  R  D KV 
Sbjct: 198 LLSSDGSHA---ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVD 254
Query: 181 -----CILLLIL 187
                C++L +L
Sbjct: 255 VWSSCCMMLHML 266

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 126 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 126 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 126 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 126 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 126 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 92/191 (48%), Gaps = 24/191 (12%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRSL 55
           E +E++K +G G FG   +++ K T+ + A+K + +   +           R+++ +   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYC 114
           +    + +        HL +VM+Y  GG+L   +     +  ED  R++  +++  ++  
Sbjct: 134 QWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 191
Query: 115 HSMQICHRDLKLENTLLDGSAAPR-------LKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           H +   HRD+K +N LLD +   R       LK+ D G  +SSV        VGTP YI+
Sbjct: 192 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTPDYIS 244
Query: 168 PEVLSRREYDG 178
           PE+L   E DG
Sbjct: 245 PEILQAME-DG 254

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 144
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 145 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 199

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 23/200 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + YEL + +G+G   V +       KE VA+K I  E+ +   + + +EI       HPN
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICN--------AGRFSEDEGRYFFQQLISGV 111
           I+ +    +    L +VM+  +GG + D I +        +G   E       ++++ G+
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 112 NYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSK-----SSVLHSRPKST-VGTP 163
            Y H     HRD+K  N LL  DGS    ++I DFG S        +  ++ + T VGTP
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 164 AYIAPEVLSR-REYDGKVCI 182
            ++APEV+ + R YD K  I
Sbjct: 186 CWMAPEVMEQVRGYDFKADI 205

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 92/191 (48%), Gaps = 24/191 (12%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRSL 55
           E +E++K +G G FG   +++ K T+ + A+K + +   +           R+++ +   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYC 114
           +    + +        HL +VM+Y  GG+L   +     +  ED  R++  +++  ++  
Sbjct: 150 QWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 207
Query: 115 HSMQICHRDLKLENTLLDGSAAPR-------LKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           H +   HRD+K +N LLD +   R       LK+ D G  +SSV        VGTP YI+
Sbjct: 208 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTPDYIS 260
Query: 168 PEVLSRREYDG 178
           PE+L   E DG
Sbjct: 261 PEILQAME-DG 270

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 23/200 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + YEL + +G+G   V +       KE VA+K I  E+ +   + + +EI       HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICN--------AGRFSEDEGRYFFQQLISGV 111
           I+ +    +    L +VM+  +GG + D I +        +G   E       ++++ G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 112 NYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSK-----SSVLHSRPKST-VGTP 163
            Y H     HRD+K  N LL  DGS    ++I DFG S        +  ++ + T VGTP
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 164 AYIAPEVLSR-REYDGKVCI 182
            ++APEV+ + R YD K  I
Sbjct: 191 CWMAPEVMEQVRGYDFKADI 210

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 153 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 207

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 188 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 242

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 24/187 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH 57
           M  + + + +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +  
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLS 244
Query: 58  -------PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
                  P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYI 166
           + + H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYM 357
Query: 167 APEVLSR 173
           APEVL +
Sbjct: 358 APEVLQK 364

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 24/187 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH 57
           M  + + + +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +  
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLS 244
Query: 58  -------PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
                  P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYI 166
           + + H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYM 357
Query: 167 APEVLSR 173
           APEVL +
Sbjct: 358 APEVLQK 364

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 24/187 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH 57
           M  + + + +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +  
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLS 244
Query: 58  -------PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
                  P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYI 166
           + + H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYM 357
Query: 167 APEVLSR 173
           APEVL +
Sbjct: 358 APEVLQK 364

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 24/187 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH 57
           M  + + + +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +  
Sbjct: 187 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLS 243
Query: 58  -------PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
                  P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYI 166
           + + H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+
Sbjct: 304 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYM 356
Query: 167 APEVLSR 173
           APEVL +
Sbjct: 357 APEVLQK 363

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 24/198 (12%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS-------LRHPNIIR 62
           +G G FG  ++ R     + VAVK        DE++++ I N R        L+HPNII 
Sbjct: 15  IGIGGFG--KVYRAFWIGDEVAVKAARHDP--DEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS---MQI 119
            + V L   +L +VME+A GG L +R+ +  R   D    +  Q+  G+NY H    + I
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 120 CHRDLKLENTLL-----DGSAAPR-LKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLS 172
            HRDLK  N L+     +G  + + LKI DFG ++    H   K S  G  A++APEV+ 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAAGAYAWMAPEVIR 187
Query: 173 RREYDGKVCILLLILFLW 190
              +     +    + LW
Sbjct: 188 ASMFSKGSDVWSYGVLLW 205

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 23/194 (11%)
Query: 2   EKYELVKDLGAGNFG---VARLLRHKETKELVAVKYIERG-----------RKIDENVAR 47
           E +EL++ LG G +G     R +    T ++ A+K +++             K + N+  
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 48  EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           E+      +HP I+       T   L +++EY +GGELF ++   G F ED   ++  ++
Sbjct: 77  EV------KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYI 166
              + + H   I +RDLK EN +L+      +K+ DFG  K S+          GT  Y+
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTVTHXFCGTIEYM 188
Query: 167 APEVLSRREYDGKV 180
           APE+L R  ++  V
Sbjct: 189 APEILMRSGHNRAV 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK--YIERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   ++H+ +  ++A K  ++E    I   + RE+        P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  A R  E+        ++ G+ Y     Q
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y+APE L    Y
Sbjct: 136 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMAPERLQGTHY 190

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 28/195 (14%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR-----EIINHRSLR 56
           ++YE+++ +G G +GV    R + T + VA+K I     +  N  R     +I+ H   +
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH--FK 111
Query: 57  HPNIIRFKEVVLTPT-------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS 109
           H NII  K++ L PT        + +V++     +L   I ++   + +  RYF  QL+ 
Sbjct: 112 HDNIIAIKDI-LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR 169
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-------KSTVGT 162
           G+ Y HS Q+ HRDLK  N L++ +    LKI DFG ++   L + P          V T
Sbjct: 170 GLKYMHSAQVIHRDLKPSNLLVNENC--ELKIGDFGMARG--LCTSPAEHQYFMTEYVAT 225
Query: 163 PAYIAPE-VLSRREY 176
             Y APE +LS  EY
Sbjct: 226 RWYRAPELMLSLHEY 240

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 12/179 (6%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNIIR 62
           +ELV+ +G G +G     RH +T +L A+K ++     +E + +EI +  +   H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 63  F------KEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYC 114
           +      K        L +VME+   G + D I N       E+   Y  ++++ G+++ 
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLS 172
           H  ++ HRD+K +N LL  +A   +K+ DFG S        R  + +GTP ++APEV++
Sbjct: 146 HQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 28/195 (14%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR-----EIINHRSLR 56
           ++YE+++ +G G +GV    R + T + VA+K I     +  N  R     +I+ H   +
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH--FK 112
Query: 57  HPNIIRFKEVVLTPT-------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS 109
           H NII  K++ L PT        + +V++     +L   I ++   + +  RYF  QL+ 
Sbjct: 113 HDNIIAIKDI-LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR 170
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-------KSTVGT 162
           G+ Y HS Q+ HRDLK  N L++ +    LKI DFG ++   L + P          V T
Sbjct: 171 GLKYMHSAQVIHRDLKPSNLLVNENC--ELKIGDFGMARG--LCTSPAEHQYFMTEYVAT 226
Query: 163 PAYIAPE-VLSRREY 176
             Y APE +LS  EY
Sbjct: 227 RWYRAPELMLSLHEY 241

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++       VGT +Y++PE L    Y
Sbjct: 129 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDEMANEFVGTRSYMSPERLQGTHY 183

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 93/186 (50%), Gaps = 16/186 (8%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHP 58
           E+ E+ + +G G FG    + H      VA++ I+  R  ++ +    RE++ +R  RH 
Sbjct: 33  EQLEIGELIGKGRFGQ---VYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSM 117
           N++ F    ++P HLAI+     G  L+  + +A      ++ R   Q+++ G+ Y H+ 
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG-YSKSSVLHS-----RPKSTVGTPAYIAPEVL 171
            I H+DLK +N   D     ++ I DFG +S S VL +     + +   G   ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 172 SRREYD 177
            +   D
Sbjct: 207 RQLSPD 212

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + +G+       RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + +G+       RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 1/170 (0%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           EKY + +DLG G FG+        +K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
              E   +   L ++ E+ +G ++F+RI  +A   +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           H D++ EN +     +  +KI +FG ++        +     P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 9/177 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSL 55
           ++YE +  LG G F      R K T ++VA+K I+ G +      I+    REI   + L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HPNII   +     +++++V ++           N+   +    + +    + G+ Y H
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
              I HRDLK  N LLD +    LK+ DFG +KS    +R     V T  Y APE+L
Sbjct: 130 QHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELL 184

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 15/178 (8%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + +G+       RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG----RYFFQQLISGVNY 113
           +    +        +L +V++Y     ++    +  R  +       + +  QL   + Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE++
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 194

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 90/185 (48%), Gaps = 29/185 (15%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  ----------KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQ 106
                     K+VV    +L +V++Y    E   R+  A  +S  +        + +  Q
Sbjct: 79  RYFFYSSGEKKDVV----YLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQ 130
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
           L   + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 167 APEVL 171
           APE++
Sbjct: 190 APELI 194

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 79
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 194
Query: 171 L 171
           +
Sbjct: 195 I 195

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 82
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 197
Query: 171 L 171
           +
Sbjct: 198 I 198

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 90
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 171 L 171
           +
Sbjct: 206 I 206

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 97
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 212
Query: 171 L 171
           +
Sbjct: 213 I 213

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 86
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 201
Query: 171 L 171
           +
Sbjct: 202 I 202

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 7/175 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           ME Y  +  LG G +      + K T  LVA+K I  E          RE+   + L+H 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRF-SEDEGRYFFQQLISGVNYCHSM 117
           NI+   +++ T   L +V EY    +L   + + G   +    + F  QL+ G+ YCH  
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           ++ HRDLK +N L++      LK+ DFG +++  + ++   + V T  Y  P++L
Sbjct: 120 KVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL 172

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 90
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 171 L 171
           +
Sbjct: 206 I 206

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 91
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 206
Query: 171 L 171
           +
Sbjct: 207 I 207

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 112
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 227
Query: 171 L 171
           +
Sbjct: 228 I 228

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 83
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 198
Query: 171 L 171
           +
Sbjct: 199 I 199

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 106
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 221
Query: 171 L 171
           +
Sbjct: 222 I 222

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 112
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 171 L 171
           +
Sbjct: 228 I 228

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 114
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 229
Query: 171 L 171
           +
Sbjct: 230 I 230

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 90/184 (48%), Gaps = 15/184 (8%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVARE----IINHRS 54
           E +E++K +G G FG   +++ K   ++ A+K +   E  ++ +    RE    ++N  S
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNY 113
                I           +L +VM+Y  GG+L   +     R  E+  R++  +++  ++ 
Sbjct: 134 KW---ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            H +   HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE+L
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 172 SRRE 175
              E
Sbjct: 249 QAME 252

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 157
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 272
Query: 171 L 171
           +
Sbjct: 273 I 273

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 89/184 (48%), Gaps = 21/184 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK------YIERGRKIDENVAREIINHRSL 55
           + +E++K +G G F    +++ K+T ++ A+K       ++RG        R+++ +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYC 114
           R    + F        +L +VMEY  GG+L   +   G R   +  R++  +++  ++  
Sbjct: 121 RWITQLHF--AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST------VGTPAYIAP 168
           H +   HRD+K +N LLD      +++ DFG    S L  R   T      VGTP Y++P
Sbjct: 179 HRLGYVHRDIKPDNILLDRCG--HIRLADFG----SCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 169 EVLS 172
           E+L 
Sbjct: 233 EILQ 236

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 116
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 231
Query: 171 L 171
           +
Sbjct: 232 I 232

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 94/189 (49%), Gaps = 11/189 (5%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNI 60
           +++ ++ LG G +       +K T   VA+K ++   +        REI   + L+H NI
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 61  IRFKEVVLTPTHLAIVMEYAAGG--ELFDR--ICNAGRFSE-DEGRYFFQQLISGVNYCH 115
           +R  +V+ T   L +V E+      +  D   + N  R  E +  +YF  QL+ G+ +CH
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVL-SR 173
             +I HRDLK +N L++     +LK+ DFG +++  +  +   S V T  Y AP+VL   
Sbjct: 126 ENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 174 REYDGKVCI 182
           R Y   + I
Sbjct: 184 RTYSTSIDI 192

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 81/185 (43%), Gaps = 20/185 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNII 61
           ++L   LG G +GV     HK T E+VA+K IE   K        REI   +  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
               +   P       E     EL      R+ +    S+D  +YF  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKST-------VGTPAYI 166
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 167 APEVL 171
           APEV+
Sbjct: 190 APEVM 194

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 81/185 (43%), Gaps = 20/185 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNII 61
           ++L   LG G +GV     HK T E+VA+K IE   K        REI   +  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
               +   P       E     EL      R+ +    S+D  +YF  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKST-------VGTPAYI 166
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 167 APEVL 171
           APEV+
Sbjct: 190 APEVM 194

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 81/185 (43%), Gaps = 20/185 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNII 61
           ++L   LG G +GV     HK T E+VA+K IE   K        REI   +  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
               +   P       E     EL      R+ +    S+D  +YF  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRP-------KSTVGTPAYI 166
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 167 APEVL 171
           APEV+
Sbjct: 190 APEVM 194

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINH-RS 54
           ++YE V ++G G +G V +    K     VA+K +     E G  +       ++ H  +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V         T L +V E+         D++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y A
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEVLSRREYDGKVCILLLILFLWRNYRPNPF 198
           PEVL +  Y   V +  +       +R  P 
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKS----TVGTPAYI 166
           +K EN LL  S  P   LK+ DFG++K +      KS    ++G   YI
Sbjct: 143 VKPEN-LLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYI 190

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 RREYDGK 179
              Y G+
Sbjct: 183 YHRYHGR 189

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINH-RS 54
           ++YE V ++G G +G V +    K     VA+K +     E G  +       ++ H  +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V         T L +V E+         D++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y A
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEVLSRREYDGKVCILLLILFLWRNYRPNPF 198
           PEVL +  Y   V +  +       +R  P 
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINH-RS 54
           ++YE V ++G G +G V +    K     VA+K +     E G  +       ++ H  +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V         T L +V E+         D++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y A
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEVLSRREYDGKVCILLLILFLWRNYRPNPF 198
           PEVL +  Y   V +  +       +R  P 
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 8/192 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I  G   +E+   E      L HP +++   
Sbjct: 11  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGKVC 181
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K  
Sbjct: 130 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 182 ILLLILFLWRNY 193
           +    + +W  +
Sbjct: 187 VWSFGVLMWEVF 198

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +A R    +   +  Q+  G+ Y  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 136 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 172 SRREY 176
           +  ++
Sbjct: 193 TESKF 197

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 RREYDGK 179
              Y G+
Sbjct: 183 YHRYHGR 189

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREII--NHR 53
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++     
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           S     +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 RREYDGK 179
              Y G+
Sbjct: 183 YHRYHGR 189

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREII--NHR 53
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++     
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           S     +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 209
Query: 173 RREYDGK 179
              Y G+
Sbjct: 210 YHRYHGR 216

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 RREYDGK 179
              Y G+
Sbjct: 188 YHRYHGR 194

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 127
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 185
Query: 173 RREYDGK 179
              Y G+
Sbjct: 186 YHRYHGR 192

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREII--NHR 53
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++     
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVME-YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           S     +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 173 RREYDGK 179
              Y G+
Sbjct: 187 YHRYHGR 193

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGK 179
              Y G+
Sbjct: 215 YHRYHGR 221

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 RREYDGK 179
              Y G+
Sbjct: 216 YHRYHGR 222

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 173 RREYDGK 179
              Y G+
Sbjct: 230 YHRYHGR 236

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 RREYDGK 179
              Y G+
Sbjct: 216 YHRYHGR 222

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREII--NHR 53
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++     
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           S     +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 RREYDGK 179
              Y G+
Sbjct: 188 YHRYHGR 194

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGK 179
              Y G+
Sbjct: 215 YHRYHGR 221

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREII--NHR 53
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++     
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           S     +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 173 RREYDGK 179
              Y G+
Sbjct: 187 YHRYHGR 193

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREII--NHR 53
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++     
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           S     +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 RREYDGK 179
              Y G+
Sbjct: 203 YHRYHGR 209

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREII--NHR 53
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++     
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           S     +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 RREYDGK 179
              Y G+
Sbjct: 203 YHRYHGR 209

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 RREYDGK 179
              Y G+
Sbjct: 216 YHRYHGR 222

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGK 179
              Y G+
Sbjct: 215 YHRYHGR 221

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGK 179
              Y G+
Sbjct: 215 YHRYHGR 221

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 RREYDGK 179
              Y G+
Sbjct: 188 YHRYHGR 194

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 RREYDGK 179
              Y G+
Sbjct: 216 YHRYHGR 222

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 173 RREYDGK 179
              Y G+
Sbjct: 230 YHRYHGR 236

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 RREYDGK 179
              Y G+
Sbjct: 203 YHRYHGR 209

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 173 RREYDGK 179
              Y G+
Sbjct: 202 YHRYHGR 208

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREII--NHR 53
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++     
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           S     +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 173 RREYDGK 179
              Y G+
Sbjct: 202 YHRYHGR 208

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 176
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 234
Query: 173 RREYDGK 179
              Y G+
Sbjct: 235 YHRYHGR 241

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 8/192 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V      + I+ EY A G L + +     RF   +     + +   + Y  S Q  HRDL
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGKVC 181
              N L++      +K+ DFG S+  VL     S+VG+     +  PEVL   ++  K  
Sbjct: 147 AARNCLVNDQGV--VKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 182 ILLLILFLWRNY 193
           I    + +W  Y
Sbjct: 204 IWAFGVLMWEIY 215

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREII--NHR 53
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++     
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           S     +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 221
Query: 173 RREYDGK 179
              Y G+
Sbjct: 222 YHRYHGR 228

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 8/192 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I  G   +E+   E      L HP +++   
Sbjct: 9   FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGKVC 181
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K  
Sbjct: 128 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 182 ILLLILFLWRNY 193
           +    + +W  +
Sbjct: 185 VWSFGVLMWEVF 196

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 8/192 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I  G   +E+   E      L HP +++   
Sbjct: 14  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGKVC 181
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K  
Sbjct: 133 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 182 ILLLILFLWRNY 193
           +    + +W  +
Sbjct: 190 VWSFGVLMWEVF 201

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 8/192 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I  G   +E+   E      L HP +++   
Sbjct: 11  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGKVC 181
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K  
Sbjct: 130 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 182 ILLLILFLWRNY 193
           +    + +W  +
Sbjct: 187 VWSFGVLMWEVF 198

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 8/192 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I  G   +E+   E      L HP +++   
Sbjct: 12  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGKVC 181
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K  
Sbjct: 131 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 182 ILLLILFLWRNY 193
           +    + +W  +
Sbjct: 188 VWSFGVLMWEVF 199

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 20/198 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 67  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+VG+     +  PEVL   +
Sbjct: 121 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 176 YDGKVCILLLILFLWRNY 193
           +  K  I    + +W  Y
Sbjct: 178 FSSKSDIWAFGVLMWEIY 195

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 20/198 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+VG+     +  PEVL   +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 182
Query: 176 YDGKVCILLLILFLWRNY 193
           +  K  I    + +W  Y
Sbjct: 183 FSSKSDIWAFGVLMWEIY 200

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 20/198 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 71  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+VG+     +  PEVL   +
Sbjct: 125 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 181
Query: 176 YDGKVCILLLILFLWRNY 193
           +  K  I    + +W  Y
Sbjct: 182 FSSKSDIWAFGVLMWEIY 199

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 8/192 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I+ G   +++   E      L HP +++   
Sbjct: 31  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGKVC 181
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K  
Sbjct: 150 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 182 ILLLILFLWRNY 193
           +    + +W  +
Sbjct: 207 VWSFGVLMWEVF 218

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 20/198 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 78  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+VG+     +  PEVL   +
Sbjct: 132 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 188
Query: 176 YDGKVCILLLILFLWRNY 193
           +  K  I    + +W  Y
Sbjct: 189 FSSKSDIWAFGVLMWEIY 206

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 8/192 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V      + I+ EY A G L + +     RF   +     + +   + Y  S Q  HRDL
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGKVC 181
              N L++      +K+ DFG S+  VL     S+VG+     +  PEVL   ++  K  
Sbjct: 147 AARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 182 ILLLILFLWRNY 193
           I    + +W  Y
Sbjct: 204 IWAFGVLMWEIY 215

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCH 115
           I+       T T L +VM    GG++   I N       F E    ++  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRR 174
              I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYDGKVCILLLILFLW 190
           EYD  V    L + L+
Sbjct: 365 EYDFSVDYFALGVTLY 380

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCH 115
           I+       T T L +VM    GG++   I N       F E    ++  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRR 174
              I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYDGKVCILLLILFLW 190
           EYD  V    L + L+
Sbjct: 365 EYDFSVDYFALGVTLY 380

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCH 115
           I+       T T L +VM    GG++   I N       F E    ++  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRR 174
              I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYDGKVCILLLILFLW 190
           EYD  V    L + L+
Sbjct: 365 EYDFSVDYFALGVTLY 380

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCH 115
           I+       T T L +VM    GG++   I N       F E    ++  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRR 174
              I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYDGKVCILLLILFLW 190
           EYD  V    L + L+
Sbjct: 365 EYDFSVDYFALGVTLY 380

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 31/197 (15%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           +E +  LG G FG     R+       A+K I    +    +  E++   SL H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  -------------KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSE-DEGRYFFQQLIS 109
                           V   + L I MEY   G L+D I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-----SVLHSRPK------- 157
            ++Y HS  I HRDLK  N  +D S    +KI DFG +K+      +L    +       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 158 ---STVGTPAYIAPEVL 171
              S +GT  Y+A EVL
Sbjct: 186 NLTSAIGTAMYVATEVL 202

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    ++ +  G +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 163 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 91/182 (50%), Gaps = 19/182 (10%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-----DENVAREIINHRSLRH 57
           KY +   LG G++G  + +   ET    AVK +++ +       + NV +EI   R LRH
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 58  PNIIRFKEVVLT--PTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
            N+I+  +V+       + +VMEY   G  E+ D +    RF   +   +F QLI G+ Y
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEY 124
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-----SRPKSTVGTPAYIAP 168
            HS  I H+D+K  N LL  +    LKI   G +++  LH        +++ G+PA+  P
Sbjct: 125 LHSQGIVHKDIKPGNLLL--TTGGTLKISALGVAEA--LHPFAADDTCRTSQGSPAFQPP 180
Query: 169 EV 170
           E+
Sbjct: 181 EI 182

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 11  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 131 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 172 SRREY 176
           +  ++
Sbjct: 188 TESKF 192

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 151 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 172 SRREY 176
           +  ++
Sbjct: 208 TESKF 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 12  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 132 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 172 SRREY 176
           +  ++
Sbjct: 189 TESKF 193

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 133 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 172 SRREY 176
           +  ++
Sbjct: 190 TESKF 194

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 164 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 172 SRREY 176
           +  ++
Sbjct: 221 TESKF 225

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 17  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 137 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 172 SRREY 176
           +  ++
Sbjct: 194 TESKF 198

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 133 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 172 SRREY 176
           +  ++
Sbjct: 190 TESKF 194

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 20  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 79
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 140 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 172 SRREY 176
           +  ++
Sbjct: 197 TESKF 201

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 151 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 172 SRREY 176
           +  ++
Sbjct: 208 TESKF 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 19  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 78
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 139 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 172 SRREY 176
           +  ++
Sbjct: 196 TESKF 200

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 136 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 172 SRREY 176
           +  ++
Sbjct: 193 TESKF 197

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 18  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 77
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 138 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 172 SRREY 176
           +  ++
Sbjct: 195 TESKF 199

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 20/198 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+ G+     +  PEVL   +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 176 YDGKVCILLLILFLWRNY 193
           +  K  I    + +W  Y
Sbjct: 183 FSSKSDIWAFGVLMWEIY 200

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 93/184 (50%), Gaps = 17/184 (9%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L R+      T E VAVK +  E G     ++ +EI   R+L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +++K +        + ++ME+   G L + +  N  + +  +   +  Q+  G++Y  S 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV----GTPAY-IAPEVLS 172
           Q  HRDL   N L++  +  ++KI DFG +K ++   +   TV     +P +  APE L 
Sbjct: 146 QYVHRDLAARNVLVE--SEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 173 RREY 176
           + ++
Sbjct: 203 QSKF 206

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 93/184 (50%), Gaps = 17/184 (9%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L R+      T E VAVK +  E G     ++ +EI   R+L H NI
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +++K +        + ++ME+   G L + +  N  + +  +   +  Q+  G++Y  S 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV----GTPAY-IAPEVLS 172
           Q  HRDL   N L++  +  ++KI DFG +K ++   +   TV     +P +  APE L 
Sbjct: 134 QYVHRDLAARNVLVE--SEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 173 RREY 176
           + ++
Sbjct: 191 QSKF 194

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N L++     R+KI DFG +K
Sbjct: 133 KRYIHRDLATRNILVENEN--RVKIGDFGLTK 162

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 40  KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----F 95
           K   +  +EI   + L HPN+I++    +    L IV+E A  G+L   I +  +     
Sbjct: 74  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 133
Query: 96  SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSS 150
            E     +F QL S + + HS ++ HRD+K  N  +  +    +K+ D G      SK++
Sbjct: 134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT 191
Query: 151 VLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLW 190
             H    S VGTP Y++PE +    Y+ K  I  L   L+
Sbjct: 192 AAH----SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ ++   LKICDFG ++ +   H         V T  Y APE++
Sbjct: 145 ANVLHRDLKPSNLLLNTTS--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 FVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 145 ANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 17/185 (9%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+++++ +  G G FG  +L + K T   VA+K + +  +      + + +   L HPNI
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 61  IRFKEVVLT-------PTHLAIVMEYAAGGELFDRIC-NAGRFSEDEG----RYFFQQLI 108
           ++ +    T         +L +VMEY    +   R C N  R          + F  QLI
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 109 SGVNYCH--SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
             +   H  S+ +CHRD+K  N L++  A   LK+CDFG +K         + + +  Y 
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVN-EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR 198
Query: 167 APEVL 171
           APE++
Sbjct: 199 APELI 203

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 96
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 97  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 155
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 156 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 211
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 212 YRKFTSASDVWSYGIVLWEVMSYGERPY 239

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 12/160 (7%)
Query: 30  VAVKYIERGRKID-------ENVAREIINHRSLRH--PNIIRFKEVVLTPTHLAIVMEYA 80
           VA+K++E+ R  D         V  E++  + +      +IR  +    P    +++E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 81  AG-GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL 139
               +LFD I   G   E+  R FF Q++  V +CH+  + HRD+K EN L+D +    L
Sbjct: 139 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-EL 197
Query: 140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           K+ DFG S + +  +      GT  Y  PE +    Y G+
Sbjct: 198 KLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 236

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 80  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 139 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M++ +L++ +G G FG   L  ++  K  VAVK I+        +A   +  + LRH N+
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQ-LRHSNL 61
Query: 61  IRFKEVVLTPTH-LAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSM 117
           ++   V++     L IV EY A G L D + + GR     D    F   +   + Y    
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-YIAPEVLSRREY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  +++
Sbjct: 122 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 176
Query: 177 DGKVCILLLILFLWRNY 193
             K  +    + LW  Y
Sbjct: 177 STKSDVWSFGILLWEIY 193

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 21/214 (9%)
Query: 1   MEKYELVKD-------LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR 53
           M+K+E+ +        LG G +G   +   K+    VAVK ++      E   +E    +
Sbjct: 24  MDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 83
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
            ++HPN+++   V        IV EY   G L D  R CN    +     Y   Q+ S +
Sbjct: 84  EIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAM 143
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYI 166
            Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    + 
Sbjct: 144 EYLEKKNFIHRDLAARNCLVGENHV--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWT 198
Query: 167 APEVLSRREYDGKVCILLLILFLWR--NYRPNPF 198
           APE L+   +  K  +    + LW    Y  +P+
Sbjct: 199 APESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M++ +L++ +G G FG   L  ++  K  VAVK I+        +A   +  + LRH N+
Sbjct: 20  MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQ-LRHSNL 76
Query: 61  IRFKEVVLTPTH-LAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSM 117
           ++   V++     L IV EY A G L D + + GR     D    F   +   + Y    
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-YIAPEVLSRREY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  +++
Sbjct: 137 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 191
Query: 177 DGKVCILLLILFLWRNY 193
             K  +    + LW  Y
Sbjct: 192 STKSDVWSFGILLWEIY 208

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 7   VKDLGAGNFGVARLLRHKETK----ELVAVKYI--ERGRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L  +  T     E+VAVK +  + G +      +EI   R+L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I++K          L +VMEY   G L D +         +   F QQ+  G+ Y H+  
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH 154
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             HRDL   N LLD      +KI DFG +K+
Sbjct: 155 YIHRDLAARNVLLDNDRL--VKIGDFGLAKA 183

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M++ +L++ +G G FG   L  ++  K  VAVK I+        +A   +  + LRH N+
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQ-LRHSNL 248
Query: 61  IRFKEVVLTPTH-LAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSM 117
           ++   V++     L IV EY A G L D + + GR     D    F   +   + Y    
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-YIAPEVLSRREY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  +++
Sbjct: 309 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 363
Query: 177 DGKVCILLLILFLWRNY 193
             K  +    + LW  Y
Sbjct: 364 STKSDVWSFGILLWEIY 380

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 106
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 107 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 165
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 166 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 221
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 222 YRKFTSASDVWSYGIVLWEVMSYGERPY 249

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 6   LVKDLGAGNFGVARLLRHKETKE---LVAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R             VAVK      + +   +D+ + RE+    SL H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS---SVLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPFI 199
            R +       +  + LW    Y   P+I
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWI 226

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 6   LVKDLGAGNFGVARLLRHKETKE---LVAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R             VAVK      + +   +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS---SVLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPFI 199
            R +       +  + LW    Y   P+I
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 85/195 (43%), Gaps = 17/195 (8%)
Query: 4   YELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHP 58
           YEL+  +G G  +     L R+K T E V V+ I      +E V     E+   +   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHS 116
           NI+ ++   +    L +V  + A G   D IC       +E    Y  Q ++  ++Y H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 117 MQICHRDLKLENTLL--DGSAA-----PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           M   HR +K  + L+  DG          L +   G  +  V+H  PK +V    +++PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 205
Query: 170 VLSR--REYDGKVCI 182
           VL +  + YD K  I
Sbjct: 206 VLQQNLQGYDAKSDI 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 31/197 (15%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           +E +  LG G FG     R+       A+K I    +    +  E++   SL H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  -------------KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSE-DEGRYFFQQLIS 109
                           V   + L I MEY     L+D I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-----SVLHSRPK------- 157
            ++Y HS  I HRDLK  N  +D S    +KI DFG +K+      +L    +       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 158 ---STVGTPAYIAPEVL 171
              S +GT  Y+A EVL
Sbjct: 186 NLTSAIGTAMYVATEVL 202

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 91/184 (49%), Gaps = 14/184 (7%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 14  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 73
Query: 60  IIRFKEVVLTPT--HLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAY-IAPEVLS 172
            +  HR+L   N L++     R+KI DFG +K       + + K    +P +  APE L+
Sbjct: 134 KRYIHRNLATRNILVENEN--RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 173 RREY 176
             ++
Sbjct: 192 ESKF 195

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 85/179 (47%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  ++ +G G +G+         K  VA+K I     +   +   REI      RH N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I  ++++   T  A+    +++     +L+ ++  + + S D   YF  Q++ G+ Y HS
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLY-KLLKSQQLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N L++ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 163 ANVLHRDLKPSNLLINTTCD--LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM 219

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 6   LVKDLGAGNFGVARLLRHKETKE---LVAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R             VAVK      + +   +D+ + RE+    SL H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 74
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS---SVLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPFI 199
            R +       +  + LW    Y   P+I
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWI 220

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 85/195 (43%), Gaps = 17/195 (8%)
Query: 4   YELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHP 58
           YEL+  +G G  +     L R+K T E V V+ I      +E V     E+   +   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHS 116
           NI+ ++   +    L +V  + A G   D IC       +E    Y  Q ++  ++Y H 
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 117 MQICHRDLKLENTLL--DGSAA-----PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           M   HR +K  + L+  DG          L +   G  +  V+H  PK +V    +++PE
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 189
Query: 170 VLSR--REYDGKVCI 182
           VL +  + YD K  I
Sbjct: 190 VLQQNLQGYDAKSDI 204

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 6   LVKDLGAGNFGVARLLRHKETKE---LVAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R             VAVK      + +   +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS---SVLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPFI 199
            R +       +  + LW    Y   P+I
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 6   LVKDLGAGNFGVARLLRHKETKE---LVAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R             VAVK      + +   +D+ + RE+    SL H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 74
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS---SVLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPFI 199
            R +       +  + LW    Y   P+I
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWI 220

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 148 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 16  KFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++ME+   G L + +  +  R    +   +  Q+  G+ Y  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 136 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 172 SRREY 176
           +  ++
Sbjct: 193 TESKF 197

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 145 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 143 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 141 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 6   LVKDLGAGNFGVARLLRHKETKE---LVAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R             VAVK      + +   +D+ + RE+    SL H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS---SVLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPFI 199
            R +       +  + LW    Y   P+I
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWI 226

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 141 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 151 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 143 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 6   LVKDLGAGNFGVARLLRHKETKE---LVAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R             VAVK      + +   +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS---SVLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPFI 199
            R +       +  + LW    Y   P+I
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 80/179 (44%), Gaps = 16/179 (8%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYIER-GRKIDENVAREIINHRSLRHPNII 61
           +  LG GNFG   L R+      T  LVAVK ++  G     +  REI   ++L    I+
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 71
Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +++ V   P    L +VMEY   G L D +  +  R        +  Q+  G+ Y  S +
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 131
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVLS 172
             HRDL   N L++  A   +KI DFG +K   L  +    V  P      + APE LS
Sbjct: 132 CVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDXXVVREPGQSPIFWYAPESLS 187

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 148 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 149 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 140 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 163 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 20/193 (10%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR- 56
           +YE V ++G G +G     R   +   VA+K +     E G  I  +  RE+   R L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V  T        + +V E+         D+    G  +E   +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQF 121
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ H+  I HRDLK EN L+       +K+ DFG ++           V T  Y A
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 168 PEVLSRREYDGKV 180
           PEVL +  Y   V
Sbjct: 180 PEVLLQSTYATPV 192

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 24/182 (13%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  E+ E VA+K + + ++      RE+   R ++HPN++  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN---RELQIMRIVKHPNVVDL 97
Query: 64  KEVVLT------PTHLAIVMEYAAGGELFDRICNAGRFSEDEG--------RYFFQQLIS 109
           K    +         L +V+EY       + +  A R              + +  QL+ 
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
            + Y HS+ ICHRD+K +N LLD  +   LK+ DFG +K  +      S + +  Y APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIAGEPNVSXICSRYYRAPE 211
Query: 170 VL 171
           ++
Sbjct: 212 LI 213

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 20/193 (10%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR- 56
           +YE V ++G G +G     R   +   VA+K +     E G  I  +  RE+   R L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V  T        + +V E+         D+    G  +E   +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI-KDLMRQF 121
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ H+  I HRDLK EN L+       +K+ DFG ++           V T  Y A
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 168 PEVLSRREYDGKV 180
           PEVL +  Y   V
Sbjct: 180 PEVLLQSTYATPV 192

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG ++  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLAR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYIER-GRKIDENVAREIINHRSLRHPNII 61
           +  LG GNFG   L R+      T  LVAVK ++  G     +  REI   ++L    I+
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 75
Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +++ V   P    L +VMEY   G L D +  +  R        +  Q+  G+ Y  S +
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 135
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL   N L++  A   +KI DFG +K
Sbjct: 136 CVHRDLAARNILVESEA--HVKIADFGLAK 163

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G FG       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 193
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 194 WAFGVLLWEIATYGMSPY 211

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYIER-GRKIDENVAREIINHRSLRHPNII 61
           +  LG GNFG   L R+      T  LVAVK ++  G     +  REI   ++L    I+
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 74
Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +++ V   P    L +VMEY   G L D +  +  R        +  Q+  G+ Y  S +
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 134
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL   N L++  A   +KI DFG +K
Sbjct: 135 CVHRDLAARNILVESEA--HVKIADFGLAK 162

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 18/185 (9%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--------VAREIINHRSLR 56
           E  K +G G FG+    R  + K +VA+K +  G    E           RE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH 115
           HPNI++   ++  P  +  VME+   G+L+ R+ + A              +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 116 SMQ--ICHRDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N     LD +A    K+ DFG S+ SV HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-HSV-SGLLGNFQWMAPET 197
Query: 171 LSRRE 175
           +   E
Sbjct: 198 IGAEE 202

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYIER-GRKIDENVAREIINHRSLRHPNII 61
           +  LG GNFG   L R+      T  LVAVK ++  G     +  REI   ++L    I+
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +++ V   P    L +VMEY   G L D +  +  R        +  Q+  G+ Y  S +
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL   N L++  A   +KI DFG +K
Sbjct: 148 CVHRDLAARNILVESEA--HVKIADFGLAK 175

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 18/203 (8%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIA 167
            H   I HRD+K  N L+  SA   +K+ DFG +++      SV  +   + +GT  Y++
Sbjct: 132 SHQNGIIHRDVKPANILI--SATNAVKVVDFGIARAIADSGNSVXQT--AAVIGTAQYLS 187
Query: 168 PEVLSRREYDGKVCILLLILFLW 190
           PE       D +  +  L   L+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLY 210

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 18/185 (9%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--------VAREIINHRSLR 56
           E  K +G G FG+    R  + K +VA+K +  G    E           RE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH 115
           HPNI++   ++  P  +  VME+   G+L+ R+ + A              +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 116 SMQ--ICHRDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N     LD +A    K+ DFG S+ SV HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV-HSV-SGLLGNFQWMAPET 197
Query: 171 LSRRE 175
           +   E
Sbjct: 198 IGAEE 202

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG  +  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I++E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 193
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 194 WAFGVLLWEIATYGMSPY 211

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCAKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +G G FG     RL    + +  VA+K ++ G    +   R+ ++  S+     HPNI
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT--DKQRRDFLSEASIMGQFDHPNI 92
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I  + VV     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M 
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMS 151
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE ++
Sbjct: 152 AVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + +W   +Y   P+
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMSYGERPY 235

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA++ I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 20/193 (10%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR- 56
           +YE V ++G G +G     R   +   VA+K +     E G  I  +  RE+   R L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V  T        + +V E+         D+    G  +E   +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI-KDLMRQF 121
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ H+  I HRDLK EN L+       +K+ DFG ++           V T  Y A
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 168 PEVLSRREYDGKV 180
           PEVL +  Y   V
Sbjct: 180 PEVLLQSTYATPV 192

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +G G FG     RL    + +  VA+K ++ G    +   R+ ++  S+     HPNI
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT--DKQRRDFLSEASIMGQFDHPNI 77
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I  + VV     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M 
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMS 136
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE ++
Sbjct: 137 YVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + +W   +Y   P+
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPY 220

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +G G FG     RL    + +  VA+K ++ G    +   R+ ++  S+     HPNI
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT--DKQRRDFLSEASIMGQFDHPNI 71
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I  + VV     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M 
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMS 130
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE ++
Sbjct: 131 YVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + +W   +Y   P+
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPY 214

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 80/195 (41%), Gaps = 8/195 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 128 NTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLL 185
           N L+  +    +K+ DFG S+  +   ++ P        + APE L+  ++  K  +   
Sbjct: 142 NCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAF 199
Query: 186 ILFLWR--NYRPNPF 198
            + LW    Y  +P+
Sbjct: 200 GVLLWEIATYGMSPY 214

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VAVK + R    +   +   RE++  + + H
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C       D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYAANVDI 208

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 7   VKDLGAGNFGVARLLRHKETK----ELVAVKYIER--GRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L  +  T     E+VAVK ++   G +      +EI   R+L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I++K          L +VMEY   G L D +         +   F QQ+  G+ Y HS  
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHSQH 137
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             HR+L   N LLD      +KI DFG +K+
Sbjct: 138 YIHRNLAARNVLLDNDRL--VKIGDFGLAKA 166

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 80/195 (41%), Gaps = 8/195 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 128 NTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLL 185
           N L+  +    +K+ DFG S+  +   ++ P        + APE L+  ++  K  +   
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAF 200
Query: 186 ILFLWR--NYRPNPF 198
            + LW    Y  +P+
Sbjct: 201 GVLLWEIATYGMSPY 215

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 10  LGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNIIR 62
           +GAG FG   +  L+    +EL VA+K ++ G    E   R+ +   S+     HPNII 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNIIH 87
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
            + VV     + IV EY   G L   +  N G+F+  +     + + +G+ Y   M   H
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVH 147
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLSRRE 175
           RDL   N L++ +     K+ DFG S+  VL   P++   T        + APE ++ R+
Sbjct: 148 RDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 176 YDGKVCILLLILFLWR--NYRPNPF 198
           +     +    + +W   +Y   P+
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPY 228

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 81/201 (40%), Gaps = 14/201 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 88
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 148
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  SA   +K+ DFG ++    S    ++  + +GT  Y++PE
Sbjct: 149 SHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 170 VLSRREYDGKVCILLLILFLW 190
                  D +  +  L   L+
Sbjct: 207 QARGDSVDARSDVYSLGCVLY 227

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 82/203 (40%), Gaps = 18/203 (8%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIA 167
            H   I HRD+K  N ++  SA   +K+ DFG +++      SV  +   + +GT  Y++
Sbjct: 132 SHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQT--AAVIGTAQYLS 187
Query: 168 PEVLSRREYDGKVCILLLILFLW 190
           PE       D +  +  L   L+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLY 210

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 82/203 (40%), Gaps = 18/203 (8%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIA 167
            H   I HRD+K  N ++  SA   +K+ DFG +++      SV  +   + +GT  Y++
Sbjct: 132 SHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQT--AAVIGTAQYLS 187
Query: 168 PEVLSRREYDGKVCILLLILFLW 190
           PE       D +  +  L   L+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLY 210

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 18/179 (10%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           HS  I HRDLK  N ++       LKI DFG ++          T GT   + PEV++R
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLAR----------TAGTSFMMTPEVVTR 189

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 20/196 (10%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +GAG FG     RL    + +  VA+K ++ G    E   RE ++  S+     HPNIIR
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG--YTERQRREFLSEASIMGQFEHPNIIR 81
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+    +S   +   +        + APE ++ R
Sbjct: 141 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 175 EYDGKVCILLLILFLW 190
           ++          + +W
Sbjct: 199 KFTSASDAWSYGIVMW 214

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 194 GYKENVDI 201

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 195 GYKENVDI 202

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 6/155 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLR- 56
           + KYELVK LG G +G+      + T E+VAVK I    +   +     REI+    L  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H NI+    V+       + + +         +  A        +Y   QLI  + Y HS
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV 151
             + HRD+K  N LL+  A   +K+ DFG S+S V
Sbjct: 128 GGLLHRDMKPSNILLN--AECHVKVADFGLSRSFV 160

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 195 GYKENVDI 202

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 83/181 (45%), Gaps = 14/181 (7%)
Query: 4   YELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREI-INHRSLRHPNI 60
           Y+L +D LG G     +   +  T +  AVK IE+    I   V RE+ + ++   H N+
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   E         +V E   GG +   I     F+E E     Q + S +++ H+  I 
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 121 HRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLHS--RPKST------VGTPAYIAPEV 170
           HRDLK EN L +     +P +KICDFG      L+    P ST       G+  Y+APEV
Sbjct: 134 HRDLKPENILCEHPNQVSP-VKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 171 L 171
           +
Sbjct: 193 V 193

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I++E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 195
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I++E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 195
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 20/182 (10%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +GAG FG     RL    + +  VA+K ++ G    E   RE ++  S+     HPNIIR
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG--YTERQRREFLSEASIMGQFEHPNIIR 79
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+    +S   +   +        + APE ++ R
Sbjct: 139 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 175 EY 176
           ++
Sbjct: 197 KF 198

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNI 60
           + Y+LV+ LG G +       +    E V VK ++  +K    + REI    +LR  PNI
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--NKIKREIKILENLRGGPNI 94
Query: 61  IRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCHSM 
Sbjct: 95  ITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHSMG 151
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRREYD 177
           I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   + YD
Sbjct: 152 IMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 GKV------CILLLILFLWRNYRPNPFI 199
             +      C+L  ++F     R  PF 
Sbjct: 211 YSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 5/149 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E  +LVK LGAG FG   +  +  + + VAVK ++ G    +    E    ++L+H  ++
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 71
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           R   VV     + I+ EY A G L D  +    G+    +   F  Q+  G+ Y      
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 131
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL+  N L+  S +   KI DFG ++
Sbjct: 132 IHRDLRAANVLV--SESLMCKIADFGLAR 158

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 81
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 141
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 142 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 199
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 200 GYKENVDI 207

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 202 GYKENVDI 209

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 82/203 (40%), Gaps = 18/203 (8%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIA 167
            H   I HRD+K  N ++  SA   +K+ DFG +++      SV  +   + +GT  Y++
Sbjct: 132 SHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQT--AAVIGTAQYLS 187
Query: 168 PEVLSRREYDGKVCILLLILFLW 190
           PE       D +  +  L   L+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLY 210

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 202 GYKENVDI 209

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           + KYE +  +G G FG     RH++T + VA+K +     + G  I     REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--HSRPK---STVG 161
           L++G+ Y H  +I HRD+K  N L+       LK+ DFG +++  L  +S+P    + V 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 162 TPAYIAPE-VLSRREY 176
           T  Y  PE +L  R+Y
Sbjct: 192 TLWYRPPELLLGERDY 207

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           + KYE +  +G G FG     RH++T + VA+K +     + G  I     REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--HSRPK---STVG 161
           L++G+ Y H  +I HRD+K  N L+       LK+ DFG +++  L  +S+P    + V 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 162 TPAYIAPE-VLSRREY 176
           T  Y  PE +L  R+Y
Sbjct: 192 TLWYRPPELLLGERDY 207

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 17/155 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E  +LVK LGAG FG   +  +  + + VAVK ++ G    +    E    ++L+H  ++
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 70
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVNY 113
           R   VV     + I+ E+ A G L D +        DEG          F  Q+  G+ Y
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFL------KSDEGGKVLLPKLIDFSAQIAEGMAY 124
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
                  HRDL+  N L+  S +   KI DFG ++
Sbjct: 125 IERKNYIHRDLRAANVLV--SESLMCKIADFGLAR 157

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 80  IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 139 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 AVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           + KYE +  +G G FG     RH++T + VA+K +     + G  I     REI   + L
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLL 73
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--HSRPK---STVG 161
           L++G+ Y H  +I HRD+K  N L+       LK+ DFG +++  L  +S+P    + V 
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 162 TPAYIAPE-VLSRREY 176
           T  Y  PE +L  R+Y
Sbjct: 191 TLWYRPPELLLGERDY 206

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 147
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 148 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 239 GYKENVDI 246

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 195
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++  +   LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDS--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 202 GYKENVDI 209

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 45/211 (21%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           +KY L K LG G+FG+   +   E+ +  A+K + +  +      RE+   + L H NII
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN---RELDIMKVLDHVNII 63
Query: 62  RF-----------------------------------KEVVLTPT---HLAIVMEYAAGG 83
           +                                    K V++ P+   +L ++MEY    
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 84  --ELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLK 140
             ++      +GR    +    +  QL   V + HS+ ICHRD+K +N L++ S    LK
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-SKDNTLK 182
Query: 141 ICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +CDFG +K  +      + + +  Y APE++
Sbjct: 183 LCDFGSAKKLIPSEPSVAXICSRFYRAPELM 213

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 200
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 195
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREYDGKVCILLLILFLWR--NYRPNPF 198
            R++     +    + LW   +Y   P+
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 150
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 151 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 204

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           + KYE +  +G G FG     RH++T + VA+K +     + G  I     REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--HSRPK---STVG 161
           L++G+ Y H  +I HRD+K  N L+       LK+ DFG +++  L  +S+P    + V 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 162 TPAYIAPE-VLSRREYD------GKVCIL 183
           T  Y  PE +L  R+Y       G  CI+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 7   VKDLGAGNFGVARLLRHKETK----ELVAVKYIERG--RKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L  +  T     E+VAVK ++ G   ++     REI   R+L H +I
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFD---RICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +++K          + +VMEY   G L D   R C        +   F QQ+  G+ Y H
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 128
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
           +    HR L   N LLD      +KI DFG +K+
Sbjct: 129 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKA 160

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 7   VKDLGAGNFGVARLLRHKETK----ELVAVKYIERG--RKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L  +  T     E+VAVK ++ G   ++     REI   R+L H +I
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFD---RICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +++K          + +VMEY   G L D   R C        +   F QQ+  G+ Y H
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 129
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
           +    HR L   N LLD      +KI DFG +K+
Sbjct: 130 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKA 161

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++  +   LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDS--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 175 EYDGKV------CIL-----LLILFLWRNY 193
            Y   V      CI+       ILF  R+Y
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 268

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 7   VKDLGAGNFGVARLLRHKETK----ELVAVKYIER--GRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L  +  T     E+VAVK ++   G +      +EI   R+L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I++K          L +VMEY   G L D +         +   F QQ+  G+ Y H+  
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH 137
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             HR+L   N LLD      +KI DFG +K+
Sbjct: 138 YIHRNLAARNVLLDNDRL--VKIGDFGLAKA 166

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMXGXVATRWYRAPEIM 214

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I  + + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKSQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++  +   LKI DFG  +    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDS--ELKILDFGLCR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTFTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 193
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 194 WAFGVLLWEIATYGMSPY 211

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I++E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 142 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 196
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 197 WAFGVLLWEIATYGMSPY 214

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VAVK + R    +   +   RE++  + + H
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C       D  R  Y   Q++ G+ + 
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 140
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+   
Sbjct: 141 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGM 198
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 199 GYKENVDI 206

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIM 190

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKEL-VAVKYIERG----RKIDENVAREIINHRSLRHPN 59
           K +GAG FG      L      KE+ VA+K ++ G    +++D      I+   S  H N
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHN 107
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCHSM 117
           IIR + V+     + I+ EY   G L D+      G FS  +     + + +G+ Y  +M
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVL 171
              HRDL   N L++ +     K+ DFG S+  VL   P++T  T        + APE +
Sbjct: 167 NYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 172 SRREYDGKVCILLLILFLW 190
           S R++     +    + +W
Sbjct: 223 SYRKFTSASDVWSFGIVMW 241

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGXVATRWYRAPEIM 194

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 192

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        ++   +AVK + R  +     +   RE+   + ++H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V    T L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 223

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I++E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 200
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 81/203 (39%), Gaps = 18/203 (8%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+         T       IVMEY  G  L D +   G  +              +N+
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIA 167
            H   I HRD+K  N ++  SA   +K+ DFG +++      SV  +   + +GT  Y++
Sbjct: 132 SHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQT--AAVIGTAQYLS 187
Query: 168 PEVLSRREYDGKVCILLLILFLW 190
           PE       D +  +  L   L+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLY 210

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 82  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 193
Query: 171 L 171
           +
Sbjct: 194 M 194

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 200
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 201

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIM 194

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 217

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIM 194

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 193

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 18/185 (9%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--------VAREIINHRSLR 56
           E  K +G G FG+    R  + K +VA+K +  G    E           RE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH 115
           HPNI++   ++  P  +  VME+   G+L+ R+ + A              +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 116 SMQ--ICHRDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N     LD +A    K+ DF  S+ SV HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV-HSV-SGLLGNFQWMAPET 197
Query: 171 LSRRE 175
           +   E
Sbjct: 198 IGAEE 202

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 83/194 (42%), Gaps = 19/194 (9%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE------RGRKIDENVAREIINHRSLR 56
           +YE V ++G G +G     R   +   VA+K +        G  +  +  RE+   R L 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 57  ---HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQ 106
              HPN++R  +V  T        + +V E+         D+    G  +E   +   +Q
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI-KDLMRQ 128
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
            + G+++ H+  I HRDLK EN L+       +K+ DFG ++           V T  Y 
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 167 APEVLSRREYDGKV 180
           APEVL +  Y   V
Sbjct: 187 APEVLLQSTYATPV 200

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREI--INHRSLRHPN 59
           +YE+V  LG G FG V   + HK     VAVK ++   +  E    EI  + H +   PN
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 60  ----IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNY 113
                ++  E      H+ IV E   G   +D I   G   F  D  R    Q+   VN+
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 114 CHSMQICHRDLKLENTLL---DGSAA--------------PRLKICDFGYSKSSVLHSRP 156
            HS ++ H DLK EN L    D + A              P +K+ DFG +     H   
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-- 191
Query: 157 KSTVGTPAYIAPEVL 171
            + V T  Y APEV+
Sbjct: 192 STLVSTRHYRAPEVI 206

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 145 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 199
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 200 WAFGVLLWEIATYGMSPY 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 84
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 144
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 145 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM 202
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 203 GYKENVDI 210

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 195
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 197
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 198 WAFGVLLWEIATYGMSPY 215

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 200
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 153
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 154 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 208
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 209 WAFGVLLWEIATYGMSPY 226

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 195
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 200
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 14/198 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 197
Query: 183 LLLILFLWR--NYRPNPF 198
               + LW    Y  +P+
Sbjct: 198 WAFGVLLWEIATYGMSPY 215

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++   A   LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 21/185 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNIIRFKEV 66
           +G+G +G       K + E VA+K + R  + +   +   RE++  + ++H N+I   +V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 67  VLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
               + L       +VM +        +I    +FSE++ +Y   Q++ G+ Y HS  + 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV-LSRREYD 177
           HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APEV LS   Y+
Sbjct: 149 HRDLKPGNLAVNEDC--ELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 202
Query: 178 GKVCI 182
             V I
Sbjct: 203 QTVDI 207

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMXGYVATRWYRAPEIM 217

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++   A   LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKY-IERGRK-----IDE-NVAREIINHRS 54
           E +EL K +G+G FG       K  K L    Y I+R +K     +DE N  RE+  H  
Sbjct: 8   EFHELEK-IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 62
Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLIS 109
           L +H +++R+        H+ I  EY  GG L D I    R    F E E +    Q+  
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPR-----------------LKICDFGYSKSSVL 152
           G+ Y HSM + H D+K  N  +  ++ P                   KI D G+      
Sbjct: 123 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 180
Query: 153 HSRPKSTVGTPAYIAPEVL 171
            S P+   G   ++A EVL
Sbjct: 181 -SSPQVEEGDSRFLANEVL 198

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 4   YELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREI-INHRSLRHPNI 60
           Y+L +D LG G     +   +  T +  AVK IE+    I   V RE+ + ++   H N+
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   E         +V E   GG +   I     F+E E     Q + S +++ H+  I 
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 121 HRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLHS--RPKST------VGTPAYIAPEV 170
           HRDLK EN L +     +P +KICDF       L+    P ST       G+  Y+APEV
Sbjct: 134 HRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 171 L 171
           +
Sbjct: 193 V 193

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKI DFG ++ +   H         V T  Y APE++
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKY-IERGRK-----IDE-NVAREIINHRS 54
           E +EL K +G+G FG       K  K L    Y I+R +K     +DE N  RE+  H  
Sbjct: 10  EFHELEK-IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLIS 109
           L +H +++R+        H+ I  EY  GG L D I    R    F E E +    Q+  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPR-----------------LKICDFGYSKSSVL 152
           G+ Y HSM + H D+K  N  +  ++ P                   KI D G+      
Sbjct: 125 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 182
Query: 153 HSRPKSTVGTPAYIAPEVL 171
            S P+   G   ++A EVL
Sbjct: 183 -SSPQVEEGDSRFLANEVL 200

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + +  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKY-IERGRK-----IDE-NVAREIINHRS 54
           E +EL K +G+G FG       K  K L    Y I+R +K     +DE N  RE+  H  
Sbjct: 10  EFHELEK-IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLIS 109
           L +H +++R+        H+ I  EY  GG L D I    R    F E E +    Q+  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPR-----------------LKICDFGYSKSSVL 152
           G+ Y HSM + H D+K  N  +  ++ P                   KI D G+      
Sbjct: 125 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 182
Query: 153 HSRPKSTVGTPAYIAPEVL 171
            S P+   G   ++A EVL
Sbjct: 183 -SSPQVEEGDSRFLANEVL 200

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 23/198 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF------ 63
           +G+G FG     +H+   +   +K ++     +E   RE+     L H NI+ +      
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 64  ---------KEVVLTPTH-LAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGV 111
                    K    + T  L I ME+   G L   I      +  +      F+Q+  GV
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +Y HS ++ +RDLK  N  L      ++KI DFG   S     +   + GT  Y++PE +
Sbjct: 136 DYIHSKKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 172 SRREYDGKVCILLLILFL 189
           S ++Y  +V +  L L L
Sbjct: 194 SSQDYGKEVDLYALGLIL 211

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI D+G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDYGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L K LGAG FG V     +K TK  VAVK ++ G    E    E    ++L+H  +
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 72
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVN 112
           ++   VV T   + I+ E+ A G L D +        DEG          F  Q+  G+ 
Sbjct: 73  VKLHAVV-TKEPIYIITEFMAKGSLLDFL------KSDEGSKQPLPKLIDFSAQIAEGMA 125
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +       HRDL+  N L+  SA+   KI DFG ++
Sbjct: 126 FIEQRNYIHRDLRAANILV--SASLVCKIADFGLAR 159

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKY-IERGRK-----IDE-NVAREIINHRS 54
           E +EL K +G+G FG       K  K L    Y I+R +K     +DE N  RE+  H  
Sbjct: 12  EFHELEK-IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLIS 109
           L +H +++R+        H+ I  EY  GG L D I    R    F E E +    Q+  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPR-----------------LKICDFGYSKSSVL 152
           G+ Y HSM + H D+K  N  +  ++ P                   KI D G+      
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 153 HSRPKSTVGTPAYIAPEVL 171
            S P+   G   ++A EVL
Sbjct: 185 -SSPQVEEGDSRFLANEVL 202

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++   A   LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++   A   LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 81/197 (41%), Gaps = 31/197 (15%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           +E +  LG G FG     R+       A+K I    +    +  E+    SL H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 64  -------------KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSE-DEGRYFFQQLIS 109
                           V   + L I  EY     L+D I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-----SVLHSRPK------- 157
            ++Y HS  I HR+LK  N  +D S    +KI DFG +K+      +L    +       
Sbjct: 128 ALSYIHSQGIIHRNLKPXNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 158 ---STVGTPAYIAPEVL 171
              S +GT  Y+A EVL
Sbjct: 186 NLTSAIGTAXYVATEVL 202

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 21/185 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNIIRFKEV 66
           +G+G +G       K + E VA+K + R  + +   +   RE++  + ++H N+I   +V
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 67  VLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
               + L       +VM +        +I     FSE++ +Y   Q++ G+ Y HS  + 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV-LSRREYD 177
           HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APEV LS   Y+
Sbjct: 167 HRDLKPGNLAVNEDC--ELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 220
Query: 178 GKVCI 182
             V I
Sbjct: 221 QTVDI 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++   A   LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L K LGAG FG V     +K TK  VAVK ++ G    E    E    ++L+H  +
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 239
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVN 112
           ++   VV T   + I+ E+ A G L D +        DEG          F  Q+  G+ 
Sbjct: 240 VKLHAVV-TKEPIYIITEFMAKGSLLDFL------KSDEGSKQPLPKLIDFSAQIAEGMA 292
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +       HRDL+  N L+  SA+   KI DFG ++
Sbjct: 293 FIEQRNYIHRDLRAANILV--SASLVCKIADFGLAR 326

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 77/189 (40%), Gaps = 12/189 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HR+L   
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 348 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 402
Query: 183 LLLILFLWR 191
               + LW 
Sbjct: 403 WAFGVLLWE 411

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L K LGAG FG V     +K TK  VAVK ++ G    E    E    ++L+H  +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 245
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVN 112
           ++   VV T   + I+ E+ A G L D +        DEG          F  Q+  G+ 
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFL------KSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +       HRDL+  N L+  SA+   KI DFG ++
Sbjct: 299 FIEQRNYIHRDLRAANILV--SASLVCKIADFGLAR 332

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 78/199 (39%), Gaps = 10/199 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR---HP 58
           E   L + +G GNFG     R +    LVAVK        D   A+ +   R L+   HP
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-AKFLQEARILKQYSHP 172
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSM 117
           NI+R   V      + IVME   GG+    +   G R              +G+ Y  S 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV--LHSRPKSTVGTPA-YIAPEVLSRR 174
              HRDL   N L+       LKI DFG S+     +++        P  + APE L+  
Sbjct: 233 CCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 175 EYDGKVCILLLILFLWRNY 193
            Y  +  +    + LW  +
Sbjct: 291 RYSSESDVWSFGILLWETF 309

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 76/176 (43%), Gaps = 21/176 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-----RGRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G FGV  + +       VAVK +         ++ +   +EI      +H N++   
Sbjct: 39  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI-CNAGR--FSEDEGRYFFQQLISGVNYCHSMQICH 121
                   L +V  Y   G L DR+ C  G    S        Q   +G+N+ H     H
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSS------VLHSRPKSTVGTPAYIAPEVL 171
           RD+K  N LLD   A   KI DFG +++S      V+ SR    VGT AY+APE L
Sbjct: 157 RDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXSR---IVGTTAYMAPEAL 207

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 2/87 (2%)
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT 162
            F+Q+  GV+Y HS ++ HRDLK  N  L      ++KI DFG   S     +   + GT
Sbjct: 141 LFEQITKGVDYIHSKKLIHRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGKRTRSKGT 198
Query: 163 PAYIAPEVLSRREYDGKVCILLLILFL 189
             Y++PE +S ++Y  +V +  L L L
Sbjct: 199 LRYMSPEQISSQDYGKEVDLYALGLIL 225

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DF  ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFYLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 135
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 194 GYKENVDI 201

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 17/178 (9%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNI 60
           Y  ++ +G+G +G         T   VA+K + R  + +   +   RE+   + +RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 61  IRFKEVVLTP-------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           I   +V  TP       T   +VM +   G    ++    +  ED  ++   Q++ G+ Y
Sbjct: 87  IGLLDV-FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            H+  I HRDLK  N  ++      LKI DFG ++ +   S     V T  Y APEV+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQA--DSEMXGXVVTRWYRAPEVI 197

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 22/198 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +G+G+ G     RL    +    VA+K ++ G    E   R+ ++  S+     HPNI
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNI 112
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV       IV EY   G L  F R  + G+F+  +     + + +G+ Y   + 
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L+D +     K+ DFG S+  VL   P +   T        + APE ++
Sbjct: 172 YVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAXTTTGGKIPIRWTAPEAIA 227
Query: 173 RREYDGKVCILLLILFLW 190
            R +     +    + +W
Sbjct: 228 FRTFSSASDVWSFGVVMW 245

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 22/197 (11%)
Query: 10  LGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +GAG FG   +  L+    +E+ VA+K ++ G    E   R+ ++  S+     HPN+I 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIH 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
            + VV   T + I+ E+   G L   +  N G+F+  +     + + +G+ Y   M   H
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVH 158
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA--------YIAPEVLSR 173
           RDL   N L++ +     K+ DFG S+   L         T A        + APE +  
Sbjct: 159 RDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 174 REYDGKVCILLLILFLW 190
           R++     +    + +W
Sbjct: 215 RKFTSASDVWSYGIVMW 231

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 81/195 (41%), Gaps = 29/195 (14%)
Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREI--INHRSLRHPN 59
           +YE+V  LG G FG V   + HK     VAVK ++   +  E    EI  + H +   PN
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 60  ----IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNY 113
                ++  E      H+ IV E   G   +D I   G   F  D  R    Q+   VN+
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 114 CHSMQICHRDLKLENTLL---DGSAA--------------PRLKICDFGYSKSSVLHSRP 156
            HS ++ H DLK EN L    D + A              P +K+ DFG +     H   
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-- 191
Query: 157 KSTVGTPAYIAPEVL 171
            + V    Y APEV+
Sbjct: 192 STLVXXRHYRAPEVI 206

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 22/198 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNI 60
           K +G+G+ G     RL    +    VA+K ++ G    E   R+ ++  S+     HPNI
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNI 112
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV       IV EY   G L  F R  + G+F+  +     + + +G+ Y   + 
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L+D +     K+ DFG S+  VL   P +   T        + APE ++
Sbjct: 172 YVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 173 RREYDGKVCILLLILFLW 190
            R +     +    + +W
Sbjct: 228 FRTFSSASDVWSFGVVMW 245

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 4   YELVKDL-GAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-VAREIIN-HRSLRHPNI 60
           Y+L  +L G G +   +     +  +  AVK IE+      + V RE+   ++   + NI
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNI 73
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   E     T   +V E   GG +   I     F+E E     + + + +++ H+  I 
Sbjct: 74  LELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIA 133
Query: 121 HRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLH------SRPKSTV--GTPAYIAPEVL 171
           HRDLK EN L +       +KICDF       L+      + P+ T   G+  Y+APEV+
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI  FG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILGFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 8/188 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKVCI 182
            Y   V I
Sbjct: 201 GYKENVDI 208

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 90/225 (40%), Gaps = 32/225 (14%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHP 58
           +  +E ++ LG G FGV    ++K      A+K I    +    E V RE+     L HP
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 59  NIIRFKEV--------VLTPT----HLAIVMEYAAGGELFDRICNAGRFSEDEGR---YF 103
            I+R+            L P+    +L I M+      L D +       E E     + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY--------SKSSVL--- 152
           F Q+   V + HS  + HRDLK  N          +K+ DFG          + +VL   
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 153 --HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRP 195
             ++R    VGT  Y++PE +    Y  KV I  L L L+    P
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 77/199 (38%), Gaps = 10/199 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR---HP 58
           E   L + +G GNFG     R +    LVAVK        D   A+ +   R L+   HP
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-AKFLQEARILKQYSHP 172
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSM 117
           NI+R   V      + IVME   GG+    +   G R              +G+ Y  S 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV--LHSRPKSTVGTPA-YIAPEVLSRR 174
              HRDL   N L+       LKI DFG S+     + +        P  + APE L+  
Sbjct: 233 CCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 175 EYDGKVCILLLILFLWRNY 193
            Y  +  +    + LW  +
Sbjct: 291 RYSSESDVWSFGILLWETF 309

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 12/188 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HR+L   
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 386
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCI 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K  +
Sbjct: 387 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIKSDV 441
Query: 183 LLLILFLW 190
               + LW
Sbjct: 442 WAFGVLLW 449

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDAGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRK--ID-ENVAREIINHRSLRHPNIIRFKEV 66
           +G G++G   L   K T++ VA+K + R  +  ID + + REI     L+   IIR  ++
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 67  VLTPT-----HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           ++         L IV+E  A  +L          +E+  +     L+ G N+ H   I H
Sbjct: 94  IIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIH 152
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKS 149
           RDLK  N LL+   +  +K+CDFG +++
Sbjct: 153 RDLKPANCLLNQDCS--VKVCDFGLART 178

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 31  AVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTH--LAIVMEYAAGGEL--- 85
           A+K IE G  I  +  REI   R L+HPN+I  ++V L+     + ++ +YA        
Sbjct: 52  ALKQIE-GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII 110
Query: 86  -FDRICNAGR----FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL--DGSAAPR 138
            F R   A +          +    Q++ G++Y H+  + HRDLK  N L+  +G    R
Sbjct: 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170
Query: 139 LKICDFGYSKSSVLHSRP----KSTVGTPAYIAPEVL 171
           +KI D G+++      +P       V T  Y APE+L
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 207

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 81/192 (42%), Gaps = 21/192 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           Y  ++ LG G F    L+         A+K I    + D E   RE   HR   HPNI+R
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 63  FKEVVL---TPTHLA-IVMEYAAGGELF---DRICNAGRF-SEDEGRYFFQQLISGVNYC 114
                L      H A +++ +   G L+   +R+ + G F +ED+  +    +  G+   
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SRPKSTVG-------TPA 164
           H+    HRDLK  N LL     P L   D G    + +H   SR   T+        T +
Sbjct: 151 HAKGYAHRDLKPTNILLGDEGQPVLM--DLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 165 YIAPEVLSRREY 176
           Y APE+ S + +
Sbjct: 209 YRAPELFSVQSH 220

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDGGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDRGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 15/188 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR------EIIN-HR 53
           M++YE+   +G G+FG       +  +E VA+K I + +K   N A+      E++N H 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
           +     I+  K   +   HL +V E  +   L+D  R  N    S +  R F QQ+ + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 112 NYCHS--MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
            +  +  + I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 228
Query: 170 VLSRREYD 177
           VL    YD
Sbjct: 229 VLLGMPYD 236

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 9   DLGAGNFGVAR--LLRHKETKELVAVKYIERG-RKID-ENVAREIINHRSLRHPNIIRFK 64
           +LG GNFG  R  + R ++ +  VA+K +++G  K D E + RE      L +P I+R  
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSE---DEGRYFFQQLISGVNYCHSMQICH 121
            V      L +VME A GG L   +   G+  E           Q+  G+ Y       H
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTP-AYIAPEVLSRREYD 177
           RDL   N LL        KI DFG SK   +   +   +S    P  + APE ++ R++ 
Sbjct: 134 RDLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 178 GKVCILLLILFLWR--NYRPNPF 198
            +  +    + +W   +Y   P+
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPY 214

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 75/176 (42%), Gaps = 21/176 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-----RGRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G FGV  + +       VAVK +         ++ +   +EI      +H N++   
Sbjct: 33  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI-CNAGR--FSEDEGRYFFQQLISGVNYCHSMQICH 121
                   L +V  Y   G L DR+ C  G    S        Q   +G+N+ H     H
Sbjct: 91  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 150
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSS------VLHSRPKSTVGTPAYIAPEVL 171
           RD+K  N LLD   A   KI DFG +++S      V+  R    VGT AY+APE L
Sbjct: 151 RDIKSANILLD--EAFTAKISDFGLARASEKFAQXVMXXR---IVGTTAYMAPEAL 201

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 15/188 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR------EIIN-HR 53
           M++YE+   +G G+FG       +  +E VA+K I + +K   N A+      E++N H 
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 92
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
           +     I+  K   +   HL +V E  +   L+D  R  N    S +  R F QQ+ + +
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTAL 151
Query: 112 NYCHS--MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
            +  +  + I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 152 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 209
Query: 170 VLSRREYD 177
           VL    YD
Sbjct: 210 VLLGMPYD 217

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 15/188 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR------EIIN-HR 53
           M++YE+   +G G+FG       +  +E VA+K I + +K   N A+      E++N H 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
           +     I+  K   +   HL +V E  +   L+D  R  N    S +  R F QQ+ + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 112 NYCHS--MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
            +  +  + I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 228
Query: 170 VLSRREYD 177
           VL    YD
Sbjct: 229 VLLGMPYD 236

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 80/177 (45%), Gaps = 11/177 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           ++ + ++ +G+G +G          ++ VAVK + R  +         RE+   + L+H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           N+I   +V    T +     + +     G   + I  +   S++  ++   QL+ G+ Y 
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYI 147
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N  ++  +   L+I DFG ++ +         V T  Y APE++
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDS--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIM 200

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 75/176 (42%), Gaps = 21/176 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-----RGRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G FGV  + +       VAVK +         ++ +   +EI      +H N++   
Sbjct: 39  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI-CNAGR--FSEDEGRYFFQQLISGVNYCHSMQICH 121
                   L +V  Y   G L DR+ C  G    S        Q   +G+N+ H     H
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSS------VLHSRPKSTVGTPAYIAPEVL 171
           RD+K  N LLD   A   KI DFG +++S      V+  R    VGT AY+APE L
Sbjct: 157 RDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXXR---IVGTTAYMAPEAL 207

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 13/178 (7%)
Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--- 58
           +YE++K +G G+FG V +   HK   + VA+K +   ++     A EI     LR     
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 59  ---NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
              N+I   E      H+ +  E  +    EL  +    G FS    R F   ++  ++ 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDA 215
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            H  +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV+
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVI 271

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 9/175 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN---VAREIINHRSLRHP 58
           +  E + +LG G +GV   +RH  + +++AVK I       E    +    I+ R++  P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 59  NIIRFKEVVLTPTHLAIVMEY--AAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCH 115
             + F   +     + I ME    +  + + ++ + G+   ED        ++  + + H
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 116 S-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           S + + HRD+K  N L++  A  ++K+CDFG S   V         G   Y+APE
Sbjct: 127 SKLSVIHRDVKPSNVLIN--ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 19/200 (9%)
Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--- 58
           +YE++K +G G+FG V +   HK   + VA+K +   ++     A EI     LR     
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 59  ---NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
              N+I   E      H+ +  E  +    EL  +    G FS    R F   ++  ++ 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDA 215
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            H  +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV+  
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILG 273
Query: 174 REYDGKV------CILLLIL 187
             Y   +      CIL  +L
Sbjct: 274 ARYGMPIDMWSLGCILAELL 293

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--ID-ENVAREIINHRSLRHP 58
           ++YE+   +G G++G       K  K +VA+K I R  +  ID + + REI     L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 59  NIIRFKEVVLTPT-----HLAIVMEYAAGGELFDRICNAGRF-SEDEGRYFFQQLISGVN 112
           ++++  ++V+         L +V+E A     F ++     + +E   +     L+ GV 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
           Y HS  I HRDLK  N L++   +  +K+CDFG +++
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLART 205

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 11/177 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           ++ + ++ +G+G +G          ++ VAVK + R  +         RE+   + L+H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           N+I   +V    T +     + +     G   + I      S++  ++   QL+ G+ Y 
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 147
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N  ++  +   L+I DFG ++ +         V T  Y APE++
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDS--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIM 200

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 73/175 (41%), Gaps = 21/175 (12%)
Query: 11  GAGNFGVARLLRHKETKELVAVKYIE-----RGRKIDENVAREIINHRSLRHPNIIRFKE 65
           G G FGV  + +       VAVK +         ++ +   +EI      +H N++    
Sbjct: 31  GEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHR 122
                  L +V  Y   G L DR+ C  G    S        Q   +G+N+ H     HR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSS------VLHSRPKSTVGTPAYIAPEVL 171
           D+K  N LLD   A   KI DFG +++S      V  SR    VGT AY APE L
Sbjct: 149 DIKSANILLD--EAFTAKISDFGLARASEKFAQXVXXSR---IVGTTAYXAPEAL 198

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--ID-ENVAREIINHRSLRHP 58
           + YE+   +G G++G   L   K   + VA+K + R  +  ID + + REI     L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 59  NIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
            IIR  +++     L    L IV+E  A  +L          +E   +     L+ G  +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
            H   I HRDLK  N LL+   +  +KICDFG +++
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCS--VKICDFGLART 180

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 9/175 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN---VAREIINHRSLRHP 58
           +  E + +LG G +GV   +RH  + +++AVK I       E    +    I+ R++  P
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 59  NIIRFKEVVLTPTHLAIVMEY--AAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCH 115
             + F   +     + I ME    +  + + ++ + G+   ED        ++  + + H
Sbjct: 111 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 170
Query: 116 S-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           S + + HRD+K  N L++  A  ++K+CDFG S   V         G   Y+APE
Sbjct: 171 SKLSVIHRDVKPSNVLIN--ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPE 223

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 68/147 (46%), Gaps = 9/147 (6%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPNIIRFK 64
           +G G+FGV      +   + +   A+K + R  ++   E   RE +  R L HPN++   
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 65  EVVLTPTHLA-IVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            ++L P  L  +++ Y   G+L   I +  R    +    F  Q+  G+ Y    +  HR
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHR 148
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS 149
           DL   N +LD S    +K+ DFG ++ 
Sbjct: 149 DLAARNCMLDESFT--VKVADFGLARD 173

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 10  LGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +GAG FG     RL    +    VA+K ++ G    E   R+ +   S+     HPN++ 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT--EKQRRDFLCEASIMGQFDHPNVVH 108
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV     + IV+E+   G L  F R  + G+F+  +     + + +G+ Y   M   
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLR-KHDGQFTVIQLVGMLRGIAAGMRYLADMGYV 167
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  V+   P++   T        + APE +  R
Sbjct: 168 HRDLAARNILVNSNLV--CKVSDFGLSR--VIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 175 EYDGKVCILLLILFLWR--NYRPNPF 198
           ++     +    + +W   +Y   P+
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERPY 249

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 78/177 (44%), Gaps = 11/177 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           ++ + ++ +G+G +G          ++ VAVK + R  +         RE+   + L+H 
Sbjct: 20  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 79
Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           N+I   +V    T +     + +     G   + I      S++  ++   QL+ G+ Y 
Sbjct: 80  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 139
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++
Sbjct: 140 HSAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIM 192

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 15/176 (8%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKY---IERGRKIDENVAREIINHRSLRHPNIIRF--K 64
           LG G        RHK+T +L A+K    I   R +D  + RE    + L H NI++    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAI 75
Query: 65  EVVLTPTHLAIVMEYAAGGELF---DRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           E   T  H  ++ME+   G L+   +   NA    E E     + ++ G+N+     I H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 122 RDLKLENTLL----DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           R++K  N +     DG +    K+ DFG ++      +  S  GT  Y+ P++  R
Sbjct: 136 RNIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 25/192 (13%)
Query: 5   ELVKDLGA---GNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-----RSLR 56
           E +KDLG    G +G    + HK + +++AVK I     +DE   ++++       RS  
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--TVDEKEQKQLLMDLDVVMRSSD 79
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE-------GRYFFQQLIS 109
            P I++F   +       I ME  +    FD+         D+       G+     + +
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
             +   +++I HRD+K  N LLD S    +K+CDFG S   V         G   Y+APE
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 195
Query: 170 VL----SRREYD 177
            +    SR+ YD
Sbjct: 196 RIDPSASRQGYD 207

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 16/160 (10%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNII 61
           +Y  +K LG G  G+       +  + VA+K I     +  ++  REI   R L H NI+
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL-------------FDRICNAGRFSEDEGRYFFQQLI 108
           +  E+ L P+   +  +  +  EL                +   G   E+  R F  QL+
Sbjct: 72  KVFEI-LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130
Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            G+ Y HS  + HRDLK  N  ++ +    LKI DFG ++
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLAR 169

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 7/170 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           +G+G+FG     +      +  +K ++   +  +    E+   R  RH NI+ F    +T
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-MT 102
Query: 70  PTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
             +LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRD+K  N
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNN 162
Query: 129 TLLDGSAAPRLKICDFGYSKSSVLHSRPKST---VGTPAYIAPEVLSRRE 175
             L       +KI DFG +      S  +      G+  ++APEV+  ++
Sbjct: 163 IFLHEGLT--VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 10  LGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +GAG FG   +  L+    +E+ VA+K ++ G    E   R+ ++  S+     HPN+I 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIH 72
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
            + VV   T + I+ E+   G L   +  N G+F+  +     + + +G+ Y   M   H
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVH 132
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA--------YIAPEVLSR 173
           R L   N L++ +     K+ DFG S+   L         T A        + APE +  
Sbjct: 133 RALAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 174 REYDGKVCILLLILFLWR--NYRPNPF 198
           R++     +    + +W   +Y   P+
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPY 215

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--- 58
           +YE++K +G G FG V +   HK   + VA+K +   ++     A EI     LR     
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHK-VHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 59  ---NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
              N+I   E      H+ +  E  +    EL  +    G FS    R F   ++  ++ 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDA 215
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            H  +I H DLK EN LL       +K+ DFG   S   H R    + +  Y APEV+
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVI 271

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 9   DLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDEN----VAREIINHRSLRHPNIIRF 63
           ++G G+F    + +  +T+  V V + E + RK+ ++       E    + L+HPNI+RF
Sbjct: 33  EIGRGSFKT--VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 64  ----KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ- 118
               +  V     + +V E    G L   +           R + +Q++ G+ + H+   
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 119 -ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I HRDLK +N  + G     +KI D G + +    S  K+ +GTP + APE    + YD
Sbjct: 151 PIIHRDLKCDNIFITGPTGS-VKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEEK-YD 207
Query: 178 GKV 180
             V
Sbjct: 208 ESV 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L+K LG G FG   +   +  TK  VA+K ++ G    E+   E    + L+H  +
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTK--VAIKTLKPGTMSPESFLEEAQIMKKLKHDKL 66
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVN 112
           ++   VV +   + IV EY   G L D +       + EGR            Q+ +G+ 
Sbjct: 67  VQLYAVV-SEEPIYIVTEYMNKGSLLDFL------KDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           Y   M   HRDL+  N L+        KI DFG ++
Sbjct: 120 YIERMNYIHRDLRSANILVGNGLI--CKIADFGLAR 153

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 18/178 (10%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE---------RGRKIDENVAREIINHRSLRHPNI 60
           LG G FG     + + T ++ A K +E             ++E    E +N R      +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF-----V 246
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQ 118
           +       T   L +V+    GG+L   I + G+  F E    ++  ++  G+   H  +
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y
Sbjct: 307 IVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 15/176 (8%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKY---IERGRKIDENVAREIINHRSLRHPNIIRF--K 64
           LG G        RHK+T +L A+K    I   R +D  + RE    + L H NI++    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAI 75
Query: 65  EVVLTPTHLAIVMEYAAGGELF---DRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           E   T  H  ++ME+   G L+   +   NA    E E     + ++ G+N+     I H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 122 RDLKLENTLL----DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           R++K  N +     DG +    K+ DFG ++      +     GT  Y+ P++  R
Sbjct: 136 RNIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYER 189

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR 157

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPN 59
           L ++LG G FG   L     L  ++ K LVAVK + +      ++  RE     +L+H +
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-------------RFSEDEGRYFFQQ 106
           I++F  V +    L +V EY   G+L   +   G               ++ +  +  QQ
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGTPA 164
           + +G+ Y  S    HRDL   N L+  +    +KI DFG S+   S  + R       P 
Sbjct: 137 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 165 -YIAPEVLSRREYDGKVCILLLILFLWR--NYRPNPF 198
            ++ PE +  R++  +  +  L + LW    Y   P+
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 231

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 80  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 138
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 139 YIHRDLRAANILVSDTLS--CKIADFGLAR 166

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 72
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 73  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 132 YIHRDLRAANILVSDTLS--CKIADFGLAR 159

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR 157

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 71
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 72  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 131 YIHRDLRAANILVSDTLS--CKIADFGLAR 158

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 9   DLGAGNFGVAR--LLRHKETKELVAVKYIERG-RKID-ENVAREIINHRSLRHPNIIRFK 64
           +LG GNFG  R  + R ++ +  VA+K +++G  K D E + RE      L +P I+R  
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSE---DEGRYFFQQLISGVNYCHSMQICH 121
            V      L +VME A GG L   +   G+  E           Q+  G+ Y       H
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTP-AYIAPEVLSRREYD 177
           R+L   N LL        KI DFG SK   +   +   +S    P  + APE ++ R++ 
Sbjct: 460 RNLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 178 GKVCILLLILFLWR--NYRPNPF 198
            +  +    + +W   +Y   P+
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 77  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 136 YIHRDLRAANILVSDTLS--CKIADFGLAR 163

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N L+D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVLIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 208 MYDYSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 52/110 (47%), Gaps = 4/110 (3%)
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKL 126
           T   L +V+    GG+L   I + G+  F E    ++  ++  G+   H  +I +RDLK 
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314
Query: 127 ENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           EN LLD      ++I D G +         K  VGT  Y+APEV+    Y
Sbjct: 315 ENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 29/197 (14%)
Query: 1   MEKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREI-----INHRS 54
            E+YE+V  LG G FG V + + H+     VA+K I+   K  E    EI     IN + 
Sbjct: 32  QERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKD 91
Query: 55  LRHPNI-IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
             + N+ ++  +      H+ I  E   G   FD  +  N   +   + R+   QL   V
Sbjct: 92  PDNKNLCVQMFDWFDYHGHMCISFE-LLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAV 150
Query: 112 NYCHSMQICHRDLKLENTLLDGS-----------------AAPRLKICDFGYSKSSVLHS 154
            + H  ++ H DLK EN L   S                  +  +++ DFG   ++  H 
Sbjct: 151 KFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG--SATFDHE 208
Query: 155 RPKSTVGTPAYIAPEVL 171
              + V T  Y APEV+
Sbjct: 209 HHSTIVSTRHYRAPEVI 225

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 77  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 136 YIHRDLRAANILVSDTLS--CKIADFGLAR 163

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 76  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 134
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 135 YIHRDLRAANILVSDTLS--CKIADFGLAR 162

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR 157

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 78
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 79  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 137
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 138 YIHRDLRAANILVSDTLS--CKIADFGLAR 165

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 81  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 139
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 140 YIHRDLRAANILVSDTLS--CKIADFGLAR 167

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 37/204 (18%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYI------ERGRKIDENVAREIINHRSLRHPN 59
           +++ +G G FG   L +H + K+  AVK +       R  KI+ ++ ++I  +  + + N
Sbjct: 39  VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKI-QNDDINNNN 97
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCHSM 117
           I+++    +   H+ ++ E   G  L++ I   N   F  ++ + +  +++  +NY   M
Sbjct: 98  IVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156
Query: 118 QICHRDLKLENTLLDG-----------------------SAAPRLKICDFGYSK-SSVLH 153
            + H DLK EN LLD                        + +  +K+ DFG +   S  H
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH 216
Query: 154 SRPKSTVGTPAYIAPEVLSRREYD 177
               S + T  Y APEV+    +D
Sbjct: 217 G---SIINTRQYRAPEVILNLGWD 237

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 65
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 66  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 125 YIHRDLRAANILVSDTLS--CKIADFGLAR 152

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 208 MYDYSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 207 MYDYSLDMWSLGCMLASMIF-----RKEPFF 232

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 208 MYDYSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 206 MYDYSLDMWSLGCMLASMIF-----RKEPFF 231

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 208 MYDYSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 208 MYDYSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 207 MYDYSLDMWSLGCMLASMIF-----RKEPFF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 208 MYDYSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 208 MYDYSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 208 MYDYSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 66
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 67  QLYAVV-SEEPIXIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAY 119
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 120 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 152

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 153
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 213 MYDYSLDMWSLGCMLASMIF-----RKEPFF 238

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 26/179 (14%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNI 60
           E + ++G+G  G    +R ++T  ++AVK + R    +EN  R +++     +S   P I
Sbjct: 28  ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYI 86
Query: 61  IRFKEVVLTPTHLAIVMEYAAG----------GELFDRICNAGRFSEDEGRYFFQQLISG 110
           ++     +T T + I ME              G + +RI      +  +  Y+ ++    
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---- 142
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
                   + HRD+K  N LLD     ++K+CDFG S   V       + G  AY+APE
Sbjct: 143 -----KHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IVMEY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVMEYMSKGCLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 15/170 (8%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 32  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +  +  +F   +     +Q   G++Y H+  I HRDL
Sbjct: 88  YSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVL 171
           K  N  L       +KI DFG +      S   + +   G+  ++APEV+
Sbjct: 147 KSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 208 MYDYSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKV------CILLLILFLWRNYRPNPFI 199
            YD  +      C+L  ++F     R  PF 
Sbjct: 208 MYDYSLDMWSLGCMLASMIF-----RKEPFF 233

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 15/170 (8%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 32  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +  +  +F   +     +Q   G++Y H+  I HRDL
Sbjct: 88  YSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVL 171
           K  N  L       +KI DFG +      S     +   G+  ++APEV+
Sbjct: 147 KSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 17/171 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 20  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +  +  +F   +     +Q   G++Y H+  I HRDL
Sbjct: 76  YSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 134
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVL 171
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+
Sbjct: 135 KSNNIFLHEDNT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVI 182

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV+EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVIEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 69
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 70  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAY 122
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 123 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 155

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV+EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVIEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 66
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 67  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HR+L+  N L+  + +   KI DFG ++
Sbjct: 126 YIHRNLRAANILVSDTLS--CKIADFGLAR 153

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 65
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 66  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 119 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 151

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 296 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 328

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 67
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 68  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 120
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 121 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 153

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 296 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 328

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 30  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEVL 171
            I H DLK  N L+ DG     LK+ DFG +   +         S VGT  Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 57/228 (25%)
Query: 7   VKDLGAG-NFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
            +D+G+G  + + RLL ++E K    ++ +   +K+               HPNI++F  
Sbjct: 47  AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS-------------GHPNIVQFCS 93
Query: 64  ------KEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
                 +E         ++ E   G   E   ++ + G  S D     F Q    V + H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 116 SMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-------SRPKSTV------ 160
             +  I HRDLK+EN LL       +K+CDFG S +++ H       ++ ++ V      
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGT--IKLCDFG-SATTISHYPDYSWSAQRRALVEEEITR 210
Query: 161 -GTPAYIAPEVLS---------RREYDGKVCILLLILFLWRNYRPNPF 198
             TP Y  PE++          +++     CIL L+ F     R +PF
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF-----RQHPF 253

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG------ETGKYLRLPQLVDMAAQIASGMAY 378
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 379 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 411

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 14  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 71
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 72  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEVL 171
            I H DLK  N L+ DG     LK+ DFG +   +         S VGT  Y+ PE +
Sbjct: 131 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVCEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 22/187 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++ ++VK +G G +G   +   K   E VAVK      +       EI     +RH NI+
Sbjct: 37  KQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL 94
Query: 62  RFKEVVL----TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
            F    +    + T L ++ +Y   G L+D + +    ++   +  +   +SG+ + H+ 
Sbjct: 95  GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTE 153
Query: 118 --------QICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPA 164
                    I HRDLK +N L+  +      I D G      S ++ +   P + VGT  
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 165 YIAPEVL 171
           Y+ PEVL
Sbjct: 212 YMPPEVL 218

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 10  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 67
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 68  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEVL 171
            I H DLK  N L+ DG     LK+ DFG +   +         S VGT  Y+ PE +
Sbjct: 127 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY   G L D +        + G+Y           Q+ SG+ Y
Sbjct: 74  QLYAVV-SEEPIYIVTEYMNKGSLLDFL------KGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 127 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 159

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 11  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 69  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VGT  Y+ PE 
Sbjct: 128 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGTVNYMPPEA 180
Query: 171 L 171
           +
Sbjct: 181 I 181

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 72  YSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 131 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 182

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY   G L D +        + G+Y           Q+ SG+ Y
Sbjct: 74  QLYAVV-SEEPIYIVTEYMNKGSLLDFL------KGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 127 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 159

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 30  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEVL 171
            I H DLK  N L+ DG     LK+ DFG +   +         S VGT  Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 8   LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 169 EVL 171
           EVL
Sbjct: 183 EVL 185

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 10  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 169 EVL 171
           EVL
Sbjct: 185 EVL 187

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 7   LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 169 EVL 171
           EVL
Sbjct: 182 EVL 184

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 243 QLYAVV-SEEPIYIVGEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 296 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 328

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 13  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 169 EVL 171
           EVL
Sbjct: 188 EVL 190

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 72  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 131 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 182

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 72  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG +      S   + +   G+  ++APEV+  ++
Sbjct: 131 KSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL   N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLAAANILVGENLV--CKVADFGLAR 162

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 77/195 (39%), Gaps = 27/195 (13%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E+YE+V +LG G FG V   L H   K  VA+K I    K  E    EI   + ++  + 
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 61  -IRFKEVVLTP-----THLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQLISGVNY 113
             +F  V+++       H+ I  E        F +  N   +     R+   QL   + +
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRL-----------------KICDFGYSKSSVLHSRP 156
            H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H   
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHH 196
Query: 157 KSTVGTPAYIAPEVL 171
            + V T  Y  PEV+
Sbjct: 197 TTIVATRHYRPPEVI 211

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDX 212
Query: 155 RPKSTVG--TPAYIAPEVLSRREYDGKVCILLLILFLW 190
             K+T G     ++APE L  R Y  +  +    + +W
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VGT  Y+ PE 
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGTVNYMPPEA 227
Query: 171 L 171
           +
Sbjct: 228 I 228

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 33  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 90
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 169 EVL 171
           EVL
Sbjct: 208 EVL 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + +RH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLV 243
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 244 QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 296
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG  +
Sbjct: 297 VERMNYVHRDLRAANILVGENLV--CKVADFGLGR 329

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 38/77 (49%), Gaps = 7/77 (9%)
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLL---DGSAAPRLKICDFGYSKSSVL----HSR 155
             QQ  SG+ + HS+ I HRDLK  N L+   +     +  I DFG  K   +     SR
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 156 PKSTVGTPAYIAPEVLS 172
                GT  +IAPE+LS
Sbjct: 183 RSGVPGTEGWIAPEMLS 199

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 77/195 (39%), Gaps = 27/195 (13%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E+YE+V +LG G FG V   L H   K  VA+K I    K  E    EI   + ++  + 
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 87
Query: 61  -IRFKEVVLTP-----THLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQLISGVNY 113
             +F  V+++       H+ I  E        F +  N   +     R+   QL   + +
Sbjct: 88  ENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 147
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRL-----------------KICDFGYSKSSVLHSRP 156
            H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H   
Sbjct: 148 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHH 205
Query: 157 KSTVGTPAYIAPEVL 171
            + V T  Y  PEV+
Sbjct: 206 TTIVATRHYRPPEVI 220

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 77/195 (39%), Gaps = 27/195 (13%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E+YE+V +LG G FG V   L H   K  VA+K I    K  E    EI   + ++  + 
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 110
Query: 61  -IRFKEVVLTP-----THLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQLISGVNY 113
             +F  V+++       H+ I  E        F +  N   +     R+   QL   + +
Sbjct: 111 ENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 170
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRL-----------------KICDFGYSKSSVLHSRP 156
            H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H   
Sbjct: 171 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHH 228
Query: 157 KSTVGTPAYIAPEVL 171
            + V T  Y  PEV+
Sbjct: 229 TTIVATRHYRPPEVI 243

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 18  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 74  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 132
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 133 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 184

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 46  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 169 EVL 171
           EVL
Sbjct: 221 EVL 223

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG  G   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR 157

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 21  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 77  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 136 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 187

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VGT  Y+ PE 
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGTVNYMPPEA 227
Query: 171 L 171
           +
Sbjct: 228 I 228

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 21  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 77  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 136 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 187

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 140
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 141 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 172 SRREYDGKVCILLL-ILFLWRNYRPNPFIW 200
             ++YD  + +  L  +F    +R  PF +
Sbjct: 200 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 229

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKVCILLL-ILFLWRNYRPNPFIW 200
             ++YD  + +  L  +F    +R  PF +
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 228

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKVCILLL-ILFLWRNYRPNPFIW 200
             ++YD  + +  L  +F    +R  PF +
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 228

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGCLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 100 YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG +      S   + +   G+  ++APEV+  ++
Sbjct: 159 KSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKVCILLL-ILFLWRNYRPNPFIW 200
             ++YD  + +  L  +F    +R  PF +
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 228

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKVCILLL-ILFLWRNYRPNPFIW 200
             ++YD  + +  L  +F    +R  PF +
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 228

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYIE----RGRKIDENVAREIINHRSLR 56
           L ++LG G FG   L     L   + K LVAVK ++      RK  +  A  + N   L+
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN---LQ 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FDR-------ICNAGRFSEDEGRYFFQQL 107
           H +I++F  V      L +V EY   G+L  F R       I   G+  + +G     Q+
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKS 158
           +       SG+ Y  S    HRDL   N L+   A   +KI DFG S+   S  + R   
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 159 TVGTPA-YIAPEVLSRREYDGKVCILLLILFLWR--NYRPNPF 198
               P  ++ PE +  R++  +  +    + LW    Y   P+
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKVCILLL-ILFLWRNYRPNPFIW 200
             ++YD  + +  L  +F    +R  PF +
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 228

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 36  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 92  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 150
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG +      S   + +   G+  ++APEV+  ++
Sbjct: 151 KSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 140
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 141 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 172 SRREYDGKVCILLL-ILFLWRNYRPNPFIW 200
             ++YD  + +  L  +F    +R  PF +
Sbjct: 200 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 229

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 9/175 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN---VAREIINHRSLRHP 58
           +  E + +LG G +GV    RH  + ++ AVK I       E    +    I+ R++  P
Sbjct: 34  DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 59  NIIRFKEVVLTPTHLAIVMEY--AAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCH 115
             + F   +     + I  E    +  + + ++ + G+   ED        ++  + + H
Sbjct: 94  FTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 153
Query: 116 S-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           S + + HRD+K  N L++  A  ++K CDFG S   V         G   Y APE
Sbjct: 154 SKLSVIHRDVKPSNVLIN--ALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPE 206

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 107 PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 160
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 161 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 219
Query: 172 SRREYDGKVCILLL-ILFLWRNYRPNPFIW 200
             ++YD  + +  L  +F    +R  PF +
Sbjct: 220 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 249

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 77  NPHVCRLLGICLTST-VQLIMQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKGM 131
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 132 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 166

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKVCILLL-ILFLWRNYRPNPFIW 200
             ++YD  + +  L  +F    +R  PF +
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 228

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 100 YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 159 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 210

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 88  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 141
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 142 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 200
Query: 172 SRREYDGKVCILLL-ILFLWRNYRPNPFIW 200
             ++YD  + +  L  +F    +R  PF +
Sbjct: 201 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 230

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 43  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 99  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 157
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 158 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 209

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 RPKSTVG--TPAYIAPEVLSRREYDGKVCILLLILFLW 190
             K+T G     ++APE L  R Y  +  +    + +W
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 RPKSTVG--TPAYIAPEVLSRREYDGKVCILLLILFLW 190
             K+T G     ++APE L  R Y  +  +    + +W
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 61/138 (44%), Gaps = 24/138 (17%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED---EGRY----FFQQLIS 109
           HPN+IR+     T   L I +E      L D + +     E+   +  Y      +Q+ S
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 110 GVNYCHSMQICHRDLKLENTLLD-----------GSAAPRLKICDFGYSK-----SSVLH 153
           GV + HS++I HRDLK +N L+            G+   R+ I DFG  K      S   
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 154 SRPKSTVGTPAYIAPEVL 171
           +   +  GT  + APE+L
Sbjct: 187 TNLNNPSGTSGWRAPELL 204

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 RPKSTVG--TPAYIAPEVLSRREYDGKVCILLLILFLW 190
             K+T G     ++APE L  R Y  +  +    + +W
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNV--MKIADFGLARDINNIDY 199
Query: 155 RPKSTVG--TPAYIAPEVLSRREYDGKVCILLLILFLW 190
             K+T G     ++APE L  R Y  +  +    + +W
Sbjct: 200 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 237

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 201
Query: 155 RPKSTVG--TPAYIAPEVLSRREYDGKVCILLLILFLW 190
             K+T G     ++APE L  R Y  +  +    + +W
Sbjct: 202 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 239

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 35/220 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FDRICNAGRFSEDEG 100
               +H NII           L +++EYA+ G L            +   +  R  E++ 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ- 153
Query: 101 RYFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVL 152
              F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 154 -MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 210
Query: 153 HSRPKSTVG--TPAYIAPEVLSRREYDGKVCILLLILFLW 190
               K+T G     ++APE L  R Y  +  +    + +W
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLH 153
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  +++ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 154 SRPKSTVGTPA-YIAPEVLSRREYDGKVCILLLILFLW 190
            +  +    P  ++APE L  R Y  +  +    + +W
Sbjct: 213 YKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 204
Query: 155 RPKSTVG--TPAYIAPEVLSRREYDGKVCILLLILFLW 190
             K+T G     ++APE L  R Y  +  +    + +W
Sbjct: 205 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 242

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 80  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 134
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 135 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 169

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 77  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 131
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 132 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 166

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 258
Query: 155 RPKSTVG--TPAYIAPEVLSRREYDGKVCILLLILFLW 190
             K+T G     ++APE L  R Y  +  +    + +W
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 78  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 132
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 133 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 167

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 79  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 133
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 134 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 168

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    ++I DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MRIADFGLARDINNIDY 212
Query: 155 RPKSTVG--TPAYIAPEVLSRREYDGKVCILLLILFLW 190
             K+T G     ++APE L  R Y  +  +    + +W
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 18/150 (12%)
Query: 59  NIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NII+  + V  P     A+V EY    + F ++      ++ + R++  +L+  ++YCHS
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 155
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRRE 175
             I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   + 
Sbjct: 156 KGIMHRDVKPHNVMIDHQQK-KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 214
Query: 176 YDGKV------CILLLILFLWRNYRPNPFI 199
           YD  +      C+L  ++F     R  PF 
Sbjct: 215 YDYSLDMWSLGCMLASMIF-----RREPFF 239

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 18/150 (12%)
Query: 59  NIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NII+  + V  P     A+V EY    + F ++      ++ + R++  +L+  ++YCHS
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 150
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL-SRRE 175
             I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   + 
Sbjct: 151 KGIMHRDVKPHNVMIDHQQK-KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 209
Query: 176 YDGKV------CILLLILFLWRNYRPNPFI 199
           YD  +      C+L  ++F     R  PF 
Sbjct: 210 YDYSLDMWSLGCMLASMIF-----RREPFF 234

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VG   Y+ PE 
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGAVNYMPPEA 227
Query: 171 L 171
           +
Sbjct: 228 I 228

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 78  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 132
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 133 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 167

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 80  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 134
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 135 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 169

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 78  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 132
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 133 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 167

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 7   VKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNI 60
           VK LG+G FG       +   +  K  VA+K +      K ++ +  E      +  P +
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
            R   + LT T + +V +    G L D +  N GR    +   +  Q+  G++Y   +++
Sbjct: 82  SRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRL 140
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL   N L+   +   +KI DFG ++
Sbjct: 141 VHRDLAARNVLV--KSPNHVKITDFGLAR 167

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 86/220 (39%), Gaps = 36/220 (16%)
Query: 5   ELVKDLGAGNFGV-----ARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRH 57
           E V+D+G G FG      A  L   E   +VAVK +  E    +  +  RE        +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD----------------------RICNAG-- 93
           PNI++   V      + ++ EY A G+L +                      R+ + G  
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 94  RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SV 151
             S  E     +Q+ +G+ Y    +  HRDL   N L+  +    +KI DFG S++  S 
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSA 227
Query: 152 LHSRPKSTVGTPA-YIAPEVLSRREYDGKVCILLLILFLW 190
            + +       P  ++ PE +    Y  +  +    + LW
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 18/180 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--------ERGRKIDENVAREIINHR 53
           + ++ +  LG G++G    +R KE   L AVK          +R RK+ E  + E +   
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG-- 114
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGV 111
             +HP  +R ++       L +  E    G    + C A   S  E +   + +  +  +
Sbjct: 115 --QHPCCVRLEQAWEEGGILYLQTELC--GPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            + HS  + H D+K  N  L      R K+ DFG           +   G P Y+APE+L
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRG--RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL 228

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 9   DLGAGNFGVARL-----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIR 62
           +LG G FG   L     L  ++ K LVAVK + E      ++  RE      L+H +I+R
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 63  FKEVVLTPTHLAIVMEYAAGGELF--------DRICNAGRFSEDEGRYFFQQLI------ 108
           F  V      L +V EY   G+L         D    AG      G     QL+      
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 109 -SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGTPA- 164
            +G+ Y   +   HRDL   N L+       +KI DFG S+   S  + R       P  
Sbjct: 145 AAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 165 YIAPEVLSRREYDGKVCILLLILFLWR--NYRPNPF 198
           ++ PE +  R++  +  +    + LW    Y   P+
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 238

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 9   DLGAGNFGVARL-----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIR 62
           +LG G FG   L     L  ++ K LVAVK + E      ++  RE      L+H +I+R
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 63  FKEVVLTPTHLAIVMEYAAGGELF--------DRICNAGRFSEDEGRYFFQQLI------ 108
           F  V      L +V EY   G+L         D    AG      G     QL+      
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 109 -SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGTPA- 164
            +G+ Y   +   HRDL   N L+       +KI DFG S+   S  + R       P  
Sbjct: 139 AAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 165 YIAPEVLSRREYDGKVCILLLILFLWR--NYRPNPF 198
           ++ PE +  R++  +  +    + LW    Y   P+
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 9   DLGAGNFGVARL-----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIR 62
           +LG G FG   L     L  ++ K LVAVK + E      ++  RE      L+H +I+R
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 63  FKEVVLTPTHLAIVMEYAAGGELF--------DRICNAGRFSEDEGRYFFQQLI------ 108
           F  V      L +V EY   G+L         D    AG      G     QL+      
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 109 -SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGTPA- 164
            +G+ Y   +   HRDL   N L+       +KI DFG S+   S  + R       P  
Sbjct: 168 AAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 165 YIAPEVLSRREYDGKVCILLLILFLWR--NYRPNPF 198
           ++ PE +  R++  +  +    + LW    Y   P+
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 16/194 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 157 DLAARNCMLDEKFT--VKVADFGLARDMYDKEXXSVHNKTGAKLPV-KWMALESLQTQKF 213
Query: 177 DGKVCILLLILFLW 190
             K  +    + LW
Sbjct: 214 TTKSDVWSFGVLLW 227

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 16/195 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 175
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSV------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 176 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 232
Query: 177 DGKVCILLLILFLWR 191
             K  +    + LW 
Sbjct: 233 TTKSDVWSFGVLLWE 247

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 16/194 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSV------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 177 DGKVCILLLILFLW 190
             K  +    + LW
Sbjct: 215 TTKSDVWSFGVLLW 228

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 16/194 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSV------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 157 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 213
Query: 177 DGKVCILLLILFLW 190
             K  +    + LW
Sbjct: 214 TTKSDVWSFGVLLW 227

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 16/194 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 152
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSV------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 153 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 209
Query: 177 DGKVCILLLILFLW 190
             K  +    + LW
Sbjct: 210 TTKSDVWSFGVLLW 223

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 7   VKDLGAGNFGVAR---LLRHKETKEL-VAVKYIER--GRKIDENVAREIINHRSLRHPNI 60
           VK LG+G FG       +   ET ++ VA+K +    G K +     E +   S+ HP++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF----QQLISGVNYCHS 116
           +R   V L+PT + +V +    G L + +       ++ G         Q+  G+ Y   
Sbjct: 103 VRLLGVCLSPT-IQLVTQLMPHGCLLEYV---HEHKDNIGSQLLLNWCVQIAKGMMYLEE 158
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            ++ HRDL   N L+   +   +KI DFG ++
Sbjct: 159 RRLVHRDLAARNVLV--KSPNHVKITDFGLAR 188

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 16/195 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 155
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSV------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 156 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 212
Query: 177 DGKVCILLLILFLWR 191
             K  +    + LW 
Sbjct: 213 TTKSDVWSFGVLLWE 227

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 16/194 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 149
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSV------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 150 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 206
Query: 177 DGKVCILLLILFLW 190
             K  +    + LW
Sbjct: 207 TTKSDVWSFGVLLW 220

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 16/194 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 176
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSV------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 177 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 233
Query: 177 DGKVCILLLILFLW 190
             K  +    + LW
Sbjct: 234 TTKSDVWSFGVLLW 247

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 16/194 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSV------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 177 DGKVCILLLILFLW 190
             K  +    + LW
Sbjct: 215 TTKSDVWSFGVLLW 228

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 74
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++ 
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRD 179

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 24/138 (17%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED---EGRY----FFQQLIS 109
           HPN+IR+     T   L I +E      L D + +     E+   +  Y      +Q+ S
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 110 GVNYCHSMQICHRDLKLENTLLD-----------GSAAPRLKICDFGYSK-----SSVLH 153
           GV + HS++I HRDLK +N L+            G+   R+ I DFG  K          
Sbjct: 145 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 154 SRPKSTVGTPAYIAPEVL 171
               +  GT  + APE+L
Sbjct: 205 XNLNNPSGTSGWRAPELL 222

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 16/194 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 154
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSV------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 155 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 211
Query: 177 DGKVCILLLILFLW 190
             K  +    + LW
Sbjct: 212 TTKSDVWSFGVLLW 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 74
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++ 
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRD 179

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 24/138 (17%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED---EGRY----FFQQLIS 109
           HPN+IR+     T   L I +E      L D + +     E+   +  Y      +Q+ S
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 110 GVNYCHSMQICHRDLKLENTLLD-----------GSAAPRLKICDFGYSK-----SSVLH 153
           GV + HS++I HRDLK +N L+            G+   R+ I DFG  K          
Sbjct: 145 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 154 SRPKSTVGTPAYIAPEVL 171
               +  GT  + APE+L
Sbjct: 205 XNLNNPSGTSGWRAPELL 222

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
           L++ +G G +G   + R     E VAVK      +       E+ N   LRH NI+ F  
Sbjct: 12  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 66  VVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
             +T  H    L ++  Y   G L+D +                 + SG+ + H      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--------VGTPAY 165
                I HRDLK +N L+  +   +  I D G +   V+HS+  +         VGT  Y
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRY 183
Query: 166 IAPEVL 171
           +APEVL
Sbjct: 184 MAPEVL 189

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
           L++ +G G +G   + R     E VAVK      +       E+ N   LRH NI+ F  
Sbjct: 12  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 66  VVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
             +T  H    L ++  Y   G L+D +                 + SG+ + H      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--------VGTPAY 165
                I HRDLK +N L+  +   +  I D G +   V+HS+  +         VGT  Y
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRY 183
Query: 166 IAPEVL 171
           +APEVL
Sbjct: 184 MAPEVL 189

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 14  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 71
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 72  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 131
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++ 
Sbjct: 132 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRD 176

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 24/138 (17%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED---EGRY----FFQQLIS 109
           HPN+IR+     T   L I +E      L D + +     E+   +  Y      +Q+ S
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 110 GVNYCHSMQICHRDLKLENTLLD-----------GSAAPRLKICDFGYSK-----SSVLH 153
           GV + HS++I HRDLK +N L+            G+   R+ I DFG  K          
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 186
Query: 154 SRPKSTVGTPAYIAPEVL 171
               +  GT  + APE+L
Sbjct: 187 XNLNNPSGTSGWRAPELL 204

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 74
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTR 178

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
           L++ +G G +G   + R     E VAVK      +       E+ N   LRH NI+ F  
Sbjct: 41  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 98
Query: 66  VVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
             +T  H    L ++  Y   G L+D +                 + SG+ + H      
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--------VGTPAY 165
                I HRDLK +N L+  +   +  I D G +   V+HS+  +         VGT  Y
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRY 212
Query: 166 IAPEVL 171
           +APEVL
Sbjct: 213 MAPEVL 218

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 74
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++ 
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRD 179

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 7   VKDLGAGNFGVAR---LLRHKETKEL-VAVKYIER--GRKIDENVAREIINHRSLRHPNI 60
           VK LG+G FG       +   ET ++ VA+K +    G K +     E +   S+ HP++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF----QQLISGVNYCHS 116
           +R   V L+PT + +V +    G L + +       ++ G         Q+  G+ Y   
Sbjct: 80  VRLLGVCLSPT-IQLVTQLMPHGCLLEYV---HEHKDNIGSQLLLNWCVQIAKGMMYLEE 135
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            ++ HRDL   N L+   +   +KI DFG ++
Sbjct: 136 RRLVHRDLAARNVLV--KSPNHVKITDFGLAR 165

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 44/76 (57%), Gaps = 5/76 (6%)
Query: 105 QQLISGVNYCHSMQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP 163
           + +++  +Y H+ + ICHRD+K  N L+D +   R+K+ DFG S+  V   + K + GT 
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGESEYMV-DKKIKGSRGTY 214
Query: 164 AYIAPEVLSRR-EYDG 178
            ++ PE  S    Y+G
Sbjct: 215 EFMPPEFFSNESSYNG 230

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 16  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 73
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 74  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 133
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++ 
Sbjct: 134 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRD 178

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 78  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 132
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 133 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 167

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 82  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 136
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 137 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 171

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 16/195 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ +  S +  HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSV------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++  +      +H++  + +    ++A E L  +++
Sbjct: 159 DLAARNCMLDEKFT--VKVADFGLARDMLDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 215
Query: 177 DGKVCILLLILFLWR 191
             K  +    + LW 
Sbjct: 216 TTKSDVWSFGVLLWE 230

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K L +G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 83  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 137
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 138 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 172

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 79  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 133
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 134 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 168

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 83  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 137
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 138 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 172

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 73  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAEGM 127
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 128 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 162

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 101 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 155
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 156 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 190

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 79  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 133
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 134 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 168

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 70  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 124
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 125 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 159

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 86  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 140
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 141 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 175

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 79  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 133
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 134 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 168

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 19/123 (15%)
Query: 57  HPNIIR-FKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           HP+I++ F  V  T  H      IVMEY  G  L  +     +    E   +  +++  +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEILPAL 195
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS---TVGTPAYIAP 168
           +Y HS+ + + DLK EN +L      +LK+ D G        SR  S     GTP + AP
Sbjct: 196 SYLHSIGLVYNDLKPENIML---TEEQLKLIDLGAV------SRINSFGYLYGTPGFQAP 246
Query: 169 EVL 171
           E++
Sbjct: 247 EIV 249

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 16/195 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ +  S +  HR
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 162
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 163 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 219
Query: 177 DGKVCILLLILFLWR 191
             K  +    + LW 
Sbjct: 220 TTKSDVWSFGVLLWE 234

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 16/195 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ +  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 177 DGKVCILLLILFLWR 191
             K  +    + LW 
Sbjct: 215 TTKSDVWSFGVLLWE 229

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 16/195 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ +  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 177 DGKVCILLLILFLWR 191
             K  +    + LW 
Sbjct: 215 TTKSDVWSFGVLLWE 229

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 16/195 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ +  S +  HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 159 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 215
Query: 177 DGKVCILLLILFLWR 191
             K  +    + LW 
Sbjct: 216 TTKSDVWSFGVLLWE 230

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 16/194 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ +  S +  HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 155
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 156 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 212
Query: 177 DGKVCILLLILFLW 190
             K  +    + LW
Sbjct: 213 TTKSDVWSFGVLLW 226

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 16/195 (8%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ +  S +  HR
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 217 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 273
Query: 177 DGKVCILLLILFLWR 191
             K  +    + LW 
Sbjct: 274 TTKSDVWSFGVLLWE 288

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 27/204 (13%)
Query: 10  LGAGNFGVARLLRHKET--KELVAVKYIERGRKIDE--NVAREI-INHRSLRHPNIIRFK 64
           +G GNFG     R K+   +   A+K ++     D+  + A E+ +  +   HPNII   
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRFSEDEGRYFFQQLI 108
                  +L + +EYA  G L D +                  A   S  +  +F   + 
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG-TPA-YI 166
            G++Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  ++
Sbjct: 143 RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVRWM 198
Query: 167 APEVLSRREYDGKVCILLLILFLW 190
           A E L+   Y     +    + LW
Sbjct: 199 AIESLNYSVYTTNSDVWSYGVLLW 222

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 27/204 (13%)
Query: 10  LGAGNFGVARLLRHKET--KELVAVKYIERGRKIDE--NVAREI-INHRSLRHPNIIRFK 64
           +G GNFG     R K+   +   A+K ++     D+  + A E+ +  +   HPNII   
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRFSEDEGRYFFQQLI 108
                  +L + +EYA  G L D +                  A   S  +  +F   + 
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG-TPA-YI 166
            G++Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  ++
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVRWM 208
Query: 167 APEVLSRREYDGKVCILLLILFLW 190
           A E L+   Y     +    + LW
Sbjct: 209 AIESLNYSVYTTNSDVWSYGVLLW 232

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 83  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 137
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 138 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 172

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 165

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 78  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 132
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 133 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 167

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 81/200 (40%), Gaps = 25/200 (12%)
Query: 13  GNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF----KEVVL 68
           G FG   + + +   E VAVK      K       E+ +   ++H NI++F    K    
Sbjct: 35  GRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 69  TPTHLAIVMEYAAGGELFDRI-CNAGRFSE--------DEGRYFFQQLISGVNYCHSMQI 119
               L ++  +   G L D +  N   ++E          G  +  + I G+   H   I
Sbjct: 93  VDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEVLS---- 172
            HRD+K +N LL  +      I DFG +   ++          VGT  Y+APEVL     
Sbjct: 153 SHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN 210
Query: 173 -RREYDGKVCILLLILFLWR 191
            +R+   ++ +  + L LW 
Sbjct: 211 FQRDAFLRIDMYAMGLVLWE 230

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR--LLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++ +K LG+G FG     L   +  K  + V  +E          +EI++      S+ 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 110 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 164
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 165 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 199

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 70/177 (39%), Gaps = 23/177 (12%)
Query: 13  GNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF----KEVVL 68
           G FG   + + +   + VAVK      K      REI +   ++H N+++F    K    
Sbjct: 26  GRFGC--VWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-----------M 117
               L ++  +   G L D +      + +E  +  + +  G++Y H             
Sbjct: 84  LEVELWLITAFHDKGSLTDYL-KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKP 142
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST---VGTPAYIAPEVL 171
            I HRD K +N LL       L   DFG +        P  T   VGT  Y+APEVL
Sbjct: 143 SIAHRDFKSKNVLLKSDLTAVL--ADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVL 197

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 74
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
              ++  G+ Y ++ +  HR+L   N ++       +KI DFG ++ 
Sbjct: 135 MAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFT--VKIGDFGMTRD 179

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 18  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 75
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 76  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 135
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
              ++  G+ Y ++ +  HR+L   N ++       +KI DFG ++ 
Sbjct: 136 MAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFT--VKIGDFGMTRD 180

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 43/102 (42%), Gaps = 15/102 (14%)
Query: 102 YFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY--------SKSSVLH 153
           + F Q+   V + HS  + HRDLK  N          +K+ DFG          + +VL 
Sbjct: 168 HIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLT 225
Query: 154 SRP-----KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLW 190
             P        VGT  Y++PE +    Y  KV I  L L L+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 68/175 (38%), Gaps = 33/175 (18%)
Query: 6   LVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHP 58
           L K LG G FG      A  L+ +     VAVK ++      E  ++  E    + + HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELF-----DRICNAGRFSE------------DEGR 101
           ++I+          L +++EYA  G L       R    G                DE  
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 102 YFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
                LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+ 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSRD 199

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 68/175 (38%), Gaps = 33/175 (18%)
Query: 6   LVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHP 58
           L K LG G FG      A  L+ +     VAVK ++      E  ++  E    + + HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELF-----DRICNAGRFSE------------DEGR 101
           ++I+          L +++EYA  G L       R    G                DE  
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 102 YFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
                LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+ 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSRD 199

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 80/193 (41%), Gaps = 36/193 (18%)
Query: 6   LVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           LV+ +G G +G V R L H E+   VAVK      +       EI N   LRH NI+ F 
Sbjct: 12  LVECVGKGRYGEVWRGLWHGES---VAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFI 68
Query: 65  EVVLTP----THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS---GVNYCH-- 115
              +T     T L ++  Y   G L+D +    +    E     +  +S   G+ + H  
Sbjct: 69  ASDMTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVE 124
Query: 116 ------SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS--------TVG 161
                    I HRD K  N L+  +   +  I D G +   V+HS+            VG
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNL--QCCIADLGLA---VMHSQGSDYLDIGNNPRVG 179
Query: 162 TPAYIAPEVLSRR 174
           T  Y+APEVL  +
Sbjct: 180 TKRYMAPEVLDEQ 192

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 8   KDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNIIR 62
           K+LG+GNFG V +     +         I +    D  +  E++      + L +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY-FFQQLISGVNYCHSMQICH 121
              +    + + +VME A  G L ++     R  +D+       Q+  G+ Y       H
Sbjct: 73  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPA-YIAPEVLSRREYD 177
           RDL   N LL        KI DFG SK   +   + + ++    P  + APE ++  ++ 
Sbjct: 131 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 178 GKVCILLLILFLWR--NYRPNPF 198
            K  +    + +W   +Y   P+
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPY 211

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/179 (20%), Positives = 72/179 (40%), Gaps = 23/179 (12%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           EL K    GN  V ++L+ ++           + R  +E   R     R   HPN++   
Sbjct: 25  ELWKGRWQGNDIVVKVLKVRDWS-------TRKSRDFNEECPR----LRIFSHPNVLPVL 73
Query: 65  EVVLTPT--HLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ-- 118
               +P   H  ++  +   G L++ +     F  D+ +   F   +  G+ + H+++  
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I    L   + ++D     R+ + D  +S  S         +  PA++APE L ++  D
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPED 186

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/63 (42%), Positives = 35/63 (55%), Gaps = 5/63 (7%)
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTV-GTPAYI 166
           G++Y H+  I HRD+K  N LLD +  P  KI DFG SK  + +  +     V GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 167 APE 169
            PE
Sbjct: 209 DPE 211

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/63 (42%), Positives = 35/63 (55%), Gaps = 5/63 (7%)
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTV-GTPAYI 166
           G++Y H+  I HRD+K  N LLD +  P  KI DFG SK  + +  +     V GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 167 APE 169
            PE
Sbjct: 209 DPE 211

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 8   KDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNIIR 62
           K+LG+GNFG V +     +         I +    D  +  E++      + L +P I+R
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY-FFQQLISGVNYCHSMQICH 121
              +    + + +VME A  G L ++     R  +D+       Q+  G+ Y       H
Sbjct: 91  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 148
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPA-YIAPEVLSRREYD 177
           RDL   N LL        KI DFG SK   +   + + ++    P  + APE ++  ++ 
Sbjct: 149 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 178 GKVCILLLILFLWR--NYRPNPF 198
            K  +    + +W   +Y   P+
Sbjct: 207 SKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 8   KDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNIIR 62
           K+LG+GNFG V +     +         I +    D  +  E++      + L +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY-FFQQLISGVNYCHSMQICH 121
              +    + + +VME A  G L ++     R  +D+       Q+  G+ Y       H
Sbjct: 93  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 150
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPA-YIAPEVLSRREYD 177
           RDL   N LL        KI DFG SK   +   + + ++    P  + APE ++  ++ 
Sbjct: 151 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 178 GKVCILLLILFLWR--NYRPNPF 198
            K  +    + +W   +Y   P+
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 8   KDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNIIR 62
           K+LG+GNFG V +     +         I +    D  +  E++      + L +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY-FFQQLISGVNYCHSMQICH 121
              +    + + +VME A  G L ++     R  +D+       Q+  G+ Y       H
Sbjct: 93  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 150
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPA-YIAPEVLSRREYD 177
           RDL   N LL        KI DFG SK   +   + + ++    P  + APE ++  ++ 
Sbjct: 151 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 178 GKVCILLLILFLWR--NYRPNPF 198
            K  +    + +W   +Y   P+
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 8   KDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNIIR 62
           K+LG+GNFG V +     +         I +    D  +  E++      + L +P I+R
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY-FFQQLISGVNYCHSMQICH 121
              +    + + +VME A  G L ++     R  +D+       Q+  G+ Y       H
Sbjct: 71  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 128
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPA-YIAPEVLSRREYD 177
           RDL   N LL        KI DFG SK   +   + + ++    P  + APE ++  ++ 
Sbjct: 129 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 178 GKVCILLLILFLWR--NYRPNPF 198
            K  +    + +W   +Y   P+
Sbjct: 187 SKSDVWSFGVLMWEAFSYGQKPY 209

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 8   KDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNIIR 62
           K+LG+GNFG V +     +         I +    D  +  E++      + L +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY-FFQQLISGVNYCHSMQICH 121
              +    + + +VME A  G L ++     R  +D+       Q+  G+ Y       H
Sbjct: 83  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPA-YIAPEVLSRREYD 177
           RDL   N LL        KI DFG SK   +   + + ++    P  + APE ++  ++ 
Sbjct: 141 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 178 GKVCILLLILFLWR--NYRPNPF 198
            K  +    + +W   +Y   P+
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 8   KDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNIIR 62
           K+LG+GNFG V +     +         I +    D  +  E++      + L +P I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY-FFQQLISGVNYCHSMQICH 121
              +    + + +VME A  G L ++     R  +D+       Q+  G+ Y       H
Sbjct: 77  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 134
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPA-YIAPEVLSRREYD 177
           RDL   N LL        KI DFG SK   +   + + ++    P  + APE ++  ++ 
Sbjct: 135 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 178 GKVCILLLILFLWR--NYRPNPF 198
            K  +    + +W   +Y   P+
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 67/175 (38%), Gaps = 33/175 (18%)
Query: 6   LVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHP 58
           L K LG G FG      A  L+ +     VAVK ++      E  ++  E    + + HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELF-----DRICNAGRFSE------------DEGR 101
           ++I+          L +++EYA  G L       R    G                DE  
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 102 YFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
                LIS       G+ Y   M + HRDL   N L+  +   ++KI DFG S+ 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILV--AEGRKMKISDFGLSRD 199

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 82/181 (45%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----PN 59
           + + K +G GNFG  RL ++  T E VA+K +E  +     +  E   ++ L      P 
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +  F        + A+V+E       +LFD +C+   FS         QLIS + Y HS 
Sbjct: 70  VYYFGPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSK 124
Query: 118 QICHRDLKLENTLLD--GSAAPR-LKICDFGY--------SKSSVLHSRPKSTVGTPAYI 166
            + +RD+K EN L+   G+   + + I DFG         +K  + +   KS  GT  Y+
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYM 184
Query: 167 A 167
           +
Sbjct: 185 S 185

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 23/177 (12%)
Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----PNIIRF 63
           K +G GNFG  RL ++  T E VA+K +E  +     +  E   ++ L      P +  F
Sbjct: 10  KKIGCGNFGELRLGKNLYTNEYVAIK-LEPIKSRAPQLHLEYRFYKQLSATEGVPQVYYF 68
Query: 64  KEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
                   + A+V+E       +LFD +C+   F+         QLI+ + Y H+  + +
Sbjct: 69  GPXG---KYNAMVLELLGPSLEDLFD-LCDR-TFTLKTVLMIAIQLITRMEYVHTKSLIY 123
Query: 122 RDLKLENTLLDGSAAPR---LKICDFGY--------SKSSVLHSRPKSTVGTPAYIA 167
           RD+K EN L+      R   + I DFG         +K  + +   KS  GT  Y++
Sbjct: 124 RDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMS 180

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K L +G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 83  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 137
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 138 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 172

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K L +G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 40.0 bits (92), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 27/204 (13%)
Query: 10  LGAGNFGVARLLRHKET--KELVAVKYIERGRKIDE--NVAREI-INHRSLRHPNIIRFK 64
           +G GNFG     R K+   +   A+K ++     D+  + A E+ +  +   HPNII   
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRFSEDEGRYFFQQLI 108
                  +L + +EYA  G L D +                  A   S  +  +F   + 
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG-TPA-YI 166
            G++Y    Q  HR+L   N L+  +     KI DFG S+   ++   K T+G  P  ++
Sbjct: 150 RGMDYLSQKQFIHRNLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVRWM 205
Query: 167 APEVLSRREYDGKVCILLLILFLW 190
           A E L+   Y     +    + LW
Sbjct: 206 AIESLNYSVYTTNSDVWSYGVLLW 229

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	200
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-118
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-99
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-98
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-75
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-74
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-74
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-74
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-73
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-73
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-72
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-70
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-70
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-70
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-69
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-68
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-68
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-68
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-67
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-67
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-67
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-67
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-66
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-66
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-66
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-66
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-65
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-65
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-65
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-65
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-65
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-65
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-65
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-65
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-64
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-63
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-63
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-63
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-63
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-62
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-62
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-62
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-62
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-62
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-62
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-62
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-61
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-61
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-60
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-60
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-60
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-60
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-59
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-59
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-59
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-59
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-58
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-58
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-58
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-58
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-58
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-57
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-56
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-54
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-53
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-51
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-50
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-49
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-48
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-48
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-47
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-47
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-44
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-43
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-41
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-41
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-41
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-41
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-41
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-40
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-40
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-40
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-40
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-40
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-40
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-40
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-40
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-40
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-39
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-39
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-38
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-38
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-38
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-38
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-38
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-38
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-37
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-37
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-37
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-36
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-36
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-36
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-36
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-36
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-36
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-36
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-36
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-35
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-35
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-35
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-35
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-34
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-34
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-33
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-32
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-32
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-32
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-32
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-32
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-31
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-31
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-30
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-30
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-29
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-29
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-28
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-28
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-28
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-27
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-27
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-27
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-27
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-27
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-26
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-26
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-26
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-26
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-26
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-25
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-25
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-25
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-25
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-24
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-20
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-17
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-17
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-16
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-15
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-15
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-15
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-15
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-14
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-12
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-12
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-11
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-07
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-07
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-06
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  340 bits (873), Expect = e-118
 Identities = 152/179 (84%), Positives = 169/179 (94%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
            ++Y+ VKD+G+GNFGVARL+R K TKELVAVKYIERG  IDENV REIINHRSLRHPNI
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +RFKEV+LTPTHLAI+MEYA+GGEL++RICNAGRFSEDE R+FFQQL+SGV+YCHSMQIC
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL R+EYDGK
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  289 bits (742), Expect = 3e-99
 Identities = 70/184 (38%), Positives = 105/184 (57%), Gaps = 7/184 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R        GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 176 YDGK 179
           +  +
Sbjct: 184 FHAE 187

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  284 bits (728), Expect = 7e-98
 Identities = 70/184 (38%), Positives = 105/184 (57%), Gaps = 7/184 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R        GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 176 YDGK 179
           +  +
Sbjct: 184 FHAE 187

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  226 bits (578), Expect = 4e-75
 Identities = 79/182 (43%), Positives = 103/182 (56%), Gaps = 6/182 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +  Y L   LG G FG  ++  H+ T   VAVK + R +     +   + REI N +  R
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP+II+  +V+ TPT   +VMEY +GGELFD IC  GR  E E R  FQQ++S V+YCH 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
             + HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+S R Y
Sbjct: 130 HMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

Query: 177 DG 178
            G
Sbjct: 188 AG 189

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  225 bits (577), Expect = 1e-74
 Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 13/194 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
             +Y   + LG G F     +   +TKE+ A K + +         E ++ EI  HRSL 
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H +++ F         + +V+E      L +        +E E RY+ +Q++ G  Y H 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG +         K  + GTP YIAPEVLS++ 
Sbjct: 134 NRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191

Query: 176 YDGKV------CIL 183
           +  +V      CI+
Sbjct: 192 HSFEVDVWSIGCIM 205

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  226 bits (578), Expect = 2e-74
 Identities = 73/181 (40%), Positives = 106/181 (58%), Gaps = 7/181 (3%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHP 58
            Y L+K +G GNF   +L RH  T   VA+K I++  +++    + + RE+   + L HP
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  EV+ T   L ++MEYA+GGE+FD +   GR  E E R  F+Q++S V YCH  +
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           I HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   ++YDG
Sbjct: 135 IVHRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192

Query: 179 K 179
            
Sbjct: 193 P 193

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  225 bits (575), Expect = 6e-74
 Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 13/194 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
             +Y   + LG G F     +   +TKE+ A K + +         E ++ EI  HRSL 
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H +++ F         + +V+E      L +        +E E RY+ +Q++ G  Y H 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG +         K  + GTP YIAPEVLS++ 
Sbjct: 160 NRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 176 YDGKV------CIL 183
           +  +V      CI+
Sbjct: 218 HSFEVDVWSIGCIM 231

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  228 bits (582), Expect = 2e-73
 Identities = 81/183 (44%), Positives = 107/183 (58%), Gaps = 8/183 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-----ENVAREIINHRSL 55
           +  Y L   LG G FG  ++ +H+ T   VAVK + R +KI        + REI N +  
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLF 73

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           RHP+II+  +V+ TP+ + +VMEY +GGELFD IC  GR  E E R  FQQ++SGV+YCH
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
              + HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+S R 
Sbjct: 134 RHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL 191

Query: 176 YDG 178
           Y G
Sbjct: 192 YAG 194

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  221 bits (565), Expect = 2e-72
 Identities = 80/180 (44%), Positives = 111/180 (61%), Gaps = 7/180 (3%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHP 58
            Y + + LG G+FG  +L  H +T++ VA+K+I R       +   V REI   + LRHP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +II+  +V+ TPT + +V+EYA GGELFD I    R +EDEGR FFQQ+I  + YCH  +
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           I HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV++ + Y G
Sbjct: 129 IVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  214 bits (548), Expect = 2e-70
 Identities = 57/186 (30%), Positives = 92/186 (49%), Gaps = 8/186 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +++   LG G+F          T   VA+K I++       + + V  E+  H  L+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH 115
           HP+I+          ++ +V+E    GE+   + N    FSE+E R+F  Q+I+G+ Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRR 174
           S  I HRDL L N LL  +    +KI DFG +    +      T+ GTP YI+PE+ +R 
Sbjct: 130 SHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 175 EYDGKV 180
            +  + 
Sbjct: 188 AHGLES 193

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  213 bits (545), Expect = 5e-70
 Identities = 58/184 (31%), Positives = 99/184 (53%), Gaps = 7/184 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           ++ +++ + LG G FG   L R K+ K ++A+K + + +     ++  + REI     LR
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R          + +++E+A  GEL+  +   GRF E     F ++L   ++YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN L+       LKI DFG+S  +    R ++  GT  Y+ PE++  + +
Sbjct: 133 RKVIHRDIKPENLLMGYKG--ELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTH 189

Query: 177 DGKV 180
           D KV
Sbjct: 190 DEKV 193

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  215 bits (549), Expect = 5e-70
 Identities = 57/189 (30%), Positives = 80/189 (42%), Gaps = 12/189 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---------KIDENVAREIIN 51
            +KY  +  LG+G FG       KE  + V VK+I++ +              V  EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 52  HRSLRHPNIIRFKEVVLTPTHLAIVMEYAA-GGELFDRICNAGRFSEDEGRYFFQQLISG 110
              + H NII+  ++        +VME    G +LF  I    R  E    Y F+QL+S 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           V Y     I HRD+K EN ++       +K+ DFG +          +  GT  Y APEV
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 171 LSRREYDGK 179
           L    Y G 
Sbjct: 201 LMGNPYRGP 209

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  212 bits (541), Expect = 2e-69
 Identities = 60/184 (32%), Positives = 99/184 (53%), Gaps = 7/184 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL  +    LKI DFG+S      SR     GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLLGSAG--ELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMH 184

Query: 177 DGKV 180
           D KV
Sbjct: 185 DEKV 188

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  211 bits (539), Expect = 1e-68
 Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 20/191 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--------VAREIINHRS 54
           +Y++   LG+G FG             VA+K++E+  +I +         V  E++  + 
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 102

Query: 55  LRH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGV 111
           +      +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAP 168
            +CH+  + HRD+K EN L+D +    LK+ DFG     K +V         GT  Y  P
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSPP 217

Query: 169 EVLSRREYDGK 179
           E +    Y G+
Sbjct: 218 EWIRYHRYHGR 228

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  209 bits (535), Expect = 4e-68
 Identities = 54/192 (28%), Positives = 76/192 (39%), Gaps = 20/192 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y L   LG G FG          +  VA+K I R R +             E+     +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 56  R----HPNIIRFKEVVLTPTHLAIVMEYAA-GGELFDRICNAGRFSEDEGRYFFQQLISG 110
                HP +IR  +   T     +V+E      +LFD I   G   E   R FF Q+++ 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIA 167
           + +CHS  + HRD+K EN L+D       K+ DFG                  GT  Y  
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVYSP 206

Query: 168 PEVLSRREYDGK 179
           PE +SR +Y   
Sbjct: 207 PEWISRHQYHAL 218

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  208 bits (532), Expect = 8e-68
 Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 16/189 (8%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----KIDENVAREIINHRSLRH 57
           KY +   LG G++G  + +   ET    AVK +++ +       + NV +EI   R LRH
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 58  PNIIRFKEVVL--TPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
            N+I+  +V+       + +VMEY   G  E+ D +    RF   +   +F QLI G+ Y
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEY 124

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEV 170
            HS  I H+D+K  N LL       LKI   G +++    +     +++ G+PA+  PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 171 LS-RREYDG 178
            +    + G
Sbjct: 183 ANGLDTFSG 191

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  207 bits (529), Expect = 3e-67
 Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 18/197 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE-NVAREIINHRSLRHPNI 60
           + +  ++ LG+G F    L++ + T +L A+K I++     + ++  EI   + ++H NI
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +  +++  + TH  +VM+  +GGELFDRI   G ++E +     QQ++S V Y H   I 
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 121 HRDLKLENTLLDGSAA-PRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           HRDLK EN L        ++ I DFG SK   + ++     +  GTP Y+APEVL+++ Y
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPY 184

Query: 177 DGKV---------CILL 184
              V          ILL
Sbjct: 185 SKAVDCWSIGVITYILL 201

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  206 bits (526), Expect = 4e-67
 Identities = 61/184 (33%), Positives = 92/184 (50%), Gaps = 6/184 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRH 57
           + Y++ ++LG G F V R   HK T    A K I   +K+     + + RE    R L+H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 177 DGKV 180
              V
Sbjct: 185 SKPV 188

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  205 bits (525), Expect = 5e-67
 Identities = 60/182 (32%), Positives = 93/182 (51%), Gaps = 5/182 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPN 59
           + Y L   +G G++G  ++   K T+   A K I +   ++  +   +EI   +SL HPN
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHPN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           IIR  E     T + +VME   GGELF+R+ +   F E +     + ++S V YCH + +
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127

Query: 120 CHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN L    +    LK+ DFG +         ++ VGTP Y++P+VL    Y  
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLYGP 186

Query: 179 KV 180
           + 
Sbjct: 187 EC 188

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  206 bits (527), Expect = 9e-67
 Identities = 67/192 (34%), Positives = 93/192 (48%), Gaps = 14/192 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---------GRKIDENVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +               NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 113 YCHSMQICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 172 S---RREYDGKV 180
                  Y+  V
Sbjct: 189 VSVGTAGYNRAV 200

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  214 bits (546), Expect = 3e-66
 Identities = 61/190 (32%), Positives = 85/190 (44%), Gaps = 12/190 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNI 60
            +E+ + LG G FG      H++T E VA+K   +    K  E    EI   + L HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 61  IRFKEVVLTPTHLA------IVMEYAAGGELFDRIC---NAGRFSEDEGRYFFQQLISGV 111
           +  +EV      LA      + MEY  GG+L   +    N     E   R     + S +
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 112 NYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
            Y H  +I HRDLK EN +L         KI D GY+K           VGT  Y+APE+
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194

Query: 171 LSRREYDGKV 180
           L +++Y   V
Sbjct: 195 LEQKKYTVTV 204

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  205 bits (525), Expect = 3e-66
 Identities = 62/183 (33%), Positives = 91/183 (49%), Gaps = 7/183 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNI 60
           + YE+ +D+G G++ V +   HK T    AVK I++ +    +   EI I  R  +HPNI
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           I  K+V     ++ +V E   GGEL D+I     FSE E       +   V Y H+  + 
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138

Query: 121 HRDLKLENTLLDGSA--APRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           HRDLK  N L    +     ++ICDFG++K     +    T   T  ++APEVL R+ YD
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198

Query: 178 GKV 180
              
Sbjct: 199 AAC 201

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  204 bits (521), Expect = 3e-66
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 41/212 (19%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------------------- 42
           +Y L  ++G G++GV +L  ++      A+K + + + I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 43  -------ENVAREIINHRSLRHPNIIRFKEVVLTPT--HLAIVMEYAAGGELFDRICNAG 93
                  E V +EI   + L HPN+++  EV+  P   HL +V E    G + + +    
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132

Query: 94  RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH 153
             SED+ R++FQ LI G+ Y H  +I HRD+K  N L+       +KI DFG S      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSN---EF 187

Query: 154 SRP----KSTVGTPAYIAPEVLS--RREYDGK 179
                   +TVGTPA++APE LS  R+ + GK
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGK 219

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  205 bits (523), Expect = 9e-66
 Identities = 56/188 (29%), Positives = 87/188 (46%), Gaps = 12/188 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---------KIDENVAREI-IN 51
           +KY+    +G G   V R   H+ T    AVK +E            ++ E   RE  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 52  HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            +   HP+II   +   + + + +V +    GELFD +      SE E R   + L+  V
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           ++ H+  I HRDLK EN LLD +    +++ DFG+S       + +   GTP Y+APE+L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271

Query: 172 SRREYDGK 179
                +  
Sbjct: 272 KCSMDETH 279

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  206 bits (527), Expect = 1e-65
 Identities = 66/192 (34%), Positives = 93/192 (48%), Gaps = 14/192 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---------GRKIDENVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA++ I +               NV  EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 113 YCHSMQICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 172 S---RREYDGKV 180
                  Y+  V
Sbjct: 314 VSVGTAGYNRAV 325

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  202 bits (517), Expect = 1e-65
 Identities = 63/189 (33%), Positives = 89/189 (47%), Gaps = 13/189 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDENVAREI-I 50
           E YE  + LG G   V R   HK T +  AVK I          E  +++ E   +E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 51  NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
             +   HPNII+ K+   T T   +V +    GELFD +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

Query: 171 LSRREYDGK 179
           +     D  
Sbjct: 195 IECSMNDNH 203

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  203 bits (517), Expect = 2e-65
 Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 17/196 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPN 59
             + L   LG G        RHK+T +L A+K        +  +   RE    + L H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 60  IIRFKEVV--LTPTHLAIVMEYAAGGELFDRIC---NAGRFSEDEGRYFFQQLISGVNYC 114
           I++   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+N+ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 115 HSMQICHRDLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
               I HR++K  N +       +   K+ DFG ++      +  S  GT  Y+ P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 173 R--------REYDGKV 180
           R        ++Y   V
Sbjct: 189 RAVLRKDHQKKYGATV 204

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  201 bits (514), Expect = 2e-65
 Identities = 63/188 (33%), Positives = 102/188 (54%), Gaps = 9/188 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRS 54
           + YE+ ++LG+G F + R  R K T +  A K+I++ R          E + RE+   R 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           +RHPNII   ++    T + +++E  +GGELFD +      +EDE   F +Q++ GV+Y 
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 115 HSMQICHRDLKLENTLLDGSAAP--RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           HS +I H DLK EN +L     P  R+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184

Query: 173 RREYDGKV 180
                 + 
Sbjct: 185 YEPLGLEA 192

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  204 bits (521), Expect = 4e-65
 Identities = 44/187 (23%), Positives = 75/187 (40%), Gaps = 9/187 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPN 59
             + L   LG G        RHK+T +L A+K        +  +   RE    + L H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 60  IIRFKEVV--LTPTHLAIVMEYAAGGELFDRIC---NAGRFSEDEGRYFFQQLISGVNYC 114
           I++   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+N+ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 115 HSMQICHRDLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
               I HR++K  N +       +   K+ DFG ++      +  S  GT  Y+ P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 173 RREYDGK 179
           R      
Sbjct: 189 RAVLRKD 195

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  200 bits (512), Expect = 5e-65
 Identities = 71/183 (38%), Positives = 97/183 (53%), Gaps = 5/183 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           E+Y +V  LG G+FG     + + T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  E++   +   IV E   GGELFD I    RFSE +     +Q+ SG+ Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 119 ICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200

Query: 178 GKV 180
            K 
Sbjct: 201 EKC 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  202 bits (517), Expect = 6e-65
 Identities = 62/184 (33%), Positives = 92/184 (50%), Gaps = 6/184 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRH 57
           + Y++ ++LG G F V R   HK T    A K I   +K+     + + RE    R L+H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 87

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 118 QICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HR+LK EN LL   A    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 177 DGKV 180
              V
Sbjct: 208 SKPV 211

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  202 bits (516), Expect = 8e-65
 Identities = 67/180 (37%), Positives = 95/180 (52%), Gaps = 2/180 (1%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           + +E+  +LG G   +    + K T++  A+K +++     + V  EI     L HPNII
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSHPNII 111

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           + KE+  TPT +++V+E   GGELFDRI   G +SE +     +Q++  V Y H   I H
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVH 171

Query: 122 RDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           RDLK EN L    +    LKI DFG SK        K+  GTP Y APE+L    Y  +V
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEV 231

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  199 bits (508), Expect = 2e-64
 Identities = 59/186 (31%), Positives = 90/186 (48%), Gaps = 8/186 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KID-ENVAREIINHRSLRHPN 59
           + +   + LG+G FG   L+  + +     +K I + R ++  E +  EI   +SL HPN
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCH 115
           II+  EV     ++ IVME   GGEL +RI          SE       +Q+++ + Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 116 SMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           S  + H+DLK EN L    S    +KI DFG ++         +  GT  Y+APEV  +R
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KR 200

Query: 175 EYDGKV 180
           +   K 
Sbjct: 201 DVTFKC 206

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  198 bits (506), Expect = 1e-63
 Identities = 63/188 (33%), Positives = 102/188 (54%), Gaps = 9/188 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRS 54
           + Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           ++HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 115 HSMQICHRDLKLENTLLDGSAA--PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           HS+QI H DLK EN +L       PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

Query: 173 RREYDGKV 180
                 + 
Sbjct: 191 YEPLGLEA 198

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  197 bits (502), Expect = 5e-63
 Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 1/180 (0%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           EKY + +DLG G FG+        +K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQIC 120
              E   +   L ++ E+ +G ++F+RI  +    +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           H D++ EN +     +  +KI +FG ++        +     P Y APEV          
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  196 bits (501), Expect = 6e-63
 Identities = 57/188 (30%), Positives = 97/188 (51%), Gaps = 9/188 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRS 54
           + Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           + H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 115 HSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           H+ +I H DLK EN +L       P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 173 RREYDGKV 180
                 + 
Sbjct: 192 YEPLGLEA 199

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  197 bits (503), Expect = 8e-63
 Identities = 60/188 (31%), Positives = 96/188 (51%), Gaps = 9/188 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-------ERGRKIDENVAREIINHRS 54
           + Y++ ++LG+G F + +  R K T    A K+I        R     E + RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           + HPNII   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY 
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 115 HSMQICHRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           H+ +I H DLK EN +L       P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 173 RREYDGKV 180
                 + 
Sbjct: 192 YEPLGLEA 199

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  200 bits (511), Expect = 1e-62
 Identities = 70/183 (38%), Positives = 97/183 (53%), Gaps = 5/183 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E+Y +V  LG G+FG     + + T++  AVK I +    +     + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  E++   +   IV E   GGELFD I    RFSE +     +Q+ SG+ Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 119 ICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200

Query: 178 GKV 180
            K 
Sbjct: 201 EKC 203

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  199 bits (508), Expect = 1e-62
 Identities = 58/185 (31%), Positives = 89/185 (48%), Gaps = 7/185 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E+Y+L ++LG G F V R        +  A   I   +      + + RE    R L+HP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +    H  ++ +   GGELF+ I     +SE +  +  QQ++  V +CH M 
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 119 ICHRDLKLENTLLDGSA--APRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVLSRRE 175
           + HR+LK EN LL      A  +K+ DFG +       +      GTP Y++PEVL +  
Sbjct: 131 VVHRNLKPENLLLASKLKGAA-VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189

Query: 176 YDGKV 180
           Y   V
Sbjct: 190 YGKPV 194

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  198 bits (504), Expect = 1e-62
 Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 2/181 (1%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           + Y+++++LG+G FGV      K T  +   K+I     +D   V  EI     L HP +
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQI 119
           I   +       + +++E+ +GGELFDRI     + SE E   + +Q   G+ + H   I
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R      
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 230

Query: 180 V 180
            
Sbjct: 231 T 231

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  195 bits (498), Expect = 2e-62
 Identities = 67/185 (36%), Positives = 101/185 (54%), Gaps = 8/185 (4%)

Query: 2   EKYEL---VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRH 57
           + Y+L    K LG G+F + R   HK++ +  AVK I +  +++ N  +EI        H
Sbjct: 8   QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGH 65

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  EV     H  +VME   GGELF+RI     FSE E  Y  ++L+S V++ H +
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVLSRRE 175
            + HRDLK EN L  D +    +KI DFG+++     ++P K+   T  Y APE+L++  
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 176 YDGKV 180
           YD   
Sbjct: 186 YDESC 190

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  199 bits (509), Expect = 2e-62
 Identities = 69/183 (37%), Positives = 96/183 (52%), Gaps = 5/183 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRHP 58
           E Y+ VK LG+G +G   L R K T    A+K I +       +  +  E+   + L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  +      +  +VME   GGELFD I +  +F+E +     +Q++SGV Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 119 ICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S       + K  +GT  YIAPEVL R++YD
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYD 215

Query: 178 GKV 180
            K 
Sbjct: 216 EKC 218

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  199 bits (507), Expect = 4e-62
 Identities = 68/184 (36%), Positives = 98/184 (53%), Gaps = 6/184 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I + +       E++ RE+   + L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 118 QICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           +I HRDLK EN LL+  +    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 204

Query: 177 DGKV 180
           D K 
Sbjct: 205 DEKC 208

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  200 bits (510), Expect = 7e-62
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 2/181 (1%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           + Y++ ++LG G FGV   +  + T    A K++    + D E V +EI     LRHP +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   +       + ++ E+ +GGELF+++ +   + SEDE   + +Q+  G+ + H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            H DLK EN +     +  LK+ DFG +         K T GT  + APEV   +     
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336

Query: 180 V 180
            
Sbjct: 337 T 337

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  198 bits (504), Expect = 2e-61
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 22/207 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--------------GRKIDENVAR 47
           E Y  V+ LG+G +G   L + K      A+K I++                K  E +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 48  EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           EI   +SL HPNII+  +V     +  +V E+  GGELF++I N  +F E +     +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
           +SG+ Y H   I HRD+K EN LL+   +   +KI DFG S       + +  +GT  YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 167 APEVLSRREYDGKV------CILLLIL 187
           APEVL +++Y+ K        I+ ++L
Sbjct: 216 APEVL-KKKYNEKCDVWSCGVIMYILL 241

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  191 bits (487), Expect = 4e-61
 Identities = 58/218 (26%), Positives = 85/218 (38%), Gaps = 38/218 (17%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
             +E +  LG G FG     R+       A+K I    +    +  E++   SL H  ++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65

Query: 62  RFKEV-------------VLTPTHLAIVMEYAAGGELFDRICNAGRF-SEDEGRYFFQQL 107
           R+                V   + L I MEY   G L+D I +       DE    F+Q+
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS---------------SVL 152
           +  ++Y HS  I HRDLK  N  +D S    +KI DFG +K+                  
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 153 HSRPKSTVGTPAYIAPEVLSRR-EYDGKV------CIL 183
                S +GT  Y+A EVL     Y+ K+       I 
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  190 bits (485), Expect = 2e-60
 Identities = 59/187 (31%), Positives = 88/187 (47%), Gaps = 8/187 (4%)

Query: 2   EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREI-INHRSLR 56
             Y L  K+LG G F V R    K T +  A K+++   RG+     +  EI +   +  
Sbjct: 28  NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYC 114
            P +I   EV    + + +++EYAAGGE+F       A   SE++     +Q++ GV Y 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 115 HSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           H   I H DLK +N LL        +KI DFG S+        +  +GTP Y+APE+L+ 
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207

Query: 174 REYDGKV 180
                  
Sbjct: 208 DPITTAT 214

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  191 bits (488), Expect = 2e-60
 Identities = 62/183 (33%), Positives = 87/183 (47%), Gaps = 4/183 (2%)

Query: 2   EKYELVK--DLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHP 58
             Y + K   LG G FG         T   +A K I+ RG K  E V  EI     L H 
Sbjct: 87  SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSM 117
           N+I+  +   +   + +VMEY  GGELFDRI +     +E +   F +Q+  G+ + H M
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I H DLK EN L     A ++KI DFG ++      + K   GTP ++APEV++     
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266

Query: 178 GKV 180
              
Sbjct: 267 FPT 269

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  191 bits (487), Expect = 5e-60
 Identities = 61/188 (32%), Positives = 94/188 (50%), Gaps = 13/188 (6%)

Query: 2   EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPN 59
           + Y++  + LG G  G    + +K T+E  A+K ++          RE+ ++ R+ + P+
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 116

Query: 60  IIRFKEV----VLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNY 113
           I+R  +V          L IVME   GGELF RI + G   F+E E     + +   + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 114 CHSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            HS+ I HRD+K EN L         LK+ DFG++K +  H+   +   TP Y+APEVL 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236

Query: 173 RREYDGKV 180
             +YD   
Sbjct: 237 PEKYDKSC 244

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  188 bits (480), Expect = 7e-60
 Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 19/197 (9%)

Query: 2   EKYELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREI-INHRSLRHP 58
           + Y+L +D LG G     +   +  T +  AVK IE+        V RE+ + ++   H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N++   E         +V E   GG +   I     F+E E     Q + S +++ H+  
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 119 ICHRDLKLENTLLD--GSAAPRLKICDFGYSK--------SSVLHSRPKSTVGTPAYIAP 168
           I HRDLK EN L +     +P +KICDF            S +      +  G+  Y+AP
Sbjct: 132 IAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 169 EVL-----SRREYDGKV 180
           EV+         YD + 
Sbjct: 191 EVVEAFSEEASIYDKRC 207

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  189 bits (482), Expect = 1e-59
 Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 14/192 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------ENVAREIINHRSL 55
           + YEL + +G G F V R   ++ET +  AVK ++  +         E++ RE      L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGV 111
           +HP+I+   E   +   L +V E+  G +L   I         +SE    ++ +Q++  +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 112 NYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAP 168
            YCH   I HRD+K    LL      AP +K+  FG +             VGTP ++AP
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202

Query: 169 EVLSRREYDGKV 180
           EV+ R  Y   V
Sbjct: 203 EVVKREPYGKPV 214

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  188 bits (480), Expect = 2e-59
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 14/195 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
           MEKY  ++ +G G+FG A L++  E      +K I   R      E   RE+    +++H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--CNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++++E       L IVM+Y  GG+LF RI       F ED+   +F Q+   + + H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRR 174
             +I HRD+K +N  L       +++ DFG ++  +      ++ +GTP Y++PE+   +
Sbjct: 143 DRKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 175 EYDGKV------CIL 183
            Y+ K       C+L
Sbjct: 201 PYNNKSDIWALGCVL 215

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  186 bits (475), Expect = 2e-59
 Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 29/207 (14%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
              ++ ++ +G+G FG     +H+   +   +K ++      E   RE+     L H NI
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNI 66

Query: 61  IRFKE----------------VVLTPTHLAIVMEYAAGGELFDRI--CNAGRFSEDEGRY 102
           + +                         L I ME+   G L   I      +  +     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT 162
            F+Q+  GV+Y HS ++ +RDLK  N  L  +   ++KI DFG   S     +   + GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 163 PAYIAPEVLSRREYDGKV------CIL 183
             Y++PE +S ++Y  +V       IL
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLIL 211

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  187 bits (476), Expect = 3e-59
 Identities = 41/185 (22%), Positives = 76/185 (41%), Gaps = 13/185 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
              Y ++K +G+G       + ++  K++ A+KY+      +   ++   EI     L+ 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85

Query: 58  PN--IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLS 172
              I H DLK  N L+       LK+ DFG +             S VGT  Y+ PE + 
Sbjct: 145 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 173 RREYD 177
                
Sbjct: 202 DMSSS 206

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  186 bits (474), Expect = 1e-58
 Identities = 38/207 (18%), Positives = 77/207 (37%), Gaps = 33/207 (15%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER------------------GRKID 42
           +  Y +++ L  G F    L       +  A+K  E+                   +   
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 43  ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG--------R 94
           ++   E+     +++   +  + ++     + I+ EY     +                 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 95  FSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH 153
                 +   + +++  +Y H+   ICHRD+K  N L+D +   R+K+ DFG S+  V  
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGESEYMV-D 204

Query: 154 SRPKSTVGTPAYIAPEVLSRRE-YDGK 179
            + K + GT  ++ PE  S    Y+G 
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGA 231

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  185 bits (472), Expect = 3e-58
 Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 53/232 (22%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------ENVAREIINHRSL 55
           +KY L   +G G++GV R+    +T+ + A+K + + +         E +  E+   + L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--------------------- 94
            HPNI R  EV     ++ +VME   GG L D++                          
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 95  -------------------FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA 135
                                E       +Q+ S ++Y H+  ICHRD+K EN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 136 APRLKICDFGYSKSSVLHSRP-----KSTVGTPAYIAPEVLS--RREYDGKV 180
           +  +K+ DFG SK     +        +  GTP ++APEVL+     Y  K 
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  185 bits (471), Expect = 3e-58
 Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 13/184 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
             Y ++K +G+G       + ++  K++ A+KY+      +   ++   EI     L+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 59  N--IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSR 173
             I H DLK  N L+       LK+ DFG +      +      S VGT  Y+ PE +  
Sbjct: 127 HGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 174 REYD 177
               
Sbjct: 184 MSSS 187

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  182 bits (464), Expect = 7e-58
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 23/204 (11%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
            E YE++  +G G++G  + +R K   +++  K ++ G   +   + +  E+   R L+H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGV 111
           PNI+R+ + ++  T   L IVMEY  GG+L   I    +      E+       QL   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 112 NYCHSM-----QICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAY 165
             CH        + HRDLK  N  LDG     +K+ DFG ++  +   S  K+ VGTP Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 166 IAPEVLSRREYDGKV------CIL 183
           ++PE ++R  Y+ K       C+L
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLL 206

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  185 bits (472), Expect = 8e-58
 Identities = 40/185 (21%), Positives = 76/185 (41%), Gaps = 13/185 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
              Y ++K +G+G       + ++  K++ A+KY+      +   ++   EI     L+ 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113

Query: 58  PN--IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLS 172
              I H DLK  N L+       LK+ DFG +      +      S VG   Y+ PE + 
Sbjct: 173 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 173 RREYD 177
                
Sbjct: 230 DMSSS 234

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  183 bits (467), Expect = 1e-57
 Identities = 56/188 (29%), Positives = 86/188 (45%), Gaps = 14/188 (7%)

Query: 2   EKYELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPN 59
           + Y+L K  LG G  G      H+ T +  A+K +           +E+  + ++   P+
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGPH 83

Query: 60  IIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNY 113
           I+   +V     H      I+ME   GGELF RI   G   F+E E     + + + + +
Sbjct: 84  IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 114 CHSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            HS  I HRD+K EN L         LK+ DFG++K     +  ++   TP Y+APEVL 
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVLG 202

Query: 173 RREYDGKV 180
             +YD   
Sbjct: 203 PEKYDKSC 210

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  180 bits (458), Expect = 1e-56
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 17/198 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           +  + + K +G G F              VA+K ++    +D     +  +EI   + L 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVL 171
           + HS ++ HRD+K  N  +  +    +K+ D G  +  S   +   S VGTP Y++PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 172 SRREYDGKV------CIL 183
               Y+ K       C+L
Sbjct: 209 HENGYNFKSDIWSLGCLL 226

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  173 bits (440), Expect = 7e-54
 Identities = 46/195 (23%), Positives = 75/195 (38%), Gaps = 15/195 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSL-R 56
            + ++ +  LG G++G    +R KE   L AVK      RG K       E+ +H  + +
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCH 115
           HP  +R ++       L +  E   G  L       G    E +   + +  +  + + H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           S  + H D+K  N  L      R K+ DFG           +   G P Y+APE+L +  
Sbjct: 175 SQGLVHLDVKPANIFLGPRG--RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGS 231

Query: 176 YDGKV------CILL 184
           Y            +L
Sbjct: 232 YGTAADVFSLGLTIL 246

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  172 bits (438), Expect = 1e-53
 Identities = 53/219 (24%), Positives = 78/219 (35%), Gaps = 38/219 (17%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHP 58
           +  +E ++ LG G FGV    ++K      A+K I    +      V RE+     L HP
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 59  NIIRFKEVVLT------------PTHLAIVMEYAAGGELFDRI---CNAGRFSEDEGRYF 103
            I+R+    L               +L I M+      L D +   C           + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-------------SS 150
           F Q+   V + HS  + HRDLK  N          +K+ DFG                  
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 151 VLHSRPKSTVGTPAYIAPEVLSRREYDGKV------CIL 183
             ++R    VGT  Y++PE +    Y  KV       IL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLIL 220

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  167 bits (425), Expect = 1e-51
 Identities = 49/216 (22%), Positives = 78/216 (36%), Gaps = 30/216 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA-REIINHRSLRHPNI 60
           + Y  ++ LG G F    L+         A+K I    + D   A RE   HR   HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 61  IRFKEVVLTPT----HLAIVMEYAAGGELFDRI----CNAGRFSEDEGRYFFQQLISGVN 112
           +R     L          +++ +   G L++ I          +ED+  +    +  G+ 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----------VGT 162
             H+    HRDLK  N LL      +  + D G    + +H                  T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 163 PAYIAPEVL---SRREYDGKV------CILLLILFL 189
            +Y APE+    S    D +       C+L  ++F 
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  164 bits (416), Expect = 2e-50
 Identities = 53/188 (28%), Positives = 80/188 (42%), Gaps = 34/188 (18%)

Query: 2   EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPN 59
           + Y++  + LG G  G    + +K T+E  A+K ++          RE+ ++ R+ + P+
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72

Query: 60  IIRFKEV----VLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNY 113
           I+R  +V          L IVME   GGELF RI + G   F+E E     + +   + Y
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 114 CHSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            HS+ I HRD+K EN L         LK+ DFG                     A E   
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT- 171

Query: 173 RREYDGKV 180
             +YD   
Sbjct: 172 GEKYDKSC 179

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  163 bits (414), Expect = 8e-49
 Identities = 56/223 (25%), Positives = 83/223 (37%), Gaps = 41/223 (18%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNI 60
                 K LG G+ G     +       VAVK +       +    EI +   S  HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY-------FFQQLISGVNY 113
           IR+     T   L I +E      L D + +     E+             +Q+ SGV +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 114 CHSMQICHRDLKLENTLLDGSAAP-----------RLKICDFGYSK-----SSVLHSRPK 157
            HS++I HRDLK +N L+  S+             R+ I DFG  K      S   +   
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 158 STVGTPAYIAPEVLS-------RREYDGKV------CILLLIL 187
           +  GT  + APE+L        +R     +      C+   IL
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  160 bits (406), Expect = 3e-48
 Identities = 32/216 (14%), Positives = 72/216 (33%), Gaps = 29/216 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKIDENVAREIIN-HRSL 55
           +   +   LG G F              + K+   +K  +     +  +  +++   +  
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC-----NAGRFSEDEGRYFFQQLISG 110
                ++F    L      +V E  + G L + I            +     F  +++  
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184

Query: 111 VNYCHSMQICHRDLKLENTLL---------DGSAAPRLKICDFGYSKSSVLHSRP---KS 158
           +   H  +I H D+K +N +L         +   +  L + D G S    L  +     +
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 159 TVGTPAYIAPEVLSRREYDGKV------CILLLILF 188
              T  +   E+LS + ++ ++        +  +LF
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  158 bits (402), Expect = 6e-48
 Identities = 51/223 (22%), Positives = 83/223 (37%), Gaps = 38/223 (17%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-VAREIINHRSLR-HPNI 60
           +  + + L  G F      +   +    A+K +    +     + +E+   + L  HPNI
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 61  IRF-------KEVVLTPTHLAIVMEYAAGGELFDRICNA---GRFSEDEGRYFFQQLISG 110
           ++F       KE   T     +++     G+L + +      G  S D     F Q    
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 111 VNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--------- 159
           V + H  +  I HRDLK+EN LL       +K+CDFG + +   +     +         
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 160 ----VGTPAYIAPEVL---SRREYDGKV------CILLLILFL 189
                 TP Y  PE++   S      K       CIL L+ F 
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  160 bits (406), Expect = 1e-47
 Identities = 53/203 (26%), Positives = 74/203 (36%), Gaps = 22/203 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNII 61
            +     LG G  G   + R       VAVK I    +      RE+ +   S  HPN+I
Sbjct: 25  SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQIC 120
           R+           I +E      L + +          E     QQ  SG+ + HS+ I 
Sbjct: 82  RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 121 HRDLKLENTLL---DGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPEVLSR 173
           HRDLK  N L+   +     +  I DFG  K         SR     GT  +IAPE+LS 
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 174 ---REYDGKV------CILLLIL 187
                    V      C+   ++
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVI 223

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  154 bits (392), Expect = 7e-47
 Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 29/205 (14%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSL-RH 57
            ++  ++ +G+G FG       +    + A+K  +    G   ++N  RE+  H  L +H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNY 113
            +++R+        H+ I  EY  GG L D I    R    F E E +    Q+  G+ Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 114 CHSMQICHRDLKLENTLLD-----------------GSAAPRLKICDFGYSKSSVLHSRP 156
            HSM + H D+K  N  +                   S     KI D G+       S P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSP 187

Query: 157 KSTVGTPAYIAPEVLS-RREYDGKV 180
           +   G   ++A EVL     +  K 
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKA 212

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  150 bits (380), Expect = 1e-44
 Identities = 50/186 (26%), Positives = 78/186 (41%), Gaps = 11/186 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           +        +G G+FG    ++ K+T    AVK +     ++     E++    L  P I
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRI 112

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +     V     + I ME   GG L   I   G   ED   Y+  Q + G+ Y H+ +I 
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEVLSRR 174
           H D+K +N LL    + R  +CDFG++                   GT  ++APEV+  +
Sbjct: 173 HGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 175 EYDGKV 180
             D KV
Sbjct: 232 PCDAKV 237

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  146 bits (370), Expect = 2e-43
 Identities = 56/184 (30%), Positives = 82/184 (44%), Gaps = 9/184 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
            E ++  K LG G+F    L R   T    A+K +E+   I EN    +   R     L 
Sbjct: 29  PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST---VGTPAYIAPEVLSR 173
             I HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+L+ 
Sbjct: 149 KGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 174 REYD 177
           +   
Sbjct: 207 KSAC 210

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  140 bits (355), Expect = 2e-41
 Identities = 55/183 (30%), Positives = 94/183 (51%), Gaps = 5/183 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +   ++   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           + + +  L    L +VMEY AGG L D +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRD+K +N LL       +K+ DFG+  + +   S+  + VGTP ++APEV++R+ Y  K
Sbjct: 139 HRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 180 VCI 182
           V I
Sbjct: 197 VDI 199

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  140 bits (355), Expect = 4e-41
 Identities = 55/183 (30%), Positives = 96/183 (52%), Gaps = 5/183 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
              +    +G G+ G+  L R K +   VAVK ++  ++   E +  E++  R  +H N+
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   +  L    L ++ME+  GG L D I +  R +E++     + ++  + Y H+  + 
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVI 163

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRD+K ++ LL      R+K+ DFG+  + S    + KS VGTP ++APEV+SR  Y  +
Sbjct: 164 HRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221

Query: 180 VCI 182
           V I
Sbjct: 222 VDI 224

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  142 bits (359), Expect = 4e-41
 Identities = 45/182 (24%), Positives = 91/182 (50%), Gaps = 6/182 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
            + +E+++ +G G+FG   +++  +TK++ A+KY+ + + ++ N  R +         L 
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP ++           + +V++   GG+L   +     F E+  + F  +L+  ++Y  +
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K +N LLD      + I DF  +      ++  +  GT  Y+APE+ S R+ 
Sbjct: 134 QRIIHRDMKPDNILLD--EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191

Query: 177 DG 178
            G
Sbjct: 192 AG 193

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  140 bits (356), Expect = 5e-41
 Identities = 66/189 (34%), Positives = 97/189 (51%), Gaps = 15/189 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           M  ++ +K LG G FG   L+R K T    A+K +   RK +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL---RK-EVIIAKDEVAHTVTESRVL 59

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           ++ RHP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + 
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVL 171
           Y HS  + +RD+KLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 172 SRREYDGKV 180
              +Y   V
Sbjct: 178 EDNDYGRAV 186

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  139 bits (353), Expect = 9e-41
 Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 16/185 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           ++ +++++ LG G+FG   L+R +      A+K +    K +  V  + + H        
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLML 60

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
             + HP IIR          + ++M+Y  GGELF  +  + RF     +++  ++   + 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           Y HS  I +RDLK EN LLD      +KI DFG++K   +     +  GTP YIAPEV+S
Sbjct: 121 YLHSKDIIYRDLKPENILLD--KNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVS 176

Query: 173 RREYD 177
            + Y+
Sbjct: 177 TKPYN 181

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  140 bits (354), Expect = 1e-40
 Identities = 55/184 (29%), Positives = 104/184 (56%), Gaps = 8/184 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R  +  GTP  +APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGY 215

Query: 177 DGKV 180
           +  V
Sbjct: 216 NKAV 219

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  140 bits (354), Expect = 1e-40
 Identities = 61/190 (32%), Positives = 94/190 (49%), Gaps = 16/190 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           +E + L K LG G+FG   L   K+T +  A+K +   +K D  +  + +          
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL---KK-DVVLMDDDVECTMVEKRVL 71

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
             +  HP +        T  +L  VMEY  GG+L   I +  +F      ++  ++I G+
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
            + HS  I +RDLKL+N LLD      +KI DFG  K ++L     +T  GTP YIAPE+
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189

Query: 171 LSRREYDGKV 180
           L  ++Y+  V
Sbjct: 190 LLGQKYNHSV 199

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  140 bits (354), Expect = 1e-40
 Identities = 62/187 (33%), Positives = 93/187 (49%), Gaps = 16/187 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           ++ +E ++ LG G+FG   L R KET +L AVK +   +K D  +  + +          
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL---KK-DVILQDDDVECTMTEKRIL 77

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
             +  HP + +      TP  L  VME+  GG+L   I  + RF E   R++  ++IS +
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISAL 137

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEV 170
            + H   I +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195

Query: 171 LSRREYD 177
           L    Y 
Sbjct: 196 LQEMLYG 202

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  140 bits (355), Expect = 1e-40
 Identities = 61/190 (32%), Positives = 95/190 (50%), Gaps = 16/190 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
              +  +K +G G+FG   L RHK  +   AVK +   +K    + ++   H        
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL---QK-KAILKKKEEKHIMSERNVL 92

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            ++++HP ++       T   L  V++Y  GGELF  +     F E   R++  ++ S +
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 152

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
            Y HS+ I +RDLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEV
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 171 LSRREYDGKV 180
           L ++ YD  V
Sbjct: 211 LHKQPYDRTV 220

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  139 bits (353), Expect = 2e-40
 Identities = 54/190 (28%), Positives = 94/190 (49%), Gaps = 16/190 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           ++ ++L++ +G G++    L+R K+T  + A+K +   +K +     E I+         
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV---KK-ELVNDDEDIDWVQTEKHVF 63

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            ++  HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +
Sbjct: 64  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
           NY H   I +RDLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 181

Query: 171 LSRREYDGKV 180
           L   +Y   V
Sbjct: 182 LRGEDYGFSV 191

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  138 bits (350), Expect = 2e-40
 Identities = 53/181 (29%), Positives = 92/181 (50%), Gaps = 5/181 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E +++++ LG G++G      HKET ++VA+K +     + E + +EI   +    P+++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHVV 87

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++       T L IVMEY   G + D I       +EDE     Q  + G+ Y H M+  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRD+K  N LL+       K+ DFG + + +   ++  + +GTP ++APEV+    Y+  
Sbjct: 148 HRDIKAGNILLNTEG--HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCV 205

Query: 180 V 180
            
Sbjct: 206 A 206

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  138 bits (349), Expect = 2e-40
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 6/184 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I  E      E++ +EI        P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL       +K+ DFG +   +    +  + VGTP ++APEV+ +  YD 
Sbjct: 141 IHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 179 KVCI 182
           K  I
Sbjct: 199 KADI 202

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  139 bits (353), Expect = 4e-40
 Identities = 52/187 (27%), Positives = 93/187 (49%), Gaps = 16/187 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           ++ ++L++ +G G++    L+R K+T  + A++ +   +K +     E I+         
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV---KK-ELVNDDEDIDWVQTEKHVF 106

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            ++  HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 166

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
           NY H   I +RDLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224

Query: 171 LSRREYD 177
           L   +Y 
Sbjct: 225 LRGEDYG 231

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  138 bits (349), Expect = 7e-40
 Identities = 58/190 (30%), Positives = 87/190 (45%), Gaps = 16/190 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           +  +  +  LG G+FG   L   K T EL AVK +   +K D  +  + +          
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KK-DVVIQDDDVECTMVEKRVL 74

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
               + P + +      T   L  VMEY  GG+L   I   GRF E    ++  ++  G+
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
            +  S  I +RDLKL+N +LD      +KI DFG  K ++       T  GTP YIAPE+
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 192

Query: 171 LSRREYDGKV 180
           ++ + Y   V
Sbjct: 193 IAYQPYGKSV 202

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  135 bits (343), Expect = 3e-39
 Identities = 54/188 (28%), Positives = 99/188 (52%), Gaps = 11/188 (5%)

Query: 1   MEKYELVKDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHR---- 53
             ++EL+K LG G+FG   + + +   + ++L A+K + +   +           R    
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILV 81

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
            + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   +++
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLS 172
            HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   +  GT  Y+APEV++
Sbjct: 142 LHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199

Query: 173 RREYDGKV 180
           RR +    
Sbjct: 200 RRGHTQSA 207

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  137 bits (347), Expect = 6e-39
 Identities = 69/190 (36%), Positives = 100/190 (52%), Gaps = 16/190 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           M ++E +K LG G FG   L++ K T    A+K +   +K +  VA++ + H        
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL---KK-EVIVAKDEVAHTLTENRVL 202

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           ++ RHP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262

Query: 113 YCHSMQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
           Y HS + + +RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEV
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320

Query: 171 LSRREYDGKV 180
           L   +Y   V
Sbjct: 321 LEDNDYGRAV 330

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  134 bits (340), Expect = 1e-38
 Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 8/183 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--VAREI-INHRSLRH 57
            + +E + +LGAGN GV   + HK +  ++A K I    K      + RE+ + H     
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NS 90

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS- 116
           P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y    
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   +  S   S VGT +Y++PE L    Y
Sbjct: 151 HKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHY 207

Query: 177 DGK 179
             +
Sbjct: 208 SVQ 210

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (336), Expect = 1e-38
 Identities = 53/180 (29%), Positives = 91/180 (50%), Gaps = 8/180 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           LG G +G+    R    +  +A+K I  R  +  + +  EI  H+ L+H NI+++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 69  TPTHLAIVMEYAAGGELFDRICNA-GRFSEDEG--RYFFQQLISGVNYCHSMQICHRDLK 125
               + I ME   GG L   + +  G   ++E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149

Query: 126 LENTLLDGSAAPRLKICDFGYSK-SSVLHSRPKSTVGTPAYIAPEVL--SRREYDGKVCI 182
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++    R Y     I
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  139 bits (350), Expect = 2e-38
 Identities = 58/190 (30%), Positives = 87/190 (45%), Gaps = 16/190 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           +  +  +  LG G+FG   L   K T EL AVK +   +K D  +  + +          
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KK-DVVIQDDDVECTMVEKRVL 395

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
               + P + +      T   L  VMEY  GG+L   I   GRF E    ++  ++  G+
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 455

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
            +  S  I +RDLKL+N +LD      +KI DFG  K ++       T  GTP YIAPE+
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 513

Query: 171 LSRREYDGKV 180
           ++ + Y   V
Sbjct: 514 IAYQPYGKSV 523

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  133 bits (338), Expect = 2e-38
 Identities = 56/192 (29%), Positives = 94/192 (48%), Gaps = 17/192 (8%)

Query: 1   MEKYELVKDLGAGNFG---VARLLRHKETKELVAVKYIERG---RKIDENVA-----REI 49
            E +EL++ LG G +G     R +    T ++ A+K +++    R   +  A     R I
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD-TAHTKAERNI 74

Query: 50  INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS 109
           +    ++HP I+       T   L +++EY +GGELF ++   G F ED   ++  ++  
Sbjct: 75  LE--EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132

Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAP 168
            + + H   I +RDLK EN +L+      +K+ DFG  K S+       T  GT  Y+AP
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190

Query: 169 EVLSRREYDGKV 180
           E+L R  ++  V
Sbjct: 191 EILMRSGHNRAV 202

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  133 bits (336), Expect = 2e-38
 Identities = 56/186 (30%), Positives = 85/186 (45%), Gaps = 14/186 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
            ++ E+ + +G G FGV    + +     VA+K I       +    E+     + HPNI
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQI-ESESERKAFIVELRQLSRVNHPNI 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI---SGVNYCHSM 117
           ++     L P  + +VMEYA GG L++ +  A         +     +    GV Y HSM
Sbjct: 64  VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 118 Q---ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           Q   + HRDLK  N LL  +    LKICDFG +    + +   +  G+ A++APEV    
Sbjct: 122 QPKALIHRDLKPPNLLLV-AGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGS 178

Query: 175 EYDGKV 180
            Y  K 
Sbjct: 179 NYSEKC 184

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  133 bits (336), Expect = 6e-38
 Identities = 29/213 (13%), Positives = 52/213 (24%), Gaps = 42/213 (19%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR-- 56
                  LG  +         +ET E   V       +      + +  E++  R LR  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 57  -----------------------HPNIIRFKEVVLTPTHLAIVMEYAA--------GGEL 85
                                     +IR +        L+    Y          G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 86  FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
                               Q+I  +   H   + H  L+  + +LD      + +  F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFLTGFE 251

Query: 146 YSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
                V       +  +  +  PE+ +RR    
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATIS 281

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  134 bits (338), Expect = 8e-38
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 17/189 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
            E YE+VK +G G FG  +L+RHK T+++ A+K +       E + R             
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIM 123

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                P +++         +L +VMEY  GG+L   + +     E   R++  +++  ++
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALD 182

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEV 170
             HSM   HRD+K +N LLD S    LK+ DFG     +     R  + VGTP YI+PEV
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

Query: 171 LSRREYDGK 179
           L  +  DG 
Sbjct: 241 LKSQGGDGY 249

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  136 bits (343), Expect = 2e-37
 Identities = 51/188 (27%), Positives = 90/188 (47%), Gaps = 11/188 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR------- 53
           M  + + + +G G FG     R  +T ++ A+K +++ R   +      +N R       
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           +   P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G+ +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL +
Sbjct: 308 MHNRFVVYRDLKPANILLDEHG--HVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQK 364

Query: 174 RE-YDGKV 180
              YD   
Sbjct: 365 GVAYDSSA 372

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  129 bits (327), Expect = 4e-37
 Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 10/189 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E +E+V +LG G FG     ++KET  L A K IE   + + E+   EI    +  HP I
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++          L I++E+  GG +   +       +E + +   +Q++  +N+ HS +I
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRRE--- 175
            HRDLK  N L+       +++ DFG S K+     +  S +GTP ++APEV+       
Sbjct: 139 IHRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196

Query: 176 --YDGKVCI 182
             YD K  I
Sbjct: 197 TPYDYKADI 205

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  132 bits (333), Expect = 4e-37
 Identities = 44/186 (23%), Positives = 84/186 (45%), Gaps = 17/186 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
            + +E++K +G G F    +++ K+T ++ A+K +    K  + + R  ++         
Sbjct: 60  RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM---NK-WDMLKRGEVSCFREERDVL 115

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGV 111
            +     I +         +L +VMEY  GG+L   +   G R   +  R++  +++  +
Sbjct: 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAI 175

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--HSRPKSTVGTPAYIAPE 169
           +  H +   HRD+K +N LLD      +++ DFG           R    VGTP Y++PE
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233

Query: 170 VLSRRE 175
           +L    
Sbjct: 234 ILQAVG 239

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  129 bits (326), Expect = 8e-37
 Identities = 42/184 (22%), Positives = 79/184 (42%), Gaps = 8/184 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREI-INHRSLRH 57
           +   E + ++G+G  G    +R ++T  ++AVK +     ++ ++ +  ++ +  +S   
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS- 116
           P I++     +T T + I ME         +    G   E         ++  + Y    
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
             + HRD+K  N LLD     ++K+CDFG S   V   + K    G  AY+APE +   +
Sbjct: 144 HGVIHRDVKPSNILLDERG--QIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERIDPPD 200

Query: 176 YDGK 179
               
Sbjct: 201 PTKP 204

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  130 bits (327), Expect = 1e-36
 Identities = 31/229 (13%), Positives = 58/229 (25%), Gaps = 48/229 (20%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHP 58
           K +LV+ L  G+  V  L+R  E  E  A+K    G +   +              L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 59  NIIRFKEV--------------------------VLTPTHLAIVMEYAAG------GELF 86
           +    ++                                +  ++M  A+         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 87  DRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY 146
                 G            QLI       S  + H     +N  +      RL + D   
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG--RLMLGDVSA 240

Query: 147 SKSSVLHSRPKSTVGTPAYIAPEVLSRRE--YDGKV------CILLLIL 187
                + +R  ++     Y   E L+     +   +        +  + 
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  132 bits (335), Expect = 1e-36
 Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 8/186 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS----LR 56
              +   + LG G FG     + + T ++ A K +E+ R          +N +     + 
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYC 114
              ++       T   L +V+    GG+L   I + G+  F E    ++  ++  G+   
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           H  +I +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+   
Sbjct: 303 HRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360

Query: 175 EYDGKV 180
            Y    
Sbjct: 361 RYTFSP 366

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  128 bits (323), Expect = 2e-36
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 19/198 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + YEL + +G+G   V +       KE VA+K I  E+ +   + + +EI       HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFD--------RICNAGRFSEDEGRYFFQQLISGV 111
           I+ +    +    L +VM+  +GG + D            +G   E       ++++ G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS------KSSVLHSRPKSTVGTPAY 165
            Y H     HRD+K  N LL    +  ++I DFG S           +   K+ VGTP +
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 166 IAPEVLSR-REYDGKVCI 182
           +APEV+ + R YD K  I
Sbjct: 193 MAPEVMEQVRGYDFKADI 210

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  130 bits (329), Expect = 2e-36
 Identities = 46/186 (24%), Positives = 85/186 (45%), Gaps = 17/186 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
            E +E++K +G G FG   +++ K   ++ A+K +    K  E + R             
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL---NK-WEMLKRAETACFREERDVL 128

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGV 111
            +     I           +L +VM+Y  GG+L   +     R  E+  R++  +++  +
Sbjct: 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI 188

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPE 169
           +  H +   HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 170 VLSRRE 175
           +L   E
Sbjct: 247 ILQAME 252

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  131 bits (331), Expect = 3e-36
 Identities = 52/189 (27%), Positives = 82/189 (43%), Gaps = 11/189 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
            + +   + LG G FG     + K T +L A K + + R       +  +  +     + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVN 112
              I+       T T L +VM    GG++   I N       F E    ++  Q++SG+ 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVL 171
           + H   I +RDLK EN LLD      ++I D G +       ++ K   GTP ++APE+L
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 172 SRREYDGKV 180
              EYD  V
Sbjct: 362 LGEEYDFSV 370

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  128 bits (323), Expect = 4e-36
 Identities = 54/188 (28%), Positives = 92/188 (48%), Gaps = 12/188 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLRH 57
           + +  ++++G G+FG     R     E+VA+K +    ++  +  +++ +E+   + LRH
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PN I+++   L      +VMEY  G        +     E E        + G+ Y HS 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS---RR 174
            + HRD+K  N LL       +K+ DFG   +S++     S VGTP ++APEV+      
Sbjct: 174 NMIHRDVKAGNILLSEPG--LVKLGDFGS--ASIMAPA-NSFVGTPYWMAPEVILAMDEG 228

Query: 175 EYDGKVCI 182
           +YDGKV +
Sbjct: 229 QYDGKVDV 236

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  128 bits (324), Expect = 4e-36
 Identities = 48/198 (24%), Positives = 83/198 (41%), Gaps = 19/198 (9%)

Query: 2   EKYELVKDLGAG--NFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLR 56
             YEL+  +G G  +     L R+K T E V V+ I       ++   +  E+   +   
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYC 114
           HPNI+ ++   +    L +V  + A G   D IC       +E    Y  Q ++  ++Y 
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYS--------KSSVLHSRPKSTVGTPAYI 166
           H M   HR +K  + L+       + +     +        +  V+H  PK +V    ++
Sbjct: 145 HHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 167 APEVLSR--REYDGKVCI 182
           +PEVL +  + YD K  I
Sbjct: 203 SPEVLQQNLQGYDAKSDI 220

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  127 bits (321), Expect = 5e-36
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 17/194 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNI 60
             +ELV+ +G G +G     RH +T +L A+K ++     +E + +EI   +    H NI
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI 83

Query: 61  IRF------KEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVN 112
             +      K        L +VME+   G + D  +        E+   Y  ++++ G++
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL 171
           + H  ++ HRD+K +N LL  +A   +K+ DFG S +      R  + +GTP ++APEV+
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 172 SRRE-----YDGKV 180
           +  E     YD K 
Sbjct: 202 ACDENPDATYDFKS 215

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (318), Expect = 7e-36
 Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 15/191 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--VAREI-INHRSLRH 57
            +  E + +LG G +GV   +RH  + +++AVK I       E   +  ++ I+ R++  
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICN-AGRFSEDEGRYFFQQLISGVNYC 114
           P  + F   +     + I ME       + + ++ +      ED        ++  + + 
Sbjct: 66  PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 115 HS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEV-- 170
           HS + + HRD+K  N L++     ++K+CDFG S   V     K    G   Y+APE   
Sbjct: 126 HSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERIN 182

Query: 171 --LSRREYDGK 179
             L+++ Y  K
Sbjct: 183 PELNQKGYSVK 193

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  125 bits (316), Expect = 8e-36
 Identities = 59/190 (31%), Positives = 82/190 (43%), Gaps = 18/190 (9%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-----ENVAREIINHRSLRHPN 59
            L + +G G FG  ++ R     + VAVK        D     ENV +E      L+HPN
Sbjct: 10  TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-- 117
           II  + V L   +L +VME+A GG L   +    R   D    +  Q+  G+NY H    
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 118 -QICHRDLKLENTLLDGSAAPR------LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
             I HRDLK  N L+             LKI DFG ++     +   S  G  A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185

Query: 171 LSRREYDGKV 180
           +    +    
Sbjct: 186 IRASMFSKGS 195

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  125 bits (317), Expect = 9e-36
 Identities = 51/192 (26%), Positives = 80/192 (41%), Gaps = 20/192 (10%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA--------REIINHRSLR 56
           E  K +G G FG+    R  + K +VA+K +  G    E           RE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCH 115
           HPNI++   ++  P    +VME+   G+L+ R+ +                +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 116 SM--QICHRDLKLENTLLDG---SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N  L     +A    K+ DFG S+ SV        +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQWMAPET 197

Query: 171 LSRRE--YDGKV 180
           +   E  Y  K 
Sbjct: 198 IGAEEESYTEKA 209

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  125 bits (317), Expect = 2e-35
 Identities = 64/187 (34%), Positives = 92/187 (49%), Gaps = 17/187 (9%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNII 61
            + + +GAG+FG   + R +     VAVK +       E V    RE+   + LRHPNI+
Sbjct: 40  NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGR--YFFQQLISGVNYCHSM- 117
            F   V  P +L+IV EY + G L+  +  +  R   DE R       +  G+NY H+  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 118 -QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSR 173
             I HR+LK  N L+D      +K+CDFG S+  +  S     KS  GTP ++APEVL  
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 174 REYDGKV 180
              + K 
Sbjct: 214 EPSNEKS 220

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  126 bits (319), Expect = 2e-35
 Identities = 52/191 (27%), Positives = 92/191 (48%), Gaps = 21/191 (10%)

Query: 1   MEKYELVKDLGAGNFG---VARLLRHKETKELVAVKYIERGRKI--DENVAR-------- 47
           +E +EL+K LG G +G   + R +   +T +L A+K +++   +   +            
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112

Query: 48  EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           E I       P ++       T T L ++++Y  GGELF  +    RF+E E + +  ++
Sbjct: 113 EHIRQ----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--SRPKSTVGTPAY 165
           +  + + H + I +RD+KLEN LLD +    + + DFG SK  V     R     GT  Y
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETERAYDFCGTIEY 226

Query: 166 IAPEVLSRREY 176
           +AP+++   + 
Sbjct: 227 MAPDIVRGGDS 237

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  124 bits (315), Expect = 4e-35
 Identities = 55/178 (30%), Positives = 85/178 (47%), Gaps = 12/178 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           MEKYE +  +G G++GV    R+++T ++VA+K      + D  +     REI   + L+
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLK 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPN++   EV      L +V EY         DR        E   +    Q +  VN+C
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFC 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           H     HRD+K EN L+   +   +K+CDFG+++     S      V T  Y +PE+L
Sbjct: 119 HKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL 174

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  125 bits (315), Expect = 4e-35
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 19/197 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           MEKYE +  +G G++G+    R+K+T  +VA+K        D+ V     REI   + LR
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLR 82

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H N++   EV        +V E+      +  +   N         + +  Q+I+G+ +C
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFC 140

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSR 173
           HS  I HRD+K EN L+  S    +K+CDFG++++           V T  Y APE+L  
Sbjct: 141 HSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG 198

Query: 174 -REYDGKV------CIL 183
             +Y   V      C++
Sbjct: 199 DVKYGKAVDVWAIGCLV 215

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  123 bits (311), Expect = 2e-34
 Identities = 47/191 (24%), Positives = 82/191 (42%), Gaps = 14/191 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--VAREI-INHRSLRH 57
            E  + + ++G G +G    + HK + +++AVK I       E   +  ++ +  RS   
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNA--GRFSEDEGRYFFQQLISGVNY 113
           P I++F   +       I ME  +    + +  + +       E+         +  +N+
Sbjct: 81  PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 114 CHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
               ++I HRD+K  N LLD S    +K+CDFG S   V         G   Y+APE + 
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198

Query: 172 ---SRREYDGK 179
              SR+ YD +
Sbjct: 199 PSASRQGYDVR 209

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  122 bits (308), Expect = 3e-34
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 18/184 (9%)

Query: 5   ELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNI 60
           E+ + +G G FG V     H E    VA++ I+  R  ++ +    RE++ +R  RH N+
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           + F    ++P HLAI+     G  L+  + +A      ++ R   Q+++ G+ Y H+  I
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEVLSR 173
            H+DLK +N   D     ++ I DFG         +     + +   G   ++APE++ +
Sbjct: 152 LHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 174 REYD 177
              D
Sbjct: 209 LSPD 212

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  122 bits (309), Expect = 3e-34
 Identities = 66/198 (33%), Positives = 93/198 (46%), Gaps = 17/198 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           +++Y  +  LG G +G         T E VA+K I R    +E V     RE+   + L+
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQ 91

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H NII  K V+     L ++ EYA   +L   +      S    + F  QLI+GVN+CHS
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150

Query: 117 MQICHRDLKLENTLLDGSAAPR---LKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL- 171
            +  HRDLK +N LL  S A     LKI DFG +++  +  R  +  + T  Y  PE+L 
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210

Query: 172 SRREYDGKV------CIL 183
             R Y   V      CI 
Sbjct: 211 GSRHYSTSVDIWSIACIW 228

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  121 bits (305), Expect = 9e-34
 Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 19/193 (9%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIER-GRKIDENVAREIINHRSLRHPNIIRF 63
              + LG G FG A  + H+ET E++ +K + R   +      +E+   R L HPN+++F
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICHR 122
             V+     L  + EY  GG L   I +    +   +   F + + SG+ Y HSM I HR
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK---------------SSVLHSRPKSTVGTPAYIA 167
           DL   N L+  +    + + DFG ++                     +  + VG P ++A
Sbjct: 133 DLNSHNCLVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 168 PEVLSRREYDGKV 180
           PE+++ R YD KV
Sbjct: 191 PEMINGRSYDEKV 203

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  119 bits (300), Expect = 4e-33
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 19/197 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLR 56
           M+KYE ++ +G G +G     +++ET E+VA+K + R    DE V     REI   + L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI+R  +V+ +   L +V E+      + FD     G    +  + F  QL+ G+ +C
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL-S 172
           HS  + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL  
Sbjct: 118 HSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 173 RREYDGKV------CIL 183
            + Y   +      CI 
Sbjct: 176 AKLYSTSIDMWSAGCIF 192

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  117 bits (295), Expect = 1e-32
 Identities = 31/182 (17%), Positives = 66/182 (36%), Gaps = 17/182 (9%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNII 61
             +  L   + G   L + +     + VK ++      +   +   E    R   HPN++
Sbjct: 13  NFLTKLNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSM 117
                  +P   H  ++  +   G L++ +     F  D+ +   F   +  G+ + H++
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 118 Q--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           +  I    L   + ++D       +I       S          +  PA++APE L ++ 
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSFQS----PGRMYAPAWVAPEALQKKP 184

Query: 176 YD 177
            D
Sbjct: 185 ED 186

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  117 bits (296), Expect = 1e-32
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 12/180 (6%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR---EIINHRSLRHPNIIRF--- 63
           +G G+F         ET   VA   ++  +       R   E    + L+HPNI+RF   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 64  -KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ--IC 120
            +  V     + +V E    G L   +           R + +Q++ G+ + H+    I 
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           HRDLK +N  + G     +KI D G +         K+ +GTP ++APE+    +YD  V
Sbjct: 154 HRDLKCDNIFITGPTG-SVKIGDLGLATLKRASFA-KAVIGTPEFMAPEMY-EEKYDESV 210

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  120 bits (302), Expect = 1e-32
 Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 28/202 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
             Y   K +G G+FGV    +  ++ ELVA+K + + ++  +N  RE+   R L H NI+
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKN--RELQIMRKLDHCNIV 110

Query: 62  RFKEVVLTPT------HLAIVMEYAAGGE-----LFDRICNAGRFSEDEGRYFFQQLISG 110
           R +    +        +L +V++Y    E                     + +  QL   
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAP 168
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K   L     +   + +  Y AP
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPNVSYICSRYYRAP 225

Query: 169 EV-LSRREYDGKV------CIL 183
           E+     +Y   +      C+L
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVL 247

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  117 bits (295), Expect = 1e-32
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 18/191 (9%)

Query: 1   MEKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLR 56
             +  + + +G+G+FG V +   H +    VAVK +       + +     E+   R  R
Sbjct: 23  DGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           H NI+ F     T   LAIV ++  G  L+  +  +  +F   +     +Q   G++Y H
Sbjct: 79  HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLS 172
           +  I HRDLK  N  L       +KI DFG +          + +   G+  ++APEV+ 
Sbjct: 138 AKSIIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 173 RRE---YDGKV 180
            ++   Y  + 
Sbjct: 196 MQDSNPYSFQS 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  116 bits (293), Expect = 6e-32
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 20/197 (10%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLR 56
           ME Y  +  LG G +      + K T  LVA+K I    E G        RE+   + L+
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLK 58

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI+   +++ T   L +V EY      +  D        +    + F  QL+ G+ YC
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL-S 172
           H  ++ HRDLK +N L++      LK+ DFG +++  + ++     V T  Y  P++L  
Sbjct: 117 HRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG 174

Query: 173 RREYDGKV------CIL 183
             +Y  ++      CI 
Sbjct: 175 STDYSTQIDMWGVGCIF 191

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  116 bits (293), Expect = 6e-32
 Identities = 37/173 (21%), Positives = 58/173 (33%), Gaps = 26/173 (15%)

Query: 40  KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI---CNAGRFS 96
              +  + +I         N +   +      +L I M+      L D +   C+     
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162

Query: 97  EDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP 156
                + F Q+   V + HS  + HRDLK  N          +K+ DFG   +       
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT--MDDVVKVGDFGLVTAMDQDEEE 220

Query: 157 KST-------------VGTPAYIAPEVLSRREYDGKV------CIL--LLILF 188
           ++              VGT  Y++PE +    Y  KV       IL  LL  F
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 59.5 bits (144), Expect = 5e-11
 Identities = 19/67 (28%), Positives = 31/67 (46%), Gaps = 2/67 (2%)

Query: 1  MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
          +  +E ++ +G G FGV    ++K      A+K I    +    E V RE+     L HP
Sbjct: 5  LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 59 NIIRFKE 65
           I+R+  
Sbjct: 65 GIVRYFN 71

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  116 bits (293), Expect = 7e-32
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 21/200 (10%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLR 56
             +++ ++ LG G +       +K T   VA+K +    E G        REI   + L+
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELK 61

Query: 57  HPNIIRFKEVVLTPTHLAIVMEY-----AAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           H NI+R  +V+ T   L +V E+         +             +  +YF  QL+ G+
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEV 170
            +CH  +I HRDLK +N L++     +LK+ DFG +++  +     S+ V T  Y AP+V
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179

Query: 171 L-SRREYDGKV------CIL 183
           L   R Y   +      CIL
Sbjct: 180 LMGSRTYSTSIDIWSCGCIL 199

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  114 bits (289), Expect = 1e-31
 Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 20/197 (10%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLR 56
           MEKY  ++ +G G +GV    ++    E  A+K I R  K DE +     REI   + L+
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELK 58

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI++  +V+ T   L +V E+      +L D     G       + F  QL++G+ YC
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYC 116

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL-S 172
           H  ++ HRDLK +N L++      LKI DFG +++  +  R  +  + T  Y AP+VL  
Sbjct: 117 HDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 173 RREYDGKV------CIL 183
            ++Y   +      CI 
Sbjct: 175 SKKYSTTIDIWSVGCIF 191

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  115 bits (290), Expect = 3e-31
 Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 20/199 (10%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVA----REIINHRS 54
            ++YE +  LG G F      R K T ++VA+K I      +  + +     REI   + 
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           L HPNII   +     +++++V ++       +     N+   +    + +    + G+ 
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLE 126

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           Y H   I HRDLK  N LLD +    LK+ DFG +KS    +R  +  V T  Y APE+L
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184

Query: 172 -SRREYDGKV------CIL 183
              R Y   V      CIL
Sbjct: 185 FGARMYGVGVDMWAVGCIL 203

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  116 bits (292), Expect = 3e-31
 Identities = 27/209 (12%), Positives = 52/209 (24%), Gaps = 41/209 (19%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR--------- 56
           LG  +         +ET E   V       +      + +  E++  R LR         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 57  -------------HPNIIRFKEVVLTPTHLAIVMEYAA-----------GGELFDRICNA 92
                         P   +   V L    + ++  +             G  L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 93  GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--S 150
                        Q+I  +   H   + H  L+  + +LD      + +  F +     +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRDGA 263

Query: 151 VLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
              S        P   A  +L   ++   
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPT 292

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  113 bits (284), Expect = 1e-30
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 20/197 (10%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLR 56
           MEKY+ ++ +G G +GV    +      +VA+K I R    DE +     REI   + L 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAEDEGIPSTAIREISLLKELH 77

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPNI+   +V+ +   L +V E+      ++ D   N     + + + +  QL+ GV +C
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL-S 172
           H  +I HRDLK +N L++      LK+ DFG +++  +  R  +  V T  Y AP+VL  
Sbjct: 136 HQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193

Query: 173 RREYDGKV------CIL 183
            ++Y   V      CI 
Sbjct: 194 SKKYSTSVDIWSIGCIF 210

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  112 bits (282), Expect = 7e-30
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 25/201 (12%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
              Y   K +G G+FGV    +  E+ E VA+K + + ++  +N  RE+   R ++HPN+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-FKN--RELQIMRIVKHPNV 94

Query: 61  IRFKEVVLTPTH------LAIVMEYAAG---GELFDRICNAGRFSEDEGRYFFQQLISGV 111
           +  K    +         L +V+EY                        + +  QL+  +
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPE 169
            Y HS+ ICHRD+K +N LLD  +   LK+ DFG +K  +L +   +   + +  Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211

Query: 170 V-LSRREYDGKV------CIL 183
           +      Y   +      C++
Sbjct: 212 LIFGATNYTTNIDIWSTGCVM 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  110 bits (278), Expect = 1e-29
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 22/201 (10%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA-REIINHRSLR-HP 58
            + Y+LV+ LG G +       +    E V VK +   + + +    REI    +LR  P
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGP 91

Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NII   ++V  P     A+V E+    +           ++ + R++  +++  ++YCHS
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS 148

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL-SR 173
           M I HRD+K  N ++D     +L++ D+G ++    H   +    V +  +  PE+L   
Sbjct: 149 MGIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDY 205

Query: 174 REYDGKV------CILLLILF 188
           + YD  +      C+L  ++F
Sbjct: 206 QMYDYSLDMWSLGCMLASMIF 226

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  109 bits (275), Expect = 4e-29
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 35/211 (16%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLR 56
           + KYE +  +G G FG     RH++T + VA+K +       E       REI   + L+
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLK 74

Query: 57  HPNIIRFKEVVLTPTHLA--------IVMEYA----AGGELFDRICNAGRFSEDEGRYFF 104
           H N++   E+  T             +V ++     AG  L   +    +F+  E +   
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRVM 130

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRP-KST 159
           Q L++G+ Y H  +I HRD+K  N L+       LK+ DFG    +S +         + 
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNR 188

Query: 160 VGTPAYIAPEVL-SRREYDGKV------CIL 183
           V T  Y  PE+L   R+Y   +      CI+
Sbjct: 189 VVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  107 bits (270), Expect = 1e-28
 Identities = 51/205 (24%), Positives = 80/205 (39%), Gaps = 25/205 (12%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRS 54
             +YE V ++G G +G     R   +   VA+K +                 RE+   R 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 55  LR---HPNIIRFKEVVLTPTH-----LAIVMEYAAG--GELFDRICNAGRFSEDEGRYFF 104
           L    HPN++R  +V  T        + +V E+         D+         +  +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA 164
           +Q + G+++ H+  I HRDLK EN L+       +K+ DFG ++           V T  
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLARIYSYQMALTPVVVTLW 184

Query: 165 YIAPEVLSRREYDGKV------CIL 183
           Y APEVL +  Y   V      CI 
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIF 209

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  106 bits (266), Expect = 4e-28
 Identities = 47/199 (23%), Positives = 73/199 (36%), Gaps = 28/199 (14%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF- 63
            L++ +G G +G       +     VAVK      +       E+ N   LRH NI+ F 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 64  ---KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ-- 118
                   + T L ++  Y   G L+D +                 + SG+ + H     
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 119 ------ICHRDLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIA 167
                 I HRDLK +N L+  +   +  I D G +      ++ L       VGT  Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 168 PEVL------SRREYDGKV 180
           PEVL         +   +V
Sbjct: 186 PEVLDETIQVDCFDSYKRV 204

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  106 bits (267), Expect = 6e-28
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 26/205 (12%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           M+++++ +  G G FG  +L + K T   VA+K +  +   +  E   + + +   L HP
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDLAVLHHP 79

Query: 59  NIIRFKEVVLTPTH-------LAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQL 107
           NI++ +    T          L +VMEY     L     N  R          + F  QL
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138

Query: 108 ISGVNYCH--SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY 165
           I  +   H  S+ +CHRD+K  N L++ +    LK+CDFG +K         + + +  Y
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPSEPNVAYICSRYY 197

Query: 166 IAPEV-LSRREYDGKV------CIL 183
            APE+    + Y   V      CI 
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIF 222

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  106 bits (265), Expect = 1e-27
 Identities = 52/199 (26%), Positives = 75/199 (37%), Gaps = 28/199 (14%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF- 63
            L + +G G FG     + +  +  VAVK      +       EI     LRH NI+ F 
Sbjct: 45  VLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 64  ---KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS---- 116
               +   T T L +V +Y   G LFD + N    + +          SG+ + H     
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 117 ----MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIA 167
                 I HRDLK +N L+  +      I D G +      +  +   P   VGT  Y+A
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 168 PEVL------SRREYDGKV 180
           PEVL         E   + 
Sbjct: 220 PEVLDDSINMKHFESFKRA 238

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  105 bits (264), Expect = 1e-27
 Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 28/199 (14%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           ++VK +G G +G   + + +  K  VAVK      +       EI     +RH NI+ F 
Sbjct: 40  QMVKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 65  EVVLTP----THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ-- 118
              +      T L ++ +Y   G L+D + +                +SG+ + H+    
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 119 ------ICHRDLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIA 167
                 I HRDLK +N L+  +      I D G +      ++ +   P + VGT  Y+ 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 168 PEVL------SRREYDGKV 180
           PEVL      +  +     
Sbjct: 215 PEVLDESLNRNHFQSYIMA 233

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  105 bits (263), Expect = 1e-27
 Identities = 52/206 (25%), Positives = 80/206 (38%), Gaps = 25/206 (12%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
            +Y  +K LG G  G+       +  + VA+K I        ++  REI   R L H NI
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG--------ELFD----RICNAGRFSEDEGRYFFQQLI 108
           ++  E++            +           E  +     +   G   E+  R F  QL+
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGTPA 164
            G+ Y HS  + HRDLK  N  ++ +    LKI DFG ++    H   K      + T  
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 165 YIAPEV-LSRREYDGKV------CIL 183
           Y +P + LS   Y   +      CI 
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIF 215

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  104 bits (261), Expect = 4e-27
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 29/206 (14%)

Query: 1   MEKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA----REI---I 50
            ++YE V ++G G +G    AR    K     VA+K + R +  +E +     RE+    
Sbjct: 10  DQQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLR 66

Query: 51  NHRSLRHPNIIRFKEVVLTP-----THLAIVMEYAAG--GELFDRICNAGRFSEDEGRYF 103
           +  +  HPN++R  +V         T L +V E+         D+         +  +  
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDM 125

Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP 163
             QL+ G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T 
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTL 183

Query: 164 AYIAPEVLSRREYDGKV------CIL 183
            Y APEVL +  Y   V      CI 
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIF 209

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  105 bits (263), Expect = 4e-27
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 29/209 (13%)

Query: 2   EKYELVKD-LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH 57
           + +E     +G G +G    A+  +  +  +  A+K IE    I  +  REI   R L+H
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKR-KDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77

Query: 58  PNIIRFKEVVLTPTHLAI--VMEYA--------AGGELFDRICNAGRFSEDEGRYFFQQL 107
           PN+I  ++V L+     +  + +YA                     +      +    Q+
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKST----VG 161
           + G++Y H+  + HRDLK  N L+ G    R  +KI D G+++      +P +     V 
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 162 TPAYIAPEVL-SRREYDGKV------CIL 183
           T  Y APE+L   R Y   +      CI 
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIF 226

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  103 bits (260), Expect = 7e-27
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 26/200 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R     I  +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V      L       +V     G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++ +      + T  V T  Y APE+
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTA----DEMTGYVATRWYRAPEI 200

Query: 171 -LSRREYDGKV------CIL 183
            L+   Y+  V      CI+
Sbjct: 201 MLNWMHYNQTVDIWSVGCIM 220

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  103 bits (259), Expect = 1e-26
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 26/200 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
             Y  ++ +G+G +G         T   VA+K + R    ++  +   RE+   + +RH 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V      L       +VM +  G +L  ++    +  ED  ++   Q++ G+ 
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGLR 142

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y H+  I HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APEV
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQ----ADSEMTGYVVTRWYRAPEV 196

Query: 171 -LSRREYDGKV------CIL 183
            L+   Y   V      CI+
Sbjct: 197 ILNWMRYTQTVDIWSVGCIM 216

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  102 bits (257), Expect = 2e-26
 Identities = 59/206 (28%), Positives = 87/206 (42%), Gaps = 34/206 (16%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVA------REIINHR 53
            +Y  +  +G G +G+         K  VA+K      KI   E+        REI    
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILL 80

Query: 54  SLRHPNIIRFKEVVLTPTH-----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI 108
             RH NII   +++  PT      + IV +     +L  ++      S D   YF  Q++
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQIL 138

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGTPA 164
            G+ Y HS  + HRDLK  N LL+ +    LKICDFG ++ +             V T  
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 165 YIAPEV-LSRREYDGKV------CIL 183
           Y APE+ L+ + Y   +      CIL
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCIL 222

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  102 bits (255), Expect = 2e-26
 Identities = 47/196 (23%), Positives = 70/196 (35%), Gaps = 32/196 (16%)

Query: 1   MEKYELVKDLGAGNFG-VAR-LLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP 58
           ++  +L++ +G G +G V +  L  +     VAVK      + +    + I     + H 
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSLDERP----VAVKVFSFANRQNFINEKNIYRVPLMEHD 67

Query: 59  NIIRF-----KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           NI RF     +          +VMEY   G L   + +               +  G+ Y
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAY 126

Query: 114 CHSM---------QICHRDLKLENTLLDGSAAPRLKICDFGYSK---------SSVLHSR 155
            H+           I HRDL   N L+         I DFG S               + 
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 156 PKSTVGTPAYIAPEVL 171
             S VGT  Y+APEVL
Sbjct: 185 AISEVGTIRYMAPEVL 200

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  101 bits (255), Expect = 3e-26
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 27/200 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           + Y     +G+G +G       K + E VA+K + R    +I  +   RE++  + ++H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V    + L       +VM +    +L   +    +FSE++ +Y   Q++ G+ 
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGLK 140

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  + HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APEV
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARH----ADAEMTGYVVTRWYRAPEV 194

Query: 171 -LSRREYDGKV------CIL 183
            LS   Y+  V      CI+
Sbjct: 195 ILSWMHYNQTVDIWSVGCIM 214

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  101 bits (253), Expect = 6e-26
 Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 41/213 (19%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVA------REIINHR 53
             ++L   LG G +GV     HK T E+VA+K      KI+  +         REI   +
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKILK 64

Query: 54  SLRHPNIIRFKEVVLTPTHLA-----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI 108
             +H NII    +    +        I+ E     +L  R+ +    S+D  +YF  Q +
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTL 122

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--------- 159
             V   H   + HRDLK  N L++ +    LK+CDFG ++     +   S          
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 160 --VGTPAYIAPEV-LSRREYDGKV------CIL 183
             V T  Y APEV L+  +Y   +      CIL
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  101 bits (253), Expect = 6e-26
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 20/198 (10%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 58  PNIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            NII    V      L       IVME      L  ++        +   Y   Q++ G+
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

Query: 172 SRREYDGKV------CIL 183
               Y   V      CI+
Sbjct: 199 LGMGYKENVDIWSVGCIM 216

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  100 bits (250), Expect = 2e-25
 Identities = 51/233 (21%), Positives = 80/233 (34%), Gaps = 56/233 (24%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVK--YIERGRKIDENVAREIINHRSLRHP 58
            +KY L K LG G+FG+   +   E+ +  A+K    +   K      RE+   + L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-----RELDIMKVLDHV 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG------------------------- 93
           NII+  +   T                     N G                         
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 94  ----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP 137
                               +    +  QL   V + HS+ ICHRD+K +N L++     
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN- 179

Query: 138 RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV-LSRREYDGKV------CIL 183
            LK+CDFG +K  +      + + +  Y APE+ L   EY   +      C+ 
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  100 bits (251), Expect = 3e-25
 Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 20/197 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           ++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           NII    V      L       +VME      L   I        +   Y   Q++ G+ 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGIK 178

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+ 
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236

Query: 173 RREYDGKV------CIL 183
              Y   V      CI+
Sbjct: 237 GMGYKENVDIWSVGCIM 253

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 99.9 bits (249), Expect = 5e-25
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 11/152 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           ++YE+   +G G++G       K  K +VA+K I R     ID + + REI     L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112

Query: 59  NIIRFKEVVLTPT-----HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           ++++  ++V+         L +V+E A   +           +E   +     L+ GV Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
            HS  I HRDLK  N L++      +K+CDFG
Sbjct: 172 VHSAGILHRDLKPANCLVNQDC--SVKVCDFG 201

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 98.5 bits (246), Expect = 8e-25
 Identities = 42/207 (20%), Positives = 74/207 (35%), Gaps = 29/207 (14%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------------REI 49
             Y + + + +G++G             VA+K +         V             REI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 50  INHRSLRHPNIIRFKEVVLTPTH-----LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYF 103
                  HPNI+  +++ +         L +V E     +L   I       S    +YF
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139

Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP 163
              ++ G++  H   + HRDL   N LL  +    + ICDF  ++     +     V   
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNN--DITICDFNLAREDTADANKTHYVTHR 197

Query: 164 AYIAPEV-LSRREYDGKV------CIL 183
            Y APE+ +  + +   V      C++
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVM 224

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 96.4 bits (240), Expect = 8e-24
 Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 41/220 (18%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           + Y +   +G G++G   L   K T++ VA+K + R     ID + + REI     L+  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85

Query: 59  NIIRFKEVVLTPTHLA-----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
            IIR  ++++    L      IV+E A   +L          +E+  +     L+ G N+
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA--------- 164
            H   I HRDLK  N LL+      +K+CDFG +++                        
Sbjct: 145 IHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 165 --------------YIAPEV-LSRREYDGKV------CIL 183
                         Y APE+ L +  Y   +      CI 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 94.8 bits (236), Expect = 2e-23
 Identities = 63/217 (29%), Positives = 88/217 (40%), Gaps = 39/217 (17%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLR-H 57
            KYELVK LG G +G+      + T E+VAVK I        D +   REI+    L  H
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            NI+    V+       + +V +Y    +L   +  A        +Y   QLI  + Y H
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYLH 126

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST---------------- 159
           S  + HRD+K  N LL+      +K+ DFG S+S V   R  +                 
Sbjct: 127 SGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 160 ------VGTPAYIAPEV-LSRREYDGKV------CIL 183
                 V T  Y APE+ L   +Y   +      CIL
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 93.6 bits (233), Expect = 2e-23
 Identities = 46/188 (24%), Positives = 71/188 (37%), Gaps = 22/188 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
              +L++    G FG     +       VAVK      K       E+ +   ++H NI+
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81

Query: 62  RF----KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +F    K        L ++  +   G L D +  A   S +E  +  + +  G+ Y H  
Sbjct: 82  QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHED 140

Query: 118 Q----------ICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPA 164
                      I HRD+K +N LL  +      I DFG +    +          VGT  
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRR 198

Query: 165 YIAPEVLS 172
           Y+APEVL 
Sbjct: 199 YMAPEVLE 206

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 85.7 bits (213), Expect = 2e-20
 Identities = 56/180 (31%), Positives = 82/180 (45%), Gaps = 24/180 (13%)

Query: 4   YELVKDLGAGNFGVA--------RLLRHKETKELVAVKYIERGRKIDENVA----REIIN 51
           Y++V  LG G  G++         L         VA+K I    +  E       RE+ N
Sbjct: 13  YKIVDKLGGG--GMSTVYLAEDTILNIK------VAIKAIFIPPREKEETLKRFEREVHN 64

Query: 52  HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
              L H NI+   +V        +VMEY  G  L + I + G  S D    F  Q++ G+
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPE 169
            + H M+I HRD+K +N L+D +    LKI DFG +K  S    ++    +GT  Y +PE
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNK--TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 86.5 bits (215), Expect = 2e-20
 Identities = 50/183 (27%), Positives = 66/183 (36%), Gaps = 12/183 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
           E   L + +G GNFG     R +    LVAVK        D      +E    +   HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I+R   V      + IVME   GG+    +     R              +G+ Y  S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI-----APEVLSR 173
             HRDL   N L+       LKI DFG S+         +  G    +     APE L+ 
Sbjct: 234 CIHRDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNY 289

Query: 174 REY 176
             Y
Sbjct: 290 GRY 292

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 85.4 bits (212), Expect = 2e-20
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)

Query: 5   ELVKDLGAGNFGVARL----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPN 59
           + ++ LG GNFG   +         T E+VAVK +     +   +  REI   +SL+H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +     L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI-----APEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P        APE L
Sbjct: 133 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 172 SRREYDGK 179
           +  ++   
Sbjct: 190 TESKFSVA 197

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 85.9 bits (213), Expect = 2e-20
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)

Query: 5   ELVKDLGAGNFGVARL----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPN 59
           + ++ LG GNFG   +         T E+VAVK +     +   +  REI   +SL+H N
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +     L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI-----APEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P        APE L
Sbjct: 164 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 172 SRREYDGK 179
           +  ++   
Sbjct: 221 TESKFSVA 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 86.4 bits (214), Expect = 3e-20
 Identities = 43/182 (23%), Positives = 68/182 (37%), Gaps = 6/182 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
               +   LG G +G       K+    VAVK ++      E   +E    + ++HPN++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   V        I+ E+   G L D  R CN    S     Y   Q+ S + Y      
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY--IAPEVLSRREYD 177
            HR+L   N L+       +K+ DFG S+     +              APE L+  ++ 
Sbjct: 340 IHRNLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 178 GK 179
            K
Sbjct: 398 IK 399

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 84.2 bits (209), Expect = 6e-20
 Identities = 42/189 (22%), Positives = 73/189 (38%), Gaps = 22/189 (11%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVK-----------YIERGRKIDENVAREIINH 52
           Y L + +G G  G          + +VA+K           +  R +       RE    
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ-------REARTA 88

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
             L+ P+++   +       L + M    G +L   +   G  +        +Q+ S ++
Sbjct: 89  GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALD 148

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFG--YSKSSVLHSRPKSTVGTPAYIAPEV 170
             H+    HRD+K EN L+  SA     + DFG   + +    ++  +TVGT  Y+APE 
Sbjct: 149 AAHAAGATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206

Query: 171 LSRREYDGK 179
            S      +
Sbjct: 207 FSESHATYR 215

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 84.3 bits (209), Expect = 7e-20
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 11/153 (7%)

Query: 5   ELVKDLGAGNFGV---ARL-LRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           + ++DLG G+FG     R       T E VAVK +  E G     ++ +EI   R+L H 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           NI+++K +        + ++ME+   G L + +  N  + +  +   +  Q+  G++Y  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           S Q  HRDL   N L++     ++KI DFG +K
Sbjct: 144 SRQYVHRDLAARNVLVESEH--QVKIGDFGLTK 174

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 84.3 bits (209), Expect = 9e-20
 Identities = 46/152 (30%), Positives = 68/152 (44%), Gaps = 10/152 (6%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKE-TKELVAVKYI-ERGRKIDENVAREIINHRSLRHPN 59
           + +  LG GNFG     R     + T  LVAVK +   G     +  REI   ++L    
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I++++ V   P    L +VMEY   G L D +  +  R        +  Q+  G+ Y  S
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N L+   +   +KI DFG +K
Sbjct: 146 RRCVHRDLAARNILV--ESEAHVKIADFGLAK 175

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 84.8 bits (210), Expect = 1e-19
 Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 25/199 (12%)

Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH---- 57
           +YE++K +G G+FG V +   HK   + VA+K +   ++     A EI   R L H    
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNEKRFHRQAAEEI---RILEHLRKQ 153

Query: 58  -----PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISG 110
                 N+I   E      H+ +  E      L++ I       FS    R F   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           ++  H  +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTYIQSRFYRAPEV 270

Query: 171 LSRREYDGKV------CIL 183
           +    Y   +      CIL
Sbjct: 271 ILGARYGMPIDMWSLGCIL 289

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 81.9 bits (203), Expect = 3e-19
 Identities = 48/152 (31%), Positives = 66/152 (43%), Gaps = 11/152 (7%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRH 57
            L++ LG G+FGV               VAVK ++           + I       SL H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N LL  +    +KI DFG  +
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMR 169

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 83.4 bits (206), Expect = 5e-19
 Identities = 40/177 (22%), Positives = 65/177 (36%), Gaps = 20/177 (11%)

Query: 4   YELVKDLGAGNFGVARLLRHKE-TKELVAVKYIERGRKIDENVA----REIINHRSLRHP 58
           YE+   +  G  G   L   +      V +K +      D         E      + HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHP 139

Query: 59  NIIRFKEVVLTPTHLA-----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           +I++    V            IVMEY  G  L        +    E   +  +++  ++Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSY 197

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
            HS+ + + DLK EN +L      +LK+ D G        +      GTP + APE+
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 80.8 bits (200), Expect = 1e-18
 Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 11/152 (7%)

Query: 5   ELVKDLGAGNFGVARL----LRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           + ++DLG G+FG   L      +  T E+VAVK +  + G +      +EI   R+L H 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93

Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +II++K          L +VMEY   G L D +         +   F QQ+  G+ Y H+
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
               HRDL   N LL       +KI DFG +K
Sbjct: 153 QHYIHRDLAARNVLL--DNDRLVKIGDFGLAK 182

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 79.6 bits (197), Expect = 4e-18
 Identities = 49/195 (25%), Positives = 72/195 (36%), Gaps = 48/195 (24%)

Query: 4   YELVKDLGAGNFGVA--------RLLRHKETKELVAVK-----------YIERGRKIDEN 44
           YEL + LG G  G++        R  R       VAVK           +  R R     
Sbjct: 14  YELGEILGFG--GMSEVHLARDLRDHRD------VAVKVLRADLARDPSFYLRFR----- 60

Query: 45  VAREIINHRSLRHPNIIRF----KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG 100
             RE  N  +L HP I+      +          IVMEY  G  L D +   G  +    
Sbjct: 61  --REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118

Query: 101 RYFFQQLISGVNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFG----YSKSSVLHS 154
                     +N+ H   I HRD+K  N ++         +K+ DFG     + S    +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN----AVKVMDFGIARAIADSGNSVT 174

Query: 155 RPKSTVGTPAYIAPE 169
           +  + +GT  Y++PE
Sbjct: 175 QTAAVIGTAQYLSPE 189

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 79.8 bits (197), Expect = 5e-18
 Identities = 45/209 (21%), Positives = 78/209 (37%), Gaps = 31/209 (14%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-----INHRSLRH 57
           +Y LV+ LG G+F    L +       VA+K +   +   E    EI     +N      
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 58  P------NIIRFKEV----VLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQ 105
                  +I++  +          H+ +V E   G  L    +            +   +
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 106 QLISGVNYCHSM-QICHRDLKLENTLLDGSAAPR----LKICDFGYSKSSVLHSRPKSTV 160
           QL+ G++Y H    I H D+K EN L++   +P     +KI D G   +        +++
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSI 196

Query: 161 GTPAYIAPEVLSRREYDGKV------CIL 183
            T  Y +PEVL    +          C++
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLI 225

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 79.2 bits (196), Expect = 5e-18
 Identities = 43/184 (23%), Positives = 77/184 (41%), Gaps = 17/184 (9%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKEL-VAVKYIERGRKIDENVAREIINH----RSLR 56
           + +K LG+G FG       +   E  ++ VA+K +           +EI++      S+ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD 75

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           +P++ R   + LT T + ++ +    G L D +  +           +  Q+  G+NY  
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT--P-AYIAPEVLS 172
             ++ HRDL   N L+       +KI DFG +K      +     G   P  ++A E + 
Sbjct: 135 DRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 173 RREY 176
            R Y
Sbjct: 193 HRIY 196

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 77.7 bits (192), Expect = 1e-17
 Identities = 39/149 (26%), Positives = 60/149 (40%), Gaps = 4/149 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
               +   LG G +G       K+    VAVK ++      E   +E    + ++HPN++
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   V        I+ E+   G L D  R CN    S     Y   Q+ S + Y      
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL   N L+  +    +K+ DFG S+
Sbjct: 133 IHRDLAARNCLVGENHL--VKVADFGLSR 159

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 77.8 bits (192), Expect = 2e-17
 Identities = 53/200 (26%), Positives = 83/200 (41%), Gaps = 23/200 (11%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP-- 58
           ++YE+   +G G+FG V +       +E VA+K I+  +        E+     +     
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRV-EQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 59  ----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVN 112
                I+  K   +   HL +V E      L+D + N      S +  R F QQ+ + + 
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 113 YCHS--MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPE 169
           +  +  + I H DLK EN LL       +KI DFG   SS    +     + +  Y +PE
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPE 228

Query: 170 VLSRREYDGKV------CIL 183
           VL    YD  +      CIL
Sbjct: 229 VLLGMPYDLAIDMWSLGCIL 248

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 78.0 bits (192), Expect = 3e-17
 Identities = 45/182 (24%), Positives = 68/182 (37%), Gaps = 8/182 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   VV +   + IV EY + G L D  +          +      Q+ SG+ Y   M  
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY--IAPEVLSRREYD 177
            HRDL+  N L+        K+ DFG ++    +               APE      + 
Sbjct: 385 VHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442

Query: 178 GK 179
            K
Sbjct: 443 IK 444

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 76.2 bits (188), Expect = 6e-17
 Identities = 37/151 (24%), Positives = 67/151 (44%), Gaps = 10/151 (6%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKEL-VAVKYIERG--RKIDENVAREIINHRSLRHP 58
           + +K LG+G FG       +   E  ++ VA+K +      K ++ +  E     S+ +P
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           ++ R   + LT T + ++ +    G L D +  +           +  Q+  G+NY    
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           ++ HRDL   N L+       +KI DFG +K
Sbjct: 137 RLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 76.7 bits (189), Expect = 7e-17
 Identities = 45/182 (24%), Positives = 68/182 (37%), Gaps = 8/182 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   VV +   + IV EY + G L D  +          +      Q+ SG+ Y   M  
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY--IAPEVLSRREYD 177
            HRDL+  N L+        K+ DFG ++    +               APE      + 
Sbjct: 302 VHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 178 GK 179
            K
Sbjct: 360 IK 361

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 76.2 bits (188), Expect = 9e-17
 Identities = 50/197 (25%), Positives = 73/197 (37%), Gaps = 31/197 (15%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP-- 58
           E+YE+V +LG G FG V   L H   K  VA+K I    K  E    EI   + ++    
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78

Query: 59  ----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVN 112
                 +   +      H+ I  E   G   F+ +       +     R+   QL   + 
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137

Query: 113 YCHSMQICHRDLKLENTLLDGSAA-----------------PRLKICDFGYSKSSVLHSR 155
           + H  Q+ H DLK EN L   S                     +++ DFG   S+     
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194

Query: 156 PKST-VGTPAYIAPEVL 171
             +T V T  Y  PEV+
Sbjct: 195 HHTTIVATRHYRPPEVI 211

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 75.4 bits (186), Expect = 1e-16
 Identities = 40/146 (27%), Positives = 62/146 (42%), Gaps = 8/146 (5%)

Query: 8   KDLGAGNFGVAR--LLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIR 62
           K+LG+GNFG  +    + K+  + VAVK ++       + + +  E    + L +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N LL        KI DFG SK
Sbjct: 142 DLAARNVLL--VTQHYAKISDFGLSK 165

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 75.1 bits (185), Expect = 2e-16
 Identities = 37/151 (24%), Positives = 68/151 (45%), Gaps = 10/151 (6%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKEL-VAVKYI--ERGRKIDENVAREIINHRSLRHP 58
             +K LG+G FG       +   E+ ++ V +K I  + GR+  + V   ++   SL H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +I+R   +    + L +V +Y   G L D +  + G         +  Q+  G+ Y    
Sbjct: 76  HIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            + HR+L   N LL   +  ++++ DFG + 
Sbjct: 135 GMVHRNLAARNVLL--KSPSQVQVADFGVAD 163

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 75.5 bits (186), Expect = 2e-16
 Identities = 47/181 (25%), Positives = 71/181 (39%), Gaps = 16/181 (8%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           +L++ +G G FG   L  ++  K  VAVK I+      +    E      LRH N+++  
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLL 252

Query: 65  EVVLT-PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
            V++     L IV EY A G L D  R         D    F   +   + Y       H
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI---APEVLSRREYDG 178
           RDL   N L+        K+ DFG +K +       +       +   APE L  +++  
Sbjct: 313 RDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFST 365

Query: 179 K 179
           K
Sbjct: 366 K 366

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 74.2 bits (183), Expect = 2e-16
 Identities = 46/160 (28%), Positives = 66/160 (41%), Gaps = 16/160 (10%)

Query: 2   EKYELVKD--------LGAGNFG-VAR-LLRHKETKELVAVKYIERGRKIDENVA--REI 49
           +K  L +D        LG GNFG V + + R ++ +  VA+K +++G +  +     RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61

Query: 50  INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLI 108
                L +P I+R   V      + +VME A GG L   +                 Q+ 
Sbjct: 62  QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            G+ Y       HRDL   N LL        KI DFG SK
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLL--VNRHYAKISDFGLSK 158

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 75.5 bits (186), Expect = 2e-16
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E  +L K LGAG FG   +  + +  + VAVK ++ G    E    E    ++L+H  ++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   VV T   + I+ E+ A G L D  +     +    +   F  Q+  G+ +      
Sbjct: 247 KLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL+  N L+  SA+   KI DFG ++
Sbjct: 306 IHRDLRAANILV--SASLVCKIADFGLAR 332

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 73.8 bits (182), Expect = 3e-16
 Identities = 40/153 (26%), Positives = 64/153 (41%), Gaps = 9/153 (5%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLR 56
           E   L + LG G FG         HK  K  VAVK  ++   +D       E +  ++L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           HP+I++   ++       I+ME    GEL   +  N           +  Q+   + Y  
Sbjct: 72  HPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           S+   HRD+ + N L+       +K+ DFG S+
Sbjct: 131 SINCVHRDIAVRNILVASPEC--VKLGDFGLSR 161

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 73.4 bits (181), Expect = 4e-16
 Identities = 38/146 (26%), Positives = 64/146 (43%), Gaps = 6/146 (4%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
             V+++G+G FG+  L       + VA+K I  G   +E+   E      L HP +++  
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 69

Query: 65  EVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
            V L    + +V E+   G L D  R    G F+ +        +  G+ Y     + HR
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N L+  +    +K+ DFG ++
Sbjct: 129 DLAARNCLVGENQV--IKVSDFGMTR 152

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 75.0 bits (184), Expect = 4e-16
 Identities = 42/144 (29%), Positives = 60/144 (41%), Gaps = 8/144 (5%)

Query: 10  LGAGNFGVAR--LLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPNIIRFKE 65
           LG GNFG  R  + R ++ +  VA+K +++G +  +     RE      L +P I+R   
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V      + +VME A GG L   +                 Q+  G+ Y       HR+L
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462

Query: 125 KLENTLLDGSAAPRLKICDFGYSK 148
              N LL        KI DFG SK
Sbjct: 463 AARNVLL--VNRHYAKISDFGLSK 484

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 73.4 bits (181), Expect = 4e-16
 Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG V     +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR 157

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 73.5 bits (181), Expect = 6e-16
 Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 10/151 (6%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
            + K +G+G+ G     RL    +    VA+K ++ G    +      E        HPN
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           IIR + VV       IV EY   G L    R  + G+F+  +     + + +G+ Y   +
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              HRDL   N L+D +     K+ DFG S+
Sbjct: 171 GYVHRDLAARNVLVDSNLV--CKVSDFGLSR 199

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 72.7 bits (179), Expect = 1e-15
 Identities = 39/162 (24%), Positives = 58/162 (35%), Gaps = 15/162 (9%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
           +   L++ LG G FG         + +  +   VAVK +       + +    E +    
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI------ 108
             H NI+R   V L      I+ME  AGG+L   +                 L+      
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 109 -SGVNYCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSK 148
             G  Y       HRD+   N LL      R+ KI DFG ++
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 72.3 bits (178), Expect = 1e-15
 Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 6/149 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           +    +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  ++
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   V      + I+ EY A G L +  R     RF   +     + +   + Y  S Q 
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL   N L++      +K+ DFG S+
Sbjct: 142 LHRDLAARNCLVNDQGV--VKVSDFGLSR 168

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 72.7 bits (179), Expect = 1e-15
 Identities = 56/197 (28%), Positives = 76/197 (38%), Gaps = 31/197 (15%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRS 54
            +YE+V  LG G FG V   + HK     VAVK ++   +       +  V   +     
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVN 112
                 ++  E      H+ IV E   G   +D I   G   F  D  R    Q+   VN
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132

Query: 113 YCHSMQICHRDLKLENTLLDGSAA-----------------PRLKICDFGYSKSSVLHSR 155
           + HS ++ H DLK EN L   S                   P +K+ DFG   S+     
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDE 189

Query: 156 PKST-VGTPAYIAPEVL 171
             ST V T  Y APEV+
Sbjct: 190 HHSTLVSTRHYRAPEVI 206

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 71.9 bits (177), Expect = 2e-15
 Identities = 37/153 (24%), Positives = 62/153 (40%), Gaps = 9/153 (5%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLR 56
           E+ EL + +G G FG       +  +     VA+K  +            +E +  R   
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           HP+I++   V+       I+ME    GEL   +              +  QL + + Y  
Sbjct: 75  HPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           S +  HRD+   N L+  S+   +K+ DFG S+
Sbjct: 134 SKRFVHRDIAARNVLV--SSNDCVKLGDFGLSR 164

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 72.8 bits (179), Expect = 2e-15
 Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 18/188 (9%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLR 56
               + K +GAG FG     RL    + +  VA+K ++ G    +      E        
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPNIIR + VV     + IV EY   G L    R  +  +F+  +     + + SG+ Y 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYI---AP 168
             M   HRDL   N L++ +     K+ DFG  +  VL   P    +T G    I   +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 169 EVLSRREY 176
           E ++ R++
Sbjct: 220 EAIAYRKF 227

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 73.0 bits (179), Expect = 2e-15
 Identities = 36/153 (23%), Positives = 61/153 (39%), Gaps = 9/153 (5%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLR 56
           E+ EL + +G G FG       +  +     VA+K  +            +E +  R   
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           HP+I++   V+       I+ME    GEL   +              +  QL + + Y  
Sbjct: 450 HPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           S +  HRD+   N L+  +    +K+ DFG S+
Sbjct: 509 SKRFVHRDIAARNVLVSSNDC--VKLGDFGLSR 539

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 72.0 bits (177), Expect = 2e-15
 Identities = 38/162 (23%), Positives = 58/162 (35%), Gaps = 15/162 (9%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
           +   L++ LG G FG         + +  +   VAVK +       + +    E +    
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI------ 108
             H NI+R   V L      I++E  AGG+L   +                 L+      
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 109 -SGVNYCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSK 148
             G  Y       HRD+   N LL      R+ KI DFG ++
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 71.1 bits (175), Expect = 3e-15
 Identities = 42/150 (28%), Positives = 62/150 (41%), Gaps = 8/150 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++ +L++ +G G FG   L  ++  K  VAVK I+      +    E      LRH N++
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKND-ATAQAFLAEASVMTQLRHSNLV 77

Query: 62  RFKEVVLTPT-HLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +   V++     L IV EY A G L D  R         D    F   +   + Y     
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL   N L+        K+ DFG +K
Sbjct: 138 FVHRDLAARNVLVSEDNV--AKVSDFGLTK 165

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 71.6 bits (176), Expect = 3e-15
 Identities = 43/202 (21%), Positives = 79/202 (39%), Gaps = 37/202 (18%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREI-----INHRSL 55
             + +++ +G G FG V         K+  AVK +   +K   +   E      I +  +
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHID-NKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNY 113
            + NI+++    +   H+ ++ E   G  L++ I       F  ++ + +  +++  +NY
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 114 CHSMQICHRDLKLENTLLDGSAA-----------------------PRLKICDFGYSKSS 150
              M + H DLK EN LLD                             +K+ DFG    +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209

Query: 151 VLHSRPKST-VGTPAYIAPEVL 171
              S    + + T  Y APEV+
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVI 231

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 71.2 bits (175), Expect = 4e-15
 Identities = 39/168 (23%), Positives = 66/168 (39%), Gaps = 26/168 (15%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSL 55
           +++ L + LG G FG    A+L +   +   VAVK ++       ++    RE    +  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 56  RHPNIIRFKEVVL------TPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQL 107
            HP++ +   V L            +++ +   G+L  F     A R  E+      Q L
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQTL 139

Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +        G+ Y  S    HRDL   N +L       + + DFG S+
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR 185

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 70.4 bits (173), Expect = 7e-15
 Identities = 35/164 (21%), Positives = 66/164 (40%), Gaps = 19/164 (11%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
           EK  + ++LG G+FG     VA+ +   E +  VA+K +     + E +    E    + 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGR--------YFF 104
               +++R   VV       ++ME    G+L  + R       +                
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTR 186

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 70.4 bits (173), Expect = 8e-15
 Identities = 44/155 (28%), Positives = 65/155 (41%), Gaps = 11/155 (7%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKEL-VAVKYIERGRKIDENVA--REIINHRSL 55
                 K +GAG FG      L      KE+ VA+K ++ G    + V    E       
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNY 113
            H NIIR + V+     + I+ EY   G L    R    G FS  +     + + +G+ Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             +M   HRDL   N L++ +     K+ DFG S+
Sbjct: 163 LANMNYVHRDLAARNILVNSNLV--CKVSDFGLSR 195

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 70.0 bits (172), Expect = 9e-15
 Identities = 41/152 (26%), Positives = 63/152 (41%), Gaps = 11/152 (7%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
              + +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 60  IIRFKEVVLTPTH-LAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           ++    + L       +V+ Y   G+L  F R       +  +   F  Q+  G+ Y  S
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N +LD      +K+ DFG ++
Sbjct: 147 KKFVHRDLAARNCMLDEKFT--VKVADFGLAR 176

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 69.5 bits (171), Expect = 9e-15
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 10/180 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E+  L+K+LG+G FGV +L + K   + VAVK I+ G   ++   +E      L HP ++
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +F  V      + IV EY + G L +  R  +       +       +  G+ +  S Q 
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI---APEVLSRREY 176
            HRDL   N L+D      +K+ DFG ++  VL  +  S+VGT   +   APEV    +Y
Sbjct: 126 IHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.4 bits (170), Expect = 1e-14
 Identities = 22/149 (14%), Positives = 43/149 (28%), Gaps = 12/149 (8%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHPN 59
           Y L+   G                  VA+ +++    + ++V        +    +  P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + R  +VV T     +V E+  GG L +        S        Q L +  +  H   +
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 120 CHRDLKLENTLL--DGSAAPRLKICDFGY 146
                      +  DG     + +     
Sbjct: 151 ALSIDHPSRVRVSIDG----DVVLAYPAT 175

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 69.6 bits (171), Expect = 1e-14
 Identities = 27/163 (16%), Positives = 54/163 (33%), Gaps = 17/163 (10%)

Query: 2   EKYELVKDLGAGNFGV-------ARLLRHKETKELVAVKYIERG-RKIDENVAREIINHR 53
           E     + LG G F               +  +  V +K +++  R   E+         
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
            L H +++    V +      +V E+   G L    +  N    +        +QL + +
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAM 126

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRL------KICDFGYSK 148
           ++     + H ++  +N LL      +       K+ D G S 
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 69.6 bits (171), Expect = 2e-14
 Identities = 38/167 (22%), Positives = 57/167 (34%), Gaps = 25/167 (14%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSL 55
               L K LG G FG      L +   T   VAVK ++        +     E    +  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 56  RHPNIIRFKEVVL-----TPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLI 108
            HPN+IR   V +           +++ +   G+L  +       R          Q L+
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQTLL 150

Query: 109 -------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
                   G+ Y  +    HRDL   N +L       + + DFG SK
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK 195

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 69.0 bits (169), Expect = 3e-14
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 11/152 (7%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
              + +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 60  IIRFKEVVLTPTH-LAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           ++    + L       +V+ Y   G+L  F R       +  +   F  Q+  G+ +  S
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N +LD      +K+ DFG ++
Sbjct: 211 KKFVHRDLAARNCMLDEKFT--VKVADFGLAR 240

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 68.4 bits (168), Expect = 4e-14
 Identities = 42/170 (24%), Positives = 59/170 (34%), Gaps = 28/170 (16%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REI-INHR 53
            +    K LGAG FG      A  L   +    VAVK ++    + E  A   E+ +   
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FDRICNAGRFSEDEGRY 102
              H NI+             ++ EY   G+L                +     +DE   
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
             + L+S       G+ +  S    HRDL   N LL        KICDFG
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFG 190

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 66.5 bits (163), Expect = 1e-13
 Identities = 37/152 (24%), Positives = 67/152 (44%), Gaps = 11/152 (7%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
              + +G G+FGV      +   + +   A+K + R  ++ +  A  RE +  R L HPN
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 60  IIRFKEVVLT--PTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           ++    ++L        +++ Y   G+L   I       +  +   F  Q+  G+ Y   
Sbjct: 84  VLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N +LD S    +K+ DFG ++
Sbjct: 143 QKFVHRDLAARNCMLDESFT--VKVADFGLAR 172

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 66.9 bits (164), Expect = 1e-13
 Identities = 40/166 (24%), Positives = 60/166 (36%), Gaps = 24/166 (14%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REI-INHR 53
              +  K LGAG FG      A  L  ++    VAVK ++     DE  A   E+ I   
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD-------RICNAGRFSEDEGRYFFQQ 106
             +H NI+           + ++ EY   G+L +        +     F+        + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 107 LIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           L+        G+ +  S    HRD+   N LL        KI DFG
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--AKIGDFG 209

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 66.5 bits (163), Expect = 2e-13
 Identities = 46/166 (27%), Positives = 66/166 (39%), Gaps = 24/166 (14%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDEN-VAREIINHRSL 55
               L ++LG G FG         L   + K LVAVK ++           RE     +L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRYFFQQ 106
           +H +I++F  V      L +V EY   G+L            I   G+  + +G     Q
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 107 LI-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           ++       SG+ Y  S    HRDL   N L+   A   +KI DFG
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFG 178

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 66.2 bits (162), Expect = 3e-13
 Identities = 46/165 (27%), Positives = 63/165 (38%), Gaps = 23/165 (13%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDEN-VAREIINHRSL 55
               L  +LG G FG         L  ++ K LVAVK ++   +       RE      L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--------FDRICNAGRFSEDEGRYFFQQL 107
           +H +I+RF  V      L +V EY   G+L         D    AG      G     QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           +       +G+ Y   +   HRDL   N L+       +KI DFG
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFG 203

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 66.5 bits (162), Expect = 3e-13
 Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 16/145 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-----INHRSLR 56
            +Y +++ LG G+F    L    + K+ VA+K ++      E    EI     + +    
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 57  HPN--IIR-----FKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQL 107
            PN  ++      FK   +  TH+ +V E   G  L   I   N         +   QQ+
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 108 ISGVNYCHS-MQICHRDLKLENTLL 131
           + G++Y H+  +I H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILL 180

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.6 bits (162), Expect = 3e-13
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 15/176 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNI 60
            K+ L + +G+G+FG   L  + +T E VA+K  E  +     +  E   +R L+    I
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
              +   +   +  +VM+   G  L D    C+  + S         Q+I+ V + HS  
Sbjct: 66  PNVRWFGVEGDYNVLVMDL-LGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 119 ICHRDLKLENTLLD-GSAAPRLKICDFGYSK-----SSVLHSRP---KSTVGTPAY 165
             HRD+K +N L+  G  A ++ I DFG +K     S+  H      K+  GT  Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 64.9 bits (159), Expect = 5e-13
 Identities = 43/175 (24%), Positives = 63/175 (36%), Gaps = 33/175 (18%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
           +   L K LG G FG      A  L+ +     VAVK ++      E      E    + 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------------FDRICNAGRFSE 97
           + HP++I+          L +++EYA  G L                      ++     
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 98  DEGRYFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           DE       LIS       G+ Y   M++ HRDL   N L+       +KI DFG
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFG 195

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 65.0 bits (159), Expect = 6e-13
 Identities = 40/170 (23%), Positives = 64/170 (37%), Gaps = 23/170 (13%)

Query: 2   EKYELVKDLGAGNFG-VAR-LLRHKETKELVAVKYIERGRKIDENVA--REI-INHRSLR 56
              +    +G GNFG V +  ++    +   A+K ++     D++     E+ +  +   
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRYFFQQL 107
           HPNII          +L + +EYA  G L D                 +        QQL
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS 150
           +        G++Y    Q  HRDL   N L+  +     KI DFG S+  
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQ 192

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 64.2 bits (157), Expect = 9e-13
 Identities = 31/167 (18%), Positives = 59/167 (35%), Gaps = 25/167 (14%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
                +++LG   FG             E  + VA+K ++   +         E +    
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRYFFQ 105
           L+HPN++    VV     L+++  Y + G+L +          + +       +      
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 106 QLI-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
             +       +G+ Y  S  + H+DL   N L+       +KI D G
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKISDLG 173

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 64.3 bits (157), Expect = 1e-12
 Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 17/178 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNI 60
             Y++ + +G G+FGV     +    + VA+K+ E  R     +  E   ++ L     I
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
                      H  +V++   G  L D   +C   +FS        +Q+++ V   H   
Sbjct: 69  PNVYYFGQEGLHNVLVIDL-LGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126

Query: 119 ICHRDLKLENTLL---DGSAAPRLKICDFGYSK-----SSVLH---SRPKSTVGTPAY 165
           + +RD+K +N L+   +   A  + + DFG  K      +  H      K+  GT  Y
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 63.5 bits (155), Expect = 2e-12
 Identities = 42/175 (24%), Positives = 62/175 (35%), Gaps = 33/175 (18%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
              E V+D+G G FG      A  L   E   +VAVK ++     D      RE      
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------------FDRICNAGRFSE 97
             +PNI++   V      + ++ EY A G+L                  D    A   S 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 98  DEGRYFFQQLI-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
                   + +       +G+ Y    +  HRDL   N L+  +    +KI DFG
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFG 219

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.2 bits (154), Expect = 3e-12
 Identities = 50/180 (27%), Positives = 75/180 (41%), Gaps = 23/180 (12%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----P 58
            + + K +G GNFG  RL ++  T E VA+K +E  +     +  E   ++ L      P
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            +  F        + A+V+E   G  L D   +C+   FS         QLIS + Y HS
Sbjct: 69  QVYYFGP---CGKYNAMVLEL-LGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHS 123

Query: 117 MQICHRDLKLENTLL---DGSAAPRLKICDFGYSK-----SSVLH---SRPKSTVGTPAY 165
             + +RD+K EN L+          + I DF  +K      +  H      KS  GT  Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 62.3 bits (152), Expect = 6e-12
 Identities = 43/169 (25%), Positives = 63/169 (37%), Gaps = 27/169 (15%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REI-INHR 53
           ++ +L K LG G FG      A  +    T   VAVK ++ G    E+ A   E+ I   
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 54  SLRHPNIIRFKEVVLTP-THLAIVMEYAAGGELFD---------RICNAGRFSEDEGRYF 103
              H N++        P   L +++E+   G L                      +    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 104 FQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
            + LI        G+ +  S +  HRDL   N LL  S    +KICDFG
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFG 193

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.0 bits (151), Expect = 7e-12
 Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 15/176 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNI 60
            +Y L + +G+G+FG   L       E VA+K  E  +     +  E   ++ ++    I
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
              +       +  +VME   G  L D    C+  +FS         Q+IS + Y HS  
Sbjct: 68  PTIRWCGAEGDYNVMVMEL-LGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125

Query: 119 ICHRDLKLENTLL-DGSAAPRLKICDFGYSK-----SSVLH---SRPKSTVGTPAY 165
             HRD+K +N L+  G     + I DFG +K      +  H      K+  GT  Y
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 61.5 bits (150), Expect = 9e-12
 Identities = 44/170 (25%), Positives = 68/170 (40%), Gaps = 28/170 (16%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKE--LVAVKYIERGRKIDENVA--REIINH 52
           +K  L K LG G FG      A  +   + KE   VAVK ++      +      E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 53  RSL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRY 102
           + + +H NII           L +++EYA+ G L +            +       E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFG 202

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 61.5 bits (150), Expect = 9e-12
 Identities = 40/179 (22%), Positives = 57/179 (31%), Gaps = 41/179 (22%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REI----- 49
           E  E  K LG+G FG      A  +        VAVK ++      E  A   E+     
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 50  INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL----------------FDRICNAG 93
           +      H NI+           + ++ EY   G+L                        
Sbjct: 105 LG----SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 94  RFSEDEGRYFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
              ED     F+ L+        G+ +       HRDL   N L+       +KICDFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFG 217

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 61.2 bits (149), Expect = 2e-11
 Identities = 41/170 (24%), Positives = 63/170 (37%), Gaps = 28/170 (16%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKE--LVAVKYIERGRKIDENVA--REI-IN 51
           ++  L K LG G FG      A  L   +      VAVK ++      +      E+ + 
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 52  HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRY 102
               +H NII           L +++EYA+ G L +            +       E + 
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
             + L+S       G+ Y  S +  HRDL   N L+       +KI DFG
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFG 236

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 60.8 bits (148), Expect = 2e-11
 Identities = 44/170 (25%), Positives = 68/170 (40%), Gaps = 28/170 (16%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKE--LVAVKYIERGRKIDENVA--REIINH 52
           +K  L K LG G FG      A  +   + KE   VAVK ++      +      E+   
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 53  RSL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRY 102
           + + +H NII           L +++EYA+ G L +            +       E + 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFG 248

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 57.2 bits (137), Expect = 3e-10
 Identities = 49/233 (21%), Positives = 69/233 (29%), Gaps = 59/233 (25%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN---------VAREIINH 52
           EK +  + +G G FG         T   VA+K I        N         +  EII  
Sbjct: 20  EKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 53  RSL---------RHPNIIRFKEVVL------------------------------TPTHL 73
           + L         R    I    V                                    L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 74  AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLD 132
            IV+E+  GG   +++      S    +    QL + +     S++  HRDL   N LL 
Sbjct: 138 FIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 133 GSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLL 185
                  K+      KSS +      + G    I    LSR E DG V    +
Sbjct: 197 --KTSLKKLHYTLNGKSSTIP-----SCGLQVSIIDYTLSRLERDGIVVFCDV 242

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.6 bits (129), Expect = 5e-09
 Identities = 31/165 (18%), Positives = 60/165 (36%), Gaps = 20/165 (12%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR 62
           ++ L K +G+G FG+  L       E  A   ++   + +  +  E+  ++ +   + I+
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 63  FKEVVLTPTHLAI-------------------VMEYAAGGELFDRICNAGRFSEDEGRYF 103
                    +L I                   VME   G +L       G F +      
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQL 156

Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             +++  + Y H  +  H D+K  N LL      ++ + D+G S 
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.0 bits (117), Expect = 2e-07
 Identities = 28/200 (14%), Positives = 65/200 (32%), Gaps = 41/200 (20%)

Query: 2   EKYELVKDLGAGNFGV--------ARLLRHKETKELVAVKYIER--GRKIDENVAREIIN 51
            +++L       N G+                 K+  ++K ++   GR  +E    +   
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNE----QNFF 96

Query: 52  HRSLRHPNIIRFKEVVLTPT---------------HLAIVMEYAAGGELFD--RICNAGR 94
            R+ +   + ++K++  TP                +  +V+    G  L     +     
Sbjct: 97  QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHV 155

Query: 95  FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSV 151
            SE        +L+  + + H  +  H ++  EN  +D     ++ +  +G++     S 
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

Query: 152 LH-----SRPKSTVGTPAYI 166
            H            G   +I
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI 235

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 48.0 bits (115), Expect = 5e-07
 Identities = 29/63 (46%), Positives = 35/63 (55%), Gaps = 5/63 (7%)

Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-STV--GTPAYI 166
           G++Y H+  I HRD+K  N LLD +  P  KI DFG SK      +   STV  GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208

Query: 167 APE 169
            PE
Sbjct: 209 DPE 211

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.1 bits (112), Expect = 9e-07
 Identities = 26/169 (15%), Positives = 53/169 (31%), Gaps = 25/169 (14%)

Query: 3   KYELVKDLGAGNFGV---ARLLRHKE--TKELVAVK---------------YIERGRKID 42
            +++   +G G FG    A +   +   +     VK               Y    +   
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 43  ENVAREIINHRSLRHPNIIRF-KEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDE 99
                     + L  P             ++  ++M+   G +L          RFS   
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKT 153

Query: 100 GRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
                 +++  + Y H  +  H D+K  N LL+     ++ + D+G + 
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 46.0 bits (110), Expect = 2e-06
 Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 17/69 (24%)

Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG-------YSKSSVLHSRPKST--V 160
           G+N+ H     HRD+K  N LLD +     KI DFG       ++++ +      ++  V
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVM------TSRIV 196

Query: 161 GTPAYIAPE 169
           GT AY+APE
Sbjct: 197 GTTAYMAPE 205

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 44.1 bits (105), Expect = 9e-06
 Identities = 52/190 (27%), Positives = 74/190 (38%), Gaps = 44/190 (23%)

Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVARE------IINHRSLRHPNI 60
           LG G FG     RL        LVAVK ++  R   +    +      +I+     H N+
Sbjct: 38  LGRGGFGKVYKGRL----ADGTLVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-----QQLISGV---- 111
           +R +   +TPT   +V  Y A G +   +         E +        Q++  G     
Sbjct: 90  LRLRGFCMTPTERLLVYPYMANGSVASCL-----RERPESQPPLDWPKRQRIALGSARGL 144

Query: 112 NYCH---SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-----GTP 163
            Y H     +I HRD+K  N LLD        + DFG +K   L     + V     GT 
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVRGTI 199

Query: 164 AYIAPEVLSR 173
            +IAPE LS 
Sbjct: 200 GHIAPEYLST 209

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.3 bits (94), Expect = 2e-04
 Identities = 31/143 (21%), Positives = 52/143 (36%), Gaps = 15/143 (10%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA----REIINH 52
           ++ +L K LG G FG      A  +    T   VAVK ++ G    E+ A     +I+ H
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 53  RSLRHPNIIRFKEVVLTPTH-LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
               H N++        P   L +++E+   G L   +    R   +E   +  +     
Sbjct: 82  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFR 136

Query: 112 NYCHSMQICHRDLKLENTLLDGS 134
                +     DLK     +  S
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSS 159

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	200
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.97
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.96
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.91
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.86
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.68
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.53
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.48
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.31
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.14
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	99.13
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	99.04
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.87
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.81
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.66
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.61
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.55
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.41
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.28
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	98.19
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	98.03
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	98.0
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.94
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.94
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.87
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.86
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.68
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.61
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.56
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.53
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.39
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.27
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.2
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.29
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.46
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	85.64
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.36

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.8e-61  Score=350.47  Aligned_cols=197  Identities=30%  Similarity=0.425  Sum_probs=180.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|++.+.    ....+.+.+|++++++++||||+++++++++++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999999999999999999753    233467999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---  154 (200)
                      ||++||+|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+||+++.++.  +||+|||+|+......   
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTCC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCcc
Confidence            99999999999999899999999999999999999999999999999999999987664  9999999997554332   


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+||+.|+|||++.+..|+.++|+|||||++|+|++|.+||.
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  235 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR  235 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            2345579999999999999999999999999999999999999994

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.8e-60  Score=339.85  Aligned_cols=197  Identities=40%  Similarity=0.624  Sum_probs=164.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      |++|++.+.||+|+||+||++.+..+++.||+|++.+..    ...+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            578999999999999999999999999999999997642    2345789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      |||+ +|+|.+++.+.+++++.++..++.|++.||+|||++||+||||||+||++++++.  +||+|||+|+........
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC---------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCcc
Confidence            9999 6799999999899999999999999999999999999999999999999987664  999999999866555555


Q ss_pred             CcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~  213 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD  213 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC
Confidence            66789999999999998876 578999999999999999999994

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.9e-60  Score=353.00  Aligned_cols=198  Identities=31%  Similarity=0.507  Sum_probs=171.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      |++|++++.||+|+||+||++.+..+++.||+|++.+..   ...+.+.+|+.++++++||||+++++++++++.+|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            579999999999999999999999999999999997643   23467899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++||+|.+++...+  .+++.+++.++.|++.||+|||++||+||||||+||+++.++.  +||+|||+|+.......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCcc
Confidence            9999999999997654  4789999999999999999999999999999999999987665  99999999975432221


Q ss_pred             -CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~  226 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE  226 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence             223469999999999999999999999999999999999999994

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2e-59  Score=347.04  Aligned_cols=196  Identities=27%  Similarity=0.431  Sum_probs=178.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +.|++.+.||+|+||+||+|.++.+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            369999999999999999999999999999999976433 3456889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~  159 (200)
                      +||+|.+++.+ .++++.++..++.|++.||+|||++||+||||||+||+++.++.  +||+|||+|+...... .....
T Consensus       154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence            99999998865 57999999999999999999999999999999999999987665  9999999997554333 34456


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +||+.|+|||++.+..|+.++|||||||++|||++|.+||+
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  271 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF  271 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            89999999999999999999999999999999999999994

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.4e-59  Score=344.19  Aligned_cols=193  Identities=26%  Similarity=0.357  Sum_probs=173.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      +.|++.+.||+|+||+||++.++.+++.||+|++......    .+|+.+++.++||||+++++++.+++.+++||||++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            4688889999999999999999999999999999864332    469999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC------
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR------  155 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~------  155 (200)
                      ||+|.+++.+.+++++.++..++.|++.||+|||++||+||||||+||+++.++. .+||+|||+|+.......      
T Consensus       134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC-----------
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceec
Confidence            9999999999889999999999999999999999999999999999999986653 599999999975443322      


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf  256 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW  256 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence            12346999999999999999999999999999999999999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.4e-59  Score=341.77  Aligned_cols=197  Identities=28%  Similarity=0.470  Sum_probs=171.2

Q ss_pred             ccccccccccCCcceEEEEEEEc---CCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|+||+||++.+.   .+++.||+|++.+..   .....+.+|+.++++++||||+++++++++++.+++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999974   467889999997642   233468899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-C
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-S  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~  154 (200)
                      ||||++||+|.+++.+.+.+++.++..++.|++.||+|||++||+||||||+||+++.++.  +||+|||+|+..... .
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----C
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCCc
Confidence            9999999999999999999999999999999999999999999999999999999987665  999999999754333 3


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+||+.|+|||++.+..|+.++|+|||||++|||++|.+||.
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~  227 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ  227 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCC
Confidence            3445689999999999999999999999999999999999999994

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.8e-58  Score=348.50  Aligned_cols=196  Identities=27%  Similarity=0.428  Sum_probs=178.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +.|++.+.||+|+||+||+|.++.+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++.+|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            469999999999999999999999999999999976433 3467899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~  159 (200)
                      +||+|.+++. ...+++.++..++.|++.||+|||++||+||||||+|||++.++.  +||+|||+|+...... .....
T Consensus       231 ~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          231 EGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             TTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred             CCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence            9999999885 457999999999999999999999999999999999999987665  9999999997554333 34456


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +||+.|+|||++.+..|+.++|||||||++|||++|.+||+
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  348 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF  348 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            89999999999999999999999999999999999999994

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-57  Score=330.45  Aligned_cols=193  Identities=24%  Similarity=0.341  Sum_probs=170.1

Q ss_pred             cccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEec----CceEEEEE
Q 029037            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLT----PTHLAIVM   77 (200)
Q Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v~   77 (200)
                      ++.+.||+|+||+||+|.+..++..||+|.+.....   ..+.+.+|+.++++++||||+++++++.+    +..+++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            677889999999999999999999999999976432   24578999999999999999999999875    35689999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++||+|.+++.+...+++..+..++.|++.||+|||++|  |+||||||+||++++.. +.+||+|||+|+... ...
T Consensus       109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~-g~vKl~DFGla~~~~-~~~  186 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT-GSVKIGDLGLATLKR-ASF  186 (290)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTT-SCEEECCTTGGGGCC-TTS
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCC-CCEEEEeCcCCEeCC-CCc
Confidence            99999999999999889999999999999999999999998  99999999999997422 259999999997432 233


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+||+.|+|||++.+ .|+.++|||||||++|||+||.+||.
T Consensus       187 ~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~  230 (290)
T 3fpq_A          187 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            345679999999999865 69999999999999999999999983

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7e-57  Score=329.23  Aligned_cols=197  Identities=25%  Similarity=0.371  Sum_probs=170.3

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|.+.+.||+|+||+||+|.+.     .++..||+|.++... ...+++.+|+.++++++||||+++++++.+++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            47889999999999999999875     357789999997643 334679999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEe
Q 029037           76 VMEYAAGGELFDRICNA-------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC  142 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~  142 (200)
                      ||||+++|+|.+++.+.             .++++.+++.++.|++.||+|||+++|+||||||+||+++++..  +||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~  170 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIG  170 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEEC
Confidence            99999999999999764             25899999999999999999999999999999999999987665  9999


Q ss_pred             ecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          143 DFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       143 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      |||+|+.......   .....+|+.|+|||.+.+..++.++||||+|+++|||+| |.+||.
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~  232 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY  232 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999974433222   223458999999999999999999999999999999999 899983

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-55  Score=323.27  Aligned_cols=191  Identities=28%  Similarity=0.379  Sum_probs=159.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCc--------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPT--------   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------   71 (200)
                      ++|++.+.||+|+||+||++.++.+++.||+|.+.....  ..+.+.+|+.++++++||||+++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            579999999999999999999999999999999975432  3467899999999999999999999987543        


Q ss_pred             ----eEEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           72 ----HLAIVMEYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        72 ----~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                          .++++|||++|++|.+++.+...   .+...++.++.|++.||+|||++||+||||||+||+++.++.  +||+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF  162 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF  162 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence                37999999999999999987654   445668899999999999999999999999999999987664  999999


Q ss_pred             CCCcccCCCCC-------------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC
Q 029037          145 GYSKSSVLHSR-------------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR  194 (200)
Q Consensus       145 ~~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~  194 (200)
                      |+|+.......             ....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~  225 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY  225 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence            99975433222             123469999999999999999999999999999999996

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-55  Score=325.70  Aligned_cols=196  Identities=25%  Similarity=0.344  Sum_probs=165.6

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|.+.+.||+|+||+||+|..+     .+++.||+|.++... ...+++.+|+.++++++||||+++++++.+++.+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46788899999999999999865     357889999997643 334679999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEE
Q 029037           76 VMEYAAGGELFDRICNA---------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLK  140 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~  140 (200)
                      ||||+++|+|.+++.+.               .++++.+++.++.|++.||+|||+++|+||||||+||+++++..  +|
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~K  198 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VK  198 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--EE
Confidence            99999999999999753               35899999999999999999999999999999999999987664  99


Q ss_pred             EeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          141 ICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       141 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      |+|||+|+.......   .....+|+.|+|||.+.+..++.++||||||+++|||+| |.+||
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf  261 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW  261 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCC
Confidence            999999975433322   223468999999999999999999999999999999999 89998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-55  Score=322.66  Aligned_cols=196  Identities=20%  Similarity=0.319  Sum_probs=170.1

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      +++++.+.||+|+||+||+|...     .+++.||+|.+....  ...+.+.+|+.++++++||||+++++++.++..++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            46788899999999999999853     356789999997542  33578999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCC
Q 029037           75 IVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPR  138 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~  138 (200)
                      +||||+++|+|.+++...                ..+++..++.++.|++.||+|||+++++||||||+||+++++..  
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--
Confidence            999999999999999653                34889999999999999999999999999999999999987665  


Q ss_pred             EEEeecCCCcccCCCC---CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          139 LKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       139 v~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +||+|||+|+......   ......+|+.|+|||.+.+..++.++||||+|+++|||+| |.+||
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf  248 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY  248 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCC
Confidence            9999999997543322   2234568999999999999999999999999999999998 78887

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.4e-55  Score=343.48  Aligned_cols=197  Identities=27%  Similarity=0.447  Sum_probs=174.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHH---HHHHhhCCCCCeeeEEEEEecCceE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVARE---IINHRSLRHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~   73 (200)
                      |++|++.+.||+|+||+||++.++.+++.||+|++.+..    .......+|   +.+++.++||||++++++|++.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            578999999999999999999999999999999997532    222333333   5666778999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      |+||||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++.++.  +||+|||+|+.... 
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~-  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC-
Confidence            999999999999999999999999999999999999999999999999999999999987765  99999999975433 


Q ss_pred             CCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ......+||+.|+|||++.+ ..|+.++|+|||||++|||++|.+||.
T Consensus       345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~  392 (689)
T 3v5w_A          345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR  392 (689)
T ss_dssp             CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            33456789999999999964 579999999999999999999999994

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-55  Score=320.36  Aligned_cols=192  Identities=24%  Similarity=0.334  Sum_probs=163.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +++++.+.||+|+||+||+|....   .||+|+++...   ...+.+.+|+.++++++||||+++++++.+ +.+++|||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            578899999999999999998753   48999987543   234678999999999999999999998865 56899999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---
Q 029037           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        79 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---  154 (200)
                      |++||+|.+++... .++++.++..++.|++.||+|||+++|+||||||+||++++++.  +||+|||+|+......   
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC--------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCcce
Confidence            99999999999765 46999999999999999999999999999999999999987664  9999999997543222   


Q ss_pred             CCCcccCCCCccCCeeecC---cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSR---REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......||+.|+|||++.+   ..++.++||||||+++|||+||.+||
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf  237 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY  237 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence            2234579999999999864   35889999999999999999999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-54  Score=325.29  Aligned_cols=196  Identities=27%  Similarity=0.431  Sum_probs=171.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEec------Cce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLT------PTH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~   72 (200)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.+....   .+.+.+|+.+++.++||||+++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            4799999999999999999999999999999999764322   3568899999999999999999998764      357


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      +|+||||++ |+|.+++.+.+++++..+..+++|++.||.|||++||+||||||+||+++.++.  +||+|||+|+....
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~  210 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC--
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeeccc
Confidence            899999996 589999988889999999999999999999999999999999999999987665  99999999975432


Q ss_pred             C-----CCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 H-----SRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .     ......+||+.|+|||++.+. .++.++||||+||++|||++|.+||.
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~  264 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP  264 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence            2     223446799999999998875 46899999999999999999999993

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.7e-54  Score=339.70  Aligned_cols=200  Identities=25%  Similarity=0.430  Sum_probs=182.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +++|++.+.||+|+||.||++.++.+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.++..++++|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            4789999999999999999999999999999999976543 346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      ++||+|.+++.+. ..+++.++..+++|++.||.|||++||+||||||+||+++.+..+.+||+|||+|+..........
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~  315 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  315 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence            9999999999643 579999999999999999999999999999999999999866555799999999986655555556


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.
T Consensus       316 ~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~  357 (573)
T 3uto_A          316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG  357 (573)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             eEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            689999999999999999999999999999999999999994

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.6e-53  Score=317.39  Aligned_cols=194  Identities=20%  Similarity=0.299  Sum_probs=167.7

Q ss_pred             ccccccccccCCcceEEEEEEEc---CCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|+||+||+|.++   .+++.||+|.+.+. ....++.+|+++++.+ +||||+++++++.+++.+++||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            57999999999999999999875   45788999988764 3456788999999988 6999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---  154 (200)
                      ||++|++|.+++.   ++++.++..+++|++.||+|||++||+||||||+||+++.+. +.+||+|||+|+......   
T Consensus       100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~~  175 (361)
T 4f9c_A          100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIEL  175 (361)
T ss_dssp             ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCGG
T ss_pred             eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccccc
Confidence            9999999999883   489999999999999999999999999999999999997653 259999999996332211   


Q ss_pred             --------------------------CCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 --------------------------RPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 --------------------------~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                                                .....+||+.|+|||++.+. .++.++|+||+||++|||++|.+||+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence                                      11234699999999999775 58999999999999999999999995

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-53  Score=313.33  Aligned_cols=193  Identities=28%  Similarity=0.333  Sum_probs=161.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCc----eEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT----HLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v~   77 (200)
                      ++|.+.+.||+|+||+||+|.+.  ++.||+|++..........+.|+..+.+++||||+++++++.+++    .+++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            47889999999999999999874  788999999765443344556677777899999999999998653    589999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM--------QICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      ||+++|+|.+++.+ .+++++.+..++.|++.||+|||++        +|+||||||+||++++++.  +||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence            99999999999965 4689999999999999999999987        9999999999999987765  99999999875


Q ss_pred             cCCCCC-----CCcccCCCCccCCeeecCc------ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          150 SVLHSR-----PKSTVGTPAYIAPEVLSRR------EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       150 ~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......     .....||+.|+|||.+.+.      .++.++||||+|+++|||+||.+||
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence            433322     2234699999999998654      5788999999999999999998765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.7e-53  Score=317.58  Aligned_cols=196  Identities=22%  Similarity=0.318  Sum_probs=169.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-----CcEEEEEEeccccc--chHHHHHHHHHHhhCCC-CCeeeEEEEEecC-ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRK--IDENVAREIINHRSLRH-PNIIRFKEVVLTP-TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~-~~   72 (200)
                      ++|++.+.||+|+||+||+|.+..+     ++.||+|.+.....  ..+.+.+|+.++++++| |||++++++|.++ ..
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            5789999999999999999998654     36799999976432  24578999999999965 8999999998664 57


Q ss_pred             EEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC
Q 029037           73 LAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA  136 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~  136 (200)
                      +++|||||++|+|.+++.+.                ..+++.++..++.|++.||+|||+++++||||||+||++++++.
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  223 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  223 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence            89999999999999999753                23789999999999999999999999999999999999987665


Q ss_pred             CCEEEeecCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          137 PRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       137 ~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                        +||+|||+|+........   ....+|+.|+|||.+.+..++.++||||+||++|||+| |.+||
T Consensus       224 --vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          224 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             --EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             --EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence              999999999754433221   23458899999999999999999999999999999998 89998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.7e-50  Score=299.49  Aligned_cols=198  Identities=32%  Similarity=0.519  Sum_probs=179.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|+||++.+..+++.||+|++.+.    ....+.+.+|..+++.++||||+++++++.+...+++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999999764    23356788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~~  155 (200)
                      ||+++|++|.+++.+...+++..+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||+++.... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCCc
Confidence            999999999999988888999999999999999999999999999999999999987664  99999999875332 233


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+|++.|+|||.+.+..++.++|+||||+++|||++|.+||.
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  206 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  206 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCC
Confidence            345678999999999999999999999999999999999999984

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3e-50  Score=299.09  Aligned_cols=197  Identities=38%  Similarity=0.639  Sum_probs=179.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            4789999999999999999999999999999999976432   2456889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      |++++++|.+++.+.+++++..+..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||++..........
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence            99999999999988889999999999999999999999999999999999999987665  9999999997665555555


Q ss_pred             cccCCCCccCCeeecCcccC-CeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYD-GKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~-~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..++++.|+|||.+.+..++ +++|+||+|+++|+|++|.+||
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  214 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF  214 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence            66799999999999888765 7899999999999999999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.1e-50  Score=302.76  Aligned_cols=197  Identities=26%  Similarity=0.455  Sum_probs=177.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|+||+||++.++.+++.||+|++.+...    ..+.+.+|..+++++ +||||+++++++.+...+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4689999999999999999999999999999999986432    234578888888776 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCccc-CCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~-~~~~  154 (200)
                      |||+++|++|.+++.+...+++..+..++.|++.||.+||++|++||||||+||+++.++.  ++|+|||+|+.. ....
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCCC
Confidence            9999999999999998889999999999999999999999999999999999999987665  999999999753 2333


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+||+.|+|||++.+..++.++|+||||+++|||++|.+||
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf  253 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF  253 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            445567999999999999999999999999999999999999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.3e-50  Score=300.81  Aligned_cols=197  Identities=32%  Similarity=0.491  Sum_probs=174.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|+||+||++.+..+++.||+|++.+.    ....+.+.+|..+++.+ +||||+++++++.+...+++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            47899999999999999999999999999999999864    23345688899999988 79999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-C
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-S  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~  154 (200)
                      ||||++|++|.+++.+...+++..+..++.|++.||++||++|++||||||+||+++.++.  ++|+|||+|+..... .
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC---
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCCc
Confidence            9999999999999998889999999999999999999999999999999999999987664  999999998753322 2


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+|++.|+|||++.+..++.++|+||||+++|||++|.+||
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf  224 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF  224 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCC
Confidence            334457999999999999989999999999999999999999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-49  Score=299.02  Aligned_cols=199  Identities=30%  Similarity=0.502  Sum_probs=181.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+...       ..+.+.+|+.+++.++||||+++++++.+...++
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            579999999999999999999999999999999976432       2467899999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC--CCEEEeecCCCcccCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA--PRLKICDFGYSKSSVL  152 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~--~~v~l~df~~~~~~~~  152 (200)
                      +|||+++|++|.+++.+...+++..+..++.|++.||.+||+.|++||||+|+||++++++.  ..++|+|||++.....
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            99999999999999988888999999999999999999999999999999999999976552  2599999999976655


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ........|++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~  219 (361)
T 2yab_A          172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  219 (361)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            555566779999999999999899999999999999999999999995

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-50  Score=296.69  Aligned_cols=200  Identities=23%  Similarity=0.348  Sum_probs=181.4

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      .++|++.+.||+|+||.||++.+..+++.+|+|.+.......+.+.+|+.+++.++||||+++++++.+....+++||++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            36899999999999999999999999999999999876555677899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      +|++|.+++.... ++++..+..++.|++.||.+||+.|++||||+|+||+++.+..+.++|+|||++............
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  163 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence            9999999997654 699999999999999999999999999999999999998644557999999999765544444455


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  204 (321)
T 1tki_A          164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL  204 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             cCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            68999999999999889999999999999999999999995

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-49  Score=299.20  Aligned_cols=199  Identities=77%  Similarity=1.206  Sum_probs=173.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++.......+.+.+|+.+++.++||||+++++++.+...+++|||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            68999999999999999999999999999999998877777889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccC
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~  161 (200)
                      +++|.+++.+.++++...+..++.|++.||++||++|++||||+|+||+++.++.+.++|+|||+++............+
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g  179 (361)
T 3uc3_A          100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  179 (361)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcC
Confidence            99999999888899999999999999999999999999999999999999877666799999999875555555566679


Q ss_pred             CCCccCCeeecCcccCCe-eehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGK-VCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~-~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.+ +|+||||+++|+|++|.+||.
T Consensus       180 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  219 (361)
T 3uc3_A          180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE  219 (361)
T ss_dssp             -CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence            999999999988877655 899999999999999999983

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=299.69  Aligned_cols=198  Identities=24%  Similarity=0.425  Sum_probs=180.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999997542    3346788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||++.|++|.+++.....++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++.........
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTCCB
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCCce
Confidence            999999999999988888999999999999999999999999999999999999987664  999999999866555555


Q ss_pred             CcccCCCCccCCeeecC---cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSR---REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....||+.|+|||++.+   ..++.++|+||||+++|+|++|.+||.
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~  218 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH  218 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence            66789999999999874   458899999999999999999999983

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.3e-49  Score=295.92  Aligned_cols=198  Identities=31%  Similarity=0.466  Sum_probs=178.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|+||+||++.++.+++.||+|++.+..    ...+.+..|..+++.+ +||||+++++++.+...+++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            478999999999999999999999999999999998642    3345678888888876 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-C
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-S  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~  154 (200)
                      |||+++|++|.+++.+...++...+..++.|++.||++||++|++||||+|+||+++.++.  ++|+|||+++..... .
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccCCC
Confidence            9999999999999988888999999999999999999999999999999999999987664  999999998754322 2


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+|++.|+|||.+.+..++.++|+||||+++|||++|.+||.
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  219 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH  219 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCC
Confidence            3345579999999999999999999999999999999999999984

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-49  Score=292.22  Aligned_cols=196  Identities=29%  Similarity=0.513  Sum_probs=178.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|+||++.+..+++.||+|++.+..    ...+.+.+|..+++.++||||+++++++.+...+++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            478999999999999999999999999999999997642    3346788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||+++|++|.+++.+...++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||+++....  ..
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~~  160 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VT  160 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CB
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--cc
Confidence            999999999999998888999999999999999999999999999999999999986664  99999999874332  23


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...++++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  204 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY  204 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence            44578999999999999999999999999999999999999984

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4e-49  Score=294.94  Aligned_cols=198  Identities=26%  Similarity=0.452  Sum_probs=177.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|++.+...    ..+.+.+|..+++++ +||||+++++++.+...+++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            4789999999999999999999999999999999986532    234578899999887 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC-CCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~-~~~  154 (200)
                      |||+++|++|.+++.+...+++..+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||+++... ...
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCCC
Confidence            9999999999999988888999999999999999999999999999999999999986664  9999999987533 223


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....++++.|+|||.+.+..++.++|+||||+++|||++|.+||.
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  211 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  211 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence            3345579999999999999999999999999999999999999983

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.9e-49  Score=296.27  Aligned_cols=199  Identities=33%  Similarity=0.522  Sum_probs=180.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            479999999999999999999999999999999976432   23568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      +++|++|.+.+.+...+++..+..++.|++.||.|||+.|++||||+|+||+++.++ ...++|+|||++..........
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~  188 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  188 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence            999999999998888899999999999999999999999999999999999997543 2469999999997665554455


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|.+|||
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~  231 (362)
T 2bdw_A          189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  231 (362)
T ss_dssp             CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            5679999999999999899999999999999999999999996

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.9e-49  Score=295.03  Aligned_cols=198  Identities=30%  Similarity=0.452  Sum_probs=178.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|+||+||++.+..+++.||+|++.+..    ...+.+.+|..++..+ +||+|+++++++.+...+++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            478999999999999999999999999999999998642    3346788899999887 79999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~  154 (200)
                      |||+++|++|.+++.+.+.+++..+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||+++.... ..
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccCCc
Confidence            9999999999999998888999999999999999999999999999999999999987664  99999999975332 23


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+|++.|+|||.+.+..++.++|+||||+++|||++|.+||.
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~  222 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE  222 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCC
Confidence            3445679999999999999999999999999999999999999984

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.1e-49  Score=292.33  Aligned_cols=196  Identities=41%  Similarity=0.676  Sum_probs=178.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|+||+||++.+..+++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999998753    22346789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||++ +++|.+++.+..++++.++..++.|++.||.+||+.|++||||+|+||++++++.  ++|+|||++.........
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTT
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCccc
Confidence            9999 6799999988889999999999999999999999999999999999999986664  999999999866666556


Q ss_pred             CcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++++.|+|||.+.+..+ ++++|+||||+++|+|++|.+||
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf  208 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF  208 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC
Confidence            66789999999999988776 68899999999999999999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.7e-49  Score=294.15  Aligned_cols=196  Identities=30%  Similarity=0.545  Sum_probs=178.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|++.+..    ...+.+.+|..+++.++||||+++++++.+...+++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999997642    3346788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||+++|++|.+++.+.+.++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||+++....  ..
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~--~~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CB
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--Cc
Confidence            999999999999998889999999999999999999999999999999999999986664  99999999875432  23


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...++++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  239 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCC
Confidence            44578999999999999999999999999999999999999984

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=289.85  Aligned_cols=199  Identities=32%  Similarity=0.534  Sum_probs=180.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....       ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            469999999999999999999999999999999976422       3467999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC--CCCEEEeecCCCcccCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKSSVL  152 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~--~~~v~l~df~~~~~~~~  152 (200)
                      +|||++++++|.+++.+...++...+..++.|++.||.+||+.|++||||+|+||++++++  ...++|+|||++.....
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            9999999999999998888899999999999999999999999999999999999997655  22599999999976655


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ........+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  218 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  218 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence            555556679999999999998899999999999999999999999984

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=300.60  Aligned_cols=199  Identities=30%  Similarity=0.490  Sum_probs=177.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.....   ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            579999999999999999999999999999999976432   23568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC-CCCCEEEeecCCCcccCCCCC-C
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHSR-P  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~-~~~~v~l~df~~~~~~~~~~~-~  156 (200)
                      +++|++|.+.+.+...+++..+..++.|++.||.|||++|++||||+|+||+++.+ ..+.++|+|||++........ .
T Consensus        91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~  170 (444)
T 3soa_A           91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW  170 (444)
T ss_dssp             CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence            99999999999998899999999999999999999999999999999999999753 234699999999965443322 2


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|.+|||
T Consensus       171 ~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~  214 (444)
T 3soa_A          171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW  214 (444)
T ss_dssp             CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            34578999999999999899999999999999999999999996

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.3e-48  Score=285.65  Aligned_cols=196  Identities=29%  Similarity=0.447  Sum_probs=176.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||++
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            58999999999999999999999999999999987543 33567889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-CCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~~~~  159 (200)
                      +|++|.+++.+. .++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||++........ ....
T Consensus       100 ~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A          100 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             TTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccCCc
Confidence            999999999654 6899999999999999999999999999999999999986664  99999999865443333 3345


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  217 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL  217 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            68999999999999999999999999999999999999983

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-48  Score=286.72  Aligned_cols=196  Identities=30%  Similarity=0.422  Sum_probs=172.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....    ..+.+.+|+..+++++||||+++++++.+++..+++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            589999999999999999999999999999999865332    2357889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      |+++|++|.+++.+.++++...+..++.|++.||++||++|++||||+|+||+++.++.  ++|+|||++........  
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC-------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccccccc
Confidence            99999999999998889999999999999999999999999999999999999986664  99999999875433322  


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  212 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF  212 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            22346899999999999999999999999999999999999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5e-49  Score=299.83  Aligned_cols=196  Identities=31%  Similarity=0.460  Sum_probs=174.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|++.+..    ...+.+.+|..+++.++||||+++++++.+...+++||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999997632    23345889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC--C
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--R  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~--~  155 (200)
                      ||++|++|.+++.+ ..+++..+..++.|++.||.+||++|++||||||+||+++.++.  ++|+|||+|+......  .
T Consensus       149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSEEE
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCccc
Confidence            99999999998865 46899999999999999999999999999999999999987664  9999999997544332  2


Q ss_pred             CCcccCCCCccCCeeecCcc----cCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRRE----YDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+||+.|+|||++.+..    ++.++|+||||+++|||++|.+||+
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  274 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY  274 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence            33567999999999998665    8899999999999999999999984

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.5e-49  Score=295.33  Aligned_cols=198  Identities=31%  Similarity=0.516  Sum_probs=170.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHH-HhhCCCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIIN-HRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|+||.||++.++.+++.||+|++.+...    ....+.+|... ++.++||||+++++++.+...+++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            3689999999999999999999999999999999986532    22345566665 467899999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC-CCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~-~~~  154 (200)
                      ||||++|++|.+++.+...+++..+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||+++... ...
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccCCC
Confidence            9999999999999998888999999999999999999999999999999999999987664  9999999987533 233


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+|++.|+|||++.+..++.++|+||||+++|||++|.+||+
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~  240 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY  240 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            4455679999999999999999999999999999999999999984

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.1e-49  Score=301.02  Aligned_cols=197  Identities=22%  Similarity=0.425  Sum_probs=175.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|++.+..    ...+.+.+|..++..++||||+++++++.+...+++||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997632    22334889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      ||++|++|.+++.+ ...+++..+..++.|++.||.+||+.|++||||||+||+++.++.  +||+|||+|+....... 
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCE
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCCCc
Confidence            99999999999987 467999999999999999999999999999999999999987664  99999999965443332 


Q ss_pred             -CCcccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       ....+||+.|+|||++.     ...++.++|+||||+++|||++|.+||+
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~  282 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY  282 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence             23357999999999987     5678999999999999999999999984

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.2e-48  Score=282.34  Aligned_cols=197  Identities=26%  Similarity=0.459  Sum_probs=172.0

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      |++|++.+.||+|++|+||++.+..+++.||+|.+.....   ..+.+.+|+.++++++||||+++++++.++...++||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            6899999999999999999999999999999999975432   2367889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CC
Q 029037           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~  155 (200)
                      |++++ ++.+.+.. ...+++..+..++.|++.||++||++|++||||+|+||+++.++.  ++|+|||++...... ..
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccc
Confidence            99976 55555544 567999999999999999999999999999999999999987664  999999999754322 22


Q ss_pred             CCcccCCCCccCCeeecCcc-cCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRRE-YDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..|||
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~  203 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence            34456899999999998765 7999999999999999999888864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=297.05  Aligned_cols=197  Identities=23%  Similarity=0.408  Sum_probs=175.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|+||+||++.++.+++.||+|++.+..    ...+.+.+|..++..++||||+++++++.+.+.+++||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997632    22345788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      ||++|++|.+++.+.+ .+++..+..++.|++.||.+||++|++||||||+||+++.++.  +||+|||+++....... 
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCE
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCcc
Confidence            9999999999998754 7999999999999999999999999999999999999987664  99999999975443332 


Q ss_pred             -CCcccCCCCccCCeeec-------CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLS-------RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~-------~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       ....+||+.|+|||++.       ...++.++|+||||+++|||++|.+||.
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  271 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY  271 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence             23457999999999997       3578999999999999999999999984

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-48  Score=294.94  Aligned_cols=199  Identities=26%  Similarity=0.399  Sum_probs=179.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.+|+|++..... ....+.+|+.+++.++||||+++++++.+....++|||++
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            579999999999999999999999999999999976533 3457889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      +|++|.+++.... .+++..+..++.|++.||++||+.|++||||+|+||+++.+..+.++|+|||++............
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~  210 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  210 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeee
Confidence            9999999987554 699999999999999999999999999999999999998655557999999999765544444455


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       211 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  251 (387)
T 1kob_A          211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA  251 (387)
T ss_dssp             CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             ccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence            78999999999999899999999999999999999999984

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=282.16  Aligned_cols=196  Identities=29%  Similarity=0.449  Sum_probs=174.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc-ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG-RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|+||++.+..+++.+|+|.+... ....+.+.+|+.+++.++||||+++++++.++...++|||++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            6899999999999999999999999999999988653 334567899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC---
Q 029037           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---  156 (200)
Q Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~---  156 (200)
                      ++++|.+++.. ...+++.++..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||++.........   
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC--------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccccccc
Confidence            99999999987 456999999999999999999999999999999999999986664  999999998643322221   


Q ss_pred             ------------CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 ------------KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ------------~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                                  ....+++.|+|||.+.+..++.++||||||+++|+|++|.+||
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~  222 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD  222 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSS
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCC
Confidence                        1346899999999999999999999999999999999999886

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.8e-48  Score=288.80  Aligned_cols=199  Identities=28%  Similarity=0.424  Sum_probs=175.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR------KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++....      ...+.+.+|+.+++.++||||+++++++.++..+++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            47999999999999999999999999999999986431      235779999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCccc
Q 029037           76 VMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSS  150 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~  150 (200)
                      |||+++|++|.+.+.+.    ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ ...++|+|||++...
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999998887543    2489999999999999999999999999999999999997543 245999999999754


Q ss_pred             CCCCC-CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          151 VLHSR-PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       151 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..... .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  234 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY  234 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence            43332 334578999999999999899999999999999999999999984

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-47  Score=285.30  Aligned_cols=197  Identities=28%  Similarity=0.429  Sum_probs=167.8

Q ss_pred             ccccccccccCCcceEEEEEEEc---CCCcEEEEEEecccc-----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|++|.||++.+.   .+++.+|+|++.+..     .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            68999999999999999999985   678999999997642     2335678899999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++|||+++|++|.+++.+...++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||+++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESIHD  174 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccccccC
Confidence            999999999999999988888999999999999999999999999999999999999986664  999999998643322


Q ss_pred             -CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 -SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       .......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  222 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT  222 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCC
Confidence             22344578999999999998889999999999999999999999983

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.5e-47  Score=277.54  Aligned_cols=199  Identities=33%  Similarity=0.523  Sum_probs=180.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|++......   .+.+.+|+.+++.++||||+++++++.+....+++||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            6899999999999999999999999999999999764322   3568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC-CCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~-~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ++++++|.+.+.....++...+..++.|++.||.+||+.|++||||+|+||+++.++. ..++|+|||.+..........
T Consensus        86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (284)
T 3kk8_A           86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  165 (284)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCC
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcccc
Confidence            9999999999988888999999999999999999999999999999999999975442 459999999997665555555


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|.+|||
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  208 (284)
T 3kk8_A          166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  208 (284)
T ss_dssp             CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence            6678999999999999999999999999999999999999985

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-47  Score=301.35  Aligned_cols=197  Identities=25%  Similarity=0.337  Sum_probs=178.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+.    ....+.+.+|..+++.++||||+++++++.+...+++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            5799999999999999999999999999999999753    233456889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      |+++|++|.+++...+.  +++..+..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||+++.......
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTCC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceecccCcc
Confidence            99999999999977554  999999999999999999999999999999999999986664  99999999976554444


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....|++.|+|||++.+..++.++|+||||+++|||++|.+||.
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~  386 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ  386 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSS
T ss_pred             ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence            455689999999999999999999999999999999999999984

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.2e-48  Score=289.07  Aligned_cols=198  Identities=34%  Similarity=0.485  Sum_probs=162.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+....+++||+++
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            46999999999999999999999999999999998643 35678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC-CCCCCEEEeecCCCcccCCCCCCCccc
Q 029037           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTV  160 (200)
Q Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~-~~~~~v~l~df~~~~~~~~~~~~~~~~  160 (200)
                      +++|.+++.+...++..++..++.|++.||.+||+.|++||||+|+||+++. +..+.++|+|||+++............
T Consensus       132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  211 (349)
T 2w4o_A          132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC  211 (349)
T ss_dssp             SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccccc
Confidence            9999999988888999999999999999999999999999999999999975 224469999999987654444445567


Q ss_pred             CCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          161 GTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +++.|+|||.+.+..++.++|+||||+++|+|++|..||+
T Consensus       212 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  251 (349)
T 2w4o_A          212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY  251 (349)
T ss_dssp             -CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            8999999999999899999999999999999999999984

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.8e-47  Score=299.19  Aligned_cols=197  Identities=28%  Similarity=0.359  Sum_probs=177.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+..    ...+.+.+|..+++.++||||+++++++.+...+++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67999999999999999999999999999999997642    33467889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           78 EYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        78 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      |+++|++|.+++.+.    ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||+++.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKAG  342 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeeccCC
Confidence            999999999999764    35999999999999999999999999999999999999987664  999999999755443


Q ss_pred             CCC-CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 SRP-KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ... ...+||+.|+|||++.+..++.++|+||||+++|||++|.+||.
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~  390 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR  390 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCC
Confidence            332 33479999999999999999999999999999999999999984

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.1e-48  Score=298.10  Aligned_cols=198  Identities=34%  Similarity=0.513  Sum_probs=169.5

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            368999999999999999999999999999999997532    2235677899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HS  154 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~  154 (200)
                      ||++++++|.+++.+...++...+..++.|++.||+|||+ .|++||||+|+||+++.++.  ++|+|||+++.... ..
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCc
Confidence            9999999999999888899999999999999999999998 99999999999999987664  99999999875332 23


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  350 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  350 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence            3345679999999999999999999999999999999999999984

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-47  Score=282.78  Aligned_cols=199  Identities=29%  Similarity=0.485  Sum_probs=180.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....       ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            479999999999999999999999999999999976422       3467999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC--CCEEEeecCCCcccCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA--PRLKICDFGYSKSSVL  152 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~--~~v~l~df~~~~~~~~  152 (200)
                      ++||++++++|.+++.+...++...+..++.|++.||.+||+.|++||||+|+||++++++.  ..++|+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            99999999999999988888999999999999999999999999999999999999976652  1599999999976655


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ........+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  219 (321)
T 2a2a_A          172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  219 (321)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCC
Confidence            555556678999999999998899999999999999999999999984

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.8e-48  Score=297.42  Aligned_cols=197  Identities=41%  Similarity=0.666  Sum_probs=178.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|.+.+.||+|+||.||++.+..+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999997542    2346789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||+++|++|.+++.+.+++++..+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++.........
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCB
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccc
Confidence            999999999999988888999999999999999999999999999999999999986664  999999999765554445


Q ss_pred             CcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++++.|+|||.+.+..+ +.++|+||||+++|+|++|.+||
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf  216 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF  216 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC
Confidence            56679999999999988765 67899999999999999999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=283.37  Aligned_cols=198  Identities=22%  Similarity=0.310  Sum_probs=174.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc--eEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPT--HLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~   77 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+..  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57999999999999999999999999999999997643  33467889999999999999999999998765  789999


Q ss_pred             EecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec--CCCCCCEEEeecCCCcccCC
Q 029037           78 EYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD--GSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~--~~~~~~v~l~df~~~~~~~~  152 (200)
                      |++++++|.+++.....   ++..++..++.|++.||++||+.|++||||+|+||++.  ++....++|+|||+++....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~  168 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence            99999999999976543   89999999999999999999999999999999999881  22333599999999976655


Q ss_pred             CCCCCcccCCCCccCCeeec--------CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLS--------RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........+++.|+|||.+.        +..++.++|+||||+++|+|++|.+||
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  223 (319)
T 4euu_A          169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF  223 (319)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSE
T ss_pred             CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            55555667899999999986        567889999999999999999999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.5e-48  Score=287.64  Aligned_cols=197  Identities=36%  Similarity=0.534  Sum_probs=173.5

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +++|++.+.||+|++|+||++.+..+++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+++..+++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            5799999999999999999999999999999999875432  23568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC---CC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SR  155 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~---~~  155 (200)
                      ++++++|.+++.....++...+..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||++......   ..
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcccc
Confidence            9999999999987778999999999999999999999999999999999999986664  999999998643222   12


Q ss_pred             CCcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|.+||
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  208 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW  208 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence            234578999999999987765 77899999999999999999998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.6e-47  Score=304.75  Aligned_cols=198  Identities=30%  Similarity=0.455  Sum_probs=178.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.+.    ....+.+..|..++..+ +||+|+++++++++...+++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999763    23346788899999887 79999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~  154 (200)
                      ||||++|++|.+++.+...+++..++.++.|++.||+|||+.||+||||||+||+++.++.  ++|+|||+++.... ..
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTTC
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCCc
Confidence            9999999999999998889999999999999999999999999999999999999987664  99999999974332 23


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+||+.|+|||++.+..++.++|+||||+++|||++|.+||.
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~  543 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE  543 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCC
Confidence            3445679999999999999999999999999999999999999983

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9.2e-47  Score=278.37  Aligned_cols=195  Identities=27%  Similarity=0.434  Sum_probs=171.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc------cchHHHHHHHHHHhhC---CCCCeeeEEEEEecCc-
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR------KIDENVAREIINHRSL---RHPNIIRFKEVVLTPT-   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~-   71 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++....      .......+|+.+++.+   +||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            68999999999999999999999999999999987432      2235677788777766   4999999999998754 


Q ss_pred             ----eEEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecC
Q 029037           72 ----HLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (200)
Q Consensus        72 ----~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~  145 (200)
                          ..+++||+++ ++|.+++.....  +++..+..++.|++.||++||++|++||||+|+||+++.++.  ++|+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg  165 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFG  165 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSCS
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeCc
Confidence                5899999996 599999987654  899999999999999999999999999999999999986664  9999999


Q ss_pred             CCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          146 YSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++.............+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf  219 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF  219 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSC
T ss_pred             cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCC
Confidence            997665555555667899999999999999999999999999999999999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.2e-47  Score=274.47  Aligned_cols=197  Identities=31%  Similarity=0.481  Sum_probs=177.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+.+++.++||||+++++++.+....+++||++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            57999999999999999999999999999999987653 33578999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC-CCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~-~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      ++++|.+++.....++...+..++.|++.||.+||++|++|+||+|+||++.. +....++|+|||.+............
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~  168 (277)
T 3f3z_A           89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK  168 (277)
T ss_dssp             CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhcc
Confidence            99999999988888999999999999999999999999999999999999932 22335999999999766555555666


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .+++.|+|||.+.+. ++.++|+||||+++|+|++|.+||
T Consensus       169 ~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~  207 (277)
T 3f3z_A          169 VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPF  207 (277)
T ss_dssp             CSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCC
Confidence            799999999998654 899999999999999999999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=288.27  Aligned_cols=197  Identities=15%  Similarity=0.126  Sum_probs=168.4

Q ss_pred             ccccccccccCCcceEEEEE-----EEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC---CCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLL-----RHKETKELVAVKYIERGRKIDENVAREIINHRSLR---HPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~-----~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~   73 (200)
                      ++|.+.+.||+|+||+||++     .+..+++.||+|++...  ....+.+|..+++.++   |++++++++++...+..
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            46999999999999999999     46778899999998764  3567778888888886   89999999999999999


Q ss_pred             EEEEEecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC---------CCCCCE
Q 029037           74 AIVMEYAAGGELFDRICN-----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG---------SAAPRL  139 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~---------~~~~~v  139 (200)
                      ++||||+++++|.+++..     ...+++..++.++.|++.||+|||++|++||||||+||+++.         +..+.+
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~  222 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL  222 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence            999999999999999974     456999999999999999999999999999999999999976         113459


Q ss_pred             EEeecCCCcccC---CCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          140 KICDFGYSKSSV---LHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       140 ~l~df~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +|+|||+|+...   .........+|+.|+|||.+.+..++.++|+||||+++|||++|.+||+
T Consensus       223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence            999999996432   2223344568999999999999999999999999999999999999984

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-46  Score=294.54  Aligned_cols=198  Identities=34%  Similarity=0.531  Sum_probs=176.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--------------cchHHHHHHHHHHhhCCCCCeeeEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--------------KIDENVAREIINHRSLRHPNIIRFKEVV   67 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   67 (200)
                      ++|++.+.||+|++|+||++.+..+++.+|+|++....              ...+.+.+|+.++++++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            57999999999999999999999999999999997643              2346789999999999999999999999


Q ss_pred             ecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC-CCEEEeecCC
Q 029037           68 LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-PRLKICDFGY  146 (200)
Q Consensus        68 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~-~~v~l~df~~  146 (200)
                      .+...+++|||+++|++|.+.+.+...+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ..++|+|||+
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  195 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL  195 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence            999999999999999999999988889999999999999999999999999999999999999986543 3599999999


Q ss_pred             CcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          147 SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +.............+++.|+|||.+. ..++.++|+||+|+++|+|++|.+||.
T Consensus       196 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~  248 (504)
T 3q5i_A          196 SSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFG  248 (504)
T ss_dssp             CEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence            97665555556677999999999986 468999999999999999999999984

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=285.52  Aligned_cols=197  Identities=29%  Similarity=0.393  Sum_probs=177.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---------chHHHHHHHHHHhhCCCCCeeeEEEEEecCce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSLRHPNIIRFKEVVLTPTH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   72 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.....         ..+.+.+|+.+++.++||||+++++++.+...
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            579999999999999999999999999999999986532         22357789999999999999999999999999


Q ss_pred             EEEEEEecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           73 LAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        73 ~~~v~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      .+++||++.++ +|.+++.+...++...+..++.|++.||.+||+.|++||||+|+||+++.++  .++|+|||++....
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC--cEEEeecccceECC
Confidence            99999998766 9999998888899999999999999999999999999999999999998765  49999999997655


Q ss_pred             CCCCCCcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .........+++.|+|||.+.+..+ +.++|+||||+++|+|++|.+||+
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  231 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC  231 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence            5555555678999999999988776 788999999999999999999984

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.6e-47  Score=295.12  Aligned_cols=198  Identities=36%  Similarity=0.553  Sum_probs=176.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++.+.   ....+.+.+|+.++++++||||+++++++.+...+++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            5799999999999999999999999999999998653   2345778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC-CCCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~-~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ++++++|.+.+.+...+++..+..++.|++.||.|||++|++||||+|+||+++.. ....++|+|||++..........
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  181 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccC
Confidence            99999999999888899999999999999999999999999999999999999643 23469999999997665555556


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+.+ .++.++|+||||+++|+|++|.+||+
T Consensus       182 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  223 (486)
T 3mwu_A          182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY  223 (486)
T ss_dssp             CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            6679999999999876 58899999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.6e-47  Score=284.78  Aligned_cols=196  Identities=32%  Similarity=0.470  Sum_probs=172.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|+||.||++.++.+++.||+|++.+....   ..+|+.++.++ +||||+++++++.+....++|||++
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            4799999999999999999999999999999999765432   34577777776 7999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC--CCEEEeecCCCcccCCCC-CCC
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA--PRLKICDFGYSKSSVLHS-RPK  157 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~--~~v~l~df~~~~~~~~~~-~~~  157 (200)
                      +|++|.+.+.+...+++..+..++.|++.||.+||+.|++||||+|+||++.++..  ..++|+|||++....... ...
T Consensus        99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  178 (342)
T 2qr7_A           99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM  178 (342)
T ss_dssp             CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCcee
Confidence            99999999988888999999999999999999999999999999999999854322  359999999997543332 234


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  221 (342)
T 2qr7_A          179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA  221 (342)
T ss_dssp             CSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence            4578999999999988889999999999999999999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.3e-47  Score=281.13  Aligned_cols=196  Identities=34%  Similarity=0.546  Sum_probs=157.6

Q ss_pred             cccccc---ccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELV---KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~---~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|.+.   +.||+|+||+||++.+..+++.||+|++...  ......+|+..++.+. ||||+++++++.++...++||
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            456665   7899999999999999999999999998753  4567889999999997 999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccCCCC-C
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHS-R  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~~~~-~  155 (200)
                      |++++++|.+++.+...+++.++..++.|++.||++||++|++||||+|+||+++.++ ...++|+|||++....... .
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999999999999988899999999999999999999999999999999999997544 2359999999997443332 2


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  209 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF  209 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence            34456799999999999999999999999999999999999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-47  Score=283.88  Aligned_cols=196  Identities=26%  Similarity=0.366  Sum_probs=167.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHHHHHhhCCCCCeeeEEEEEecCc----eE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPT----HL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   73 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++......    .+.+.+|+..++.++||||+++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            6899999999999999999999999999999999764322    346889999999999999999999987654    35


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++|||+++|++|.+++...++++..++..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||++......
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCccccccc
Confidence            999999999999999988889999999999999999999999999999999999999986664  999999998644332


Q ss_pred             CC----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SR----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..    .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  219 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF  219 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            22    22345899999999999999999999999999999999999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-46  Score=293.58  Aligned_cols=198  Identities=35%  Similarity=0.523  Sum_probs=175.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|+||++.+..++..+|+|++.+..   ...+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46999999999999999999999999999999997642   335778999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ++++++|.+.+.+..++++..+..++.|++.||.|||++|++||||+|+||+++..+ ...++|+|||++..........
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~  196 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK  196 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence            999999999998888899999999999999999999999999999999999997533 3459999999997665555556


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+. ..++.++|+||+|+++|+|++|.+||.
T Consensus       197 ~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~  238 (494)
T 3lij_A          197 ERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFG  238 (494)
T ss_dssp             CCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCC
Confidence            667999999999986 468999999999999999999999984

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.6e-47  Score=274.91  Aligned_cols=196  Identities=32%  Similarity=0.563  Sum_probs=174.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|.||++.+..+++.+|+|++....    ...+.+.+|+.+++.++||||+++++++.+....+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            478999999999999999999999999999999986532    2346788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||++++++|.+++.+..+++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||++.... ....
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~-~~~~  164 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRR  164 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC------
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCC-cccc
Confidence            999999999999988888999999999999999999999999999999999999986664  9999999885332 2233


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  207 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF  207 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC
Confidence            4457899999999999988999999999999999999999997

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-46  Score=280.41  Aligned_cols=197  Identities=27%  Similarity=0.347  Sum_probs=168.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc-------
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPT-------   71 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------   71 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            368999999999999999999999999999999997543  33567999999999999999999999986543       


Q ss_pred             --------------------------------------------------eEEEEEEecCCCchHHHHHhcCC---CCHH
Q 029037           72 --------------------------------------------------HLAIVMEYAAGGELFDRICNAGR---FSED   98 (200)
Q Consensus        72 --------------------------------------------------~~~~v~e~~~~~~L~~~l~~~~~---~~~~   98 (200)
                                                                        ..+++||++++++|.+++.....   .+..
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              38999999999999999987653   4556


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-------------CCCcccCCCCc
Q 029037           99 EGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-------------RPKSTVGTPAY  165 (200)
Q Consensus        99 ~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-------------~~~~~~~~~~~  165 (200)
                      .++.++.|++.||++||++|++||||+|+||+++.++  .++|+|||++.......             ......+++.|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            7899999999999999999999999999999998666  49999999987544332             22334689999


Q ss_pred             cCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          166 IAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       166 ~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +|||.+.+..++.++|+||||+++|+|++|.+|+
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            9999999999999999999999999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.2e-46  Score=277.41  Aligned_cols=196  Identities=28%  Similarity=0.413  Sum_probs=158.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      .++|++.+.||+|++|.||++.+..+++.||+|.+....  ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            368999999999999999999999999999999997543  334778899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           79 YAAGGELFDRICNA------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        79 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      +++ ++|.+++...      ..++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++.....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGI  160 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETTS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecCC
Confidence            997 5999988654      34899999999999999999999999999999999999987664  99999999875433


Q ss_pred             C-CCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 H-SRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      . .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  209 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF  209 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            2 22334568999999999976 46899999999999999999999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.8e-47  Score=278.50  Aligned_cols=197  Identities=28%  Similarity=0.419  Sum_probs=169.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +++|++.+.||+|++|+||++.+..+++.||+|.+......   .+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            58999999999999999999999999999999998765332   356789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~  156 (200)
                      |++++++|.+++.....++...+..++.|++.||++||+.|++||||+|+||+++.++  .++|+|||.+....... ..
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECC------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC--CEEEeeCCCchhccCccccc
Confidence            9999999999888788899999999999999999999999999999999999998666  49999999986544222 22


Q ss_pred             CcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  203 (311)
T 4agu_A          160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW  203 (311)
T ss_dssp             ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence            34568899999999976 56799999999999999999999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.7e-46  Score=273.76  Aligned_cols=198  Identities=32%  Similarity=0.554  Sum_probs=175.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-------KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....       ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57999999999999999999999999999999987542       13567999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC--CCCEEEeecCCCcccCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKSSVL  152 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~--~~~v~l~df~~~~~~~~  152 (200)
                      ++||++++++|.+++.+...++...+..++.|++.||.+||+.|++|+||+|+||++++++  ...++|+|||.+.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888899999999999999999999999999999999999997654  23599999999876554


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  211 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  211 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC
Confidence            44445557899999999999889999999999999999999999998

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.8e-47  Score=284.71  Aligned_cols=194  Identities=30%  Similarity=0.405  Sum_probs=168.9

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      .+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||++++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            578999999999999999999999999998654 3356789999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCC
Q 029037           86 FDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA  164 (200)
Q Consensus        86 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~  164 (200)
                      .+++.+. ..+++..+..++.|++.||.+||+.|++||||+|+||++.++....++|+|||++.............+++.
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~  253 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE  253 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCT
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCc
Confidence            9988654 369999999999999999999999999999999999999544445699999999976655555555679999


Q ss_pred             ccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          165 YIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       165 ~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      |+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       254 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  289 (373)
T 2x4f_A          254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL  289 (373)
T ss_dssp             TCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence            999999998889999999999999999999999983

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.8e-47  Score=280.69  Aligned_cols=197  Identities=23%  Similarity=0.341  Sum_probs=169.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc---EEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|+||.||++.+..+++   .||+|.+....  ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            579999999999999999999986554   49999998642  3346789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++... ..++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++........
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC----
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccccCcc
Confidence            9999999999999655 47999999999999999999999999999999999999986654  99999999875433322


Q ss_pred             C----CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          156 P----KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       156 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      .    ....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||+
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~  256 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW  256 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence            2    12234668999999998899999999999999999999 999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-46  Score=286.84  Aligned_cols=195  Identities=33%  Similarity=0.513  Sum_probs=163.0

Q ss_pred             cccccc-ccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHH-hhCCCCCeeeEEEEEec----CceEEE
Q 029037            2 EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-RSLRHPNIIRFKEVVLT----PTHLAI   75 (200)
Q Consensus         2 ~~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~~~~   75 (200)
                      ++|.+. +.||+|++|+||++.+..+++.||+|++..    .....+|+.++ +..+||||+++++++..    ...+++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            567776 789999999999999999999999999864    34566788776 45689999999998875    567899


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccCC
Q 029037           76 VMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVL  152 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~~  152 (200)
                      |||+++|++|.+++.+..  .+++..+..++.|++.||.|||+.|++||||+|+||+++.+. .+.+||+|||+++....
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999999997654  499999999999999999999999999999999999998632 34699999999976554


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .......++++.|+|||++.+..++.++||||||+++|+|++|.+||+
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  264 (400)
T 1nxk_A          217 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence            444455678999999999999999999999999999999999999984

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.7e-46  Score=282.40  Aligned_cols=196  Identities=23%  Similarity=0.396  Sum_probs=175.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-----CCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-----HPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++.......+....|..+++.+.     ||||+++++++......++|
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv  114 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI  114 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence            6899999999999999999999999999999999876666677888999999886     99999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC--------------------
Q 029037           77 MEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS--------------------  134 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~--------------------  134 (200)
                      ||++ +++|.+++....  .++...+..++.|++.||++||++|++||||||+||+++..                    
T Consensus       115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  193 (360)
T 3llt_A          115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI  193 (360)
T ss_dssp             ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred             EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence            9999 889999997765  48999999999999999999999999999999999999751                    


Q ss_pred             ---CCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          135 ---AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       135 ---~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                         ....++|+|||++....  .......+++.|+|||.+.+..++.++||||||+++|+|++|.+||.
T Consensus       194 ~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          194 YRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             EEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence               23469999999986432  23345578999999999999999999999999999999999999983

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.9e-47  Score=276.31  Aligned_cols=196  Identities=29%  Similarity=0.451  Sum_probs=168.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      |++|++.+.||+|++|+||++.+ .+++.+|+|.+....   ...+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            68999999999999999999998 568889999987543   23467889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CC
Q 029037           78 EYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~  155 (200)
                      |++++ +|.+++... ..++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||++...... ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC----
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCccccc
Confidence            99975 999988764 56999999999999999999999999999999999999986664  999999998644322 22


Q ss_pred             CCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  202 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP  202 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            2344689999999999764 58999999999999999999999983

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-46  Score=278.05  Aligned_cols=195  Identities=29%  Similarity=0.478  Sum_probs=167.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +++|++.+.||+|++|+||++.+.. ++.||+|.+.....   ..+.+.+|+.+++.++||||+++++++.++...++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            4789999999999999999999964 78899999875432   2367889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CC
Q 029037           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~  155 (200)
                      |++++ +|.+.+.... .++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++...... ..
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC-
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCccc
Confidence            99975 8888886654 4999999999999999999999999999999999999987664  999999999754322 22


Q ss_pred             CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  220 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF  220 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC
Confidence            334468999999999876 56899999999999999999999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9e-47  Score=280.91  Aligned_cols=196  Identities=25%  Similarity=0.219  Sum_probs=173.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.... ..+.+.+|+.+++.+ +||||+++++++.+....+++||++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            57999999999999999999999999999999987643 345688999999999 8999999999999999999999999


Q ss_pred             CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC---CCEEEeecCCCcccCCCCC-
Q 029037           81 AGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA---PRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~---~~v~l~df~~~~~~~~~~~-  155 (200)
                       +++|.+++... ..++...+..++.|++.||++||+.|++||||+|+||+++.++.   ..++|+|||+++....... 
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~  166 (330)
T 2izr_A           88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK  166 (330)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence             89999999764 57999999999999999999999999999999999999975542   2399999999975433222 


Q ss_pred             -------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 -------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                             .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf  217 (330)
T 2izr_A          167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW  217 (330)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence                   23457899999999999999999999999999999999999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.6e-46  Score=283.34  Aligned_cols=196  Identities=24%  Similarity=0.360  Sum_probs=173.5

Q ss_pred             ccccccccccCC--cceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g--~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|  ++|+||++.+..+++.||+|++......   .+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            689999999999  9999999999999999999999765322   35678899999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-
Q 029037           77 MEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-  153 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-  153 (200)
                      ||++++++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.++  .++|+|||.+...... 
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~--~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCGGGCEECEETT
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccccceeecccc
Confidence            9999999999999876  5699999999999999999999999999999999999998666  4999999987432211 


Q ss_pred             -------CCCCcccCCCCccCCeeecC--cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 -------SRPKSTVGTPAYIAPEVLSR--REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 -------~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                             .......+++.|+|||.+.+  ..++.++|+||||+++|+|++|.+||
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  237 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  237 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence                   12223467888999999987  57899999999999999999999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-46  Score=274.04  Aligned_cols=197  Identities=30%  Similarity=0.441  Sum_probs=169.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|.+.+.||+|++|.||++.+..+++.+++|.+....  ...+.+.+|+.+++.++||||+++++++.+....++|||+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            57999999999999999999999999999999997653  2347899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC-CCCCEEEeecCCCcccCCCC
Q 029037           80 AAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        80 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~-~~~~v~l~df~~~~~~~~~~  154 (200)
                      +++++|.+.+...    ..++...+..++.|++.||.+||+.|++||||+|+||+++++ ..+.++|+|||++.......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~  181 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE  181 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence            9999999988543    579999999999999999999999999999999999999643 23469999999997655555


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......+++.|+|||.+. ..++.++|+||||+++|+|++|.+||
T Consensus       182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf  225 (285)
T 3is5_A          182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPF  225 (285)
T ss_dssp             -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCC
Confidence            555667899999999985 56888999999999999999999998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-46  Score=275.69  Aligned_cols=198  Identities=22%  Similarity=0.287  Sum_probs=167.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|.||++.+..+++.|++|++......    .+.+.+|+..++.++||||+++++++.+++..+++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            57899999999999999999999999999999999764322    36788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      ||++++++|.+++.+..+++...+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||++........ 
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSCCC----------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--CEEEecCccCccccccccc
Confidence            99999999999998888899999999999999999999999999999999999998666  499999999864433221 


Q ss_pred             -CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ  236 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence             223468899999999999899999999999999999999999983

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.6e-46  Score=272.99  Aligned_cols=196  Identities=30%  Similarity=0.559  Sum_probs=177.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|.||++.+..+++.|++|.+....    ...+.+.+|+.+++.++||||+++++++.+....+++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999987532    2346789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||++++++|.+++.+...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||++..... ...
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~  169 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LRR  169 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SCB
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-ccc
Confidence            999999999999988888999999999999999999999999999999999999986664  99999999864332 233


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  212 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF  212 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCC
Confidence            4456899999999999989999999999999999999999998

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-47  Score=277.02  Aligned_cols=197  Identities=30%  Similarity=0.488  Sum_probs=167.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---------------------------chHHHHHHHHHHh
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------------------------IDENVAREIINHR   53 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---------------------------~~~~~~~e~~~l~   53 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|++.....                           ..+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4789999999999999999999999999999999975431                           1246889999999


Q ss_pred             hCCCCCeeeEEEEEec--CceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeee
Q 029037           54 SLRHPNIIRFKEVVLT--PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL  131 (200)
Q Consensus        54 ~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i  131 (200)
                      .++||||+++++++.+  ....+++||++++++|.+++ ...++++..+..++.|++.||.+||+.|++||||+|+||++
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999999987  56899999999999998754 44579999999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEeecCCCcccCCCCC-CCcccCCCCccCCeeecCcc---cCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          132 DGSAAPRLKICDFGYSKSSVLHSR-PKSTVGTPAYIAPEVLSRRE---YDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       132 ~~~~~~~v~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +.++.  ++|+|||++........ .....+++.|+|||.+.+..   ++.++|+||||+++|+|++|.+||.
T Consensus       171 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          171 GEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            86664  99999999875433222 23456899999999997654   4678899999999999999999983

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=272.35  Aligned_cols=197  Identities=29%  Similarity=0.440  Sum_probs=155.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|.||++.+..+++.|++|.+....    ...+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            478999999999999999999999999999999997542    2236789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-
Q 029037           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-  154 (200)
                      ||++++++|.+++.+. .+++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+....... 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCC
Confidence            9999999999999765 56899999999999999999999999999999999999986664  9999999986543222 


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  212 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF  212 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSS
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            223456889999999999888999999999999999999999997

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.7e-46  Score=281.00  Aligned_cols=197  Identities=31%  Similarity=0.492  Sum_probs=175.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---------chHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---------~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.....         ..+.+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            468999999999999999999998999999999875431         134678899999998 7999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      ..++|||+++|++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence            99999999999999999988888999999999999999999999999999999999999987664  9999999987665


Q ss_pred             CCCCCCcccCCCCccCCeeecC------cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSR------REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .........+++.|+|||.+.+      ..++.++|+||||+++|+|++|.+||+
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~  306 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW  306 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence            5555556678999999999863      357889999999999999999999985

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.1e-46  Score=276.60  Aligned_cols=194  Identities=31%  Similarity=0.478  Sum_probs=163.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|+||++.+.  ++.||+|++......   .+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            58999999999999999999874  677999998765432   3568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           79 YAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++++++|.+++.+...   ++...++.++.|++.||++||+.|  ++||||+|+||+++.++.  ++|+|||+++.....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKAST  192 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC--------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCcccccc
Confidence            9999999999976553   899999999999999999999999  999999999999986664  999999998643332


Q ss_pred             CC-CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SR-PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .. .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf  239 (309)
T 3p86_A          193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW  239 (309)
T ss_dssp             ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTT
T ss_pred             ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            22 33456899999999999999999999999999999999999998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.9e-46  Score=272.00  Aligned_cols=196  Identities=30%  Similarity=0.455  Sum_probs=176.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|++....    ...+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            58999999999999999999999999999999987643    23456889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~  156 (200)
                      |++++++|.+++.....++..++..++.|++.||++||+.|++|+||+|+||+++.++.  ++|+|||.+....... ..
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTCCB
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCcccc
Confidence            99999999999988888999999999999999999999999999999999999986664  9999999987544322 23


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  215 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF  215 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            3456899999999999888999999999999999999999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5e-46  Score=280.67  Aligned_cols=196  Identities=23%  Similarity=0.326  Sum_probs=169.8

Q ss_pred             ccccccccccCCcceEEEEEEEc-------CCCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-------ETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      ++|++.+.||+|+||.||++.+.       .++..||+|.+.....  ..+.+.+|+.+++.+ +||||+++++++.+..
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            57999999999999999999975       3456799999976432  235789999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           72 HLAIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      .+++|||++++++|.+++....                .++...+..++.|++.||+|||++|++||||+|+||+++.++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence            9999999999999999997653                378899999999999999999999999999999999998666


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .  +||+|||+++.......   .....+++.|+|||.+.+..++.++|+||||+++|||++ |.+||
T Consensus       241 ~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          241 V--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             C--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             C--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            4  99999999874433222   223346778999999999999999999999999999999 88887

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.9e-47  Score=294.54  Aligned_cols=198  Identities=35%  Similarity=0.512  Sum_probs=177.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++...    ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            4799999999999999999999999999999998654    234577999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC-CCCCEEEeecCCCcccCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~-~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      |++.+++|.+.+.+..++++..+..++.|++.||.|||++|++||||+|+||+++.. ..+.++|+|||++.........
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  185 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM  185 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence            999999999999888899999999999999999999999999999999999999532 2346999999998755544444


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+++.|+|||.+.+ .++.++|+||||+++|+|++|.+||.
T Consensus       186 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  228 (484)
T 3nyv_A          186 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN  228 (484)
T ss_dssp             HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence            45578999999999876 68999999999999999999999984

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-46  Score=271.17  Aligned_cols=195  Identities=23%  Similarity=0.381  Sum_probs=172.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+.. ++.||+|.+.......+.+.+|+.++++++||||+++++++.++...+++||+++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            589999999999999999999875 5669999999877777889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC--CCCc
Q 029037           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKS  158 (200)
Q Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~--~~~~  158 (200)
                      +++|.+++.+.. .++...+..++.|++.||.+||+.|++||||+|+||++++++  .++|+|||++.......  ....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC--CEEeccccccccccccccccccC
Confidence            999999996644 589999999999999999999999999999999999997665  49999999986433221  2233


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~  208 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY  208 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCC
Confidence            446778999999988889999999999999999999 88887

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.5e-46  Score=269.65  Aligned_cols=195  Identities=27%  Similarity=0.415  Sum_probs=172.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+.. +..||+|.+.......+.+.+|+..+++++||||+++++++.++...+++||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            689999999999999999998764 5669999998877777889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--CCc
Q 029037           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PKS  158 (200)
Q Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--~~~  158 (200)
                      +++|.+++.... .++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||.+........  ...
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEECCS
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhcccC
Confidence            999999997754 4999999999999999999999999999999999999986664  99999999864332221  223


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  206 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY  206 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCc
Confidence            345677999999998899999999999999999999 88887

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.2e-46  Score=276.90  Aligned_cols=196  Identities=30%  Similarity=0.455  Sum_probs=177.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|++....    ...+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            57999999999999999999999999999999987643    23467889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~  156 (200)
                      |++++++|.+++.....++..++..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||++....... ..
T Consensus       121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTCCB
T ss_pred             ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcccc
Confidence            99999999999988888999999999999999999999999999999999999986664  9999999987544322 23


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  241 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF  241 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCC
Confidence            3456899999999999988999999999999999999999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.6e-47  Score=292.10  Aligned_cols=193  Identities=26%  Similarity=0.351  Sum_probs=165.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC------ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   72 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|++....   ...+.+.+|+.+++.++||||+++++++...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            68999999999999999999999999999999997642   2346788999999999999999999999654      45


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .++|||++++ +|.+.+..  .++...+..++.|++.||+|||+.|++||||||+||+++.++.  +||+|||+++....
T Consensus       142 ~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC-----
T ss_pred             EEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecCC
Confidence            7999999976 56666633  4899999999999999999999999999999999999987664  99999999986655


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++|.+||
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF  263 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF  263 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCC
Confidence            55555678999999999999999999999999999999999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.3e-46  Score=274.72  Aligned_cols=198  Identities=28%  Similarity=0.400  Sum_probs=170.0

Q ss_pred             cccccc-ccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++. +.||+|++|+||++.+..+++.||+|++.... ...+.+.+|+..+.++ +||||+++++++.+++.+++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            478885 78999999999999999999999999997654 3357789999999885 79999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC-CCEEEeecCCCcccCCCC---
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~-~~v~l~df~~~~~~~~~~---  154 (200)
                      ++++++|.+++.+...++...+..++.|++.||++||++|++||||+|+||+++.++. ..++|+|||++.......   
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (316)
T 2ac3_A           92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS  171 (316)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred             cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence            9999999999988888999999999999999999999999999999999999976543 359999999986433221   


Q ss_pred             -----CCCcccCCCCccCCeeecC-----cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 -----RPKSTVGTPAYIAPEVLSR-----REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 -----~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                           ......+++.|+|||.+.+     ..++.++|+||||+++|+|++|.+||
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  226 (316)
T 2ac3_A          172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF  226 (316)
T ss_dssp             ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCC
Confidence                 1123358899999999875     56889999999999999999999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-45  Score=274.00  Aligned_cols=194  Identities=28%  Similarity=0.446  Sum_probs=173.2

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      |...+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++......+++||++++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            6777899999999999999999999999999976543 346788999999999999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcccC
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVG  161 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~~~  161 (200)
                      ++|.+++. ...+++..+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++....... ......+
T Consensus       127 ~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  203 (321)
T 2c30_A          127 GALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVG  203 (321)
T ss_dssp             CBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCCS
T ss_pred             CCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCccccccccC
Confidence            99999884 457999999999999999999999999999999999999986664  9999999986544332 2334578


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       204 t~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~  242 (321)
T 2c30_A          204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF  242 (321)
T ss_dssp             CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999899999999999999999999999984

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.4e-46  Score=277.76  Aligned_cols=193  Identities=26%  Similarity=0.315  Sum_probs=168.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCc----eEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT----HLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v~   77 (200)
                      ++|++.+.||+|+||+||++.+.  ++.||+|++...........+|+..++.++||||+++++++.+..    .+++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            68999999999999999999876  678999999876665667778999999999999999999998743    479999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM----------QICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~----------~i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                      |++++++|.+++.+ ..+++..+..++.|++.||.+||+.          |++||||+|+||+++.++  .+||+|||++
T Consensus       102 e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~--~~kL~DFg~a  178 (322)
T 3soc_A          102 AFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--TACIADFGLA  178 (322)
T ss_dssp             ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC--CEEECCCTTC
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC--eEEEccCCcc
Confidence            99999999999965 4589999999999999999999999          999999999999998665  4999999999


Q ss_pred             cccCCCCC---CCcccCCCCccCCeeecC-----cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          148 KSSVLHSR---PKSTVGTPAYIAPEVLSR-----REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       148 ~~~~~~~~---~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +.......   .....+++.|+|||.+.+     ..++.++||||||+++|+|++|.+||
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf  238 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA  238 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCC
Confidence            64433322   233468999999999986     46778889999999999999999987

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-46  Score=282.56  Aligned_cols=196  Identities=31%  Similarity=0.401  Sum_probs=160.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCc--eEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLR-HPNIIRFKEVVLTPT--HLA   74 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~~~   74 (200)
                      +++|++.+.||+|+||.||++.+..+++.||+|.+....   ...+...+|+.+++.+. ||||+++++++..++  .++
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            368999999999999999999999999999999986532   33456789999999997 999999999997544  689


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-  153 (200)
                      +|||+++ ++|.+.+.. ..++...+..++.|++.||+|||+.|++||||+|+||+++.++.  ++|+|||+|+..... 
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence            9999997 589888865 57899999999999999999999999999999999999986664  999999998643221 


Q ss_pred             ---------------------CCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 ---------------------SRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ---------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                                           .......+|+.|+|||.+.+ ..++.++|+||||+++|||++|.+||.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence                                 11223468899999999986 678999999999999999999999983

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1e-45  Score=271.51  Aligned_cols=198  Identities=33%  Similarity=0.489  Sum_probs=176.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----------cchHHHHHHHHHHhhCC-CCCeeeEEEEEec
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----------KIDENVAREIINHRSLR-HPNIIRFKEVVLT   69 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----------~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   69 (200)
                      .++|++.+.||+|++|.||++.+..+++.||+|++....          ...+.+.+|+.+++++. ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            478999999999999999999999999999999997542          12356788999999995 9999999999999


Q ss_pred             CceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           70 PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        70 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      +...+++||++++++|.+++.+...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhh
Confidence            9999999999999999999988888999999999999999999999999999999999999986664  99999999876


Q ss_pred             cCCCCCCCcccCCCCccCCeeec------CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          150 SVLHSRPKSTVGTPAYIAPEVLS------RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...........+++.|+|||.+.      ...++.++|+||||+++|+|++|.+||+
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  230 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW  230 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence            55554555567899999999985      4467889999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.9e-46  Score=273.60  Aligned_cols=197  Identities=32%  Similarity=0.531  Sum_probs=173.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+....+++||++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            479999999999999999999999999999999986543 3456889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC-CCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~-~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      ++++|.+++.+.+.++...+..++.|++.||.+||+.|++|+||+|+||++.. +..+.++|+|||.+.... .......
T Consensus        89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~  167 (304)
T 2jam_A           89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTA  167 (304)
T ss_dssp             CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC-CBTTHHH
T ss_pred             CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC-CCccccc
Confidence            99999999988888999999999999999999999999999999999999932 233469999999986432 2223334


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  207 (304)
T 2jam_A          168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF  207 (304)
T ss_dssp             HSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            6899999999999988999999999999999999999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.4e-46  Score=269.85  Aligned_cols=197  Identities=41%  Similarity=0.647  Sum_probs=168.5

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|.||++.+..+++.|++|.+....    ...+.+.+|+..++.++||||+++++++.+....+++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            368999999999999999999999999999999987532    2346788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||++++++|.+++.+..+++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+.........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC----
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcce
Confidence            999999999999988888999999999999999999999999999999999999986664  999999998765544444


Q ss_pred             CcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+..+ +.++|+||||+++|+|++|.+||
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  211 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF  211 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            45578999999999987765 67899999999999999999997

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.6e-46  Score=276.75  Aligned_cols=197  Identities=29%  Similarity=0.442  Sum_probs=170.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|.+......   .+.+.+|+.+++.++||||+++++++.+....+++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            47899999999999999999999999999999998654332   345789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~  156 (200)
                      |++++++|.++......++...+..++.|++.||.+||+.|++||||+|+||+++.++  .++|+|||++...... ...
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCTTC----------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC--cEEEEeCCCceeecCCcccc
Confidence            9999988988887777899999999999999999999999999999999999998666  4999999998644332 223


Q ss_pred             CcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  225 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF  225 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC
Confidence            445689999999999875 7889999999999999999999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.2e-46  Score=287.86  Aligned_cols=190  Identities=26%  Similarity=0.388  Sum_probs=154.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC-----ceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   73 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|++....   ...+.+.+|+.+++.++||||+++++++...     ..+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            57999999999999999999999999999999987642   2246788999999999999999999998543     569


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++|||++ +++|.+++.....+++..+..++.|++.||+|||+.|++||||||+||+++.++.  +||+|||+++.....
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTSC
T ss_pred             EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccCc
Confidence            9999998 5699999988888999999999999999999999999999999999999987664  999999999754322


Q ss_pred             C----------------------------CCCcccCCCCccCCeee-cCcccCCeeehhhhhhhhhhcCC
Q 029037          154 S----------------------------RPKSTVGTPAYIAPEVL-SRREYDGKVCILLLILFLWRNYR  194 (200)
Q Consensus       154 ~----------------------------~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slg~~l~~~~~  194 (200)
                      .                            .....++|+.|+|||++ ....++.++|||||||++|||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            1                            12234579999999986 45679999999999999999999

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-46  Score=287.90  Aligned_cols=197  Identities=35%  Similarity=0.498  Sum_probs=165.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---------chHHHHHHHHHHhhCCCCCeeeEEEEEecCce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSLRHPNIIRFKEVVLTPTH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   72 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|++.....         ....+.+|+.++++++||||+++++++.. ..
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence            579999999999999999999999999999999976421         11247899999999999999999999865 45


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSV  151 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~  151 (200)
                      .++|||++++++|.+++.+...+++..+..++.|++.||+|||++|++||||+|+||+++.++ ...++|+|||+++...
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  293 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  293 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred             eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence            789999999999999998888899999999999999999999999999999999999996533 3359999999998665


Q ss_pred             CCCCCCcccCCCCccCCeeecC---cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSR---REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .........+++.|+|||.+.+   ..++.++|+||||+++|+|++|.+||
T Consensus       294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf  344 (419)
T 3i6u_A          294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF  344 (419)
T ss_dssp             -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            5544556679999999999853   56788999999999999999999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.8e-46  Score=273.25  Aligned_cols=195  Identities=22%  Similarity=0.259  Sum_probs=164.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHh-hCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHR-SLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++......   ......|+..+. ..+||||+++++++.+....+++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            4699999999999999999999999999999998754322   233444554444 448999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      |++ +++|.+++...+ .+++..+..++.|++.||++||+.|++||||||+||+++.++.  ++|+|||++.........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence            999 669988887654 5999999999999999999999999999999999999986664  999999998766555555


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....+++.|+|||.+.+ .++.++||||||+++|||++|..|||
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~  256 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH  256 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred             cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            55678999999999876 78999999999999999999987764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=278.92  Aligned_cols=196  Identities=27%  Similarity=0.461  Sum_probs=165.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch--HHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      |++|++.+.||+|++|+||++.+..+++.||+|.+.......  ..+.+|+.+++.++||||+++++++.+....++|||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            689999999999999999999999999999999987543222  245679999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CC
Q 029037           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RP  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~  156 (200)
                      ++++ +|.+++.+.. .++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++....... ..
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC-------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCcccc
Confidence            9975 8988887654 5899999999999999999999999999999999999987664  9999999986443222 22


Q ss_pred             CcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  201 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF  201 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            34467999999999876 56899999999999999999999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.9e-46  Score=279.03  Aligned_cols=199  Identities=31%  Similarity=0.423  Sum_probs=167.4

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +++|++.+.||+|++|+||++.+..+++.||+|++......   .+.+.+|+.+++.++||||+++++++.++...++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            47899999999999999999999999999999999754322   346789999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC---CCCCEEEeecCCCcccCCC-
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS---AAPRLKICDFGYSKSSVLH-  153 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~---~~~~v~l~df~~~~~~~~~-  153 (200)
                      |++++ +|.+++.+...++...+..++.|++.||.+||++|++||||+|+||+++.+   ....++|+|||++...... 
T Consensus       113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            99975 999999988889999999999999999999999999999999999999532   2235999999998644322 


Q ss_pred             CCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .......+++.|+|||.+.+. .++.++||||||+++|+|++|.+||.
T Consensus       192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  239 (329)
T 3gbz_A          192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP  239 (329)
T ss_dssp             --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            223344679999999999874 48999999999999999999999983

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.9e-46  Score=270.30  Aligned_cols=195  Identities=24%  Similarity=0.388  Sum_probs=170.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+. ++..||+|++.......+.+.+|+.+++.++||||+++++++.+....+++||+++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            58999999999999999999887 46679999999877777889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC--CCCc
Q 029037           82 GGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKS  158 (200)
Q Consensus        82 ~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~--~~~~  158 (200)
                      +++|.+++.+ ...++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||.+.......  ....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccccccccC
Confidence            9999999976 456999999999999999999999999999999999999986664  9999999986433221  1223


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~  222 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY  222 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            345678999999998889999999999999999998 88887

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.3e-46  Score=284.67  Aligned_cols=195  Identities=27%  Similarity=0.350  Sum_probs=167.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC-----ceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   73 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++....   ...+.+.+|+.+++.++||||+++++++...     ...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            68999999999999999999999999999999997642   2236788999999999999999999999876     569


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++|||+++ ++|.+++.....++...+..++.|++.||+|||+.|++||||||+||+++.++.  +||+|||+++.....
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC---
T ss_pred             EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCccccccc
Confidence            99999986 599999988888999999999999999999999999999999999999986654  999999999754332


Q ss_pred             CC-----------------------CCcccCCCCccCCeee-cCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SR-----------------------PKSTVGTPAYIAPEVL-SRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~-----------------------~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..                       .....+|+.|+|||.+ ....++.++|+|||||++|||++|..||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            21                       2445689999999986 4567999999999999999999854443

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=286.75  Aligned_cols=198  Identities=22%  Similarity=0.315  Sum_probs=173.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc--eEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPT--HLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~   77 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+..  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            57999999999999999999999999999999997643  33467889999999999999999999998765  789999


Q ss_pred             EecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec--CCCCCCEEEeecCCCcccCC
Q 029037           78 EYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD--GSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~--~~~~~~v~l~df~~~~~~~~  152 (200)
                      |++++++|.+++.+...   ++...++.++.|++.||++||+.|++||||+|+||++.  ++....++|+|||+++....
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~  168 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence            99999999999965443   89999999999999999999999999999999999982  22333599999999976655


Q ss_pred             CCCCCcccCCCCccCCeeecC--------cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR--------REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........+++.|+|||.+.+        ..++.++|+||||+++|+|++|.+||
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf  223 (396)
T 4eut_A          169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF  223 (396)
T ss_dssp             GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSE
T ss_pred             CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            555556678999999999865        56788999999999999999999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.2e-46  Score=278.85  Aligned_cols=197  Identities=15%  Similarity=0.172  Sum_probs=164.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-----CcEEEEEEecccccc------------hHHHHHHHHHHhhCCCCCeeeEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRKI------------DENVAREIINHRSLRHPNIIRFK   64 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~~K~~~~~~~~------------~~~~~~e~~~l~~l~~~~i~~~~   64 (200)
                      ++|++.+.||+|+||.||++.+..+     ++.||+|++......            ......|+..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4899999999999999999999765     578999998764311            12334555667788999999999


Q ss_pred             EEEecC----ceEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCE
Q 029037           65 EVVLTP----THLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (200)
Q Consensus        65 ~~~~~~----~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v  139 (200)
                      +++...    ...+++||++ |++|.+++... ..+++..++.++.|++.||+|||+.|++||||+|+||+++.+..+.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence            998764    4589999999 99999999776 57999999999999999999999999999999999999984444569


Q ss_pred             EEeecCCCcccCCCCCC--------CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          140 KICDFGYSKSSVLHSRP--------KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       140 ~l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +|+|||+++........        ....+++.|+|||.+.+..++.++||||||+++|+|++|.+||
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999999643322221        2334899999999999999999999999999999999999998

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.7e-46  Score=272.08  Aligned_cols=196  Identities=22%  Similarity=0.296  Sum_probs=175.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+.......+.+.+|+.++++++||||+++++++.++...+++||+++
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   92 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   92 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            57999999999999999999999999999999998876667889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--CC
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--~~  157 (200)
                      +++|.+++.+..  .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+........  ..
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSSEEET
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCcccccc
Confidence            999999998744  4899999999999999999999999999999999999986664  99999999875433222  12


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~  213 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY  213 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            2345778999999988889999999999999999999 88876

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-46  Score=280.14  Aligned_cols=198  Identities=30%  Similarity=0.444  Sum_probs=169.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc------ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG------RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|++|.||++.+..+++.+|+|++...      ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            5799999999999999999999999999999998753      2334678999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 029037           76 VMEYAAGGELFDRICNA----------------------------------------GRFSEDEGRYFFQQLISGVNYCH  115 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~----------------------------------------~~~~~~~~~~~~~~i~~~l~~lh  115 (200)
                      |||+++|++|.+++...                                        ..+++..+..++.|++.||++||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999988420                                        01356778899999999999999


Q ss_pred             hCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-----CCCcccCCCCccCCeeecC--cccCCeeehhhhhhh
Q 029037          116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-----RPKSTVGTPAYIAPEVLSR--REYDGKVCILLLILF  188 (200)
Q Consensus       116 ~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~~  188 (200)
                      +.|++||||+|+||+++.++...++|+|||++.......     ......+++.|+|||.+.+  ..++.++|+||||++
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence            999999999999999987665569999999986432221     1234568999999999975  678899999999999


Q ss_pred             hhhcCCCCCCC
Q 029037          189 LWRNYRPNPFI  199 (200)
Q Consensus       189 l~~~~~~~~pf  199 (200)
                      +|+|++|.+||
T Consensus       266 l~el~~g~~pf  276 (345)
T 3hko_A          266 LHLLLMGAVPF  276 (345)
T ss_dssp             HHHHHHSSCSS
T ss_pred             HHHHHHCCCCC
Confidence            99999999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-45  Score=269.34  Aligned_cols=196  Identities=21%  Similarity=0.200  Sum_probs=173.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++... ...+.+.+|+..++.+ +|++++++++++.+....+++||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            5799999999999999999999999999999998754 3345688899999999 7999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC---CCEEEeecCCCcccCCCCC-
Q 029037           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA---PRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~---~~v~l~df~~~~~~~~~~~-  155 (200)
                       +++|.+++...+ +++...+..++.|++.||.+||++|++||||+|+||+++.++.   ..++|+|||++........ 
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~  167 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  167 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence             899999998754 5999999999999999999999999999999999999975432   3499999999874443322 


Q ss_pred             -------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 -------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                             .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  218 (298)
T 1csn_A          168 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW  218 (298)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCc
Confidence                   23446899999999999989999999999999999999999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.2e-45  Score=266.78  Aligned_cols=196  Identities=26%  Similarity=0.379  Sum_probs=170.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|.+....   .....+.+|+..+..+ +||||+++++++.+++..+++|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999999999999999998642   2345788899999988 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-----------------C
Q 029037           78 EYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-----------------A  136 (200)
Q Consensus        78 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-----------------~  136 (200)
                      |++++++|.+++.+.    ..++...+..++.|++.||.+||++|++||||+|+||+++.++                 .
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999999999999765    5689999999999999999999999999999999999997432                 2


Q ss_pred             CCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          137 PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       137 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..++|+|||.+.....   .....+++.|+|||.+.+. .+++++|+||||+++|+|++|.+|++
T Consensus       171 ~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             CCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             eEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            3699999999864432   2334589999999999865 56788999999999999999998763

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-45  Score=278.11  Aligned_cols=193  Identities=26%  Similarity=0.346  Sum_probs=161.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc------e
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT------H   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~   72 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++....   ...+.+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            68999999999999999999999999999999997642   22356889999999999999999999997664      7


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .++|||++++ +|.+.+.  ..++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||++.....
T Consensus       105 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC------
T ss_pred             eEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeeccccccc
Confidence            8999999965 7888875  35899999999999999999999999999999999999986664  99999999975544


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  226 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF  226 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            44445567899999999999989999999999999999999999998

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.9e-46  Score=279.95  Aligned_cols=195  Identities=30%  Similarity=0.402  Sum_probs=174.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+++..++|||+
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57999999999999999999999999999999997642  3346789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      +++++|.+++.+...++...+..++.|++.||.+||+. |++||||+|+||+++.++.  ++|+|||++..... .....
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~  189 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  189 (360)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC---
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-ccccC
Confidence            99999999999888899999999999999999999986 9999999999999987664  99999999853321 22334


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  230 (360)
T 3eqc_A          190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI  230 (360)
T ss_dssp             -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCS
T ss_pred             CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            57899999999999999999999999999999999999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7e-46  Score=280.10  Aligned_cols=197  Identities=25%  Similarity=0.364  Sum_probs=161.6

Q ss_pred             ccccccccccCCcceEEEEEEEc---CCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|+||.||++.+.   .++..||+|.+....  ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47999999999999999999987   457779999997642  3346789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.+.. .++..++..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||+++.......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccCCc
Confidence            99999999999997754 6999999999999999999999999999999999999986664  99999999875433222


Q ss_pred             C----CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          156 P----KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       156 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      .    ....++..|+|||.+.+..++.++|+||||+++||+++ |.+|||
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~  252 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW  252 (373)
T ss_dssp             -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred             cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence            1    11234678999999998889999999999999999987 999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.2e-46  Score=277.95  Aligned_cols=197  Identities=19%  Similarity=0.204  Sum_probs=165.9

Q ss_pred             ccccccccccCCcceEEEEEEEcC---CCcEEEEEEeccccc------------chHHHHHHHHHHhhCCCCCeeeEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE---TKELVAVKYIERGRK------------IDENVAREIINHRSLRHPNIIRFKEV   66 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~~K~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~   66 (200)
                      ++|++.+.||+|++|.||++.+..   ++..+++|.......            ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            579999999999999999999987   788899999876432            12346678888999999999999999


Q ss_pred             Eec----CceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEe
Q 029037           67 VLT----PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC  142 (200)
Q Consensus        67 ~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~  142 (200)
                      +.+    ....+++||++ +++|.+++.+.+.++..+++.++.|++.||++||+.|++||||+|+||+++.++...++|+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            988    77899999999 8999999987778999999999999999999999999999999999999987764569999


Q ss_pred             ecCCCcccCCCCCC--------CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          143 DFGYSKSSVLHSRP--------KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       143 df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      |||+++........        ....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf  260 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW  260 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999644322211        3346899999999999989999999999999999999999998

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.6e-46  Score=274.40  Aligned_cols=196  Identities=23%  Similarity=0.275  Sum_probs=171.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..+++||++
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  117 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM  117 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred             hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence            68999999999999999999975 578899998876533 3467899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           81 AGGELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        81 ~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      ++++|.+++....    .+++..+..++.|++.||.+||++|++||||+|+||+++.++  .++|+|||++........ 
T Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  195 (321)
T 2qkw_B          118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF--VPKITDFGISKKGTELDQT  195 (321)
T ss_dssp             TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC--CEEECCCTTCEECSSSSCC
T ss_pred             CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC--CEEEeeccccccccccccc
Confidence            9999999886543    489999999999999999999999999999999999998666  499999999864332222 


Q ss_pred             --CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 --PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                        .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||+
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~  242 (321)
T 2qkw_B          196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV  242 (321)
T ss_dssp             CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred             ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccc
Confidence              223357899999999988889999999999999999999999984

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.5e-45  Score=275.18  Aligned_cols=196  Identities=28%  Similarity=0.429  Sum_probs=168.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC-------
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP-------   70 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------   70 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++.+.       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            478999999999999999999999999999999986543   2346788999999999999999999999873       


Q ss_pred             -ceEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           71 -THLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        71 -~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                       +..++|||++++ +|.+.+... ..++..++..++.|++.||++||++|++||||+|+||+++.++.  ++|+|||++.
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~  172 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLAR  172 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCE
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhcc
Confidence             468999999975 777777654 46999999999999999999999999999999999999986664  9999999986


Q ss_pred             ccCCC-----CCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          149 SSVLH-----SRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       149 ~~~~~-----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....     .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  229 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM  229 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence            44321     22233467899999999876 45799999999999999999999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-45  Score=274.33  Aligned_cols=197  Identities=24%  Similarity=0.300  Sum_probs=170.0

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEE--EEEEecccc--cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELV--AVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~--~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|++|.||++.+..++..+  ++|.+....  ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            368999999999999999999998888755  899887532  2345688999999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCE
Q 029037           76 VMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v  139 (200)
                      +||++++++|.+++.+..                .++...++.++.|++.||.+||++|++||||+|+||+++.++  .+
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~  181 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA  181 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CE
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC--eE
Confidence            999999999999997654                689999999999999999999999999999999999998665  49


Q ss_pred             EEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       140 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +|+|||++.............+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf  242 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY  242 (327)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCC
Confidence            9999999874444334444557889999999988889999999999999999998 98887

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-45  Score=278.56  Aligned_cols=193  Identities=27%  Similarity=0.426  Sum_probs=166.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEec------------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT------------   69 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------------   69 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|.+..+...   ..+|+.+++.++||||+++++++..            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            6899999999999999999999999999999998764322   3479999999999999999999843            


Q ss_pred             --------------------------CceEEEEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 029037           70 --------------------------PTHLAIVMEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSMQI  119 (200)
Q Consensus        70 --------------------------~~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i  119 (200)
                                                ...+++|||++++ +|.+.+.    ....++...+..++.|++.||+|||+.|+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence                                      3348999999975 7766654    35679999999999999999999999999


Q ss_pred             EeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCC
Q 029037          120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       120 ~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      +||||+|+||+++... +.++|+|||+++............+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+|
T Consensus       163 ~H~Dikp~Nil~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  241 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKD-NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL  241 (383)
T ss_dssp             ECSCCCGGGEEEETTT-TEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCccCHHHEEEcCCC-CcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence            9999999999997322 25999999999866666666667789999999998765 589999999999999999999999


Q ss_pred             C
Q 029037          199 I  199 (200)
Q Consensus       199 f  199 (200)
                      |
T Consensus       242 f  242 (383)
T 3eb0_A          242 F  242 (383)
T ss_dssp             S
T ss_pred             C
Confidence            8

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.6e-46  Score=269.39  Aligned_cols=196  Identities=36%  Similarity=0.537  Sum_probs=173.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|++....  ...+.+.+|+.+++.++||||+++++++.+.+..+++||+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            68999999999999999999999999999999987543  2346789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---CC
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---RP  156 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---~~  156 (200)
                      +++++|.+++.+...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+.......   ..
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhcc
Confidence            999999999977778999999999999999999999999999999999999986664  9999999986433221   22


Q ss_pred             CcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  208 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW  208 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence            34568899999999987665 67899999999999999999998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-45  Score=287.76  Aligned_cols=196  Identities=21%  Similarity=0.292  Sum_probs=174.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+.++++++||||+++++++.+...+++|||+++
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            46889999999999999999999989999999998876677889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC--CCC
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPK  157 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~--~~~  157 (200)
                      +++|.+++.+..  .++...++.++.|++.||+|||++|++||||+|+||+++.++  .+||+|||+++......  ...
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEEECCTTCEECCTTCCEECCT
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC--cEEEeecccceeccCCceeecC
Confidence            999999997643  589999999999999999999999999999999999998665  49999999987543221  122


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |.+||
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~  420 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY  420 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCC
Confidence            2345678999999998899999999999999999999 88887

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.7e-45  Score=272.13  Aligned_cols=193  Identities=24%  Similarity=0.394  Sum_probs=173.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEec--CceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLT--PTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++..  ...+.+.+|+.+++.++ ||||+++++++.+  ....+++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            579999999999999999999999999999999875  33577899999999997 9999999999987  667899999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      ++++++|.+++..   ++...+..++.|++.||++||++|++||||+|+||+++.++. .++|+|||++...........
T Consensus       114 ~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~~  189 (330)
T 3nsz_A          114 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNV  189 (330)
T ss_dssp             CCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCS
T ss_pred             ccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCcccc
Confidence            9999999888743   899999999999999999999999999999999999985553 599999999976655555566


Q ss_pred             ccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||+
T Consensus       190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~  232 (330)
T 3nsz_A          190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  232 (330)
T ss_dssp             CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            678999999999987 678999999999999999999999984

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.8e-45  Score=267.96  Aligned_cols=198  Identities=36%  Similarity=0.553  Sum_probs=176.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|++....   ...+.+.+|+.++++++||||+++++++.+....+++||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            57999999999999999999999999999999987543   345678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ++++++|.+.+.+...++...+..++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|||++..........
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~  181 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCS
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccc
Confidence            999999999998888899999999999999999999999999999999999997543 3469999999987555444444


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+.+ .++.++|+||||+++|+|++|.+||.
T Consensus       182 ~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~  223 (287)
T 2wei_A          182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY  223 (287)
T ss_dssp             CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence            5567889999999865 48899999999999999999999984

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-45  Score=281.20  Aligned_cols=196  Identities=26%  Similarity=0.331  Sum_probs=173.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC------CCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL------RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|++.......+.+.+|+.+++.+      +|+||+++++.+......++
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            479999999999999999999999999999999987665566777888887766      67799999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           76 VMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +||+++ ++|.+++....  .++...+..++.|++.||+|||+.|++||||||+||+++.++...++|+|||+++...  
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~--  253 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--  253 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT--
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC--
Confidence            999995 59999987764  4899999999999999999999999999999999999987765559999999986432  


Q ss_pred             CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++|.+||.
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~  300 (429)
T 3kvw_A          254 QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP  300 (429)
T ss_dssp             CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence            23344578999999999999999999999999999999999999983

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-46  Score=279.63  Aligned_cols=198  Identities=21%  Similarity=0.272  Sum_probs=168.9

Q ss_pred             ccccccccccCCcceEEEEEE-----EcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLR-----HKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|+||+||++.     +..+++.||+|.+....  .....+.+|+.+++.++||||+++++++.+....+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            579999999999999999999     45567889999997542  23356889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCC
Q 029037           75 IVMEYAAGGELFDRICNAG-------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGY  146 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~  146 (200)
                      +|||++++++|.+++....       .++...++.++.|++.||++||++|++||||+|+||+++.++ ...++|+|||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            9999999999999997653       489999999999999999999999999999999999997443 23599999999


Q ss_pred             CcccC---CCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          147 SKSSV---LHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       147 ~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++...   .........+++.|+|||.+.+..++.++||||||+++|||++ |.+||
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf  287 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY  287 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            86322   1222334457889999999988899999999999999999998 88887

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3e-46  Score=282.67  Aligned_cols=196  Identities=26%  Similarity=0.360  Sum_probs=170.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....  ..+.+.+|+.+++.++||||+++++++.++...++|||+
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            578999999999999999999998999999999876422  234688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--
Q 029037           80 AAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--  156 (200)
Q Consensus        80 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--  156 (200)
                      +++++|.+++.+.+ .++...+..++.|++.||++||+.|++||||+|+||++++++  .+||+|||+++........  
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~--~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECTTSEEECC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC--cEEECcCCCceecCCCceeec
Confidence            99999999997654 599999999999999999999999999999999999998666  4999999998643221111  


Q ss_pred             -CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          157 -KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       157 -~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                       ....++..|+|||.+.+..++.++|+||||+++|||++ |.+||
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~  316 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY  316 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence             11224567999999998889999999999999999998 88887

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-45  Score=267.76  Aligned_cols=193  Identities=26%  Similarity=0.376  Sum_probs=172.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEec------------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT------------   69 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------------   69 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+....   +.+.+|+.+++.++||||+++++++..            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            47999999999999999999999899999999987643   456789999999999999999998864            


Q ss_pred             ----CceEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEee
Q 029037           70 ----PTHLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (200)
Q Consensus        70 ----~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~d  143 (200)
                          ...++++||++++++|.+++.+.  ..++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~D  165 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGD  165 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECc
Confidence                44589999999999999999764  56999999999999999999999999999999999999986664  99999


Q ss_pred             cCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          144 FGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       144 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ||++.............+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             chhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            99987665555555667899999999999989999999999999999999999886

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-45  Score=276.48  Aligned_cols=196  Identities=24%  Similarity=0.334  Sum_probs=170.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-------CcEEEEEEecccccc--hHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-------KELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-------~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      ++|++.+.||+|+||.||++.+..+       +..||+|++......  .+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            5799999999999999999997543       357999999765332  36788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           72 HLAIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      ..++|||++++++|.+++....                .+++..++.++.|++.||.+||+.|++||||||+||+++.++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  228 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  228 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence            9999999999999999997754                489999999999999999999999999999999999998666


Q ss_pred             CCCEEEeecCCCcccCCCC---CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          136 APRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .  ++|+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||
T Consensus       229 ~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~  294 (382)
T 3tt0_A          229 V--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  294 (382)
T ss_dssp             C--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             c--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            4  9999999987543322   2223346778999999999999999999999999999999 88887

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-45  Score=275.94  Aligned_cols=192  Identities=26%  Similarity=0.369  Sum_probs=163.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc------e
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT------H   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~   72 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+....   ...+.+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            57999999999999999999999999999999986542   22457889999999999999999999998753      4


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ++++||++ +++|.+++.. .+++...+..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||+++... 
T Consensus       105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~-  179 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD-  179 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeecccccc-
Confidence            69999999 7899998865 57999999999999999999999999999999999999987664  9999999987533 


Q ss_pred             CCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                       .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||
T Consensus       180 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  226 (367)
T 1cm8_A          180 -SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF  226 (367)
T ss_dssp             -SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             -cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence             22344578999999999887 67899999999999999999999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.7e-45  Score=271.04  Aligned_cols=196  Identities=22%  Similarity=0.297  Sum_probs=170.3

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+.     .+++.||+|.+....  ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            57999999999999999999984     445789999997643  22367889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCee
Q 029037           75 IVMEYAAGGELFDRICNAGR------------------------FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~  130 (200)
                      ++||++++++|.+++.+...                        ++...+..++.|++.||.+||++|++||||+|+||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL  182 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence            99999999999999986543                        889999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          131 LDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       131 i~~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++.++.  ++|+|||++........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       183 i~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          183 VAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             EETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             EcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            986654  99999999864433222   223346778999999998889999999999999999999 88887

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=275.94  Aligned_cols=196  Identities=23%  Similarity=0.354  Sum_probs=170.4

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..     +++.||+|.+.....  ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            589999999999999999999973     458899999976432  2467899999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCee
Q 029037           75 IVMEYAAGGELFDRICNA------------------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~  130 (200)
                      ++||++++++|.+++.+.                        ..++..+++.++.|++.||.+||++|++||||+|+||+
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  206 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence            999999999999999764                        46899999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCC---CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          131 LDGSAAPRLKICDFGYSKSSVLH---SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       131 i~~~~~~~v~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++.++.  ++|+|||++......   .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       207 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          207 VGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             ECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            986664  999999998643222   12233457888999999988889999999999999999999 88887

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.4e-46  Score=278.21  Aligned_cols=196  Identities=22%  Similarity=0.345  Sum_probs=168.7

Q ss_pred             ccccccccccCCcceEEEEEE-----EcCCCcEEEEEEecccccc--hHHHHHHHHHHhhC-CCCCeeeEEEEEecCc-e
Q 029037            2 EKYELVKDLGAGNFGVARLLR-----HKETKELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTPT-H   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~-~   72 (200)
                      ++|++.+.||+|+||.||++.     +..+++.||+|++......  .+.+.+|+.+++++ +||||+++++++.+.. .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            689999999999999999999     5566789999999864322  35689999999999 7899999999998765 4


Q ss_pred             EEEEEEecCCCchHHHHHhcCC----------------------------------------------------------
Q 029037           73 LAIVMEYAAGGELFDRICNAGR----------------------------------------------------------   94 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~----------------------------------------------------------   94 (200)
                      .+++||++++++|.+++.....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            8999999999999999976543                                                          


Q ss_pred             --------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC---CCcccCCC
Q 029037           95 --------FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTP  163 (200)
Q Consensus        95 --------~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~  163 (200)
                              ++...+..++.|++.||++||++|++||||+|+||+++.++.  ++|+|||++........   .....+++
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCCCc
Confidence                    889999999999999999999999999999999999986664  99999999874433222   22345778


Q ss_pred             CccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          164 AYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       164 ~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .|+|||.+.+..++.++||||||+++|+|++ |.+||
T Consensus       260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  296 (359)
T 3vhe_A          260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  296 (359)
T ss_dssp             GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCC
Confidence            8999999998889999999999999999998 99887

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-45  Score=269.99  Aligned_cols=196  Identities=15%  Similarity=0.137  Sum_probs=170.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCC-------cEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETK-------ELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~-------~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|++|+||++.+..++       ..|++|.+.... ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            68999999999999999999998776       469999987644 3457799999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC------CEEEeecCC
Q 029037           74 AIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP------RLKICDFGY  146 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~------~v~l~df~~  146 (200)
                      +++||++++++|.+++.+... ++...+..++.|++.||.+||++|++||||+|+||+++.++..      .++|+|||.
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~  167 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI  167 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence            999999999999999987664 9999999999999999999999999999999999999765531      299999998


Q ss_pred             CcccCCCCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          147 SKSSVLHSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +....   ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..|+|
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~  219 (289)
T 4fvq_A          168 SITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL  219 (289)
T ss_dssp             CTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence            85332   1223457888999999987 678999999999999999999766554

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.6e-46  Score=272.24  Aligned_cols=196  Identities=26%  Similarity=0.396  Sum_probs=166.9

Q ss_pred             ccccccccccCCcceEEEEEE----EcCCCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTP--THLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~----~~~~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   74 (200)
                      ++|++.+.||+|++|+||++.    +..+++.||+|++...... .+.+.+|+.+++.++||||+++++++...  ..++
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            689999999999999999998    6678899999999865333 46789999999999999999999998654  4589


Q ss_pred             EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           75 IVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +|||++++++|.+++.+.. +++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++......
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-----
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccCC
Confidence            9999999999999997755 4999999999999999999999999999999999999986664  999999998754333


Q ss_pred             CC----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SR----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..    .....++..|+|||.+.+..++.++||||||+++|+|++|..|+
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~  217 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS  217 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccccc
Confidence            22    12233566799999999889999999999999999999998876

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-46  Score=278.25  Aligned_cols=197  Identities=29%  Similarity=0.481  Sum_probs=170.8

Q ss_pred             CccccccccccCCcceEEEEEEEc---CCCcEEEEEEecccc-----cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      +++|++.+.||+|+||.||++.+.   .+++.||+|++....     ...+.+.+|+.+++.+ +||||+++++++.+..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            368999999999999999999984   478999999987532     2345677899999999 6999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      ..++|||++++++|.+++.....++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||+++...
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~  210 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecc
Confidence            99999999999999999988888999999999999999999999999999999999999986664  9999999986433


Q ss_pred             CCC--CCCcccCCCCccCCeeecC--cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHS--RPKSTVGTPAYIAPEVLSR--REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~--~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...  ......+++.|+|||.+.+  ..++.++|+||||+++|+|++|.+||
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf  262 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF  262 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            222  2233468999999999985  35788999999999999999999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=267.25  Aligned_cols=196  Identities=28%  Similarity=0.423  Sum_probs=171.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+... ...+.+.+|+.+++.++||||+++++++.+....+++||+++
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            5799999999999999999999999999999999764 345788999999999999999999999999999999999999


Q ss_pred             CCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcc
Q 029037           82 GGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (200)
Q Consensus        82 ~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~  159 (200)
                      +++|.+++. ....++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+....... .....
T Consensus       108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~  185 (314)
T 3com_A          108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNTV  185 (314)
T ss_dssp             TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCCC
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCcc
Confidence            999999986 3557999999999999999999999999999999999999986664  9999999986443322 23345


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  226 (314)
T 3com_A          186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA  226 (314)
T ss_dssp             CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            68899999999999899999999999999999999999983

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4e-45  Score=273.64  Aligned_cols=192  Identities=30%  Similarity=0.445  Sum_probs=169.0

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +|++.+.||+|++|+||++.+..+++.||+|.+......    .+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            588999999999999999999999999999999754322    2568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           79 YAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        79 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      ++. ++|.+.+.. ..++++..+..++.|++.||.+||+.|++||||+|+||+++.++  .++|+|||++.....   ..
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~---~~  208 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---AN  208 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS---BC
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecCC---CC
Confidence            997 588777754 45799999999999999999999999999999999999998666  499999999865432   23


Q ss_pred             cccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+.   ...++.++|+||||+++|||++|.+||+
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  254 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  254 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            457899999999984   5678999999999999999999999984

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.2e-45  Score=280.38  Aligned_cols=191  Identities=26%  Similarity=0.395  Sum_probs=167.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCc-eEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT-HLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~   80 (200)
                      ++|++.+.||+|+||.||++.+.  ++.||+|.++... ..+.+.+|+.++++++||||+++++++.+.. ..++|||++
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            57999999999999999999886  5689999998753 5678999999999999999999999987665 799999999


Q ss_pred             CCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           81 AGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      ++++|.+++.+.+.  ++...+..++.|++.||+|||++|++||||+|+||+++.++  .+||+|||+++.....  ...
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~--~~~  345 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST--QDT  345 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS--CEEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC--CEEEeeCCCccccccc--ccC
Confidence            99999999987654  79999999999999999999999999999999999998666  4999999998743222  222


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||||+++|||++ |.+||
T Consensus       346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~  387 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY  387 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            356788999999999999999999999999999998 99887

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-45  Score=274.25  Aligned_cols=197  Identities=36%  Similarity=0.498  Sum_probs=169.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---------chHHHHHHHHHHhhCCCCCeeeEEEEEecCce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSLRHPNIIRFKEVVLTPTH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   72 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.....         ....+.+|+.+++.++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            579999999999999999999999999999999875321         1235789999999999999999999987665 


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSV  151 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~  151 (200)
                      .+++||++++++|.+++.....++...+..++.|++.||.+||++|++||||+|+||+++.++ ...++|+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            899999999999999998888899999999999999999999999999999999999997544 2359999999987543


Q ss_pred             CCCCCCcccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .........+++.|+|||.+.   ...++.++|+||||+++|+|++|.+||
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  219 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF  219 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            322223346899999999974   457889999999999999999999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.7e-44  Score=264.21  Aligned_cols=193  Identities=23%  Similarity=0.335  Sum_probs=169.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEec----CceEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT----PTHLAI   75 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~   75 (200)
                      .|++.+.||+|++|.||++.+..++..|++|.+....   ...+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            5888999999999999999999999999999987643   234568899999999999999999998875    456899


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCCeeec-CCCCCCEEEeecCCCcccCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLD-GSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~ni~i~-~~~~~~v~l~df~~~~~~~~  152 (200)
                      |||++++++|.+++.+...++...+..++.|++.||.+||+.|  ++|+||+|+||+++ +++  .++|+|||++.... 
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~kl~Dfg~~~~~~-  183 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKR-  183 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCC-
T ss_pred             EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC--CEEEeeCCCccccc-
Confidence            9999999999999988888999999999999999999999999  99999999999997 344  59999999986332 


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........+++.|+|||.+.+ .++.++|+||||+++|+|++|.+||
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf  229 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY  229 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCC
Confidence            223334568999999998864 5899999999999999999999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.1e-44  Score=266.69  Aligned_cols=195  Identities=29%  Similarity=0.448  Sum_probs=174.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|++....  ...+.+.+|+.+++.++||||+++++++.++...+++||+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46999999999999999999999999999999997643  3357899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~  158 (200)
                      +++++|.+++. ..+++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+....... ....
T Consensus       102 ~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          102 LGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             CTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBCCBCC
T ss_pred             CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCccccccCc
Confidence            99999999885 457999999999999999999999999999999999999986664  9999999986543332 2234


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  219 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH  219 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCC
Confidence            56889999999999989999999999999999999999997

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.3e-45  Score=264.23  Aligned_cols=195  Identities=24%  Similarity=0.393  Sum_probs=172.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+. +++.|++|.+.......+.+.+|+..++.++||||+++++++.++...+++||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            58999999999999999999987 45679999998876667889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC--CCCc
Q 029037           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKS  158 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~--~~~~  158 (200)
                      +++|.+++.+. ..++...+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||.+.......  ....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccccccc
Confidence            99999999775 45899999999999999999999999999999999999986654  9999999986432211  1223


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  206 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY  206 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCC
Confidence            446778999999988889999999999999999999 78887

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.8e-45  Score=267.94  Aligned_cols=196  Identities=24%  Similarity=0.345  Sum_probs=169.0

Q ss_pred             ccccccccccCCcceEEEEEE----EcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceE
Q 029037            2 EKYELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~----~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   73 (200)
                      ++|++.+.||+|++|.||++.    +..+++.||+|.+....  ...+.+.+|+.+++.++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            468999999999999999999    66789999999997543  3347899999999999999999999999877  668


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           74 AIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      +++||++++++|.+++.+. ..++...+..++.|++.||++||+.|++|+||+|+||+++.++  .++|+|||++.....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIET  178 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC--CEEECcccccccccC
Confidence            9999999999999999554 4699999999999999999999999999999999999998666  499999999875443


Q ss_pred             CCC----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSR----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...    .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  229 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD  229 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence            322    23345677899999999888999999999999999999998874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.3e-44  Score=267.15  Aligned_cols=198  Identities=26%  Similarity=0.366  Sum_probs=164.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|.+....    ...+.+.+|+..++.++||||+++++++.+.+..+++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            468999999999999999999999999999999987532    2345788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ||++++++|.+++..    ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||++.....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC--------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceeeecC
Confidence            999999999998864    34689999999999999999999999999999999999998665  499999999864433


Q ss_pred             CCC-CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 HSR-PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||+
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  237 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  237 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            222 233468899999999998889999999999999999999999984

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.5e-45  Score=272.36  Aligned_cols=196  Identities=20%  Similarity=0.300  Sum_probs=154.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc---EEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceE--
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHL--   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--   73 (200)
                      ++|++.+.||+|++|.||++.+..++.   .||+|.+....   ...+.+.+|+.++++++||||+++++++.+....  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            579999999999999999999887764   79999997642   3346789999999999999999999999877654  


Q ss_pred             ----EEEEEecCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEee
Q 029037           74 ----AIVMEYAAGGELFDRICNAG------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (200)
Q Consensus        74 ----~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~d  143 (200)
                          +++||++++++|.+++....      .++...+..++.|++.||++||+.|++||||+|+||++++++  .++|+|
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~kl~D  180 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TVCVAD  180 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CEEEee
Confidence                99999999999999996543      589999999999999999999999999999999999998665  499999


Q ss_pred             cCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          144 FGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       144 f~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ||+++........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~  240 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY  240 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCc
Confidence            9998754333222   22345678999999998889999999999999999999 88887

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=269.72  Aligned_cols=196  Identities=29%  Similarity=0.433  Sum_probs=167.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEec------CceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLT------PTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..+++.|++|++.......+.+.+|+..++.+ +||||+++++++..      ....+
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            689999999999999999999999999999999987766678899999999998 79999999999987      46789


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           75 IVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ++||++++++|.+++...  ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||++.....
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC----
T ss_pred             EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCc
Confidence            999999999999999764  46899999999999999999999999999999999999986664  99999999865432


Q ss_pred             CC-CCCcccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HS-RPKSTVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .. ......+++.|+|||.+.     +..++.++|+||||+++|+|++|.+||
T Consensus       182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  234 (326)
T 2x7f_A          182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL  234 (326)
T ss_dssp             ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence            22 233446899999999987     456888999999999999999999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.1e-45  Score=270.85  Aligned_cols=195  Identities=29%  Similarity=0.355  Sum_probs=172.1

Q ss_pred             ccccccccccCCcceEEEEEEE-cCCCcEEEEEEecccccchHHHHHHHHHHhhCCCC------CeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRH-KETKELVAVKYIERGRKIDENVAREIINHRSLRHP------NIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~-~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|+||++.+ ..+++.||+|++.......+.+.+|+.+++.++|+      +++++++++.+.+..+
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            6899999999999999999998 56788999999987666567788999998887654      5999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-----------------
Q 029037           75 IVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-----------------  135 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-----------------  135 (200)
                      ++||++ +++|.+++....  +++...+..++.|++.||++||++|++||||+|+||+++.+.                 
T Consensus        94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            999999 889999997765  588999999999999999999999999999999999997643                 


Q ss_pred             CCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .+.++|+|||.+....  .......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       173 ~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  234 (339)
T 1z57_A          173 NPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF  234 (339)
T ss_dssp             CCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence            4469999999986432  2334457899999999999989999999999999999999999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.2e-45  Score=275.43  Aligned_cols=197  Identities=26%  Similarity=0.389  Sum_probs=160.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCc-------eE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT-------HL   73 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------~~   73 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|.+...........+++..++.++||||+++++++....       ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            47899999999999999999999999999999999876666667888889999999999999999986533       38


Q ss_pred             EEEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCcEeecCCCCCeeecC-CCCCCEEEeecCC
Q 029037           74 AIVMEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCH--SMQICHRDLKLENTLLDG-SAAPRLKICDFGY  146 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~ni~i~~-~~~~~v~l~df~~  146 (200)
                      +++||++++ +|.+.+.    ....++...+..++.|++.||.+||  +.|++||||+|+||+++. ++  .++|+|||+
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~  178 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGS  178 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTT
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCC
Confidence            999999976 5544443    4556899999999999999999999  999999999999999985 44  599999999


Q ss_pred             CcccCCCCCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          147 SKSSVLHSRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +.............+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~  233 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR  233 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence            9866665555666789999999998765 48999999999999999999999984

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.6e-44  Score=262.79  Aligned_cols=194  Identities=25%  Similarity=0.433  Sum_probs=167.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc--------hHHHHHHHHHHhhCCCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--------DENVAREIINHRSLRHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+......        .+.+.+|+.+++.++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6899999999999999999999999999999998653221        167889999999999999999999997766  


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCCeeecCCCC---CCEEEeecCCC
Q 029037           74 AIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAA---PRLKICDFGYS  147 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~ni~i~~~~~---~~v~l~df~~~  147 (200)
                      +++||++++++|.+.+.+.. .++...+..++.|++.||++||+.|  ++||||+|+||+++.++.   ..++|+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            69999999999988886554 6999999999999999999999999  999999999999975442   23899999998


Q ss_pred             cccCCCCCCCcccCCCCccCCeeec--CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          148 KSSVLHSRPKSTVGTPAYIAPEVLS--RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +...  .......+++.|+|||.+.  ...++.++|+||||+++|+|++|.+||
T Consensus       177 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  228 (287)
T 4f0f_A          177 QQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF  228 (287)
T ss_dssp             BCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence            6332  2233456899999999984  556788999999999999999999998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-45  Score=272.29  Aligned_cols=193  Identities=23%  Similarity=0.321  Sum_probs=164.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCC--CCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRH--PNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|+||.||++.+. +++.||+|++......   .+.+.+|+.+++.++|  |||+++++++.++...+++
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            47999999999999999999985 5788999998754332   3568899999999976  9999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      || +.+++|.+++.+...+++.++..++.|++.||.+||+.|++||||+|+||++++ +  .++|+|||++........ 
T Consensus        88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC------
T ss_pred             Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccCccccc
Confidence            99 557899999999889999999999999999999999999999999999999963 3  499999999975443322 


Q ss_pred             --CCcccCCCCccCCeeecC-----------cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 --PKSTVGTPAYIAPEVLSR-----------REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        .....+++.|+|||.+.+           ..++.++||||||+++|+|++|.+||
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf  220 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  220 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcc
Confidence              234568999999999864           56788999999999999999999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7e-45  Score=276.12  Aligned_cols=193  Identities=22%  Similarity=0.317  Sum_probs=165.5

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCC--CCCeeeEEEEEecCceEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLR--HPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +|++.+.||+|+||.||++.+.. ++.||+|++.....   ..+.+.+|+.+++.++  ||||+++++++..+..+++||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            59999999999999999999876 88899999975432   2367889999999996  599999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      | +.+++|.+++.+...+++.++..++.|++.||.|||+.|++||||+|+||++++ +  .+||+|||+++.......  
T Consensus       136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~--~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S--CEEECCCSSSCCC-------
T ss_pred             e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C--eEEEEecCccccccCCCccc
Confidence            9 567899999998888999999999999999999999999999999999999953 3  599999999975433322  


Q ss_pred             -CCcccCCCCccCCeeecC-----------cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLSR-----------REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       .....+++.|+|||.+.+           ..++.++||||||+++|+|++|.+||+
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~  268 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  268 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence             234568999999999865           367889999999999999999999984

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-45  Score=272.76  Aligned_cols=196  Identities=23%  Similarity=0.319  Sum_probs=168.3

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEecccc--cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|++|.||++.+.     .++..||+|.+....  ...+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            57899999999999999999973     356789999997542  3356799999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCee
Q 029037           74 AIVMEYAAGGELFDRICNAG-----------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~  130 (200)
                      +++||++++++|.+++....                       .++...++.++.|++.||.+||+.|++||||+|+||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            99999999999999997653                       2789999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          131 LDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       131 i~~~~~~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++.++  .++|+|||++.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       205 l~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          205 VTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             EETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             EcCCC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            98666  4999999998754333221   22346778999999988889999999999999999998 88887

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.4e-45  Score=272.10  Aligned_cols=199  Identities=29%  Similarity=0.434  Sum_probs=170.4

Q ss_pred             cccccc-ccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|.+. +.||+|++|.||++.+..+++.||+|++....   .....+.+|+.+++.+. ||||+++++++.+....++|
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            357777 89999999999999999999999999997643   23467899999999995 69999999999999999999


Q ss_pred             EEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccCCC
Q 029037           77 MEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLH  153 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~~~  153 (200)
                      ||++++++|.+++...  ..++...+..++.|++.||++||++|++||||+|+||+++... .+.++|+|||++......
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            9999999999988543  5699999999999999999999999999999999999997521 346999999999765555


Q ss_pred             CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  234 (327)
T 3lm5_A          188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV  234 (327)
T ss_dssp             ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            45555678999999999999999999999999999999999999983

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.1e-45  Score=272.11  Aligned_cols=195  Identities=25%  Similarity=0.298  Sum_probs=170.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+. +++.||+|++.....  ....+.+|+.+++.++||||+++++++.+....+++||+
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            68999999999999999999864 578899999876432  234689999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           80 AAGGELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSM---QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        80 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      +++++|.+++....    +++...+..++.|++.||.+||+.   |++||||+|+||++++++.  ++|+|||++.....
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMDY  186 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEECCS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccccCc
Confidence            99999999997643    389999999999999999999999   9999999999999986654  99999999875433


Q ss_pred             CCC--CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSR--PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...  .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  235 (326)
T 3uim_A          187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF  235 (326)
T ss_dssp             SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred             ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcc
Confidence            222  22335899999999998888999999999999999999999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-45  Score=273.06  Aligned_cols=196  Identities=30%  Similarity=0.406  Sum_probs=166.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc------chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....      ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            689999999999999999999999999999999975321      12467899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +||++++ +|.+.+.... .++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||++.......
T Consensus        90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCC
T ss_pred             EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccCCc
Confidence            9999976 8888886554 5899999999999999999999999999999999999987664  9999999987543322


Q ss_pred             -CCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 -RPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 -~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~  214 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP  214 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence             23445689999999999754 57889999999999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.9e-45  Score=267.74  Aligned_cols=192  Identities=28%  Similarity=0.386  Sum_probs=161.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhh--CCCCCeeeEEEEEec----CceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS--LRHPNIIRFKEVVLT----PTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----~~~~~~   75 (200)
                      ++|++.+.||+|++|+||++.+  +++.||+|++....  .+.+.+|.+++..  ++||||+++++++.+    ....++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            6899999999999999999988  47889999987643  3445556655555  799999999998654    346899


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH--------SMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                      +||++++++|.+++ +...++...+..++.|++.||++||        +.|++||||+|+||+++.++.  ++|+|||++
T Consensus        84 v~e~~~~g~L~~~l-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a  160 (301)
T 3q4u_A           84 ITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLA  160 (301)
T ss_dssp             EECCCTTCBHHHHH-TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTC
T ss_pred             ehhhccCCCHHHHH-hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCCe
Confidence            99999999999999 4457999999999999999999999        999999999999999986664  999999998


Q ss_pred             cccCCCCC-----CCcccCCCCccCCeeecCc------ccCCeeehhhhhhhhhhcCCC----------CCCCC
Q 029037          148 KSSVLHSR-----PKSTVGTPAYIAPEVLSRR------EYDGKVCILLLILFLWRNYRP----------NPFIW  200 (200)
Q Consensus       148 ~~~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slg~~l~~~~~~----------~~pf~  200 (200)
                      +.......     .....+++.|+|||.+.+.      .++.++|+||||+++|||++|          .+||+
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            64332222     2234689999999999876      566789999999999999999          88874

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.5e-45  Score=271.22  Aligned_cols=195  Identities=21%  Similarity=0.288  Sum_probs=166.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcE----EEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKEL----VAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~----~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|+||+||++.+..+++.    +++|.+....  ...+.+.+|+..++.++||||+++++++.+ ...++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence            6899999999999999999999887765    6777765432  223567889999999999999999998864 56889


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +||++.+++|.+++... ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||+++......
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCCT
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccccCccc
Confidence            99999999999999764 46999999999999999999999999999999999999986664  9999999997544333


Q ss_pred             CC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          155 RP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..   ....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  218 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY  218 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCc
Confidence            22   23346778999999998889999999999999999999 99887

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.5e-45  Score=269.26  Aligned_cols=196  Identities=23%  Similarity=0.318  Sum_probs=171.0

Q ss_pred             ccccccccccCCcceEEEEEEE-----cCCCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRH-----KETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|++|.||++.+     ..+++.||+|.+.....  ..+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999985     45678899999976532  346789999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           74 AIVMEYAAGGELFDRICNAG------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      +++||++++++|.+++....                  .++...+..++.|++.||.+||+.|++||||+|+||+++.++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  182 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence            99999999999999997654                  389999999999999999999999999999999999998665


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .  ++|+|||++........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       183 ~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  248 (313)
T 1t46_A          183 I--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (313)
T ss_dssp             E--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             C--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence            4  99999999875443322   123346778999999988889999999999999999998 88887

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1e-44  Score=269.45  Aligned_cols=196  Identities=27%  Similarity=0.388  Sum_probs=171.0

Q ss_pred             ccccccccccCCcceEEEEEE----EcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEe--cCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVL--TPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~----~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.    +..+++.|++|.+..... ..+.+.+|+.++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            589999999999999999999    567889999999976533 3456899999999999999999999886  456789


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           75 IVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++||++++++|.+++... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.  ++|+|||.+......
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCTT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccccceecccC
Confidence            999999999999999764 46999999999999999999999999999999999999986664  999999998754332


Q ss_pred             CC----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SR----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..    .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~  230 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS  230 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            22    22334677899999999888999999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-44  Score=277.20  Aligned_cols=192  Identities=29%  Similarity=0.434  Sum_probs=164.7

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecC------ceEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTP------THLAIV   76 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~~v   76 (200)
                      +|++.+.||+|+||.||++.+..+++.||+|.+.....   ...+|+.+++.++||||+++++++...      ..++++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            69999999999999999999999999999999876432   234799999999999999999988532      247899


Q ss_pred             EEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           77 MEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        77 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ||++++ ++.+.+.    ....++...+..++.|++.||+|||+.|++||||||+||+++.+.. .+||+|||+++....
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhccc
Confidence            999975 6655553    2457999999999999999999999999999999999999985543 589999999986555


Q ss_pred             CCCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ........+++.|+|||.+.+. .++.++||||||+++|||++|.+||
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf  257 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF  257 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence            5555566789999999999765 7899999999999999999999998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-44  Score=264.83  Aligned_cols=195  Identities=24%  Similarity=0.305  Sum_probs=155.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++.......   +.+.++...++.++||||+++++++.+++..+++||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            68999999999999999999999999999999997643222   234455556788899999999999999999999999


Q ss_pred             ecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           79 YAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        79 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++++ +|.+++..    ...+++..+..++.|++.||.+||++ |++||||+|+||+++.++  .++|+|||.+......
T Consensus        87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLVDD  163 (290)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC---------
T ss_pred             hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCccccccc
Confidence            9975 88776643    45799999999999999999999998 999999999999998665  4999999999766555


Q ss_pred             CCCCcccCCCCccCCeee----cCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVL----SRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~----~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .......+++.|+|||.+    .+..++.++|+||||+++|+|++|.+||
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  213 (290)
T 3fme_A          164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY  213 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred             ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            555556789999999996    4567888999999999999999999998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.3e-45  Score=263.62  Aligned_cols=196  Identities=30%  Similarity=0.393  Sum_probs=161.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-----chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|++|.||++.+.  ++.+|+|++.....     ..+.+.+|+.+++.++||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            478999999999999999999985  67899999876422     23678899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cEeecCCCCCeeecCC------CCCCEEEeecCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ---ICHRDLKLENTLLDGS------AAPRLKICDFGY  146 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~ni~i~~~------~~~~v~l~df~~  146 (200)
                      +||++++++|.+++ +..++++..+..++.|++.||.+||+.|   ++||||+|+||+++.+      ..+.++|+|||.
T Consensus        84 v~e~~~~~~L~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            99999999999888 4567999999999999999999999999   8899999999999752      134699999999


Q ss_pred             CcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          147 SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.
T Consensus       163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  215 (271)
T 3dtc_A          163 AREWHRT-TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR  215 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred             ccccccc-cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            8643322 2234568999999999988889999999999999999999999983

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.4e-45  Score=271.52  Aligned_cols=195  Identities=22%  Similarity=0.306  Sum_probs=162.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcE----EEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKEL----VAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~----~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|+||+||++.+..+++.    |++|.+....  ...+.+.+|+.++++++||||+++++++.++. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            5799999999999999999999877665    4777765432  34567999999999999999999999998765 788


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +++++.+++|.+++.+. ..++...++.++.|++.||.+||++|++||||||+||+++.++.  ++|+|||+++......
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTTC
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCCc
Confidence            99999999999999774 46999999999999999999999999999999999999987664  9999999986543332


Q ss_pred             CC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          155 RP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..   ....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  220 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY  220 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCc
Confidence            22   22345778999999999999999999999999999999 88887

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.4e-45  Score=276.48  Aligned_cols=195  Identities=24%  Similarity=0.335  Sum_probs=170.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC--------CCCeeeEEEEEe----c
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR--------HPNIIRFKEVVL----T   69 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~----~   69 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++.......+.+.+|+.+++.++        |+||+++++.+.    +
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~  116 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN  116 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence            6899999999999999999999999999999999876666678899999998885        788999999988    5


Q ss_pred             CceEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCCeeecCCC-----------
Q 029037           70 PTHLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSA-----------  135 (200)
Q Consensus        70 ~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~ni~i~~~~-----------  135 (200)
                      ....++|||++ +++|.+.+.+.  ..++...++.++.|++.||.+||++ |++||||||+||+++.++           
T Consensus       117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            56799999999 56776766554  4599999999999999999999998 999999999999997553           


Q ss_pred             ------------------------------------CCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCe
Q 029037          136 ------------------------------------APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (200)
Q Consensus       136 ------------------------------------~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (200)
                                                          ...++|+|||.+.....  ......+++.|+|||.+.+..++.+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~  273 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNTP  273 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCcH
Confidence                                                12599999999865432  2344578999999999999999999


Q ss_pred             eehhhhhhhhhhcCCCCCCC
Q 029037          180 VCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       180 ~Di~slg~~l~~~~~~~~pf  199 (200)
                      +||||||+++|+|++|.+||
T Consensus       274 ~DiwslG~il~elltg~~pf  293 (397)
T 1wak_A          274 ADIWSTACMAFELATGDYLF  293 (397)
T ss_dssp             HHHHHHHHHHHHHHHSSCSC
T ss_pred             HHHHHHHHHHHHHhhCCCCC
Confidence            99999999999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-44  Score=273.24  Aligned_cols=197  Identities=27%  Similarity=0.348  Sum_probs=172.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-CC-----CeeeEEEEEecCceEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HP-----NIIRFKEVVLTPTHLA   74 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~~~~   74 (200)
                      +++|++.+.||+|++|+||++.+..+++.||+|++.......+.+.+|+.+++.++ |+     +++++.+.+......+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            36899999999999999999999999999999999876555667788888888774 44     4999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcEeecCCCCCeeecCCCCCCEEEeecCCCccc
Q 029037           75 IVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCH--SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~  150 (200)
                      +|||++++ +|.+++....  .++...+..++.|++.||.+||  +.|++||||||+||+++++..+.++|+|||+++..
T Consensus       133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            99999964 9999997653  5899999999999999999999  57999999999999997655557999999998754


Q ss_pred             CCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          151 VLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .  .......+++.|+|||.+.+..++.++||||||+++|+|++|.+||.
T Consensus       212 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          212 G--QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             T--CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             c--cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            3  23345678999999999999999999999999999999999999983

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.5e-44  Score=264.63  Aligned_cols=195  Identities=23%  Similarity=0.328  Sum_probs=166.6

Q ss_pred             ccccccc-cccCCcceEEEEEEE--cCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVK-DLGAGNFGVARLLRH--KETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~-~l~~g~~g~v~~~~~--~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+ .||+|++|.||++.+  ..+++.|++|++.....   ..+.+.+|+.+++.++||||+++++++ +....++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            5788888 999999999999954  56678899999976432   246789999999999999999999999 5567899


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      +||++++++|.+++.+...++...+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||++........
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCS
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--cEEEccCCcceeeccCCC
Confidence            999999999999999888899999999999999999999999999999999999998666  499999999864433322


Q ss_pred             C----CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 P----KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .    ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  221 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY  221 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCC
Confidence            1    12235678999999988889999999999999999999 99887

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-44  Score=269.10  Aligned_cols=196  Identities=23%  Similarity=0.329  Sum_probs=168.5

Q ss_pred             ccccccccccCCcceEEEEEEEc-------CCCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-------ETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      ++|++.+.||+|++|.||++.+.       .++..||+|++.....  ..+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            68999999999999999999985       3567899999976432  345788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           72 HLAIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      ..++|||++++++|.+++....                .++...++.++.|++.||.+||+.|++||||+|+||+++.++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence            9999999999999999997654                388999999999999999999999999999999999998666


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .  ++|+|||++........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       195 ~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  260 (334)
T 2pvf_A          195 V--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  260 (334)
T ss_dssp             C--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             C--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence            4  99999999864433221   223346778999999988889999999999999999999 88887

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-44  Score=279.89  Aligned_cols=194  Identities=24%  Similarity=0.300  Sum_probs=169.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|+||.||++.+.. +..||+|.+.......+.+.+|+.+++.++||||+++++++. ....++|||+++
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            578999999999999999999864 567999999877666788999999999999999999999986 567899999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC--CCC
Q 029037           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPK  157 (200)
Q Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~--~~~  157 (200)
                      +++|.+++.+.  ..++...+..++.|++.||+|||++|++||||+|+||+++.++  .+||+|||+++......  ...
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~~~~~~  343 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTARE  343 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC--CEEECSTTGGGGBCCHHHHTTC
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC--cEEEeeCCCceEcCCCceeccC
Confidence            99999999754  3688999999999999999999999999999999999998665  49999999987543221  122


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||.+....++.++||||||+++|||++ |.+||
T Consensus       344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~  386 (454)
T 1qcf_A          344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY  386 (454)
T ss_dssp             SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCC
Confidence            3345678999999988889999999999999999999 89887

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4e-46  Score=281.98  Aligned_cols=192  Identities=16%  Similarity=0.064  Sum_probs=161.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHH---HHHhhCCCCCeeeEE-------EEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREI---INHRSLRHPNIIRFK-------EVV   67 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~---~~l~~l~~~~i~~~~-------~~~   67 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++...    ....+.+.+|+   ..++.++||||++++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            5799999999999999999999999999999999743    23346788999   455566899999987       666


Q ss_pred             ecCc-----------------eEEEEEEecCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCcEeec
Q 029037           68 LTPT-----------------HLAIVMEYAAGGELFDRICNAGRFSE-------DEGRYFFQQLISGVNYCHSMQICHRD  123 (200)
Q Consensus        68 ~~~~-----------------~~~~v~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~i~~~l~~lh~~~i~h~d  123 (200)
                      .+.+                 ..+++||++ +|+|.+++.+...++.       ..+..++.|++.||+|||++|++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            6553                 278999999 5799999987655555       77888999999999999999999999


Q ss_pred             CCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCc-----------ccCCeeehhhhhhhhhhc
Q 029037          124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR-----------EYDGKVCILLLILFLWRN  192 (200)
Q Consensus       124 l~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Di~slg~~l~~~  192 (200)
                      |||+||+++.++  .+||+|||+++....  ......+ +.|+|||.+.+.           .++.++|+||||+++|+|
T Consensus       232 ikp~NIll~~~~--~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          232 LRPVDIVLDQRG--GVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCGGGEEECTTC--CEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCC--CEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            999999998666  499999999874222  2233456 999999999887           899999999999999999


Q ss_pred             CCCCCCC
Q 029037          193 YRPNPFI  199 (200)
Q Consensus       193 ~~~~~pf  199 (200)
                      ++|.+||
T Consensus       307 ltg~~Pf  313 (377)
T 3byv_A          307 WCADLPI  313 (377)
T ss_dssp             HHSSCCC
T ss_pred             HHCCCCC
Confidence            9999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.6e-45  Score=265.25  Aligned_cols=195  Identities=22%  Similarity=0.293  Sum_probs=158.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCC---CcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|++|.||++.+..+   +..+++|.+....  ...+.+.+|+..+++++||||+++++++. ++..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            5899999999999999999998654   4569999887643  23467889999999999999999999985 4568899


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.... .++...+..++.|++.||.+||+.|++||||+|+||+++.++  .++|+|||++........
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC------------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC--CEEECccccccccCcccc
Confidence            99999999999997655 689999999999999999999999999999999999998665  499999999875433222


Q ss_pred             C--CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 P--KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 ~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .  ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf  218 (281)
T 1mp8_A          172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF  218 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCC
Confidence            1  22345678999999988889999999999999999996 88887

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.8e-45  Score=273.80  Aligned_cols=192  Identities=25%  Similarity=0.383  Sum_probs=152.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC------ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   72 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++....   ...+.+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            58999999999999999999999999999999997542   2345788999999999999999999998754      55


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      .+++++++ +++|.+++.. ..++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||+++....
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~  184 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTAD  184 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC---------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeeccccccccc
Confidence            79999999 7799888855 57999999999999999999999999999999999999986664  99999999874332


Q ss_pred             CCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  230 (367)
T 2fst_X          185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  230 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence              2334578999999999887 67899999999999999999999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.7e-44  Score=270.84  Aligned_cols=194  Identities=28%  Similarity=0.436  Sum_probs=168.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecC-----ceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....  ..+.+.+|+.++++++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            489999999999999999999999999999999975332  236788999999999999999999998754     3689


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      ++||++++ +|.+++.. ..++...+..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||++.......
T Consensus       107 iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          107 IVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGG
T ss_pred             EEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCC
Confidence            99999964 99998854 56999999999999999999999999999999999999986664  9999999987443332


Q ss_pred             C----CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 R----PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .    .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  232 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF  232 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC
Confidence            2    233478999999998765 45899999999999999999999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.6e-44  Score=261.75  Aligned_cols=194  Identities=23%  Similarity=0.302  Sum_probs=168.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+.+++.++||||+++++++.+ +..+++||+++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence            57999999999999999999976 45679999998776667889999999999999999999999864 45899999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC--CCC
Q 029037           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPK  157 (200)
Q Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~--~~~  157 (200)
                      +++|.+++....  .++...+..++.|++.||++||+.|++|+||+|+||++++++.  ++|+|||.+.......  ...
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  168 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTARE  168 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCT
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCccccccc
Confidence            999999986543  6899999999999999999999999999999999999986654  9999999986443322  122


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  211 (279)
T 1qpc_A          169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY  211 (279)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence            3346778999999988889999999999999999999 88887

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-44  Score=267.62  Aligned_cols=197  Identities=24%  Similarity=0.320  Sum_probs=164.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCC----cEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETK----ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~----~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|++|.||++.+..++    ..||+|.+.....  ....+.+|+.+++.++||||+++++++.+....++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            57889999999999999999987553    4599999876432  34568899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      |||++++++|.+++.+. ..++...+..++.|++.||.+||+.|++||||+|+||+++.++  .++|+|||.+.......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC--------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhcccc
Confidence            99999999999999765 4699999999999999999999999999999999999998665  49999999987543322


Q ss_pred             CC----CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          155 RP----KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       155 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      ..    ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||+
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~  252 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  252 (333)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence            11    12235678999999998899999999999999999998 999984

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=265.87  Aligned_cols=196  Identities=24%  Similarity=0.341  Sum_probs=166.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEe----cCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVL----TPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~v   76 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.    .....+++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            57999999999999999999999999999999886543 33567889999999999999999999987    33578999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ||++++++|.+++..    ...+++.++..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|||.+.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~  186 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACI  186 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCE
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhccc
Confidence            999999999999876    356999999999999999999999999999999999999986664  99999998764322


Q ss_pred             CCCC----------CcccCCCCccCCeeecCc---ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRP----------KSTVGTPAYIAPEVLSRR---EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~----------~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....          ....+++.|+|||.+.+.   .++.++|+||||+++|+|++|..||
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  246 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY  246 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCCh
Confidence            1111          112368899999998754   3688999999999999999999997

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.6e-44  Score=261.24  Aligned_cols=194  Identities=23%  Similarity=0.178  Sum_probs=167.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEE-ecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVV-LTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.... ..+.+.+|+.+++.++|+++++.+..+ .+....+++||++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            68999999999999999999999999999999987643 345688999999999987766555544 6677889999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec---CCCCCCEEEeecCCCcccCCCCC-
Q 029037           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD---GSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~---~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                       +++|.+++.. ..+++...+..++.|++.||.+||++|++||||+|+||+++   +++  .++|+|||++........ 
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCcccccccccc
Confidence             8899999974 44699999999999999999999999999999999999994   333  599999999865443322 


Q ss_pred             -------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 -------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                             .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  215 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW  215 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence                   23456899999999999989999999999999999999999998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=269.32  Aligned_cols=195  Identities=25%  Similarity=0.318  Sum_probs=158.5

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEe-----cCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVL-----TPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (200)
                      +++|++.+.||+|++|.||++.+  +++.||+|++............++..+..++||||+++++.+.     ....+++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            57899999999999999999976  4788999999765433333344444455689999999987543     2346799


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM---------QICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~---------~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                      |||++++++|.+++... ..+...+..++.|++.||.+||+.         |++||||+|+||+++.++  .++|+|||+
T Consensus        90 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG~  166 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGL  166 (336)
T ss_dssp             EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCTT
T ss_pred             EEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeeccc
Confidence            99999999999999654 458899999999999999999999         999999999999998665  499999999


Q ss_pred             CcccCCCC---------CCCcccCCCCccCCeeecC-------cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          147 SKSSVLHS---------RPKSTVGTPAYIAPEVLSR-------REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       147 ~~~~~~~~---------~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +.......         ......+++.|+|||.+.+       ..++.++||||||+++|||++|..||+
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            96443221         1223468999999999987       567788999999999999999977663

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-44  Score=268.33  Aligned_cols=196  Identities=22%  Similarity=0.290  Sum_probs=169.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc-----EEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE-----LVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|++|.||++.+..+++     .|++|.+.....  ..+.+.+|+.+++.+ +||||+++++++.+....
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            579999999999999999999976654     799999876532  346788999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCE
Q 029037           74 AIVMEYAAGGELFDRICNA--------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v  139 (200)
                      +++||++++++|.+++...              ..++...+..++.|++.||.+||+.|++||||+|+||++++++.  +
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~  203 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--A  203 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE--E
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe--E
Confidence            9999999999999998653              35799999999999999999999999999999999999986664  9


Q ss_pred             EEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          140 KICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       140 ~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +|+|||++........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  267 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY  267 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999874433222   122345778999999988889999999999999999998 88887

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.7e-45  Score=266.23  Aligned_cols=197  Identities=31%  Similarity=0.520  Sum_probs=168.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEec--CceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~   75 (200)
                      +++|++.+.||+|++|.||++.+..+++.+++|.+....   ...+.+.+|+..+++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            378999999999999999999999999999999997643   234568899999999999999999998753  568999


Q ss_pred             EEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----cEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           76 VMEYAAGGELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSMQ-----ICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                      +||++++++|.+++.+..    .+++..+..++.|++.||.+||+.|     ++|+||+|+||+++.++.  ++|+|||.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCch
Confidence            999999999999996542    4899999999999999999999999     999999999999986664  99999999


Q ss_pred             CcccCCCCC-CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          147 SKSSVLHSR-PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       147 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  216 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF  216 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            864332211 12235889999999999888999999999999999999999997

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.7e-45  Score=267.60  Aligned_cols=196  Identities=29%  Similarity=0.415  Sum_probs=153.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+....  ...+.+.+|+..++.++||||+++++++...+..+++||+
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            68999999999999999999999899999999887542  3346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           80 AAGGELFDRICN--------AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        80 ~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      +++++|.+++..        ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+....
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~  172 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLA  172 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHHHHHCC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccchheec
Confidence            999999999864        345899999999999999999999999999999999999986664  9999999886433


Q ss_pred             CCC------CCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHS------RPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~------~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  227 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY  227 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            221      1223468899999999876 46889999999999999999999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.8e-44  Score=265.34  Aligned_cols=196  Identities=30%  Similarity=0.423  Sum_probs=167.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.+++|++.... ...+.+.+|+.+++.++||||+++++++.+++..+++||++
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            57999999999999999999999999999999987643 33578899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC-CCCCCc
Q 029037           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKS  158 (200)
Q Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~-~~~~~~  158 (200)
                      ++++|.+++.+ ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||++..... ......
T Consensus        99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  176 (302)
T 2j7t_A           99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKRDS  176 (302)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC---
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCcccccccccccc
Confidence            99999998876 456999999999999999999999999999999999999986664  99999998642211 112234


Q ss_pred             ccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..+++.|+|||.+.     +..++.++|+||||+++|+|++|.+||
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  222 (302)
T 2j7t_A          177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH  222 (302)
T ss_dssp             --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCC
Confidence            56889999999983     567888999999999999999999997

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=273.95  Aligned_cols=193  Identities=12%  Similarity=0.101  Sum_probs=166.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCC--------CcEEEEEEecccccchHHHHHHHHHHhhCCCCCeee-----------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET--------KELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR-----------   62 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~--------~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-----------   62 (200)
                      ++|++.+.||+|++|.||++.+..+        ++.||+|.+...    +.+.+|+.++++++|||+++           
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            5899999999999999999999874        788999998764    46788999999999988887           


Q ss_pred             ----EEEEEec-CceEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           63 ----FKEVVLT-PTHLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        63 ----~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                          +++++.. +...+++||++ +++|.+++.+.  ..+++..+..++.|++.||.+||++|++||||+|+||+++.++
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence                6677765 67899999999 99999999876  6799999999999999999999999999999999999998765


Q ss_pred             CCCEEEeecCCCcccCCCCC--------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSR--------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++|+|||+++.......        .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            33599999999964433221        12336899999999999989999999999999999999999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.4e-44  Score=270.92  Aligned_cols=194  Identities=22%  Similarity=0.336  Sum_probs=159.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc------------hHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI------------DENVAREIINHRSLRHPNIIRFKEVVLT   69 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~   69 (200)
                      ++|++.+.||+|++|.||++.+.. ++.||+|.+......            .+.+.+|+.++++++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            689999999999999999999866 888999988653211            2678999999999999999999999843


Q ss_pred             -----CceEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEee
Q 029037           70 -----PTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (200)
Q Consensus        70 -----~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~d  143 (200)
                           ....+++||+++ ++|.+.+.... .++...+..++.|++.||.+||+.|++||||+|+||+++.++.  ++|+|
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~D  177 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICD  177 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEe
Confidence                 346899999997 58888886554 6999999999999999999999999999999999999986664  99999


Q ss_pred             cCCCcccCCCCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          144 FGYSKSSVLHSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       144 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ||++.............+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  234 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF  234 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence            999975555555555678899999999876 67899999999999999999999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-44  Score=278.05  Aligned_cols=194  Identities=24%  Similarity=0.273  Sum_probs=165.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|+||.||++.+..+ ..||+|.+.......+.+.+|+.++++++||||+++++++.+ ...++|||+++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            4689999999999999999999764 569999998766667889999999999999999999999876 67899999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--CC
Q 029037           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (200)
Q Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--~~  157 (200)
                      +++|.+++.+.  ..++...+..++.|++.||++||++|++||||+|+||++++++  .+||+|||+++.......  ..
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~  339 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  339 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC-----------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC--CEEECCCccceecCCCceeccc
Confidence            99999999643  4689999999999999999999999999999999999998665  499999999975432221  12


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |.+||
T Consensus       340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~  382 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY  382 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCC
Confidence            2345678999999988889999999999999999999 88887

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=267.52  Aligned_cols=195  Identities=22%  Similarity=0.305  Sum_probs=162.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEE----EEEEeccc--ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELV----AVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~----~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|+||.||++.+..+++.+    ++|.+...  ....+.+.+|+.+++.++||||+++++++.++. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            68999999999999999999998877655    66665432  234578999999999999999999999998765 788


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +++++.+++|.+++... ..++...++.++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||+++......
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC--------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCcc
Confidence            99999999999999774 46999999999999999999999999999999999999986664  9999999997543332


Q ss_pred             CC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          155 RP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~  220 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY  220 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCC
Confidence            22   22345678999999999899999999999999999999 88887

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-44  Score=271.20  Aligned_cols=194  Identities=22%  Similarity=0.382  Sum_probs=171.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch------------------HHHHHHHHHHhhCCCCCeee
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------------------ENVAREIINHRSLRHPNIIR   62 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~------------------~~~~~e~~~l~~l~~~~i~~   62 (200)
                      +++|++.+.||+|++|.||++.+  +++.||+|.+.......                  +.+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            36899999999999999999999  78899999997542211                  78999999999999999999


Q ss_pred             EEEEEecCceEEEEEEecCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecC
Q 029037           63 FKEVVLTPTHLAIVMEYAAGGELFDR------ICN--AGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDG  133 (200)
Q Consensus        63 ~~~~~~~~~~~~~v~e~~~~~~L~~~------l~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~  133 (200)
                      +++++.+.+..++|||++++++|.++      +.+  ...++...+..++.|++.||.+||+ .|++|+||+|+||+++.
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999999999988      655  4579999999999999999999999 99999999999999986


Q ss_pred             CCCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCc-ccCC-eeehhhhhhhhhhcCCCCCCC
Q 029037          134 SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR-EYDG-KVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       134 ~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++.  ++|+|||.+...... ......++..|+|||.+.+. .++. ++|+||||+++|+|++|.+||
T Consensus       188 ~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  252 (348)
T 2pml_X          188 NGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF  252 (348)
T ss_dssp             TSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence            664  999999998754332 33445688999999999877 6666 899999999999999999998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7e-44  Score=264.77  Aligned_cols=195  Identities=28%  Similarity=0.429  Sum_probs=168.0

Q ss_pred             ccccccccccCCcceEEEEEEEc-CCCcEEEEEEeccccc---chHHHHHHHHHHhhC---CCCCeeeEEEEEe-----c
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-ETKELVAVKYIERGRK---IDENVAREIINHRSL---RHPNIIRFKEVVL-----T   69 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~   69 (200)
                      ++|++.+.||+|++|.||++.+. .+++.||+|++.....   ....+.+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            68999999999999999999995 6788899999875322   223566777666655   8999999999987     5


Q ss_pred             CceEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037           70 PTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus        70 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                      ....+++||+++ ++|.+++....  .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~~  167 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA  167 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCccc
Confidence            567899999997 59999997754  3899999999999999999999999999999999999986664  999999998


Q ss_pred             cccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          148 KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .............+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  219 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF  219 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence            7655444445567899999999999889999999999999999999999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.2e-44  Score=258.93  Aligned_cols=192  Identities=16%  Similarity=0.294  Sum_probs=167.0

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~   75 (200)
                      +++|++.+.||+|++|.||++.+.  ++.+|+|++....   ...+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            478999999999999999999986  6779999998643   2235688999999999999999999999887  77899


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           76 VMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      +||++++++|.+++.+..  .++...+..++.|++.||.+||+.|  ++|+||+|+||++++++.  ++|.||+++..  
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~--  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFS--  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCT--
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceee--
Confidence            999999999999998765  4899999999999999999999999  999999999999987665  88888887643  


Q ss_pred             CCCCCCcccCCCCccCCeeecCcccCC---eeehhhhhhhhhhcCCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSRREYDG---KVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Di~slg~~l~~~~~~~~pf~  200 (200)
                        .......+++.|+|||.+.+..++.   ++|+||||+++|+|++|.+||.
T Consensus       163 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  212 (271)
T 3kmu_A          163 --FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA  212 (271)
T ss_dssp             --TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred             --ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence              2223456789999999998766554   6899999999999999999983

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.4e-44  Score=272.77  Aligned_cols=191  Identities=28%  Similarity=0.424  Sum_probs=161.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecC------ceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTP------THLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~~   75 (200)
                      .+|++.+.||+|+||+||++.+..+++ +++|.+......   ..+|+.+++.++||||+++++++...      ..+++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            479999999999999999999988776 777766543322   23699999999999999999998543      33889


Q ss_pred             EEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec-CCCCCCEEEeecCCCccc
Q 029037           76 VMEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-GSAAPRLKICDFGYSKSS  150 (200)
Q Consensus        76 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~-~~~~~~v~l~df~~~~~~  150 (200)
                      |||+++++ +.+.+.    ....++...+..++.|++.||+|||++|++||||+|+||+++ .++  .++|+|||+++..
T Consensus       116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEEC
T ss_pred             EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccc
Confidence            99999764 433332    245799999999999999999999999999999999999997 344  5999999999866


Q ss_pred             CCCCCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          151 VLHSRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..........+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  242 (394)
T 4e7w_A          193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF  242 (394)
T ss_dssp             CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            666666667889999999998765 5899999999999999999999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.8e-44  Score=266.52  Aligned_cols=196  Identities=19%  Similarity=0.265  Sum_probs=169.0

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+.     .+++.|++|.+.....  ....+.+|+.+++.++||||+++++++.+....+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            57999999999999999999887     3577899999976433  2356889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           75 IVMEYAAGGELFDRICNA----------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                      ++||++++++|.+++.+.          .+++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+||
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~Df  182 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDF  182 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCT
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEECcC
Confidence            999999999999998653          35689999999999999999999999999999999999986654  999999


Q ss_pred             CCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          145 GYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       145 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      |++........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  241 (322)
T 1p4o_A          183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY  241 (322)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcc
Confidence            99864432221   122345788999999988889999999999999999999 77776

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.9e-44  Score=262.23  Aligned_cols=196  Identities=29%  Similarity=0.410  Sum_probs=165.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHHHhhCCCCCeeeEEEEEe--cCceE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----KIDENVAREIINHRSLRHPNIIRFKEVVL--TPTHL   73 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~   73 (200)
                      +++|++.+.||+|++|.||++.+..+++.+++|++....     ...+.+.+|+.+++.++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            479999999999999999999999999999999997642     33467899999999999999999999984  45578


Q ss_pred             EEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           74 AIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      +++||+++++ |.+.+..  ...++...+..++.|++.||.+||++|++|+||+|+||+++.++.  ++|+|||.+....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~  160 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH  160 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence            9999999775 7777765  346999999999999999999999999999999999999986664  9999999986543


Q ss_pred             CCCC---CCcccCCCCccCCeeecCcc--cCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSR---PKSTVGTPAYIAPEVLSRRE--YDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~---~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....   .....+++.|+|||.+.+..  ++.++|+||||+++|+|++|..||
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  213 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF  213 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC
Confidence            2211   23345889999999987643  477899999999999999999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.3e-44  Score=261.62  Aligned_cols=194  Identities=23%  Similarity=0.179  Sum_probs=164.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEE-ecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVV-LTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|+..... ..+.+.+|..+++.++|++++..+..+ .+....+++||++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            58999999999999999999999999999999876543 234688899999999887766655554 6677889999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeee---cCCCCCCEEEeecCCCcccCCCCC-
Q 029037           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL---DGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i---~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                       +++|.+++.. ..+++...+..++.|++.||.+||++|++||||+|+||++   ++++  .++|+|||++........ 
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccCcccC
Confidence             8899999975 4569999999999999999999999999999999999999   4444  599999999875433322 


Q ss_pred             -------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 -------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                             .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  215 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW  215 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCC
Confidence                   23456899999999999999999999999999999999999998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=260.00  Aligned_cols=197  Identities=27%  Similarity=0.392  Sum_probs=167.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|.....||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++.+....+++||++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34555569999999999999999999999999987653 33567899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC-CCCCCEEEeecCCCcccCCCC-C
Q 029037           81 AGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHS-R  155 (200)
Q Consensus        81 ~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~-~~~~~v~l~df~~~~~~~~~~-~  155 (200)
                      ++++|.+++....   .++...+..++.|++.||.+||+.|++|+||+|+||+++. ++  .++|+|||.+....... .
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC--CEEECCTTTCEESCC----
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC--CEEEeecccccccCCCCCc
Confidence            9999999997653   4678889999999999999999999999999999999975 33  59999999986443322 2


Q ss_pred             CCcccCCCCccCCeeecCc--ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRR--EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .....+++.|+|||.+.+.  .++.++|+||||+++|+|++|.+||+
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  226 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY  226 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence            3345688999999999764  37889999999999999999999984

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.7e-44  Score=266.53  Aligned_cols=198  Identities=22%  Similarity=0.278  Sum_probs=165.1

Q ss_pred             ccccccccccCCcceEEEEEE-----EcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLR-----HKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|.||++.     +..+++.||+|.+....  .....+.+|+.+++.++||||+++++++.+....+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            589999999999999999999     55678889999997542  33457889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCC
Q 029037           75 IVMEYAAGGELFDRICNAG-------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGY  146 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~  146 (200)
                      ++||++++++|.+++....       .++...++.++.|++.||.+||+.|++||||+|+||+++.++ ...++|+|||+
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            9999999999999998753       388999999999999999999999999999999999997433 33599999998


Q ss_pred             CcccCCCC---CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          147 SKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       147 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      +.......   ......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  246 (327)
T 2yfx_A          190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY  246 (327)
T ss_dssp             HHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            86332221   2233457889999999988889999999999999999998 87876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-44  Score=259.81  Aligned_cols=195  Identities=25%  Similarity=0.367  Sum_probs=166.4

Q ss_pred             ccccccc-cccCCcceEEEEEEEc--CCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVK-DLGAGNFGVARLLRHK--ETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~-~l~~g~~g~v~~~~~~--~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|.+.+ .||+|++|.||++.+.  .++..||+|++....  ...+.+.+|+.+++.++||||+++++++ ..+..+++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4677777 9999999999999864  467789999998743  3346789999999999999999999999 45568999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.+. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||++........
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceeeeccCcc
Confidence            9999999999999654 4599999999999999999999999999999999999998665  499999999875433222


Q ss_pred             ----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 ----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                          .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  214 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY  214 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence                122345788999999988889999999999999999998 99887

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.2e-44  Score=261.20  Aligned_cols=192  Identities=27%  Similarity=0.403  Sum_probs=161.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecC-ceEEEEEEe
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTP-THLAIVMEY   79 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~   79 (200)
                      +++|++.+.||+|++|+||++.+.  ++.|++|.+... ...+.+.+|+..++.++|||++++++++.+. ...+++||+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            368999999999999999999875  678999998764 3467899999999999999999999987654 478999999


Q ss_pred             cCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           80 AAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      +++++|.+++.+...  ++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+.....  ...
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~--~~~  172 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--TQD  172 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeeccccccccc--ccc
Confidence            999999999976543  899999999999999999999999999999999999986664  99999999864332  222


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  215 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY  215 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCC
Confidence            3456788999999988889999999999999999998 88887

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=264.49  Aligned_cols=195  Identities=24%  Similarity=0.325  Sum_probs=154.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCC-CCCeeeEEEEEe--------cCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLR-HPNIIRFKEVVL--------TPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--------~~~   71 (200)
                      .+|++.+.||+|++|.||++.+..+++.||+|.+..... ..+.+.+|+..++++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            379999999999999999999999999999998865433 3467889999999996 999999999983        345


Q ss_pred             eEEEEEEecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           72 HLAIVMEYAAGGELFDRICN---AGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                      .++++||+++ ++|.+++..   ..+++...++.++.|++.||.+||+.|  ++||||+|+||+++.++.  ++|+|||+
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCTT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCcc
Confidence            6899999995 689888864   456999999999999999999999999  999999999999987664  99999999


Q ss_pred             CcccCCCCCC-------------CcccCCCCccCCeee---cCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          147 SKSSVLHSRP-------------KSTVGTPAYIAPEVL---SRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       147 ~~~~~~~~~~-------------~~~~~~~~~~aPE~~---~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +.........             ....+++.|+|||.+   .+..++.++|+||||+++|+|++|.+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            8754432221             134588899999998   5667888999999999999999999997

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.2e-44  Score=265.27  Aligned_cols=194  Identities=28%  Similarity=0.377  Sum_probs=165.6

Q ss_pred             cc-cccccccCCcceEEEEEE----EcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecC--ceE
Q 029037            3 KY-ELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THL   73 (200)
Q Consensus         3 ~y-~~~~~l~~g~~g~v~~~~----~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   73 (200)
                      +| ++.+.||+|++|+||++.    +..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+.  ..+
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            45 999999999999997765    45578899999998653  2346789999999999999999999999874  678


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +++||++++++|.+++.+. .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.  ++|+|||.+......
T Consensus       111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCTT
T ss_pred             EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCcccccccccc
Confidence            9999999999999998554 5899999999999999999999999999999999999986654  999999998754433


Q ss_pred             CC----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SR----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..    .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~  237 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS  237 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcc
Confidence            22    22334677899999999888999999999999999999999887

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-43  Score=263.50  Aligned_cols=196  Identities=24%  Similarity=0.307  Sum_probs=149.4

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHH-HHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREII-NHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      .++|++.+.||+|++|.||++.+..+++.||+|.+.....  ....+..|+. +++.++||||+++++++.+++..+++|
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            3689999999999999999999999999999999976432  2334555555 677889999999999999999999999


Q ss_pred             EecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           78 EYAAGGELFDRICN-----AGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        78 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      |++++ +|.+++..     ...++...+..++.|++.||.+||+. |++||||+|+||+++.++.  ++|+|||++....
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCceecc
Confidence            99975 88777753     45789999999999999999999998 9999999999999986664  9999999997655


Q ss_pred             CCCCCCcccCCCCccCCeee----cCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVL----SRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .........+++.|+|||.+    .+..++.++|+||||+++|+|++|..||
T Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (327)
T 3aln_A          178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY  229 (327)
T ss_dssp             ----------------------------CCSHHHHHHHHHHHHHHHHSCCCS
T ss_pred             cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            44444445789999999998    4567889999999999999999999997

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.8e-44  Score=260.65  Aligned_cols=195  Identities=22%  Similarity=0.271  Sum_probs=165.3

Q ss_pred             ccccccccccCCcceEEEEEEEcC---CCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE---TKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|++|.||++.+..   ++..|++|.+....  ...+.+.+|+.+++.++||||+++++++.++ ..+++
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence            689999999999999999999654   34569999987642  2346788999999999999999999998754 56899


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.+.. .++...+..++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||.+........
T Consensus        91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE--CVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT--EEEECCCCGGGCC-----
T ss_pred             EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC--cEEeCccCCCcccccccc
Confidence            99999999999997654 599999999999999999999999999999999999998666  499999999875433222


Q ss_pred             --CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 --PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                        .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~  215 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF  215 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCc
Confidence              223346778999999988889999999999999999998 99987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.7e-44  Score=266.50  Aligned_cols=195  Identities=26%  Similarity=0.395  Sum_probs=170.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-------chHHHHHHHHHHhhCC--CCCeeeEEEEEecCce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR--HPNIIRFKEVVLTPTH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~   72 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....       ..+.+.+|+.+++.++  |||++++++++.+...
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            579999999999999999999999999999999976432       1245678999999886  5999999999999999


Q ss_pred             EEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec-CCCCCCEEEeecCCCccc
Q 029037           73 LAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-GSAAPRLKICDFGYSKSS  150 (200)
Q Consensus        73 ~~~v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~-~~~~~~v~l~df~~~~~~  150 (200)
                      .++++|++.+ ++|.+++.+...++...+..++.|++.||++||+.|++||||+|+||+++ +++  .++|+|||++...
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~~  200 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALL  200 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCcccccc
Confidence            9999999976 79999998888899999999999999999999999999999999999997 334  5999999998744


Q ss_pred             CCCCCCCcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCC
Q 029037          151 VLHSRPKSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .. .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||
T Consensus       201 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf  249 (320)
T 3a99_A          201 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF  249 (320)
T ss_dssp             CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence            32 23334568999999999876665 67889999999999999999997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.6e-44  Score=272.68  Aligned_cols=192  Identities=18%  Similarity=0.135  Sum_probs=149.6

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHH---HHHhhCCCCCeeeEE-------EEEe
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREI---INHRSLRHPNIIRFK-------EVVL   68 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~---~~l~~l~~~~i~~~~-------~~~~   68 (200)
                      +|++.+.||+|++|.||++.+..+++.||+|++.....    ..+.+.+|+   ..++. +|||+++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            58999999999999999999999999999999987532    234566774   45555 799988855       4443


Q ss_pred             cC-----------------ceEEEEEEecCCCchHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHhCCcEeecC
Q 029037           69 TP-----------------THLAIVMEYAAGGELFDRICNAG-RFSEDEG------RYFFQQLISGVNYCHSMQICHRDL  124 (200)
Q Consensus        69 ~~-----------------~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~------~~~~~~i~~~l~~lh~~~i~h~dl  124 (200)
                      ..                 ...++|||+++ ++|.+++...+ .++....      ..++.|++.||+|||++|++||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            32                 34899999998 79999997643 3555555      678899999999999999999999


Q ss_pred             CCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecC--cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR--REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       125 ~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ||+||+++.++.  +||+|||+++....  ......+++.|+|||.+.+  ..++.++|+||||+++|+|++|.+||.
T Consensus       221 kp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          221 TPDNLFIMPDGR--LMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             SGGGEEECTTSC--EEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CHHHEEECCCCC--EEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            999999987664  99999999874422  1114456799999999987  678999999999999999999999983

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.9e-44  Score=265.62  Aligned_cols=194  Identities=30%  Similarity=0.436  Sum_probs=148.6

Q ss_pred             ccccccc-cccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEec----CceEEEE
Q 029037            2 EKYELVK-DLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT----PTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~-~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v   76 (200)
                      ++|.+.+ .||+|++|+||++.+..+++.||+|++.....   ...+....++.++|||++++++++..    ....++|
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            5788855 69999999999999999999999999876432   22233344667799999999999876    4568999


Q ss_pred             EEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccCCC
Q 029037           77 MEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLH  153 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~~~  153 (200)
                      ||+++|++|.+++.+..  .++..+++.++.|++.||.+||++|++||||+|+||+++.++ ...++|+|||++.... .
T Consensus       105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~-~  183 (336)
T 3fhr_A          105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-Q  183 (336)
T ss_dssp             EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc-c
Confidence            99999999999998764  599999999999999999999999999999999999997533 3459999999986433 2


Q ss_pred             CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (336)
T 3fhr_A          184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF  229 (336)
T ss_dssp             --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            2334456799999999999889999999999999999999999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.8e-43  Score=259.77  Aligned_cols=191  Identities=30%  Similarity=0.459  Sum_probs=162.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEec------------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT------------   69 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------------   69 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.......+.+.+|+.+++.++|||++++++++.+            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            57999999999999999999999999999999998765556789999999999999999999998865            


Q ss_pred             -CceEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037           70 -PTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus        70 -~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                       ....+++||++++++|.+++.+.. .++...+..++.|++.||++||++|++|+||+|+||+++.++.  ++|+|||.+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~  163 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLA  163 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcch
Confidence             356899999999999999997654 5788999999999999999999999999999999999986664  999999998


Q ss_pred             cccCCC---------------CCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCC
Q 029037          148 KSSVLH---------------SRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYR  194 (200)
Q Consensus       148 ~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~  194 (200)
                      ......               .......+++.|+|||.+.+. .++.++|+||||+++|+|++
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            644321               112334588999999999865 68899999999999999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.7e-44  Score=262.71  Aligned_cols=196  Identities=23%  Similarity=0.281  Sum_probs=158.5

Q ss_pred             ccccccccccCCcceEEEEEEEcC---CCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecCc----
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE---TKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPT----   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   71 (200)
                      ++|++.+.||+|++|.||++.+..   ++..||+|.+......   .+.+.+|+..+++++||||+++++++.+..    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            579999999999999999998765   5568999998764322   356889999999999999999999998754    


Q ss_pred             -eEEEEEEecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           72 -HLAIVMEYAAGGELFDRICN------AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        72 -~~~~v~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                       ..+++||++++++|.+++..      ...++...++.++.|++.||.+||+.|++||||+|+||+++.++.  ++|+||
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~Df  191 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADF  191 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECSC
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEeec
Confidence             35999999999999999843      345899999999999999999999999999999999999986664  999999


Q ss_pred             CCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          145 GYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       145 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      |++........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  250 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY  250 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCC
Confidence            99865433221   122346778999999999899999999999999999999 77776

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=261.63  Aligned_cols=195  Identities=27%  Similarity=0.361  Sum_probs=161.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEe------------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVL------------   68 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------------   68 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            68999999999999999999999999999999987643 33467889999999999999999999874            


Q ss_pred             --cCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCC
Q 029037           69 --TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (200)
Q Consensus        69 --~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~  146 (200)
                        +....+++||+++ ++|.+++. ..+++...+..++.|++.||++||++|++||||+|+||+++.++ ..++|+|||.
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~  167 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGL  167 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTT
T ss_pred             ccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCcc
Confidence              3467899999997 59999884 45789999999999999999999999999999999999997433 2599999999


Q ss_pred             CcccCCC----CCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          147 SKSSVLH----SRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       147 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +......    .......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf  225 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF  225 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC
Confidence            8754322    12233456889999999865 67889999999999999999999998

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.7e-44  Score=265.83  Aligned_cols=196  Identities=22%  Similarity=0.338  Sum_probs=168.3

Q ss_pred             ccccccccccCCcceEEEEEEE-----cCCCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCc-e
Q 029037            2 EKYELVKDLGAGNFGVARLLRH-----KETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPT-H   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~-~   72 (200)
                      ++|++.+.||+|++|.||++.+     ..+++.||+|++.....  ..+.+.+|+.+++.+ +||||+++++++.+.+ .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999985     35678899999986533  235688999999999 6899999999987754 5


Q ss_pred             EEEEEEecCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGR----------------FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA  136 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~  136 (200)
                      ++++||++++++|.+++.....                ++...+..++.|++.||.+||+.|++||||+|+||+++.++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence            8999999999999999977654                789999999999999999999999999999999999986654


Q ss_pred             CCEEEeecCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          137 PRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       137 ~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                        ++|+|||++.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       187 --~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          187 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             --EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             --EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence              999999998754332221   22346788999999998889999999999999999998 88887

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-43  Score=266.19  Aligned_cols=195  Identities=24%  Similarity=0.343  Sum_probs=169.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCC-cEEEEEEecccccchHHHHHHHHHHhhCCCCC------eeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETK-ELVAVKYIERGRKIDENVAREIINHRSLRHPN------IIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~-~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|+||++.+..++ +.||+|++.......+.+.+|+.+++.++|++      ++.+.+++......+
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            68999999999999999999998776 68999999876666678888999998886554      899999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC-----------------C
Q 029037           75 IVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-----------------A  135 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~-----------------~  135 (200)
                      ++||++ ++++.+.+....  +++...+..++.|++.||++||++|++||||+|+||+++.+                 .
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence            999999 667777776654  69999999999999999999999999999999999999432                 2


Q ss_pred             CCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...++|+|||++....  .......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       178 ~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (355)
T 2eu9_A          178 NTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF  239 (355)
T ss_dssp             CCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence            3469999999986432  2334457899999999999999999999999999999999999998

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=259.93  Aligned_cols=196  Identities=23%  Similarity=0.336  Sum_probs=165.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCc---EEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceE-EEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHL-AIV   76 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~v   76 (200)
                      .|++.+.||+|++|+||++.+..+++   .+++|.+.....  ..+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            35667999999999999999765544   799999876433  236788999999999999999999999876654 999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC--
Q 029037           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--  153 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~--  153 (200)
                      ||++.+++|.+++.+. ..++...+..++.|++.||++||+.|++||||+|+||++++++.  ++|+|||++......  
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCcc
Confidence            9999999999999763 46899999999999999999999999999999999999986664  999999998643322  


Q ss_pred             ---CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 ---SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                         .......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+|
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~  229 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY  229 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence               12233456788999999999999999999999999999999666654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=264.01  Aligned_cols=196  Identities=26%  Similarity=0.395  Sum_probs=168.7

Q ss_pred             ccccccccccCCcceEEEEEE----EcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCc--eEE
Q 029037            2 EKYELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPT--HLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~----~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~   74 (200)
                      ++|++.+.||+|++|.||++.    +..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++....  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            469999999999999999998    466789999999976433 3467899999999999999999999987654  689


Q ss_pred             EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           75 IVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++||++++++|.+++.+.. .++...+..++.|++.||.+||+.|++||||+|+||++++++.  ++|+|||++......
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQD  198 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCSS
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhcccc
Confidence            9999999999999998764 5999999999999999999999999999999999999986664  999999998754433


Q ss_pred             CC----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SR----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..    .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~  248 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS  248 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred             ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence            22    12234567799999998888999999999999999999998876

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.4e-44  Score=268.49  Aligned_cols=191  Identities=27%  Similarity=0.402  Sum_probs=164.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceE-----
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHL-----   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-----   73 (200)
                      ++|.+.+.||+|++|.||++.+..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++......     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            589999999999999999999999999999999976432   246788999999999999999999999877654     


Q ss_pred             -EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           74 -AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        74 -~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                       +++||+++ ++|.+.+.  ..++...+..++.|++.||++||+.|++||||+|+||+++.++.  ++|+|||+++... 
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~-  195 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD-  195 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC-----
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc-
Confidence             99999996 58877763  35999999999999999999999999999999999999986664  9999999986432 


Q ss_pred             CCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                       .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       196 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  242 (371)
T 4exu_A          196 -AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF  242 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             -cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence             22344568999999999987 67899999999999999999999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-43  Score=265.66  Aligned_cols=195  Identities=29%  Similarity=0.386  Sum_probs=166.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecC-----ceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   74 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++++...     ...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            58999999999999999999999999999999997532  2245678999999999999999999988754     6789


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      ++||+++ ++|.+++.. ..++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||++.......
T Consensus        91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC---
T ss_pred             EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEeccccccccccc
Confidence            9999996 589988865 57999999999999999999999999999999999999986664  9999999986443221


Q ss_pred             C-----------CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 R-----------PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~-----------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .           .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||.
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  224 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP  224 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence            1           122357899999998764 678899999999999999999999983

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=261.81  Aligned_cols=190  Identities=31%  Similarity=0.494  Sum_probs=161.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|++|+||++.+.  ++.|++|.+... ...+.+.+|+..+++++||||+++++++.+.  .++|||+++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCC
Confidence            68999999999999999999885  577999998753 3457789999999999999999999988743  689999999


Q ss_pred             CCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           82 GGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHS---MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        82 ~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      +++|.+++....   .++...++.++.|++.||++||+   +|++||||+|+||++++++. .++|+|||++.....  .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~--~  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT--H  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC---------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc--c
Confidence            999999997655   37889999999999999999999   89999999999999976553 379999999864332  2


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~  203 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF  203 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred             cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            23346899999999999989999999999999999999999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.2e-43  Score=271.99  Aligned_cols=194  Identities=25%  Similarity=0.243  Sum_probs=168.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCC-CCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... .+.+.+|..+++.++| +++..+..++.+....+++||++
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            689999999999999999999999999999998776432 3458889999999976 56666667777888899999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec---CCCCCCEEEeecCCCcccCCCCC-
Q 029037           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD---GSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~---~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                       +++|.+++.. ...++..+++.++.||+.||.|||++|++||||+|+||+++   .++  .++|+|||+++....... 
T Consensus        86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC--eEEEEeCCcceeccCCccc
Confidence             8899999975 45799999999999999999999999999999999999994   333  599999999975443322 


Q ss_pred             -------CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 -------PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                             .....+++.|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf  213 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW  213 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence                   12456899999999999999999999999999999999999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6e-44  Score=283.23  Aligned_cols=199  Identities=29%  Similarity=0.371  Sum_probs=174.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc--ccchHHHHHHHHHHhhCCCCCeeeEEEEEec------Cce
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLT------PTH   72 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~   72 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|++...  ....+.+.+|+.+++.++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999999999999999998764  2334678899999999999999999998765      667


Q ss_pred             EEEEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC-CCEEEeecCCCc
Q 029037           73 LAIVMEYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-PRLKICDFGYSK  148 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~-~~v~l~df~~~~  148 (200)
                      .++|||+++|++|.+++....   .+++..+..++.|++.||++||+.|++||||+|+||+++.++. ..++|+|||.+.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999999999999997654   5899999999999999999999999999999999999986543 248999999998


Q ss_pred             ccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          149 SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ............+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf  223 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF  223 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence            666555556667999999999999999999999999999999999999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.3e-44  Score=279.84  Aligned_cols=194  Identities=24%  Similarity=0.275  Sum_probs=169.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|+||.||++.+..+ ..||+|.+.......+.+.+|+.++++++||||+++++++.+ ...++|||+++
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            4789999999999999999999764 569999998766667889999999999999999999999876 67899999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC--CCC
Q 029037           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPK  157 (200)
Q Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~--~~~  157 (200)
                      +++|.+++.+.  ..++..+++.++.|++.||+|||++|++||||+|+||+++.++  .+||+|||+++......  ...
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~  422 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  422 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCTTSTTTCCCHHHHTTC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC--cEEEcccccceecCCCceeccc
Confidence            99999999643  4689999999999999999999999999999999999998665  49999999987443211  122


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |.+||
T Consensus       423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~  465 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY  465 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSS
T ss_pred             CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            3345678999999988889999999999999999999 88887

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=270.92  Aligned_cols=195  Identities=27%  Similarity=0.395  Sum_probs=152.7

Q ss_pred             cccc-cccccCCcceEEEEEEEc--CCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEec--CceEEEEE
Q 029037            3 KYEL-VKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAIVM   77 (200)
Q Consensus         3 ~y~~-~~~l~~g~~g~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~   77 (200)
                      .|++ .+.||+|+||+||++.+.  .+++.||+|.+... .....+.+|+.+++.++||||+++++++..  ....++||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            4666 458999999999999966  46788999999764 345678899999999999999999999954  67899999


Q ss_pred             EecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC--CCCCCEEEeecCC
Q 029037           78 EYAAGGELFDRICNA---------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG--SAAPRLKICDFGY  146 (200)
Q Consensus        78 e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~--~~~~~v~l~df~~  146 (200)
                      |++++ +|.+.+...         ..++...++.++.|++.||+|||+.|++||||+|+||++..  +..+.++|+|||+
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            99965 887777532         14899999999999999999999999999999999999942  2334699999999


Q ss_pred             CcccCCC----CCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          147 SKSSVLH----SRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       147 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ++.....    .......+++.|+|||.+.+. .++.++||||||+++|+|++|.+||
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  236 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  236 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence            9754332    122345689999999999874 5899999999999999999999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-43  Score=261.79  Aligned_cols=187  Identities=26%  Similarity=0.402  Sum_probs=155.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHh--hCCCCCeeeEEEEEecC----ceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR--SLRHPNIIRFKEVVLTP----THLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~----~~~~~   75 (200)
                      ++|++.+.||+|++|.||++.+.  ++.||+|++....  .....+|.+++.  .++||||+++++++.+.    ...++
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            57999999999999999999886  7889999987543  333444444444  45999999999999887    68999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM--------QICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                      +||++++++|.+++.+ ..++...+..++.|++.||.+||+.        |++||||+|+||+++.++.  ++|+|||++
T Consensus       113 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a  189 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA  189 (337)
T ss_dssp             EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTC
T ss_pred             EEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCc
Confidence            9999999999999955 4689999999999999999999998        9999999999999986664  999999998


Q ss_pred             cccCCCCCC-----CcccCCCCccCCeeecCcccCCe------eehhhhhhhhhhcCCC
Q 029037          148 KSSVLHSRP-----KSTVGTPAYIAPEVLSRREYDGK------VCILLLILFLWRNYRP  195 (200)
Q Consensus       148 ~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~------~Di~slg~~l~~~~~~  195 (200)
                      .........     ....+++.|+|||.+.+...+..      +||||||+++|||++|
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            644332222     24468999999999987766555      8999999999999999

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.4e-43  Score=256.77  Aligned_cols=191  Identities=28%  Similarity=0.345  Sum_probs=164.3

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      |...+.||+|++|.||++.+  +++.+++|.+....     ...+.+.+|+.+++.++||||+++++++.+....+++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44558999999999999987  46789999987532     234678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           79 YAAGGELFDRICN---AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        79 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ++++++|.+++..   ..+++...++.++.|++.||.+||+.|++||||+|+||+++.++  .++|+|||.+........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSCSS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeecccccccccccc
Confidence            9999999999964   34589999999999999999999999999999999999998665  499999999864433222


Q ss_pred             ---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 ---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                         .....+++.|+|||.+.+ .++.++|+||||+++|+|++|.+||
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~  234 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV  234 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred             cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCc
Confidence               233468999999998865 5889999999999999999999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2e-43  Score=259.34  Aligned_cols=196  Identities=22%  Similarity=0.273  Sum_probs=162.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCC---CcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEe-cCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVL-TPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~   75 (200)
                      .+|++.+.||+|++|+||++.+..+   ...+++|.+.....  ..+.+.+|+.++++++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            3688999999999999999997543   34589998876432  3467889999999999999999999854 4567899


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +||++++++|.+++.+. ..++...+..++.|++.||.+||++|++||||+|+||++++++  .++|+|||.+.......
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSCGG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECcccccccccccc
Confidence            99999999999999764 3589999999999999999999999999999999999998665  49999999987443322


Q ss_pred             C-----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 R-----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .     .....+++.|+|||.+.+..+++++|+||||+++|+|++|..|+
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  232 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP  232 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            1     22334677899999999888999999999999999999955444

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-43  Score=259.47  Aligned_cols=192  Identities=24%  Similarity=0.345  Sum_probs=155.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|++|+||++.+..   .+++|++.....   ..+.+.+|+.++++++||||++++++. .....+++||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            579999999999999999998754   489999875432   235688999999999999999999965 5566899999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC---CC
Q 029037           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL---HS  154 (200)
Q Consensus        79 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~---~~  154 (200)
                      ++++++|.+++... ..++...+..++.|++.||.+||+.|++||||+|+||+++.++  .++|+|||++.....   ..
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC------------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceeccccccccccc
Confidence            99999999999544 4599999999999999999999999999999999999998766  499999999864332   12


Q ss_pred             CCCcccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......+++.|+|||.+.   +..++.++|+||||+++|+|++|..||
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  225 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY  225 (289)
T ss_dssp             ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence            223346899999999986   556788999999999999999999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.5e-44  Score=268.50  Aligned_cols=195  Identities=23%  Similarity=0.289  Sum_probs=171.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-----------CCCeeeEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-----------HPNIIRFKEVVLTP   70 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~~   70 (200)
                      ++|++.+.||+|++|+||++.+..+++.||+|++.......+.+.+|+.+++.++           ||||+++++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            5899999999999999999999999999999999876666678889999988875           78999999998865


Q ss_pred             c----eEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCCeeecCC----CCCCE
Q 029037           71 T----HLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGS----AAPRL  139 (200)
Q Consensus        71 ~----~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~ni~i~~~----~~~~v  139 (200)
                      .    ..+++||++ +++|.+++.+.  ..++...+..++.|++.||++||++ |++||||+|+||+++.+    ....+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceE
Confidence            4    789999999 88999999764  3599999999999999999999998 99999999999999532    22359


Q ss_pred             EEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       140 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +|+|||++.....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||
T Consensus       178 kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  235 (373)
T 1q8y_A          178 KIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF  235 (373)
T ss_dssp             EECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             EEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            9999999864432  234457899999999999999999999999999999999999998

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.7e-43  Score=281.34  Aligned_cols=190  Identities=24%  Similarity=0.337  Sum_probs=161.9

Q ss_pred             ccccCCcceEEEEEEE--cCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRH--KETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~--~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|+||.||++.+  ..+++.||+|+++....   ..+.+.+|+.+++.++||||+++++++.+ ...++|||++++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999955  45678899999986432   34789999999999999999999999975 458899999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC----CCc
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR----PKS  158 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~----~~~  158 (200)
                      ++|.+++.+...++...+..++.|++.||+|||++|++||||+|+||+++.++.  +||+|||+++.......    ...
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccccccccC
Confidence            999999988888999999999999999999999999999999999999986664  99999999864433222    122


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      ..+++.|+|||.+.+..++.++||||||+++|||++ |.+||.
T Consensus       532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~  574 (635)
T 4fl3_A          532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  574 (635)
T ss_dssp             ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            235678999999998899999999999999999998 999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=257.61  Aligned_cols=196  Identities=24%  Similarity=0.319  Sum_probs=150.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      +++|++.+.||+|++|.||++.+..+++.||+|.+.......   +.+.++..+++.++||||+++++++.++...+++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            468999999999999999999999999999999997643222   23444556678889999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      |++ ++.+...... ...++...+..++.|++.||.+||+. |++|+||+|+||+++.++.  ++|+|||++........
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC--------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCcc
Confidence            999 5556555543 45799999999999999999999995 9999999999999986664  99999999875554444


Q ss_pred             CCcccCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....+++.|+|||.+.     ...++.++|+||||+++|+|++|..||
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY  229 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCC
Confidence            45567899999999984     456788999999999999999999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-43  Score=265.89  Aligned_cols=195  Identities=22%  Similarity=0.281  Sum_probs=155.9

Q ss_pred             cccccccccCCcceEEEEEEEcCC---CcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEec-CceEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLAIV   76 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v   76 (200)
                      +|++.+.||+|+||+||++.+..+   +..+++|.+....  ...+.+.+|+.++++++||||+++++++.+ ++..+++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            477889999999999999997543   3468999887532  234678999999999999999999998654 4578999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.+.. .++...+..++.|++.||.+||++|++||||+|+||+++.++  .+||+|||+++.......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC--CEEEeecccccccccccc
Confidence            99999999999997654 588999999999999999999999999999999999998665  499999999874432221


Q ss_pred             -----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 -----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 -----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                           .....+++.|+|||.+.+..++.++|+||||+++|||++ |.+||
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~  297 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY  297 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCC
Confidence                 122346678999999998899999999999999999999 55555

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-44  Score=263.08  Aligned_cols=195  Identities=29%  Similarity=0.406  Sum_probs=163.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc-------hHHHHHHHHHHhhC----CCCCeeeEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-------DENVAREIINHRSL----RHPNIIRFKEVVLTP   70 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~e~~~l~~l----~~~~i~~~~~~~~~~   70 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++......       ...+.+|+..++++    +||||+++++++.+.
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            5799999999999999999999999999999999764321       23356788888888    899999999999999


Q ss_pred             ceEEEEEEe-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeec-CCCCCCEEEeecCCCc
Q 029037           71 THLAIVMEY-AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-GSAAPRLKICDFGYSK  148 (200)
Q Consensus        71 ~~~~~v~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~-~~~~~~v~l~df~~~~  148 (200)
                      +..++++|+ +.+++|.+++.+...++...+..++.|++.||.+||+.|++||||+|+||+++ +++  .++|+|||++.
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~  188 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGA  188 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCE
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhh
Confidence            999999999 78899999999888899999999999999999999999999999999999997 444  59999999987


Q ss_pred             ccCCCCCCCcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCC
Q 029037          149 SSVLHSRPKSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .... .......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||
T Consensus       189 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  239 (312)
T 2iwi_A          189 LLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF  239 (312)
T ss_dssp             ECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             hccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCC
Confidence            4433 23344568999999999876655 45899999999999999999998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-42  Score=259.55  Aligned_cols=187  Identities=29%  Similarity=0.363  Sum_probs=161.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhh--CCCCCeeeEEEEEecCc----eEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS--LRHPNIIRFKEVVLTPT----HLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~----~~~~   75 (200)
                      ++|++.+.||+|++|.||++.+.  ++.||+|++...  ..+.+.+|.++++.  ++||||+++++++....    ..++
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            57999999999999999999984  788999998753  34567788888877  78999999999998876    7999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH--------SMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                      +||++++++|.+++.+ .+++...+..++.|++.||.+||        +.|++||||+|+||+++.++.  ++|+|||++
T Consensus       118 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~  194 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA  194 (342)
T ss_dssp             EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTC
T ss_pred             EEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCc
Confidence            9999999999999965 46899999999999999999999        899999999999999987664  999999998


Q ss_pred             cccCCCC-----CCCcccCCCCccCCeeecCc------ccCCeeehhhhhhhhhhcCCC
Q 029037          148 KSSVLHS-----RPKSTVGTPAYIAPEVLSRR------EYDGKVCILLLILFLWRNYRP  195 (200)
Q Consensus       148 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slg~~l~~~~~~  195 (200)
                      .......     ......+++.|+|||.+.+.      .++.++|+||||+++|+|++|
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            6544333     22345689999999999765      445789999999999999999

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=264.05  Aligned_cols=191  Identities=26%  Similarity=0.397  Sum_probs=163.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCce------
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTH------   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------   72 (200)
                      ++|.+.+.||+|++|.||++.+..+++.||+|.+.....   ..+.+.+|+.+++.++||||+++++++.+...      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            579999999999999999999999999999999976432   23568899999999999999999999987653      


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      ++++||+++ ++|.+.+.  .+++...+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||++.....
T Consensus       104 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADA  178 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC---
T ss_pred             EEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCCC
Confidence            599999996 58877763  35899999999999999999999999999999999999986664  99999999874332


Q ss_pred             CCCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||
T Consensus       179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf  224 (353)
T 3coi_A          179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF  224 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence              2334568899999999876 67889999999999999999999998

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-43  Score=277.78  Aligned_cols=193  Identities=25%  Similarity=0.348  Sum_probs=161.6

Q ss_pred             ccccc-cccCCcceEEEEEEEcC--CCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            4 YELVK-DLGAGNFGVARLLRHKE--TKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         4 y~~~~-~l~~g~~g~v~~~~~~~--~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +.+.+ .||+|+||.||++.+..  ++..||+|+++...  ...+.+.+|+.++++++||||+++++++.+ ...++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            33444 79999999999998763  45679999998643  345789999999999999999999999976 56899999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-
Q 029037           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-  156 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-  156 (200)
                      ++++++|.+++.... .++...+..++.|++.||+|||++|++||||+|+||++++++  .+||+|||+++........ 
T Consensus       416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCSTTTTCC------
T ss_pred             eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--cEEEeeccCcccccCCCcee
Confidence            999999999996543 599999999999999999999999999999999999998666  4999999999754332221 


Q ss_pred             ---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          157 ---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       157 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                         ....+++.|+|||.+.+..++.++||||||+++|||++ |.+||
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf  540 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY  540 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence               12234578999999998899999999999999999998 99998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.8e-43  Score=256.43  Aligned_cols=195  Identities=30%  Similarity=0.420  Sum_probs=158.0

Q ss_pred             ccccccccccCCcceEEEEEEEcC-CC--cEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-TK--ELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-~~--~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|++|+||++.+.. ++  ..|++|++....    ...+.+.+|+..+++++||||+++++++.++. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            589999999999999999998643 33  358999887542    23467889999999999999999999998765 88


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           75 IVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++||++++++|.+++.+. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||.+......
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQN  174 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC--CEEEcccccccccccc
Confidence            999999999999999765 4699999999999999999999999999999999999998666  4999999998654333


Q ss_pred             CC----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          154 SR----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..    .....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  225 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW  225 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            22    122346678999999988889999999999999999999 88887

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.3e-42  Score=256.79  Aligned_cols=193  Identities=23%  Similarity=0.322  Sum_probs=163.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCC--CCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLR--HPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|++|.||++.+.. ++.||+|++.....   ..+.+.+|+.+++.++  ||||+++++++.++...+++
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            479999999999999999999864 78899999975432   3467889999999997  59999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-  155 (200)
                      || +.+++|.+++.+...++...+..++.|++.||.+||+.|++||||+|+||++++   +.++|+|||++........ 
T Consensus       107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC-------
T ss_pred             Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeeccccccccCcccc
Confidence            99 557899999998888999999999999999999999999999999999999964   3599999999875433222 


Q ss_pred             --CCcccCCCCccCCeeecC-----------cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 --PKSTVGTPAYIAPEVLSR-----------REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                        .....+++.|+|||.+.+           ..++.++|+||||+++|+|++|.+||
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  239 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence              223468999999999875           46788899999999999999999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-42  Score=280.09  Aligned_cols=189  Identities=22%  Similarity=0.257  Sum_probs=162.5

Q ss_pred             ccccccccccCCcceEEEEEEEcC-CCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCce-----E
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-TKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTH-----L   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~   73 (200)
                      ++|++.+.||+|++|.||++.+.. +++.|++|.+....  ...+.+.+|+.++++++||||+++++++.+...     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999976 68899999886532  223568899999999999999999999987654     7


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++|||+++|++|.+++..  ++++.+++.++.|++.||.|||++||+||||||+||+++++   .+||+|||+++.....
T Consensus       160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC
T ss_pred             EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC
Confidence            999999999999887754  79999999999999999999999999999999999999864   5999999998754322


Q ss_pred             CCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                         ....+++.|+|||.+.+. ++.++||||||+++|+|++|.+||
T Consensus       235 ---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~  276 (681)
T 2pzi_A          235 ---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTR  276 (681)
T ss_dssp             ---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEE
T ss_pred             ---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCC
Confidence               445689999999998654 488999999999999999998886

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.3e-42  Score=274.76  Aligned_cols=195  Identities=22%  Similarity=0.295  Sum_probs=164.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCC---CcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|+||.||++.+..+   +..+++|.+....  ...+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence            5789999999999999999998653   4569999887543  223678999999999999999999999854 568999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.... .++...+..++.|++.||.+||++|++||||+|+||+++.++  .++|+|||++........
T Consensus       469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~--~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCCCCSCCC---
T ss_pred             EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC--CEEEEecCCCeecCCCcc
Confidence            99999999999997654 689999999999999999999999999999999999998666  499999999875433322


Q ss_pred             C--CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 P--KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 ~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .  ....+++.|+|||.+.+..++.++|+||||+++|||++ |.+||
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  593 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF  593 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence            2  12345678999999988889999999999999999987 88887

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.1e-42  Score=262.47  Aligned_cols=193  Identities=27%  Similarity=0.265  Sum_probs=155.8

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      +|.+.+.||+|++|+|+. ....+++.||+|++.....  +...+|+.+++.+ +||||+++++++.+....+++||+++
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            588999999999999764 3445678899999875432  2356899999998 79999999999999999999999996


Q ss_pred             CCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC---CCCCCEEEeecCCCcccCCCC---
Q 029037           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG---SAAPRLKICDFGYSKSSVLHS---  154 (200)
Q Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~---~~~~~v~l~df~~~~~~~~~~---  154 (200)
                       ++|.+++.... ......+..++.|++.||.|||+.|++||||+|+||+++.   ++...++|+|||+++......   
T Consensus       102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~  180 (432)
T 3p23_A          102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF  180 (432)
T ss_dssp             -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred             -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence             59999997654 3566677899999999999999999999999999999953   333468899999987544332   


Q ss_pred             -CCCcccCCCCccCCeeec---CcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          155 -RPKSTVGTPAYIAPEVLS---RREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       155 -~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                       ......+++.|+|||.+.   ...++.++||||||+++|+|++ |.+||
T Consensus       181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf  230 (432)
T 3p23_A          181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF  230 (432)
T ss_dssp             -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred             eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence             223356899999999997   4567789999999999999999 77776

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.1e-43  Score=262.47  Aligned_cols=190  Identities=22%  Similarity=0.233  Sum_probs=157.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---------chHHHHHHHHHHhhCC---------CCCeeeE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSLR---------HPNIIRF   63 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---------~~~~~~~e~~~l~~l~---------~~~i~~~   63 (200)
                      ++|++.+.||+|+||+||++.+  +++.||+|++.....         ..+.+.+|+.+++.++         |||++++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999998  578999999986421         2267888998888775         7777777


Q ss_pred             EEEE-----------------ec-------------CceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 029037           64 KEVV-----------------LT-------------PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY  113 (200)
Q Consensus        64 ~~~~-----------------~~-------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~  113 (200)
                      .+.+                 .+             ...+++|||+++++++.+.+.+ ..+++..++.++.|++.||.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence            6654                 22             6789999999999977666633 568999999999999999999


Q ss_pred             HH-hCCcEeecCCCCCeeecCCCC------------------CCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecCc
Q 029037          114 CH-SMQICHRDLKLENTLLDGSAA------------------PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR  174 (200)
Q Consensus       114 lh-~~~i~h~dl~~~ni~i~~~~~------------------~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  174 (200)
                      || ++|++||||||+||+++.++.                  ..+||+|||+|+....    ....+|+.|+|||.+.+.
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCC
T ss_pred             HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCC
Confidence            99 999999999999999986641                  1599999999975432    244789999999999876


Q ss_pred             ccCCeeehhhhhhh-hhhcCCCCCCC
Q 029037          175 EYDGKVCILLLILF-LWRNYRPNPFI  199 (200)
Q Consensus       175 ~~~~~~Di~slg~~-l~~~~~~~~pf  199 (200)
                      . +.++||||++.. .+++++|.+||
T Consensus       253 ~-~~~~Diwsl~~~~~~~~~~g~~p~  277 (336)
T 2vuw_A          253 G-DYQFDIYRLMKKENNNRWGEYHPY  277 (336)
T ss_dssp             S-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred             C-ccceehhhhhCCCCcccccccCCC
Confidence            6 889999998776 78899999886

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3e-41  Score=246.41  Aligned_cols=169  Identities=12%  Similarity=0.043  Sum_probs=149.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccch----HHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.......    +.+.+|+..++.++||||+++++++.+++..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999999999999999998754332    67899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      |+++|++|.+++.+.  ....++..++.|++.||.+||++|++||||||+||++++++.  ++|++++            
T Consensus       111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~------------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA------------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC------------
T ss_pred             EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc------------
Confidence            999999999998443  466788999999999999999999999999999999987665  8887443            


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                             |++       .++.++|+||||+++|+|++|.+||.
T Consensus       175 -------~~~-------~~~~~~Di~slG~il~elltg~~Pf~  203 (286)
T 3uqc_A          175 -------TMP-------DANPQDDIRGIGASLYALLVNRWPLP  203 (286)
T ss_dssp             -------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSC
T ss_pred             -------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                   222       26788999999999999999999983

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.5e-41  Score=261.08  Aligned_cols=193  Identities=27%  Similarity=0.263  Sum_probs=153.3

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .|.+.+.||+|++|+||.+. ..+++.||+|.+..+  ..+.+.+|+.+++.+ +||||+++++++.++...+++||+++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            45567889999999998754 456889999998753  245678899999875 89999999999999999999999996


Q ss_pred             CCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC-----------CCCCEEEee
Q 029037           82 GGELFDRICNAGRF-------SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-----------AAPRLKICD  143 (200)
Q Consensus        82 ~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~-----------~~~~v~l~d  143 (200)
                       ++|.+++......       +...++.++.|++.||++||++|++||||+|+||+++.+           ....++|+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence             5999999765432       223457899999999999999999999999999999753           234699999


Q ss_pred             cCCCcccCCCCC-----CCcccCCCCccCCeeecC-------cccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          144 FGYSKSSVLHSR-----PKSTVGTPAYIAPEVLSR-------REYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       144 f~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ||+++.......     .....+++.|+|||.+.+       ..++.++||||||+++|||++ |.+||
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence            999975443322     123468999999999975       568899999999999999998 88887

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=255.97  Aligned_cols=193  Identities=25%  Similarity=0.396  Sum_probs=162.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      .++|++.+.||+|++|.||++.+..   .+++|.+....   ...+.+.+|+..+++++||||+++++++.+....+++|
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            3689999999999999999999864   38999887542   22356788999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC---
Q 029037           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---  153 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~---  153 (200)
                      |++++++|.+++.+.. .++...+..++.|++.||++||+.|++||||+|+||++++ +  .++|+|||++......   
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~-~--~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-G--KVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC--------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC-C--CEEEeecCCcccccccccc
Confidence            9999999999997655 6899999999999999999999999999999999999973 3  5999999987643211   


Q ss_pred             ---CCCCcccCCCCccCCeeecC---------cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 ---SRPKSTVGTPAYIAPEVLSR---------REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ---~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                         .......+++.|+|||.+.+         ..++.++|+||||+++|+|++|..||
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  243 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF  243 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence               11223357889999999874         34688899999999999999999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.3e-40  Score=243.25  Aligned_cols=175  Identities=31%  Similarity=0.502  Sum_probs=152.7

Q ss_pred             Ccccccc-ccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHH-hhCCCCCeeeEEEEEec----CceEE
Q 029037            1 MEKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-RSLRHPNIIRFKEVVLT----PTHLA   74 (200)
Q Consensus         1 ~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~~~   74 (200)
                      +++|.+. +.||+|++|.||++.+..+++.||+|++..    .....+|+..+ +..+||||+++++++..    ....+
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3678887 789999999999999999999999999865    34567788777 66699999999999887    67799


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccC
Q 029037           75 IVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSV  151 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~  151 (200)
                      ++||++++++|.+++.+..  .++...+..++.|++.||.+||+.|++||||+|+||+++.+. ...++|+|||++... 
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~-  170 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-  170 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC-
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc-
Confidence            9999999999999998765  599999999999999999999999999999999999998632 346999999987522 


Q ss_pred             CCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                                          .+..++.++|+||||+++|+|++|.+||.
T Consensus       171 --------------------~~~~~~~~~DiwslG~il~el~tg~~pf~  199 (299)
T 3m2w_A          171 --------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFY  199 (299)
T ss_dssp             --------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             --------------------ccccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence                                23567889999999999999999999983

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.9e-40  Score=251.81  Aligned_cols=192  Identities=15%  Similarity=0.027  Sum_probs=150.5

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHHHHHHHhhCCC-CCe-----------------
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRH-PNI-----------------   60 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~-~~i-----------------   60 (200)
                      +|+..+.||+|+||+||++.+..+++.||+|++....    ...+.+.+|+..++.++| ++.                 
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            4778899999999999999999999999999988432    234678999999999976 211                 


Q ss_pred             ----eeEEEEEec-----CceEEEEEEecCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecC
Q 029037           61 ----IRFKEVVLT-----PTHLAIVMEYAAGGELFDRICN-------AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL  124 (200)
Q Consensus        61 ----~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl  124 (200)
                          ..+..++..     ...++++|+.+ +++|.+++..       ...+++..++.++.|++.||+|||++|++||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                111111221     22467888876 6799888842       223777889999999999999999999999999


Q ss_pred             CCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeee----------cCcccCCeeehhhhhhhhhhcCC
Q 029037          125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL----------SRREYDGKVCILLLILFLWRNYR  194 (200)
Q Consensus       125 ~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Di~slg~~l~~~~~  194 (200)
                      ||+||+++.++.  +||+|||+++.....  .....+ +.|+|||.+          .+..++.++||||||+++|+|++
T Consensus       238 Kp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          238 RPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999987765  999999998643332  334456 999999999          66678899999999999999999


Q ss_pred             CCCCCC
Q 029037          195 PNPFIW  200 (200)
Q Consensus       195 ~~~pf~  200 (200)
                      |..||.
T Consensus       313 g~~Pf~  318 (413)
T 3dzo_A          313 ADLPNT  318 (413)
T ss_dssp             SSCCCC
T ss_pred             CCCCCC
Confidence            999983

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.4e-38  Score=251.02  Aligned_cols=184  Identities=14%  Similarity=0.041  Sum_probs=131.8

Q ss_pred             cccCCcceEEEEEEEcCCCcEEEEEEecccc-----------cchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEEE
Q 029037            9 DLGAGNFGVARLLRHKETKELVAVKYIERGR-----------KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         9 ~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-----------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ..+.|+.|....++....|+.+++|++.+..           ...+++.+|+++|+++ .|+||+++++++++++.+|+|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3456666777776766778889999997531           2235689999999999 699999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-C
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-R  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~  155 (200)
                      |||++|++|.+.+.+.++++..   .++.||+.||+|+|++||+||||||+||++++++.  +||+|||+|+...... .
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence            9999999999999988888765   47899999999999999999999999999987664  9999999987544332 2


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      ....+||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus       396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            3344689999999999764 56788999999999998876543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.97  E-value=6.4e-33  Score=217.78  Aligned_cols=179  Identities=21%  Similarity=0.115  Sum_probs=135.8

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---------chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ..+.||+|+||.||++..  .++.+++|.......         ..+.+.+|+.++++++||||+++..++.+....+++
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            457899999999999943  456788887643211         124578999999999999999555555566677999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      |||++|++|.+++.+        +..++.|++.+|.+||++|++||||||+||++++    .+||+|||+++........
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence            999999999998855        6789999999999999999999999999999986    5999999999755332221


Q ss_pred             --------CcccCCCCccCCeeecC--cccCCeeehhhhhhhhhhcCCCCCC
Q 029037          157 --------KSTVGTPAYIAPEVLSR--REYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       157 --------~~~~~~~~~~aPE~~~~--~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                              ....+|+.|+|||.+..  ..|+..+|+||..+-..+......+
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence                    23468999999999987  6788888999988777665544433

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.96  E-value=2.3e-29  Score=183.03  Aligned_cols=155  Identities=21%  Similarity=0.174  Sum_probs=120.5

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-------------------chHHHHHHHHHHhhCCCCCeeeEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------------------IDENVAREIINHRSLRHPNIIRFK   64 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~i~~~~   64 (200)
                      |.+.+.||+|++|.||++.+ .+++.||+|.+.....                   ....+.+|+.+++.++|   +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence            34459999999999999999 7889999999964321                   23568899999999984   4555


Q ss_pred             EEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           65 EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        65 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                      +++.. +..++|||+++|++|.+ +      .......++.|++.||.+||+.|++||||+|+||+++ ++  .++|+||
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DF  236 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDF  236 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEEC
Confidence            54433 45699999999999987 4      1234557999999999999999999999999999998 44  5999999


Q ss_pred             CCCcccCCCCCCCcccCCCCccCCeeecC----------cccCCeeehhhh
Q 029037          145 GYSKSSVLHSRPKSTVGTPAYIAPEVLSR----------REYDGKVCILLL  185 (200)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----------~~~~~~~Di~sl  185 (200)
                      |+|+.            +..+.|||.+.+          +.+...+|+|.+
T Consensus       237 G~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          237 PQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             TTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             CCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            98852            344678888754          455666677654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.91  E-value=1.2e-24  Score=156.32  Aligned_cols=135  Identities=13%  Similarity=0.088  Sum_probs=105.6

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcE--EEEEEecccccc-------------------------hHHHHHHHHHHhhCC
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERGRKI-------------------------DENVAREIINHRSLR   56 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~--~~~K~~~~~~~~-------------------------~~~~~~e~~~l~~l~   56 (200)
                      |.+.+.||+|++|.||++.+..+++.  ||+|++......                         ...+.+|+..++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56789999999999999999777888  999987543111                         136788999999987


Q ss_pred             CCCe--eeEEEEEecCceEEEEEEecCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCC
Q 029037           57 HPNI--IRFKEVVLTPTHLAIVMEYAAG-G----ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLEN  128 (200)
Q Consensus        57 ~~~i--~~~~~~~~~~~~~~~v~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~n  128 (200)
                      |+++  +.+++.    ...++||||+.+ |    +|.+....   .+...+..++.|++.+|.+|| +.|++||||+|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            7653  344432    345899999942 3    66665422   235578899999999999999 9999999999999


Q ss_pred             eeecCCCCCCEEEeecCCCcc
Q 029037          129 TLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus       129 i~i~~~~~~~v~l~df~~~~~  149 (200)
                      |++++    .++|+|||+|..
T Consensus       202 ILl~~----~~~liDFG~a~~  218 (258)
T 1zth_A          202 IMYID----KVYFIDMGQAVT  218 (258)
T ss_dssp             EEESS----SEEECCCTTCEE
T ss_pred             EEEcC----cEEEEECccccc
Confidence            99976    499999999863

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.86  E-value=8.9e-22  Score=147.26  Aligned_cols=134  Identities=15%  Similarity=0.115  Sum_probs=98.7

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---------------h--------HHHHHHHHHHhhCCCCCe
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---------------D--------ENVAREIINHRSLRHPNI   60 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---------------~--------~~~~~e~~~l~~l~~~~i   60 (200)
                      |++.+.||.|++|.||+|.+. +|+.||+|++......               .        -....|...+.++.++++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            789999999999999999986 5888999987532110               0        112456777777754443


Q ss_pred             e--eEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCC-
Q 029037           61 I--RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP-  137 (200)
Q Consensus        61 ~--~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~-  137 (200)
                      .  ..++.  .  ..++|||+++|.+|.+..      ..+....++.|++.+|.+||++|++||||||.||++++++.. 
T Consensus       176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEE--E--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeec--c--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            2  23322  2  237999999998885432      223456788999999999999999999999999999765532 


Q ss_pred             -------CEEEeecCCCc
Q 029037          138 -------RLKICDFGYSK  148 (200)
Q Consensus       138 -------~v~l~df~~~~  148 (200)
                             .+.|+||+.+.
T Consensus       246 d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             CTTSEEEEEEECCCTTCE
T ss_pred             cccccccceEEEEeCCcc
Confidence                   37899999875

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.68  E-value=3.2e-16  Score=112.64  Aligned_cols=138  Identities=19%  Similarity=0.120  Sum_probs=109.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +.|++...++.++.+.||++...  +..+++|...... .....+.+|...++.+. +..++++++++.+.+..+++||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            56888888888888999999754  5679999887532 22346888999998884 67788899999888899999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-------------------------------------------  116 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-------------------------------------------  116 (200)
                      ++|.+|.+.+     .+......++.++..+++.||+                                           
T Consensus        92 i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           92 ADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             cCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            9999987653     1223345788899999999998                                           


Q ss_pred             ----------------CCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          117 ----------------MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       117 ----------------~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                                      .+++|+|++|.||+++++.  .+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence                            4589999999999997532  25699999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.53  E-value=7.5e-14  Score=99.99  Aligned_cols=133  Identities=14%  Similarity=0.120  Sum_probs=94.5

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCC--eeeEEEEEecCceEEEEEEec
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN--IIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      .|.+....+.|..+.||++.. .++..+++|+....  ....+.+|...++.+++.+  +++++.+..+++..+++||++
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            344444444556689999965 34567899987654  2345778888888775433  566888888877899999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ------------------------------------------  118 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------  118 (200)
                      +|.++.  .   ....   ...++.+++..|+.||+..                                          
T Consensus        98 ~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A           98 PGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             SSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             CCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence            998884  2   1112   2356677777777777643                                          


Q ss_pred             ----------------cEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          119 ----------------ICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       119 ----------------i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                                      ++|+|++|.||+++++.  .+.|+||+.+.
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~liD~~~a~  213 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence                            99999999999997543  25699999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.48  E-value=1.8e-13  Score=102.68  Aligned_cols=139  Identities=16%  Similarity=0.243  Sum_probs=103.7

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEEEec--ccc--cchHHHHHHHHHHhhCC--CCCeeeEEEEEecC---ceEEEE
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGR--KIDENVAREIINHRSLR--HPNIIRFKEVVLTP---THLAIV   76 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~--~~~--~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~---~~~~~v   76 (200)
                      -.+.++.|.+..+|++....  ..+++|+..  ...  .....+.+|..+++.+.  +..+++++.++.+.   +..+++
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            45678889999999998753  568888876  332  22456888999998886  45578888888766   447999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS----------------------------------------  116 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~----------------------------------------  116 (200)
                      ||+++|.++.+.  ....++......++.+++..|+.||+                                        
T Consensus       120 me~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          120 MEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             EECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999998777431  12246788888999999999999997                                        


Q ss_pred             ------------------CCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          117 ------------------MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       117 ------------------~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                                        .+++|||++|.||++++++...+.|+||+.+.
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                              36899999999999986553235899999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.31  E-value=8.9e-13  Score=96.69  Aligned_cols=185  Identities=15%  Similarity=0.064  Sum_probs=118.2

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-CCC--eeeEEEEEecCc---eEEEEEEec
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPN--IIRFKEVVLTPT---HLAIVMEYA   80 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~~v~e~~   80 (200)
                      .+.++.|....+|++.     ..+++|+.... .....+.+|...++.+. +..  +++++.......   ..++||+++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3557888988999874     34888976543 33567889999988773 322  444554443333   348899999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS--------------------------------------------  116 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~--------------------------------------------  116 (200)
                      +|.++.+...  ..++..+...++.+++..++.||+                                            
T Consensus        99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A           99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            9988865432  246778888888888888888885                                            


Q ss_pred             --------------CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccCCCCccCCeeecC---------
Q 029037          117 --------------MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR---------  173 (200)
Q Consensus       117 --------------~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---------  173 (200)
                                    ..++|+|++|.||+++++....+.++||+.+.................-..|+....         
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~  256 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD  256 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence                          236999999999999864222478999998753321111000000000012222110         


Q ss_pred             -----cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          174 -----REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       174 -----~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                           .......+.|+++.+++.+.+|+++|
T Consensus       257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                 01112248999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=99.13  E-value=1.8e-09  Score=77.68  Aligned_cols=131  Identities=19%  Similarity=0.234  Sum_probs=94.2

Q ss_pred             ccCCcce-EEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEecCCCchHH
Q 029037           10 LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFD   87 (200)
Q Consensus        10 l~~g~~g-~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   87 (200)
                      +..|..+ .||+......+..+++|+-...  ....+.+|...++.+. +-.+++++.++.+.+..+++|++++|.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            3445554 6899988777778999986643  3456788888888774 3447788888888899999999999988876


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------
Q 029037           88 RICNAGRFSEDEGRYFFQQLISGVNYCHSM--------------------------------------------------  117 (200)
Q Consensus        88 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------------------------------------------------  117 (200)
                      .....    ......+..++...|+.||+.                                                  
T Consensus       110 ~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  185 (272)
T 4gkh_A          110 VLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK  185 (272)
T ss_dssp             HHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred             cccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence            55331    223344555666666666631                                                  


Q ss_pred             --------CcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          118 --------QICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       118 --------~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                              .++|+|+.+.||+++++.  .+-|+||+.+.
T Consensus       186 ~~~~~~~~~l~HGDl~~~Nil~~~~~--~~~viDwe~a~  222 (272)
T 4gkh_A          186 LLPFSPDSVVTHGDFSLDNLIFDEGK--LIGCIDVGRVG  222 (272)
T ss_dssp             TCCCCCCEEEECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             cccccCCcEEEcCCCCCCeEEEECCe--EEEEEECcccc
Confidence                    268999999999997543  25699999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=99.04  E-value=5.4e-09  Score=76.64  Aligned_cols=135  Identities=19%  Similarity=0.161  Sum_probs=89.7

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCC---CeeeEEEEEe-cCceEEEEEEecCC
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP---NIIRFKEVVL-TPTHLAIVMEYAAG   82 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~~v~e~~~~   82 (200)
                      .+.++.|....+|+.     +..+++|+... ......+.+|...++.+++.   .+++++.+.. ..+..+++|++++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356777888889988     34578887432 23356788999999988642   3556666664 34557899999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM---------------------------------------------  117 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~---------------------------------------------  117 (200)
                      .++.+...  ..++......++.++...|+.||+.                                             
T Consensus        98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            88765321  1234445555555555555555532                                             


Q ss_pred             ---------------CcEeecCCCCCeeecCC-CCCCE-EEeecCCCcc
Q 029037          118 ---------------QICHRDLKLENTLLDGS-AAPRL-KICDFGYSKS  149 (200)
Q Consensus       118 ---------------~i~h~dl~~~ni~i~~~-~~~~v-~l~df~~~~~  149 (200)
                                     .++|+|+.|.||+++++ ..+.+ .|+||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           35899999999999861 11234 7999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.81  E-value=3e-08  Score=75.24  Aligned_cols=75  Identities=15%  Similarity=0.057  Sum_probs=48.3

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccc--------cchHHHHHHHHHHhhCCC--C-CeeeEEEEEecCceEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGR--------KIDENVAREIINHRSLRH--P-NIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--------~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~~   75 (200)
                      .+.+|.|..+.||++....+++.+++|......        ...+....|...++.++.  + .+++++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            567899999999999876566779999764321        123456778888876632  3 34455544  3344589


Q ss_pred             EEEecCCC
Q 029037           76 VMEYAAGG   83 (200)
Q Consensus        76 v~e~~~~~   83 (200)
                      +||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.61  E-value=3.1e-08  Score=74.05  Aligned_cols=79  Identities=10%  Similarity=0.091  Sum_probs=53.1

Q ss_pred             cccc-cCCcceEEEEEEEc---C---CCcEEEEEEecccc---c-chHHHHHHHHHHhhCC---CCCeeeEEEEEecC--
Q 029037            7 VKDL-GAGNFGVARLLRHK---E---TKELVAVKYIERGR---K-IDENVAREIINHRSLR---HPNIIRFKEVVLTP--   70 (200)
Q Consensus         7 ~~~l-~~g~~g~v~~~~~~---~---~~~~~~~K~~~~~~---~-~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~--   70 (200)
                      .+.| +.|....+|++...   .   ++..+++|+.....   . ....+.+|...++.+.   ...+++++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 77888899988754   0   14568889776533   1 1245777888887764   23566777776654  


Q ss_pred             -ceEEEEEEecCCCch
Q 029037           71 -THLAIVMEYAAGGEL   85 (200)
Q Consensus        71 -~~~~~v~e~~~~~~L   85 (200)
                       +..+++||+++|.++
T Consensus       105 ~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TSSCEEEEECCCCBCC
T ss_pred             cCCceEEEEecCCCCh
Confidence             346899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.55  E-value=1.4e-06  Score=64.54  Aligned_cols=72  Identities=14%  Similarity=0.170  Sum_probs=39.9

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC--CCCeeeEEE------EEecCceEEEEEEe
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR--HPNIIRFKE------VVLTPTHLAIVMEY   79 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~------~~~~~~~~~~v~e~   79 (200)
                      +.++.|....+|++.... + .+++|+...+   .+.+..|...++.+.  .-.+++++.      +....+..+++|++
T Consensus        38 ~~l~gG~~n~~~~v~~~~-~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS-G-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETT-E-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCC-C-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            455556678999987643 3 4889988763   233444455454442  112333332      12345678999999


Q ss_pred             cCCCc
Q 029037           80 AAGGE   84 (200)
Q Consensus        80 ~~~~~   84 (200)
                      ++|.+
T Consensus       113 i~G~~  117 (346)
T 2q83_A          113 IEGRP  117 (346)
T ss_dssp             CCCBC
T ss_pred             ecCcc
Confidence            99854

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.41  E-value=3.2e-07  Score=66.98  Aligned_cols=74  Identities=15%  Similarity=0.117  Sum_probs=44.5

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCe-eeEEEEEecCceEEEEEEec-C
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYA-A   81 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~e~~-~   81 (200)
                      +.-.+.|+.|....+|++      ..+++|+........-...+|...++.+....+ ++++...  ....+++++++ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            333677888988999999      348889887542222223457766666532222 4555543  33347899999 6


Q ss_pred             CCch
Q 029037           82 GGEL   85 (200)
Q Consensus        82 ~~~L   85 (200)
                      |.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6554

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.28  E-value=6.4e-06  Score=62.94  Aligned_cols=32  Identities=16%  Similarity=0.261  Sum_probs=26.8

Q ss_pred             HhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037          115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus       115 h~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      +...++|||+.|.||++++++   +.++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC---EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC---CEEEeCccccc
Confidence            456899999999999997543   89999998763

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=98.19  E-value=5.8e-06  Score=62.23  Aligned_cols=137  Identities=15%  Similarity=0.137  Sum_probs=79.2

Q ss_pred             ccccCCcceEEEEEEEcC-------CCcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEe
Q 029037            8 KDLGAGNFGVARLLRHKE-------TKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +.+..|-...+|++....       .++.+++|+..........+.+|..+++.+. +.-.+++++.+.+    .+|||+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            456667777899998743       3467899987543334566778998888774 3233566666543    399999


Q ss_pred             cCCCchH--------------HHHH---hcC-----CCC--HHHHHHHHHHHHH-------------------HHHHHH-
Q 029037           80 AAGGELF--------------DRIC---NAG-----RFS--EDEGRYFFQQLIS-------------------GVNYCH-  115 (200)
Q Consensus        80 ~~~~~L~--------------~~l~---~~~-----~~~--~~~~~~~~~~i~~-------------------~l~~lh-  115 (200)
                      ++|.+|.              ..+.   ...     +..  ..++..+..++-.                   .+..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            9985442              1111   111     111  2344445444321                   123332 


Q ss_pred             ---h----CCcEeecCCCCCeeecCC--CCCCEEEeecCCCc
Q 029037          116 ---S----MQICHRDLKLENTLLDGS--AAPRLKICDFGYSK  148 (200)
Q Consensus       116 ---~----~~i~h~dl~~~ni~i~~~--~~~~v~l~df~~~~  148 (200)
                         +    ..++|+|+.+.||+++++  ....+.++||..+.
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               2    358999999999999765  12359999999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=98.03  E-value=0.00012  Score=54.08  Aligned_cols=34  Identities=29%  Similarity=0.386  Sum_probs=26.6

Q ss_pred             hCCcEeecCCCCCeeecCCC--CCCEEEeecCCCcc
Q 029037          116 SMQICHRDLKLENTLLDGSA--APRLKICDFGYSKS  149 (200)
Q Consensus       116 ~~~i~h~dl~~~ni~i~~~~--~~~v~l~df~~~~~  149 (200)
                      ...++|||+.+.||+++++.  ...+.++||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            35799999999999997541  13589999998763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=98.00  E-value=2.7e-05  Score=59.66  Aligned_cols=73  Identities=12%  Similarity=0.110  Sum_probs=48.3

Q ss_pred             cccccCCcceEEEEEEEcC-------CCcEEEEEEecccccchHHHHHHHHHHhhCCCCC-eeeEEEEEecCceEEEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKE-------TKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~v~e   78 (200)
                      .+.|+.|....+|++....       .++.+++|+.... ...+.+.+|...++.+...+ .+++++.+.+    .++++
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            3567778888999998653       2467899988542 22256667888888774333 3556665432    38999


Q ss_pred             ecCCCc
Q 029037           79 YAAGGE   84 (200)
Q Consensus        79 ~~~~~~   84 (200)
                      +++|.+
T Consensus       153 ~l~G~~  158 (429)
T 1nw1_A          153 YIPSRP  158 (429)
T ss_dssp             CCCEEE
T ss_pred             EeCCcc
Confidence            998743

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.94  E-value=2.3e-05  Score=57.54  Aligned_cols=137  Identities=15%  Similarity=0.114  Sum_probs=72.3

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCC--eeeEEEE------EecCceEEEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN--IIRFKEV------VLTPTHLAIVME   78 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~~v~e   78 (200)
                      .+.|+.|....+|++.... + .+++|+.... ...+.+..|...++.+....  +++++..      ....+..+++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCC-c-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            3556677778899987653 3 5788988753 12334556666666553211  2333211      122356789999


Q ss_pred             ecCCCchH-----------HH---HHhc-CCC--------CHHHHHH---------------HHHHHHHHHHHHH-----
Q 029037           79 YAAGGELF-----------DR---ICNA-GRF--------SEDEGRY---------------FFQQLISGVNYCH-----  115 (200)
Q Consensus        79 ~~~~~~L~-----------~~---l~~~-~~~--------~~~~~~~---------------~~~~i~~~l~~lh-----  115 (200)
                      +++|.++.           ..   ++.. ..+        ....-..               +...+...+..+.     
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            99885431           11   1111 111        1000000               0011233344444     


Q ss_pred             --hCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       116 --~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                        ..+++|+|+.+.||+++++.  .+.++||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~--~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCc--eEEEecchhcc
Confidence              24689999999999997543  24799999875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.94  E-value=0.0001  Score=54.17  Aligned_cols=75  Identities=11%  Similarity=0.055  Sum_probs=46.3

Q ss_pred             ccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCC--CeeeEEEE-----EecCceEEEEEEec
Q 029037            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--NIIRFKEV-----VLTPTHLAIVMEYA   80 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~-----~~~~~~~~~v~e~~   80 (200)
                      +.++ |....+|++... +++.+++|.........+.+..|...++.+...  .+++++..     ...++..+.+++++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3455 667789987654 345689998874433455677777777766321  23334332     12245668899999


Q ss_pred             CCCc
Q 029037           81 AGGE   84 (200)
Q Consensus        81 ~~~~   84 (200)
                      +|.+
T Consensus       110 ~G~~  113 (328)
T 1zyl_A          110 GGRQ  113 (328)
T ss_dssp             CCEE
T ss_pred             CCCC
Confidence            8854

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.87  E-value=3.5e-05  Score=57.81  Aligned_cols=74  Identities=14%  Similarity=0.054  Sum_probs=43.0

Q ss_pred             cccccCCcceEEEEEEEcCC--------CcEEEEEEecccccchHHHHHHHHHHhhCCCCC-eeeEEEEEecCceEEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKET--------KELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~--------~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~v~   77 (200)
                      .+.++.|..-.+|++.....        +..+++|+.............|...++.+.... .+++++..  .+  +++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            45667777789999986541        256889987654322222456777777664223 44555543  22  6899


Q ss_pred             EecCCCc
Q 029037           78 EYAAGGE   84 (200)
Q Consensus        78 e~~~~~~   84 (200)
                      ++++|.+
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998854

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.86  E-value=0.00018  Score=55.54  Aligned_cols=75  Identities=13%  Similarity=0.070  Sum_probs=47.2

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCe-eeEEEEEecCceEEEEEEecCCCch
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      .+.|+.|-...+|++.....+..+++|+........-...+|..+++.+...++ +++++.+.  +  ..+++|++|.+|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            356777888899999876544678899875432221123578888887764444 55666652  2  359999988443

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.68  E-value=0.00052  Score=50.25  Aligned_cols=94  Identities=17%  Similarity=0.112  Sum_probs=70.8

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC---CCCeeeEEEEEecCceEEEEEEecCCC
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR---HPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (200)
                      .+.|+.|....+|++...  +..+++|+....  ....+..|...++.+.   ...+++++......+..+++||+++|.
T Consensus        41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC--CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            467888988999999863  556888987643  3556788888887773   356778888888778899999999987


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 029037           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ  118 (200)
Q Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~  118 (200)
                      ++.          .    ....++...|+.||+.+
T Consensus       117 ~~~----------~----~~~~~lG~~LA~LH~~~  137 (312)
T 3jr1_A          117 KNK----------Q----SSFTIFAEKIAQLHQIQ  137 (312)
T ss_dssp             CCC----------T----THHHHHHHHHHHHHHCC
T ss_pred             CCC----------c----hhHHHHHHHHHHHHcCC
Confidence            542          1    23567888889999864

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.61  E-value=0.0013  Score=48.69  Aligned_cols=30  Identities=23%  Similarity=0.478  Sum_probs=25.2

Q ss_pred             CCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       117 ~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      .+++|+|+.+.||++++++  .+.++||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~--~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEE--SIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGG--CEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCC--eEEEEECCCCe
Confidence            4689999999999997544  38999998765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.56  E-value=0.00041  Score=50.08  Aligned_cols=75  Identities=12%  Similarity=0.052  Sum_probs=51.7

Q ss_pred             cccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCC---CCeeeEEEEEecCceEEEEEEec
Q 029037            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRH---PNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      .-.+.+|.|..+.||++... +|+.+++|+...... ....+..|...|+.+..   -.+++++..  +.  .+++||++
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l   92 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECC
T ss_pred             EEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEee
Confidence            34577888999999999865 467799998765433 23457889888887742   234455544  22  37899998


Q ss_pred             CCCc
Q 029037           81 AGGE   84 (200)
Q Consensus        81 ~~~~   84 (200)
                      ++..
T Consensus        93 ~~~~   96 (288)
T 3f7w_A           93 DERP   96 (288)
T ss_dssp             CCCC
T ss_pred             cccC
Confidence            8754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.39  E-value=0.00049  Score=52.55  Aligned_cols=74  Identities=12%  Similarity=0.021  Sum_probs=46.6

Q ss_pred             cccccCCcceEEEEEEEcCC-------CcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKET-------KELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      .+.+..|-.-.+|++.....       ++.+++|+........-...+|..+++.+. +.-.+++++.+  .+  +.|++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e  150 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE  150 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence            35566677778999987531       467899987654322223457777777664 22344555533  22  78999


Q ss_pred             ecCCCc
Q 029037           79 YAAGGE   84 (200)
Q Consensus        79 ~~~~~~   84 (200)
                      +++|.+
T Consensus       151 fI~G~~  156 (424)
T 3mes_A          151 FIDGEP  156 (424)
T ss_dssp             CCCSEE
T ss_pred             EeCCcc
Confidence            999865

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.27  E-value=0.00075  Score=46.44  Aligned_cols=100  Identities=12%  Similarity=0.036  Sum_probs=62.9

Q ss_pred             chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcccC
Q 029037           84 ELFDRICNA-GRFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (200)
Q Consensus        84 ~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~~~  161 (200)
                      ||.+.+... .++++++++.+..|.+.+|..+- +..-..+=+.|..|++..+++  |...+ ..+           ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s-----------~~~   99 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AAD-----------DAG   99 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-ccc-----------ccc
Confidence            789988754 47999999999999999987762 222223445668888887776  65442 110           012


Q ss_pred             CCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCC
Q 029037          162 TPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPF  198 (200)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~p  198 (200)
                      ...+.|||... ...+.+.=|||||+++|.-+....|
T Consensus       100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            33466787752 2334566899999999988776544

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.20  E-value=0.023  Score=43.07  Aligned_cols=30  Identities=40%  Similarity=0.621  Sum_probs=23.9

Q ss_pred             cEeecCCCCCeeecC----CCCCCEEEeecCCCc
Q 029037          119 ICHRDLKLENTLLDG----SAAPRLKICDFGYSK  148 (200)
Q Consensus       119 i~h~dl~~~ni~i~~----~~~~~v~l~df~~~~  148 (200)
                      ++|+|+.+.||++.+    +....+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            579999999999943    223469999999975

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.29  E-value=1.8  Score=29.81  Aligned_cols=83  Identities=16%  Similarity=0.100  Sum_probs=57.6

Q ss_pred             CCCCeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           56 RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        56 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      .||++ + ...-.+++.+.+.++.-+++.-...+.   ..+....++++.+++.... -|...-+|--+.|+|++++.+.
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~~  121 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRAL  121 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTTC
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCCC
Confidence            57888 3 334466777888787765543334443   4789999999988876433 2345668889999999998776


Q ss_pred             CCCEEEeecCC
Q 029037          136 APRLKICDFGY  146 (200)
Q Consensus       136 ~~~v~l~df~~  146 (200)
                      .  +++.=.|+
T Consensus       122 ~--p~i~hRGi  130 (219)
T 4ano_A          122 E--PFFLHVGV  130 (219)
T ss_dssp             C--EEESCCEE
T ss_pred             c--EEEEEcCC
Confidence            5  88876664

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.46  E-value=1.4  Score=30.29  Aligned_cols=84  Identities=13%  Similarity=0.091  Sum_probs=58.0

Q ss_pred             CCCCCeeeEEEEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC
Q 029037           55 LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS  134 (200)
Q Consensus        55 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~  134 (200)
                      ..+|++++. .+-.+++.+.+.++.-+.+.-...+   ...+....++++.+++...  -|...-+|--+.|+|++++.+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~--~~~~~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLE--EVNRTRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGG--GGGGSSEECCCSGGGEEECTT
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHH--HHhcCceEEEEecceEEEcCC
Confidence            368888877 4666667777777765433222223   3478899999999987755  333445788999999999876


Q ss_pred             CCCCEEEeecCC
Q 029037          135 AAPRLKICDFGY  146 (200)
Q Consensus       135 ~~~~v~l~df~~  146 (200)
                      ..  +++.=-|+
T Consensus       116 ~~--p~i~~RGi  125 (215)
T 4ann_A          116 GL--PIAKTRGL  125 (215)
T ss_dssp             SC--EEESCCEE
T ss_pred             CC--EEEEEccC
Confidence            65  78776554

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=85.64  E-value=13  Score=30.41  Aligned_cols=44  Identities=25%  Similarity=0.377  Sum_probs=29.1

Q ss_pred             HHHHHHHHHHH--HHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           99 EGRYFFQQLIS--GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        99 ~~~~~~~~i~~--~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      ....++++++.  .+.|+  .|+  +|=.++||+++.+  +.+.=+|||.+-
T Consensus       530 ar~nF~~SlA~~Svv~YI--LGl--GDRH~~NILid~t--G~v~HIDFG~~f  575 (696)
T 2x6h_A          530 VMDTYIKSCAGYCVITYL--LGV--GDRHLDNLLLTTN--GKLFHIDFGYIL  575 (696)
T ss_dssp             HHHHHHHHHHHHHHHHHH--HTC--CCCCTTTEEECTT--SCEEECCCCSCT
T ss_pred             HHHHHHHHHHHHHHHHHH--ccC--CCCCCcceEEeCC--CCEEEEeehhhh
Confidence            34455555543  23333  343  6899999999854  459999999874

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.36  E-value=0.16  Score=39.35  Aligned_cols=58  Identities=7%  Similarity=0.014  Sum_probs=14.6

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEE------EEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAV------KYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVV   67 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~------K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~   67 (200)
                      .+.+|   ||.||++....+..+||+      |........   ...+.+|..+.+.++|||+++.+.+.
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            45555   999999998755456777      555432211   23577788888888999998876654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	200
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-55
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-53
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-50
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-49
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-47
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-46
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-44
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-43
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-42
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-42
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-42
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-41
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-40
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-39
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-38
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-37
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-37
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-36
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-34
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-33
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-13

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (446), Expect = 7e-55
 Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 2/192 (1%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           ++ Y++ ++LG G FGV   +  + T    A K++    + D E V +EI     LRHP 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 84

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQ 118
           ++   +       + ++ E+ +GGELF+++ +   + SEDE   + +Q+  G+ + H   
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV   +    
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 179 KVCILLLILFLW 190
              +  + +  +
Sbjct: 205 YTDMWSVGVLSY 216

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (443), Expect = 2e-54
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 2/191 (1%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           + Y+++++LG+G FGV      K T  +   K+I     +D   V  EI     L HP +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQI 119
           I   +       + +++E+ +GGELFDRI     + SE E   + +Q   G+ + H   I
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R      
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208

Query: 180 VCILLLILFLW 190
             +  + +  +
Sbjct: 209 TDMWAIGVLGY 219

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 9e-54
 Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 13/207 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPN 59
           E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + I
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST---VGTPAYIAPEVLSRREY 176
            HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 177 DGK------VCILLLILFLWRNYRPNP 197
             +        I+L  +         P
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQP 209

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-53
 Identities = 61/184 (33%), Positives = 99/184 (53%), Gaps = 7/184 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     V     RE+     LR
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL  +    LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 125 KRVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 177 DGKV 180
           D KV
Sbjct: 182 DEKV 185

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-53
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 12/204 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ- 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y      
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 179 KV------CILLLILFLWRNYRPN 196
           +         L+ +        P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPP 206

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 6e-50
 Identities = 47/194 (24%), Positives = 84/194 (43%), Gaps = 7/194 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           EKY + +DLG G FG+        +K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
              E   +   L ++ E+ +G ++F+RI  +A   +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
           H D++ EN +     +  +KI +FG ++        +     P Y APEV          
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 181 ------CILLLILF 188
                  ++ ++L 
Sbjct: 185 DMWSLGTLVYVLLS 198

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (409), Expect = 8e-50
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 13/205 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRH 57
           + +  ++++G G+FG     R     E+VA+K +    K      +++ +E+   + LRH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PN I+++   L      +VMEY  G        +     E E        + G+ Y HS 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL---SRR 174
            + HRD+K  N LL       +K+ DFG +    + +   S VGTP ++APEV+      
Sbjct: 135 NMIHRDVKAGNILLSEPG--LVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDEG 189

Query: 175 EYDGKVCILLL-ILFLWRNYRPNPF 198
           +YDGKV +  L I  +    R  P 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL 214

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 1e-49
 Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 3/192 (1%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPN 59
           + Y+    LG G F    L   K T++LVA+K I +      + ++  EI     ++HPN
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+   ++  +  HL ++M+  +GGELFDRI   G ++E +      Q++  V Y H + I
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 120 CHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN L        ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188

Query: 179 KVCILLLILFLW 190
            V    + +  +
Sbjct: 189 AVDCWSIGVIAY 200

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-49
 Identities = 57/186 (30%), Positives = 82/186 (44%), Gaps = 9/186 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    +         L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K     S   R  S VGT  Y++PE+L+ +
Sbjct: 128 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 175 EYDGKV 180
                 
Sbjct: 186 SACKSS 191

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-49
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 11/195 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +   ++   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           + + +  L    L +VMEY AGG L D +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGK 179
           HRD+K +N LL       +K+ DFG+          +ST VGTP ++APEV++R+ Y  K
Sbjct: 139 HRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 180 V------CILLLILF 188
           V       + + ++ 
Sbjct: 197 VDIWSLGIMAIEMIE 211

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 6e-49
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 5/181 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           + +E++ +LG G FG     ++KET  L A K I+   + + E+   EI    S  HPNI
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           ++  +      +L I++E+ AGG +   +    R  +E + +   +Q +  +NY H  +I
Sbjct: 72  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK  N L        +K+ DFG S  +     R  S +GTP ++APEV+       
Sbjct: 132 IHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 179 K 179
           +
Sbjct: 190 R 190

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-47
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 16/209 (7%)

Query: 1   MEKYELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHP 58
           ++ Y++    LG G  G    + +K T+E  A+K ++   K      RE+ ++ R+ + P
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR----REVELHWRASQCP 65

Query: 59  NIIRFKEVVLTP----THLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVN 112
           +I+R  +V          L IVME   GGELF RI + G   F+E E     + +   + 
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 113 YCHSMQICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y HS+ I HRD+K EN L         LK+ DFG++K +  H+   +   TP Y+APEVL
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185

Query: 172 SRREYDGKV--CILLLILFLWRNYRPNPF 198
              +YD       L +I+++     P PF
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYP-PF 213

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  152 bits (386), Expect = 1e-46
 Identities = 63/189 (33%), Positives = 89/189 (47%), Gaps = 13/189 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDENVAREIIN 51
           E YE  + LG G   V R   HK T +  AVK I          E  +++ E   +E+  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 52  HRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
            R +  HPNII+ K+   T T   +V +    GELFD +      SE E R   + L+  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 171 LSRREYDGK 179
           +     D  
Sbjct: 181 IECSMNDNH 189

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 1e-46
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 8/197 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-----VAREIINHRSL 55
           +E + L K LG G+FG   L   K+T +  A+K +++   + ++     +  + +   + 
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP +        T  +L  VMEY  GG+L   I +  +F      ++  ++I G+ + H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRR 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L     +T  GTP YIAPE+L  +
Sbjct: 121 SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 175 EYDGKVCILLLILFLWR 191
           +Y+  V      + L+ 
Sbjct: 179 KYNHSVDWWSFGVLLYE 195

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 3e-46
 Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 17/194 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E YE++  +G G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 113 YCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYI 166
            CH        + HRDLK  N  LDG     +K+ DFG ++     +       GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 167 APEVLSRREYDGKV 180
           +PE ++R  Y+ K 
Sbjct: 182 SPEQMNRMSYNEKS 195

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 5e-46
 Identities = 63/190 (33%), Positives = 103/190 (54%), Gaps = 9/190 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRS 54
           + Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           ++HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 115 HSMQICHRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           HS+QI H DLK EN +L       PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

Query: 173 RREYDGKVCI 182
                 +  +
Sbjct: 190 YEPLGLEADM 199

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  147 bits (372), Expect = 3e-44
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 8/194 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           ++ +++++ LG G+FG   L+R +      A+K +++   +     E+   E +    + 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP IIR          + ++M+Y  GGELF  +  + RF     +++  ++   + Y HS
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
             I +RDLK EN LLD +    +KI DFG++K   +     +  GTP YIAPEV+S + Y
Sbjct: 123 KDIIYRDLKPENILLDKNG--HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 177 DGKVCILLLILFLW 190
           +  +      + ++
Sbjct: 179 NKSIDWWSFGILIY 192

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 9e-44
 Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 6/192 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           +    +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  ++
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   V      + I+ EY A G L + +     RF   +     + +   + Y  S Q  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVLSRREYDG 178
           HRDL   N L++      +K+ DFG S+  +      S        +  PEVL   ++  
Sbjct: 123 HRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 179 KVCILLLILFLW 190
           K  I    + +W
Sbjct: 181 KSDIWAFGVLMW 192

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  144 bits (365), Expect = 1e-43
 Identities = 48/199 (24%), Positives = 76/199 (38%), Gaps = 10/199 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 58  PNIIRFKEVVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFG--YSKSSVLHSRPKSTVGTPAYIAPEVL 171
            H   I HRD+K  N ++  + A ++         + S    ++  + +GT  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 172 SRREYDGKVCILLLILFLW 190
                D +  +  L   L+
Sbjct: 187 RGDSVDARSDVYSLGCVLY 205

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 4e-43
 Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 18/200 (9%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNI 60
            +   ++G G+F         ET   VA   ++  +      +    E    + L+HPNI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 61  IRFKEVVLTPT----HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +RF +   +       + +V E    G L   +           R + +Q++ G+ + H+
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 117 M--QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
               I HRDLK +N  + G     +KI D G +      S  K+ +GTP ++APE+    
Sbjct: 131 RTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY-EE 187

Query: 175 EYDGKV------CILLLILF 188
           +YD  V        +L +  
Sbjct: 188 KYDESVDVYAFGMCMLEMAT 207

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  144 bits (365), Expect = 1e-42
 Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 10/188 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR------- 53
           M  + + + +G G FG     R  +T ++ A+K +++ R   +      +N R       
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           +   P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G+ +
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL +
Sbjct: 123 MHNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQK 179

Query: 174 REYDGKVC 181
                   
Sbjct: 180 GVAYDSSA 187

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 7e-42
 Identities = 67/204 (32%), Positives = 100/204 (49%), Gaps = 8/204 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLR 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I ++       E    ++ R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 176 YDGKV-CILLLILFLWRNYRPNPF 198
           Y   V    L ++         PF
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPF 205

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (358), Expect = 8e-42
 Identities = 60/203 (29%), Positives = 109/203 (53%), Gaps = 9/203 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +     E+   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K      R  +  GTP  +APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGY 215

Query: 177 DGKV-CILLLILFLWRNYRPNPF 198
           +  V    L +L         PF
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-41
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 12/203 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M++ +L++ +G G FG   L  ++  K  VAVK I +     +    E      LRH N+
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNL 62

Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSM 117
           ++   V++     L IV EY A G L D + + GR     D    F   +   + Y    
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
              HRDL   N L+        K+ DFG +K     S   +      + APE L  +++ 
Sbjct: 123 NFVHRDLAARNVLVSEDN--VAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFS 178

Query: 178 GKVCI--LLLILFLWRNYRPNPF 198
            K  +    ++L+   ++   P+
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPY 201

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (350), Expect = 2e-41
 Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 6/193 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
               +   LG G +G       K+    VAVK ++      E   +E    + ++HPN++
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQI 119
           +   V        I+ E+   G L D +    R   S     Y   Q+ S + Y      
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL   N L+  +    +K+ DFG S+  +   ++          + APE L+  ++ 
Sbjct: 137 IHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 178 GKVCILLLILFLW 190
            K  +    + LW
Sbjct: 195 IKSDVWAFGVLLW 207

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-40
 Identities = 51/189 (26%), Positives = 83/189 (43%), Gaps = 12/189 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG     +  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLN-RGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 182

Query: 173 RREYDGKVC 181
              Y G+  
Sbjct: 183 YHRYHGRSA 191

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-40
 Identities = 47/202 (23%), Positives = 82/202 (40%), Gaps = 22/202 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHP 58
            +  + + +G+G+FG     +       VAVK +       + +     E+   R  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSM 117
           NI+ F     T   LAIV ++  G  L+  +     +F   +     +Q   G++Y H+ 
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVL--- 171
            I HRDLK  N  L       +KI DFG +          + +   G+  ++APEV+   
Sbjct: 124 SIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 172 SRREYDGKV------CILLLIL 187
            +  Y  +        +L  ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELM 203

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 5e-39
 Identities = 53/184 (28%), Positives = 80/184 (43%), Gaps = 9/184 (4%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLRHP 58
           E +  LG G F      R K T ++VA+K I+ G +      I+    REI   + L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NII   +     +++++V ++           N+   +    + +    + G+ Y H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK  N LLD +    LK+ DFG +KS    +      V T  Y APE+L      
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 178 GKVC 181
           G   
Sbjct: 179 GVGV 182

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  134 bits (337), Expect = 5e-39
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 9/184 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPN 59
            + Y+LV+ LG G +       +    E V VK ++  +K  + + REI    +LR  PN
Sbjct: 34  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 91

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           II   ++V  P     A+V E+    +           ++ + R++  +++  ++YCHSM
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 148

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +  
Sbjct: 149 GIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 178 GKVC 181
               
Sbjct: 208 DYSL 211

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 8e-39
 Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 6/192 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
            +   V+++G+G FG+  L      K+ VA+K I  G   +E+   E      L HP ++
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   V L    + +V E+   G L D      G F+ +        +  G+ Y     + 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDL   N L+  +    +K+ DFG ++      ++    T     + +PEV S   Y  
Sbjct: 124 HRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 179 KVCILLLILFLW 190
           K  +    + +W
Sbjct: 182 KSDVWSFGVLMW 193

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 4e-38
 Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 13/187 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78

Query: 64  KEVVLTP------THLAIVMEYAAGG---ELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           +    +        +L +V++Y                        + +  QL   + Y 
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  ICHRD+K +N LLD   A   K+CDFG +K  V      S + +  Y APE++   
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197

Query: 175 EYDGKVC 181
                  
Sbjct: 198 TDYTSSI 204

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 6e-38
 Identities = 48/205 (23%), Positives = 77/205 (37%), Gaps = 14/205 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   VV +   + IV EY + G L D  +          +      Q+ SG+ Y   M  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 135 VHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 178 GKV------CILLLILFLWRNYRPN 196
            K        +L  +    R   P 
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPG 217

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-37
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 19/197 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           + KYE +  +G G FG     RH++T + VA+K +              REI   + L+H
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68

Query: 58  PNIIRFKEVVLTPT--------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS 109
            N++   E+  T           + +V ++              +F+  E +   Q L++
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPA 164
           G+ Y H  +I HRD+K  N L+       LK+ DFG ++      +   +R  + V T  
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 165 YIAPEVL-SRREYDGKV 180
           Y  PE+L   R+Y   +
Sbjct: 187 YRPPELLLGERDYGPPI 203

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-37
 Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 17/212 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
            +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH N
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 60  IIRFKEVVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           II   +++  PT        ++ +  G +L+  +      S D   YF  Q++ G+ Y H
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPEVL 171
           S  + HRDLK  N LL+ +    LKICDFG ++               V T  Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 172 SRREYDGK---VCILLLILFLWRNYRPNPFIW 200
              +   K   +  +  IL    + RP  F  
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRP-IFPG 215

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-37
 Identities = 45/193 (23%), Positives = 83/193 (43%), Gaps = 8/193 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E  +LV+ LGAG FG   +  +    + VAVK +++G    +    E    + L+H  ++
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI--CNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           R   VV T   + I+ EY   G L D +   +  + + ++      Q+  G+ +      
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     KI DFG ++      ++  +       + APE ++   + 
Sbjct: 131 IHRDLRAANILVSDT--LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 178 GKVCILLLILFLW 190
            K  +    + L 
Sbjct: 189 IKSDVWSFGILLT 201

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-37
 Identities = 46/223 (20%), Positives = 76/223 (34%), Gaps = 36/223 (16%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKEL-----VAVKYIERGRKIDE--NVAREIINHRS 54
           E  E  K LG+G FG           +      VAVK ++      E   +  E+     
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-----------------------C 90
           L  H NI+           + ++ EY   G+L + +                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 91  NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-- 148
           +    + ++   F  Q+  G+ +       HRDL   N L+       +KICDFG ++  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLARDI 214

Query: 149 -SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLW 190
            S   +    +      ++APE L    Y  K  +    + LW
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-37
 Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 6/185 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           M+KYE ++ +G G +G     +++ET E+VA+K +   +    +  +  REI   + L+H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
            NI+R  +V+ +   L +V E+             G    +  + F  QL+ G+ +CHS 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVLSRREY 176
            + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL   + 
Sbjct: 121 NVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 177 DGKVC 181
                
Sbjct: 179 YSTSI 183

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 8e-37
 Identities = 50/190 (26%), Positives = 77/190 (40%), Gaps = 12/190 (6%)

Query: 10  LGAGNFGVARLLRHKETKE--LVAVKYIERGRKID--ENVAREIINHRSLRHPNIIRFKE 65
           LG GNFG  R   ++  K+   VA+K +++G +    E + RE      L +P I+R   
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V      L +VME A GG L   +                 Q+  G+ Y       HRDL
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135

Query: 125 KLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
              N LL        KI DFG SK        ++   +      + APE ++ R++  + 
Sbjct: 136 AARNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 193

Query: 181 CILLLILFLW 190
            +    + +W
Sbjct: 194 DVWSYGVTMW 203

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (320), Expect = 9e-37
 Identities = 48/212 (22%), Positives = 87/212 (41%), Gaps = 16/212 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERG--RKIDENVAREIINHRSL 55
           +   ++ + +GAG FG       K   +    VA+K ++ G   K   +   E       
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGRYFFQQLISGVNYC 114
            HPN+I  + VV   T + I+ E+   G L      N G+F+  +     + + +G+ Y 
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAP 168
             M   HRDL   N L++ +     K+ DFG S+      S   ++          + AP
Sbjct: 145 ADMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202

Query: 169 EVLSRREYDGK--VCILLLILFLWRNYRPNPF 198
           E +  R++     V    ++++   +Y   P+
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-36
 Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 7/186 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAA-GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           PNI++  +V+ T   L +V E+     + F              + +  QL+ G+ +CHS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
            ++ HRDLK +N L++      +K+ DFG +++  +  R  +  V T  Y APE+L   +
Sbjct: 121 HRVLHRDLKPQNLLINTE--GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 176 YDGKVC 181
           Y     
Sbjct: 179 YYSTAV 184

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-36
 Identities = 45/192 (23%), Positives = 77/192 (40%), Gaps = 12/192 (6%)

Query: 8   KDLGAGNFGVARL--LRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIR 62
           K+LG+GNFG  +    + K+  + VAVK ++       + + +  E    + L +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS----SVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK+       +           + APE ++  ++  
Sbjct: 132 DLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 179 KVCILLLILFLW 190
           K  +    + +W
Sbjct: 190 KSDVWSFGVLMW 201

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-36
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 17/211 (8%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRS 54
           +   L++ LG G+FGV               VAVK ++          ++  RE+    S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNY 113
           L H N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPE 169
             S +  HRDL   N LL       +KI DFG  +    +   +   +      A+ APE
Sbjct: 127 LESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 170 VLSRREYDGKVCILLLILFLWR--NYRPNPF 198
            L  R +       +  + LW    Y   P+
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-36
 Identities = 40/196 (20%), Positives = 71/196 (36%), Gaps = 11/196 (5%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI------ERGRKIDENVAREIINHRSLRH 57
           ++ +K LG+G FG           E V +             K ++ +  E     S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P++ R   + LT T   I      G  L     +           +  Q+  G+NY    
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
           ++ HRDL   N L+       +KI DFG +K   +       +       ++A E +  R
Sbjct: 131 RLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 175 EYDGKVCILLLILFLW 190
            Y  +  +    + +W
Sbjct: 189 IYTHQSDVWSYGVTVW 204

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (317), Expect = 3e-36
 Identities = 42/188 (22%), Positives = 72/188 (38%), Gaps = 11/188 (5%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR 62
           +Y L + +G+G+FG   L       E VA+K +E  +     +  E   ++ ++    I 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 63  -FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             +       +  +VME             + +FS         Q+IS + Y HS    H
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 122 RDLKLENTLL-DGSAAPRLKICDFGYSK--------SSVLHSRPKSTVGTPAYIAPEVLS 172
           RD+K +N L+  G     + I DFG +K          + +   K+  GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 173 RREYDGKV 180
             E   + 
Sbjct: 187 GIEQSRRD 194

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  126 bits (316), Expect = 3e-36
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 7/185 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           MEKY  ++ +G G +GV    ++    E  A+K I   +    I     REI   + L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
            NI++  +V+ T   L +V E+             G       + F  QL++G+ YCH  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRREY 176
           ++ HRDLK +N L++      LKI DFG +++  +   +    + T  Y AP+VL   + 
Sbjct: 120 RVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 177 DGKVC 181
                
Sbjct: 178 YSTTI 182

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 3e-36
 Identities = 44/197 (22%), Positives = 83/197 (42%), Gaps = 11/197 (5%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           E+ EL + +G G FG       +  +     VA+K  +      + E   +E +  R   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH 115
           HP+I++   V+ T   + I+ME    GEL   +              +  QL + + Y  
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVLSR 173
           S +  HRD+   N L+  +    +K+ DFG S+     +  K++       ++APE ++ 
Sbjct: 126 SKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 174 REYDGKVCILLLILFLW 190
           R +     + +  + +W
Sbjct: 184 RRFTSASDVWMFGVCMW 200

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 5e-36
 Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 19/211 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRHP 58
             Y  ++ +G+G +G         T   VA+K + R        +   RE+   + +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 59  NIIRFKEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V          T   +VM +   G    ++    +  ED  ++   Q++ G+ 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           Y H+  I HRDLK  N  ++      LKI DFG ++     S     V T  Y APEV+ 
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191

Query: 173 RREYDGK---VCILLLILFLWRNYRPNPFIW 200
                 +   +  +  I+      +   F  
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKT-LFKG 221

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-35
 Identities = 49/211 (23%), Positives = 77/211 (36%), Gaps = 23/211 (10%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERGRKID--ENVAREIINHRSL- 55
               +    +G GNFG     R K+       A+K ++     D   + A E+     L 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRFSEDE 99
            HPNII          +L + +EYA  G L D +                  A   S  +
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 100 GRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST 159
             +F   +  G++Y    Q  HRDL   N L+  +     KI DFG S+   ++ +    
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTMG 186

Query: 160 VGTPAYIAPEVLSRREYDGKVCILLLILFLW 190
                ++A E L+   Y     +    + LW
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  124 bits (311), Expect = 2e-35
 Identities = 37/205 (18%), Positives = 73/205 (35%), Gaps = 19/205 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
             Y++ + +G G+FGV     +    + VA+K+  R R     +  E   ++ L     I
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63

Query: 62  -RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
                      H  +V++               +FS        +Q+++ V   H   + 
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 121 HRDLKLENTLLDGSAAP---RLKICDFGYSK--------SSVLHSRPKSTVGTPAYIAPE 169
           +RD+K +N L+    +     + + DFG  K          + +   K+  GT  Y++  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 170 VLSRREYDGKV------CILLLILF 188
               RE   +        + +  L 
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLR 208

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-34
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 21/205 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKET-KELVAVKYI---ERGRKIDENVAREIINHRSL-- 55
           ++YE V ++G G +G     R  +     VA+K +        +  +  RE+   R L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 56  -RHPNIIRFKEVVLTP-----THLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQLI 108
             HPN++R  +V         T L +V E+       +           +  +    QL+
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAP 168
            G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 169 EVLSRREYDGKV------CILLLIL 187
           EVL +  Y   V      CI   + 
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMF 209

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-34
 Identities = 48/218 (22%), Positives = 75/218 (34%), Gaps = 31/218 (14%)

Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRS 54
            +    K LGAG FG      A  L   +    VAVK ++    +   E +  E+     
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC------------------NAGRF 95
           L  H NI+             ++ EY   G+L + +                   +    
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 96  SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR 155
             ++   F  Q+  G+ +  S    HRDL   N LL        KICDFG ++     S 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKNDSN 200

Query: 156 PKST---VGTPAYIAPEVLSRREYDGKVCILLLILFLW 190
                       ++APE +    Y  +  +    +FLW
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-33
 Identities = 55/195 (28%), Positives = 72/195 (36%), Gaps = 22/195 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
               L + +G G FG     R K   E VAVK      +       EI     LRH NI+
Sbjct: 3   RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 62  RFKEVV----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS- 116
            F         T T L +V +Y   G LFD + N    + +          SG+ + H  
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 119

Query: 117 -------MQICHRDLKLENTLLDGSAAPRLKICDFG-----YSKSSVLHSRPKSTVGTPA 164
                    I HRDLK +N L+  +      I D G      S +  +   P   VGT  
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 165 YIAPEVLSRREYDGK 179
           Y+APEVL        
Sbjct: 178 YMAPEVLDDSINMKH 192

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  118 bits (297), Expect = 2e-33
 Identities = 46/213 (21%), Positives = 78/213 (36%), Gaps = 36/213 (16%)

Query: 2   EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKID--ENVAREIINHRS 54
              E V+D+G G FG     R       E   +VAVK ++     D   +  RE      
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-------------------- 94
             +PNI++   V      + ++ EY A G+L + + +                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 95  ----FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-- 148
                S  E     +Q+ +G+ Y    +  HRDL   N L+  +    +KI DFG S+  
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190

Query: 149 -SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKV 180
            S+  +    +      ++ PE +    Y  + 
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTES 223

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (300), Expect = 3e-33
 Identities = 47/191 (24%), Positives = 77/191 (40%), Gaps = 14/191 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R  +     +   RE++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 58  PNIIRFKEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            NII    V            + +VME                   +   Y   Q++ G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGI 132

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 172 SRREYDGKVCI 182
               Y   V I
Sbjct: 191 LGMGYKENVDI 201

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 2e-32
 Identities = 47/200 (23%), Positives = 76/200 (38%), Gaps = 13/200 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGRKIDENVA--REIINHRSL 55
                 K +GAG FG       K +       VA+K ++ G    + V    E       
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYC 114
            H NIIR + V+     + I+ EY   G L   +    G FS  +     + + +G+ Y 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPEV 170
            +M   HRDL   N L++ +     K+ DFG S+                    + APE 
Sbjct: 127 ANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 171 LSRREYDGKVCILLLILFLW 190
           +S R++     +    + +W
Sbjct: 185 ISYRKFTSASDVWSFGIVMW 204

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 4e-32
 Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 9/185 (4%)

Query: 1   MEKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGR-----KIDENVAREIINH 52
           +E +EL+K LG G +G     R +   +T +L A+K +++       K  E+   E    
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 53  RSLRH-PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
             +R  P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++  +
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            + H + I +RD+KLEN LLD +    L          +    R     GT  Y+AP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 172 SRREY 176
              + 
Sbjct: 203 RGGDS 207

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-31
 Identities = 44/205 (21%), Positives = 77/205 (37%), Gaps = 20/205 (9%)

Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94

Query: 65  EVVL-TPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L +         +  +   F  Q+  G+ +  S +  HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 154

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           DL   N +LD      +K+ DFG ++                     ++A E L  +++ 
Sbjct: 155 DLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212

Query: 178 GKV------CILLLILFLWRNYRPN 196
            K        +L  ++       P+
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPD 237

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 4e-31
 Identities = 40/209 (19%), Positives = 81/209 (38%), Gaps = 22/209 (10%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRS 54
           EK  + ++LG G+FG     VA+ +   E +  VA+K +     + E      E    + 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRF----------SEDEGRYFF 104
               +++R   VV       ++ME    G+L   + +              S  +     
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVG 161
            ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++    +  + +    + 
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 162 TPAYIAPEVLSRREYDGKVCILLLILFLW 190
              +++PE L    +     +    + LW
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLW 226

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 5e-31
 Identities = 45/186 (24%), Positives = 81/186 (43%), Gaps = 13/186 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 59  NIIRFKEVVLTPTHLA-----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G    + I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            HS  I HRDLK  N  ++      LKI DFG ++           V T  Y APE++  
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLN 192

Query: 174 REYDGK 179
             +  +
Sbjct: 193 WMHYNQ 198

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-30
 Identities = 44/226 (19%), Positives = 80/226 (35%), Gaps = 29/226 (12%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKE-------LVAVKYI--ERGRKIDENVAREIINH 52
           ++  L K LG G FG   L       +        VAVK +  +   K   ++  E+   
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 53  RSL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRF 95
           + + +H NII           L +++EYA+ G L + +                    + 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 96  SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHS 154
           S  +      Q+  G+ Y  S +  HRDL   N L+      ++              + 
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 155 RPKSTVGTPAYIAPEVLSRREYDGK--VCILLLILFLWRNYRPNPF 198
           +  +      ++APE L  R Y  +  V    ++L+       +P+
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 8e-30
 Identities = 47/217 (21%), Positives = 81/217 (37%), Gaps = 30/217 (13%)

Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDEN---VAREIINHR 53
           ++ +L K LG G FG      A  +    T   VAVK ++ G    E+   ++   I   
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 54  SLRHPNIIRFKEVVLTP-THLAIVMEYAAGGELFDRICNAGR----------------FS 96
              H N++        P   L +++E+   G L   + +                    +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 97  EDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLH 153
            +    +  Q+  G+ +  S +  HRDL   N LL       +KICDFG ++       +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPDY 190

Query: 154 SRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLW 190
            R         ++APE +  R Y  +  +    + LW
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 95.9 bits (237), Expect = 3e-24
 Identities = 39/197 (19%), Positives = 69/197 (35%), Gaps = 19/197 (9%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR 62
           +Y LV+ LG G+F    L +       VA+K +   +   E    EI   + +   +  +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 63  ---------------FKEVVLTPTHLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQ 106
                          F        H+ +V E      L   +            +   +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 107 LISGVNYCHSMQ-ICHRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLHSRPKSTVGTP 163
           L+ G++Y H    I H D+K EN L++   S    ++I       +        +++ T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 164 AYIAPEVLSRREYDGKV 180
            Y +PEVL    +    
Sbjct: 194 EYRSPEVLLGAPWGCGA 210

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 63.6 bits (154), Expect = 2e-13
 Identities = 24/161 (14%), Positives = 46/161 (28%), Gaps = 26/161 (16%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----------KIDENVAREIINH 52
             + K +G G          ++  E   VK+ + G              D + +   I  
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 53  RSLRHPNIIRFKEVVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI 108
                  + + + + +   +     A++ME               R   +        ++
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             V   +   I H DL   N L+       + I DF  S  
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	200
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.96
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.02
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.66
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.49
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.89
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.86
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.42

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-59  Score=333.05  Aligned_cols=197  Identities=31%  Similarity=0.551  Sum_probs=180.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      |++|++.+.||+|+||+||++.++.+++.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999998753    23456789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      |||++|++|.+++.+.+++++..+..++.|++.||+|||++|++||||||+||++++++.  +||+|||+|.... ....
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~-~~~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCC-CCCC
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecC-CCcc
Confidence            999999999999999889999999999999999999999999999999999999987665  9999999997443 2333


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  205 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE  205 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCC
Confidence            45579999999999999999999999999999999999999983

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-59  Score=333.85  Aligned_cols=197  Identities=36%  Similarity=0.535  Sum_probs=175.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      +++|++.+.||+|+||+||+|.++.+++.||+|++.....  ..+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            5789999999999999999999999999999999976432  23568999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC---C
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---R  155 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~---~  155 (200)
                      |++|++|.+++.+...+++.+++.++.|++.||+|||++|++||||||+||++++++.  +||+|||+|+......   .
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcccc
Confidence            9999999999988788999999999999999999999999999999999999986664  9999999997543222   2


Q ss_pred             CCcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .....||+.|+|||++.+..+ +.++||||+|+++|||++|.+||
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf  206 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW  206 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCC
Confidence            334579999999999988776 57799999999999999999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-57  Score=329.53  Aligned_cols=196  Identities=29%  Similarity=0.449  Sum_probs=177.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999999999999999997644 34567999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCcc
Q 029037           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~~  159 (200)
                      +|++|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++.  +||+|||+|+...... .....
T Consensus       100 ~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1         100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             TTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeecccccccccc
Confidence            99999988755 56999999999999999999999999999999999999987664  9999999997554333 33455


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .||+.|+|||++.+..++.++||||+|+++|+|++|.+||.
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  217 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL  217 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCC
Confidence            79999999999999999999999999999999999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-57  Score=332.96  Aligned_cols=199  Identities=32%  Similarity=0.538  Sum_probs=164.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++.+..  ...+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45999999999999999999999999999999997643  2245678999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC-CCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~-~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      ++|++|.+++.+.+.+++.++..++.|++.||+|||++|++||||||+||++.. +.++.+||+|||+|+..........
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  168 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST  168 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence            999999999998889999999999999999999999999999999999999964 2334699999999986655555566


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..||+.|+|||++.+..+++++|||||||++|+|++|.+||.
T Consensus       169 ~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  210 (307)
T d1a06a_         169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY  210 (307)
T ss_dssp             ----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence            789999999999999999999999999999999999999984

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-57  Score=332.80  Aligned_cols=197  Identities=32%  Similarity=0.517  Sum_probs=181.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      |++|++++.||+|+||+||++.++.+++.||+|++.+.    ....+.+.+|+.+++.++||||++++++++++..+++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            58999999999999999999999999999999999764    23346788999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~  155 (200)
                      |||++||+|.+++.+...+++..++.+++|++.||+|||++|++||||||+||+++.++.  +||+|||+|+..... ..
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCcc
Confidence            999999999999999999999999999999999999999999999999999999987664  999999999855443 33


Q ss_pred             CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+||+.|+|||++.+..++.++|+|||||++|||++|.+||
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf  205 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  205 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCC
Confidence            34567999999999999999999999999999999999999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=329.36  Aligned_cols=197  Identities=29%  Similarity=0.421  Sum_probs=177.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.+.    ....+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999999753    233467899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      ||++|++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||++++++.  ++|+|||+|+.......  
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCccc
Confidence            99999999999999999999999999999999999999999999999999999987665  99999999975443322  


Q ss_pred             -CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  211 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR  211 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCC
Confidence             234579999999999999999999999999999999999999984

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.4e-57  Score=336.14  Aligned_cols=199  Identities=25%  Similarity=0.438  Sum_probs=181.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      |++|++.+.||+|+||+||+|.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4789999999999999999999999999999999976543 346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      ++|++|.+++.+ .+++++..+..++.||+.||.|||++|++||||||+||+++.+..+.+||+|||+|+..........
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  184 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  184 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence            999999999854 4569999999999999999999999999999999999999765556799999999986665555556


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..+|+.|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus       185 ~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf  225 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF  225 (350)
T ss_dssp             ECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCC
Confidence            78999999999999999999999999999999999999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=334.67  Aligned_cols=196  Identities=30%  Similarity=0.391  Sum_probs=177.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|++.+.||+|+||+||++.+..+++.||+|++....  ...+.+.+|+.++++++||||+++++++.++..+++||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            68999999999999999999999999999999997542  3346789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      ++|++|.+++.+.+.+++..+..++.|++.||.|||+ +||+||||||+||++++++.  +||+|||+|+.... .....
T Consensus        86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~~~~  162 (322)
T d1s9ja_          86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  162 (322)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HTC--
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-Ccccc
Confidence            9999999999988899999999999999999999997 59999999999999987664  99999999974332 23345


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..||+.|+|||++.+..++.++||||+||++|||++|.+||.
T Consensus       163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~  204 (322)
T d1s9ja_         163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP  204 (322)
T ss_dssp             -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred             ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            689999999999999999999999999999999999999984

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-57  Score=330.85  Aligned_cols=200  Identities=23%  Similarity=0.348  Sum_probs=183.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      +++|++.+.||+|+||+||+|.+..+++.||+|.+.........+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            57999999999999999999999999999999999887665667889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      +|++|.+++.+.+ ++++.++..++.|++.||.|||++|++||||+|+||+++.+....++|+|||+++...........
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~  163 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence            9999999997665 699999999999999999999999999999999999998766667999999999765544444556


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+++.|+|||...+..++.++||||+|+++|+|++|.+||.
T Consensus       164 ~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~  204 (321)
T d1tkia_         164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL  204 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC
Confidence            78999999999999999999999999999999999999984

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-56  Score=323.55  Aligned_cols=199  Identities=32%  Similarity=0.532  Sum_probs=181.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-------cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-------KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++.+..       ...+.+.+|+.++++++||||+++++++.++..++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46999999999999999999999999999999997532       23467999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC--CCEEEeecCCCcccCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA--PRLKICDFGYSKSSVL  152 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~--~~v~l~df~~~~~~~~  152 (200)
                      +||||++|++|.+++.+.+.+++..++.++.|++.||+|||++|++||||||+||+++.++.  ..+||+|||+|.....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            99999999999999998889999999999999999999999999999999999999975543  3599999999986665


Q ss_pred             CCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ........+++.|+|||.+.+..++.++||||+|+++|||++|.+||.
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  217 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  217 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence            556666788999999999999999999999999999999999999984

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.7e-56  Score=326.70  Aligned_cols=196  Identities=29%  Similarity=0.514  Sum_probs=179.7

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      |++|++.+.||+|+||+||+|.++.+++.||+|++.+.    ....+.+.+|+.++++++||||+++++++.++..+++|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            58999999999999999999999999999999999753    23356789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      |||++|++|.+.+.....++...+..++.|++.||+|||++||+||||||+||+++.++.  +||+|||+|+....  ..
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--~~  158 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VT  158 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CB
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--cc
Confidence            999999999999999889999999999999999999999999999999999999987664  99999999975432  33


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+||+.|+|||++.+..++.++||||||+++|+|++|.+||.
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~  202 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY  202 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC
Confidence            45679999999999999999999999999999999999999983

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.4e-56  Score=333.12  Aligned_cols=199  Identities=26%  Similarity=0.410  Sum_probs=180.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...... .+.+.+|+.++++++||||+++++++.++..+++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999999999999999999765433 456889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCcc
Q 029037           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (200)
Q Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~~  159 (200)
                      +|++|.+.+.+.. ++++.++..++.|++.||.|||++|++||||||+||+++....+.+||+|||+|............
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~  188 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  188 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeec
Confidence            9999998876554 699999999999999999999999999999999999998555567999999999876665555566


Q ss_pred             cCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .+++.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus       189 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  229 (352)
T d1koba_         189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA  229 (352)
T ss_dssp             CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             cCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence            79999999999999999999999999999999999999983

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=325.12  Aligned_cols=196  Identities=31%  Similarity=0.431  Sum_probs=173.9

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      .|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            5899999999999999999999999999999997643 334678999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-CCCCcc
Q 029037           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKST  159 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~~~~~~  159 (200)
                      |++|.+++.+. .++++.++..++.|++.||.|||++||+||||||+||+++.++.  +||+|||+|+..... ......
T Consensus        93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~~  170 (288)
T d2jfla1          93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSF  170 (288)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTCC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCccccccc
Confidence            99999997654 46999999999999999999999999999999999999987665  999999998643222 122345


Q ss_pred             cCCCCccCCeeec-----CcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          160 VGTPAYIAPEVLS-----RREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       160 ~~~~~~~aPE~~~-----~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .||+.|+|||++.     +..++.++|||||||++|||++|.+||+
T Consensus       171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~  216 (288)
T d2jfla1         171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH  216 (288)
T ss_dssp             CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC
Confidence            7899999999984     4567899999999999999999999985

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-55  Score=327.42  Aligned_cols=196  Identities=30%  Similarity=0.546  Sum_probs=179.8

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      |++|++++.||+|+||+||+|.++.+++.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+....+++
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            57899999999999999999999999999999998753    23346789999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~  156 (200)
                      ||++.|++|.+.+.+.+.+++..+..++.|++.||.|||++||+||||||+||+++.++  .+||+|||+|+...  ...
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~~--~~~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVK--GRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS--SCB
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeecc--ccc
Confidence            99999999999999999999999999999999999999999999999999999998766  49999999997543  233


Q ss_pred             CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  239 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence            45679999999999999999999999999999999999999984

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=319.44  Aligned_cols=197  Identities=31%  Similarity=0.506  Sum_probs=163.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEec--CceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v   76 (200)
                      ++|++.+.||+|+||+||++.++.+++.||+|.+.....   ..+.+.+|+.++++++||||+++++++.+  ++.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            689999999999999999999999999999999976532   23568899999999999999999999865  4568999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeecCCCCCeeecCCCCCCEEEeecCCC
Q 029037           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQ-----ICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~ni~i~~~~~~~v~l~df~~~  147 (200)
                      |||++||+|.+++.+    ...+++..++.++.|++.||.|||++|     |+||||||+||+++.++.  +||+|||+|
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a  161 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLA  161 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccce
Confidence            999999999998864    356999999999999999999999876     999999999999987664  999999999


Q ss_pred             cccCCCC-CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          148 KSSVLHS-RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       148 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      +...... ......+|+.|+|||++.+..++.++||||||+++|||++|.+||.
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~  215 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT  215 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence            7544332 2344578999999999999999999999999999999999999984

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=314.04  Aligned_cols=194  Identities=24%  Similarity=0.340  Sum_probs=169.6

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEec----CceEEEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLT----PTHLAIV   76 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v   76 (200)
                      |++.+.||+|+||+||++.+..+++.||+|.+.....   ..+.+.+|++++++++||||+++++++.+    +..+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            3677889999999999999999999999999876432   23568899999999999999999999875    4568999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      |||+++++|.+++.+...+++..+..++.|++.||+|||+++  |+||||||+||+++++. +.+||+|||+|+... ..
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~-~~~Kl~DFGla~~~~-~~  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT-GSVKIGDLGLATLKR-AS  168 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT-SCEEECCTTGGGGCC-TT
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCC-CCEEEeecCcceecc-CC
Confidence            999999999999998889999999999999999999999998  99999999999996422 259999999997432 22


Q ss_pred             CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ......||+.|+|||.+.+ .++.++||||||+++|||++|.+||.
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~  213 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  213 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence            3345579999999999865 59999999999999999999999983

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-55  Score=320.29  Aligned_cols=197  Identities=22%  Similarity=0.297  Sum_probs=176.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|+||+||+|.++.+++.||+|+++.+....+.+.+|+.++++++||||+++++++.+++..+++|||++
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            47889999999999999999999999999999998877777889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--C
Q 029037           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--K  157 (200)
Q Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~  157 (200)
                      +|+|.+++.+.  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.  +||+|||+|+........  .
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSEEET
T ss_pred             CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCceeec
Confidence            99999999765  35899999999999999999999999999999999999987664  999999999754433222  2


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+.+..++.++||||+|+++|||+++..|||
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~  217 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY  217 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence            2347889999999999999999999999999999999877764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-55  Score=320.19  Aligned_cols=193  Identities=29%  Similarity=0.426  Sum_probs=173.3

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc----hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      .|+..+.||+|+||+||+|.+..+++.||+|++......    .+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            499999999999999999999999999999999765322    2468899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      |+++++|..++....++++.++..++.|++.||.|||++|++||||||+||++++++.  +||+|||+|.....   ...
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~~  170 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANS  170 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CCc
Confidence            9999999888877888999999999999999999999999999999999999986664  99999999875432   334


Q ss_pred             ccCCCCccCCeeecC---cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSR---REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~---~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..||+.|+|||++.+   ..++.++||||||+++|||++|.+||.
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~  215 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence            579999999999864   458999999999999999999999984

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=318.95  Aligned_cols=198  Identities=31%  Similarity=0.465  Sum_probs=177.2

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc----ccchHHHHHHHHHH-hhCCCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINH-RSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      |++|++.+.||+|+||+||+|.+..+++.||+|++.+.    ....+.+..|...+ +.++||||+++++++.+++.+++
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            68999999999999999999999999999999999753    23335566666665 47899999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||||++||+|.+++.+...+++.+++.++.|++.||+|||++|++||||||+||++++++.  +||+|||+++.......
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhcccccc
Confidence            9999999999999999899999999999999999999999999999999999999986664  99999999975544333


Q ss_pred             -CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       .....||+.|+|||++.+..+++++||||+||++|+|++|.+||.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~  204 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH  204 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence             334578999999999999999999999999999999999999983

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9e-55  Score=324.81  Aligned_cols=197  Identities=26%  Similarity=0.438  Sum_probs=174.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc----cchHHHHH---HHHHHhhCCCCCeeeEEEEEecCceE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAR---EIINHRSLRHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~   73 (200)
                      |++|++.+.||+|+||+||+|.+..+++.||+|++.+..    .....+.+   ++.+++.++||||+++++++.+++.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            689999999999999999999999999999999986532    12223333   46777788999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++||||++|++|.+++.+...+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||+|+.... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~-  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS-
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC-
Confidence            999999999999999999889999999999999999999999999999999999999987664  99999999975433 


Q ss_pred             CCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||+
T Consensus       160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  207 (364)
T d1omwa3         160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR  207 (364)
T ss_dssp             SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence            34455679999999999974 568999999999999999999999994

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.4e-54  Score=311.68  Aligned_cols=198  Identities=33%  Similarity=0.481  Sum_probs=178.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----------chHHHHHHHHHHhhCC-CCCeeeEEEEEec
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----------IDENVAREIINHRSLR-HPNIIRFKEVVLT   69 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----------~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   69 (200)
                      .++|++.+.||+|+||+||++.+..+++.||+|++.+...          ..+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            3799999999999999999999999999999999976421          1245889999999997 9999999999999


Q ss_pred             CceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           70 PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        70 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      ++..++||||++|++|.+++...+++++.+++.++.|++.||+|||++|++||||+|+||++++++.  +||+|||+++.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~  159 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ  159 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeE
Confidence            9999999999999999999999889999999999999999999999999999999999999986664  99999999987


Q ss_pred             cCCCCCCCcccCCCCccCCeeecC------cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          150 SVLHSRPKSTVGTPAYIAPEVLSR------REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...........||+.|+|||.+.+      ..++.++||||+|+++|+|++|.+||.
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~  216 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW  216 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC
Confidence            666555666789999999999863      346788999999999999999999984

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=319.25  Aligned_cols=195  Identities=32%  Similarity=0.497  Sum_probs=173.4

Q ss_pred             Cccccccc-cccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHh-hCCCCCeeeEEEEEec----CceEE
Q 029037            1 MEKYELVK-DLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR-SLRHPNIIRFKEVVLT----PTHLA   74 (200)
Q Consensus         1 ~~~y~~~~-~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~----~~~~~   74 (200)
                      +++|++.+ .||+|+||+||+|.+..+++.||+|++.+    .+...+|+.++. ..+||||+++++++++    +..++
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            47899875 69999999999999999999999999865    345778888765 5589999999999875    46789


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC-CCCEEEeecCCCcccC
Q 029037           75 IVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSV  151 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~-~~~v~l~df~~~~~~~  151 (200)
                      +|||||+||+|.+++.+.+  .+++.+++.++.|++.||+|||++|++||||||+||++++.. .+.+||+|||+|+...
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence            9999999999999997643  699999999999999999999999999999999999997533 3469999999998766


Q ss_pred             CCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf  213 (335)
T d2ozaa1         166 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF  213 (335)
T ss_dssp             CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred             CCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC
Confidence            666666778999999999999999999999999999999999999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=310.10  Aligned_cols=195  Identities=23%  Similarity=0.390  Sum_probs=165.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|+||+||+|.+.+ ++.||+|.+.......+++.+|+.++++++||||+++++++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            589999999999999999999874 5679999998877777899999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--Cc
Q 029037           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--KS  158 (200)
Q Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~~  158 (200)
                      +|+|.+++.+.. .+++..+..++.|++.||+|||+++++||||||+||++++++.  +||+|||+++........  ..
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC---------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceeecc
Confidence            999999987654 5889999999999999999999999999999999999987665  999999999754433322  23


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..+++.|+|||.+.+..++.++||||+|+++|||+|+..|+
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~  202 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP  202 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCC
Confidence            46889999999999999999999999999999999965554

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.7e-54  Score=311.57  Aligned_cols=196  Identities=26%  Similarity=0.371  Sum_probs=168.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc----chHHHHHHHHHHhhCCCCCeeeEEEEEecCc----eE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPT----HL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   73 (200)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.....    ..+.+.+|+.+++.++||||+++++++.+..    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            579999999999999999999999999999999976432    2346889999999999999999999987643    48


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      ++||||++|++|.+++...+++++.+++.++.|++.||++||++|++||||||+||+++.++.  ++++|||.+......
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC--
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhccc
Confidence            999999999999999999999999999999999999999999999999999999999987665  999999987533222


Q ss_pred             C----CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 S----RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .    ......||+.|+|||++.+..+++++||||+|+++|+|+||.+||
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf  214 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF  214 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCC
Confidence            2    233446899999999999999999999999999999999999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.9e-54  Score=311.81  Aligned_cols=197  Identities=22%  Similarity=0.342  Sum_probs=161.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc---EEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|+||+||+|.++.+++   .||+|.+....  ...+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            578899999999999999999976654   58888876542  3345799999999999999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      |||+++|+|.+++.... .+++.+++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+|+.......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCC
Confidence            99999999999887754 6899999999999999999999999999999999999987664  99999999975433222


Q ss_pred             CC------cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCCC
Q 029037          156 PK------STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFIW  200 (200)
Q Consensus       156 ~~------~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf~  200 (200)
                      ..      ...+++.|+|||.+.+..++.++||||||+++|||+| |.+||+
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~  235 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW  235 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence            11      2346789999999999999999999999999999998 899985

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=302.04  Aligned_cols=195  Identities=24%  Similarity=0.384  Sum_probs=174.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|+||+||++.++ +++.||+|.++++....+++.+|+.++++++||||+++++++.+++.+++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            68999999999999999999985 56789999999887778899999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC--Cc
Q 029037           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--KS  158 (200)
Q Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~--~~  158 (200)
                      +|+|.+++... ..+++..++.++.|++.||+|||+.|++||||+|+||++++++.  +||+|||+++........  ..
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeecc
Confidence            99999987654 46899999999999999999999999999999999999987664  999999999754433322  23


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..+++.|+|||.+.+..++.++||||+|+++|||+| |.+||
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf  202 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY  202 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCC
Confidence            457889999999999999999999999999999998 67776

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=307.01  Aligned_cols=194  Identities=23%  Similarity=0.302  Sum_probs=169.6

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|+||+||+|.++ +++.||+|.+.......+.+.+|+.++++++||||+++++++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            57899999999999999999986 46679999998877777889999999999999999999998765 55789999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC--CCC
Q 029037           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPK  157 (200)
Q Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~--~~~  157 (200)
                      +|+|.+++...  .++++..++.++.|++.||.|||+++++||||||+||++++++.  +||+|||+|+......  ...
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCcccccc
Confidence            99999877443  35899999999999999999999999999999999999987664  9999999997544332  233


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ...+++.|+|||.+.+..++.++||||+|+++|||+|+..|+
T Consensus       169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~  210 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP  210 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence            456889999999999889999999999999999999976554

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-53  Score=305.16  Aligned_cols=193  Identities=24%  Similarity=0.316  Sum_probs=162.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccc---ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (200)
                      ++|++.+.||+|+||+||+|..+.   .||+|++...   ....+.+.+|+.++++++||||+++++++.+ +.+++|||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            579999999999999999998643   4999998754   2334678899999999999999999998754 56899999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--
Q 029037           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (200)
Q Consensus        79 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--  155 (200)
                      |+++++|.+++... .++++..+..++.|++.||+|||++||+||||||+||+++.++.  +||+|||+|+.......  
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC--------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCCcc
Confidence            99999999999765 46999999999999999999999999999999999999987664  99999999975433222  


Q ss_pred             -CCcccCCCCccCCeeecCc---ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          156 -PKSTVGTPAYIAPEVLSRR---EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       156 -~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       .....+|+.|+|||.+.+.   .++.++||||+|+++|||+||..||.
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~  210 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS  210 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence             2344689999999998643   47889999999999999999999983

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=309.49  Aligned_cols=196  Identities=23%  Similarity=0.329  Sum_probs=168.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc-----EEEEEEeccc--ccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE-----LVAVKYIERG--RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~~~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|+||+||+|.+..+++     .||+|.+...  ....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            578999999999999999999876543     5899988653  33456789999999888 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCee
Q 029037           74 AIVMEYAAGGELFDRICNAG-----------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~  130 (200)
                      ++||||+++|+|.+++.+..                       .+++..++.++.|++.||+|||++||+||||||+||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            99999999999999996542                       3788999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          131 LDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       131 i~~~~~~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ++.++.  +||+|||+|+........   ....+|+.|+|||.+.+..++.++||||+|+++|||+| |.+||
T Consensus       197 l~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         197 VTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             EETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             cccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            986664  999999999754443332   23357899999999999999999999999999999998 88988

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=304.84  Aligned_cols=197  Identities=26%  Similarity=0.382  Sum_probs=171.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc-------hHHHHHHHHHHhhCC--CCCeeeEEEEEecCce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-------DENVAREIINHRSLR--HPNIIRFKEVVLTPTH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~   72 (200)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.+....       ..++.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5899999999999999999999999999999998754211       234678999999886  8999999999999999


Q ss_pred             EEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           73 LAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        73 ~~~v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      .++|||++.+ +++.+++.+...+++.+++.++.|++.||+|||++|++||||||+||+++.+. +.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceecc
Confidence            9999999976 57888888888999999999999999999999999999999999999997543 259999999997433


Q ss_pred             CCCCCCcccCCCCccCCeeecCccc-CCeeehhhhhhhhhhcCCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSRREY-DGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                       ........||+.|+|||.+.+..+ +.++||||+||++|+|++|.+||.
T Consensus       163 -~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  211 (273)
T d1xwsa_         163 -DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  211 (273)
T ss_dssp             -SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             -cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence             233345679999999999987665 567899999999999999999984

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=301.97  Aligned_cols=189  Identities=23%  Similarity=0.330  Sum_probs=161.9

Q ss_pred             ccccCCcceEEEEEEEcC--CCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecCC
Q 029037            8 KDLGAGNFGVARLLRHKE--TKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~--~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (200)
                      +.||+|+||+||+|.+..  +++.||+|+++...   ...+.+.+|+.++++++||||+++++++.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            469999999999998653  55789999997542   2246799999999999999999999999654 57899999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC----CCc
Q 029037           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR----PKS  158 (200)
Q Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~----~~~  158 (200)
                      |+|.+++.+..++++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+|||+++.......    ...
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC---
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccccccc
Confidence            999999998889999999999999999999999999999999999999986664  99999999975433322    223


Q ss_pred             ccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          159 TVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..+++.|+|||.+.+..++.++||||||+++|||+| |.+||
T Consensus       170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf  211 (277)
T d1xbba_         170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY  211 (277)
T ss_dssp             -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCC
Confidence            357889999999999999999999999999999998 78887

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=301.66  Aligned_cols=195  Identities=25%  Similarity=0.346  Sum_probs=166.2

Q ss_pred             cccccccc-ccCCcceEEEEEEEcC--CCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKD-LGAGNFGVARLLRHKE--TKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~-l~~g~~g~v~~~~~~~--~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||+|.++...  ...+.+.+|+.++++++||||+++++++.++ .+++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            45777774 9999999999998764  34579999997643  3346799999999999999999999998754 57899


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      |||+++|+|.+++... ..+++.++..++.|++.||+|||++|++||||||+||+++.++.  +||+|||+|+.......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDS  164 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSC
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccccccc
Confidence            9999999999988654 46999999999999999999999999999999999999987664  99999999975443322


Q ss_pred             ----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 ----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                          .....+++.|+|||.+....++.++||||+|+++|||+| |.+||
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf  213 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY  213 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCC
Confidence                223357889999999998899999999999999999998 89987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=303.28  Aligned_cols=196  Identities=30%  Similarity=0.435  Sum_probs=169.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      |++|++.+.||+|+||+||+|.+..+++.||+|+++...   ...+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            689999999999999999999999999999999997543   23567899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC-C
Q 029037           78 EYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-S  154 (200)
Q Consensus        78 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~-~  154 (200)
                      |++.+ ++.+.+..  ...+++..+..++.|++.||.|||++||+||||||+||+++.++.  +||+|||.|+..... .
T Consensus        81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSB
T ss_pred             eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcc
Confidence            99966 44444433  346999999999999999999999999999999999999986664  999999999755433 3


Q ss_pred             CCCcccCCCCccCCeeecCcc-cCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 RPKSTVGTPAYIAPEVLSRRE-YDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......+++.|+|||.+.... ++.++|+||+|+++|+|++|.+||
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf  203 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF  203 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC
Confidence            334457899999999987665 578899999999999999999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=300.98  Aligned_cols=195  Identities=24%  Similarity=0.290  Sum_probs=166.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEecC
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (200)
                      ++|++.+.||+|+||+||+|.++++. .||+|.+.......+.+.+|+.++++++||||+++++++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~-~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTE-EEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCC-EEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            68999999999999999999998764 59999998877777889999999999999999999999865 45789999999


Q ss_pred             CCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC--CC
Q 029037           82 GGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (200)
Q Consensus        82 ~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~--~~  157 (200)
                      +|+|..++..  ...+++.+++.++.|++.||++||+.|++||||||+||++++++.  +||+|||+++.......  ..
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~  172 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  172 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCceeec
Confidence            9999888854  346999999999999999999999999999999999999987664  99999999975433322  23


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ...+++.|+|||.+.+..++.++||||+|+++|||++|..||+
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~  215 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY  215 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence            3468899999999999999999999999999999999776664

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-52  Score=304.55  Aligned_cols=193  Identities=28%  Similarity=0.346  Sum_probs=166.3

Q ss_pred             ccccccCCcceEEEEEEEcCCCcEEEEEEecccccc------hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEEEe
Q 029037            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI------DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      .++.||+|+||+||+|.++.+++.||+|++......      .+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            468899999999999999999999999998754321      24688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC-CCCc
Q 029037           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKS  158 (200)
Q Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~-~~~~  158 (200)
                      +.++++.........+++..+..+++|++.||+|||++|++||||||+||+++.++.  +||+|||.|+...... ....
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence            988777766665667999999999999999999999999999999999999986664  9999999997544433 2344


Q ss_pred             ccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..+|+.|+|||.+.+. .++.++||||+||++|||++|.+||.
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~  202 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP  202 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence            5789999999998754 57999999999999999999999983

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=298.06  Aligned_cols=196  Identities=24%  Similarity=0.301  Sum_probs=163.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCC----cEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETK----ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~----~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|+||+||+|..+.++    ..||+|.+....  ...+.+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            57899999999999999999987654    469999986543  233568899999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +||++.++++.+.+.+. ..+++.++..++.|++.||+|||+++++||||||+||+++.++.  +||+|||+++......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC--------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCC
Confidence            99999999998888665 46999999999999999999999999999999999999987664  9999999997543322


Q ss_pred             C----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 R----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .    .....+|+.|+|||.+.+..++.++||||+|+++|||+++..||
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~  213 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP  213 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence            2    12235788999999999999999999999999999999976554

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=298.44  Aligned_cols=197  Identities=24%  Similarity=0.305  Sum_probs=169.5

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcE--EEEEEeccc--ccchHHHHHHHHHHhhC-CCCCeeeEEEEEecCceEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERG--RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~--~~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   75 (200)
                      +++|++.+.||+|+||+||+|.++.++..  ||+|.+...  ....+.+.+|+++++++ +||||+++++++.+++.+++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            36899999999999999999999888764  677776543  22345799999999998 79999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCE
Q 029037           76 VMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v  139 (200)
                      ||||+++|+|.+++.+.                ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+..  +
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~  166 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--A  166 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--E
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--e
Confidence            99999999999999654                45899999999999999999999999999999999999987664  9


Q ss_pred             EEeecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       140 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ||+|||+|+............++..|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus       167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p  226 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP  226 (309)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCC
Confidence            999999997666555555667899999999999999999999999999999999976544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.6e-51  Score=296.18  Aligned_cols=196  Identities=29%  Similarity=0.428  Sum_probs=169.6

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      |++|++.+.||+|+||+||+|.++ +++.||+|++....   ...+.+.+|+.++++++||||+++++.+.+++..+++|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            689999999999999999999986 67889999997642   33578999999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC-C
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~-~  156 (200)
                      +++.++.+.......+.+++..+..++.|++.||++||+.||+||||||+||+++.++.  +|++|||.|........ .
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCcccc
Confidence            99988777766666778999999999999999999999999999999999999987665  99999999865433222 3


Q ss_pred             CcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ....+++.|+|||.+.+. .++.++|+||+|+++|||++|.+||
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf  201 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF  201 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC
Confidence            444688999999999765 4689999999999999999999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-51  Score=298.24  Aligned_cols=197  Identities=27%  Similarity=0.386  Sum_probs=166.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCC-CcEEEEEEecccc---cchHHHHHHHHHHhhC---CCCCeeeEEEEEec-----
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET-KELVAVKYIERGR---KIDENVAREIINHRSL---RHPNIIRFKEVVLT-----   69 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~-~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----   69 (200)
                      ++|++++.||+|+||+||+|.+..+ ++.||+|++....   .....+.+|+.+++.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            6899999999999999999999765 6679999987532   2233566777766655   89999999999853     


Q ss_pred             CceEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037           70 PTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus        70 ~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      ....+++||+++++++...... ...+++..++.++.|++.||+|||++||+||||||+||++++++.  ++|+|||++.
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~  164 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLAR  164 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhh
Confidence            3468999999988766544433 345899999999999999999999999999999999999986664  9999999988


Q ss_pred             ccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          149 SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ............||+.|+|||.+.+..++.++||||+||++|||++|.+||+
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~  216 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  216 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence            6666666667789999999999999999999999999999999999999984

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-51  Score=293.14  Aligned_cols=195  Identities=22%  Similarity=0.307  Sum_probs=158.2

Q ss_pred             ccccccccccCCcceEEEEEEEcCCC---cEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETK---ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~---~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (200)
                      ++|++.+.||+|+||.||+|.+..++   ..||+|.+....  ...+.+.+|+.++++++||||+++++++.+ +.+++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence            58999999999999999999986543   468888886532  224678999999999999999999999864 678999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCC
Q 029037           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (200)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~  155 (200)
                      ||++++++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||++++++.  +||+|||+|+.......
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCcc
Confidence            99999999999876544 6899999999999999999999999999999999999987664  99999999975433322


Q ss_pred             --CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          156 --PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                        .....+++.|+|||.+.+..++.++||||+|+++|||++ |.+||
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~  210 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF  210 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCC
Confidence              223457889999999999999999999999999999987 78887

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=296.39  Aligned_cols=195  Identities=21%  Similarity=0.300  Sum_probs=162.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCc----EEEEEEeccc--ccchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (200)
                      ++|++.+.||+|+||+||+|.+..+++    .||+|.+...  ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999999987765    4788877643  33457899999999999999999999999875 4677


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      +++++.+++|.+.+... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+|+......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTC
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccccc
Confidence            78888899998888665 46999999999999999999999999999999999999986664  9999999997544333


Q ss_pred             CC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          155 RP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ..   ....+|+.|+|||.+.+..++.++||||+|+++|||+| |.+||
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~  214 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY  214 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence            32   22357899999999999999999999999999999998 56665

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=288.57  Aligned_cols=198  Identities=26%  Similarity=0.430  Sum_probs=176.1

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEEEEE
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (200)
                      |++|++++.||+|+||+||+|.+..+++.||+|++....   ...+.+.+|+.+++.++||||+++++++.+....++++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            689999999999999999999999999999999997543   23467899999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC-
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-  156 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~-  156 (200)
                      +++.++++..++...+.++...+..++.|++.||+|||++||+||||||+||+++.++.  ++|+|||.|+........ 
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccc
Confidence            99999999988888888999999999999999999999999999999999999986654  999999999765443333 


Q ss_pred             CcccCCCCccCCeeecCcc-cCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 KSTVGTPAYIAPEVLSRRE-YDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....++..|+|||.+.+.. ++.++||||+|+++|||++|..||+
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  203 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence            3345677899999987664 6899999999999999999998874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=289.53  Aligned_cols=192  Identities=27%  Similarity=0.398  Sum_probs=160.9

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEec-CceEEEEEEe
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLAIVMEY   79 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~   79 (200)
                      +++|++.+.||+|+||.||+|.++  ++.||+|.++++ ...+.+.+|+.++++++||||+++++++.+ ++.+++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            478999999999999999999985  667999999764 456789999999999999999999999865 4568999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCC
Q 029037           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (200)
Q Consensus        80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~  157 (200)
                      +++|+|.+++.+..  .+++..++.++.|++.||.|||+.+++||||+|+||+++.++.  ++|+|||.++...  ....
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~--~~~~  158 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS--STQD  158 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecC--CCCc
Confidence            99999999997653  4899999999999999999999999999999999999987665  9999999987432  2233


Q ss_pred             cccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          158 STVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...++..|+|||.+.+..+++++||||||+++|||+| |.+||
T Consensus       159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~  201 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY  201 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCC
Confidence            4467889999999998899999999999999999998 56665

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-50  Score=296.95  Aligned_cols=194  Identities=28%  Similarity=0.401  Sum_probs=166.5

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEec------CceEEEE
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT------PTHLAIV   76 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~~v   76 (200)
                      +|+..+.||+|+||+||+|.+..+++.||+|++.+....   ..+|+.++++++||||+++++++..      ..++++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            588999999999999999999999999999999765432   3479999999999999999999854      2357999


Q ss_pred             EEecCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           77 MEYAAGGELFDR---ICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        77 ~e~~~~~~L~~~---l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      |||++++.+...   ......+++.+++.++.|++.||+|||++||+||||||+||+++.++. .+||+|||++......
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTT
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCC
Confidence            999976533222   234557999999999999999999999999999999999999986553 5999999999876666


Q ss_pred             CCCCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      .......+++.|+|||.+.+ ..++.++||||+||++|||++|.+||.
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~  224 (350)
T d1q5ka_         177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP  224 (350)
T ss_dssp             SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence            66667789999999999875 468999999999999999999999983

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-49  Score=288.84  Aligned_cols=196  Identities=21%  Similarity=0.204  Sum_probs=170.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCC-CCeeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNIIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++... ...+.+.+|++.++.++| ++++.+++++.++...++|||++
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            5899999999999999999999999999999988654 234567788999998875 89999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCC---CCCCEEEeecCCCcccCCCC--
Q 029037           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS---AAPRLKICDFGYSKSSVLHS--  154 (200)
Q Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~---~~~~v~l~df~~~~~~~~~~--  154 (200)
                       +++|.+++...+ .++..++..++.|++.||++||++|++||||||+||+++..   ..+.++|+|||+|+......  
T Consensus        84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (293)
T d1csna_          84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  162 (293)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence             679999887654 69999999999999999999999999999999999999642   23469999999997433221  


Q ss_pred             ------CCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 ------RPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                            ......||+.|+|||.+.+..+++++|+||||+++|||++|..||
T Consensus       163 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf  213 (293)
T d1csna_         163 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW  213 (293)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcC
Confidence                  123346999999999999999999999999999999999999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=292.95  Aligned_cols=198  Identities=26%  Similarity=0.360  Sum_probs=167.5

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHhhCCCCCeeeEEEEEec--------
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT--------   69 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   69 (200)
                      +++|++++.||+|+||+||+|.+..+++.||+|++....   ...+.+.+|+.+++.++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            479999999999999999999999999999999986542   334678999999999999999999998865        


Q ss_pred             CceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           70 PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        70 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      +...+++||+++++.+.........++...++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++..
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~  166 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARA  166 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeee
Confidence            3458999999987766665556667999999999999999999999999999999999999987664  99999999864


Q ss_pred             cCCC-----CCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          150 SVLH-----SRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       150 ~~~~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ....     .......+|+.|+|||.+.+. .+++++||||+|+++|||++|.+||.
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~  223 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ  223 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence            3322     222334689999999998765 68999999999999999999999984

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-50  Score=291.78  Aligned_cols=196  Identities=23%  Similarity=0.353  Sum_probs=169.0

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|+||+||+|..+.     +++.||+|++......  .+.+.+|+.++++++|||++++++++.+....+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            579999999999999999999763     5678999998764322  457999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCee
Q 029037           75 IVMEYAAGGELFDRICNAG------------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~  130 (200)
                      ++||++++++|.+++....                        .++...++.++.|++.||+|||+++++||||||+||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            9999999999999996432                        3788999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCC-CCC
Q 029037          131 LDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPN-PFI  199 (200)
Q Consensus       131 i~~~~~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~-~pf  199 (200)
                      ++.++.  +||+|||+|+.......   .....+++.|+|||.+.+..++.++||||||+++|||+++. +||
T Consensus       173 ld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         173 VGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             ECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            987664  99999999864332222   22345788999999999999999999999999999999986 666

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2e-49  Score=293.12  Aligned_cols=193  Identities=24%  Similarity=0.386  Sum_probs=171.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEec--CceEEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLT--PTHLAIVME   78 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~e   78 (200)
                      ++|++++.||+|+||+||+|++..+++.||+|+++..  ..+.+.+|+.+++.++ ||||+++++++..  ....++|||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            6899999999999999999999999999999998753  3567889999999985 9999999999974  456999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCCCc
Q 029037           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (200)
Q Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~~~  158 (200)
                      ++++++|....   +.+++..++.++.|++.||.|||++||+||||||+||+++.++. .++|+|||+|...........
T Consensus       113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~~  188 (328)
T d3bqca1         113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNV  188 (328)
T ss_dssp             CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCCS
T ss_pred             ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcccc
Confidence            99999987653   46999999999999999999999999999999999999985553 589999999986666666667


Q ss_pred             ccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          159 TVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       159 ~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                      ..+|+.|+|||.+.+. .++.++|+||+|+++|+|++|.+||.
T Consensus       189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~  231 (328)
T d3bqca1         189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  231 (328)
T ss_dssp             CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence            7889999999998765 47899999999999999999999984

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=286.72  Aligned_cols=195  Identities=29%  Similarity=0.403  Sum_probs=157.9

Q ss_pred             ccccccccccCCcceEEEEEEEcCC---CcEEEEEEecccc----cchHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|+||.||+|.....   ...||+|.+.+..    ...+++.+|+.++++++||||+++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            5799999999999999999986533   2368999887532    223578999999999999999999999976 4678


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           75 IVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +|||+++++++.+.+... ++++...++.++.|++.||.|||++|++||||+|+||+++.+.  .+||+|||+++.....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~--~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc--ceeeccchhhhhcccC
Confidence            999999999999887654 4699999999999999999999999999999999999998766  4999999999754333


Q ss_pred             CCC----CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          154 SRP----KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       154 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      ...    ....++..|+|||.+.+..++.++||||||+++|||+| |.+||
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf  215 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW  215 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCC
Confidence            322    22346778999999999999999999999999999998 78887

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=292.08  Aligned_cols=194  Identities=29%  Similarity=0.444  Sum_probs=162.7

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc--cchHHHHHHHHHHhhCCCCCeeeEEEEEecCc-----eEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPT-----HLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   74 (200)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+..  ...+.+.+|+.++++++|||++++++++....     .++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            47999999999999999999999999999999997543  23457889999999999999999999987643     245


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCC
Q 029037           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~  154 (200)
                      ++ +++.+++|.+++.. .++++..++.++.|++.||+|||++||+||||||+||++++++.  +||+|||+|.......
T Consensus        88 l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          88 LV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH  163 (345)
T ss_dssp             EE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGG
T ss_pred             EE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCCC
Confidence            55 55668899999955 47999999999999999999999999999999999999986664  9999999986443332


Q ss_pred             C----CCcccCCCCccCCeeecC-cccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          155 R----PKSTVGTPAYIAPEVLSR-REYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .    .....+++.|+|||.+.. ..++.++|+||+|+++|+|++|.+||
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf  213 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF  213 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC
Confidence            2    234568999999999854 46788999999999999999999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=289.95  Aligned_cols=196  Identities=22%  Similarity=0.330  Sum_probs=156.5

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEecccc--cchHHHHHHHHHHhhC-CCCCeeeEEEEEecC-ce
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTP-TH   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~   72 (200)
                      ++|++.+.||+|+||.||+|.+..     +++.||+|.+....  ...+.+.+|...+.++ +|+||+.+++++.++ ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            579999999999999999999754     34689999987543  2235677777777666 689999999987654 46


Q ss_pred             EEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCC
Q 029037           73 LAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA  136 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~  136 (200)
                      ++++|||+++|+|.+++...                ..+++.++..++.|++.||.|||++|++||||||+||++++++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~  172 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  172 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence            89999999999999999653                23789999999999999999999999999999999999986664


Q ss_pred             CCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCC-CC
Q 029037          137 PRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNP-FI  199 (200)
Q Consensus       137 ~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~-pf  199 (200)
                        +||+|||+|+.......   .....||+.|+|||.+.+..++.++||||+|+++|||+|+.. ||
T Consensus       173 --~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~  237 (299)
T d1ywna1         173 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  237 (299)
T ss_dssp             --EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             --EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence              99999999974433322   223468899999999999999999999999999999999764 54

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-50  Score=293.59  Aligned_cols=197  Identities=29%  Similarity=0.494  Sum_probs=172.4

Q ss_pred             CccccccccccCCcceEEEEEEE---cCCCcEEEEEEecccc-----cchHHHHHHHHHHhhCCC-CCeeeEEEEEecCc
Q 029037            1 MEKYELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-----KIDENVAREIINHRSLRH-PNIIRFKEVVLTPT   71 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~---~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~   71 (200)
                      |++|++.+.||+|+||+||+|.+   +.+++.||+|.+.+..     ...+.+.+|+.++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            57899999999999999999987   4468899999987532     334678899999999976 89999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      .++++||++.+++|.+++.....+++..+..++.|++.||.|+|+.|++||||+|+||+++.++  .++|+|||+++...
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECC
T ss_pred             ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC--CEEEeeccchhhhc
Confidence            9999999999999999999999999999999999999999999999999999999999998765  49999999986433


Q ss_pred             CC--CCCCcccCCCCccCCeeecCc--ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LH--SRPKSTVGTPAYIAPEVLSRR--EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~--~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ..  .......+++.|++||.+.+.  .++.++|||||||++|+|++|.+||
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF  232 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF  232 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence            22  223445689999999999754  4678899999999999999999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=288.02  Aligned_cols=196  Identities=24%  Similarity=0.329  Sum_probs=164.3

Q ss_pred             ccccccccccCCcceEEEEEEEcCCC-------cEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCc
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETK-------ELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~-------~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   71 (200)
                      ++|++.+.||+|+||.||+|.+..++       ..||+|.+..+..  ...++.+|...+.++ +||||+++++++.++.
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            68999999999999999999986554       4699999976543  336788888888777 7999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           72 HLAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      ..++||||+++|+|.+++...                ..++..+++.++.|++.||+|||+.+++||||||+||+++.++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence            999999999999999999644                2489999999999999999999999999999999999998776


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCC-CCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYR-PNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~-~~~pf  199 (200)
                      .  +||+|||.++.......   .....+++.|+|||.+.++.++.++||||||+++|||++ |.+||
T Consensus       173 ~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         173 V--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             C--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             C--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence            5  99999999875433332   233467889999999999999999999999999999998 57776

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=293.72  Aligned_cols=194  Identities=26%  Similarity=0.351  Sum_probs=159.3

Q ss_pred             CccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEec------Cc
Q 029037            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLT------PT   71 (200)
Q Consensus         1 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~   71 (200)
                      +++|++++.||+|+||+||+|.+..+++.||+|++.+...   ..+++.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            3689999999999999999999999999999999976532   23468899999999999999999999964      36


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccC
Q 029037           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (200)
Q Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~  151 (200)
                      .+|+||||+.++ +.+.+  ...++...++.++.|++.||.+||++|++||||||+||+++.++.  ++++|||.++...
T Consensus        96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~  170 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred             eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccc
Confidence            789999999764 44444  346899999999999999999999999999999999999987665  9999999988766


Q ss_pred             CCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .........+|+.|+|||.+.+..+++++|+||+||++|+|++|.+||
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF  218 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF  218 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCC
Confidence            666666778999999999999999999999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-48  Score=285.62  Aligned_cols=196  Identities=23%  Similarity=0.180  Sum_probs=165.1

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCC-eeeEEEEEecCceEEEEEEec
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVMEYA   80 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~v~e~~   80 (200)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.... ..+.+.+|.++++.++|++ ++.+..++.++...++|||++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            47999999999999999999999999999999887643 3456889999999998665 555666677888899999999


Q ss_pred             CCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecC-CCCCCEEEeecCCCcccCCCCC---
Q 029037           81 AGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSR---  155 (200)
Q Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~-~~~~~v~l~df~~~~~~~~~~~---  155 (200)
                       ++++.+.+. ....++...+..++.|++.||++||++|++||||||+||+++. +....++|+|||+|+.......   
T Consensus        86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          86 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             -CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence             456655554 4557999999999999999999999999999999999999853 2234699999999975433221   


Q ss_pred             -----CCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          156 -----PKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       156 -----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                           .....||+.|+|||.+.+..+++++||||||+++|||++|.+||
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~  213 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW  213 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcc
Confidence                 23346899999999999999999999999999999999999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=290.69  Aligned_cols=192  Identities=26%  Similarity=0.379  Sum_probs=162.0

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc---chHHHHHHHHHHhhCCCCCeeeEEEEEecCc------e
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT------H   72 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~   72 (200)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+...   ..+.+.+|+.++++++|||++++++++...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            589999999999999999999999999999999976432   2357889999999999999999999997654      4


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCC
Q 029037           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (200)
Q Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~  152 (200)
                      +++|||++ +.+|.... +..++++..++.++.|++.||.|||++||+||||||+||+++.++.  ++++|||.|+... 
T Consensus        98 ~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~-  172 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD-  172 (346)
T ss_dssp             CEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred             EEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccC-
Confidence            79999999 55776655 5668999999999999999999999999999999999999987665  9999999997443 


Q ss_pred             CCCCCcccCCCCccCCeeecCc-ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          153 HSRPKSTVGTPAYIAPEVLSRR-EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                       .......+++.|+|||.+.+. .++.++||||+|+++|+|++|.+||
T Consensus       173 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf  219 (346)
T d1cm8a_         173 -SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF  219 (346)
T ss_dssp             -SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             -CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC
Confidence             233456789999999998764 5688999999999999999999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=285.07  Aligned_cols=193  Identities=28%  Similarity=0.330  Sum_probs=160.4

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCeeeEEEEEecCc----eEEEEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT----HLAIVM   77 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v~   77 (200)
                      .+|.+.+.||+|+||.||+|..  +++.||+|.+..........+.|+..+.+++||||+++++++.++.    .+++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4688999999999999999986  4778999999765433333455666667889999999999997653    589999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEeecCCCCCeeecCCCCCCEEEeecCCCcc
Q 029037           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS--------MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (200)
Q Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~--------~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~  149 (200)
                      ||+++++|.+++.+. ++++...+.++.|++.||+++|+        .||+||||||+||++++++.  +||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcccc
Confidence            999999999999664 68999999999999999999996        59999999999999986664  99999999875


Q ss_pred             cCCCCC-----CCcccCCCCccCCeeecCc------ccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          150 SVLHSR-----PKSTVGTPAYIAPEVLSRR------EYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       150 ~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      ......     .....||+.|+|||.+.+.      .++.++||||||+++|||+||.+||
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~  218 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence            433322     2345689999999998754      3677899999999999999998876

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=285.16  Aligned_cols=196  Identities=23%  Similarity=0.306  Sum_probs=169.0

Q ss_pred             ccccccccccCCcceEEEEEEEc-----CCCcEEEEEEeccccc--chHHHHHHHHHHhhC-CCCCeeeEEEEEecCceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   73 (200)
                      ++|++.+.||+|+||.||+|...     .+++.||+|.++....  ....+.+|+.+++.+ +||||+++++++.+....
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            57889999999999999999863     4567899999976432  335688999999988 699999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCC
Q 029037           74 AIVMEYAAGGELFDRICNAG------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~  135 (200)
                      +++|||+++++|.+++.+..                  .++...+..++.|++.||++||++|++||||||+||+++.++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            99999999999999997543                  488999999999999999999999999999999999998666


Q ss_pred             CCCEEEeecCCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          136 APRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       136 ~~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .  ++++|||.++........   ....+++.|+|||.+.+..++.++||||||+++|||+|+..|+
T Consensus       183 ~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         183 I--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             E--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             c--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence            4  999999999754433222   2346789999999999889999999999999999999955554

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-48  Score=281.51  Aligned_cols=192  Identities=21%  Similarity=0.273  Sum_probs=162.8

Q ss_pred             cccccCCcceEEEEEEEcCCC---cEEEEEEeccc--ccchHHHHHHHHHHhhCCCCCeeeEEEEEec-CceEEEEEEec
Q 029037            7 VKDLGAGNFGVARLLRHKETK---ELVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLAIVMEYA   80 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~---~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~   80 (200)
                      .+.||+|+||+||+|.+..++   ..||+|.+.+.  ....+++.+|++++++++||||+++++++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            578999999999999986543   35899998753  2334679999999999999999999999865 56899999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCCCCC---
Q 029037           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---  156 (200)
Q Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~~~~---  156 (200)
                      ++++|.+++.... ..+...++.++.|++.||.|||+.+++||||+|+||+++++..  +||+|||+++........   
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccce
Confidence            9999999887554 4778889999999999999999999999999999999986654  999999999754333222   


Q ss_pred             --CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCCC
Q 029037          157 --KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFIW  200 (200)
Q Consensus       157 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf~  200 (200)
                        ....+++.|+|||.+.+..++.++||||||+++|||+++..||+
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~  235 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY  235 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence              22357889999999999999999999999999999999888774

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=280.74  Aligned_cols=196  Identities=19%  Similarity=0.257  Sum_probs=168.0

Q ss_pred             ccccccccccCCcceEEEEEEEcC-----CCcEEEEEEecccccc--hHHHHHHHHHHhhCCCCCeeeEEEEEecCceEE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (200)
                      ++|++.+.||+|+||+||+|.++.     ++..||+|++......  ...+.+|+.++++++||||+++++++..+...+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            688999999999999999999863     3567999999764322  345889999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           75 IVMEYAAGGELFDRICNA----------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        75 ~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                      +|||++++|+|.+++...          ..++...+..++.|++.||.|||+++++||||+|+||+++.+..  +||+||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~DF  177 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDF  177 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEeec
Confidence            999999999999988643          23688899999999999999999999999999999999986664  999999


Q ss_pred             CCCcccCCCCCC---CcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCC-CCC
Q 029037          145 GYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPN-PFI  199 (200)
Q Consensus       145 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~-~pf  199 (200)
                      |+|+........   ....+++.|+|||.+.+..++.++|+||+|+++|||+|+. +||
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~  236 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY  236 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCC
Confidence            998744333221   2235789999999999999999999999999999999986 554

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=285.93  Aligned_cols=193  Identities=24%  Similarity=0.369  Sum_probs=162.8

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHhhCCCCCeeeEEEEEecC-----ceE
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTP-----THL   73 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   73 (200)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.+....   .+.+.+|+.++++++|||++++++++...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            5899999999999999999999999999999999865332   35688999999999999999999998643     334


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeecCCCcccCCC
Q 029037           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (200)
Q Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~~~~~~  153 (200)
                      +++++++.|++|.+++. .+++++.++..++.|++.||+|||++|++||||||+||+++.++.  ++++|||.+....  
T Consensus        98 ~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~--  172 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD--  172 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT--
T ss_pred             EEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC--
Confidence            66667777999999884 457999999999999999999999999999999999999987765  9999999986432  


Q ss_pred             CCCCcccCCCCccCCeeecCcc-cCCeeehhhhhhhhhhcCCCCCCC
Q 029037          154 SRPKSTVGTPAYIAPEVLSRRE-YDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|.+||
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF  219 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  219 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC
Confidence            2334456788999999977654 688999999999999999999998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-41  Score=254.89  Aligned_cols=195  Identities=22%  Similarity=0.286  Sum_probs=161.4

Q ss_pred             cccccccccCCcceEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC-----------CCCeeeEEEEEecC-
Q 029037            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-----------HPNIIRFKEVVLTP-   70 (200)
Q Consensus         3 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~~-   70 (200)
                      +|++++.||+|+||+||+|.+..+++.||+|++.++....+...+|+.+++.++           |+||+++++++... 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            699999999999999999999999999999999887666677888998888774           57899998887643 


Q ss_pred             -ceEEEEEEecCCCch-HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCCeeecCCCC----CCEEE
Q 029037           71 -THLAIVMEYAAGGEL-FDRIC--NAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAA----PRLKI  141 (200)
Q Consensus        71 -~~~~~v~e~~~~~~L-~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~ni~i~~~~~----~~v~l  141 (200)
                       ...++++.++..... .....  ....++...+..++.|++.||++||+ .||+||||||+||+++.++.    ..+++
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl  173 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI  173 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeE
Confidence             456666666655433 22222  33468999999999999999999997 89999999999999975443    24899


Q ss_pred             eecCCCcccCCCCCCCcccCCCCccCCeeecCcccCCeeehhhhhhhhhhcCCCCCCC
Q 029037          142 CDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKVCILLLILFLWRNYRPNPFI  199 (200)
Q Consensus       142 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slg~~l~~~~~~~~pf  199 (200)
                      +|||.+....  .......+++.|+|||.+....++.++|+||+|+++++|++|.+||
T Consensus       174 ~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF  229 (362)
T d1q8ya_         174 ADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF  229 (362)
T ss_dssp             CCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             eecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence            9999986432  3345567899999999999999999999999999999999999998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.96  E-value=8.3e-30  Score=173.85  Aligned_cols=164  Identities=17%  Similarity=0.115  Sum_probs=119.9

Q ss_pred             ccccccccCCcceEEEEEEEcCCCcEEEEEEeccccc-------------------chHHHHHHHHHHhhCCCCCeeeEE
Q 029037            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------------------IDENVAREIINHRSLRHPNIIRFK   64 (200)
Q Consensus         4 y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~i~~~~   64 (200)
                      +.+.+.||+|++|+||+|.+. +++.||+|++.....                   .......|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999986 578899998753210                   012345678889999999999887


Q ss_pred             EEEecCceEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCCeeecCCCCCCEEEeec
Q 029037           65 EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (200)
Q Consensus        65 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni~i~~~~~~~v~l~df  144 (200)
                      +...    .+++||++++..+.+       ++......++.|++.++.+||++|++||||||+||++++++   ++|+||
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF  146 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF  146 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred             EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence            6532    279999998865532       55666788999999999999999999999999999998543   899999


Q ss_pred             CCCcccCCCCCCCcccCCCCccCCe-----eecCcccCCeeehhhhhhhh
Q 029037          145 GYSKSSVLHSRPKSTVGTPAYIAPE-----VLSRREYDGKVCILLLILFL  189 (200)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~aPE-----~~~~~~~~~~~Di~slg~~l  189 (200)
                      |.|.........       .|+...     .+..+.|+.++|+||+.--+
T Consensus       147 G~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            988643211110       111100     01246788899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.02  E-value=1.9e-09  Score=75.39  Aligned_cols=85  Identities=19%  Similarity=0.056  Sum_probs=59.5

Q ss_pred             ccccccccccCCcceEEEEEEEcCCCcEEEEEEecccc-cchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEe
Q 029037            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         2 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      ++|+..+..+.++.+.||++..  .++.+++|+..... .....+.+|...++.+. +-.+++++.+..+++..+++|++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            4566666655555578998864  34457888876543 23445778888877664 44467788888888889999999


Q ss_pred             cCCCchHHH
Q 029037           80 AAGGELFDR   88 (200)
Q Consensus        80 ~~~~~L~~~   88 (200)
                      ++|.++.+.
T Consensus        92 l~G~~~~~~  100 (263)
T d1j7la_          92 ADGVLCSEE  100 (263)
T ss_dssp             CSSEEHHHH
T ss_pred             ccccccccc
Confidence            999777543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.66  E-value=1e-07  Score=70.45  Aligned_cols=77  Identities=13%  Similarity=0.024  Sum_probs=47.9

Q ss_pred             cccccCCcceEEEEEEEcCCCcEEEEEEeccc--------ccchHHHHHHHHHHhhCC--C-CCeeeEEEEEecCceEEE
Q 029037            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERG--------RKIDENVAREIINHRSLR--H-PNIIRFKEVVLTPTHLAI   75 (200)
Q Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~~~~K~~~~~--------~~~~~~~~~e~~~l~~l~--~-~~i~~~~~~~~~~~~~~~   75 (200)
                      .+.||.|..-.||++.+..+++.+++|.-...        +...++...|...++.+.  . ..+++++.+  ++....+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            35688888899999998888888999964321        122345566777776552  2 345566554  3344578


Q ss_pred             EEEecCCCch
Q 029037           76 VMEYAAGGEL   85 (200)
Q Consensus        76 v~e~~~~~~L   85 (200)
                      +||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.49  E-value=7.8e-07  Score=61.44  Aligned_cols=74  Identities=15%  Similarity=0.063  Sum_probs=50.3

Q ss_pred             cccCCcc-eEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCC--CCCeeeEEEEEecCceEEEEEEecCCCch
Q 029037            9 DLGAGNF-GVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR--HPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (200)
Q Consensus         9 ~l~~g~~-g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   85 (200)
                      .+..|.. +.||+..... +..+++|......  ...+..|...++.+.  .-.+++++....+++..+++|++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-SCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCC-CCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3444443 6889998754 5557888765432  334666777776653  33466778888888889999999988654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.89  E-value=6.5e-05  Score=55.10  Aligned_cols=73  Identities=14%  Similarity=0.096  Sum_probs=48.8

Q ss_pred             ccccCCcceEEEEEEEcCC-------CcEEEEEEecccccchHHHHHHHHHHhhCC-CCCeeeEEEEEecCceEEEEEEe
Q 029037            8 KDLGAGNFGVARLLRHKET-------KELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEY   79 (200)
Q Consensus         8 ~~l~~g~~g~v~~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~   79 (200)
                      +.|+.|-.=.+|++.....       .+.+++++.... .......+|..+++.+. +.-.+++++++.+    ..|+++
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            5666677779999987542       355778877643 33445678888888774 3334567766643    688999


Q ss_pred             cCCCch
Q 029037           80 AAGGEL   85 (200)
Q Consensus        80 ~~~~~L   85 (200)
                      ++|.++
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.86  E-value=4.8e-05  Score=54.35  Aligned_cols=66  Identities=11%  Similarity=0.075  Sum_probs=43.4

Q ss_pred             EEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHhhCCCCCe--eeEE-----EEEecCceEEEEEEecCCC
Q 029037           17 VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI--IRFK-----EVVLTPTHLAIVMEYAAGG   83 (200)
Q Consensus        17 ~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~-----~~~~~~~~~~~v~e~~~~~   83 (200)
                      .||++... +|..+++|+........+.+..|...+..|....+  +..+     ..+..+...+.++++++|.
T Consensus        37 ~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          37 RVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             EEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             eeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            68988875 46678999987765567778888888876632221  1111     1223456688899999873

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.42  E-value=0.00015  Score=51.30  Aligned_cols=30  Identities=23%  Similarity=0.340  Sum_probs=25.1

Q ss_pred             CCcEeecCCCCCeeecCCCCCCEEEeecCCCc
Q 029037          117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (200)
Q Consensus       117 ~~i~h~dl~~~ni~i~~~~~~~v~l~df~~~~  148 (200)
                      .|++|+|+.++|++++++.  ..-++||+.|+
T Consensus       183 ~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             cccccCCcchhhhhccccc--ceeEecccccc
Confidence            5799999999999998544  25799999875